PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moerke, NJ; Aktas, H; Chen, H; Cantel, S; Reibarkh, MY; Fahmy, A; Gross, JD; Degterev, A; Yuan, JY; Chorev, M; Halperin, JA; Wagner, G				Moerke, Nathan J.; Aktas, Huseyin; Chen, Han; Cantel, Sonia; Reibarkh, Mikhail Y.; Fahmy, Amr; Gross, John D.; Degterev, Alexei; Yuan, Junying; Chorev, Michael; Halperin, Jose A.; Wagner, Gerhard			Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G	CELL			English	Article							CAP-DEPENDENT TRANSLATION; BINDING PROTEIN EIF4E; MESSENGER-RNA CAP; FACTOR EIF-4E; MALIGNANT-TRANSFORMATION; MTOR INHIBITORS; CANCER; PHOSPHORYLATION; STIMULATION; REGULATORS	Assembly of the eIF4E/eIF4G complex has a central role in the regulation of gene expression at the level of translation initiation. This complex is regulated by the 4E-BPs, which compete with eIF4G for binding to eIF4E and which have tumor-suppressor activity. To pharmacologically mimic 4E-BP function we developed a high-throughput screening assay for identifying small-molecule inhibitors of the eIF4E/eIF4G interaction. The most potent compound identified, 4EGI-1, binds eIF4E, disrupts eIF4E/eIF4G association, and inhibits cap-dependent translation but not initiation factor-independent translation. While 4EGI-1 displaces eIF4G from eIF4E, it effectively enhances 4E-BP1 association both in vitro and in cells. 4EGI-1 inhibits cellular expression of oncogenic proteins encoded by weak mRNAs, exhibits activity against multiple cancer cell lines, and appears to have a preferential effect on transformed versus nontransformed cells. The identification of this compound provides a new tool for studying translational control and establishes a possible new strategy for cancer therapy.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lab Translat Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu	cantel, sonia/C-7121-2012	Reibarkh, Mikhail/0000-0002-6589-707X	NCI NIH HHS [CA87427, CA68262, CA078411] Funding Source: Medline; NIBIB NIH HHS [EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467, GM47467] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068262, R01CA078411, U19CA087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DeFatta RJ, 2000, LARYNGOSCOPE, V110, P928, DOI 10.1097/00005537-200006000-00007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; EDERY I, 1988, GENE, V74, P517, DOI 10.1016/0378-1119(88)90184-9; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fan YH, 2004, BIOORG MED CHEM LETT, V14, P2547, DOI 10.1016/j.bmcl.2004.02.087; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Herbert TP, 2000, CURR BIOL, V10, P793, DOI 10.1016/S0960-9822(00)00567-4; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miura T, 2003, J BIOMOL NMR, V27, P279, DOI 10.1023/A:1025442322316; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rousseau D, 1996, ONCOGENE, V13, P2415; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Svitkin YV, 2001, RNA, V7, P1743; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	58	402	418	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					257	267		10.1016/j.cell.2006.11.046	http://dx.doi.org/10.1016/j.cell.2006.11.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254965	Bronze			2022-12-24	WOS:000244420500012
J	Zegerman, P; Diffley, JFX				Zegerman, Philip; Diffley, John F. X.			Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast	NATURE			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; S-PHASE; CHROMOSOMAL DNA; POLYMERASE-ALPHA; CELL-CYCLE; PROTEIN; COMPLEX; G1; ORIGINS	Cyclin-dependent kinases (CDKs) drive major cell cycle events including the initiation of chromosomal DNA replication. We identified two S phase CDK (S-CDK) phosphorylation sites in the budding yeast Sld3 protein that, together, are essential for DNA replication. Here we show that, when phosphorylated, these sites bind to the amino-terminal BRCT repeats of Dpb11. An Sld3 - Dpb11 fusion construct bypasses the requirement for both Sld3 phosphorylation and the N-terminal BRCT repeats of Dpb11. Co-expression of this fusion with a phospho-mimicking mutant in a second essential CDK substrate, Sld2, promotes DNA replication in the absence of S-CDK. Therefore, Sld2 and Sld3 are the minimal set of S-CDK targets required for DNA replication. DNA replication in cells lacking G1 phase CDK (G1-CDK) required expression of the Cdc7 kinase regulatory subunit, Dbf4, as well as Sld2 and Sld3 bypass. Our results help to explain how G1- and S-CDKs promote DNA replication in yeast.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Diffley, John/0000-0001-5184-7680; Zegerman, Philip/0000-0002-5707-1083				Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARLOW E, 1998, USING ANTIBODIES LAB; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; KUHNE C, 1993, EMBO J, V12, P3437, DOI 10.1002/j.1460-2075.1993.tb06018.x; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Noguchi E, 2002, CURR BIOL, V12, P599, DOI 10.1016/S0960-9822(02)00739-X; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yamamoto RR, 2000, GENETICS, V156, P711; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	40	358	361	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					281	285		10.1038/nature05432	http://dx.doi.org/10.1038/nature05432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167417				2022-12-24	WOS:000243504700037
J	Sari, ABA; Sheldon, TA; Cracknell, A; Turnbull, A				Sari, Ali Baba-Akbari; Sheldon, Trevor A.; Cracknell, Alison; Turnbull, Alastair			Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADVERSE EVENTS; BARRIERS; ERROR	Objective To evaluate the performance of a routine incident reporting system in identifying patient safety incidents. Design Two stage retrospective review of patients' case notes and analysis of data submitted to the routine incident reporting system on the same patients. Setting A large NHS hospital in England. Population 1006 hospital admissions between January and May 2004: surgery (n=311), general medicine (n=251), elderly care (n=184), orthopaedics (n=131), urology (n=61), and three other specialties (n=68). Main outcome measures Proportion of admissions with at least one patient safety incident; proportion and type of patient safety incidents missed by routine incident reporting and case note review methods. Results 324 patient safety incidents were identified in 230/1006 admissions (22.9%; 95% confidence interval 20.3% to 25.5%). 270 (83%) patient safety incidents were identified by case note review only, 21 (7%) by the routine reporting system only, and 33 (100%) by both methods. 110 admissions (10.9%; 9.0% to 12.8%) had at least one patient safety incident resulting in patient harm, all of which were detected by the case note review and six (5%) by the reporting system. Conclusion The routine incident reporting system may be poor at identifying patient safety incidents, particularly those resulting in harm. Structured case note review may have a useful role in surveillance of routine incident reporting and associated quality improvement programmes.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; York Hosp, York YO31 8HE, N Yorkshire, England	University of York - UK; Leeds General Infirmary	Sheldon, TA (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	tas5@york.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913				Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Campbell M.J., 1999, MED STAT SUMMARY APP, V3rd; Davis Peter, 2002, N Z Med J, V115, pU271; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Firth-Cozens J, 2002, QUAL SAF HEALTH CARE, V11, P7, DOI 10.1136/qhc.11.1.7; Kilbridge PM, 2006, QUAL SAF HEALTH CARE, V15, P148, DOI 10.1136/qshc.2006.018218; Kingston MJ, 2004, MED J AUSTRALIA, V181, P36, DOI 10.5694/j.1326-5377.2004.tb06158.x; National Patient Safety Agency, 2005, BUILD MEM PREV HARM; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Uribe CL, 2002, J HEALTHC MANAG, V47, P263, DOI 10.1097/00115514-200207000-00009; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; VINCENT C, 2001, CLIN RISK MANAGEMENT; Vincent C., 2006, PATIENT SAFETY; Walsh T, 2002, PHYSIOL MEAS, V23, pR111, DOI 10.1088/0967-3334/23/3/201; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	16	252	255	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2007	334	7584					79	81		10.1136/bmj.39031.507153.AE	http://dx.doi.org/10.1136/bmj.39031.507153.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	127DZ	17175566	Green Published, Bronze			2022-12-24	WOS:000243566800030
J	Allemann, Y; Hutter, D; Lipp, E; Sartori, C; Duplain, H; Egli, M; Cook, S; Scherrer, U; Seiler, C				Allemann, Yves; Hutter, Damian; Lipp, Ernst; Sartori, Claudio; Duplain, Herve; Egli, Marc; Cook, Stephane; Scherrer, Urs; Seiler, Christian			Patent Foramen ovale and high-altitude pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECOMPRESSION ILLNESS; HYPOXEMIA; CLOSURE; PREVENTION; PREVALENCE; PRESSURE	Context Individuals susceptible to high-altitude pulmonary edema ( HAPE) are characterized by exaggerated pulmonary hypertension and arterial hypoxemia at high altitude, but the underlying mechanism is incompletely understood. Anecdotal evidence suggests that shunting across a patent foramen ovale (PFO) may exacerbate hypoxemia in HAPE. Objective We hypothesized that PFO is more frequent in HAPE-susceptible individuals and may contribute to more severe arterial hypoxemia at high altitude. Design, Setting, and Participants Case-control study of 16 HAPE-susceptible participants and 19 mountaineers resistant to this condition ( repeated climbing to peaks above 4000 m and no symptoms of HAPE). Main Outcome Measures Presence of PFO determined by transesophageal echocardiography, estimated pulmonary artery pressure by Doppler echocardiography, and arterial oxygen saturation measured by pulse oximetry in HAPE-susceptible and HAPE-resistant participants at low ( 550 m) and high altitude ( 4559 m). Results The frequency of PFO was more than 4 times higher in HAPE-susceptible than in HAPE-resistant participants, both at low altitude (56% vs 11%, P=.004; odds ratio [ OR], 10.9 [95% confidence interval {CI}, 1.9-64.0]) and high altitude (69% vs 16%, P=. 001; OR, 11.7 [ 95% CI, 2.3-59.5]). At high altitude, mean (SD) arterial oxygen saturation prior to the onset of pulmonary edema was significantly lower in HAPE-susceptible participants than in the control group (73% [10%] vs 83% [7%], P=. 001). Moreover, in the HAPE-susceptible group, participants with a large PFO had more severe arterial hypoxemia (65% [6%] vs 77% [8%], P=. 02) than those with smaller or no PFO. Conclusions Patent foramen ovale was roughly 4 times more frequent in HAPE-susceptible mountaineers than in participants resistant to this condition. At high altitude, HAPE-susceptible participants with a large PFO had more severe hypoxemia. We speculate that at high altitude, a large PFO may contribute to exaggerated arterial hypoxemia and facilitate HAPE.	Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland; CHU Vaudois, Dept Internal Med, Lausanne, Switzerland; CHU Vaudois, Botnar Ctr Extreme Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Allemann, Y (corresponding author), Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	yves.allemann@insel.ch						Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Das BB, 2004, ARCH PEDIAT ADOL MED, V158, P1170, DOI 10.1001/archpedi.158.12.1170; Godart F, 2000, EUR HEART J, V21, P483, DOI 10.1053/euhj.1999.1944; HACKETT PH, 1988, J APPL PHYSIOL, V64, P1268, DOI 10.1152/jappl.1988.64.3.1268; HACKETT PH, 1992, INT J SPORTS MED, V13, pS68, DOI 10.1055/s-2007-1024599; Hegland DD, 2005, NEW ENGL J MED, V353, P2385, DOI 10.1056/NEJMcps050473; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; Landzberg MJ, 2004, HEART, V90, P219, DOI 10.1136/hrt.2003.019315; LEVINE BD, 1991, ANN INTERN MED, V114, P569, DOI 10.7326/0003-4819-114-7-569; Maggiorini M, 2001, CIRCULATION, V103, P2078; Sartori C, 2004, EUR RESPIR J, V23, P916, DOI 10.1183/09031936.04.00115304; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; Seiler C, 2004, HEART, V90, P1245, DOI 10.1136/hrt.2003.031500; Shanoudy H, 1998, CHEST, V113, P91, DOI 10.1378/chest.113.1.91; Soliman A, 1999, J AM SOC ECHOCARDIOG, V12, P99, DOI 10.1016/S0894-7317(99)70121-5; Torti SR, 2004, EUR HEART J, V25, P1014, DOI 10.1016/j.ehj.2004.04.028; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3	20	105	105	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2954	2958		10.1001/jama.296.24.2954	http://dx.doi.org/10.1001/jama.296.24.2954			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190896	Bronze			2022-12-24	WOS:000243069000027
J	Eisenstein, M				Eisenstein, Michael			Protein arrays - Growing pains	NATURE			English	Article																			0	33	37	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					959	964		10.1038/444959a	http://dx.doi.org/10.1038/444959a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167490	Green Published, Bronze			2022-12-24	WOS:000242805400063
J	Chen, IA				Chen, Irene A.			The emergence of cells during the origin of life	SCIENCE			English	Editorial Material							FATTY-ACID VESICLES; GROWTH; RNA		Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; MIT, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Chen, IA (corresponding author), Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA.	ichen@post.harvard.edu		Chen, Irene/0000-0001-6040-7927				ALLEN WILLIAM V., 1967, CURR MOD BIOL, V1, P24; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Chen IA, 2006, COLD SPRING HARB MON, V43, P57; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Knoll AH, 2003, LIFE YOUNG PLANET 1; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Rushdi AI, 2001, ORIGINS LIFE EVOL B, V31, P103, DOI 10.1023/A:1006702503954; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; YUEN GU, 1973, NATURE, V246, P301, DOI 10.1038/246303a0	16	31	32	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1558	1559		10.1126/science.1137541	http://dx.doi.org/10.1126/science.1137541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158315				2022-12-24	WOS:000242624600029
J	Kopec, C; Malinow, R				Kopec, Charles; Malinow, Roberto			Matters of size	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; DENDRITIC SPINES; AMPA RECEPTORS; ACTIN; PLASTICITY; HIPPOCAMPUS; LTP; SYNAPSES		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kopec, C (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	19	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1554	1555		10.1126/science.1137595	http://dx.doi.org/10.1126/science.1137595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158312				2022-12-24	WOS:000242624600026
J	Walker, J; Cliff, RA; Latham, AG				Walker, Joanne; Cliff, Robert A.; Latham, Alfred G.			U-Pb isotopic age of the StW 573 hominid from Sterkfontein, South Africa	SCIENCE			English	Article							COSMOGENIC AL-26; FOOT BONES; REAPPRAISAL; INFORMATION; BE-10; DECAY; RIVER	Sterkfontein cave, South Africa, has yielded an australopith skeleton, StW 573, whose completeness has excited great interest in paleoanthropology. StW 573, or "Little Foot," was found 25 meters below the surface in the Silberberg Grotto. U-238-Pb-206 measurements on speleothems immediately above and below the fossil remains, corrected for initial U-234 disequilibrium, yield ages of 2.17 +/- 0.17 million years ago (Ma) and 2.24(-0.07)(+0.09) Ma, respectively, indicating an age for StW 573 of close to 2.2 Ma. This age is in contrast to an age of similar to 3.3 Ma suggested by magnetochronology and ages of similar to 4 Ma based on Be-10 and Al-26, but it is compatible with a faunal age range of 4 to 2 Ma.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; Univ Liverpool, Sch Archaeol Class & Egyptol, Liverpool L69 3GS, Merseyside, England	University of Leeds; University of Liverpool	Cliff, RA (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	bob@earth.leeds.ac.uk						Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BRAIN CK, 1958, TRANSVAAL MUS MEM, V111; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Clarke RJ, 2002, S AFR J SCI, V98, P523; Clarke RJ, 2002, S AFR J SCI, V98, P415; Clarke RJ, 1998, S AFR J SCI, V94, P460; de Lumley MA, 1982, P 1 INT C HUM PAL, P707; Delson E., 1988, P317; Gibbons A, 2003, SCIENCE, V300, P562, DOI 10.1126/science.300.5619.562; Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; Granger DE, 2001, GEOL SOC AM BULL, V113, P825, DOI 10.1130/0016-7606(2001)113<0825:PPIOTG>2.0.CO;2; KENDALL AC, 1978, J SEDIMENT PETROL, V48, P519; KRONFELD J, 1994, EARTH PLANET SC LETT, V123, P81, DOI 10.1016/0012-821X(94)90259-3; Lanphere MA, 2002, GEOL SOC AM BULL, V114, P559, DOI 10.1130/0016-7606(2002)114<0559:RAFTOT>2.0.CO;2; Latham AG, 1993, APPL PALEOMAGNETISM, P150; LUDWIG KR, 1977, J RES US GEOL SURV, V5, P663; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; McKee JK, 1996, SCIENCE, V272, P339; Muzikar P, 2006, EARTH PLANET SC LETT, V243, P400, DOI 10.1016/j.epsl.2005.12.020; Partridge T. C., 2005, Transactions of the Royal Society of South Africa, V60, P107; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 1999, J QUATERNARY SCI, V14, P293, DOI 10.1002/(SICI)1099-1417(199907)14:4<293::AID-JQS471>3.0.CO;2-X; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; SCHWARCZ HP, 1994, J HUM EVOL, V26, P175, DOI 10.1006/jhev.1994.1010; Turner A., 1997, Palaeontologia Africana, V34, P115; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385	28	73	83	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1592	1594		10.1126/science.1132916	http://dx.doi.org/10.1126/science.1132916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158326				2022-12-24	WOS:000242624600040
J	Coombes, R				Coombes, Rebecca			Hunting down the H5N1 virus	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					342	+		10.1136/bmj.39126.577488.59	http://dx.doi.org/10.1136/bmj.39126.577488.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303878	Green Published			2022-12-24	WOS:000244560400027
J	Kao, G; Nordenson, C; Still, M; Ronnlund, A; Tuck, S; Naredi, P				Kao, Gautam; Nordenson, Cecilia; Still, Maria; Ronnlund, Agneta; Tuck, Simon; Naredi, Peter			ASNA-1 positively regulates insulin secretion in C-elegans and mammalian cells	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; DAF-16; ATPASE; LONGEVITY; ARREST; MEMBER; GENE; SUPERFAMILY	C. elegans worms hatching in the absence of food show growth arrest during the first larval stage (U). While much has been learned about the later diapause, dauer, which worms enter under adverse conditions, much less is known about the mechanisms governing L1 arrest. Here we show that worms lacking activity of the asna-1 gene arrest growth reversibly at the L1 stage even when food is abundant. asna-1 encodes an ATPase that functions nonautonomously to regulate growth. asna-1 is expressed in a restricted set of sensory neurons and in insulin-producing intestinal cells. asna-1 mutants are reduced in insulin secretion while overexpression of asna-1 mimics the effects of insulin overexpression. Human ASNA1 is highly expressed in pancreatic beta cells, but not in other pancreatic endocrine cell types, and regulates insulin secretion in cultured cells. We propose that ASNA1 is an evolutionarily conserved modulator of insulin signaling.	Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden; Umea Univ Hosp, Dept Surg, SE-90185 Umea, Sweden	Umea University; Umea University	Tuck, S (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden.	simon.tuck@ucmp.umu.se; peter.naredi@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Naredi, Peter/0000-0002-5652-0422				Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; AVERY L, 1993, GENETICS, V133, P897; Avery Leon, 1993, Genetics, V134, P455; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Collet J, 1998, GENETICS, V148, P187; Fares H, 2001, GENETICS, V159, P133; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gems D, 1998, GENETICS, V150, P129; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hong Y, 1998, DEVELOPMENT, V125, P3585; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Kurdi-Haidar B, 1998, J HISTOCHEM CYTOCHEM, V46, P1243, DOI 10.1177/002215549804601104; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Priess J. R., 1997, C ELEGANS 2; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; THOMAS JH, 1993, GENETICS, V134, P1105; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032	41	84	131	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					577	587		10.1016/j.cell.2006.12.031	http://dx.doi.org/10.1016/j.cell.2006.12.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289575	Bronze			2022-12-24	WOS:000244842700022
J	Smith, NL; Hindorff, LA; Heckbert, SR; Lemaitre, RN; Marciante, KD; Rice, K; Lumley, T; Bis, JC; Wiggins, KL; Rosendaal, FR; Psaty, BM				Smith, Nicholas L.; Hindorff, Lucia A.; Heckbert, Susan R.; Lemaitre, Rozenn N.; Marciante, Kristin D.; Rice, Kenneth; Lumley, Thomas; Bis, Joshua C.; Wiggins, Kerri L.; Rosendaal, Frits R.; Psaty, Bruce M.			Association of genetic variations with nonfatal venous thrombosis in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR-V-LEIDEN; DEEP-VEIN-THROMBOSIS; ACTIVATED PROTEIN-C; MARBURG-I POLYMORPHISM; PATHWAY INHIBITOR GENE; BETA-FIBRINOGEN-GENE; FACTOR-XIII VA134LEU; FALSE DISCOVERY RATE; MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM	Context Although the roles of clotting proteins and enzymes that activate or inhibit fibrin production and lysis are well characterized, the underlying contribution of genetic variation in these constituents to risk of venous thrombosis (VT) has not been fully investigated. Objective To describe the association of common genetic variation in 24 coagulation, anticoagulation, fibrinolysis, and antifibrinolysis candidate genes with risk of incident nonfatal VT in postmenopausal women. Design, Setting, and Participants Population-based case-control study conducted in a large integrated health care system in Washington State. Participants were perimenopausal and postmenopausal women aged 30 to 89 years who sustained a first VT event between January 1995 and December 2002 ( n= 349) and 1680 controls matched on age, hypertension status, and calendar year ( n= 1680). Main Outcome Measure Risk of venous thrombosis associated with global variation within a gene as measured by common haplotypes and with individual haplotypes and single nucleotide polymorphisms ( SNPs). Significance of the associations was assessed by a .20 threshold of the false-discovery rate q value, which accounts for multiple testing. Results Only the tissue factor pathway inhibitor gene demonstrated global association with risk (q=. 13). Five significant SNP associations were identified across 3 of the candidate genes ( factors V, XI, and protein C) in SNP analyses. Two associations have been previously reported. Another 22 variants across 15 genes had P values less than .05 but q values between .20 and .35. Five of these confirm previously reported associations ( fibrinogen genes and protein C), 2 were inconsistent with earlier reports ( thrombomodulin and plasminogen activator inhibitor 1), and 15 were new discoveries. Conclusions After accounting for multiple testing, 5 SNPs associated with VT risk were identified, 3 of which have not been previously reported. Replication of these novel associations in other populations is necessary to corroborate these findings and identify which genetic factors may influence VT risk in postmenopausal women.	Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smith, NL (corresponding author), Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	nlsmith@u.washington.edu	Rice, Kenneth M/A-4150-2013; Rosendaal, Frits/Q-3842-2017	Rice, Kenneth M/0000-0001-5779-4495; Rosendaal, Frits/0000-0003-2558-7496; Wiggins, Kerri L/0000-0003-2749-1279	NHLBI NIH HHS [HL74745, HL73410, HL68986, HL60739, HL68639, HL43201] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL043201, R01HL060739, R01HL073410, R01HL068639, R01HL068986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aiach M, 1999, ARTERIOSCL THROM VAS, V19, P1573, DOI 10.1161/01.ATV.19.6.1573; Ameziane N, 2002, THROMB HAEMOSTASIS, V88, P195; Amini-Nekoo A, 2001, BRIT J HAEMATOL, V113, P537, DOI 10.1046/j.1365-2141.2001.02752.x; Arnaud E, 2000, ARTERIOSCL THROM VAS, V20, P892, DOI 10.1161/01.ATV.20.3.892; Arnaud E, 1999, THROMB HAEMOSTASIS, V82, P159, DOI 10.1055/s-0037-1614654; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertina RM, 2005, J THROMB HAEMOST, V3, P597, DOI 10.1111/j.1538-7836.2005.01198.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blake GJ, 2001, EUR HEART J, V22, P2262, DOI 10.1053/euhj.2001.2692; Camilleri RS, 2005, BLOOD COAGUL FIBRIN, V16, P193, DOI 10.1097/01.mbc.0000164428.13417.e2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Castaman G, 2003, HAEMATOLOGICA, V88, P1182; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; de Visser MCH, 2000, THROMB HAEMOSTASIS, V83, P577; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Evans GD, 2000, THROMB HAEMOSTASIS, V83, P511, DOI 10.1055/s-0037-1613847; Franco RF, 2001, HAEMATOLOGICA, V86, P510; Franco RF, 2000, BRIT J HAEMATOL, V111, P118, DOI 10.1046/j.1365-2141.2000.02338.x; French B, 2006, GENET EPIDEMIOL, V30, P485, DOI 10.1002/gepi.20161; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Hoppe B, 2005, BLOOD, V105, P1549, DOI 10.1182/blood-2004-08-3328; Kleesiek K, 1999, THROMB HAEMOSTASIS, V82, P1; Ko YL, 2006, HUM GENET, V119, P84, DOI 10.1007/s00439-005-0102-0; Komanasin N, 2005, J THROMB HAEMOST, V3, P2487, DOI 10.1111/j.1538-7836.2005.01624.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Renner W, 2000, THROMB RES, V99, P35, DOI 10.1016/S0049-3848(00)00219-X; Renner W, 2002, EUR J CLIN INVEST, V32, P755, DOI 10.1046/j.1365-2362.2002.01070.x; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Scanavini D, 2005, THROMB HAEMOSTASIS, V93, P453, DOI 10.1160/TH04-09-0629; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; Stegnar M, 1998, THROMB HAEMOSTASIS, V79, P975; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tirado I, 2004, THROMB HAEMOSTASIS, V91, P899, DOI 10.1160/TH03-10-0620; van Minkelen R, 2005, BLOOD, V105, P4898, DOI 10.1182/blood-2005-02-0576; Vlieg AV, 2002, BRIT J HAEMATOL, V119, P169; Nossent AY, 2006, THROMB HAEMOSTASIS, V95, P942, DOI 10.1160/TH06-01-0024; Zee RYL, 2006, CIRCULATION, V113, P2193, DOI 10.1161/CIRCULATIONAHA.106.615401; Zee RYL, 2005, J THROMB HAEMOST, V3, P2819, DOI 10.1111/j.1538-7836.2005.01665.x; Zidane M, 2003, THROMB HAEMOSTASIS, V90, P439, DOI 10.1160/TH03-01-0035	47	142	145	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					489	498		10.1001/jama.297.5.489	http://dx.doi.org/10.1001/jama.297.5.489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284699	Bronze			2022-12-24	WOS:000243999100026
J	Suttle, KB; Thomsen, MA; Power, ME				Suttle, K. B.; Thomsen, Meredith A.; Power, Mary E.			Species interactions reverse grassland responses to changing climate	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CALIFORNIA; ECOSYSTEM; VEGETATION; MOUNTAIN; DIVERSITY; COMMUNITY; PATTERNS; RANGES; SHIFTS	Predictions of ecological response to climate change are based largely on direct climatic effects on species. We show that, in a California grassland, species interactions strongly influence responses to changing climate, overturning direct climatic effects within 5 years. We manipulated the seasonality and intensity of rainfall over large, replicate plots in accordance with projections of leading climate models and examined responses across several trophic levels. Changes in seasonal water availability had pronounced effects on individual species, but as precipitation regimes were sustained across years, feedbacks and species interactions overrode autecological responses to water and reversed community trajectories. Conditions that sharply increased production and diversity through 2 years caused simplification of the food web and deep reductions in consumer abundance after 5 years. Changes in these natural grassland communities suggest a prominent role for species interactions in ecosystem response to climate change.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of California System; University of California Berkeley; University of Wisconsin System	Suttle, KB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kbsuttle@socrates.berkeley.edu		Thomsen, Meredith/0000-0001-9843-5202				BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BENTLEY J. R., 1958, JOUR RANGE MANAGEMENT, V11, P133, DOI 10.2307/3893716; BENTLEY J. R., 1954, JOUR RANGE MANAGEMENT, V7, P25, DOI 10.2307/3894622; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; FIELD CB, 1999, CONFRONTING GLOBAL C; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; HOBBS RJ, 1988, OECOLOGIA, V75, P291, DOI 10.1007/BF00378612; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; JACKSON LE, 1986, ACTA OECOL-OEC PLANT, V7, P191; JONES MB, 1990, J PROD AGRIC, V3, P534, DOI 10.2134/jpa1990.0534; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; *NAT ASS SYNTH TEA, 2002, CLIM CHANG IMP US PO; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rothley KD, 2006, CAN J ZOOL, V84, P1053, DOI 10.1139/Z06-076; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	35	553	578	13	524	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					640	642		10.1126/science.1136401	http://dx.doi.org/10.1126/science.1136401			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272720				2022-12-24	WOS:000243909400041
J	Deutsch, C; Sarmiento, JL; Sigman, DM; Gruber, N; Dunne, JP				Deutsch, Curtis; Sarmiento, Jorge L.; Sigman, Daniel M.; Gruber, Nicolas; Dunne, John P.			Spatial coupling of nitrogen inputs and losses in the ocean	NATURE			English	Article							PACIFIC SUBTROPICAL GYRE; TROPICAL NORTH PACIFIC; ATLANTIC OCEAN; FIXATION; DENITRIFICATION; NITRATE; REMINERALIZATION; TRICHODESMIUM; CYCLES; SEA	Nitrogen fixation is crucial for maintaining biological productivity in the oceans, because it replaces the biologically available nitrogen that is lost through denitrification. But, owing to its temporal and spatial variability, the global distribution of marine nitrogen fixation is difficult to determine from direct shipboard measurements. This uncertainty limits our understanding of the factors that influence nitrogen fixation, which may include iron, nitrogen-to-phosphorus ratios, and physical conditions such as temperature. Here we determine nitrogen fixation rates in the world's oceans through their impact on nitrate and phosphate concentrations in surface waters, using an ocean circulation model. Our results indicate that nitrogen fixation rates are highest in the Pacific Ocean, where water column denitrification rates are high but the rate of atmospheric iron deposition is low. We conclude that oceanic nitrogen fixation is closely tied to the generation of nitrogen-deficient waters in denitrification zones, supporting the view that nitrogen fixation stabilizes the oceanic inventory of fixed nitrogen over time.	Univ Washington, Sch Oceanog, Program Climate Change, Seattle, WA 98195 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Princeton University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Oceanic Atmospheric Admin (NOAA) - USA	Deutsch, C (corresponding author), Univ Washington, Sch Oceanog, Program Climate Change, Seattle, WA 98195 USA.	cdeutsch@ocean.washington.edu	Deutsch, Curtis A/D-1703-2011; Sigman, Daniel M/A-2649-2008; Gruber, Nicolas/B-7013-2009; Dunne, John P/F-8086-2012	Sigman, Daniel M/0000-0002-7923-1973; Gruber, Nicolas/0000-0002-2085-2310; Dunne, John P/0000-0002-8794-0489				Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Brandes JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001856; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; Conkright M. E., 2002, WORLD OCEAN ATLAS 20, P1; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2003, CARBON CLIMATE INTER, P97; Hansell DA, 2004, MAR CHEM, V84, P243, DOI 10.1016/j.marchem.2003.08.004; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Lehmann MF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002508; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; SARMIENTO JL, 2006, OCEAN BIOGEOCHEMICAL, P118; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Tanaka T, 2004, CONT SHELF RES, V24, P1271, DOI 10.1016/j.csr.2004.04.004; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	30	513	527	6	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					163	167		10.1038/nature05392	http://dx.doi.org/10.1038/nature05392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215838				2022-12-24	WOS:000243384300042
J	Halperin, SA				Halperin, Scott A.			The control of pertussis - 2007 and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Halperin, SA (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.			Halperin, Scott/0000-0003-0525-589X				Lievano FA, 2002, J CLIN MICROBIOL, V40, P2801, DOI 10.1128/JCM.40.8.2801-2805.2002; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Skowronski DM, 2002, J INFECT DIS, V185, P1696; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; SMITH S, 2006, BOSTON GLOBE    1102; TALBOT EA, 2006, ANN M INF DIS SOC AM	6	74	81	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					110	113		10.1056/NEJMp068288	http://dx.doi.org/10.1056/NEJMp068288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124NE	17215528				2022-12-24	WOS:000243373700003
J	Gavin, AL; Hoebe, K; Duong, B; Ota, T; Martin, C; Beutler, B; Nemazee, D				Gavin, Amanda L.; Hoebe, Kasper; Duong, Bao; Ota, Takayuki; Martin, Christopher; Beutler, Bruce; Nemazee, David			Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling	SCIENCE			English	Article							ACTIVATE B-CELLS; INTERFERON-GAMMA; HOST-RESISTANCE; ENGAGEMENT; IMMUNITY; PATHWAY; MICE	Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nemazee@scripps.edu	Ota, Takayuki/Q-5528-2017	Ota, Takayuki/0000-0001-6249-0664; Hoebe, Kasper/0000-0002-3626-8098	NIAID NIH HHS [AI050241, T32AI07606] Funding Source: Medline; NIGMS NIH HHS [R01GM44809, R01 GM044809] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606, R01AI050241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON J, 1972, TRANSPLANT REV-DENMA, V11, P131; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	17	452	467	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1936	1938		10.1126/science.1135299	http://dx.doi.org/10.1126/science.1135299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185603	Green Accepted			2022-12-24	WOS:000242996800052
J	Petruk, S; Sedkov, Y; Riley, KM; Hodgson, J; Schweisguth, F; Hirose, S; Jaynes, JB; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Riley, Kristen M.; Hodgson, Jacob; Schweisguth, Francois; Hirose, Susumu; Jaynes, James B.; Brock, Hugh W.; Mazo, Alexander			Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference	CELL			English	Article							DROSOPHILA BITHORAX COMPLEX; HISTONE METHYLTRANSFERASE COMPLEX; GROUP RESPONSE ELEMENTS; HOX GENE-EXPRESSION; POLYCOMB-GROUP; HOMEOTIC GENE; INTERGENIC TRANSCRIPTION; ULTRABITHORAX; MAINTENANCE; PROTEINS	Much of the genome is transcribed into long noncoding RNAs (ncRNAs). Previous data suggested that bithoraxoid (bxd) ncRNAs of the Drosophila bithorax complex (BX-C) prevent silencing of Ultrabithorax (Ubx) and recruit activating proteins of the trithorax group (trxG) to their maintenance elements (MEs). We found that, surprisingly, Ubx and several bxd ncRNAs are expressed in nonoverlapping patterns in both embryos and imaginal discs, suggesting that transcription of these ncRNAs is associated with repression, not activation, of Ubx. Our data rule out siRNA or miRNA-based mechanisms for repression by bxd ncRNAs. Rather, ncRNA transcription itself, acting in cis, represses Ubx. The Trithorax complex TAC1 binds the Ubx coding region in nuclei expressing Ubx, and the bxd region in nuclei not expressing Ubx. We propose that TAC1 promotes the mosaic pattern of Ubx expression by facilitating transcriptional elongation of bxd ncRNAs, which represses Ubx transcription.	Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Ecole Normale Super, CNRS, UMR 8542, Paris, France; Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Jefferson University; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA.	mazo@mail.tju.edu	Hirose, Susumu/I-8865-2019	Jaynes, James/0000-0001-7943-794X	NATIONAL CANCER INSTITUTE [P01CA050507] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141, R01GM050231] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA050507, 5P01CA50507] Funding Source: Medline; NHLBI NIH HHS [T32 HL007780, T32-HL07780] Funding Source: Medline; NIGMS NIH HHS [R01 GM075141, 2R01GM50231, R01 GM050231-09A2, R01 GM050231, 1R01GM075141] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bender W, 2002, DEVELOPMENT, V129, P4923; BROWER DL, 1987, DEVELOPMENT, V101, P83; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; Dzitoyeva S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-33; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Hogga I, 2002, DEVELOPMENT, V129, P4915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; IRISH VF, 1989, EMBO J, V8, P1527, DOI 10.1002/j.1460-2075.1989.tb03537.x; IRVINE KD, 1991, DEVELOPMENT, V111, P407; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; MULLER J, 1991, EMBO J, V10, P3147, DOI 10.1002/j.1460-2075.1991.tb04876.x; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; PIRROTTA V, 1995, GENETICS, V141, P1439; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; SOTO MC, 1995, GENETICS, V140, P231; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	48	220	231	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1209	1221		10.1016/j.cell.2006.10.039	http://dx.doi.org/10.1016/j.cell.2006.10.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174895	Green Accepted, Bronze			2022-12-24	WOS:000242991000018
J	Sugiyama, T; Cam, HP; Sugiyama, R; Noma, K; Zofall, M; Kobayashi, R; Grewal, SIS				Sugiyama, Tomoyasu; Cam, Hugh P.; Sugiyama, Rie; Noma, Ken-ichi; Zofall, Martin; Kobayashi, Ryuji; Grewal, Shiv I. S.			SHREC, an effector complex for heterochromatic transcriptional silencing	CELL			English	Article							DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; GENOME-WIDE ANALYSIS; MATING-TYPE LOCI; FISSION YEAST; HISTONE H3; SCHIZOSACCHAROMYCES-POMBE; DOMAIN PROTEIN; RNA-POLYMERASE; PERICENTRIC HETEROCHROMATIN	Transcriptional gene silencing (TGS) is the mechanism generally thought by which heterochromatin effects silencing. However, recent discovery in fission yeast of a cis-acting posttranscriptional gene-silencing (cis-PTGS) pathway operated by the RNAi machinery at heterochromatin challenges the role of TGS in heterochromatic silencing. Here, we describe a multienzyme effector complex (termed SHREC) that mediates heterochromatic TGS in fission yeast. SHREC consists of a core quartet of proteins-Clr1, Clr2, Clr3, and Mit1-which distribute throughout all major heterochromatin domains to effect TGS via distinct activities associated with the histone deacetylase Clr3 and the SNF2 chromatin-remodeling factor homolog Mit1. SHREG is also recruited to the telomeres by multiple independent mechanisms involving telomere binding protein Ccq1 cooperating with Taz1 and the RNAi machinery, and to euchromatic sites, via mechanism(s) distinct from its heterochromatin localization aided by Swi6/HP1. Our analyses suggest that SHREC regulates nucleosome positioning to assemble higher-order chromatin structures critical for heterochromatin functions.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Sugiyama, Tomoyasu/0000-0001-5704-6606; Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bjerling P, 2004, NUCLEIC ACIDS RES, V32, P4421, DOI 10.1093/nar/gkh780; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cryderman DE, 1998, CHROMOSOMA, V107, P277, DOI 10.1007/s004120050309; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Eissenberg JC, 2001, BIOESSAYS, V23, P767, DOI 10.1002/bies.1111; EKWALL K, 1994, GENETICS, V136, P53; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Freeman-Cook LL, 2005, GENETICS, V169, P1243, DOI 10.1534/genetics.104.032714; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schulte KM, 2001, THYROID, V11, P3, DOI 10.1089/10507250150500603; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thon G, 2000, GENETICS, V155, P551; THON G, 1992, GENETICS, V131, P287; THON G, 1994, GENETICS, V138, P29; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	71	234	243	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					491	504		10.1016/j.cell.2006.12.035	http://dx.doi.org/10.1016/j.cell.2006.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289569	Bronze			2022-12-24	WOS:000244842700016
J	Grine, FE; Bailey, RM; Harvati, K; Nathan, RP; Morris, AG; Henderson, GM; Ribot, I; Pike, AWG				Grine, F. E.; Bailey, R. M.; Harvati, K.; Nathan, R. P.; Morris, A. G.; Henderson, G. M.; Ribot, I.; Pike, A. W. G.			Late Pleistocene human skull from Hofmeyr, South Africa, and modern human origins	SCIENCE			English	Article							MITOCHONDRIAL GENOMES; CHRONOLOGY; DISPERSALS	The lack of Late Pleistocene human fossils from sub-Saharan Africa has limited paleontological testing of competing models of recent human evolution. We have dated a skull from Hofmeyr, South Africa, to 36.2 +/- 3.3 thousand years ago through a combination of optically stimulated luminescence and uranium-series dating methods. The skull is morphologically modern overall but displays some archaic features. Its strongest morphometric affinities are with Upper Paleolithic ( UP) Eurasians rather than recent, geographically proximate people. The Hofmeyr cranium is consistent with the hypothesis that UP Eurasians descended from a population that emigrated from sub-Saharan Africa in the Late Pleistocene.	SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; Univ Cape Town, Dept Human Biol, ZA-7925 Cape Town, South Africa; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Montreal, Dept Anthropol, Montreal, PQ H3C 3J7, Canada; Univ Bristol, Dept Archaeol & Anthropol, Bristol BS8 1UU, Avon, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Oxford; Max Planck Society; University of Oxford; University of Cape Town; University of Oxford; Universite de Montreal; University of Bristol	Grine, FE (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	fgrine@notes.cc.sunysb.edu	Morris, Alan G/V-7363-2019; Rohlf, F J/A-8710-2008; Harvati, Katerina/A-5197-2008	Pike, Alistair/0000-0002-5610-8948; Henderson, Gideon/0000-0002-6279-7137				Aitken M.J., 1998, INTRO OPTICAL DATING; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; BRIESMEISTER JF, LA13709M LOS AL NAT; deVilliers H., 1968, SKULL S AFRICAN NEGR; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Hawks JD, 2001, QUATERN INT, V75, P41, DOI 10.1016/S1040-6182(00)00076-8; HIGHARN T, COMMUNICATION; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Lahr M. M, 1996, EVOLUTION MODERN HUM; LUDWIG KR, 1993, 93531 USGS; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Nathan RP, 2003, RADIAT MEAS, V37, P305, DOI 10.1016/S1350-4487(03)00008-8; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Ribot Isabelle, 2004, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V16, P143; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; SMITH FH, 1989, HUMAN REVOLUTION, P172; Szilvassy JV, 1987, ANN VIENNA NAT HIST, V89, P313; Takasaka T, 2006, AM J PHYS ANTHROPOL, V129, P465, DOI 10.1002/ajpa.20208; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Turbon D, 1997, J HUM EVOL, V32, P449, DOI 10.1006/jhev.1996.0119; VOGEL JC, 1969, S AFRICAN ARCHAEOLOG, V24, P56	27	86	90	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					226	229		10.1126/science.1136294	http://dx.doi.org/10.1126/science.1136294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124XZ	17218524				2022-12-24	WOS:000243407400043
J	Schlaitz, AL; Srayko, M; Dammermann, A; Quintin, S; Wielsch, N; MacLeod, I; de Robillard, Q; Zinke, A; Yates, JR; Muller-Reichert, T; Shevchenko, A; Oegema, K; Hyman, AA				Schlaitz, Anne-Lore; Srayko, Martin; Dammermann, Alexander; Quintin, Sohie; Wielsch, Natalie; MacLeod, Ian; de Robillard, Quentin; Zinke, Andrea; Yates, John R., III; Mueller-Reichert, Thomas; Shevchenko, Andrei; Oegema, Karen; Hyman, Anthony A.			The C-elegans RSA complex localizes protein phosphatase 2A to centrosomes and regulates mitotic spindle assembly	CELL			English	Article							AURORA-A KINASE; MICROTUBULE DYNAMICS; CAENORHABDITIS-ELEGANS; PHOSPHORYLATION; KINETOCHORE; MATURATION; MCAK; TARGET; GROWTH	Microtubule behavior changes during the cell cycle and during spindle assembly. However, it remains unclear how these changes are regulated and coordinated. We describe a complex that targets the Protein Phosphatase 2A holoenzyme (PP2A) to centrosomes in C. elegans embryos. This complex includes Regulator of Spindle Assembly 1 (RSA-1), a targeting subunit for PP2A, and RSA-2, a protein that binds and recruits RSA-1 to centrosomes. In contrast to the multiple functions of the PP2A catalytic subunit, RSA-1 and RSA-2 are specifically required for microtubule outgrowth from centrosomes and for spindle assembly. The centrosomally localized RSA-PP2A complex mediates these functions in part by regulating two critical mitotic effectors: the microtubule destabilizer KLP-7 and the C. elegans regulator of spindle assembly TPXL-1. By regulating a subset of PP2A functions at the centrosome, the RSA complex could therefore provide a means of coordinating microtubule outgrowth from centrosomes and kinetochore microtubule stability during mitotic spindle assembly.	MPI CBG, D-01307 Dresden, Germany; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Max Planck Society; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Hyman, AA (corresponding author), MPI CBG, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Srayko, Martin/A-3755-2014	Hyman, Anthony A/0000-0003-3664-154X; Srayko, Martin/0000-0003-0196-0364; QUINTIN, Sophie/0000-0003-4059-5486; Dammermann, Alexander/0000-0002-1251-0978	NIGMS NIH HHS [R01 GM074207, R01 GM074207-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; BRENNER S, 1974, GENETICS, V77, P71; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harlow E., 1988, ANTIBODIES LAB MANUA; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OEGEMA K, 2006, C ELEGANS, DOI DOI 10.1895/WORMBOOK.1.72.1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Praitis V, 2001, GENETICS, V157, P1217; Siddiqui SS, 2002, TRAFFIC, V3, P20, DOI 10.1034/j.1600-0854.2002.30104.x; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	44	71	87	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					115	127		10.1016/j.cell.2006.10.050	http://dx.doi.org/10.1016/j.cell.2006.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218259	Green Accepted, Bronze			2022-12-24	WOS:000244420400017
J	Stark, J; Andl, T; Millar, SE				Stark, Jaroslav; Andl, Thomas; Millar, Sarah E.			Hairy math: Insights into hair-follicle spacing and orientation	CELL			English	Editorial Material							POLARITY; WNT	Hair follicles in the skin have a characteristic spacing and orientation. Two recent papers (Sick et al., 2006; Wang et al., 2006) report the use of contrasting mathematical models and experimental manipulations to gain insight into the mechanisms underlying patterns of hair-follicle distribution and orientation.	Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol, London SW7 2AZ, England	University of Pennsylvania; University of Pennsylvania; Imperial College London; Imperial College London	Millar, SE (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA.	millars@mail.med.upenn.edu		Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890				Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barrow JR, 2006, SEMIN CELL DEV BIOL, V17, P185, DOI 10.1016/j.semcdb.2006.04.002; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104	10	22	22	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					17	20		10.1016/j.cell.2006.12.020	http://dx.doi.org/10.1016/j.cell.2006.12.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218249	Bronze			2022-12-24	WOS:000244420400007
J	Gilsdorf, JR				Gilsdorf, Janet R.			A long time ago	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												gilsdorf@umich.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2777	2778		10.1001/jama.296.23.2777	http://dx.doi.org/10.1001/jama.296.23.2777			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179446				2022-12-24	WOS:000242826400001
J	Olivieri, A; Achilli, A; Pala, M; Battaglia, V; Fornarino, S; Al-Zahery, N; Scozzari, R; Cruciani, F; Behar, DM; Dugoujon, JM; Coudray, C; Santachiara-Benerecetti, AS; Semino, O; Bandelt, HJ; Torroni, A				Olivieri, Anna; Achilli, Alessandro; Pala, Maria; Battaglia, Vincenza; Fornarino, Simona; Al-Zahery, Nadia; Scozzari, Rosaria; Cruciani, Fulvio; Behar, Doron M.; Dugoujon, Jean-Michel; Coudray, Clotilde; Santachiara-Benerecetti, A. Silvana; Semino, Ornella; Bandelt, Hans-Juergen; Torroni, Antonio			The mtDNA legacy of the Levantine early Upper Palaeolithic in Africa	SCIENCE			English	Article							SUB-SAHARAN AFRICA; NEAR-EASTERN; GENE FLOW; MITOCHONDRIAL; ASIA; HUMANS; NORTH	Sequencing of 81 entire human mitochondrial DNAs (mtDNAs) belonging to haplogroups M1 and U6 reveals that these predominantly North African clades arose in southwestern Asia and moved together to Africa about 40,000 to 45,000 years ago. Their arrival temporally overlaps with the event(s) that led to the peopling of Europe by modern humans and was most likely the result of the same change in climate conditions that allowed humans to enter the Levant, opening the way to the colonization of both Europe and North Africa. Thus, the early Upper Palaeolithic population( s) carrying M1 and U6 did not return to Africa along the southern coastal route of the "out of Africa" exit, but from the Mediterranean area; and the North African Dabban and European Aurignacian industries derived from a common Levantine source.	Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Mol Med Lab, IL-31096 Haifa, Israel; Univ Toulouse 3, Ctr Anthropol, FRE 2960, CNRS, F-31073 Toulouse, France; Univ Hamburg, Dept Math, D-20146 Hamburg, Germany	University of Pavia; University of Baghdad; Sapienza University Rome; Rambam Health Care Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	OLIVIERI, ANNA/I-9235-2012; Al-Zahery, Nadia/AAV-5878-2020; Battaglia, Vincenza/F-6950-2017; Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012	OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Pala, Maria/0000-0001-9202-8331; Cruciani, Fulvio/0000-0002-6900-024X; SEMINO, Ornella/0000-0002-9675-9403				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Burroughs W.J., 2005, CLIMATE CHANGE PREHI, DOI [10.1017/CBO9780511535826, DOI 10.1017/CBO9780511535826]; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2006, NUCL ACID M, V18, P225; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Van Peer P., 1990, EMERGENCE MODERN HUM, P139; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	29	190	191	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1767	1770		10.1126/science.1135566	http://dx.doi.org/10.1126/science.1135566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170302				2022-12-24	WOS:000242833600056
J	Fathalla, MF; Sinding, SW; Rosenfield, A; Fathalla, MMF				Fathalla, Mahmoud F.; Sinding, Steven W.; Rosenfield, Allan; Fathalla, Mohammed M. F.			Sexual and reproductive health 6 - Sexual and reproductive health for all: a call for action	LANCET			English	Article							GOALS	At the United Nations International Conference on Population and Development in Cairo in 1994, the international community agreed to make reproductive health care universally available no later than 2015. After a 5-year review of progress towards implementation of the Cairo programme of action, that commitment was extended to include sexual, as well as reproductive, health and rights. Although progress has been made towards this commitment, it has fallen a long way short of the original goal. We argue that sexual and reproductive health for all is an achievable goal-if cost-effective interventions are properly scaled up; political commitment is revitalised; and financial resources are mobilised, rationally allocated, and more effectively used. National action will need to be backed up by international action. Sustained effort is needed by governments in developing countries and in the donor community, by inter-governmental organisations, non-governmental. organisations, civil society groups, the women's health movement, philanthropic foundations, the private for-profit sector, the health profession, and the research community.	Assiut Univ, Dept Obstet & Gynaecol, Assiut, Egypt; Int Planned Parenthood Federat, London, England; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Egyptian Knowledge Bank (EKB); Assiut University; Columbia University	Fathalla, MF (corresponding author), Assiut Univ, Dept Obstet & Gynaecol, POB 30, Assiut, Egypt.	mfathall@intouch.com		Fathalla, Mahmoud/0000-0001-6955-1933				Bernstein S., 2006, PUBLIC CHOICES PRIVA; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cleland J, 2005, LANCET, V366, P1899, DOI 10.1016/S0140-6736(05)67603-9; CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69480-4; Fathalla MF., 2002, AGENDA PEOPLE UNFPA, P24; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2004, OBSTET GYNECOL, V104, P220, DOI 10.1097/01.AOG.0000135804.89369.59; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; LANGER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69486-5; LOW N, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69482-8; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Rosenfield A, 2005, NEW ENGL J MED, V352, P647, DOI 10.1056/NEJMp048281; Simmons R., 2006, SCALING HLTH SERVICE; Singh S, 2003, ADDING BENEFITS INVE; *UN, 1994, INT C POP DEV 1994 S; *UN COMM POP DEV, 2006, INT C POP DEV NEW YO; *UN FUND POP ACT, 2004, SEC SUPPL PEOPL REL; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UN POP DIV DEP EC, 2004, STESASERA215 UN POP; VLASSOFF M, RESOURCE REQUIREMENT; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; *WHO DEP REPR HLTH, 2004, WHORHR048; *WHO DEP REPR HLTH, 2006, WHORHR063; *WHO UNFPA UNAIDS, 2005, SEX REPR HLTH HIV AI; [No title captured]	26	55	55	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2095	2100		10.1016/S0140-6736(06)69483-X	http://dx.doi.org/10.1016/S0140-6736(06)69483-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114JY	17161731				2022-12-24	WOS:000242663700024
J	Richmond, C				Richmond, Caroline			Shark cartilage in the water - Ignorance based cancer treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												c@roline.demon.co.uk						Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	1	1	1	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.727350.3A	http://dx.doi.org/10.1136/bmj.39051.727350.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158402	Green Published			2022-12-24	WOS:000243009600032
J	Shin, D; Lee, J; Huang, H; Groisman, EA				Shin, Dongwoo; Lee, Eun-Jin; Huang, Henry; Groisman, Eduardo A.			A positive feedback loop promotes transcription surge that jump-starts Salmonella virulence circuit	SCIENCE			English	Article							2-COMPONENT REGULATORY SYSTEM; ANTIMICROBIAL PEPTIDE RESISTANCE; SIGNAL-TRANSDUCTION SYSTEM; ESCHERICHIA-COLI; PHOP-PHOQ; STREPTOCOCCUS-PNEUMONIAE; TYPHIMURIUM VIRULENCE; ENTERICA; EXPRESSION; GENE	The PhoP/ PhoQ two-component system is a master regulator of Salmonella pathogenicity. Here we report that induction of the PhoP/ PhoQ system results in an initial surge of PhoP phosphorylation; the occupancy of target promoters by the PhoP protein; and the transcription of PhoP-activated genes, which then subsides to reach new steady-state levels. This surge in PhoP activity is due to PhoP positively activating its own transcription, because a strain constitutively expressing the PhoP protein attained steady-state levels of activation asymptotically, without the surge. The strain constitutively expressing the PhoP protein was attenuated for virulence in mice, demonstrating that the surge conferred by PhoP's positive feedback loop is necessary to jump-start Salmonella's virulence program.	Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu			NIAID NIH HHS [AI49561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Guiral S, 2006, MICROBIOL-SGM, V152, P323, DOI 10.1099/mic.0.28425-0; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Hutchings MI, 2006, MOL MICROBIOL, V59, P923, DOI 10.1111/j.1365-2958.2005.04953.x; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Valdivia RH, 2000, INFECT IMMUN, V68, P7126, DOI 10.1128/IAI.68.12.7126-7131.2000; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	29	105	107	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1607	1609		10.1126/science.1134930	http://dx.doi.org/10.1126/science.1134930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158330				2022-12-24	WOS:000242624600045
J	Strickfaden, SC; Winters, MJ; Ben-Ari, G; Lamson, RE; Tyers, M; Pryciak, PM				Strickfaden, Shelly C.; Winters, Matthew J.; Ben-Ari, Giora; Lamson, Rachel E.; Tyers, Mike; Pryciak, Peter M.			A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MATING FACTOR; PHEROMONE RESPONSE; BUDDING YEAST; G-BETA; PROTEIN-KINASES; MEKK STE11; G1 CYCLIN; IN-VIVO; PHOSPHORYLATION	Yeast cells arrest in the G1 phase of the cell cycle upon exposure to mating pheromones. As cells commit to a new cycle, G1 CDK activity (Cln/CDK) inhibits signaling through the mating MAPK cascade. Here we show that the target of this inhibition is Ste5, the MAPK cascade scaffold protein. Cln/CDK disrupts Ste5 membrane localization by phosphorylating a cluster of sites that flank a small, basic, membrane-binding motif in Ste5. Effective inhibition of Ste5 signaling requires multiple phosphorylation sites and a substantial accumulation of negative charge, which suggests that Ste5 acts as a sensor for high G1 CDK activity. Thus, Ste5 is an integration point for both external and internal signals. When Ste5 cannot be phosphorylated, pheromone triggers an aberrant arrest of cells outside G1 either in the presence or absence of the CDK-inhibitor protein Far1. These findings define a mechanism and physiological benefit of restricting antiproliferative signaling to G1.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pryciak, PM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	peter.pryciak@umassmed.edu	Tyers, Michael/ABE-3194-2021; Pryciak, Peter/P-7205-2019	Pryciak, Peter/0000-0001-9142-1369	NIGMS NIH HHS [R01 GM057769, GM57769] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057769] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHANG F, 1992, MOL BIOL CELL, V3, P445, DOI 10.1091/mbc.3.4.445; Cherkasova V, 1999, GENETICS, V151, P989; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; Flotho A, 2004, J BIOL CHEM, V279, P47391, DOI 10.1074/jbc.M405681200; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; KRANZ JE, 1994, GENE DEV, V8, P313, DOI 10.1101/gad.8.3.313; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oehlen LJWM, 1998, MOL GEN GENET, V258, P183, DOI 10.1007/s004380050722; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; VALDIVIESO MH, 1993, MOL CELL BIOL, V13, P1013, DOI 10.1128/MCB.13.2.1013; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Vidwans SJ, 2001, NAT CELL BIOL, V3, pE35, DOI 10.1038/35050681; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wu CL, 1998, J BIOL CHEM, V273, P28107, DOI 10.1074/jbc.273.43.28107	42	173	175	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					519	531		10.1016/j.cell.2006.12.032	http://dx.doi.org/10.1016/j.cell.2006.12.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289571	Green Accepted, Bronze			2022-12-24	WOS:000244842700018
J	Kreitzer, AC; Malenka, RC				Kreitzer, Anatol C.; Malenka, Robert C.			Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models	NATURE			English	Article							TERM SYNAPTIC DEPRESSION; DOPAMINE D2 RECEPTORS; BASAL GANGLIA; GENE-EXPRESSION; PLASTICITY; NEURONS; HYDROLYSIS; MICE; INTERNEURONS; INHIBITION	The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia(1,2). Striatal projection neurons target the substantia nigra pars reticulata ( direct pathway) or the lateral globus pallidus ( indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease(3,4). However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity(5,6). Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-D-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	malenka@stanford.edu						ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Obeso JA, 2000, NEUROLOGY, V55, pS7; Saario SM, 2006, CHEM BIOL, V13, P811, DOI 10.1016/j.chembiol.2006.07.008; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	30	553	577	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					643	647		10.1038/nature05506	http://dx.doi.org/10.1038/nature05506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287809				2022-12-24	WOS:000244039400043
J	Zarrin, AA; Del Vecchio, C; Tseng, E; Gleason, M; Zarin, P; Tian, M; Alt, FW				Zarrin, Ali A.; Del Vecchio, Catherine; Tseng, Eva; Gleason, Megan; Zarin, Payam; Tian, Ming; Alt, Frederick W.			Antibody class switching mediated by yeast endonuclease-generated DNA breaks	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; S-MU REGION; SOMATIC HYPERMUTATION; GENE CONVERSION; B-CELLS; RECOMBINATION; AID; MECHANISM; TRANSLOCATIONS; DELETION	Antibody class switching in activated B cells uses class switch recombination (CSR), which joins activation-induced cytidine deaminase (AID)-dependent double-strand breaks (DSBs) within two large immunoglobulin heavy chain (IgH) locus switch (S) regions that lie up to 200 kilobases apart. To test postulated roles of S regions and AID in CSR, we generated mutant B cells in which donor S mu and accepter S gamma 1 regions were replaced with yeast 1-SceI endonuclease sites. We found that site-specific 1-SceI DSBs mediate recombinational IgH locus class switching from IgM to IgG(2) without S regions or AID. We propose that CSR evolved to exploit a general DNA repair process that promotes joining of widely separated DSBs within a chromosome.	Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Austin	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Del Vecchio Fitz, Catherine/0000-0002-9554-411X	NCI NIH HHS [P01CA092625-05] Funding Source: Medline; NIAID NIH HHS [2P01AI031541-15] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 2003, EMBO J, V22, P5893, DOI 10.1093/emboj/cdg550; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Zarrin AA, 2005, P NATL ACAD SCI USA, V102, P2466, DOI 10.1073/pnas.0409847102; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	30	78	84	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					377	381		10.1126/science.1136386	http://dx.doi.org/10.1126/science.1136386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170253				2022-12-24	WOS:000243535400042
J	Imboden, M; Swan, H; Denjoy, I; Van Langen, IM; Latinen-Forsblom, PJ; Napolitano, C; Fressart, V; Breithardt, G; Berthet, M; Priori, S; Hainque, B; Wilde, AAM; Schulze-Bahr, E; Feingold, J; Guicheney, P				Imboden, Medea; Swan, Heikki; Denjoy, Isabelle; Marijke Van Langen, Irene; Latinen-Forsblom, Paivi Johanna; Napolitano, Carlo; Fressart, Veronique; Breithardt, Guenter; Berthet, Myriam; Priori, Silvia; Hainque, Bernard; Wilde, Arthur Arnold Maria; Schulze-Bahr, Eric; Feingold, Josue; Guicheney, Pascale			Female predominance and transmission distortion in the long-QT syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-COURSE; RISK-FACTOR; DE-POINTES; GENDER; AGE; SEGREGATION; LQTS	BACKGROUND: Congenital long-QT syndrome is a disorder resulting in ventricular arrhythmias and sudden death. The most common forms of the long-QT syndrome, types 1 and 2, are caused by mutations in the potassium-channel genes KCNQ1 and KCNH2, respectively. Although inheritance of the long-QT syndrome is autosomal dominant, female predominance has often been observed and has been attributed to an increased susceptibility to cardiac arrhythmias in women. We investigated the possibility of an unbalanced transmission of the deleterious trait. METHODS: We investigated the distribution of alleles for the long-QT syndrome in 484 nuclear families with type 1 disease and 269 nuclear families with type 2 disease, all with fully genotyped offspring. The families were recruited in five European referral centers for the long-QT syndrome. Mutation segregation, sex ratio, and parental transmission were analyzed after correction for single ascertainment. RESULTS: Classic mendelian inheritance ratios were not observed in the offspring of either female carriers of the long-QT syndrome type 1 or male and female carriers of the long-QT syndrome type 2. Among the 1534 descendants, the proportion of genetically affected offspring was significantly greater than that expected according to mendelian inheritance: 870 were carriers of a mutation (57%), and 664 were noncarriers (43%, P<0.001). Among the 870 carriers, the allele for the long-QT syndrome was transmitted more often to female offspring (476 [55%]) than to male offspring (394 [45%], P=0.005). Increased maternal transmission of the long-QT syndrome mutations to daughters was also observed, possibly contributing to the excess of female patients with autosomal dominant long-QT syndrome. CONCLUSIONS: Positive selection of the mutated alleles that cause the long-QT syndrome leads to transmission distortion, with increased proportions of mutation carriers among the offspring of affected families. Alleles for the long-QT syndrome are more often transmitted to daughters than to sons.	Univ Paris 06, Assistance Publ Hop Paris,Inst Federatif Rech 14, Inst Myol, INSERM, Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Cardiol, F-75475 Paris, France; Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Serv Biochim, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Dept Genet, F-75634 Paris, France; Univ Zurich, Dept Mol Epidemiol, Inst Social & Prevent Med, Zurich, Switzerland; Univ Helsinki, Dept Med, Helsinki, Finland; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; Univ Pavia, I-27100 Pavia, Italy; Fdn Salvatore Maugeri, Ist Ric & Cura Carattere Sci, Mol Cardiol Labs, Pavia, Italy; Univ Munster, Dept Mol Cardiol, Leibniz Inst Arteriosclerosis Res, D-4400 Munster, Germany; Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; University of Zurich; University of Helsinki; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Munster; University of Munster	Imboden, M (corresponding author), Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U582, 47 Blvd Hop, F-75013 Paris, France.	imboden@medgen.unizh.ch	Napolitano, Carlo/K-4760-2016; Priori, Silvia G G/A-6116-2014; Guicheney, Pascale/D-1034-2017; Priori, Silvia G/ABH-6894-2020; napolitano, carlo/ABI-4608-2020	Napolitano, Carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; Guicheney, Pascale/0000-0002-7663-2050; Priori, Silvia G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; van Langen, Irene/0000-0002-0960-7154	Telethon [GGP04066] Funding Source: Medline	Telethon(Fondazione Telethon)		Conrath CE, 2002, CARDIOVASC RES, V53, P770, DOI 10.1016/S0008-6363(01)00477-1; Drici MD, 2001, DRUG SAFETY, V24, P575, DOI 10.2165/00002018-200124080-00002; Fodstad H, 2004, ANN MED, V36, P53, DOI 10.1080/17431380410032689; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; HASHIBA K, 1992, ANN NY ACAD SCI, V644, P142, DOI 10.1111/j.1749-6632.1992.tb31008.x; Hashiba K, 1987, Heart Vessels Suppl, V2, P47; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jiang S, 1998, GENOMICS, V53, P395, DOI 10.1006/geno.1998.5511; Kimbrough J, 2001, CIRCULATION, V104, P557, DOI 10.1161/hc3001.093501; Lehmann MH, 1997, J AM COLL CARDIOL, V29, P93, DOI 10.1016/S0735-1097(96)00454-8; Lehmann MH, 1996, CIRCULATION, V94, P2535, DOI 10.1161/01.CIR.94.10.2535; Li C, 1961, HUMAN GENETICS PRINC; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; Magee AC, 1998, J MED GENET, V35, P1045, DOI 10.1136/jmg.35.12.1045; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; Malloy K J, 1999, J Gend Specif Med, V2, P37; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schollen E, 2004, J MED GENET, V41, P877, DOI 10.1136/jmg.2004.022350; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; StrambaBadiale M, 1997, EUR HEART J, V18, P1000; ZAREBA W, 1995, J AM COLL CARDIOL, V26, P1685, DOI 10.1016/0735-1097(95)60383-2; Zareba W, 2003, J AM COLL CARDIOL, V42, P103, DOI 10.1016/S0735-1097(03)00554-0; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	29	59	64	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2744	2751		10.1056/NEJMoa042786	http://dx.doi.org/10.1056/NEJMoa042786			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192539	Green Accepted, Bronze			2022-12-24	WOS:000243110500006
J	Offit, K; Sagi, M; Hurley, K				Offit, Kenneth; Sagi, Michal; Hurley, Karen			Preimplantation genetic diagnosis for cancer syndromes - A new challenge for preventive medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PGD		Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Psychiat, New York, NY 10021 USA; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						*AM MED ASS, E 2 12 GEN COUNS AMA; BARUCH S, 2006, FERTIL STERIL; Braude P, 2006, NEW ENGL J MED, V355, P541, DOI 10.1056/NEJMp068139; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; *CHURCH ENGL, HUM GEN CONS; de Wert G, 2005, HUM REPROD, V20, P3261, DOI 10.1093/humrep/dei222; Eugster A, 1999, SOC SCI MED, V48, P575, DOI 10.1016/S0277-9536(98)00386-4; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; *GEN PUBL POL CTR, 2004, REPR GEN TEST ISS OP; Hamann HA, 2005, PSYCHOSOM MED, V67, P766, DOI 10.1097/01.psy.0000181273.74398.d7; *J HOPK U, ONL MEND INH MAN DAT; Kalfoglou AL, 2005, FERTIL STERIL, V83, P1612, DOI 10.1016/j.fertnstert.2005.01.090; Kalfoglou AL, 2005, REPROD BIOMED ONLINE, V11, P486, DOI 10.1016/S1472-6483(10)61145-5; Kuliev A, 2006, REPROD BIOMED ONLINE, V12, P328, DOI 10.1016/S1472-6483(10)61005-X; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Offit K, 2006, J CLIN ONCOL, V24, P4775, DOI 10.1200/JCO.2006.06.6100; Ola B, 2006, CURR OPIN OBSTET GYN, V18, P440, DOI 10.1097/01.gco.0000233940.82296.49; President's Council on Bioethics Eugenics and Inequality, REPR RESP REG NEW BI; Smith KR, 2004, CANCER EPIDEM BIOMAR, V13, P733; Thornhill AR, 2005, HUM REPROD, V20, P35, DOI 10.1093/humrep/deh579; van Asperen CJ, 2002, J MED GENET, V39, P410, DOI 10.1136/jmg.39.6.410; Verlinsky Y, 2004, FERTIL STERIL, V82, P292, DOI 10.1016/j.fertnstert.2003.09.082	24	58	58	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2727	2730		10.1001/jama.296.22.2727	http://dx.doi.org/10.1001/jama.296.22.2727			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164459				2022-12-24	WOS:000242765700028
J	Mullan, F				Mullan, Fitzhugh			Responding to the global HIV/AIDS crisis - A peace corps for health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Dept Hlth Policy, Washington, DC 20006 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Dept Hlth Policy, Suite 800,2021 K St NW, Washington, DC 20006 USA.	fmullan@gwu.edu						*AM INT HLTH ALL, WHAT IS TWINN; *ASS AM MED COLL, MED SCH GRAD QUEST 1; *BAYL INT PED AIDS, PED AIDS CORPS; *CTR GLOB DEV, COMM DEV IND 2006; *HJ KAIS FAM FDN, 2006, US FED FUND HIV AIDS; *I MED, 2005, HEAL ABROAD RESP HUM; *MED STUD ED, COST DEBT RES STIP F; PEPFAR, US PRES EM PLAN AIDS; Tuturu, 2020, COMM CONS HLTH ED; WHO, 2006, WORLD HLTH REP 20O6, P190; *WHO, 2006, AFR REG REP HLTH PEO; WOLK M, 2006, COST IRAQ WAR COULD	12	16	17	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					744	746		10.1001/jama.297.7.744	http://dx.doi.org/10.1001/jama.297.7.744			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312295				2022-12-24	WOS:000244291100028
J	Lathem, WW; Price, PA; Miller, VL; Goldman, WE				Lathem, Wyndham W.; Price, Paul A.; Miller, Virginia L.; Goldman, William E.			A plasminogen-activating protease specifically controls the development of primary pneumonic plague	SCIENCE			English	Article							YERSINIA-PESTIS; ESCHERICHIA-COLI; SURFACE PROTEASE; INFECTION; VIRULENCE; SEQUENCE; STRAINS; AGENT	Primary pneumonic plague is transmitted easily, progresses rapidly, and causes high mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely unknown. We show that the plasminogen activator Pla is essential for Y. pestis to cause primary pneumonic plague but is less important for dissemination during pneumonic plague than during bubonic plague. Experiments manipulating its temporal expression showed that Pla allows Y. pestis to replicate rapidly in the airways, causing a lethal fulminant pneumonia; if unexpressed, inflammation is aborted, and lung repair is activated. Inhibition of Pla expression prolonged the survival of animals with the disease, offering a therapeutic option to extend the period during which antibiotics are effective.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldman, WE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	goldman@wustl.edu		Miller, Virginia/0000-0002-9522-1767; Goldman, William/0000-0002-1551-6718; Lathem, Wyndham/0000-0003-4347-089X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, F32AI069688, R21AI053298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; NIAID NIH HHS [F32 AI069688-01, AI53298, U54 AI057160] Funding Source: Medline; NIDDK NIH HHS [DK52574] Funding Source: Medline; NIGMS NIH HHS [NRSA T32 GM07067] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*APPL BIOS, 1977, ABI PRISM 7700 SEQ D; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Huang XZ, 2006, CLIN MED RES, V4, P189, DOI 10.3121/cmr.4.3.189; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; LINDLER IE, 2004, ENCY MED GENOMICS PR, P1355; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; WU LT, 1926, TREATISE PNEUMONIC P, P466	22	227	237	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					509	513		10.1126/science.1137195	http://dx.doi.org/10.1126/science.1137195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255510				2022-12-24	WOS:000243726600045
J	Torres-Padilla, ME; Parfitt, DE; Kouzarides, T; Zernicka-Goetz, M				Torres-Padilla, Maria-Elena; Parfitt, David-Emlyn; Kouzarides, Tony; Zernicka-Goetz, Magdalena			Histone arginine methylation regulates pluripotency in the early mouse embryo	NATURE			English	Article							PROTEIN METHYLTRANSFERASE; STEM-CELLS; BLASTOMERES; EXPRESSION; CLEAVAGE; RECEPTOR; H3; SPECIFICATION; EMBRYOGENESIS; TRANSCRIPTION	It has been generally accepted that the mammalian embryo starts its development with all cells identical, and only when inside and outside cells form do differences between cells first emerge. However, recent findings show that cells in the mouse embryo can differ in their developmental fate and potency as early as the four-cell stage(1-4). These differences depend on the orientation and order of the cleavage divisions that generated them(2,5). Because epigenetic marks are suggested to be involved in sustaining pluripotency(6,7), we considered that such developmental properties might be achieved through epigenetic mechanisms. Here we show that modification of histone H3, through the methylation of specific arginine residues, is correlated with cell fate and potency. Levels of H3 methylation at specific arginine residues are maximal in four-cell blastomeres that will contribute to the inner cell mass (ICM) and polar trophectoderm and undertake full development when combined together in chimaeras. Arginine methylation of H3 is minimal in cells whose progeny contributes more to the mural trophectoderm and that show compromised development when combined in chimaeras. This suggests that higher levels of H3 arginine methylation predispose blastomeres to contribute to the pluripotent cells of the ICM. We confirm this prediction by overexpressing the H3-specific arginine methyltransferase CARM1 in individual blastomeres and show that this directs their progeny to the ICM and results in a dramatic upregulation of Nanog and Sox2. Thus, our results identify specific histone modifications as the earliest known epigenetic marker contributing to development of ICM and show that manipulation of epigenetic information influences cell fate determination.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	mzg@mole.bio.cam.ac.uk		Zernicka-Goetz, Magdalena/0000-0002-7004-2471; Kouzarides, Tony/0000-0002-8918-4162	Medical Research Council [G0300723, G0800784] Funding Source: Medline; Wellcome Trust [064421] Funding Source: Medline; MRC [G0300723] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tassy O, 2006, CURR BIOL, V16, P345, DOI 10.1016/j.cub.2005.12.044; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	25	430	455	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					214	218		10.1038/nature05458	http://dx.doi.org/10.1038/nature05458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215844	Green Accepted			2022-12-24	WOS:000243384300053
J	Goldsmith, BR; Coroneus, JG; Khalap, VR; Kane, AA; Weiss, GA; Collins, PG				Goldsmith, Brett R.; Coroneus, John G.; Khalap, Vaikunth R.; Kane, Alexander A.; Weiss, Gregory A.; Collins, Philip G.			Conductance-controlled point functionalization of single-walled carbon nanotubes	SCIENCE			English	Article							CHEMICAL FUNCTIONALIZATION; ELECTRONIC-STRUCTURE; CHEMISTRY; FABRICATION; TRANSISTORS; DEFECTS; TRANSPORT; OXIDATION; GRAPHITE; BUNDLES	We used covalent attachments to single-walled carbon nanotubes (SWNTs) to fabricate single-molecule electronic devices. The technique does not rely on submicrometer lithography or precision mechanical manipulation, but instead uses circuit conductance to monitor and control covalent attachment to an electrically connected SWNT. Discrete changes in the circuit conductance revealed chemical processes happening in real time and allowed the SWNT sidewalls to be deterministically broken, reformed, and conjugated to target species. By controlling the chemistry through electronically controlled electrochemical potentials, we were able to achieve single chemical attachments. We routinely functionalized pristine, defect-free SWNTs at one, two, or more sites and demonstrated three-terminal devices in which a single attachment controls the electronic response.	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Collins, PG (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	collinsp@uci.edu	Weiss, Gregory/AEN-4604-2022	Kane, Alexander/0000-0002-5901-5296	NIAID NIH HHS [R43 AI58365-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM078528-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078528] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1988, CARBON ELECTROCHEMIC, DOI DOI 10.1016/j.jpowsour.2007.12.091; Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; BESENHARD JO, 1981, SYNTHETIC MET, V3, P187, DOI 10.1016/0379-6779(81)90007-2; Bockrath M, 2001, SCIENCE, V291, P283, DOI 10.1126/science.291.5502.283; Burghard M, 2005, SURF SCI REP, V58, P1, DOI 10.1016/j.surfrep.2005.07.001; Chiu PW, 2002, APPL PHYS LETT, V80, P3811, DOI 10.1063/1.1480487; Diehl MR, 2003, CHEMPHYSCHEM, V4, P1335, DOI 10.1002/cphc.200300871; Eom JH, 2006, PHYSICA B, V376, P7, DOI 10.1016/j.physb.2005.12.005; Fan YW, 2005, NAT MATER, V4, P906, DOI 10.1038/nmat1516; Freitag M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.216801; Graupner R, 2003, PHYS CHEM CHEM PHYS, V5, P5472, DOI 10.1039/b311016h; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Heller I, 2005, NANO LETT, V5, P137, DOI 10.1021/nl048200m; Ho W, 2002, J CHEM PHYS, V117, P11033, DOI 10.1063/1.1521153; Kruger M, 2001, APPL PHYS LETT, V78, P1291, DOI 10.1063/1.1350427; Lee YS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116801; Lu X, 2005, CHEM REV, V105, P3643, DOI 10.1021/cr030093d; Mannik J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016601; Maruccio G, 2004, ELECTROANAL, V16, P1853, DOI 10.1002/elan.200403073; METROT A, 1981, SYNTHETIC MET, V3, P201, DOI 10.1016/0379-6779(81)90009-6; Pan H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245425; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park H, 2005, NANOTECHNOLOGY, V16, P635, DOI 10.1088/0957-4484/16/6/003; Rosenblatt S, 2002, NANO LETT, V2, P869, DOI 10.1021/nl025639a; Son YW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.216602; Star A, 2003, NANO LETT, V3, P459, DOI 10.1021/nl0340172; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Strachan DR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857095; Sumanasekera GU, 1999, J PHYS CHEM B, V103, P4292, DOI 10.1021/jp984362t; Tans SJ, 2000, NATURE, V404, P834, DOI 10.1038/35009026; Tao NJ, 2005, J MATER CHEM, V15, P3260, DOI 10.1039/b503307a; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; Zhao JJ, 2005, CHEMPHYSCHEM, V6, P598, DOI 10.1002/cphc.200400593; Zhou YX, 2003, NANO LETT, V3, P1371, DOI 10.1021/nl034512y	37	202	216	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					77	81		10.1126/science.1135303	http://dx.doi.org/10.1126/science.1135303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204645	Green Published			2022-12-24	WOS:000243259100038
J	Steinbrook, R				Steinbrook, Robert			Medicare and erythropoietic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*FDA PUBL HLTH ADV, 2006, EP ALF MARK PROCR EP; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9; US Renal Data System, 2006, USRDS 2006 ANN DAT R	4	35	35	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					4	6		10.1056/NEJMp068296	http://dx.doi.org/10.1056/NEJMp068296			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202449				2022-12-24	WOS:000243209600002
J	O'Donnell, M				O'Donnell, Michael			The night Bernard Shaw taught us a lesson	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mod@doctors.org.uk						GUINNESS A, 2000, COMMONPLACE BOOK, P29; ODONNELL M, 2005, MADNESS CREATIVITY L, P45; SHAW B, 1946, DOCTORS DILEMMA, P104; Skelton JR, 2005, BRIT J GEN PRACT, V55, P40	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2006	333	7582					1338	1340		10.1136/bmj.39062.728900.55	http://dx.doi.org/10.1136/bmj.39062.728900.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185735	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000243160700032
J	Danilczyk, U; Sarao, R; Remy, C; Benabbas, C; Stange, G; Richter, A; Arya, S; Pospisilik, JA; Singer, D; Camargo, SMR; Makrides, V; Ramadan, T; Verrey, F; Wagner, CA; Penninger, JM				Danilczyk, Ursula; Sarao, Renu; Remy, Christine; Benabbas, Chahira; Stange, Gerti; Richter, Andreas; Arya, Sudha; Pospisilik, J. Andrew; Singer, Dustin; Camargo, Simone M. R.; Makrides, Victoria; Ramadan, Tamara; Verrey, Francois; Wagner, Carsten A.; Penninger, Josef M.			Essential role for collectrin in renal amino acid transport	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; KIDNEY; ACE2	Angiotensin-converting enzyme 2 (ACE2) is a regulator of the renin angiotensin system involved in acute lung failure, cardiovascular functions and severe acute respiratory syndrome (SARS) infections in mammals(1-3). A gene encoding a homologue to ACE2, termed collectrin (Tmem27), has been identified in immediate proximity to the ace2 locus(4). The in vivo function of collectrin was unclear. Here we report that targeted disruption of collectrin in mice results in a severe defect in renal amino acid uptake owing to downregulation of apical amino acid transporters in the kidney. Collectrin associates with multiple apical transporters and defines a novel group of renal amino acid transporters. Expression of collectrin in Xenopus oocytes and Madin-Darby canine kidney (MDCK) cells enhances amino acid transport by the transporter B-0 AT1. These data identify collectrin as a key regulator of renal amino acid uptake.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Univ Vienna, Ctr Ecol, Dept chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Vienna; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	wagnerca@access.unizh.ch; josef.penninger@imba.oeaw.ac.at	Richter, Andreas/D-8483-2012; Penninger, Josef M/I-6860-2013; makrides, victoria/GSN-6210-2022	Richter, Andreas/0000-0003-3282-4808; Penninger, Josef M/0000-0002-8194-3777; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824				Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Bauch C, 2003, J BIOL CHEM, V278, P1316, DOI 10.1074/jbc.M210449200; Bergeron A, 2003, M S-MED SCI, V19, P976, DOI 10.1051/medsci/20031910976; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Endo F, 2003, J NUTR, V133, p2063S, DOI 10.1093/jn/133.6.2063S; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; FOMEO E, 2006, AM J PHYSIOL-RENAL, V290, pF376; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; KOWALCZUK S, 2005, BIOCH J MAR, V15, P417; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; MALATHI P, 1979, BIOCHIM BIOPHYS ACTA, V554, P259, DOI 10.1016/0005-2736(79)90023-3; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200	23	161	165	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1088	1091		10.1038/nature05475	http://dx.doi.org/10.1038/nature05475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167413				2022-12-24	WOS:000242971100060
J	Roche, S; Rey, FA; Gaudin, Y; Bressanelli, S				Roche, Stephane; Rey, Felix A.; Gaudin, Yves; Bressanelli, Stephane			Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G	SCIENCE			English	Article							FUSION-INACTIVE CONFORMATION; RABIES VIRUS; MEMBRANE-FUSION; LOW-PH; INFLUENZA HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE; AMINO-ACIDS; PROTEIN; MUTATIONS	Glycoprotein G of the vesicular stomatitis virus triggers membrane fusion via a low pH-induced structural rearrangement. Despite the equilibrium between the pre- and postfusion states, the structure of the prefusion form, determined to 3.0 angstrom resolution, shows that the fusogenic transition entails an extensive structural reorganization of G. Comparison with the structure of the postfusion form suggests a pathway for the conformational change. In the prefusion form, G has the shape of a tripod with the fusion loops exposed, which point toward the viral membrane, and with the antigenic sites located at the distal end of the molecule. A large number of G glycoproteins, perhaps organized as in the crystals, act cooperatively to induce membrane merging.	CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay	Gaudin, Y (corresponding author), CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France.	gaudin@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Gaudin, Yves/0000-0002-0122-2954; Bressanelli, Stephane/0000-0002-0921-6727; Rey, Felix/0000-0002-9953-7988				BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; Gaudin Y, 1997, J VIROL, V71, P3742, DOI 10.1128/JVI.71.5.3742-3750.1997; GAUDIN Y, 1995, J VIROL, V69, P5528, DOI 10.1128/JVI.69.9.5528-5534.1995; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gaudin Y, 2000, Subcell Biochem, V34, P379; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Lafay F, 1996, J GEN VIROL, V77, P339, DOI 10.1099/0022-1317-77-2-339; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LUO LZ, 1988, VIROLOGY, V163, P341, DOI 10.1016/0042-6822(88)90274-7; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rose JK, 2001, FIELDS VIROLOGY, P1221; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	37	270	285	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					843	848		10.1126/science.1135710	http://dx.doi.org/10.1126/science.1135710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289996				2022-12-24	WOS:000244069000069
J	Pielke, R; Prins, G; Rayner, S; Sarewitz, D				Pielke, Roger, Jr.; Prins, Gwyn; Rayner, Steve; Sarewitz, Daniel			Lifting the taboo on adaptation	NATURE			English	Editorial Material							CLIMATE-CHANGE		Univ Colorado, Boulder, CO 80309 USA; London Sch Econ, London, England; Columbia Univ, New York, NY 10027 USA; Univ Oxford, James Martin Inst, Oxford OX1 2JD, England; Arizona State Univ, Tempe, AZ 85287 USA	University of Colorado System; University of Colorado Boulder; University of London; London School Economics & Political Science; Columbia University; University of Oxford; Arizona State University; Arizona State University-Tempe	Pielke, R (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pielke@colorado.edu		rayner, steve/0000-0001-6779-9345				Bouwer LM, 2006, DISASTERS, V30, P49, DOI 10.1111/j.1467-9523.2006.00306.x; Burton I., 2005, POLICY OPTIONS, P33; Goklany IM, 2004, SCIENCE, V306, P55, DOI 10.1126/science.306.5693.55; Huq S, 2004, IDS BULL-I DEV STUD, V35, P15, DOI 10.1111/j.1759-5436.2004.tb00129.x; Pielke RA, 2005, ENVIRON SCI POLICY, V8, P548, DOI 10.1016/j.envsci.2005.06.013; Pielke RA, 2005, POPUL ENVIRON, V26, P255, DOI 10.1007/s11111-005-1877-6; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Stern N., 2006, EC CLIMATE CHANGE ST; THOMPSON M, 1998, HUMAN CHOICE CLIMATE, V1; *UNFCCC, 2002, DELH DECL CLIM CHANG	10	326	336	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					597	598		10.1038/445597a	http://dx.doi.org/10.1038/445597a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	133UM	17287795	Bronze			2022-12-24	WOS:000244039400024
J	Pogach, L; Engelgau, M; Aron, D				Pogach, Leonard; Engelgau, Michael; Aron, David			Measuring progress toward achieving hemoglobin A(1c) goals in diabetes care - Pass/fail or partial credit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC CONTROL		VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, E Orange, NJ 07018 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Case Sch Med, Cleveland, OH 44106 USA	New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Pogach, L (corresponding author), VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, 385 Tremont Ave, E Orange, NJ 07018 USA.	Leonard.Pogach@va.gov						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 1996, DIABETES, V45, P1289; Berlowitz DR, 2005, HEALTH SERV RES, V40, P1836, DOI 10.1111/j.1475-6773.2005.00436.x; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; *COLL AM PATH, 2006, GLYC SURV 2006 GH2 A; Engelgau MM, 2005, ANN INTERN MED, V143, P301, DOI 10.7326/0003-4819-143-4-200508160-00011; Gavin L A, 2000, Endocr Pract, V6, P305; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Lohr K.N., 1990, MEDICARE STRATEGY QU, V1; *NAT COMM QUAL ASS, 2006, HEDIS 2007, V2; *NAT COMM QUAL ASS, BRIDG EXC; Pogach LM, 2006, DIABETES CARE, V29, P241, DOI 10.2337/diacare.29.02.06.dc05-1468; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; AMBULATORY CARE QUAL	22	37	39	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					520	523		10.1001/jama.297.5.520	http://dx.doi.org/10.1001/jama.297.5.520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284702				2022-12-24	WOS:000243999100029
J	Sidorenko, A; Krupenkin, T; Taylor, A; Fratzl, P; Aizenberg, J				Sidorenko, Alexander; Krupenkin, Tom; Taylor, Ashley; Fratzl, Peter; Aizenberg, Joanna			Reversible switching of hydrogel-actuated nanostructures into complex micropatterns	SCIENCE			English	Article							SHAPE-MEMORY; PHOTONIC CRYSTALS; MICROSTRUCTURES; TENSEGRITY; SURFACES	Responsive behavior, which is intrinsic to natural systems, is becoming a key requirement for advanced artificial materials and devices, presenting a substantial scientific and engineering challenge. We designed dynamic actuation systems by integrating high-aspect-ratio silicon nanocolumns, either free-standing or substrate-attached, with a hydrogel layer. The nanocolumns were put in motion by the "muscle" of the hydrogel, which swells or contracts depending on the humidity level. This actuation resulted in a fast reversible reorientation of the nanocolumns from tilted to perpendicular to the surface. By further controlling the stress field in the hydrogel, the formation of a variety of elaborate reversibly actuated micropatterns was demonstrated. The mechanics of the actuation process have been assessed. Dynamic control over the movement and orientation of surface nanofeatures at the micron and submicron scales may have exciting applications in actuators, microfluidics, or responsive materials.	Bell Labs, Alcatel Lucent, Murray Hill, NJ 07974 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Alcatel-Lucent; AT&T; Max Planck Society	Aizenberg, J (corresponding author), Bell Labs, Alcatel Lucent, 600 Mt Ave, Murray Hill, NJ 07974 USA.	jaizenberg@alcatel-lucent.com	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Sidorenko, Alexander/0000-0002-3109-7605				Asher SA, 2004, NAN SCI TEC, P145; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; BUCKMINSTERFULL.R, 1961, PORTFOLIO ART NEWS A, V4, P112; Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M; Defossez M, 2003, MECH RES COMMUN, V30, P311, DOI 10.1016/S0093-6413(03)00030-2; Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914; Gates BD, 2004, ANGEW CHEM INT EDIT, V43, P2780, DOI 10.1002/anie.200353009; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Iyer KS, 2003, MACROMOLECULES, V36, P6519, DOI 10.1021/ma034460z; Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lee SB, 2004, J AM CHEM SOC, V126, P13400, DOI 10.1021/ja048463i; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Maurer MK, 2005, ADV FUNCT MATER, V15, P1401, DOI 10.1002/adfm.200400070; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; Minko S., 2006, RESPONSIVE POLYM MAT; OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Zhai L, 2004, NANO LETT, V4, P1349, DOI 10.1021/nl049463j	26	471	485	15	690	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					487	490		10.1126/science.1135516	http://dx.doi.org/10.1126/science.1135516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255505	Green Submitted			2022-12-24	WOS:000243726600038
J	Bibbins-Domingo, K; Fernandez, A				Bibbins-Domingo, Kirsten; Fernandez, Alicia			BiDil for heart failure in black patients: Implications of the U.S. Food and Drug Administration approval	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ISOSORBIDE DINITRATE; RACIAL DISPARITIES; RANDOMIZED-TRIAL; RACE; HYDRALAZINE; MANAGEMENT; COMMITTEE; OUTCOMES; DISEASE	In 2005, the combination of hydralazine hydrochloride and isosorbide dinitrate was approved by the U. S. Food and Drug Administration (FDA) for treating heart failure in black patients. In departing from its long history of approving drugs for general clinical indications without regard to demographic classification, the FDA cited the need to address racial disparities in health as an important contributor to their decision. The authors argue that this decision, although perhaps well-intentioned, was based on flawed scientific interpretation of trial results that claimed differential drug response by race and ignored the considerable literature on the cause of racial disparities in health and health care. Because of its potential impact on future drug approvals, the FDA's decision is a setback in the scientific and policy discourse on medical therapeutics and race and specifically hinders the efforts aimed at eliminating health and health care disparities.	Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu			NCRR NIH HHS [K23 RR01832401] Funding Source: Medline; NHLBI NIH HHS [N01-HC-95095] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; BROOKS J, 2006, HATTIESBURG AM  0718; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; CARLSON RJ, 2005, HLTH AFF MILLWO 1011; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kahn J, 2005, NAT GENET, V37, P655, DOI 10.1038/ng0705-655; Kahn J, 2003, PERSPECT BIOL MED, V46, P473, DOI 10.1353/pbm.2003.0087; KAHN J, 2005, HASTING CENT REP, V35; Kahn JD, 2005, BRIT MED J, V330, P1508, DOI 10.1136/bmj.330.7506.1508-a; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lillie-Blanton M, 2004, J AM COLL CARDIOL, V44, P503, DOI 10.1016/j.jacc.2004.04.043; Mathew J, 2005, AM HEART J, V150, P968, DOI 10.1016/j.ahj.2005.03.060; Meade TW, 1998, LANCET, V351, P233; Moran AE, 2005, NEW ENGL J MED, V352, P1041; NAINGGOLAN L, 2006, HEART WIRE      0711; *NIH, 2005, INCL WOM MIN PART RE; Nissen SE, 2005, CIRCULATION, V112, P2043, DOI 10.1161/CIRCULATIONAHA.105.573105; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; SANKAR P, 2005, HLTH AFF MILLWO 1011; SAUL S, 2006, NY TIMES        0522; Saul Stephanie, 2005, N Y Times Web, pC4; Saul Stephanie, 2005, N Y Times Web, pC3; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; *US FDA, 2005, SUMM MIN CARD REN DR; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	49	35	35	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					52	W8		10.7326/0003-4819-146-1-200701020-00009	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200222				2022-12-24	WOS:000247893300007
J	Hanauer, DI; Jacobs-Sera, D; Pedulla, ML; Cresawn, SG; Hendrix, RW; Hatfull, GF				Hanauer, David I.; Jacobs-Sera, Deborah; Pedulla, Marisa L.; Cresawn, Steven G.; Hendrix, Roger W.; Hatfull, Graham F.			Teaching scientific inquiry	SCIENCE			English	Editorial Material							SCIENCE; PHAGE		Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Montana, Dept Biol Sci, Butte, MT 59701 USA	Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Montana System; University of Montana	Hanauer, DI (corresponding author), Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA.	hanauer@iup.edu; gfh@pitt.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975] Funding Source: NIH RePORTER; NCRR NIH HHS [RR16455] Funding Source: Medline; NIGMS NIH HHS [GM51975] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2006, AM LAB REP INV HIGH; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; Dunbar K., 1997, CREATIVE THOUGHT INV, P461, DOI [10.1037/10227-017, DOI 10.1037/10227-017]; HANAUER D, 2006, AM ASS APPL LING C M; Hanauer D., 2006, SCI DISCOURSE MULTIL; Harris Richard, 1997, LANDMARK ESSAYS RHET; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Ivezic Z, 2001, ASTRON J, V122, P2749, DOI 10.1086/323452; KUHN D, 1993, SCI EDUC, V77, P319, DOI 10.1002/sce.3730770306; Lemke J. L, 1990, TALKING SCI LANGUAGE; Lewis Jennifer R, 2002, Cell Biol Educ, V1, P26, DOI 10.1187/cbe.02-02-0003; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; National Research Council (NRC), 1996, NAT SCI ED STAND; NOTT M, 1995, INT J SCI EDUC, V17, P399, DOI 10.1080/0950069950170310; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pfund C, 2006, SCIENCE, V311, P473, DOI 10.1126/science.1123806; Prelli LawrenceJ., 1989, RHETORIC SCI INVENTI; QIN Y, 1990, COGNITIVE SCI, V14, P281, DOI 10.1207/s15516709cog1402_4; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131	20	93	93	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1880	1881		10.1126/science.1136796	http://dx.doi.org/10.1126/science.1136796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185586				2022-12-24	WOS:000242996800030
J	Small, GW; Kepe, V; Ercoli, LM; Siddarth, P; Bookheimer, SY; Miller, KJ; Lavretsky, H; Burggren, AC; Cole, GM; Vinters, HV; Thompson, PM; Huang, SC; Satyamurthy, N; Phelps, ME; Barrio, JR				Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.; Siddarth, Prabha; Bookheimer, Susan Y.; Miller, Karen J.; Lavretsky, Helen; Burggren, Alison C.; Cole, Greg M.; Vinters, Harry V.; Thompson, Paul M.; Huang, S. -C.; Satyamurthy, N.; Phelps, Michael E.; Barrio, Jorge R.			PET of brain amyloid and tau in mild cognitive impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; PLAQUES; DEMENTIA; CLASSIFICATION; BINDING; TANGLES; HEALTH; RISK; AGE	BACKGROUND Amyloid senile plaques and tau neurofibrillary tangles are neuropathological hallmarks of Alzheimer's disease that accumulate in the cortical regions of the brain in persons with mild cognitive impairment who are at risk for Alzheimer's disease. Noninvasive methods to detect these abnormal proteins are potentially useful in developing surrogate markers for drug discovery and diagnostics. METHODS We enrolled 83 volunteers with self-reported memory problems who had undergone neurologic and psychiatric evaluation and positron-emission tomography ( PET). On the basis of cognitive testing, 25 volunteers were classified as having Alzheimer's disease, 28 as having mild cognitive impairment, and 30 as having no cognitive impairment ( healthy controls). PET was performed after injection of 2-(1-{6-[(2-[F-18] fluoroethyl) ( methyl) amino]-2-naphthyl} ethylidene) malononitrile (FDDNP), a molecule that binds to plaques and tangles in vitro. All subjects also underwent 2- deoxy-2-[ F-18] fluoro-D-glucose (FDG) PET, and 72 underwent magnetic resonance imaging (MRI). RESULTS Global values for FDDNP-PET binding ( average of the values for the temporal, parietal, posterior cingulate, and frontal regions) were lower in the control group than in the group with mild cognitive impairment ( P< 0.001), and the values for binding in the group with mild cognitive impairment were lower than in the group with Alzheimer's disease ( P< 0.001). FDDNP-PET binding differentiated among the diagnostic groups better than did metabolism on FDG-PET or volume on MRI. CONCLUSIONS FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment. This technique is potentially useful as a noninvasive method to determine regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, Brain Mapping Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Lab Neuro Imaging, Los Angeles, CA USA; Univ Calif Los Angeles, Alzheimers Dis Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Ctr Aging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Small, GW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Suite 88-201,760 Westwood Plaza, Los Angeles, CA 90024 USA.	gsmall@mednet.ucla.edu	Thompson, Paul M/C-4194-2018; Lavretsky, Helen/M-5711-2015	Thompson, Paul M/0000-0002-4720-8867; Lavretsky, Helen/0000-0001-9990-5085; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [M01-RR00865] Funding Source: Medline; NIA NIH HHS [AG10123, MH/AG58156, P01AG025831, AG13308, P50AG16570] Funding Source: Medline; NIMH NIH HHS [MH52453, K23 MH001948] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453, K23MH001948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013308, P50AG016570, P01AG025831, P30AG010123] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agdeppa ED, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0004.2001; Agdeppa ED, 2003, NEUROSCIENCE, V117, P723, DOI 10.1016/S0306-4522(02)00907-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; De Jager CA, 2005, NEUROCASE, V11, P72, DOI 10.1080/13554790490896820; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilewski M.J., 1986, CLIN MEMORY ASSESSME, P93, DOI [10.1037/10057-008, DOI 10.1037/10057-008]; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; SMALL GW, 1989, ARCH GEN PSYCHIAT, V46, P527; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMALL GW, 2004, 9 INT C ALZH DIS REL; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Verhoeff NPLG, 2004, AM J GERIAT PSYCHIAT, V12, P584, DOI 10.1176/appi.ajgp.12.6.584; Vinters HV, 2004, CLIN NEUROSCI RES, V3, P413, DOI 10.1016/j.cnr.2004.04.007; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	32	523	550	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2652	2663		10.1056/NEJMoa054625	http://dx.doi.org/10.1056/NEJMoa054625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182990				2022-12-24	WOS:000242956200006
J	Iwasaki, A				Iwasaki, Akiko			Division of labor by dendritic cells	CELL			English	Editorial Material							CROSS-PRESENTATION; LYMPH-NODE; T-CELLS; ANTIGEN; IMMUNITY; CD8(+)		Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					435	436		10.1016/j.cell.2007.01.024	http://dx.doi.org/10.1016/j.cell.2007.01.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289563	Bronze			2022-12-24	WOS:000244842700010
J	Todd, JD; Rogers, R; Li, YG; Wexler, M; Bond, PL; Sun, L; Curson, ARJ; Malin, G; Steinke, M; Johnston, AWB				Todd, Jonathan D.; Rogers, Rachel; Li, You Guo; Wexler, Margaret; Bond, Philip L.; Sun, Lei; Curson, Andrew R. J.; Malin, Gill; Steinke, Michael; Johnston, Andrew W. B.			Structural and regulatory genes required to make the gas dimethyl sulfide in bacteria	SCIENCE			English	Article							HIGHER-PLANTS; DMSP; DIMETHYLSULFONIOPROPIONATE; DIMETHYLSULPHONIOPROPIONATE; ENVIRONMENT; METABOLISM; RHIZOBIUM; SULFUR; FLUX	Dimethyl sulfide (DMS) is a key compound in global sulfur and carbon cycles. DMS oxidation products cause cloud nucleation and may affect weather and climate. DMS is generated largely by bacterial catabolism of dimethylsulfoniopropionate (DMSP), a secondary metabolite made by marine algae. We demonstrate that the bacterial gene dddD is required for this process and that its transcription is induced by the DMSP substrate. Cloned dddD from the marine bacterium Marinomonas and from two bacterial strains that associate with higher plants, the N-2-fixing symbiont Rhizobium NGR234 and the root-colonizing Burkholderia cepacia AMMD, conferred to Escherichia coli the ability to make DMS from DMSP. The inferred enzymatic mechanism for DMS liberation involves an initial step in which DMSP is modified by addition of acyl coenzyme A, rather than the immediate release of DMS by a DMSP lyase, the previously suggested mechanism.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Wexler, Margaret/G-3423-2011; Steinke, Michael/A-6137-2012; Johnston, Andrew W B/D-1859-2009; Todd, Jonathan/B-8967-2009; Curson, Andrew RJ/B-8964-2009; Bond, Philip/N-6649-2017; Rogers, Rachel/GVT-5579-2022; Malin, Gill/C-6985-2009; Bond, Philip/C-6046-2009	Steinke, Michael/0000-0001-6820-0154; Todd, Jonathan/0000-0003-0777-9312; Bond, Philip/0000-0002-9025-4797; Malin, Gill/0000-0002-3639-9215; 	Biotechnology and Biological Sciences Research Council [BB/E01688X/1] Funding Source: Medline; Natural Environment Research Council [NE/B501039/1, NER/T/S/2001/00253, NE/B500282/1] Funding Source: researchfish; BBSRC [BB/E01688X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ansede JH, 2001, APPL ENVIRON MICROB, V67, P1210, DOI 10.1128/AEM.67.3.1210-1217.2001; Ansede JH, 2001, APPL ENVIRON MICROB, V67, P3134, DOI 10.1128/AEM.67.7.3134-3139.2001; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Ramette A, 2005, APPL ENVIRON MICROB, V71, P1193, DOI 10.1128/AEM.71.3.1193-1201.2005; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; REED RH, 1983, MAR BIOL LETT, V4, P173; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; STEFELS J, IN PRESS BIOGEOCHEMI; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	21	200	209	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					666	669		10.1126/science.1135370	http://dx.doi.org/10.1126/science.1135370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272727				2022-12-24	WOS:000243909400049
J	Perry, B; Sones, K				Perry, Brian; Sones, Keith			Science for development - Poverty reduction through animal health	SCIENCE			English	Editorial Material							EPIDEMIOLOGY; VIRUS		Int Livestock Res Inst, Nairobi 00100, Kenya; Keith Sones Associates, Nairobi 00502, Kenya	CGIAR; International Livestock Research Institute (ILRI)	Perry, B (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya.	b.perry@cgiar.org		Perry, Brian/0000-0002-6962-2102				ANDERSON R M, 1991; Baylis M, 2006, EFFECTS CLIMATE CHAN; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Catley A, 2004, PREV VET MED, V65, P17, DOI 10.1016/j.prevetmed.2004.06.007; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; *DFID, 2004, 2 DFID; *DFID, AN HLTH PROGR; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gulati A., 2005, S HIGH VAL AGR VERT; Hall A., 2002, Agricultural research policy in an era of privatization, P155, DOI 10.1079/9780851996004.0155; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jones P. G., COMMUNICATION; *LIV DEV, 1999, LIV POV FOC DEV; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; MCLEOD A, AN HLTH PROGR; Perry B, 2001, PREV VET MED, V48, P231, DOI 10.1016/S0167-5877(00)00203-8; Perry B. D, 2002, INVESTING ANIMAL HLT; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Thornton P.K., 2002, MAPPING POVERTY LIVE; *U PRET FAC VET EQ, 2006, IMP AFR HORS SICKN S; *UK FOR PROGR, 2006, INF DIS PREP FUT F 1; *UN FAO, AN PROD HLTH PROGR; WEARVER J, 2006, PARTICIPATORY DIS SU; *WOODD MACK LTD, 2005, ANN REP INT FED AN H	25	54	57	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					333	334		10.1126/science.1138614	http://dx.doi.org/10.1126/science.1138614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126SI	17234933				2022-12-24	WOS:000243535400023
J	Baier, DB; Gatesy, SM; Jenkins, FA				Baier, David B.; Gatesy, Stephen M.; Jenkins, Farish A., Jr.			A critical ligamentous mechanism in the evolution of avian flight	NATURE			English	Article							PIGEONS COLUMBA-LIVIA; FLAPPING FLIGHT; SPEEDS; RANGE; CHINA; BIRD; KINEMATICS; SHOULDER; ANATOMY; HUMERUS	Despite recent advances in aerodynamic(1,2), neuromuscular(3-5) and kinematic(6,7) aspects of avian flight and dozens of relevant fossil discoveries(8), the origin of aerial locomotion and the transition from limbs to wings continue to be debated(9,10). Interpreting this transition depends on understanding the mechanical interplay of forces in living birds, particularly at the shoulder where most wing motion takes place. Shoulder function depends on a balance of forces from muscles, ligaments and articular cartilages, as well as inertial, gravitational and aerodynamic loads on the wing(11). Here we show that the force balance system of the shoulder evolved from a primarily muscular mechanism to one in which the acrocoracohumeral ligament has a critical role. Features of the shoulder of Mesozoic birds and closely related theropod dinosaurs indicate that the evolution of flight preceded the acquisition of the ligament-based force balance system and that some basal birds are intermediate in shoulder morphology.	Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Brown University; Harvard University; Harvard University	Baier, DB (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	David_Baier@brown.edu						Bannasch R., 1986, Gegenbaurs Morphologisches Jahrbuch, V132, P757; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM., 2002, MESOZOIC BIRDS; de Beer G., 1954, CRAFTSMANS HDB; DIAL KP, 1993, J EXP BIOL, V176, P31; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gatesy S, 2004, J VERTEBR PALEONTOL, V24, p63A; Goslow GE, 2000, BRAIN BEHAV EVOLUT, V55, P85; Gray S.J., 1968, ANIMAL LOCOMOTION; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Paul G. S., 2002, DINOSAURS OF THE AIR; PENNYCUICK CJ, 1967, J EXP BIOL, V46, P219; Poore SO, 1997, J EXP BIOL, V200, P2987; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Sy M., 1936, Journal fuer Ornithologie Berlin, V84, P199, DOI 10.1007/BF01906709; Tobalske BW, 1999, J EXP BIOL, V202, P1725; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; Usherwood JR, 2005, J EXP BIOL, V208, P355, DOI 10.1242/jeb.01359; Woolley JD, 2000, J EXP BIOL, V203, P1767; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	30	52	54	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					307	310		10.1038/nature05435	http://dx.doi.org/10.1038/nature05435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17173029				2022-12-24	WOS:000243504700043
J	Joshi, P; Islam, S; Pais, P; Reddy, S; Dorairaj, P; Kazmi, K; Pandey, MR; Haque, S; Mendis, S; Rangarajan, S; Yusuf, S				Joshi, Prashant; Islam, Shofiqul; Pais, Prem; Reddy, Srinath; Dorairaj, Prabhakaran; Kazmi, Khawar; Pandey, Mrigendra Raj; Haque, Sirajul; Mendis, Shanthi; Rangarajan, Sumathy; Yusuf, Salim			Risk factors for early myocardial infarction in South Asians compared with individuals in other countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; ARTERY-DISEASE; FOLLOW-UP; ATTRIBUTABLE RISK; GLOBAL BURDEN; ETHNIC-GROUPS; HOMOCYSTEINE	Context South Asians have high rates of acute myocardial infarction ( AMI) at younger ages compared with individuals from other countries but the reasons for this are unclear. Objective To evaluate the association of risk factors for AMI in native South Asians, especially at younger ages, compared with individuals from other countries. Design, Setting, and Participants Standardized case-control study of 1732 cases with first AMI and 2204 controls matched by age and sex from 15 medical centers in 5 South Asian countries and 10 728 cases and 12 431 controls from other countries. Individuals were recruited to the study between February 1999 and March 2003. Main Outcome Measure Association of risk factors for AMI. Results The mean(SD) age for first AMI was lower in South Asian countries ( 53.0 [11.4] years) than in other countries ( 58.8 [12.2] years; P <. 001). Protective factors were lower in South Asian controls than in controls from other countries (moderate- or high-intensity exercise, 6.1% vs 21.6%; daily intake of fruits and vegetables, 26.5% vs 45.2%; alcohol consumption >= once/wk, 10.7% vs 26.9%). However, some harmful factors were more common in native South Asians than in individuals from other countries ( elevated apolipoprotein B-100/ apolipoprotein A-I ratio, 43.8% vs31.8%; history of diabetes, 9.5% vs 7.2%). Similar relative associations were found in South Asians compared with individuals from other countries for the risk factors of current and former smoking, apolipoprotein B100/ apolipoprotein A-I ratio for the top vs lowest tertile, waist-to-hip ratio for the top vs lowest tertile, history of hypertension, history of diabetes, psychosocial factors such as depression and stress at work or home, regular moderate- or high-intensity exercise, and daily intake of fruits and vegetables. Alcohol consumption was not found to be a risk factor for AMI in South Asians. The combined odds ratio for all 9 risk factors was similar in South Asians (123.3; 95% confidence interval [CI], 38.7-400.2] and in individuals from other countries (125.7; 95% CI, 88.5-178.4). The similarities in the odds ratios for the risk factors explained a high and similar degree of population attributable risk in both groups (85.8%[ 95% CI, 78.0%-93.7%] vs 88.2% [ 95% CI, 86.3%-89.9%], respectively). When stratified by age, South Asians had more risk factors at ages younger than 60 years. After adjusting for all 9 risk factors, the predictive probability of classifying an AMI case as being younger than 40 years was similar in individuals from South Asian countries and those from other countries. Conclusion The earlier age of AMI in South Asians can be largely explained by higher risk factor levels at younger ages.	Govt Med Coll, Dept Med, Nagpur, Maharashtra, India; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; St Johns Med Coll, Dept Med, Bangalore, Karnataka, India; All India Inst Med Sci, New Delhi, India; Aga Khan Univ, Dept Cardiol, Karachi, Pakistan; Sheikh Med Univ, Dept Cardiol, Sheilkh, Bangladesh; WHO, CH-1211 Geneva, Switzerland	McMaster University; Population Health Research Institute; McMaster University; St. John's National Academy of Health Sciences; St. John's Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi; Aga Khan University; World Health Organization	Yusuf, S (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, McMaster Clin, 2nd Floor,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Prabhakaran, Dorairaj/B-4147-2011; Mendis, Shanthi/GLT-0465-2022	Prabhakaran, Dorairaj/0000-0002-3172-834X; mendis, shanthi/0000-0002-8959-5738; Yusuf, Salim/0000-0003-4776-5601				Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brunner E, 1996, LANCET, V347, P1008, DOI 10.1016/S0140-6736(96)90147-6; ENAS EA, 1992, AM J CARDIOL, V70, P945, DOI 10.1016/0002-9149(92)90744-J; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; JOSHI PP, 2003, S ASIAN J PREV CARDI, V7, P195; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; MATTHEWS JH, 1984, CLIN LAB HAEMATOL, V6, P1; MCKEIGUE PM, 1988, BRIT MED J, V297, P903, DOI 10.1136/bmj.297.6653.903; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Murray C.J, 1994, GLOBAL COMP ASSESSME; Murray C.J.L., 1996, GLOBAL BURDEN DIS IN, VII, P906; Pais P, 1996, LANCET, V348, P358, DOI 10.1016/S0140-6736(96)02507-X; Panagiotakos DB, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-2; Patil SS, 2004, NATL MED J INDIA, V17, P189; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Rastogi T, 2004, AM J CLIN NUTR, V79, P582; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosengren A, 1997, ANN EPIDEMIOL, V7, P69, DOI 10.1016/S1047-2797(96)00106-8; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; WALTER SD, 1975, BIOMETRIKA, V62, P371, DOI 10.1093/biomet/62.2.371; Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	46	562	570	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					286	294		10.1001/jama.297.3.286	http://dx.doi.org/10.1001/jama.297.3.286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227980	Bronze			2022-12-24	WOS:000243472300023
J	Gibney, EM				Gibney, Eric M.			Concurrent sentences - Dialysis in the state penitentiary	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Gibney, EM (corresponding author), Virginia Commonwealth Univ, Div Nephrol, Med Coll Virginia Campus, Richmond, VA 23284 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					108	110		10.1056/NEJMp068102	http://dx.doi.org/10.1056/NEJMp068102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	124NE	17215527				2022-12-24	WOS:000243373700002
J	Huang, B; Wu, HK; Bhaya, D; Grossman, A; Granier, S; Kobilka, BK; Zare, RN				Huang, Bo; Wu, Hongkai; Bhaya, Devaki; Grossman, Arthur; Granier, Sebastien; Kobilka, Brian K.; Zare, Richard N.			Counting low-copy number proteins in a single cell	SCIENCE			English	Article							CAPILLARY-ELECTROPHORESIS; ELECTROKINETIC TRANSPORT; FLUORESCENCE DETECTION; MOLECULE DETECTION; PHYCOBILISOME; POLY(DIMETHYLSILOXANE); NANOCHANNELS; ARCHITECTURE; CONFINEMENT; EXPRESSION	We have designed a microfluidic device in which we can manipulate, lyse, label, separate, and quantify the protein contents of a single cell using single-molecule fluorescence counting. Generic labeling of proteins is achieved through fluorescent-antibody binding. The use of cylindrical optics enables high-efficiency (approximate to 60%) counting of molecules in micrometer-sized channels. We used this microfluidic device to quantify beta(2) adrenergic receptors expressed in insect cells (SF9). We also analyzed phycobiliprotein contents in individual cyanobacterial cells ( Synechococcus sp. PCC 7942) and observed marked differences in the levels of specific complexes in cell populations that were grown under nitrogen-depleted conditions.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol & Med, Stanford, CA 94305 USA	Stanford University; Carnegie Institution for Science; Stanford University	Zare, RN (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	zare@stanford.edu	Zare, Richard N./A-8410-2009; Granier, Sebastien/J-1089-2016; Huang, Bo/D-4854-2009	Kobilka, Brian/0000-0001-5958-3990; Zare, Richard/0000-0001-5266-4253				Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CASTRO A, 1993, ANAL CHEM, V65, P849, DOI 10.1021/ac00055a004; Chen DY, 1996, ANAL CHEM, V68, P690, DOI 10.1021/ac950651r; Cottingham K, 2004, ANAL CHEM, V76, p235A, DOI 10.1021/ac041584g; Foquet M, 2004, ANAL CHEM, V76, P1618, DOI 10.1021/ac035088o; GLAZER AN, 1983, ANN INST PASTEUR MIC, VB134, P159, DOI 10.1016/S0769-2609(83)80103-3; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Haab BB, 1999, ANAL CHEM, V71, P5137, DOI 10.1021/ac990644t; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Hu S, 2004, ANAL CHEM, V76, P4044, DOI 10.1021/ac0498314; Huang B, 2005, LAB CHIP, V5, P1005, DOI 10.1039/b509251e; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lundqvist A, 2003, ELECTROPHORESIS, V24, P1737, DOI 10.1002/elps.200305429; Lyon WA, 1997, ANAL CHEM, V69, P3400, DOI 10.1021/ac9700742; Ma YF, 2001, ELECTROPHORESIS, V22, P421, DOI 10.1002/1522-2683(200102)22:3<421::AID-ELPS421>3.0.CO;2-W; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ocvirk G, 2000, ELECTROPHORESIS, V21, P107, DOI 10.1002/(SICI)1522-2683(20000101)21:1<107::AID-ELPS107>3.0.CO;2-Y; Pennathur S, 2005, ANAL CHEM, V77, P6772, DOI 10.1021/ac052141v; Pennathur S, 2005, ANAL CHEM, V77, P6782, DOI 10.1021/ac0508346; Whelan RJ, 2002, ANAL CHEM, V74, P4570, DOI 10.1021/ac025669y; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; YAMANAKA G, 1980, ARCH MICROBIOL, V124, P39, DOI 10.1007/BF00407026; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	24	316	340	2	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					81	84		10.1126/science.1133992	http://dx.doi.org/10.1126/science.1133992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204646				2022-12-24	WOS:000243259100039
J	Skewgar, E; Boersma, PD; Harris, G; Caille, G				Skewgar, Elizabeth; Boersma, P. Dee; Harris, Graham; Caille, Guillermo			Sustainability - Anchovy fishery threat to Patagonian ecosystem	SCIENCE			English	Editorial Material								Unsustainable anchovy harvest could disrupt ecosystem function, other fisheries, and ecotourism revenues.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Fdn Patagonia Nat, RA-9120 Puerto Madryn, Chubut, Argentina	University of Washington; University of Washington Seattle	Skewgar, E (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	skewes@u.washington.edu	Caille, Guillermo Martín/AAU-4135-2021					Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; DELCHUBUT G, 2006, TURISMO CHUBUT GENER; *FAO FISH DEP, 2001, INF ORD PESQ REP ARG; *FAO FISH DEP, 2004, STAT WORLD FISH AQ S; Frere E., 1996, Ornitologia Neotropical, V7, P35; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; MAGNUSON JJ, 2006, DYNAMIC CHANGES MARI; *PRES REP OR UR, 2002, ADJ LIC PUBL FIRM IB; SCHONBERGER SN, 2001, 22816 WORLD BANK; *SECR AGR, 2006, DES CAPT MAR TOT	10	38	39	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					45	45		10.1126/science.1135767	http://dx.doi.org/10.1126/science.1135767			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204628				2022-12-24	WOS:000243259100021
J	King, JC,; Stoddard, JJ; Gaglani, MJ; Moore, KA; Magder, L; McClure, E; Rubin, JD; Englund, JA; Neuzil, K				King, James C., Jr.; Stoddard, Jeffrey J.; Gaglani, Manjusha J.; Moore, Kristine A.; Magder, Laurence; McClure, Elizabeth; Rubin, Judith D.; Englund, Janet A.; Neuzil, Kathleen			Effectiveness of school-based influenza vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS INFECTIONS; CAIV-T; CHILDREN; SCHOOLCHILDREN; SURVEILLANCE; COMMUNITY; TRIVALENT; ILLNESS	BACKGROUND: Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities. METHODS: We identified 11 demographically similar clusters of elementary schools in four states, consisting of one school we assigned to participate in a vaccination program (intervention school) and one or two schools that did not participate (control schools). During a predicted week of peak influenza activity in each state, all households with children in intervention and control schools were surveyed regarding demographic characteristics, influenza vaccination, and outcomes of influenza-like illness during the previous 7 days. RESULTS: In all, 47% of students in intervention schools received live attenuated influenza vaccine. As compared with control-school households, intervention-school households had significantly fewer influenza-like symptoms and outcomes during the recall week. Paradoxically, intervention-school households (both children and adults) had higher rates of hospitalization per 100 persons than did control-school households. However, there was no difference in the overall hospitalization rates for children or adults in households with vaccinated children, as compared with those with unvaccinated children, regardless of study-group assignment. Rates of school absenteeism for any cause (based on school records) were not significantly different between intervention and control schools. CONCLUSIONS: Most outcomes related to influenza-like illness were significantly lower in intervention-school households than in control-school households.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Medimmune Inc, Gaithersburg, MD 20878 USA; Texas A&M Univ, Scott & White Clin, Temple, TX USA; Univ Minnesota, Minneapolis, MN USA; Univ Washington, Seattle, WA 98195 USA	University System of Maryland; University of Maryland Baltimore; AstraZeneca; Medimmune; Scott & White Medical Center; Texas A&M University System; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	King, JC, (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 737 W Lombard St, Baltimore, MD 21201 USA.	jking@peds.umaryland.edu	Gaglani, Manjusha/AFQ-6802-2022	Gaglani, Manjusha/0000-0002-3952-9230				CLOVER RD, 1986, AM J DIS CHILD, V140, P706, DOI 10.1001/archpedi.1986.02140210104036; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1988, J INFECT DIS, V157, P180, DOI 10.1093/infdis/157.1.180; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Long CE, 1997, ARCH FAM MED, V6, P459, DOI 10.1001/archfami.6.5.459; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; *MEDIMMUNE VACC, 2004, FLUMIST INFL VIR VAC; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2005, MMWR MORB MORTAL WKL, V54, P328	18	233	240	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2523	2532		10.1056/NEJMoa055414	http://dx.doi.org/10.1056/NEJMoa055414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167135				2022-12-24	WOS:000242778800004
J	Bowles, S				Bowles, Samuel			Group competition, reproductive leveling, and the evolution of human altruism	SCIENCE			English	Article							GROUP SELECTION; CHIMPANZEES; BEHAVIORS; EVOLVE	Humans behave altruistically in natural settings and experiments. A possible explanation-that groups with more altruists survive when groups compete-has long been judged untenable on empirical grounds for most species. But there have been no empirical tests of this explanation for humans. My empirical estimates show that genetic differences between early human groups are likely to have been great enough so that lethal intergroup competition could account for the evolution of altruism. Crucial to this process were distinctive human practices such as sharing food beyond the immediate family, monogamy, and other forms of reproductive leveling. These culturally transmitted practices presuppose advanced cognitive and linguistic capacities, possibly accounting for the distinctive forms of altruism found in our species.	Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu						Alexander R., 2008, ESSAYS PEDAGOGY; AOKI K, 1983, EVOL INT J ORG EVOL, V36, P832; BOEHM C, 1982, J SOC BIOL STRUCT, V5, P413, DOI 10.1016/S0140-1750(82)92069-3; BOEHM C, 2000, HIERARCHY FOREST; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; BOYD R, 2003, P NATL ACAD SCI USA, V20, P123; COHEN MN, 1980, BIOSOCIAL MECHANISMS, P275; Darwin Charles, 1998, DESCENT MAN; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; EIBLEIBESFELDT I, 1982, Z TIERPSYCHOL, V60, P177; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hassan Fekri A., 1980, BIOSOCIAL MECH POPUL; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Kaplan H., 2005, MORAL SENTIMENTS MAT; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; NOE R, 1995, INT J PRIMATOL, V16, P77, DOI 10.1007/BF02700154; Pandit SA, 2003, BEHAV ECOL SOCIOBIOL, V55, P161, DOI 10.1007/s00265-003-0692-2; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; RIDLEY M, 1981, ANIM BEHAV, V29, P954, DOI 10.1016/S0003-3472(81)80034-6; ROGERS AR, 1987, ANN HUM GENET, V51, P169, DOI 10.1111/j.1469-1809.1987.tb01059.x; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; Williams G. C., 1966, P307; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; WILSON DS, 1997, AM NAT S, V150; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	37	334	342	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1569	1572		10.1126/science.1134829	http://dx.doi.org/10.1126/science.1134829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158320				2022-12-24	WOS:000242624600033
J	Okeoma, CM; Lovsin, N; Peterlin, BM; Ross, SR				Okeoma, Chioma M.; Lovsin, Nika; Peterlin, B. Matija; Ross, Susan R.			APOBEC3 inhibits mouse mammary tumour virus replication in vivo	NATURE			English	Article							HIV-1 INFECTION; T-CELLS; B-CELLS; PROTEIN; MICE; DNA; RETROVIRUSES; RECEPTOR; GENE	Genomes of all mammals encode apobec3 genes, which are thought to have a function in intrinsic cellular immunity to several viruses including human immunodeficiency virus type 1 (HIV-1)(1). APOBEC3 (A3) proteins are packaged into virions and inhibit retroviral replication in newly infected cells, at least in part by deaminating cytidines on the negative strand DNA intermediates(2). However, the role of A3 in innate resistance to mouse retroviruses is not understood. Here we show that A3 functions during retroviral infection in vivo and provides partial protection to mice against infection with mouse mammary tumour virus ( MMTV). Both mouse A3 and human A3G proteins interacted with the MMTV nucleocapsid in an RNA-dependent fashion and were packaged into virions. In addition, mouse A3-containing and human A3G-containing virions showed a marked decrease in titre. Last, A3(-/-) mice were more susceptible to MMTV infection, because virus spread was more rapid and extensive than in their wild-type littermates.	Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Ctr, Philadelphia, PA 19104 USA; Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, SI-1000 Ljubljana, Slovenia; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Ljubljana; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ross, SR (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	rosss@mail.med.upenn.edu		Ross, Susan R/0000-0002-3094-3769; Okeoma, Chioma/0000-0001-7737-6493	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baillie GJ, 2004, J VIROL, V78, P5784, DOI 10.1128/JVI.78.11.5784-5798.2004; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Dzuris JL, 1997, J VIROL, V71, P6044, DOI 10.1128/JVI.71.8.6044-6048.1997; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GOLOVKINA TV, 1995, P NATL ACAD SCI USA, V92, P4828, DOI 10.1073/pnas.92.11.4828; Golovkina TV, 1998, J VIROL, V72, P3066, DOI 10.1128/JVI.72.4.3066-3071.1998; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Indik S, 2005, CANCER RES, V65, P6651, DOI 10.1158/0008-5472.CAN-04-2609; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; MORRIS VL, 1977, J MOL BIOL, V114, P73, DOI 10.1016/0022-2836(77)90284-4; NANDI S, 1973, ADV CANCER RES, V17, P353; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Ross SR, 2000, MICROBES INFECT, V2, P1215, DOI 10.1016/S1286-4579(00)01275-2; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Uz-Zaman T, 2003, VIROLOGY, V314, P294, DOI 10.1016/S0042-6822(03)00429-X; Zhang YM, 2003, J VIROL, V77, P10468, DOI 10.1128/JVI.77.19.10468-10478.2003; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	29	156	160	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					927	930		10.1038/nature05540	http://dx.doi.org/10.1038/nature05540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259974				2022-12-24	WOS:000244341200052
J	Lieberman, D; Tooby, J; Cosmides, L				Lieberman, Debra; Tooby, John; Cosmides, Leda			The architecture of human kin detection	NATURE			English	Article							INBREEDING DEPRESSION; SIBLING INCEST; SELECTION; EVOLUTION; SEX; PREFERENCES; HYPOTHESES; HISTORY	Evolved mechanisms for assessing genetic relatedness have been found in many species, but their existence in humans has been a matter of controversy. Here we report three converging lines of evidence, drawn from siblings, that support the hypothesis that kin detection mechanisms exist in humans. These operate by computing, for each familiar individual, a unitary regulatory variable ( the kinship index) that corresponds to a pairwise estimate of genetic relatedness between self and other. The cues that the system uses were identified by quantitatively matching individual exposure to potential cues of relatedness to variation in three outputs relevant to the system's evolved functions: sibling altruism, aversion to personally engaging in sibling incest, and moral opposition to third party sibling incest. As predicted, the kin detection system uses two distinct, ancestrally valid cues to compute relatedness: the familiar other's perinatal association with the individual's biological mother, and duration of sibling coresidence.	Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA; Univ Hawaii, Dept Psychol, Honolulu, HI 96822 USA	University of California System; University of California Santa Barbara; University of Hawaii System	Lieberman, D (corresponding author), Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA.	debra@debralieberman.com			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000516] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000516-02, DP1 OD000516] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 1995, SEXUAL ATTRACTION CH; Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Bernstein I.S., 1991, P6; Bevc I, 2000, EVOL HUM BEHAV, V21, P151, DOI 10.1016/S1090-5138(99)00041-0; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cade B.S., 2005, USER MANUAL BLOSSOM; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crozier R.H., 1996, EVOLUTION SOCIAL INS; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Fessler DMT, 2004, EVOL HUM BEHAV, V25, P277, DOI 10.1016/j.evolhumbehav.2004.05.004; Fletcher DJ., 1987, KIN RECOGNITION ANIM; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hepper PG., 1991, KIN RECOGNITION; Hewlett B. S., 2005, HUNTER GATHERER CHIL; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOWELL N, 2000, DEMOGRAPHY DOBEL KUN; ITO Y, 1989, TRENDS ECOL EVOL, V4, P69, DOI 10.1016/0169-5347(89)90151-1; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Lee Richard, 1968, MAN HUNTER; Lieberman D, 2003, P ROY SOC B-BIOL SCI, V270, P819, DOI 10.1098/rspb.2002.2290; Mielke P. W., 2001, PERMUTATION METHODS; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; SHEPHER J, 1971, ARCH SEX BEHAV, V1, P293, DOI 10.1007/BF01638058; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TOOBY J, 1982, J THEOR BIOL, V97, P557, DOI 10.1016/0022-5193(82)90358-7; Walters J.R., 1987, P359; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; Westermarck E, 1891, HIST HUMAN MARRIAGE; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809	43	340	350	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					727	731		10.1038/nature05510	http://dx.doi.org/10.1038/nature05510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301784	Green Accepted			2022-12-24	WOS:000244205200036
J	Staudt, LM				Staudt, Louis M.			A closer look at follicular lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTHY-INDIVIDUALS; B-CELLS		NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.		Staudt, Louis/AAC-5324-2019					Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Giannelli F, 2003, BLOOD, V102, P1196, DOI 10.1182/blood-2002-05-1537; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292	4	41	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					741	742		10.1056/NEJMcibr067155	http://dx.doi.org/10.1056/NEJMcibr067155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301308				2022-12-24	WOS:000244193300016
J	Sinha, A; Levine, O; Knoll, MD; Muhib, F; Lieu, TA				Sinha, Anushua; Levine, Orin; Knoll, Maria D.; Muhib, Farzona; Lieu, Tracy A.			Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; EFFICACY; DISEASE; IMMUNIZATION; SAFETY; GAMBIA	Background Routine vaccination of infants against Streptococcus pneumoniae (pneumococcus) needs substantial investment by governments and charitable organisations. Policymakers need information about the projected health benefits, costs, and cost-effectiveness of vaccination when considering these investments. Our aim was to incorporate these data into an economic analysis of pneumococcal vaccination of infants in countries eligible for financial support from the Global Alliance for Vaccines & immunization (GAVI). Methods We constructed a decision analysis model to compare pneumococcal vaccination of infants aged 6, 10, and 14 weeks with no vaccination in the 72 countries that were eligible as of 2005. We used published and unpublished data to estimate child mortality, effectiveness of pneumococcal conjugate vaccine, and immunisation. rates. Findings Pneumococcal vaccination at the rate of diptheria-tetanus-pertussis vaccine coverage was projected to prevent 262000 deaths per year (7%) in children aged 3-29 months in the 72 developing countries studied, thus averting 8.34 million disability-adjusted life years (DALYs) yearly. If every child could be reached, up to 407 000 deaths per year would be prevented. At a vaccine cost of International $5 per dose, vaccination would have a net cost of $838 million, a cost of $100 per DALY averted. Vaccination at this price was projected to be highly cost-effective in 68 of 72 countries when each country's per head gross domestic product per DALY averted was used as a benchmark. Interpretation At a vaccine cost of between $1 and $5 per dose, purchase and accelerated uptake of pneumococcal vaccine in the world's poorest countries is projected to substantially reduce childhood mortality and to be highly cost-effective.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07101 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Ctr Child Hlth Care Studies, Boston, MA USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Sinha, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, MSB F506,185 S Orange Ave, Newark, NJ 07101 USA.	sinhaan1@umdnj.edu		Deloria Knoll, Maria/0000-0001-9041-2671				Berndt ER, 2005, HEALTH AFFAIR, V24, P653, DOI 10.1377/hlthaff.24.3.653; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DRUMMOND M, 2000, METHODS EC EVALUATIO; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; *FIN TASK FORC, IMM PROGR EXP FIN FU; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; Hinman AR, 2004, AM J PREV MED, V26, P84, DOI 10.1016/j.amepre.2003.09.008; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kuntz KM, 2001, EC EVALUATION HLTH C, P141; Levine OS, 2004, J HEALTH POPUL NUTR, V22, P268; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lieu TA, 2005, HEALTH AFFAIR, V24, P666, DOI 10.1377/hlthaff.24.3.666; LOPEZ AD, 2001, LIFE TABLES 191 COUN, P1; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; Murray C. J. L., 1996, GLOBAL BURDEN DIS; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; SHEPARD DS, 1995, VACCINE, V13, P707, DOI 10.1016/0264-410X(94)00063-S; TREMONTI G, 2005, 0127 G8 FIN MIN; *UNICEF, 2005 VACC PROJ QUANT; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2005, 01229 WHO; WHO, UN COSTS PAT SERV; *WHO, 2002, 01230 WHO; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; *WORLD BANK, WDI ONL; World Health Organization, 1991, TECHN BAS WHO REC MA	34	102	112	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					389	396		10.1016/S0140-6736(07)60195-0	http://dx.doi.org/10.1016/S0140-6736(07)60195-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	132LN	17276779				2022-12-24	WOS:000243944400033
J	Konradsen, F; Dawson, AH; Eddleston, M; Gunnell, D				Konradsen, Flemming; Dawson, Andrew H.; Eddleston, Michael; Gunnell, David			Pesticide self-poisoning: thinking outside the box	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; SUICIDE		Univ Copenhagen, Dept Int Hlth, DK-1014 Copenhagen K, Denmark; Univ Peradeniya, S Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; Univ Newcastle, Sch Populat Hlth Sci, Fac Med & Hlth Sci, Newcastle, NSW 2308, Australia; Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Copenhagen; University of Peradeniya; University of Newcastle; University of Oxford; University of Bristol	Konradsen, F (corresponding author), Univ Copenhagen, Dept Int Hlth, DK-1014 Copenhagen K, Denmark.	f.konradsen@pubhealth.ku.dk	Dawson, Andrew H/U-8041-2019; Gunnell, David/ABE-6653-2020; Dawson, Andrew/D-5085-2012	Dawson, Andrew H/0000-0002-8047-397X; Gunnell, David/0000-0002-0829-6470; Dawson, Andrew/0000-0002-8047-397X; Konradsen, Flemming/0000-0003-1036-6949	Wellcome Trust [063560, 071669] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bertolote JM, 2006, B WORLD HEALTH ORGAN, V84, P260; *CROPL INT, 1998, GUID SAF EFF US CROP; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; MISHARA BL, 2005, ANN C INT ASS SUIC P; PIERIS R, 2005, FINAL REPORT USE SUR; *SYNG, 2006, SOC RES PROD STEW; WHO, 2001, WORLD HLTH REPORT 20; , 2004, IMP PEST HLTH PREV I; 2006, IASP NEWS B      APR	11	34	34	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					169	170		10.1016/S0140-6736(07)60085-3	http://dx.doi.org/10.1016/S0140-6736(07)60085-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	128XG	17240268	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000243692400007
J	Goldston, D				Goldston, David			Climate of opportunity	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					248	248		10.1038/445248a	http://dx.doi.org/10.1038/445248a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230163	Bronze			2022-12-24	WOS:000243504700012
J	Shimada, K; Gasser, SM				Shimada, Kenji; Gasser, Susan M.			The origin recognition complex functions in sister-chromatid cohesion in Saccharomyces cerevisiae	CELL			English	Article							DNA-DAMAGE CHECKPOINT; BUDDING YEAST; MCM PROTEINS; HETEROCHROMATIN PROTEIN-1; CHROMOSOME CONDENSATION; PRECOCIOUS SEPARATION; CELL-CYCLE; S-PHASE; REPLICATION; ORC	High-fidelity chromosomal segregation requires the properly timed establishment of sisterchromatid cohesion mediated by the Cohesin complex, and its resolution at the metaphaseto-anaphase transition. We have examined cell-cycle progression in a yeast strain from which the origin recognition complex protein Orc2 was depleted after the assembly of prereplication complexes. We find that Orc2 depletion causes a delay in progression through mitosis, reflecting activation of both the DNAdamage and Mad2-spindle checkpoints. Surprisingly, sister-chromatid cohesion is impaired in Orc2-depleted cells, although Cohesin subunits are properly associated with chromatin. Reexpression of Orc2 in late G2/M phase restores chromatid cohesion. Finally, the targeting of Orc2 to a specific chromosomal locus suppresses premature sister-chromatid separation locally in a temperature-sensitive cohesin mutant. We conclude that ORG mediates sisterchromatid interaction on a pathway that is additive with Cohesin-mediated pairing.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Gasser, SM (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch		Gasser, Susan/0000-0003-3610-9123				Badugu R, 2003, J BIOL CHEM, V278, P34491, DOI 10.1074/jbc.M305262200; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chastain PD, 2004, J BIOL CHEM, V279, P36354, DOI 10.1074/jbc.M403501200; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; de Gramont A, 2005, TRENDS BIOCHEM SCI, V30, P559, DOI 10.1016/j.tibs.2005.08.008; Dillin A, 1998, SCIENCE, V279, P1733, DOI 10.1126/science.279.5357.1733; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Garber PM, 2002, GENETICS, V161, P521; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moore LL, 2005, MOL CELL BIOL, V25, P2583, DOI 10.1128/MCB.25.7.2583-2592.2005; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NEWTON CS, 1993, COLD SPRING HARB SYM, V58, P415; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Thomas SE, 2005, CELL, V123, P555, DOI 10.1016/j.cell.2005.08.043; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101	61	79	79	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					85	99		10.1016/j.cell.2006.11.045	http://dx.doi.org/10.1016/j.cell.2006.11.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218257	Bronze			2022-12-24	WOS:000244420400015
J	Simon, GE				Simon, Gregory E.			The antidepressant quandray - Considering suicide risk whem treating adolescent depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Simon, GE (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA.							Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; National Committee for Quality Assurance, 2006, STAT HLTH CAR QUAL 2; ROSACK J, 2004, PSYCHIAT NEWS, V39, P9; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41	5	21	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2722	2723		10.1056/NEJMp068270	http://dx.doi.org/10.1056/NEJMp068270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	120UA	17192536				2022-12-24	WOS:000243110500003
J	Bradbeer, C; Soni, S; Ekbote, A; Martin, T				Bradbeer, C.; Soni, S.; Ekbote, A.; Martin, T.			You're not going to give me the umbrella, are you?	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Thomas Hosp, Dept Genitourinary Med, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Bradbeer, C (corresponding author), St Thomas Hosp, Dept Genitourinary Med, London SE1 7EH, England.	caroline.bradbeer@gstt.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1287	1288		10.1136/bmj.39043.717245.F7	http://dx.doi.org/10.1136/bmj.39043.717245.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185709	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000243160700007
J	Walden, WE; Selezneva, AI; Dupuy, J; Volbeda, A; Fontecilla-Camps, JC; Theil, EC; Volz, K				Walden, William E.; Selezneva, Anna I.; Dupuy, Jerome; Volbeda, Anne; Fontecilla-Camps, Juan C.; Theil, Elizabeth C.; Volz, Karl			Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA	SCIENCE			English	Article							ELEMENT-BINDING-PROTEIN; RECEPTOR MESSENGER-RNA; RESPONSIVE ELEMENT; CYTOSOLIC ACONITASE; MOLECULAR CONTROL; RECOGNITION; METABOLISM; LOCALIZATION; LOOP/BULGE; REGION	Iron regulatory protein 1 (IRP1) binds iron-responsive elements (IREs) in messenger RNAs (mRNAs), to repress translation or degradation, or binds an iron-sulfur cluster, to become a cytosolic aconitase enzyme. The 2.8 angstrom resolution crystal structure of the IRP1: ferritin H IRE complex shows an open protein conformation compared with that of cytosolic aconitase. The extended, L-shaped IRP1 molecule embraces the IRE stem-loop through interactions at two sites separated by similar to 30 angstroms, each involving about a dozen protein: RNA bonds. Extensive conformational changes related to binding the IRE or an iron-sulfur cluster explain the alternate functions of IRP1 as an mRNA regulator or enzyme.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Grenoble 1, Inst Biol Struct Jean Pierre Horowitz, IBS, Lab Cristallog & Cristallog Prot, F-38207 Grenoble, France; Univ Grenoble 1, CEA, F-38207 Grenoble, France; Univ Grenoble 1, CNRS, F-38207 Grenoble, France; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Mol Toxicol, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Volz, K (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	kvolz@uic.edu	Dupuy, Jerome/AAD-3438-2020	Dupuy, Jerome/0000-0002-2721-5365; Volbeda, Anne/0000-0002-6038-0979	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020251, R56DK020251, R01DK020251, R01DK047281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047522] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20251, DK47281] Funding Source: Medline; NIGMS NIH HHS [GM47522] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Brazzolotto X, 2002, J BIOL CHEM, V277, P11995, DOI 10.1074/jbc.M110938200; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gegout V, 1999, J BIOL CHEM, V274, P15052, DOI 10.1074/jbc.274.21.15052; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Haasnoot PCJ, 2003, P NATL ACAD SCI USA, V100, P12596, DOI 10.1073/pnas.2135413100; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2002, J BIOL CHEM, V277, P2373, DOI 10.1074/jbc.C100614200; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIKINIS Z, 1995, NUCLEIC ACIDS RES, V23, P4190, DOI 10.1093/nar/23.20.4190; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; *MOL SIM INC, 1997, QUANTA; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; Schlegl J, 1997, RNA, V3, P1159; Selezneva AI, 2006, ACTA CRYSTALLOGR F, V62, P249, DOI 10.1107/S1744309106004192; SWENSON GR, 1994, NUCLEIC ACIDS RES, V22, P2627, DOI 10.1093/nar/22.13.2627; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; TOUAULT TA, 2006, NAT CHEM BIOL, V2, P406	37	213	219	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1903	1908		10.1126/science.1133116	http://dx.doi.org/10.1126/science.1133116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185597				2022-12-24	WOS:000242996800041
J	Chai, Q; Arndt, JW; Dong, M; Tepp, WH; Johnson, EA; Chapman, ER; Stevens, RC				Chai, Qing; Arndt, Joseph W.; Dong, Min; Tepp, William H.; Johnson, Eric A.; Chapman, Edwin R.; Stevens, Raymond C.			Structural basis of cell surface receptor recognition by botulinum neurotoxin B	NATURE			English	Article							H-CC-DOMAIN; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; TOXIN; IDENTIFICATION; GANGLIOSIDES; FRAGMENT; GT1B	Botulinum neurotoxins (BoNTs) are potent bacterial toxins that cause paralysis at femtomolar concentrations 1 by blocking neurotransmitter release. A 'double receptor' model has been proposed in which BoNTs recognize nerve terminals via interactions with both gangliosides and protein receptors that mediate their entry(2). Of seven BoNTs (subtypes A-G), the putative receptors for BoNT/A(3,4), BoNT/B-5,B-6 and BoNT/G(7) have been identified, but the molecular details that govern recognition remain undefined. Here we report the crystal structure of full-length BoNT/B in complex with the synaptotagmin II (Syt-II) recognition domain at 2.6 angstrom resolution. The structure of the complex reveals that Syt-II forms a short helix that binds to a hydrophobic groove within the binding domain of BoNT/B. In addition, mutagenesis of amino acid residues within this interface on Syt-II affects binding of BoNT/B. Structural and sequence analysis reveals that this hydrophobic groove is conserved in the BoNT/G and BoNT/B subtypes, but varies in other clostridial neurotoxins. Furthermore, molecular docking studies using the ganglioside G(T1b) indicate that its binding site is more extensive than previously proposed and might form contacts with both BoNT/B and synaptotagmin. The results provide structural insights into how BoNTs recognize protein receptors and reveal a promising target for blocking toxin-receptor recognition.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Food Res Inst, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA	Scripps Research Institute; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chapman@physiology.wisc.edu; stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Taylor, Graham/A-4027-2012	Stevens, Raymond/0000-0002-4522-8725; Chapman, Edwin/0000-0001-9787-8140				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Ginalski K, 2000, FEBS LETT, V482, P119, DOI 10.1016/S0014-5793(00)01954-2; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, NEUROSCI LETT, V208, P105, DOI 10.1016/0304-3940(96)12557-X; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Simpson LL, 2000, BIOCHIMIE, V82, P943, DOI 10.1016/S0300-9084(00)01169-X; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis WI, 1997, CURR OPIN STRUC BIOL, V7, P624, DOI 10.1016/S0959-440X(97)80070-X; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	29	162	172	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1096	1100		10.1038/nature05411	http://dx.doi.org/10.1038/nature05411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167418				2022-12-24	WOS:000242971100062
J	Townley, R; Shapiro, L				Townley, Robert; Shapiro, Lawrence			Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase	SCIENCE			English	Article							PARKINSON-WHITE-SYNDROME; FATTY-ACID OXIDATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; CYTOPLASMIC DOMAIN; GAMMA(2) SUBUNIT; SKELETAL-MUSCLE; BETA-SUBUNITS; SNF1; MUTATIONS	The 5'-AMP (adenosine monophosphate)-activated protein kinase (AMPK) coordinates metabolic function with energy availability by responding to changes in intracellular ATP (adenosine triphosphate) and AMP concentrations. Here, we report crystal structures at 2.9 and 2.6 angstrom resolution for ATP- and AMP-bound forms of a core alpha beta gamma adenylate-binding domain from the fission yeast AMPK homolog. ATP and AMP bind competitively to a single site in the g subunit, with their respective phosphate groups positioned near function-impairing mutants. Unexpectedly, ATP binds without counterions, amplifying its electrostatic effects on a critical regulatory region where all three subunits converge.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	LSS8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Townley, Robert/0000-0002-9347-2431				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	34	149	156	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1726	1729		10.1126/science.1137503	http://dx.doi.org/10.1126/science.1137503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17289942				2022-12-24	WOS:000245106900044
J	Farb, A; Boam, AB				Farb, Andrew; Boam, Ashley B.			Stent thrombosis redux - The FDA perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Farb, A (corresponding author), US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.							American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; CAMENZIND E, 2006, WORLD C CARD 2006 BA; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Muni NI, 2004, NEW ENGL J MED, V351, P1593, DOI 10.1056/NEJMp048262; Wenaweser P., 2006, WORLD C CARD 2006 BA	5	210	220	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					984	987		10.1056/NEJMp068304	http://dx.doi.org/10.1056/NEJMp068304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296827				2022-12-24	WOS:000244699200002
J	Siekmann, AF; Lawson, ND				Siekmann, Arndt F.; Lawson, Nathan D.			Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; ENDOTHELIAL-GROWTH-FACTOR; EXPRESSION; ACTIVATION; PATHWAY; DIFFERENTIATION; SUPPRESSOR; RECEPTORS; HAIRLESS	Recent evidence indicates that growing blood-vessel sprouts consist of endothelial cells with distinct cell fates and behaviours(1,2); however, it is not clear what signals determine these sprout cell characteristics. Here we show that Notch signalling is necessary to restrict angiogenic cell behaviour to tip cells in developing segmental arteries in the zebrafish embryo. In the absence of the Notch signalling component Rbpsuh ( recombining binding protein suppressor of hairless) we observed excessive sprouting of segmental arteries, whereas Notch activation suppresses angiogenesis. Through mosaic analysis we find that cells lacking Rbpsuh preferentially localize to the terminal position in developing sprouts. In contrast, cells in which Notch signalling has been activated are excluded from the tip-cell position. In vivo time-lapse analysis reveals that endothelial tip cells undergo a stereotypical pattern of proliferation and migration during sprouting. In the absence of Notch, nearly all sprouting endothelial cells exhibit tip-cell behaviour, leading to excessive numbers of cells within segmental arteries. Furthermore, we find that flt4 (fms-related tyrosine kinase 4, also called vegfr3) is expressed in segmental artery tip cells and becomes ectopically expressed throughout the sprout in the absence of Notch. Loss of flt4 can partially restore normal endothelial cell number in Rbpsuh-deficient segmental arteries. Finally, loss of the Notch ligand dll4 (delta-like 4) also leads to an increased number of endothelial cells within segmental arteries. Together, these studies indicate that proper specification of cell identity, position and behaviour in a developing blood-vessel sprout is required for normal angiogenesis, and implicate the Notch signalling pathway in this process.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Lazare Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu	Siekmann, Arndt/AAE-4769-2021	Lawson, Nathan/0000-0001-7788-9619; Siekmann, Arndt/0000-0001-6972-2173				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Childs S, 2002, DEVELOPMENT, V129, P973; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Roman BL, 2002, DEVELOPMENT, V129, P3009; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Shutter JR, 2000, GENE DEV, V14, P1313; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Westerfield M, 1993, ZEBRAFISH BOOK; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	24	498	533	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					781	784		10.1038/nature05577	http://dx.doi.org/10.1038/nature05577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259972				2022-12-24	WOS:000244205200048
J	Shuster, E				Shuster, Evelyne			Microarray genetic screening: a prenatal roadblock for life?	LANCET			English	Article							DIAGNOSIS; DNA		Philadelphia Vet Affairs Med Ctr, Off Med Eth, Philadelphia, PA USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Shuster, E (corresponding author), Philadelphia Dept Vet Affairs, Univ & Woodland Ave, Philadelphia, PA 19104 USA.	Evelyn.shuster@med.va.gov						American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Annas G., 1998, SOME CHOICE LAW MED; ANNAS GJ, 1975, FAM LAW QUART, V9, P463; Asch A, 1999, AM J PUBLIC HEALTH, V89, P1649, DOI 10.2105/AJPH.89.11.1649; ASCH A, 2006, 7 ANN JOINT APPL URB; ASCH A, 2003, FLORIDA STATE U L RE, V315, P47; *BAYL COLL MED, CHROM MICR AN; BOTKIN JR, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3562793; Buchanan Allen, 2001, CHANCE CHOICE GENETI; Canguilhem G., 2012, NORMAL PATHOLOGICAL, V3; Check E, 2005, NATURE, V438, P733, DOI 10.1038/438733a; *COMM STUD INB ERR, 1975, GEN SCREEN PROGR PRI; Cremonesi L, 2004, ANN NY ACAD SCI, V1022, P105, DOI 10.1196/annals.1318.017; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Haddow JE, 1993, ESSENTIALS PRENATAL, P185; HARMON A, 2004, NY TIMES NEW YO 0620; Henn W, 1999, J MED ETHICS, V25, P200, DOI 10.1136/jme.25.2.200; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Larrabee PB, 2004, AM J HUM GENET, V75, P485, DOI 10.1086/423288; NELSON JP, 2006, BMJ-BRIT MED J, V332, P443; NISAND MI, 2000, P INT S BIOETH RIGHT, P31; Rawls J., 1971, THEORY JUSTICE; REGALADO A, 2006, WALL STREET J N 0414; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; SHUSTER E, 2001, J LAW MED ETHICS, V29, P35; SHUSTER E, 1992, GENE MAPPING USING L, P115; Stone JH, 2006, NEW ENGL J MED, V354, P2748, DOI 10.1056/NEJMp058264; Suter SM, 2002, AM J LAW MED, V28, P233; TESTART J, 2004, VONT VALEURS, P365; WADE N, 2006, NY TIMES NEW YO 0718	31	53	53	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					526	529		10.1016/S0140-6736(07)60239-6	http://dx.doi.org/10.1016/S0140-6736(07)60239-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292772				2022-12-24	WOS:000244188300035
J	Stephanopoulos, G				Stephanopoulos, Gregory			Challenges in engineering microbes for biofuels production	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; ETHANOL; PATHWAY	Economic and geopolitical factors ( high oil prices, environmental concerns, and supply instability) have been prompting policy-makers to put added emphasis on renewable energy sources. For the scientific community, recent advances, embodied in new insights into basic biology and technology that can be applied to metabolic engineering, are generating considerable excitement. There is justified optimism that the full potential of biofuel production from cellulosic biomass will be obtainable in the next 10 to 15 years.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu						Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; *DEP EN, 2005, BIOM BIOF ROADM EN F; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MCFARLAND KC, 2006, WORLD C IND BIOT BIO; PATNAIK R, 1995, BIOTECHNOL BIOENG, V46, P361, DOI 10.1002/bit.260460409; STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Stephanopoulos G, 2002, AICHE J, V48, P920, DOI 10.1002/aic.690480502; Takagi M, 1977, P BIOCONVERSION S, P551; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240	16	540	583	3	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					801	804		10.1126/science.1139612	http://dx.doi.org/10.1126/science.1139612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289987				2022-12-24	WOS:000244069000055
J	Wagner, AK; Ross-Degnan, D; Gurwitz, JH; Zhang, F; Gilden, DB; Cosler, L; Soumerai, SB				Wagner, Anita K.; Ross-Degnan, Dennis; Gurwitz, Jerry H.; Zhang, Fang; Gilden, Daniel B.; Cosler, Leon; Soumerai, Stephen B.			Effect of New York state regulatory action on benzodiazepine prescribing and hip fracture rates	ANNALS OF INTERNAL MEDICINE			English	Article							TRIPLICATE PRESCRIPTION PROGRAM; RISK-FACTORS; MEDICATION USE; OLDER-PEOPLE; HALF-LIFE; FALLS; SURVEILLANCE; PATTERNS; DOSAGE; IMPACT	Background: Medicare Part D excludes benzodiazepines from coverage, and numerous state government policies limit use of benzodiazepines. No data indicate that such policies have decreased the incidence of hip fracture. Objective: To assess whether a statewide policy that decreased the use of benzodiazepines among elderly persons by more than 50% has decreased the incidence of hip fracture. Design: A quasi-experiment comparing changes in outcomes before and after a policy change in a study U.S. state (New York) and a control state (New Jersey). Setting: Two U.S. state Medicaid programs, 1988-1990. Patients: Medicaid enrollees in New York (n = 51529) and New Jersey (n = 42 029) who received or did not receive a benzodiazepine. Measurements: Benzodiazepine prescribing and hazard ratios for hip fracture, adjusted for age and eligibility category. Intervention: A statewide policy, implemented in New York in 1989, that required triplicate forms for benzodiazepine prescribing to allow surveillance by health authorities. Results: The triplicate prescription policy immediately resulted in a 60.3% (95% CI, -66.3% to -54.2%) reduction in benzodiazepine use among women and 58.5% (-64.3% to -52.8%) among men. Benzodiazepine use in New Jersey remained stable. Hazard ratios for hip fracture that were adjusted for age and eligibility category did not change in New York or New Jersey when the periods before and after use of the triplicate prescription policy were compared (change from 1.2 to 1.1 among female benzodiazepine recipients [P = 0.70], 1.3 to 1.1 [P = 0.08] among female nonrecipients, 0.8 to 1.1 [P = 0.56] among male recipients, and 1.1 to 1.3 [P = 0.46] among male nonrecipients). Limitations: Information was lacking on race, benzodiazepine dose, and other potential determinants of continued benzodiazepine prescribing. Conclusions: Policies that lead to substantial reductions in the use of benzodiazepines among elderly persons do not necessarily lead to decreased incidence of hip fracture. Limitations on coverage of benzodiazepines under Medicare Part D may not achieve this widely assumed clinical benefit.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Fdn, Worcester, MA 01605 USA; Fallon Community Hlth Plan, Worcester, MA USA; JEN Associates Inc, Cambridge, MA USA; New York State Dept Hlth, Albany Coll Pharm & Management Reports & Res Unit, Off Medicaid Management, Albany, NY USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System	Soumerai, SB (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA.	ssoumerai@hms.harvard.edu	Zhang, Fang/HHN-2153-2022		AHRQ HHS [U 18 HS 11843] Funding Source: Medline; NIA NIH HHS [R01 AG19808-01A1] Funding Source: Medline; NIDA NIH HHS [R01DA10 371-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010371] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1979, QUASIEXPERIMENTATION; Bambauer KZ, 2005, PSYCHIAT SERV, V56, P1143, DOI 10.1176/appi.ps.56.9.1143; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; EADIE JL, 1993, IMPACT PRESCRIPTION, V179; ENSRUD KE, 1996, EPIDEMIOLOGY, V7, P335; FEDERSPIEL CF, 1976, MED CARE, V14, P166, DOI 10.1097/00005650-197602000-00006; GALES BJ, 1995, ANN PHARMACOTHER, V29, P354, DOI 10.1177/106002809502900402; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; HENNESSEY S, 2005, PHARMACOEPIDEMIOLOGY; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Karagas MR, 1996, AM J EPIDEMIOL, V143, P677; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; LIU BA, 1995, J AM GERIATR SOC, V43, P1141, DOI 10.1111/j.1532-5415.1995.tb07016.x; LURIE P, 1992, JAMA-J AM MED ASSOC, V268, P472; *NAT PHARM COUNC, 2003, PHARM BEN STAT MED A; Neutel CI, 1996, AGE AGEING, V25, P273, DOI 10.1093/ageing/25.4.273; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Pearson SA, 2006, ARCH INTERN MED, V166, P572, DOI 10.1001/archinte.166.5.572; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; Ray WA, 2000, J AM GERIATR SOC, V48, P682, DOI 10.1111/j.1532-5415.2000.tb04729.x; Ross-Degnan D, 2004, INT J PSYCHIAT MED, V34, P103, DOI 10.2190/8FR4-QYY1-7MYG-2AGJ; ROSSDEGNAN D, 1993, JAMA-J AM MED ASSOC, V270, P1937, DOI 10.1001/jama.270.16.1937; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schneeweiss S, 2005, J AM GERIATR SOC, V53, P948, DOI 10.1111/j.1532-5415.2005.53303.x; Sgadari A, 2000, J CLIN PSYCHOPHARM, V20, P234, DOI 10.1097/00004714-200004000-00017; Simoni-Wastila L, 2004, CLIN THER, V26, P322, DOI 10.1016/S0149-2918(04)90030-6; Sloan FA, 1999, AM J PUBLIC HEALTH, V89, P935, DOI 10.2105/AJPH.89.6.935; SOROCK GS, 1988, ARCH INTERN MED, V148, P2441, DOI 10.1001/archinte.148.11.2441; TAGGART HM, 1988, J AM GERIATR SOC, V36, P1006, DOI 10.1111/j.1532-5415.1988.tb04367.x; Tamblyn R, 2005, J AM GERIATR SOC, V53, P233, DOI 10.1111/j.1532-5415.2005.53108.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VanHaaren AM, 2001, PHARMACOTHERAPY, V21, P1159, DOI 10.1592/phco.21.15.1159.33898; WADHWANI A, 2006, TENNESSEAN      0223; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; WEINTRAUB M, 1991, JAMA-J AM MED ASSOC, V266, P2392, DOI 10.1001/jama.266.17.2392; WEINTRAUB M, 1993, CLIN PHARMACOL THER, V54, P252, DOI 10.1038/clpt.1993.145; ZULLICH SG, 1992, ANN PHARMACOTHER, V26, P539	46	52	53	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					96	103		10.7326/0003-4819-146-2-200701160-00004	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227933				2022-12-24	WOS:000243901000003
J	Armstead, I; Donnison, I; Aubry, S; Harper, J; Hortensteiner, S; James, C; Mani, J; Moffet, M; Ougham, H; Roberts, L; Thomas, A; Weeden, N; Thomas, H; King, I				Armstead, Ian; Donnison, Iain; Aubry, Sylvain; Harper, John; Hortensteiner, Stefan; James, Caron; Mani, Jan; Moffet, Matt; Ougham, Helen; Roberts, Luned; Thomas, Ann; Weeden, Norman; Thomas, Howard; King, Ian			Cross-species identification of Mendel's/locus	SCIENCE			English	Article							STAY GREEN		Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Aberystwyth University; University of Bern; Montana State University System; Montana State University Bozeman	Armstead, I (corresponding author), Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales.	ian.armstead@bbsrc.ac.uk	Donnison, Iain S/K-6138-2014; Thomas, Howard/G-6812-2011; Aubry, Sylvain/V-6364-2019; King, Ian/N-4500-2014	Donnison, Iain S/0000-0001-6276-555X; Aubry, Sylvain/0000-0002-7598-3609; 	Biotechnology and Biological Sciences Research Council [BBS/E/G/00003001] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Armstead I, 2006, NEW PHYTOL, V172, P592, DOI 10.1111/j.1469-8137.2006.01922.x; Cha KW, 2002, THEOR APPL GENET, V104, P526, DOI 10.1007/s001220100750; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; THOMAS H, 1993, ANN APPL BIOL, V123, P193, DOI 10.1111/j.1744-7348.1993.tb04086.x; Thomas H, 1996, BOT ACTA, V109, P3, DOI 10.1111/j.1438-8677.1996.tb00862.x	6	137	154	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					73	73		10.1126/science.1132912	http://dx.doi.org/10.1126/science.1132912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204643				2022-12-24	WOS:000243259100036
J	Kroeger, A; Nathan, MB				Kroeger, Axel; Nathan, Michael B.			Dengue: setting the global research agenda	LANCET			English	Editorial Material							CLASSIFICATION		UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva 27, Switzerland; Dept Control Neglected Trop Dis Vector Ecol & Man, CH-1211 Geneva 27, Switzerland	The World Bank; World Health Organization	Kroeger, A (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva 27, Switzerland.	kroegera@who.int		Kroeger, Axel/0000-0001-8438-2904				Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Focks DA, 2006, MULTICOUNTRY STUDY A; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; *UN, WORLD URB PRSP 2001; *WORLD HLTH ASS, DENG FEV DENG HAEM F	6	60	63	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2193	2195		10.1016/S0140-6736(06)69873-5	http://dx.doi.org/10.1016/S0140-6736(06)69873-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189016				2022-12-24	WOS:000243076800008
J	Niedernhofer, LJ; Garinis, GA; Raams, A; Lalai, AS; Robinson, AR; Appeldoorn, E; Odijk, H; Oostendorp, R; Ahmad, A; Van Leeuwen, W; Theil, AF; Vermeulen, W; van der Horst, GTJ; Meinecke, P; Kleijer, WJ; Vijg, J; Jaspers, NGJ; Hoeijmakers, JHJ				Niedernhofer, Laura J.; Garinis, George A.; Raams, Anja; Lalai, Astrid S.; Robinson, Andria Rasile; Appeldoorn, Esther; Odijk, Hanny; Oostendorp, Roos; Ahmad, Anwaar; Van Leeuwen, Wibeke; Theil, Arjan F.; Vermeulen, Wim; van der Horst, Gijsbertus T. J.; Meinecke, Peter; Kleijer, Wim J.; Vijg, Jan; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.			A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis	NATURE			English	Article							PIGMENTOSUM GROUP-F; DNA-REPAIR DEFECTS; XERODERMA-PIGMENTOSUM; LIFE-SPAN; GROWTH-HORMONE; NUCLEAR ABNORMALITIES; GENOMIC INSTABILITY; CALORIC RESTRICTION; GENE; MICE	XPF-ERCC1 endonuclease is required for repair of helix-distorting DNA lesions and cytotoxic DNA interstrand crosslinks. Mild mutations in XPF cause the cancer-prone syndrome xeroderma pigmentosum. A patient presented with a severe XPF mutation leading to profound crosslink sensitivity and dramatic progeroid symptoms. It is not known how unrepaired DNA damage accelerates ageing or its relevance to natural ageing. Here we show a highly significant correlation between the liver transcriptome of old mice and a mouse model of this progeroid syndrome. Expression data from XPF-ERCC1-deficient mice indicate increased cell death and anti-oxidant defences, a shift towards anabolism and reduced growth hormone/insulin-like growth factor 1 (IGF1) signalling, a known regulator of lifespan. Similar changes are seen in wild-type mice in response to chronic genotoxic stress, caloric restriction, or with ageing. We conclude that unrepaired cytotoxic DNA damage induces a highly conserved metabolic response mediated by the IGF1/insulin pathway, which re-allocates resources from growth to somatic preservation and life extension. This highlights a causal contribution of DNA damage to ageing and demonstrates that ageing and end-of-life fitness are determined both by stochastic damage, which is the cause of functional decline, and genetics, which determines the rates of damage accumulation and decline.	Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Expt Radiol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Pittsburgh, Sch Med, Inst Canc, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Altonaer kinderkrankenhaus, Abt Med Genet, D-22763 Hamburg, Germany; Buck Inst Age Res, Novato, CA 94945 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Buck Institute for Research on Aging	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.hoeijmakers@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Garinis, George A./B-2943-2012; Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Garinis, George A./0000-0002-3200-5004; Vermeulen, Wim/0000-0003-3616-734X; 	NCI NIH HHS [K22 CA111525] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA111525] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Bootsma D., 2001, METABOLIC MOL BASES, V1, P677; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Ghoshal AK, 2000, P SOC EXP BIOL MED, V225, P128, DOI 10.1046/j.1525-1373.2000.22516.x; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196; Kasai H, 1998, CARCINOGENESIS, V19, P1459, DOI 10.1093/carcin/19.8.1459; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kirkwood TBL, 2000, HUM EXP TOXICOL, V19, P338, DOI 10.1191/096032700678816025; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANDERPLUIJM I, IN PRESS PLOS BIOL, DOI DOI 10.1037/JOURNAL.PBIO.0050002; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	49	517	526	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1038	1043		10.1038/nature05456	http://dx.doi.org/10.1038/nature05456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183314				2022-12-24	WOS:000242971100047
J	Rosenthal, E				Rosenthal, Elisabeth			HIV injustice in Libya - Scapegoating foreign medical professionals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOSOCOMIAL OUTBREAK											MONTAGNIER L, COMMUNICATION; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	3	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2505	2508		10.1056/NEJMp068241	http://dx.doi.org/10.1056/NEJMp068241			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167132	Bronze			2022-12-24	WOS:000242778800001
J	Li, W; Tu, DQ; Brunger, AT; Ye, YH				Li, Wei; Tu, Daqi; Brunger, Axel T.; Ye, Yihong			A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN LIGASE; DEGRADATION; DOMAIN; HERP; COMPLEX; CDC34; PATHWAY; LYSINE; GP78	In eukaryotic cells, many short-lived proteins are conjugated with Lys48-linked ubiquitin chains and degraded by the proteasome(1). Ubiquitination requires an activating enzyme (E1), a conjugating enzyme (E2) and a ligase (E3)(2). Most ubiquitin ligases use either a HECT (homologous to E6-associated protein C terminus) or a RING (really interesting new gene) domain to catalyse polyubiquitination(3), but the mechanism of E3 catalysis is poorly defined(4). Here we dissect this process using mouse Ube2g2 (E2; identical at the amino acid level to human Ube2g2) and human gp78 (E3), an endoplasmic reticulum (ER)-associated conjugating system essential for the degradation of misfolded ER proteins(5,6). We demonstrate by expressing recombinant proteins in Escherichia coli that Ube2g2/gp78-mediated polyubiquitination involves preassembly of Lys48-linked ubiquitin chains at the catalytic cysteine of Ube2g2. The growth of Ube2g2-anchored ubiquitin chains seems to be mediated by an aminolysis-based transfer reaction between two Ube2g2 molecules that each carries a ubiquitin moiety in its active site. Intriguingly, polyubiquitination of a substrate can be achieved by transferring preassembled ubiquitin chains from Ube2g2 to a lysine residue in a substrate.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol Neurol & Neurol Sci S, Stanford, CA 94305 USA; Stanford Univ, SSRL, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ye, YH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Brunger, Axel/0000-0001-5121-2036	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036137, Z01DK036137] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai R, 2006, ACTA CRYSTALLOGR F, V62, P330, DOI 10.1107/S1744309106009006; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; CHEN JZ, 1993, J THERM SPRAY TECHN, V2, P357; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169	26	171	176	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					333	337		10.1038/nature05542	http://dx.doi.org/10.1038/nature05542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17310145				2022-12-24	WOS:000244892900049
J	Bagchi, A; Papazoglu, C; Wu, Y; Capurso, D; Brodt, M; Francis, D; Bredel, M; Vogel, H; Mills, AA				Bagchi, Anindya; Papazoglu, Cristian; Wu, Ying; Capurso, Daniel; Brodt, Michael; Francis, Dailia; Bredel, Markus; Vogel, Hannes; Mills, Alea A.			CHD5 is a tumor suppressor at human 1p36	CELL			English	Article							SUSCEPTIBILITY GENE; CELL-PROLIFERATION; BREAST-CANCER; IN-VIVO; IDENTIFICATION; DELETION; P53; SENESCENCE; SEQUENCE; REGIONS	Cancer gene discovery has relied extensively on analyzing tumors for gains and losses to reveal the location of oncogenes and tumor suppressor genes, respectively. Deletions of 1p36 are extremely common genetic lesions in human cancer, occurring in malignancies of epithelial, neural, and hematopoietic origin. Although this suggests that 1p36 harbors a gene that drives tumorigenesis when inactivated, the identity of this tumor suppressor has remained elusive. Here we use chromosome engineering to generate mouse models with gain and loss of a region corresponding to human 1p36. This approach functionally identifies chromodomain helicase DNA binding domain 5 (Chd5) as a tumor suppressor that controls proliferation, apoptosis, and senescence via the p19(Arf)/p53 pathway. We demonstrate that Chd5 functions as a tumor suppressor in vivo and implicate deletion of CHD5 in human cancer. Identification of this tumor suppressor provides new avenues for exploring innovative clinical interventions for cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Stanford Univ, Palo Alto, CA 94304 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Mills, AA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mills@cshl.edu		Vogel, Otto Hannes/0000-0002-0960-3508	NCI NIH HHS [CA45508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLE SH, 1995, CLIN TRANSPL, V1, P19; BIECHE I, 1993, CANCER RES, V53, P1990; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Esteller M, 2001, CANCER RES, V61, P3225; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kleer CG, 2000, ENDOCR PATHOL, V11, P137, DOI 10.1385/EP:11:2:137; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Melendez B, 2003, LEUKEMIA RES, V27, P627, DOI 10.1016/S0145-2126(02)00278-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; MOLEY JF, 1992, CANCER RES, V52, P770; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Piaskowski S, 2005, CANCER GENET CYTOGEN, V162, P63, DOI 10.1016/j.cancergencyto.2005.02.009; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; PRAML C, 1995, ONCOGENE, V11, P1357; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	53	255	280	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					459	475		10.1016/j.cell.2006.11.052	http://dx.doi.org/10.1016/j.cell.2006.11.052			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289567	Bronze			2022-12-24	WOS:000244842700014
J	Scharfman, HE; Hen, R				Scharfman, Helen E.; Hen, Rene			Is more Neurogenesis always better?	SCIENCE			English	Editorial Material							SEIZURE-INDUCED NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; ADULT; REPLACEMENT; PRECURSORS; NEOCORTEX; NEURONS; MEMORY; STROKE		Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Helen Hayes Hosp, Ctr Neural Recovery & Rehabil Res, W Haverstraw, NY 10993 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Scharfman, HE (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	scharfmanh@helenhayeshosp.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037562] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037562] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Keilhoff G, 2004, BIOL PSYCHIAT, V56, P317, DOI 10.1016/j.biopsych.2004.06.010; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Longo Frank M., 2006, Current Alzheimer Research, V3, P5, DOI 10.2174/156720506775697089; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAXE M, 2006, 2666 SOC NEUR; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	24	93	99	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					336	338		10.1126/science.1138711	http://dx.doi.org/10.1126/science.1138711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234934	Green Accepted			2022-12-24	WOS:000243535400025
J	Shen, WH; Balajee, AS; Wang, JL; Wu, H; Eng, C; Pandolfi, PP; Yin, YX				Shen, Wen Hong; Balajee, Adayabalam S.; Wang, Jianli; Wu, Hong; Eng, Charis; Pandolfi, Pier Paolo; Yin, Yuxin			Essential role for nuclear PTEN in maintaining chromosomal integrity	CELL			English	Article							TUMOR-SUPPRESSOR GENE; CENP-C; CELL-SURVIVAL; KINETOCHORE; PROTEIN; AMPLIFICATION; INSTABILITY; NEOPLASIA; CANCER; REPAIR	A broad spectrum of mutations in PTEN, encoding a lipid phosphatase that inactivates the P13-K/AKT pathway, is found associated with primary tumors. Some of these mutations occur outside the phosphatase domain, suggesting that additional activities of PTEN function in tumor suppression. We report a nuclear function for PTEN in controlling chromosomal integrity. Disruption of Pten leads to extensive centromere breakage and chromosomal translocations. PTEN was found localized at centromeres and physically associated with CENP-C, an integral component of the kinetochore. C-terminal PTEN mutants disrupt the association of PTEN with centromeres and cause centromeric instability. Furthermore, Pten null cells exhibit spontaneous DNA double-strand breaks (DSBs). We show that PTEN acts on chromatin and regulates expression of Rad51, which reduces the incidence of spontaneous DSBs. Our results demonstrate that PTEN plays a fundamental role in the maintenance of chromosomal stability through the physical interaction with centromeres and control of DNA repair. We propose that PTEN acts as a guardian of genome integrity.	Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA; Univ Calif Los Angeles, Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA	Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation; Memorial Sloan Kettering Cancer Center	Yin, YX (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, 630 W 168th St, New York, NY 10032 USA.	yy151@columbia.edu	wang, jian/GVS-0711-2022	Eng, Charis/0000-0002-3693-5145; SHEN, WEN/0000-0002-5830-6518	NATIONAL CANCER INSTITUTE [R01CA102447, R01CA093677] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093677, R01 CA102447] Funding Source: Medline; NIGMS NIH HHS [R01 GM100478] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Li G, 2002, DEVELOPMENT, V129, P4159; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	48	737	779	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					157	170		10.1016/j.cell.2006.11.042	http://dx.doi.org/10.1016/j.cell.2006.11.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218262	Bronze			2022-12-24	WOS:000244420400020
J	Rasmussen, JN; Chong, A; Alter, DA				Rasmussen, Jeppe N.; Chong, Alice; Alter, David A.			Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-THERAPY; MEDICATION NONADHERENCE; SECONDARY PREVENTION; PHARMACY RECORDS; ELDERLY-PATIENTS; STATIN THERAPY; BLOOD-PRESSURE; BETA-BLOCKERS; IMPACT; CARE	Context The extent to which drug adherence may affect survival remains unclear, in part because mortality differences may be attributable to "healthy adherer" behavioral attributes more so than to pharmacological benefits. Objective To explore the relationship between drug adherence and mortality in survivors of acute myocardial infarction (AMI). Design, Setting, and Participants Population-based, observational, longitudinal study of 31 455 elderly AMI survivors between 1999 and 2003 in Ontario. All patients filled a prescription for statins, beta-blockers, or calcium channel blockers, with the latter drug considered a control given the absence of clinical trial-proven survival benefits. Main Outcome Measures Patient adherence was subdivided a priori into 3 categories - high (proportion of days covered, >= 80%), intermediate (proportion of days covered, 40%-79%), and low (proportion of days covered, <40%) - and compared with long-term mortality (median of 2.4 years of follow-up) using multivariable survival models (and propensity analyses) adjusted for sociodemographic factors, illness severity, comorbidities, and concomitant use of evidence-based therapies. Results Among statin users, compared with their high-adherence counterparts, the risk of mortality was greatest for low adherers (deaths in 261/1071 (24%) vs 2310/14345 (16%); adjusted hazard ratio, 1.25; 95% confidence interval, 1.09-1.42; P = .001) and was intermediary for intermediate adherers (deaths in 472/2407 (20%); adjusted hazard ratio, 1.12; 95% confidence interval, 1.01-1.25; P = .03). A similar but less pronounced dose-response - type adherence-mortality association was observed for beta-blockers. Mortality was not associated with adherence to calcium channel blockers. Moreover, sensitivity analyses demonstrated no relationships between drug adherence and cancer-related admissions, outcomes for which biological plausibility do not exist. Conclusion The long-term survival advantages associated with improved drug adherence after AMI appear to be class-specific, suggesting that adherence outcome benefits are mediated by drug effects and do not merely reflect an epiphenomenon of "healthy adherer" behavioral attributes.	Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; Univ Toronto, Div Cardiol, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med & Hlth Policy, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Management, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Evaluat, Toronto, ON M4N 3M5, Canada; Natl Inst Publ Hlth, Copenhagen, Denmark	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Alter, DA (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca						Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bertolet BD, 1999, DRUG AGING, V15, P461, DOI 10.2165/00002512-199915060-00006; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Dobbels F, 2004, J HEART LUNG TRANSPL, V23, P1245, DOI 10.1016/j.healun.2003.09.016; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Garcia R, 2002, ENZYME MICROB TECH, V30, P110, DOI 10.1016/S0141-0229(01)00462-8; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson ES, 2002, AM J MANAG CARE, V8, pS249; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mackillop WJ, 2000, CANCER-AM CANCER SOC, V89, P901, DOI 10.1002/1097-0142(20000815)89:4<901::AID-CNCR25>3.0.CO;2-I; McDermott MM, 1997, ARCH INTERN MED, V157, P1921, DOI 10.1001/archinte.157.17.1921; Mickley H, 2004, EUR HEART J, V25, P96, DOI 10.1016/j.ehj.2003.06.011; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peterson AM, 2005, PHARMACOECONOMICS, V23, P13, DOI 10.2165/00019053-200523010-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Simpson E, 2003, AM HEART J, V145, P438, DOI 10.1067/mhj.2003.143; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV., 1999, CARDIOVASCULAR HLTH, P83; Wei L, 2002, HEART, V88, P229, DOI 10.1136/heart.88.3.229; Wei L, 2004, PHARMACOEPIDEM DR S, V13, P761, DOI 10.1002/pds.963; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563	40	738	756	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					177	186		10.1001/jama.297.2.177	http://dx.doi.org/10.1001/jama.297.2.177			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213401				2022-12-24	WOS:000243355900027
J	Moroz, LL; Edwards, JR; Puthanveettil, SV; Kohn, AB; Hla, T; Heyland, A; Knudsen, L; Sahni, A; Yu, FH; Liu, L; Jezzini, S; Lovell, P; Iannucculli, W; Chen, MC; Nguyen, T; Sheng, HT; Shaw, R; Kalachikov, S; Panchin, YV; Farmerie, W; Russo, JJ; Ju, JY; Kandel, ER				Moroz, Leonid L.; Edwards, John R.; Puthanveettil, Sathyanarayanan V.; Kohn, Andrea B.; Hla, Thomas; Heyland, Andreas; Knudsen, Ljame; Sahni, Anuj; Yu, Fahong; Liu, Li; Jezzini, Sami; Lovell, Peter; Iannucculli, William; Chen, Minchen; Nguyen, Tuan; Sheng, Huitao; Shaw, Regina; Kalachikov, Sergey; Panchin, Yuri V.; Farmerie, William; Russo, James J.; Ju, Jingyue; Kandel, Eric R.			Neuronal transcriptome of Aplysia: neuronal compartments and circuitry	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; OPISTHOBRANCHIA MOLLUSCA; PHYLOGENETIC ANALYSIS; ABDOMINAL GANGLION; METACEREBRAL CELLS; ANIMAL PHYLOGENY; GENE-SEQUENCES; CDNA LIBRARY; CALIFORNICA; EVOLUTION	Molecular analyses of Aplysia, a well-established model organism for cellular and systems neural science, have been seriously handicapped by a lack of adequate genomic information. By sequencing cDNA libraries from the central nervous system (CNS), we have identified over 175,000 expressed sequence tags (ESTs), of which 19,814 are unique neuronal gene products and represent 50%-70% of the total Aplysia neuronal transcriptome. We have characterized the transcriptome at three levels: (1) the central nervous system, (2) the elementary components of a simple behavior: the gill-withdrawal reflex-by analyzing sensory, motor, and serotonergic modulatory neurons, and (3) processes of individual neurons. In addition to increasing the amount of available gene sequences of Aplysia by two orders of magnitude, this collection represents the largest database available for any member of the Lophotrochozoa and therefore provides additional insights into evolutionary strategies used by this highly successful diversified lineage, one of the three proposed super-clacles of bilateral animals.	Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32611 USA; Columbia Univ, Columbia Genome Ctr, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, New York, NY 10032 USA; Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; State University System of Florida; University of Florida; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Moroz, LL (corresponding author), Univ Florida, Whitney Lab Marine Biosci, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.	moroz@whitney.ufl.edu; erk5@columbia.edu		Panchin, Yuri/0000-0002-8006-2839; Heyland, Andreas/0000-0002-7592-4473; Moroz, Leonid/0000-0002-1333-3176	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG002806] Funding Source: Medline; NIMH NIH HHS [R01 MH075026] Funding Source: Medline; NINDS NIH HHS [R01 NS039103, NS39103] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Brannvall K, 2003, BIOCHEM BIOPH RES CO, V308, P369, DOI 10.1016/S0006-291X(03)01386-X; Brusca RC, 2003, INVERTEBRATES; CASH D, 1989, J NEUROBIOL, V20, P25, DOI 10.1002/neu.480200104; Cheney-Choker S, 2004, POETRY WALES, V40, P55; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; Cravchik A, 2001, ARCH NEUROL-CHICAGO, V58, P1772, DOI 10.1001/archneur.58.11.1772; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Diaz-Rios M, 1999, J COMP NEUROL, V413, P255, DOI 10.1002/(SICI)1096-9861(19991018)413:2<255::AID-CNE7>3.0.CO;2-E; Fantappie MR, 2001, EXP PARASITOL, V98, P162, DOI 10.1006/expr.2001.4630; Fitzgerald KK, 1997, LEARN MEMORY, V3, P366, DOI 10.1101/lm.3.5.366; FU GK, 2002, Patent No. 6387624; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; GILLER E, 1971, J NEUROPHYSIOL, V34, P93, DOI 10.1152/jn.1971.34.1.93; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; JAHANPARWAR B, 1979, BEHAV NEURAL BIOL, V27, P39, DOI 10.1016/S0163-1047(79)92744-4; Jezzini SH, 2005, J NEUROSCI METH, V149, P15, DOI 10.1016/j.jneumeth.2005.05.007; Jezzini SH, 2004, MOL BRAIN RES, V127, P27, DOI 10.1016/j.molbrainres.2004.05.007; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KANDEL E.R., 1979, BEHAV BIOL APLYSIA; KANDEL ER, 1966, J PHYSIOL-LONDON, V183, P287, DOI 10.1113/jphysiol.1966.sp007867; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kandel ER., 1976, CELLULAR BASIS BEHAV; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; KUPFERMANN I, 1982, BRAIN RES, V241, P334, DOI 10.1016/0006-8993(82)91072-1; KUPFERMANN I, 1969, SCIENCE, V164, P847, DOI 10.1126/science.164.3881.847; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lehesjoki AE, 2003, EMBO J, V22, P3473, DOI 10.1093/emboj/cdg338; Lovell P, 2006, INTEGR COMP BIOL, V46, P847, DOI 10.1093/icb/icl042; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Moccia R, 2003, J NEUROSCI, V23, P9409; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Pojeta J. Jr, 1987, P270; RAE PMM, 1979, NUCLEIC ACIDS RES, V6, P2987, DOI 10.1093/nar/6.9.2987; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; ROSEN SC, 1989, J NEUROSCI, V9, P1562; Sakharov D A, 1974, J Neural Transm, VSuppl 11, P43; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; VALENTINE JW, 2004, ORIGIN PHYLA; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; WEISS KR, 1976, BRAIN RES, V117, P33, DOI 10.1016/0006-8993(76)90554-0; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; YANG ZB, 1994, J MOL EVOL, V39, P105; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	70	246	251	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1453	1467		10.1016/j.cell.2006.09.052	http://dx.doi.org/10.1016/j.cell.2006.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190607	Bronze, Green Accepted			2022-12-24	WOS:000243690000023
J	Lange, LA; Carlson, CS; Hindorff, LA; Lange, EM; Walston, J; Durda, JP; Cushman, M; Bis, JC; Zeng, DL; Lin, D; Kuller, LH; Nickerson, DA; Psaty, BM; Tracy, RP; Reiner, AP				Lange, Leslie A.; Carlson, Christopher S.; Hindorff, Lucia A.; Lange, Ethan M.; Walston, Jeremy; Durda, J. Peter; Cushman, Mary; Bis, Joshua C.; Zeng, Donglin; Lin, Danyu; Kuller, Lewis H.; Nickerson, Deborah A.; Psaty, Bruce M.; Tracy, Russell P.; Reiner, Alexander P.			Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; MENDELIAN RANDOMIZATION; INFLAMMATORY RESPONSE; RISK-FACTORS; HEALTH; ATHEROSCLEROSIS; PROMOTER; LINKAGE	Context C-reactive protein (CRP) is an inflammation protein that may play a role in the pathogenesis of cardiovascular disease (CVD). Objective To assess whether polymorphisms in the CRP gene are associated with plasma CRP, carotid intima-media thickness (CIMT), and CVD events. Design, Setting, and Participants In the prospective, population-based Cardiovascular Health Study, 4 tag single-nucleotide polymorphisms ( SNPs) (1919A/ T, 2667G/C, 3872G/A, 5237A/G) were genotyped in 3941 white ( European American) participants and 5 tag SNPs ( addition of 790A/T) were genotyped in 700 black ( African American) participants, aged 65 years or older, all of whom were without myocardial infarction (MI) or stroke before study entry. Median follow-up was 13 years (1989-2003). Main Outcome Measures Baseline CIMT; occurrence of MI, stroke, and CVD mortality during follow-up. Results In white participants, 461 incident MIs, 491 incident strokes, and 490 CVD-related deaths occurred; in black participants, 67 incident MIs, 78 incident strokes, and 75 CVD-related deaths occurred. The 1919T and 790T alleles were associated with higher CRP levels in white and black participants, respectively. The 3872A allele was associated with lower CRP levels in both populations, and the 2667C allele was associated with lower CRP levels in white participants only. There was no association between CIMT and any CRP gene polymorphism in either population. In white participants, the 1919T allele was associated with increased risk of stroke for TT vs AA ( hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06- 1.87) and for CVD mortality ( HR, 1.40; 95% CI, 1.10-1.90). In black participants, homozygosity for the 790T allele was associated with a 4-fold increased risk of MI compared with homozygosity for the 790A allele ( 95% CI, 1.58-10.53). The minor alleles of the 2 SNPs associated with lower plasma CRP concentration in white participants ( 2667C and 3872A) were associated with decreased risk of CVD mortality. Conclusions Genetic variation in the CRP gene is associated with plasma CRP levels and CVD risk in older adults.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Ctr Aging & Hlth, Baltimore, MD USA; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Vermont; University of Vermont; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lange, LA (corresponding author), Univ N Carolina, Dept Genet, Campus Box 7264,103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	leslie_lange@med.unc.edu			NHLBI NIH HHS [N01 HC-15103, N01-HC-85083, N01-HC-85086, N01-HC-85084, N01-HC-85085, N01-HC-85081, N01-HC-85080, N01-HC-85079, N01-HC-85082, N01-HC-35129, R01 HL-071862-03] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085081, N01HC085080, N01HC085084, N01HC085083, N01HC015103, N01HC085085, N01HC085082, N01HC085079, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071862] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, ANN HUM GENET, V70, P705, DOI 10.1111/j.1469-1809.2006.00272.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Ledue TB, 2003, CLIN CHEM, V49, P1258, DOI 10.1373/49.8.1258; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Macy EM, 1997, CLIN CHEM, V43, P52; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2004, QJM-INT J MED, V97, P163, DOI 10.1093/qjmed/hch025; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Williams TN, 2004, ARTERIOSCL THROM VAS, V24, P61, DOI 10.1161/01.ATV.0000104014.24367.16; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	45	209	222	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2703	2711		10.1001/jama.296.22.2703	http://dx.doi.org/10.1001/jama.296.22.2703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164456	Bronze			2022-12-24	WOS:000242765700025
J	Basson, R				Basson, Rosemary			Sexuality in chronic illness: no longer ignored	LANCET			English	Editorial Material							TESTOSTERONE; DYSFUNCTION; MEN		Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Basson, R (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada.	sexmed@interchange.ubc.ca						Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; BHASIN S, IN PRESS LANCET; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; de Vries CS, 2006, MATURITAS, V53, P343, DOI 10.1016/j.maturitas.2005.06.004; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; REES P, IN PRESS LANCET; SANTORO A, 2005, J CLIN ENDOCR METAB, V90, P2004; *WHO, GEND REPR RIGHTS	11	25	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					350	352		10.1016/S0140-6736(07)60166-4	http://dx.doi.org/10.1016/S0140-6736(07)60166-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276757				2022-12-24	WOS:000243944400006
J	Sun, PQ; Yoshizuka, N; New, L; Moser, BA; Li, YL; Liao, R; Xie, CC; Chen, JM; Deng, QD; Yamout, M; Dong, MQ; Frangou, CG; Yates, JR; Wright, PE; Han, JH				Sun, Peiqing; Yoshizuka, Naoto; New, Liguo; Moser, Bettina A.; Li, Yilei; Liao, Rong; Xie, Changchuan; Chen, Jianming; Deng, Qingdong; Yamout, Mana; Dong, Meng-Qiu; Frangou, Costas G.; Yates, John R., III; Wright, Peter E.; Han, Jiahuai			PRAK is essential for ras-induced senescence and tumor suppression	CELL			English	Article							INDUCED PREMATURE SENESCENCE; CELL-CYCLE ARREST; ONCOGENIC RAS; HUMAN FIBROBLASTS; MOUSE SKIN; HUMAN P53; KINASE; ACTIVATION; PATHWAY; DEFICIENT	Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38regulated/activated protein kinase (PRAK) is a p38 MAIPIK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol, Xiamen 361005, Peoples R China	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; Xiamen University	Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pqsun@scripps.edu; jhan@scripps.edu	Han, J/G-4671-2010; xie, chang/GYJ-2493-2022	Wright, Peter/0000-0002-1368-0223	NATIONAL CANCER INSTITUTE [R01CA106768, R01CA091922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER; NCI NIH HHS [CA106768, CA91922] Funding Source: Medline; NIAID NIH HHS [AI054696, AI041637] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Haq R, 2002, CANCER RES, V62, P5076; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1999, CANCER RES, V59, P2217; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	42	245	264	3	94	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					295	308		10.1016/j.cell.2006.11.050	http://dx.doi.org/10.1016/j.cell.2006.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254968	Bronze			2022-12-24	WOS:000244420500015
J	Gewin, V				Gewin, Virginia			Crunch time for multiple-gene tests	NATURE			English	News Item																			0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					354	355		10.1038/445354a	http://dx.doi.org/10.1038/445354a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251949				2022-12-24	WOS:000243689500010
J	Anderson, GF; Chu, E				Anderson, Gerard F.; Chu, Edward			Expanding priorities - Confronting chronic disease in countries with low income	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Thorpe, Allison/A-2705-2011					[Anonymous], 2005, PREV CHRON DIS VIT I; World Bank. Oxford University, 2006, DIS CONTR PRIOR DEV; 2006, GATES BUFFETT GIFT M	3	135	141	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					209	211		10.1056/NEJMp068182	http://dx.doi.org/10.1056/NEJMp068182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126BV	17229946				2022-12-24	WOS:000243488100001
J	Nguyen, T; Vazquez, M; Toto, R				Nguyen, Thai; Vazquez, Miguel; Toto, Robert			Living kidney donation and hypertension risk	LANCET			English	Editorial Material							DONOR; TRANSPLANTATION; NEPHRECTOMY		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Toto, R (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	Robert.toto@utsouthwestern.edu	Toto, Robert/AAQ-3336-2021					Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Cohen DJ, 2006, AM J TRANSPLANT, V6, P1153, DOI 10.1111/j.1600-6143.2006.01272.x; Davis CL, 2005, J AM SOC NEPHROL, V16, P2098, DOI 10.1681/ASN.2004100824; Davis CL, 2004, AM J KIDNEY DIS, V43, P508, DOI 10.1053/j.ajkd.2003.10.044; HOSTETTER T, 1981, AM J PHYSIOL, V241, P85; Johnson EM, 1997, TRANSPLANTATION, V64, P1124, DOI 10.1097/00007890-199710270-00007; KASISKE BL, 1995, KIDNEY INT, V48, P814, DOI 10.1038/ki.1995.355; McCune TR, 2004, CLIN TRANSPLANT, V18, P33, DOI 10.1111/j.1399-0012.2004.00215.x; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Waterman Amy D, 2006, Prog Transplant, V16, P17	11	4	4	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 13	2007	369	9556					87	88		10.1016/S0140-6736(07)60046-4	http://dx.doi.org/10.1016/S0140-6736(07)60046-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126TK	17223455				2022-12-24	WOS:000243538200008
J	Phillips, JA				Phillips, John A.			Is Burkitt's lymphoma sexy enough?	LANCET			English	Editorial Material											Phillips, JA (corresponding author), 60 Old Rossorry Rd, Enniskillen BT74 7LF, Fermanagh, North Ireland.	jnsphillips@tiscali.co.uk							0	5	5	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2006	368	9554					2251	2252		10.1016/S0140-6736(06)69898-X	http://dx.doi.org/10.1016/S0140-6736(06)69898-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189037				2022-12-24	WOS:000243076800033
J	Boutin, S; Wauters, LA; McAdam, AG; Humphries, MM; Tosi, G; Dhondt, AA				Boutin, Stan; Wauters, Lucas A.; McAdam, Andrew G.; Humphries, Murray M.; Tosi, Guido; Dhondt, Andre A.			Anticipatory reproduction and population growth in seed predators	SCIENCE			English	Article							SCIURUS-VULGARIS; LIFE-HISTORY; RED; DYNAMICS	Mast seeding, the intermittent, synchronous production of large seed crops by a population of plants, is a well-known example of resource pulses that create lagged responses in successive trophic levels of ecological communities. These lags arise because seed predators are thought capable of increasing reproduction and population size only after the resource pulse is available for consumption. The resulting satiation of predators is a widely cited explanation for the evolution of masting. Our study shows that both American and Eurasian tree squirrels anticipate resource pulses and increase reproductive output before a masting event, thereby increasing population size in synchrony with the resource pulse and eliminating the population lag thought to be universal in resource pulse systems.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Insubria, Dept Environm Hlth & Safety, I-21100 Varese, Italy; Michigan State Univ, Dept Zool, Dept Fisheries & Wildlife, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Cornell Univ, Ornithol Lab, Ithaca, NY 14850 USA; Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium	University of Alberta; University of Insubria; Michigan State University; McGill University; Cornell University; University of Antwerp	Boutin, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	stan.boutin@ualberta.ca	Boutin, Stan A/A-2619-2014; McAdam, Andrew G/G-1802-2010; Dhondt, André/A-8292-2008	Boutin, Stan A/0000-0001-6317-038X; McAdam, Andrew G/0000-0001-7323-2572; Wauters, Lucas Armand/0000-0002-7012-9200; Wauters, Lucas/0000-0002-4871-5035; Dhondt, Andre/0000-0002-4946-1401				Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; BECKER CD, 1993, CAN J ZOOL, V71, P1326, DOI 10.1139/z93-183; BERGER PJ, 1981, SCIENCE, V214, P69, DOI 10.1126/science.7025210; BRONSON FH, 1989, REPROD BIOL; CAUGHLEY G, 1981, THEORETICAL ECOLOGY, pCH6; Clutton-Brock T. H., 1988, REPROD SUCCESS; CLUTTONBROCK TH, 1999, EVOLUTION PARENTAL C; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; EIS S, 1972, Canadian Journal of Forest Research, V2, P460, DOI 10.1139/x72-070; Fitzgerald BM, 2004, NEW ZEAL J ZOOL, V31, P167, DOI 10.1080/03014223.2004.9518370; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; HEDLIN A. F., 1964, FOREST SCI, V10, P124; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Larsen KW, 1997, J MAMMAL, V78, P192, DOI 10.2307/1382652; LIGON JD, 1974, NATURE, V250, P80, DOI 10.1038/250080a0; McAdam AG, 2003, EVOLUTION, V57, P1689; McKone MJ, 2001, NEW ZEAL J ZOOL, V28, P89, DOI 10.1080/03014223.2001.9518259; McNeilly AS, 2001, REPROD FERT DEVELOP, V13, P583, DOI 10.1071/RD01056; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ruf T, 2006, ECOLOGY, V87, P372, DOI 10.1890/05-0672; RUSCH DA, 1978, ECOLOGY, V59, P400, DOI 10.2307/1936382; SMITH MC, 1968, J WILDLIFE MANAGE, V32, P305, DOI 10.2307/3798975; WAUTERS L, 1992, J ZOOL, V227, P71, DOI 10.1111/j.1469-7998.1992.tb04345.x; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; WAUTERS LA, 1989, J ZOOL, V217, P93, DOI 10.1111/j.1469-7998.1989.tb02477.x; Wilson PR, 1998, BIOL CONSERV, V83, P175, DOI 10.1016/S0006-3207(97)00055-4; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690	31	197	201	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1928	1930		10.1126/science.1135520	http://dx.doi.org/10.1126/science.1135520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185600				2022-12-24	WOS:000242996800049
J	Rome, LC; Flynn, L; Yoo, TD				Rome, Lawrence C.; Flynn, Louis; Yoo, Taeseung D.			Biomechanics - Rubber bands reduce the cost of carrying loads	NATURE			English	Article							BACK-PAIN; WALKING; CHILDREN; MASS		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rome, LC (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	lrome@sas.upenn.edu		Flynn, Louis/0000-0003-2966-0355				BALOGUN JA, 1986, ERGONOMICS, V29, P1623, DOI 10.1080/00140138608967274; Chatterjee A, 2002, INT J ROBOT RES, V21, P621, DOI 10.1177/027836402322023213; Donelan JM, 2002, J EXP BIOL, V205, P3717; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; Negrini S, 2002, SPINE, V27, P187, DOI 10.1097/00007632-200201150-00014; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; TROUSSIER B, 1994, SCAND J REHABIL MED, V26, P143	10	102	104	12	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1023	1024		10.1038/4441023a	http://dx.doi.org/10.1038/4441023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183310				2022-12-24	WOS:000242971100043
J	Gross, CP; Andersen, MS; Krumholz, HM; McAvay, GJ; Proctor, D; Tinetti, ME				Gross, Cary P.; Andersen, Martin S.; Krumholz, Harlan M.; McAvay, Gail J.; Proctor, Deborah; Tinetti, Mary E.			Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; BREAST-CANCER; UNITED-STATES; COVERAGE; US; COLONOSCOPY; POPULATION; PREDICTORS; INSURANCE; CARCINOMA	Context Medicare's reimbursement policy was changed in 1998 to provide coverage for screening colonoscopies for patients with increased colon cancer risk, and expanded further in 2001 to cover screening colonoscopies for all individuals. Objective To determine whether the Medicare reimbursement policy changes were associated with an increase in either colonoscopy use or early stage colon cancer diagnosis. Design, Setting, and Participants Patients in the Surveillance, Epidemiology, and End Results Medicare linked database who were 67 years of age and older and had a primary diagnosis of colon cancer during 1992-2002, as well as a group of Medicare beneficiaries who resided in Surveillance, Epidemiology, and End Results areas but who were not diagnosed with cancer. Main Outcome Measures Trends in colonoscopy and sigmoidoscopy use among Medicare beneficiaries without cancer were assessed using multivariate Poisson regression. Among the patients with cancer, stage was classified as early ( stage I) vs all other ( stages II-IV). Time was categorized as period 1 ( no screening coverage, 19921997), period 2 ( limited coverage, January 1998-June 2001), and period 3 ( universal coverage, July 2001-December 2002). A multivariate logistic regression (outcome = early stage) was used to assess temporal trends in stage at diagnosis; an interaction term between tumor site and time was included. Results Colonoscopy use increased from an average rate of 285/ 100 000 per quarter in period 1 to 889 and 1919/100 000 per quarter in periods 2 ( P <. 001) and 3 ( P vs 2 <. 001), respectively. During the study period, 44 924 eligible patients were diagnosed with colorectal cancer. The proportion of patients diagnosed at an early stage increased from 22.5% in period 1 to 25.5% in period 2 and 26.3% in period 3 ( P <. 001 for each pair-wise comparison). The changes in Medicare coverage were strongly associated with early stage at diagnosis for patients with proximal colon lesions ( adjusted relative risk period 2 vs 1, 1.19; 95% confidence interval, 1.13-1.26; adjusted relative risk period 3 vs 2, 1.10; 95% confidence interval, 1.02-1.17) but weakly associated, if at all, for patients with distal colon lesions ( adjusted relative risk period 2 vs 1, 1.07; 95% confidence interval, 1.01-1.13; adjusted relative risk period 3 vs 2, 0.97; 95% confidence interval, 0.90-1.05). Conclusions Expansion of Medicare reimbursement to cover colon cancer screening was associated with an increased use of colonoscopy for Medicare beneficiaries, and for those who were diagnosed with colon cancer, an increased probability of being diagnosed at an early stage. The selective effect of the coverage change on proximal colon lesions suggests that increased use of whole-colon screening modalities such as colonoscopy may have played a pivotal role.	Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Gastroenterol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	Andersen, Martin/J-7018-2019; , Harlan/AAI-2875-2020	Andersen, Martin/0000-0001-5982-2541; 	NATIONAL INSTITUTE ON AGING [P30AG021342, K08AG024842] Funding Source: NIH RePORTER; NIA NIH HHS [P30AG21342, 1 K08 AG24842] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams EK, 2004, PREV MED, V38, P551, DOI 10.1016/j.ypmed.2003.12.014; *AM CANC SOC, 2005, CANC FACTS FIG; *AM CANC SOC, EST NEW CANC CAS DEA; [Anonymous], 2001, FED REGISTER, V66, P55246; Berg AO, 2002, AM J NURS, V102, P107; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Cooper GS, 2005, CANCER, V103, P696, DOI 10.1002/cncr.20839; Cooper GS, 2004, AM J GASTROENTEROL, V99, P1544, DOI 10.1111/j.1572-0241.2004.30902.x; Cress RD, 2000, PREV MED, V31, P447, DOI 10.1006/pmed.2000.0730; Dans PE, 1996, RADIOLOGY, V198, P657, DOI 10.1148/radiology.198.3.8628850; Etzioni DA, 2004, CANCER-AM CANCER SOC, V101, P2523, DOI 10.1002/cncr.20692; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Greene J, 2001, HEALTH CARE FINANC R, V22, P141; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Ko CW, 2002, ARCH INTERN MED, V162, P2581, DOI 10.1001/archinte.162.22.2581; MILLER BA, 1992, NIH PUBLICATION, V92, P2789; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTOSKY AL, 1993, MED CARE, V31, P732; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ries L, 2004, SEER CANC STAT REV 1; Ries L., 2005, SEER CANC STAT REV 1; RIES LAG, 1999, SEER CANC STAT REV; Riley GF, 1999, JAMA-J AM MED ASSOC, V281, P720, DOI 10.1001/jama.281.8.720; RILEY GF, 1994, AM J PUBLIC HEALTH, V84, P1598, DOI 10.2105/AJPH.84.10.1598; SAS Institute, 2008, SAS STAT US GUID; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shih YCT, 2006, HEALTH AFFAIR, V25, P1153, DOI 10.1377/hlthaff.25.4.1153; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith S, 2003, HIST TODAY, V53, P43; Tomoda H, 1998, ONCOL REP, V5, P481; Troisi RJ, 1999, CANCER, V85, P1670, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1670::AID-CNCR5>3.0.CO;2-M; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	163	164	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2815	2822		10.1001/jama.296.23.2815	http://dx.doi.org/10.1001/jama.296.23.2815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179458				2022-12-24	WOS:000242826400023
J	Razavi, R; Chan, Y; Afifiyan, FN; Liu, XJ; Wan, X; Yantha, J; Tsui, H; Tang, L; Tsai, S; Santamaria, P; Drivers, JP; Serreze, D; Salter, MW; Dosch, HM				Razavi, Rozita; Chan, Yin; Afifiyan, F. Nikoo; Liu, Xue Jun; Wan, Xiang; Yantha, Jason; Tsui, Hubert; Tang, Lan; Tsai, Sue; Santamaria, Pere; Drivers, John P.; Serreze, David; Salter, Michael W.; Dosch, H. -Michael			TRPV1(+) sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes	CELL			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GENE-RELATED PEPTIDE; DELAYED-TYPE HYPERSENSITIVITY; REGULATORY T-CELLS; SUBSTANCE-P; INSULIN-SECRETION; NOD MICE; RECEPTOR; MOUSE; SUSCEPTIBILITY	In type 1 diabetes, T cell-mediated death of pancreatic beta cells produces insulin deficiency. However, what attracts or restricts broadly autoreactive lymphocyte pools to the pancreas remains unclear. We report that TRPV1(+) pancreatic sensory neurons control islet inflammation and insulin resistance. Eliminating these neurons in diabetes-prone NOD mice prevents insulitis and diabetes, despite systemic persistence of pathogenic T cell pools. Insulin resistance and beta cell stress of prediabetic NOD mice are prevented when TRPV1(+) neurons are eliminated. TRPV1(NOD), localized to the Idd4.1 diabetes-risk locus, is a hypofunctional mutant, mediating depressed neurogenic inflammation. Delivering the neuropeptide substance P by intra-arterial injection into the NOD pancreas reverses abnormal insulin resistance, insulitis, and diabetes for weeks. Concordantly, insulin sensitivity is enhanced in trpv1(-/-) mice, whereas insulitis/diabetes-resistant NODxB6Idd4-congenic mice, carrying wild-type TRPV1, show restored TRPV1 function and insulin sensitivity. Our data uncover a fundamental role for insulin-responsive TRPV1(+) sensory neurons in beta cell function and diabetes pathoetiology.	Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Jackson Lab, Bar Harbor, ME 04609 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Calgary; Jackson Laboratory	Dosch, HM (corresponding author), Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada.	hmdosch@sickkids.ca	Santamaria, Pere/ABF-6823-2021	Chan, Yin/0000-0003-2741-8258; Tsai, Sue/0000-0002-6261-5233				Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2001, J IMMUNOL, V167, P655, DOI 10.4049/jimmunol.167.2.655; Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Babaya N, 2005, BIOCHEM BIOPH RES CO, V328, P158, DOI 10.1016/j.bbrc.2004.12.149; BARAKAT A, 1994, BIOSCIENCE REP, V14, P1, DOI 10.1007/BF01901633; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Boulard O, 2002, J IMMUNOL, V168, P4192, DOI 10.4049/jimmunol.168.8.4192; BRETHERTONWATT D, 1992, ANN NY ACAD SCI, V657, P299, DOI 10.1111/j.1749-6632.1992.tb22777.x; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; ChancellorFreeland C, 1995, ANN NY ACAD SCI, V771, P472, DOI 10.1111/j.1749-6632.1995.tb44703.x; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Grattan M, 2002, DIABETES, V51, P215, DOI 10.2337/diabetes.51.1.215; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; HELME RD, 1987, J IMMUNOL, V139, P3470; HERMANSEN K, 1990, REGUL PEPTIDES, V27, P149, DOI 10.1016/0167-0115(90)90213-G; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Ivakine EA, 2005, J IMMUNOL, V174, P7129, DOI 10.4049/jimmunol.174.11.7129; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Khachatryan A, 1997, J IMMUNOL, V158, P1409; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Moesgaard SG, 2005, AM J PHYSIOL-ENDOC M, V288, pE1137, DOI 10.1152/ajpendo.00356.2004; MORIKAWA Y, 1993, CELL IMMUNOL, V152, P200, DOI 10.1006/cimm.1993.1279; Nielsen K, 2004, DIABETOLOGIA, V47, P2185, DOI 10.1007/s00125-004-1578-1; NILSSON G, 1991, INT J IMMUNOPHARMACO, V13, P21, DOI 10.1016/0192-0561(91)90021-X; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Persson-Sjogren S, 2005, J AUTOIMMUN, V24, P269, DOI 10.1016/j.jaut.2005.02.003; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosmalen JGM, 2002, TRENDS ENDOCRIN MET, V13, P209, DOI 10.1016/S1043-2760(02)00600-8; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Santoni G, 1996, J NEUROIMMUNOL, V68, P131, DOI 10.1016/0165-5728(96)00081-1; Sathianathan V, 2003, EUR J NEUROSCI, V18, P2477, DOI 10.1046/j.1460-9568.2003.03004.x; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; van de Wall EHEM, 2005, LIFE SCI, V77, P1283, DOI 10.1016/j.lfs.2005.03.011; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	60	242	289	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1123	1135		10.1016/j.cell.2006.10.038	http://dx.doi.org/10.1016/j.cell.2006.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174891	Bronze			2022-12-24	WOS:000242991000012
J	de Oliveira, T; Pybus, OG; Rambaut, A; Salemi, M; Cassol, S; Ciccozzi, M; Rezza, G; Gattinara, GC; D'Arrigo, R; Amicosante, M; Perrin, L; Colizzi, V; Perno, CF				de Oliveira, Tulio; Pybus, Oliver G.; Rambaut, Andrew; Salemi, Marco; Cassol, Sharon; Ciccozzi, Massimo; Rezza, Giovanni; Gattinara, Guido Castelli; D'Arrigo, Roberta; Amicosante, Massimo; Perrin, Luc; Colizzi, Vittorio; Perno, Carlo Federico		Benghazi Study Grp	Molecular epidemiology - HIV-1 and HCV sequences from Libyan outbreak	NATURE			English	Article							HEPATITIS-C VIRUS; NOSOCOMIAL OUTBREAK		Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Pretoria, Fac Hlth Sci, ZA-0001 Pretoria, South Africa; Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy; Bambino Gesu Pediat Hosp, Dept Immunol & Infect Dis, I-00165 Rome, Italy; Spallanzani Inst Infect Dis, I-00149 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; Univ Hosp Geneva, CH-1211 Geneva, Switzerland; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy	University of Oxford; University of Edinburgh; State University System of Florida; University of Florida; University of Pretoria; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Rome Tor Vergata; University of Geneva; University of Rome Tor Vergata; University of Rome Tor Vergata	de Oliveira, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tulio.deoliveira@zoo.ox.ac.uk	Pybus, Oliver G/B-2640-2012; castelli, guido/AAA-1507-2020; Rambaut, Andrew/B-2481-2009; perno, carlo federico/O-1544-2016; rezza, giovanni/D-4393-2016; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016	Pybus, Oliver G/0000-0002-8797-2667; castelli, guido/0000-0002-3282-7462; Rambaut, Andrew/0000-0003-4337-3707; rezza, giovanni/0000-0003-0268-6790; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; Amicosante, Massimo/0000-0002-2372-3311; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X				Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; *EUR COMM, 2006, TECHN MISS LIB ILL I; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Goldmann DA, 2002, J ALLERGY CLIN IMMUN, V110, pS21, DOI 10.1067/mai.2002.125337; *HUMAN RIGHTS WATC, 2006, STEMM FLOW, V18; MONTAGNIER L, 2006, REPORT BENGHAZI OUTB; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	12	99	100	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					836	837		10.1038/444836a	http://dx.doi.org/10.1038/444836a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17171825	Bronze			2022-12-24	WOS:000242805400034
J	Bhutta, A; Gilliam, C; Honeycutt, M; Schexnayder, S; Green, J; Moss, M; Anand, KJS				Bhutta, Adnan; Gilliam, Craig; Honeycutt, Michele; Schexnayder, Stephen; Green, Jerril; Moss, Michele; Anand, K. J. S.			Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach	BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; NOSOCOMIAL INFECTIONS; RISK-FACTORS; PREVENTION; GUIDELINE	Problem Bloodstream infections associated with catheters were the most common nosocomial infections in one paediatric intensive care unit in 1994-7, with rates well above the national average. Design Clinical data were collected prospectively to assess the rates of infection from 1994 onwards. The high rates in 1994-7 led to the stepwise introduction of interventions over a five year period. At quarterly intervals, prospective data continued to be collected during this period and an additional three year follow-up period. Setting A 292 bed tertiary care children's hospital. Key measures for improvement We aimed to reduce our infection rates to below the national mean rates for similar units by 2000 (a 25% reduction). Strategies for change A stepwise introduction of interventions designed to reduce infection rates, including maximal barrier precautions, transition to antibiotic impregnated central venous catheters, annual handwashing campaigns, and changing the skin disinfectant from povidone-iodine to chlorhexidine. Effects of change Significant decreases in rates of infection occurred over the intervention period. These were sustained over the three year follow-up. Annual rates decreased from 9.7/1000 days with a central venous catheter in 1997 to 3.0/1000 days in 2005, which translates to a relative risk reduction of 75% (95% confidence interval 35% to 126%), an absolute risk reduction of 6% (2% to 10%), and a number needed to treat of 16 (10 to 35). Lessons learnt A stepwise introduction of interventions leading to a greater than threefold reduction in nosocomial infections can be implemented successfully. This requires a multidisciplinary team, support from hospital leadership, ongoing data collection, shared data interpretation, and introduction of evidence based interventions.	Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA; Arkansas Childrens Hosp, Little Rock, AR 72202 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Bhutta, A (corresponding author), Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, 800 Marshall St,Slot 512-3, Little Rock, AR 72202 USA.	bhuttaadnant@uams.edu	Bhutta, Adnan T/ADN-9072-2022; Bhutta, Adnan/AAN-8551-2021; Anand, Kanwaljeet/B-3287-2014	Bhutta, Adnan/0000-0003-3362-5835; Anand, Kanwaljeet/0000-0001-6498-1483				[Anonymous], 2005, MMWR MORB MORTAL WKL; Bourn J., 2000, MANAGEMENT CONTROL H; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Garland JS, 2002, PEDIATRICS, V110, P1009, DOI 10.1542/peds.110.5.1009; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; MILLIKEN J, 1988, CRIT CARE MED, V16, P233, DOI 10.1097/00003246-198803000-00005; *NNIS, 1998, DAT SUMM OCT 1986 AP; O'Grady NP, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e51; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; PRATT RJ, 2004, COMPARISON INT PRACT; Raad Issam, 1999, P165; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; SinghNaz N, 1996, CRIT CARE MED, V24, P875, DOI 10.1097/00003246-199605000-00024; Slonim Anthony D., 2001, Pediatr Crit Care Med, V2, P170, DOI 10.1097/00130478-200104000-00012; *US DEP HHS, 2006, CDCS ROL MON PREV HE; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	19	64	66	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					362	365		10.1136/bmj.39064.457025.DE	http://dx.doi.org/10.1136/bmj.39064.457025.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303886	Green Published			2022-12-24	WOS:000244560400035
J	Raviglione, MC; Smith, IM				Raviglione, Mario C.; Smith, Ian M.			XDR tuberculosis - Implications for global public health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Stop TB Dept, Geneva, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, Geneva, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; 2006, MMWR MORB MORTAL WKL, V55, P301	5	262	275	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					656	659		10.1056/NEJMp068273	http://dx.doi.org/10.1056/NEJMp068273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301295				2022-12-24	WOS:000244193300002
J	Martianov, I; Ramadass, A; Barros, AS; Chow, N; Akoulitchev, A				Martianov, Igor; Ramadass, Aroul; Barros, Ana Serra; Chow, Natalie; Akoulitchev, Alexandre			Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript	NATURE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; TATA-ELEMENT; COMPLEX; EXPRESSION; CELLS; TFIIB; SPECIFICITY; PROMOTER; SITE	Alternative promoters within the same gene are a general phenomenon in gene expression(1,2). Mechanisms of their selective regulation vary from one gene to another and are still poorly understood. Here we show that in quiescent cells the mechanism of transcriptional repression of the major promoter of the gene encoding dihydrofolate reductase depends on a non-coding transcript initiated from the upstream minor promoter and involves both the direct interaction of the RNA and promoter-specific interference. The specificity and efficiency of repression is ensured by the formation of a stable complex between non-coding RNA and the major promoter, direct interaction of the non-coding RNA with the general transcription factor IIB and dissociation of the preinitiation complex from the major promoter. By using in vivo and in vitro assays such as inducible and reconstituted transcription, RNA bandshifts, RNA interference, chromatin immunoprecipitation and RNA immunoprecipitation, we show that the regulatory transcript produced from the minor promoter has a critical function in an epigenetic mechanism of promoter-specific transcriptional repression.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade de Aveiro	Akoulitchev, A (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	alexandre.akoulitchev@path.ox.ac.uk		Martiyanov, Igor/0000-0001-6108-2036	MRC [G0200452] Funding Source: UKRI; Medical Research Council [G0200452] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Blume SW, 2003, J CELL BIOCHEM, V88, P165, DOI 10.1002/jcb.10326; Carbone GM, 2003, NUCLEIC ACIDS RES, V31, P833, DOI 10.1093/nar/gkg198; GEE JE, 1992, J BIOL CHEM, V267, P11163; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; HENDRICKSON SL, 1980, P NATL ACAD SCI-BIOL, V77, P5140, DOI 10.1073/pnas.77.9.5140; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kazmi MA, 1996, BIOTECHNIQUES, V21, P304; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; LETAI AG, 1988, BIOCHEMISTRY-US, V27, P9108, DOI 10.1021/bi00426a007; MARCK C, 1978, NUCLEIC ACIDS RES, V5, P1017, DOI 10.1093/nar/5.3.1017; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MASTERS JN, 1985, MOL CELL BIOL, V5, P493, DOI 10.1128/MCB.5.3.493; MORGAN AR, 1968, J MOL BIOL, V37, P63, DOI 10.1016/0022-2836(68)90073-9; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; Xu ZL, 2003, GENE, V309, P145, DOI 10.1016/S0378-1119(03)00506-7	21	559	617	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					666	670		10.1038/nature05519	http://dx.doi.org/10.1038/nature05519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237763				2022-12-24	WOS:000244039400048
J	Tumpey, TM; Maines, TR; Van Hoeven, N; Glaser, L; Solorzano, A; Pappas, C; Cox, NJ; Swayne, DE; Palese, P; Katz, JM; Garcia-Sastre, A				Tumpey, Terrence M.; Maines, Taronna R.; Van Hoeven, Neal; Glaser, Laurel; Solorzano, Alicia; Pappas, Claudia; Cox, Nancy J.; Swayne, David E.; Palese, Peter; Katz, Jacqueline M.; Garcia-Sastre, Adolfo			A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission	SCIENCE			English	Article							RECEPTOR SPECIFICITY; PANDEMIC VIRUS; HUMAN AIRWAY; A VIRUSES; EVOLUTION; GENE; H2	The 1918 influenza pandemic was a catastrophic series of virus outbreaks that spread across the globe. Here, we show that only a modest change in the 1918 influenza hemagglutinin receptor binding site alters the transmissibility of this pandemic virus. Two amino acid mutations that cause a switch in receptor binding preference from the human alpha-2,6 to the avian alpha-2,3 sialic acid resulted in a virus incapable of respiratory droplet transmission between ferrets but that maintained its lethality and replication efficiency in the upper respiratory tract. Furthermore, poor transmission of a 1918 virus with dual alpha-2,6 and alpha-2,3 specificity suggests that a predominant human alpha-2,6 sialic acid binding preference is essential for optimal transmission of this pandemic virus. These findings confirm an essential role of hemagglutinin receptor specificity for the transmission of influenza viruses among mammals.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; USDA, SE Poultry Res Lab, Agr Res Lab, Athens, GA USA	Centers for Disease Control & Prevention - USA; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA)	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Mailstop G-16,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	tft9@cdc.gov	Swayne, David/AAP-7166-2020	Solorzano, Alicia/0000-0003-0072-3463; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Swayne, David/0000-0001-7472-1992; Palese, Peter/0000-0002-0337-5823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, P01AI058113] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI058113, U19 AI62623] Funding Source: Medline; PHS HHS [U54 AIO57158] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Burnet F. M., 1942, INFLUENZA SURVEY LAS; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; PATTERSON KD, 1991, B HIST MED, V65, P4; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; WHO, EP PAND AL RESP EPR	25	450	506	5	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					655	659		10.1126/science.1136212	http://dx.doi.org/10.1126/science.1136212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272724				2022-12-24	WOS:000243909400046
J	Stern, E; Klemic, JF; Routenberg, DA; Wyrembak, PN; Turner-Evans, DB; Hamilton, AD; LaVan, DA; Fahmy, TM; Reed, MA				Stern, Eric; Klemic, James F.; Routenberg, David A.; Wyrembak, Pauline N.; Turner-Evans, Daniel B.; Hamilton, Andrew D.; LaVan, David A.; Fahmy, Tarek M.; Reed, Mark A.			Label-free immunodetection with CMOS-compatible semiconducting nanowires	NATURE			English	Article							ELECTRICAL DETECTION; SILICON NANOWIRES; NANOSENSORS; SENSORS; SURFACES; DEVICES; ARRAYS; DNA	Semiconducting nanowires have the potential to function as highly sensitive and selective sensors for the label-free detection of low concentrations of pathogenic microorganisms(1-10). Successful solution-phase nanowire sensing has been demonstrated for ions(3), small molecules(4), proteins(5,6), DNA(7) and viruses(8); however, 'bottom-up' nanowires ( or similarly configured carbon nanotubes(11)) used for these demonstrations require hybrid fabrication schemes(12,13), which result in severe integration issues that have hindered widespread application. Alternative 'top-down' fabrication methods of nanowire-like devices(9,10,14-17) produce disappointing performance because of process-induced material and device degradation. Here we report an approach that uses complementary metal oxide semiconductor (CMOS) field effect transistor compatible technology and hence demonstrate the specific label-free detection of below 100 femtomolar concentrations of antibodies as well as real-time monitoring of the cellular immune response. This approach eliminates the need for hybrid methods and enables system-scale integration of these sensors with signal processing and information systems. Additionally, the ability to monitor antibody binding and sense the cellular immune response in real time with readily available technology should facilitate widespread diagnostic applications.	Yale Univ, Dept Elect Engn, New Haven, CT 06511 USA; Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA; Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Reed, MA (corresponding author), Yale Univ, Dept Elect Engn, POB 208284, New Haven, CT 06511 USA.	tarek.fahmy@yale.edu; mark.reed@yale.edu	Reed, Mark/A-9970-2011; Turner-Evans, Daniel/J-4488-2016; LaVan, David/C-3943-2012	Reed, Mark/0000-0001-6479-7256; Turner-Evans, Daniel/0000-0002-8020-0170; LaVan, David/0000-0002-1952-0028				Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; Bunimovich YL, 2004, LANGMUIR, V20, P10630, DOI 10.1021/la047913h; Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Clement N, 2002, PHYSICA E, V13, P999, DOI 10.1016/S1386-9477(02)00288-6; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Elibol OH, 2003, APPL PHYS LETT, V83, P4613, DOI 10.1063/1.1630853; Englander O, 2005, NANO LETT, V5, P705, DOI 10.1021/nl050109a; Evoy S, 2004, MICROELECTRON ENG, V75, P31, DOI 10.1016/j.mee.2003.09.010; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, pCH1; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA, pCH12; Laws GM, 2002, PHYS STATUS SOLIDI B, V233, P83, DOI 10.1002/1521-3951(200209)233:1<83::AID-PSSB83>3.0.CO;2-#; Li Z, 2004, NANO LETT, V4, P245, DOI 10.1021/nl034958e; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Liu YX, 2003, IEEE ELECTR DEVICE L, V24, P484, DOI 10.1109/LED.2003.815004; Madou MJ, 2003, P IEEE, V91, P830, DOI 10.1109/JPROC.2003.813577; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; Saitoh M, 2003, IEEE T NANOTECHNOL, V2, P241, DOI 10.1109/TNANO.2003.820796; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Strother T, 2000, NUCLEIC ACIDS RES, V28, P3535, DOI 10.1093/nar/28.18.3535; SUN SC, 1980, IEEE J SOLID-ST CIRC, V15, P562, DOI 10.1109/JSSC.1980.1051439; SZE SM, 1981, PHYSICS SEMICONDUCTO, P849; TABATA O, 1992, SENSOR ACTUAT A-PHYS, V34, P51, DOI 10.1016/0924-4247(92)80139-T; Tang T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1881783; Trautmann A, 2005, NAT IMMUNOL, V6, P1213, DOI 10.1038/ni1205-1213; Wang DW, 2006, NANO LETT, V6, P1096, DOI 10.1021/nl052558g; Wang WU, 2005, P NATL ACAD SCI USA, V102, P3208, DOI 10.1073/pnas.0406368102; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	30	1113	1178	6	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					519	522		10.1038/nature05498	http://dx.doi.org/10.1038/nature05498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268465				2022-12-24	WOS:000243867300039
J	Psaty, BM; Weiss, NS				Psaty, Bruce M.; Weiss, Noel S.			NSAID trials and the choice of comparators - Questions of public health importance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITORS; RISK		Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Grp Hlth, Ctr Hlth Studies, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.							Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; *COMM ASS US DRUG, IN PRESS FUT DRUG SA; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704	5	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2007	356	4					328	330		10.1056/NEJMp068286	http://dx.doi.org/10.1056/NEJMp068286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128FT	17251528				2022-12-24	WOS:000243644300002
J	Sujeet, K; Shankar, S				Sujeet, Kumar; Shankar, Stuti			Prevertebral emphysema after a dental procedure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Good Samaritan Hosp, Baltimore, MD 21239 USA		Sujeet, K (corresponding author), Good Samaritan Hosp, Baltimore, MD 21239 USA.	kumar.sujeet@medstar.net							0	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					173	173		10.1056/NEJMicm053300	http://dx.doi.org/10.1056/NEJMicm053300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124NE	17215535				2022-12-24	WOS:000243373700010
J	Sharp, D				Sharp, David			Fusion energy far away	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							*EUR FUS DEV AGR, NUCL FUS BAS; GIRAUD JP, 2006, ITER REL IAEA FUS EN; *GREENP INT, 2005, NUCL FUS REACT PROJ; *ITER, 2001, ITER TECHN BAS 2001; *ITER, 2005, BEYOND ITER; Naranjo B, 2005, NATURE, V434, P1115, DOI 10.1038/nature03575; Sharp D, 2002, LANCET, V359, P908, DOI 10.1016/S0140-6736(02)08016-9	7	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					259	260		10.1016/S0140-6736(07)60126-3	http://dx.doi.org/10.1016/S0140-6736(07)60126-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258652				2022-12-24	WOS:000243912000010
J	Glenner, H; Thomsen, PF; Hebsgaard, MB; Sorensen, MV; Willerslev, E				Glenner, Henrik; Thomsen, Philip Francis; Hebsgaard, Martin Bay; Sorensen, Martin Vinther; Willerslev, Eske			The origin of insects	SCIENCE			English	Editorial Material							TERRESTRIAL CRUSTACEANS; ARTHROPOD PHYLOGENY; GENES; SEQUENCES; CLASSIFY; HEXAPODS; 28S		Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, DK-2100 Copenhagen, Denmark	University of Copenhagen	Willerslev, E (corresponding author), Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, Univ Pk 15, DK-2100 Copenhagen, Denmark.	ewillerslev@bi.ku.dk	Sørensen, Martin V/A-8852-2013; Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/A-9619-2011; Hebsgaard, Martin B/C-8220-2009; Willerslev, Eske/AAA-5686-2019	Sørensen, Martin V/0000-0002-0377-0276; Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Budd G E, 2001, Science, V294, P2047; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Dove H, 2003, DEVELOPMENT, V130, P2161, DOI 10.1242/dev.00442; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Fayers SR, 2003, T ROY SOC EDIN-EARTH, V93, P355; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Haas F, 2003, ORG DIVERS EVOL, V3, P39, DOI 10.1078/1439-6092-00057; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P136, DOI 10.1006/mpev.2001.0956; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; WALOSSEK D, 1993, FOSSILS STRATA, V52, P54; Willmann R, 2005, ORG DIVERS EVOL, V5, P199, DOI 10.1016/j.ode.2004.11.011	24	134	142	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1883	1884		10.1126/science.1129844	http://dx.doi.org/10.1126/science.1129844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185588				2022-12-24	WOS:000242996800032
J	Learmonth, ID; Case, CP				Learmonth, Ian D.; Case, C. Patrick			Metallic debris from orthopaedic implants	LANCET			English	Editorial Material							TOTAL HIP-REPLACEMENT; ARTHROPLASTY; COBALT		Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England	University of Bristol	Learmonth, ID (corresponding author), Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England.	Ian.Learmonth@bristol.ac.uk						Archibeck M J, 2001, Instr Course Lect, V50, P185; *CAN JOINT REPL RE, 2004, 2004 REP TOT HIP TOT, P30; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grubl A, 2006, J BONE JOINT SURG BR, V88B, P1003, DOI 10.1302/0301-620X.88B8; HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734; Huk OL, 2004, J ARTHROPLASTY, V19, P84, DOI 10.1016/j.arth.2004.09.011; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3; *NAT I CLIN EXC, 2002, GUID US MET MET HIP; *UK DEP HLTH, 2006, STAT BIOL EFF WEAR D; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri TI, 2006, P I MECH ENG H, V220, P399, DOI 10.1243/095441105X63282; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	18	11	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					542	544		10.1016/S0140-6736(07)60251-7	http://dx.doi.org/10.1016/S0140-6736(07)60251-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307087				2022-12-24	WOS:000244368000009
J	Lee, DM; Kiener, HP; Agarwal, SK; Noss, EH; Watts, GFM; Chisaka, O; Takeichi, M; Brenner, MB				Lee, David M.; Kiener, Hans P.; Agarwal, Sandeep K.; Noss, Erika H.; Watts, Gerald F. M.; Chisaka, Osamu; Takeichi, Masatoshi; Brenner, Michael B.			Cadherin-11 in synovial lining formation and pathology in arthritis	SCIENCE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; JOINT DESTRUCTION; CELLS; DISEASE; ADHESION; ROLES; EPITHELIUM; ENZYME	The normal synovium forms a membrane at the edges of joints and provides lubrication and nutrients for the cartilage. In rheumatoid arthritis, the synovium is the site of inflammation, and it participates in an organized tissue response that damages cartilage and bone. We identified cadherin-11 as essential for the development of the synovium. Cadherin-11-deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis. Cadherin-11 therapeutics prevent and reduce arthritis in mouse models. Thus, synovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive tissue response in inflammatory arthritis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyoto University; RIKEN	Brenner, MB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, 1 Jimmy Fund Way, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Watts, Gerald/0000-0003-2276-1524	NIAMS NIH HHS [K08 AR2214, R01 AR48114] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002214, R01AR048114] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATHANASOU NA, 1991, ANN RHEUM DIS, V50, P311, DOI 10.1136/ard.50.5.311; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HENDERSON B, 1985, SEMIN ARTHRITIS RHEU, V15, P1, DOI 10.1016/0049-0172(85)90007-1; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; HOLLYWELL C, 1983, VIRCHOWS ARCH A, V400, P345, DOI 10.1007/BF00612195; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KULKA JP, 1955, ARCH PATHOL, V59, P129; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE DM, 2004, KELLEYS TXB RHEUMATO; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; SCHUMACHER HR, 1972, ARTHRITIS RHEUM-US, V15, P465, DOI 10.1002/art.1780150502; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	26	296	317	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1006	1010		10.1126/science.1137306	http://dx.doi.org/10.1126/science.1137306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17255475				2022-12-24	WOS:000244229800048
J	Cordenonsi, M; Montagner, M; Adorno, M; Zacchigna, L; Martello, G; Mamidi, A; Soligo, S; Dupont, S; Piccolo, S				Cordenonsi, Michelangelo; Montagner, Marco; Adorno, Maddalena; Zacchigna, Luca; Martello, Graziano; Mamidi, Anant; Soligo, Sandra; Dupont, Sirio; Piccolo, Stefano			Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation	SCIENCE			English	Article							MESODERM INDUCTION; REQUIRES FGF; TRANSDUCTION; ACTIVATION; KINASE	During development and tissue homeostasis, cells must integrate different signals. We investigated how cell behavior is controlled by the combined activity of transforming growth factor-beta (TGF-beta) and receptor tyrosine kinase (RTK) signaling, whose integration mechanism is unknown. We find that RTK/Ras/ MAPK (mitogen-activated protein kinase) activity induces p53 N-terminal phosphorylation, enabling the interaction of p53 with the TGF-beta-activated Smads. This mechanism confines mesoderm specification in Xenopus embryos and promotes TGF-beta cytostasis in human cells. These data indicate a mechanism to allow extracellular cues to specify the TGF-beta gene-expression program.	Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, Padua, Italy	University of Padua	Piccolo, S (corresponding author), Univ Padua, Dept Med Biotechnol, Sect Histol & Embryol, Padua, Italy.	piccolo@civ.bio.unipd.it	Montagner, Marco/AAY-3236-2020; Cordenonsi, Michelangelo/K-7692-2016; Dupont, Sirio/AAP-8133-2021	Montagner, Marco/0000-0003-3080-2138; Cordenonsi, Michelangelo/0000-0002-8253-5724; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966; Martello, Graziano/0000-0001-5520-085X; Mamidi, Anant/0000-0001-7953-7991	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; CORNELL RA, 1994, DEVELOPMENT, V120, P453; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; LABONNE C, 1994, DEVELOPMENT, V120, P463; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	15	171	183	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					840	843		10.1126/science.1135961	http://dx.doi.org/10.1126/science.1135961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17234915	Bronze			2022-12-24	WOS:000244069000068
J	Gale, CR; Deary, IJ; Batty, GD; Schoon, I				Gale, Catharine R.; Deary, Ian J.; Batty, G. David; Schoon, Ingrid			IQ in childhood and vegetarianism in adulthood: 1970 British cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL SURVEY 1932; MORTALITY; INTELLIGENCE; MIDSPAN; ABILITY; LINKING; HEALTH; DIETS; RISK; LIFE	Objective To examine the relation between IQ in childhood and vegetarianism in adulthood. Design Prospective cohort study in which IQ was assessed by tests of mental ability at age 10 years and vegetarianism by self-report at age 30 years. Setting Great Britain. Participants 8170 men and women aged 30 years participating in the 1970 British cohort study, a national birth cohort. Main outcome measures Self-reported vegetarianism and type of diet followed. Results 366 (4.5%) participants said they were vegetarian, although 123 (33.6%) admitted eating fish or chicken. Vegetarians were more likely to be female, to be of higher social class (both in childhood and currently), and to have attained higher academic or vocational qualifications, although these socioeconomic advantages were not reflected in their income. Higher IQ at age 10 years was associated with an increased likelihood of being vegetarian at age 30 (odds ratio for one standard deviation increase in childhood IQ score 1.38, 95% confidence interval 1.24 to 1.53). IQ remained a statistically significant predictor of being vegetarian as an adult after adjustment for social class (both in childhood and currently), academic or vocational qualifications, and sex (1.20, 1.06 to 1.36). Exclusion of those who said they were vegetarian but ate fish or chicken had little effect on the strength of this association. Conclusion Higher scores for IQ in childhood are associated with an increased likelihood of being a vegetarian as an adult.	Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; Univ Glasgow, Med Res Council, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; City Univ London, Dept Psychol, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; City University London	Gale, CR (corresponding author), Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	crg@mrc.soton.ac.uk	Batty, GD/Y-4401-2018; Schoon, Ingrid/AAC-5715-2019; Deary, Ian J/C-6297-2009; Gale, Catharine R/B-1653-2012; Schoon, Ingrid/E-7430-2010	Batty, GD/0000-0003-1822-5753; Schoon, Ingrid/0000-0002-4262-3711; Deary, Ian J/0000-0002-1733-263X; Gale, Catharine/0000-0002-3361-8638	Economic and Social Research Council [RES-225-25-2001] Funding Source: researchfish; Medical Research Council [U1475000002] Funding Source: researchfish; Medical Research Council [MC_U130059821] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U130059821] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; BATTY GD, 2006, IN PRESS J EPIDEMIOL; CARROLL J, 2006, HUMAN COGNITIVE ABIL; DEARY I, 2006, IN PRESS INTELLIGENC; Elliott C., 1978, BRIT ABILITY SCALES; FRANKLIN B, 1962, AUTOBIOGRAPHY B FRAN; Fu CH, 2006, AM J CARDIOL, V97, P380, DOI 10.1016/j.amjcard.2005.08.057; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444; Schoon I., 2003, CHANGING BRITAIN CHA; Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464	15	52	52	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					245	248B		10.1136/bmj.39030.675069.55	http://dx.doi.org/10.1136/bmj.39030.675069.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17175567	Green Published, Bronze			2022-12-24	WOS:000244172400030
J	Vukusic, P; Hallam, B; Noyes, J				Vukusic, Pete; Hallam, Benny; Noyes, Joe			Brilliant whiteness in ultrathin beetle scales	SCIENCE			English	Article							SCATTERING		Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; Imerys Minerals Ltd, Par PL24 2SQ, Cornwall, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	P.Vukusic@ex.ac.uk			BBSRC [BB/E000177/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000177/1, JF16983] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		FITZWATER S, 1985, J COATING TECHNOL, V57, P39; GANZ E, 1976, APPL OPTICS, V15, P2039, DOI 10.1364/AO.15.002039; Kinoshita S., 2005, STRUCTURAL COLORS BI; McNeil LE, 2000, ACTA MATER, V48, P4571, DOI 10.1016/S1359-6454(00)00243-3; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941	6	192	196	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					348	348		10.1126/science.1134666	http://dx.doi.org/10.1126/science.1134666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234940				2022-12-24	WOS:000243535400031
J	Chen, ZQ; Zhang, GC; Gong, XD; Lin, C; Gao, X; Liang, GJ; Yue, XL; Chen, XS; Cohen, MS				Chen, Zhi-Qiang; Zhang, Guo-Cheng; Gong, Xiang-Dong; Lin, Charles; Gao, Xing; Liang, Guo-Jun; Yue, Xiao-Li; Chen, Xiang-Sheng; Cohen, Myron S.			Syphilis in China: results of a national surveillance programme	LANCET			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIGH PREVALENCE; HEALTH-CARE; SEX WORKERS; HIV; SPREAD; INFECTION; TRANSMISSION; TRENDS; MEN	Background After a massive syphilis epidemic in the first half of the 20th century, China was able to eliminate this infection for 20 years (1960-80). However, substantial changes in Chinese society have been followed by a resurgent epidemic of sexually transmitted diseases. Sporadic reports have provided clues to the magnitude of the spread of syphilis, but a national surveillance effort is needed to provide data for planning and intervention. Methods We collected and assessed case report data from China's national sexually transmitted disease surveillance system and sentinel site network. Findings In 1993, the reported total rate of cases of syphilis in China was 0.2 cases per 100000, whereas primary and secondary syphilis alone represented 5.7 cases per 100000 persons in 2005. The rate of congenital syphilis increased greatly with an average yearly rise of 71.9%, from 0.01 cases per 100000 livebirths in 1991 to 19.68 cases per 100000 livebirths in 2005. Interpretation The results suggest that a range of unique biological and social forces are driving the spread of syphilis in China. A national campaign for detection and treatment of syphilis, and a credible prevention strategy, are urgently needed.	Chinese Acad Med Sci, Natl Ctr STD Control, Nanjing 210042, Peoples R China; Peking Union Med Coll Inst, Nanjing 210042, Peoples R China; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill	Chen, XS (corresponding author), Chinese Acad Med Sci, Natl Ctr STD Control, 12 Jiangwangmiao St, Nanjing 210042, Peoples R China.	chenxs@vip.163.com		Lin, Charles/0000-0002-5347-4811				Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P269; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P108; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Borisenko KK, 1999, INT J STD AIDS, V10, P665, DOI 10.1258/0956462991913240; Brown AE, 2004, SEX TRANSM INFECT, V80, P159, DOI 10.1136/sti.2004.009571; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chang ZQ, 2004, HDB SEXUALLY TRANSMI; Chen J, 2000, EXP THERM FLUID SCI, V21, P206, DOI 10.1016/S0894-1777(00)00004-2; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; CHEN YL, 2001, CHIN J STD AIDS PREV, V8, P237; Choi KH, 1999, INT J STD AIDS, V10, P309, DOI 10.1258/0956462991914177; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; COHEN MS, 1984, CHINESE HOSP SOCIALI; Ding YP, 2005, JAIDS-J ACQ IMM DEF, V38, P314; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; GONG XD, 2001, CHIN J SEX TRANSM IN, V1, P1; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Hershatter Gail, 1997, DANGEROUS PLEASURES; Hesketh T, 2005, INT J STD AIDS, V16, P262, DOI 10.1258/0956462053420257; Ho D, 2005, NATURE, V435, P421, DOI 10.1038/435421a; Hopkins S, 2001, SEX TRANSM INFECT, V77, P316, DOI 10.1136/sti.77.5.316; HORN J, 1974, AWAY ALL PESTS ENGLI; HU CK, 1964, BEIJ SCI C, P167; Hu CKYG, 1959, CHINESE J DERMATOL, V7, P290; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Jing F, 2004, HEALTH POLICY PLANN, V19, pI40, DOI 10.1093/heapol/czh044; Lim MK, 2004, HEALTH AFFAIR, V23, P222, DOI 10.1377/hlthaff.23.6.222; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; Lin Z, 2001, CHIN J STD AIDS PREV, V7, P273; LIU M, 1958, CHINESE J DERMATOL, V6, P76; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; *NAT BUR STAT CHIN, NAT YEARL STAT DAT; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; *S BTS MOH, 1996, GB159741995 SBTSMOH; SIDEL VW, 1972, NEW ENGL J MED, V286, P1292, DOI 10.1056/NEJM197206152862404; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; WANG J, 1923, CHUNG HUA I HSUEH TS, V9, P17; World Health Organisation (WHO), 2004, EXP 100 COND US PROG; Yu AL, 1999, CHIN J AIDS STD, V6, P33; Zhang HJ, 2002, CHIN J FAMILY PLAN, V5, P273; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhao RL, 2003, CHIN J AIDS STD S, P98	48	242	287	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					132	138		10.1016/S0140-6736(07)60074-9	http://dx.doi.org/10.1016/S0140-6736(07)60074-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126TK	17223476	Green Published, Bronze			2022-12-24	WOS:000243538200032
J	Armakolas, A; Klar, AJS				Armakolas, Athanasios; Klar, Amar J. S.			Left-right dynein motor implicated in selective chromatid segregation in mouse cells	SCIENCE			English	Article							MOUSE-CHROMOSOME-7 DNA STRANDS; LEFT-RIGHT ASYMMETRY	During cell division, copies of mouse chromosome 7 are segregated selectively or randomly to daughter cells depending on the cell type. The mechanism for differential segregation is unknown. Because mouse left-right dynein (LRD) gene mutations result in randomization of visceral organs' laterality, we hypothesized that LRD may also function in selective chromatid segregation. Indeed, upon knock-down by RNA interference methods, LRD depletion disrupts biased segregation. LRD messenger RNA presence or absence correlates with the observed segregation patterns. This work supports the claim that LRD functions in a mechanism for selective chromatid segregation.	NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klar, AJS (corresponding author), NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, POB B, Frederick, MD 21702 USA.	klar@ncifcrf.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010386, Z01BC010386] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Haber JE, 2006, SCIENCE, V313, DOI 10.1126/science.1127836; Hummel K. P., 1959, Journal of Heredity, V50, P9; Klar AJS, 2004, GENETICS, V167, P1833, DOI 10.1534/genetics.104.028217; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; Klar AJS, 2006, SCIENCE, V313, DOI 10.1126/science.1128552; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin C, 2005, J MOL HISTOL, V36, P317, DOI 10.1007/s10735-005-9000-y; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	11	60	60	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					100	101		10.1126/science.1129429	http://dx.doi.org/10.1126/science.1129429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204651				2022-12-24	WOS:000243259100045
J	Sandall, S; Severin, F; McLeod, IX; Yates, JR; Oegema, K; Hyman, A; Desai, A				Sandall, Sharsti; Severin, Fedor; McLeod, Ian X.; Yates, John R., III; Oegema, Karen; Hyman, Anthony; Desai, Arshad			A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension	CELL			English	Article							CHROMOSOME SEGREGATION; BUDDING YEAST; AURORA-B; PROTEIN-KINASE; SPINDLE CHECKPOINT; CELL-DIVISION; SACCHAROMYCES-CEREVISIAE; APOPTOSIS FAMILY; CLEAVAGE FURROW; INCENP BINDS	Proper connections between centromeres and spindle microtubules are of critical importance in ensuring accurate segregation of the genome during cell division. Using an in vitro approach based on the sequence-specific budding yeast centromere, we identified a complex of the chromosomal passenger proteins Bir1 and Sli15 (Survivin and INCENP) that links centromeres to microtubules. This linkage does not require Ipl1/Aurora B kinase, whose targeting and activation are controlled by Bir1 and Sli15. Ipl1 is the tension-dependent regulator of centromere-microtubule interactions that ensures chromosome biorientation on the spindle. Elimination of the linkage between centromeres and microtubules mediated by Bir1-Sli15 phenocopies mutations that selectively cripple Ipl1 kinase activation. These findings lead us to propose that the Bir1-Sli15-mediated linkage, which bridges centromeres and microtubules and includes the Aurora kinase-activating domain of INCENP family proteins, is the tension sensor that relays the mechanical state of centromere-microtubule attachments into local control of Ipl1 kinase activity.	Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Scripps Research Institute	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, CMM E Room 3052,9500 Gilman Dr, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Hyman, Tony/F-1923-2011; Severin, Fedor/AAD-5444-2019	Severin, Fedor/0000-0001-6703-1256	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823, P41 RR011823] Funding Source: Medline; NIGMS NIH HHS [R01 GM074215-01, R01 GM074215-02, R01 GM074215] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HYMAN AA, 1992, NATURE, V359, P533, DOI 10.1038/359533a0; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; KINGSBURY J, 1991, CELL, V66, P483, DOI 10.1016/0092-8674(81)90012-X; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Severin F, 1999, METHOD CELL BIOL, V61, P145; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Stoepel J, 2005, MOL BIOL CELL, V16, P5465, DOI 10.1091/mbc.E05-04-0337; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	56	100	108	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1179	1191		10.1016/j.cell.2006.09.049	http://dx.doi.org/10.1016/j.cell.2006.09.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174893	Green Accepted, Bronze			2022-12-24	WOS:000242991000016
J	Sandford, SA; Aleon, J; Alexander, CMO; Araki, T; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Brucato, JR; Burchell, MJ; Busemann, H; Butterworth, A; Clemett, SJ; Cody, G; Colangeli, L; Cooper, G; D'Hendecourt, L; Djouadi, Z; Dworkin, JP; Ferrini, G; Fleckenstein, H; Flynn, GJ; Franchi, IA; Fries, M; Gilles, MK; Glavin, DP; Gounelle, M; Grossemy, F; Jacobsen, C; Keller, LP; Kilcoyne, ALD; Leitner, J; Matrajt, G; Meibom, A; Mennella, V; Mostefaoui, S; Nittler, LR; Palumbo, ME; Papanastassiou, DA; Robert, F; Rotundi, A; Snead, CJ; Spencer, MK; Stadermann, FJ; Steele, A; Stephan, T; Tsou, P; Tyliszczak, T; Westphal, AJ; Wirick, S; Wopenka, B; Yabuta, H; Zare, RN; Zolensky, ME				Sandford, Scott A.; Aleon, Jerome; Alexander, Conel M. O'D.; Araki, Tohru; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Donald E.; Brucato, John R.; Burchell, Mark J.; Busemann, Henner; Butterworth, Anna; Clemett, Simon J.; Cody, George; Colangeli, Luigi; Cooper, George; D'Hendecourt, Louis; Djouadi, Zahia; Dworkin, Jason P.; Ferrini, Gianluca; Fleckenstein, Holger; Flynn, George J.; Franchi, Ian A.; Fries, Marc; Gilles, Mary K.; Glavin, Daniel P.; Gounelle, Matthieu; Grossemy, Faustine; Jacobsen, Chris; Keller, Lindsay P.; Kilcoyne, A. L. David; Leitner, Jan; Matrajt, Graciela; Meibom, Anders; Mennella, Vito; Mostefaoui, Smail; Nittler, Larry R.; Palumbo, Maria E.; Papanastassiou, Dimitri A.; Robert, Francois; Rotundi, Alessandra; Snead, Christopher J.; Spencer, Maegan K.; Stadermann, Frank J.; Steele, Andrew; Stephan, Thomas; Tsou, Peter; Tyliszczak, Tolek; Westphal, Andrew J.; Wirick, Sue; Wopenka, Brigitte; Yabuta, Hikaru; Zare, Richard N.; Zolensky, Michael E.			Organics captured from comet 81P/Wild 2 by the Stardust spacecraft	SCIENCE			English	Article							RAMAN-SPECTROSCOPY; INTERSTELLAR; DUST; IDENTIFICATION; MOLECULES; MATTER; IDPS	Organics found in comet 81P/ Wild 2 samples show a heterogeneous and unequilibrated distribution in abundance and composition. Some organics are similar, but not identical, to those in interplanetary dust particles and carbonaceous meteorites. A class of aromatic-poor organic material is also present. The organics are rich in oxygen and nitrogen compared with meteoritic organics. Aromatic compounds are present, but the samples tend to be relatively poorer in aromatics than are meteorites and interplanetary dust particles. The presence of deuterium and nitrogen-15 excesses suggest that some organics have an interstellar/ protostellar heritage. Although the variable extent of modification of these materials by impact capture is not yet fully constrained, a diverse suite of organic compounds is present and identifiable within the returned samples.	NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Lawrence Livermore Natl Lab, Glenn I Seaborg Inst, Livermore, CA 94550 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; NASA, Lyndon B Johnson Space Ctr, Expense Reduct Consulting Inc, Houston, TX 77058 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA; NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Calif Berkeley, Div Chem Sci, Berkeley, CA 94720 USA; Museum Natl Hist Nat, Lab Etud Mat Extraterr, Paris, France; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Munster, Inst Planetol, D-48149 Munster, Germany; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; Univ Naples Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Carnegie Institution for Science; Universite de Lorraine; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); University of Kent; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; University of California System; University of California Berkeley; Museum National d'Histoire Naturelle (MNHN); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munster; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sandford, SA (corresponding author), NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA.	ssandford@mail.arc.nasa.gov	Leitner, Jan/A-7391-2015; Stephan, Thomas/C-1023-2008; Yabuta, Hikaru/S-2662-2018; Steele, Andrew/A-3573-2013; Araki, Tohru/K-9301-2015; Bajt, Sasa/O-4695-2019; Jacobsen, Chris Johnson/E-2827-2015; Zare, Richard N./A-8410-2009; Alexander, Conel M. O'D./N-7533-2013; Yabuta, Hikaru/M-9041-2014; Bajt, Sasa/G-2228-2010; Matrajt, Graciela/A-4812-2017; 1.4, ALS Beamline/I-1886-2014; Appourchaux, Thierry/F-4692-2010; Kilcoyne, Arthur A L/I-1465-2013; Baratta, Giuseppe/AAY-6188-2021; Dworkin, Jason P./C-9417-2012; Glavin, Daniel P/D-6194-2012	Leitner, Jan/0000-0003-3655-6273; Stephan, Thomas/0000-0001-6377-8731; Steele, Andrew/0000-0001-9643-2841; Araki, Tohru/0000-0002-2689-4642; Bajt, Sasa/0000-0002-7163-7602; Jacobsen, Chris Johnson/0000-0001-8562-0353; Alexander, Conel M. O'D./0000-0002-8558-1427; Yabuta, Hikaru/0000-0002-4625-5362; Kilcoyne, Arthur A L/0000-0002-8805-8690; Dworkin, Jason P./0000-0002-3961-8997; Glavin, Daniel P/0000-0001-7779-7765; Palumbo, MariaElisabetta/0000-0002-9122-491X; Butterworth, Anna/0000-0002-6439-1472; Baratta, Giuseppe/0000-0002-3688-160X; Meibom, Anders/0000-0002-4542-2819; Burchell, Mark/0000-0002-2680-8943; Zare, Richard/0000-0001-5266-4253; Busemann, Henner/0000-0002-0867-6908; Zolensky, Michael/0000-0002-3181-1303; Mennella, Vito/0000-0001-9525-895X; Brucato, John Robert/0000-0002-4738-5521; Rotundi, Alessandra/0000-0001-5467-157X; Colangeli, Luigi/0000-0001-6801-9152				Aleon J, 2004, ICARUS, V167, P424, DOI 10.1016/j.icarus.2003.10.012; Baratta GA, 2004, J RAMAN SPECTROSC, V35, P487, DOI 10.1002/jrs.1169; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; Brownlee DE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002087; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; DELSEMME AH, 1992, ADV SPACE RES-SERIES, V12, P5, DOI 10.1016/0273-1177(92)90147-P; Festou C.M., 2004, COMETS 2; FLYNN GJ, 2006, IPAP C SERIES, V7, P315; Glavin DP, 2006, METEORIT PLANET SCI, V41, P889, DOI 10.1111/j.1945-5100.2006.tb00493.x; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1171; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Quirico E, 2005, PLANET SPACE SCI, V53, P1443, DOI 10.1016/j.pss.2005.07.009; SCHUTTE WA, 1993, ICARUS, V104, P118, DOI 10.1006/icar.1993.1087; Strazzulla G, 2001, SPECTROCHIM ACTA A, V57, P825, DOI 10.1016/S1386-1425(00)00447-9; Strazzulla G, 1999, SPACE SCI REV, V90, P269, DOI 10.1023/A:1005270703284; WOPENKA B, 1993, AM MINERAL, V78, P533; WOPENKA B, 1988, EARTH PLANET SC LETT, V88, P221, DOI 10.1016/0012-821X(88)90079-9; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	29	458	465	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1720	1724		10.1126/science.1135841	http://dx.doi.org/10.1126/science.1135841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170291				2022-12-24	WOS:000242833600043
J	Hoffman, JI; Forcada, J; Trathan, PN; Amos, W				Hoffman, J. I.; Forcada, J.; Trathan, P. N.; Amos, W.			Female fur seals show active choice for males that are heterozygous and unrelated	NATURE			English	Article							ARCTOCEPHALUS-GAZELLA; LEK PARADOX; PARENTAL RELATEDNESS; MATE CHOICE; GREY SEAL; PATERNITY; SELECTION; EVOLUTION; FITNESS; CAPTURE	Much debate surrounds the exact rules that influence mating behaviour, and in particular the selective forces that explain the evolution of female preferences. A key example is the lek paradox, in which female choice is expected rapidly to become ineffective owing to loss of additive genetic variability for the preferred traits(1-3). Here we exploit a remarkable system in which female fur seals exert choice by moving across a crowded breeding colony to visit largely static males. We show that females move further to maximize the balance between male high multilocus heterozygosity and low relatedness. Such a system shows that female choice can be important even in a strongly polygynous species, and at the same time may help to resolve the lek paradox because heterozygosity has low heritability and inbreeding avoidance means there is no single 'best' male for all females.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	jih24@cam.ac.uk	Forcada, Jaume/GYU-0677-2022; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	NERC [bas010017] Funding Source: UKRI; Natural Environment Research Council [bas010017] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arnould JPY, 1997, J ZOOL, V241, P649, DOI 10.1111/j.1469-7998.1997.tb05739.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Borgia G., 1979, SEXUAL SELECTION REP, P19; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Goldsworthy SD, 1999, BEHAV ECOL SOCIOBIOL, V45, P253, DOI 10.1007/s002650050560; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Irwin AJ, 2000, EVOL ECOL RES, V2, P119; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Lidgard DC, 2004, MOL ECOL, V13, P3543, DOI 10.1111/j.1365-294X.2004.02334.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; PARTRIDGE L, 1983, MATE CHOICE, P227; Pujolar JM, 2005, EVOLUTION, V59, P189; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Tiira K, 2006, BEHAV ECOL SOCIOBIOL, V59, P657, DOI 10.1007/s00265-005-0094-8; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wilmer JW, 1999, MOL ECOL, V8, P1417, DOI 10.1046/j.1365-294x.1999.00705.x	30	153	156	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					912	914		10.1038/nature05558	http://dx.doi.org/10.1038/nature05558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287726				2022-12-24	WOS:000244341200048
J	Raby, CR; Alexis, DM; Dickinson, A; Clayton, NS				Raby, C. R.; Alexis, D. M.; Dickinson, A.; Clayton, N. S.			Planning for the future by western scrub-jays	NATURE			English	Article							MENTAL TIME-TRAVEL; HUMAN MIND; MEMORY; EVOLUTION; RECOVERY; ABILITY; MAZE	Knowledge of and planning for the future is a complex skill that is considered by many to be uniquely human. We are not born with it; children develop a sense of the future at around the age of two and some planning ability by only the age of four to five(1-3). According to the Bischof-Kohler hypothesis(4), only humans can dissociate themselves from their current motivation and take action for future needs: other animals are incapable of anticipating future needs, and any future-oriented behaviours they exhibit are either fixed action patterns or cued by their current motivational state. The experiments described here test whether a member of the corvid family, the western scrub-jay (Aphelocoma californica), plans for the future. We show that the jays make provision for a future need, both by preferentially caching food in a place in which they have learned that they will be hungry the following morning and by differentially storing a particular food in a place in which that type of food will not be available the next morning. Previous studies have shown that, in accord with the Bischof-Kohler hypothesis, rats(5) and pigeons(6) may solve tasks by encoding the future but only over very short time scales. Although some primates and corvids(7-9) take actions now that are based on their future consequences, these have not been shown to be selected with reference to future motivational states(10), or without extensive reinforcement of the anticipatory act(11). The results described here suggest that the jays can spontaneously plan for tomorrow without reference to their current motivational state, thereby challenging the idea that this is a uniquely human ability.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X	Biotechnology and Biological Sciences Research Council [BB/D000335/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atance CM, 2005, COGNITIVE DEV, V20, P341, DOI 10.1016/j.cogdev.2005.05.001; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2005, J EXP PSYCHOL-ANIM B, V31, P115, DOI 10.1037/0097-7403.31.2.115; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; COOK RG, 1985, J EXP PSYCHOL ANIM B, V11, P453, DOI 10.1037/0097-7403.11.3.453; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; PETROVICH GD, IN PRESS PHYSL BEHAV; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Roitman MF, 2001, BEHAV BRAIN RES, V122, P193, DOI 10.1016/S0166-4328(01)00189-9; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2006, SCIENCE, V312, P1006, DOI 10.1126/science.1129217; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; ZENTALL TR, 1990, J EXP PSYCHOL ANIM B, V16, P358, DOI 10.1037/0097-7403.16.4.358	20	379	393	9	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					919	921		10.1038/nature05575	http://dx.doi.org/10.1038/nature05575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314979				2022-12-24	WOS:000244341200050
J	Shuchman, M				Shuchman, Miriam			Debating the risks of drug-eluting stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; EISENSTEIN EL, IN PRESS JAMA; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; WALLENTIN L, 2006, M CIRC SYST DEV PAN	6	65	71	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2007	356	4					325	328		10.1056/NEJMp068300	http://dx.doi.org/10.1056/NEJMp068300			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128FT	17251527				2022-12-24	WOS:000243644300001
J	Pinkett, HW; Lee, AT; Lum, P; Locher, KP; Rees, DC				Pinkett, H. W.; Lee, A. T.; Lum, P.; Locher, K. P.; Rees, D. C.			An inward-facing conformation of a putative metal-chelate-type ABC transporter	SCIENCE			English	Article							BINDING CASSETTE DIMER; ATP-BINDING; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MECHANISM; ARCHITECTURE; SUBUNIT; DOMAINS; CHANNEL; MEMBRANE	The crystal structure of a putative metal-chelate-type adenosine triphosphate (ATP)-binding cassette (ABC) transporter encoded by genes HI1470 and HI1471 of Haemophilus influenzae has been solved at 2.4 angstrom resolution. The permeation pathway exhibits an inward-facing conformation, in contrast to the outward-facing state previously observed for the homologous vitamin B-12 importer BtuCD. Although the structures of both HI1470/1 and BtuCD have been solved in nucleotide-free states, the pairs of ABC subunits in these two structures differ by a translational shift in the plane of the membrane that coincides with a repositioning of the membrane-spanning subunits. The differences observed between these ABC transporters involve relatively modest rearrangements and may serve as structural models for inward- and outward-facing conformations relevant to the alternating access mechanism of substrate translocation.	CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	California Institute of Technology; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, MC 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Pinkett, Heather Wendy/M-9235-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45162] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Crosa JH., 2004, IRON TRANSPORT BACTE; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HEISCHMANN RD, 1995, SCIENCE, V269, P496; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	32	235	242	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					373	377		10.1126/science.1133488	http://dx.doi.org/10.1126/science.1133488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158291				2022-12-24	WOS:000243535400041
J	Bailey, MS; de Silva, HJ				Bailey, Mark S.; de Silva, H. Janaka			Sri Lankan sanni masks: an ancient classification of disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									Army Med Directorate, Surrey GU15 4NP, England; Univ Kelaniya, Dept Med, Ragama, Sri Lanka	University Kelaniya	Bailey, MS (corresponding author), Army Med Directorate, Surrey GU15 4NP, England.	mark@ramc.org	Bailey, Mark S./D-3854-2013	Bailey, Mark S./0000-0003-4840-5093				Bartlett A, 1989, Int J Soc Psychiatry, V35, P245, DOI 10.1177/002076408903500305; Kapferer B., 2005, TOVIL EXORCISM HEALI; Kapferer Bruce, 1991, CELEBRATION DEMONS E; OBEYESEKERE G, 1969, COMP STUD SOC HIST, V11, P174, DOI 10.1017/S0010417500005260; PERTOLD O, 1930, CEREMONIAL DANCES SI; Wijesuriya B., 2001, TRADITIONAL SINHALES; Wirz Paul, 1954, EXORCISM ART HEALING	7	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1327	1328		10.1136/bmj.39055.445417.BE	http://dx.doi.org/10.1136/bmj.39055.445417.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185730	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000243160700027
J	Steinbrook, R				Steinbrook, Robert			Haernoglobin concentrations in chronic kidney disease	LANCET			English	Editorial Material									Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; VA Outcomes Grp, White River Jct, VT 05009 USA	Dartmouth College; VA Outcomes Group	Steinbrook, R (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	rsteinbrook@attglobal.net						*AMG, 2006, AR SINGL DARB ALF; *AMG, 2006, EP EP ALF REC PROD I; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; COTTER D, 2006, HLTH AFF MILWOOD, V26, P1249; COYNE DW, IN PRESS CLIN J AM S; *DAVITA, 2005 ANN REP; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; *NAT KIDN FDN, 2006, AM J KIDNEY DIS S, V27, pS11; *NAT KIDN FDN, 2005 ANN REP; *NAT KIDN FDN, 2006, KIDN DIS OUTC QUAL I; *ORTH BIOT PROD, 2006, PROCR EP ALF; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; US Renal Data System, 2006, USRDS 2006 ANN DAT R	14	28	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2191	2193		10.1016/S0140-6736(06)69707-9	http://dx.doi.org/10.1016/S0140-6736(06)69707-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189015				2022-12-24	WOS:000243076800007
J	Vajdic, CM; McDonald, SP; McCredie, MRE; van Leeuwen, MT; Stewart, JH; Law, M; Chapman, JR; Webster, AC; Kaldor, JM; Grulich, AE				Vajdic, Claire M.; McDonald, Stephen P.; McCredie, Margaret R. E.; van Leeuwen, Marina T.; Stewart, John H.; Law, Matthew; Chapman, Jeremy R.; Webster, Angela C.; Kaldor, John M.; Grulich, Andrew E.			Cancer incidence before and after kidney transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; RENAL-TRANSPLANTATION; RISK; INFECTION; DIALYSIS; PEOPLE; VIRUS; AIDS	Context Immune suppression after organ transplantation is associated with a markedly increased risk of nonmelanoma skin cancer and a few virus-associated cancers. Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed. Objective To compare the incidence of cancer in patients receiving immune suppression after kidney transplantation with incidence in the same population in 2 periods before receipt of immune suppression: during dialysis and during end-stage kidney disease before renal replacement therapy (RRT). Design, Setting, and Participants A population-based cohort study of 28 855 patients with end-stage kidney disease who received RRT, with 273 407 person-years of follow-up. Incident cancers (1982-2003) were ascertained by record linkage between the Australia and New Zealand Dialysis and Transplant Registry and the Australian National Cancer Statistics Clearing House. Main Outcome Measure Standardized incidence ratios (SIRs) of cancer, using age-specific, sex-specific, calendar year - specific, and state/territory-specific population cancer incidence rates. Results The overall incidence of cancer, excluding nonmelanoma skin cancer and those cancers known to frequently cause end-stage kidney disease, was markedly increased after transplantation (n= 1236; SIR, 3.27; 95% confidence interval [CI], 3.09-3.46). In contrast, cancer incidence was only slightly increased during dialysis ( n= 870; SIR, 1.35; 95% CI, 1.27-1.45) and before RRT ( n= 689; SIR, 1.16; 95% CI, 1.08-1.25). After transplantation, cancer occurred at significantly increased incidence at 25 sites, and risk exceeded 3-fold at 18 of these sites. Most of these cancers were of known or suspected viral etiology. Conclusions Kidney transplantation is associated with a marked increase in cancer risk at a wide variety of sites. Because SIRs for most types of cancer were not increased before transplantation, immune suppression may be responsible for the increased risk. These data suggest a broader than previously appreciated role of the interaction between the immune system and common viral infections in the etiology of cancer.	Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA, Australia; Univ Adelaide, Discipline Med, Adelaide, SA, Australia; Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Sydney, Westmead Hosp, Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Kirby Institute; University of Adelaide; University of Adelaide; University of Otago; University of Sydney	Vajdic, CM (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, 376 Victoria St,Level 2, Darlinghurst, NSW 2010, Australia.	cvajdic@nchecr.unsw.edu.au	Vajdic, Claire/AAP-5940-2020; Webster, Angela/J-2186-2012; Kaldor, John M/D-4545-2011; McDonald, Stephen/G-4010-2013; van Leeuwen, Marina T/AAQ-5339-2021	Webster, Angela/0000-0001-7509-0512; McDonald, Stephen/0000-0001-6103-1386; van Leeuwen, Marina T/0000-0002-1570-2852; Vajdic, Claire/0000-0002-3612-8298; Law, Matthew/0000-0002-3540-8837				*AIHW, 2005, 57 AIHW PHE; *AIHW AACR, 2001, CANC SER, V19; *AIHW AACR, 2004, CANC SER, V28; [Anonymous], 1994, IARC MON EV CARC RIS, V61; [Anonymous], 1997, IARC MON EV CARC RIS, V70; [Anonymous], 1996, IARC MON EV CARC RIS; Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Girndt M, 2001, KIDNEY INT, V59, pS206, DOI 10.1046/j.1523-1755.2001.59780206.x; GOLDBLUM SE, 1980, ANN INTERN MED, V93, P597, DOI 10.7326/0003-4819-93-4-597; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Grulich AE, 1996, J EPIDEMIOL BIOSTAT, V1, P207; *IARC, 1994, IARC MON EV CARC RIS, V59; *IARC, 1995, IARC MON EV CARC RIS, V64; International Agency for Research on Cancer (IARC), 2004, INT RUL MULT PRIM CA; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kinlen L J, 1992, IARC Sci Publ, P237; Li YM, 2002, AM J EPIDEMIOL, V155, P153, DOI 10.1093/aje/155.2.153; MAYNE ST, 2006, CANC EPIDEMIOLOGY PR, P686; MCDONALD SP, 2005, ANZDATA REG REPORT 2; Mitsuishi T, 2005, CANCER LETT, V222, P139, DOI 10.1016/j.canlet.2004.09.019; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; PORT FK, 1989, AM J KIDNEY DIS, V14, P119, DOI 10.1016/S0272-6386(89)80187-8; *S AUSTR CANC REG, 2000, EP CANC S AUSTR; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Winkelspecht B, 1997, NEPHROL DIAL TRANSPL, V12, P2099, DOI 10.1093/ndt/12.10.2099; World Health Organization, 1992, INT STAT CLASS DIS 1	31	794	809	4	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2823	2831		10.1001/jama.296.23.2823	http://dx.doi.org/10.1001/jama.296.23.2823			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179459	Bronze			2022-12-24	WOS:000242826400024
J	Gilchrist, A; Au, CE; Hiding, J; Bell, AW; Fernandez-Rodriguez, J; Lesimple, S; Nagaya, H; Roy, L; Gosline, SJC; Hallett, M; Paiement, J; Kearney, RE; Nilsson, T; Bergeron, JJM				Gilchrist, Annalyn; Au, Catherine E.; Hiding, Johan; Bell, Alexander W.; Fernandez-Rodriguez, Julia; Lesimple, Souad; Nagaya, Hisao; Roy, Line; Gosline, Sara J. C.; Hallett, Michael; Paiement, Jacques; Kearney, Robert E.; Nilsson, Tommy; Bergeron, John J. M.			Quantitative proteomics analysis of the secretory pathway	CELL			English	Article							CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; PROTEIN EXPRESSION; MEMBRANE-PROTEINS; GOLGI-APPARATUS; COMPLEX; COPI; LOCALIZATION; TRAFFICKING; REVEALS	We report more than 1400 proteins of the secretory-pathway proteome and provide spatial information on the relative presence of each protein in the rough and smooth ER Golgi cisternae and Golgi-derived COPT vesicles. The data support a role for COPT vesicles in recycling and cisternal maturation, showing that Golgi-resident proteins are present at a higher concentration than secretory cargo. Of the 1400 proteins, 345 were identified as previously uncharacterized. Of these, 230 had their subcellular location deduced by proteomics. This study provides a comprehensive catalog of the ER and Golgi proteomes with insight into their identity and function.	McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, McGill Ctr Bioinformat, Sch Comp Sci, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada; Gothenburg Univ, Inst Biomed, Dept Med & Clin Genet, S-41390 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Proteom Ctr, S-41390 Gothenburg, Sweden; Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; University of Gothenburg; University of Gothenburg; Universite de Montreal	Bergeron, JJM (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	john.bergeron@mcgill.ca	Bergeron, John/AAW-1893-2021; Kearney, Robert E/D-3917-2012	Kearney, Robert/0000-0002-5107-6190; Gosline, Sara/0000-0002-6534-4774; Hallett, Michael/0000-0001-6738-6786; Fernandez-Rodriguez, Julia/0000-0003-4522-0966				Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; Dominguez M, 1999, J CELL BIOL, V145, P673, DOI 10.1083/jcb.145.4.673; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goolsby KM, 2003, NUCLEIC ACIDS RES, V31, P5644, DOI 10.1093/nar/gkg768; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KARTBERG F, 2005, CELL BIOL LAB HDB, P45; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; MARINEZMENARGUE.JA, 2001, J CELL BIOL, V155, P1213; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; PAIEMENT J, 2005, CELL BIOL LAB HDB, P41; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Scott M, 2004, BIOINFORMATICS, V20, P937, DOI 10.1093/bioinformatics/bth010; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	45	349	366	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1265	1281		10.1016/j.cell.2006.10.036	http://dx.doi.org/10.1016/j.cell.2006.10.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174899	Bronze			2022-12-24	WOS:000242991000022
J	McKeegan, KD; Aleon, J; Bradley, J; Brownlee, D; Busemann, H; Butterworth, A; Chaussidon, M; Fallon, S; Floss, C; Gilmour, J; Gounelle, M; Graham, G; Guan, YB; Heck, PR; Hoppe, P; Hutcheon, ID; Huth, J; Ishii, H; Ito, M; Jacobsen, SB; Kearsley, A; Leshin, LA; Liu, MC; Lyon, I; Marhas, K; Marty, B; Matrajt, G; Meibom, A; Messenger, S; Mostefaoui, S; Mukhopadhyay, S; Nakamura-Messenger, K; Nittler, L; Palma, R; Pepin, RO; Papanastassiou, DA; Robert, F; Schlutter, D; Snead, CJ; Stadermann, FJ; Stroud, R; Tsou, P; Westphal, A; Young, ED; Ziegler, K; Zimmermann, L; Zinner, E				McKeegan, Kevin D.; Aleon, Jerome; Bradley, John; Brownlee, Donald; Busemann, Henner; Butterworth, Anna; Chaussidon, Marc; Fallon, Stewart; Floss, Christine; Gilmour, Jamie; Gounelle, Matthieu; Graham, Giles; Guan, Yunbin; Heck, Philipp R.; Hoppe, Peter; Hutcheon, Ian D.; Huth, Joachim; Ishii, Hope; Ito, Motoo; Jacobsen, Stein B.; Kearsley, Anton; Leshin, Laurie A.; Liu, Ming-Chang; Lyon, Ian; Marhas, Kuljeet; Marty, Bernard; Matrajt, Graciela; Meibom, Anders; Messenger, Scott; Mostefaoui, Smail; Mukhopadhyay, Sujoy; Nakamura-Messenger, Keiko; Nittler, Larry; Palma, Russ; Pepin, Robert O.; Papanastassiou, Dimitri A.; Robert, Francois; Schlutter, Dennis; Snead, Christopher J.; Stadermann, Frank J.; Stroud, Rhonda; Tsou, Peter; Westphal, Andrew; Young, Edward D.; Ziegler, Karen; Zimmermann, Laurent; Zinner, Ernst			Isotopic compositions of cometary matter returned by Stardust	SCIENCE			English	Article							INTERPLANETARY DUST PARTICLES; CRYSTALLINE SILICATES; HALE-BOPP; OXYGEN ISOTOPES; ORGANIC-MATTER; METEORITES; NITROGEN; PRESOLAR; ORIGIN; RATIOS	Hydrogen, carbon, nitrogen, and oxygen isotopic compositions are heterogeneous among comet 81P/Wild 2 particle fragments; however, extreme isotopic anomalies are rare, indicating that the comet is not a pristine aggregate of presolar materials. Nonterrestrial nitrogen and neon isotope ratios suggest that indigenous organic matter and highly volatile materials were successfully collected. Except for a single O-17-enriched circumstellar stardust grain, silicate and oxide minerals have oxygen isotopic compositions consistent with solar system origin. One refractory grain is O-16-enriched, like refractory inclusions in meteorites, suggesting that Wild 2 contains material formed at high temperature in the inner solar system and transported to the Kuiper belt before comet accretion.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94550 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Max Planck Inst Chem, Particle Chem Dept, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res Explorat Sci Directorate, Houston, TX 77058 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Nat Hist Museum, Dept Mineral, Impacts & Astromat Res Ctr, London SW7 5BD, England; NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; Jacobs Sverdrup, Houston, TX 77058 USA; Minnesota State Univ, Dept Phys & Astron, Mankato, MN 56001 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; USN, Res Lab, Washington, DC 20375 USA	University of California System; University of California Los Angeles; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; Carnegie Institution for Science; University of California System; University of California Berkeley; Universite de Lorraine; Washington University (WUSTL); University of Manchester; Museum National d'Histoire Naturelle (MNHN); California Institute of Technology; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Harvard University; Imperial College London; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory	McKeegan, KD (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	mckeegan@ess.ucla.edu	Fallon, Stewart J/G-6645-2011; Heck, Philipp R/AAU-1433-2021; Hoppe, Peter/B-3032-2015; Stroud, Rhonda M./C-5503-2008; Jacobsen, Stein/ABA-1063-2021; Chaussidon, Marc/E-7067-2017; Heck, Philipp/C-6092-2012; McKeegan, Kevin D/A-4107-2008; Matrajt, Graciela/A-4812-2017; Stroud, Rhonda/GQZ-0151-2022; Gilmour, Jamie/G-7515-2011; Liu, Ming-Chang/D-1885-2010; Jacobsen, Stein/B-1759-2013; Stroud, Rhonda M/S-4584-2018	Fallon, Stewart J/0000-0002-8064-5903; Heck, Philipp R/0000-0002-6319-2594; Hoppe, Peter/0000-0003-3681-050X; Stroud, Rhonda M./0000-0001-5242-8015; Jacobsen, Stein/0000-0003-2164-0720; McKeegan, Kevin D/0000-0002-1827-729X; Stroud, Rhonda/0000-0001-5242-8015; Liu, Ming-Chang/0000-0003-4030-5258; Stroud, Rhonda M/0000-0001-5242-8015; Gilmour, Jamie/0000-0003-1990-8636; Ishii, Hope/0000-0002-7976-5078; Marhas, Kuljeet/0000-0002-3375-3047; Young, Edward/0000-0002-1299-0801; Busemann, Henner/0000-0002-0867-6908; Butterworth, Anna/0000-0002-6439-1472; Meibom, Anders/0000-0002-4542-2819	STFC [PP/E000894/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E000894/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aleon J, 2003, GEOCHIM COSMOCHIM AC, V67, P3773, DOI [10.1016/S0016-7037(03)00170-4, 10.1016/S0016-7037(00)00170-4]; Aleon M, 2001, GEOCHIM COSMOCHIM AC, V65, P4399, DOI 10.1016/S0016-7037(01)00720-7; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Bar-Nun A, 1998, ASTROPHYS SPACE SC L, V227, P353, DOI 10.1007/978-94-011-5252-5_15; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bouwman J, 2003, ASTRON ASTROPHYS, V401, P577, DOI 10.1051/0004-6361:20030043; Bouwman J, 2001, ASTRON ASTROPHYS, V375, P950, DOI 10.1051/0004-6361:20010878; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Floss C, 2006, GEOCHIM COSMOCHIM AC, V70, P2371, DOI 10.1016/j.gca.2006.01.023; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; HUISEMEKERS D, 2005, ASTRON ASTROPHYS, V440, pL21; Jehin E, 2004, ASTROPHYS J, V613, pL161, DOI 10.1086/425254; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; LIFFMAN K, 1995, ICARUS, V116, P275, DOI 10.1006/icar.1995.1126; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; MESSENGER S, 1997, AIP C P, V402, P545; Molster F, 2005, SPACE SCI REV, V119, P3, DOI 10.1007/s11214-005-8066-x; Nittler LR, 1997, AIP CONF PROC, P59, DOI 10.1063/1.51767; Owen T, 2003, SPACE SCI REV, V106, P121, DOI 10.1023/A:1024633603624; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Shu FH, 1996, SCIENCE, V271, P1545, DOI 10.1126/science.271.5255.1545; van Boekel R, 2004, NATURE, V432, P479, DOI 10.1038/nature03088; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	329	331	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1724	1728		10.1126/science.1135992	http://dx.doi.org/10.1126/science.1135992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170292				2022-12-24	WOS:000242833600044
J	Natsume, R; Eitoku, M; Akai, Y; Sano, N; Horikoshi, M; Senda, T				Natsume, Ryo; Eitoku, Masamitsu; Akai, Yusuke; Sano, Norihiko; Horikoshi, Masami; Senda, Toshiya			Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4	NATURE			English	Article							CHROMATIN; ASF1; TRANSCRIPTION; DEPOSITION; IDENTIFICATION; REPLICATION; HISTORIES; GENES; RAD53	CIA(CCG1-interacting factor A)/ASF1, which is the most conserved histone chaperone among the eukaryotes, was genetically identified as a factor for an anti-silencing function (Asf1)(1) by yeast genetic screening. Shortly after that, the CIA-histone-H3-H4 complex was isolated from Drosophila as a histone chaperone CAF-1 stimulator(2). Human CIA-I/II (ASF1a/b) was identified as a histone chaperone that interacts with the bromodomain - an acetylated-histone-recognizing domain - of CCG1, in the general transcription initiation factor TFIID3-5. Intensive studies have revealed that CIA/ASF1 mediates nucleosome assembly by forming a complex with another histone chaperone in human cells 6 and yeast 7, and is involved in DNA replication 1,2, transcription 4,8 - 10, DNA repair 1,2,11,12 and silencing/ anti-silencing(1,2,8,13-15) in yeast. CIA/ASF1 was shown as a major storage chaperone for soluble histones in proliferating human cells(6,16). Despite all these biochemical and biological functional analyses, the structure - function relationship of the nucleosome assembly/disassembly activity of CIA/ASF1 has remained elusive. Here we report the crystal structure, at 2.7 angstrom resolution, of CIA-I in complex with histones H3 and H4. The structure shows the histone H3 - H4 dimer's mutually exclusive interactions with another histone H3 - H4 dimer and CIA-I. The carboxy-terminal beta-strand of histone H4 changes its partner from the beta-strand in histone H2A to that of CIA-I through large conformational change. In vitro functional analysis demonstrated that CIA-I has a histone H3 - H4 tetramer-disrupting activity. Mutants with weak histone H3-H4 dimer binding activity showed critical functional effects on cellular processes related to transcription. The histone H3-H4 tetramer-disrupting activity of CIA/ASF1 and the crystal structure of the CIA/ASF1-histone-H3-H4 dimer complex should give insights into mechanisms of both nucleosome assembly/disassembly and nucleosome semi-conservative replication.	Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; JST, ERATO, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan; JBIC, JBIRC, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tokyo	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, 2-42 Aomi, Tokyo 1350064, Japan.	horikosh@iam.u-tokyo.ac.jp; tsenda@jbirc.aist.go.jp		Senda, Toshiya/0000-0002-5153-928X				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; SILVERMAN SJ, 1984, MOL CELL BIOL, V4, P1246, DOI 10.1128/MCB.4.7.1246; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842	30	229	232	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					338	341		10.1038/nature05613	http://dx.doi.org/10.1038/nature05613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17293877				2022-12-24	WOS:000244892900050
J	Curtis, MA; Kam, M; Nannmark, U; Anderson, MF; Axell, MZ; Wikkelso, C; Holtas, S; van Roon-Mom, WMC; Bjork-Eriksson, T; Nordborg, C; Frisen, J; Dragunow, M; Faull, RLM; Eriksson, PS				Curtis, Maurice A.; Kam, Monica; Nannmark, Ulf; Anderson, Michelle F.; Axell, Mathilda Zetterstrom; Wikkelso, Carsten; Holtas, Stig; van Roon-Mom, Willeke M. C.; Bjork-Eriksson, Thomas; Nordborg, Claes; Frisen, Jonas; Dragunow, Michael; Faull, Richard L. M.; Eriksson, Peter S.			Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension	SCIENCE			English	Article							PRECURSOR CELL-PROLIFERATION; SUBVENTRICULAR ZONE; DIAGNOSTIC-TOOL; ADULT; NEURONS; DOUBLECORTIN; BROMODEOXYURIDINE; PLASTICITY; MEDICINE; BIOLOGY	The rostral migratory stream (RMS) is the main pathway by which newly born subventricular zone cells reach the olfactory bulb ( OB) in rodents. However, the RMS in the adult human brain has been elusive. We demonstrate the presence of a human RMS, which is unexpectedly organized around a lateral ventricular extension reaching the OB, and illustrate the neuroblasts in it. The RMS ensheathing the lateral olfactory ventricular extension, as seen by magnetic resonance imaging, cell-specific markers, and electron microscopy, contains progenitor cells with migratory characteristics and cells that incorporate 5-bromo-2'-deoxyuridine and become mature neurons in the OB.	Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Auckland 1, New Zealand; Sahlgrens Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, SE-40530 Gothenburg, Sweden; Sahlgrens Acad, Inst Biomed, SE-40530 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, SE-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Univ Auckland, Fac Med & Hlth Sci, Dept Pharmacol, Auckland, New Zealand; Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden	University of Auckland; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; University of Auckland; Sahlgrenska University Hospital	Eriksson, PS (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Private Bag 92019, Auckland 1, New Zealand.	rlm.faull@auckland.ac.nz; per@neuro.gu.se	van Roon-Mom, Willeke/Y-3039-2018	van Roon-Mom, Willeke/0000-0002-3035-0533; Faull, Richard/0000-0003-3385-9498; Curtis, Maurice/0000-0003-4496-0233; Bjork-Eriksson, Thomas/0000-0003-3680-5196				Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; BERNARD A, 2004, DEV BRAIN RES, V19, P159; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Doetsch F, 1997, J NEUROSCI, V17, P5046; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dolbeare F, 1996, HISTOCHEM J, V28, P531, DOI 10.1007/BF02331377; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lee A, 2003, ANN NEUROL, V53, P668, DOI 10.1002/ana.10579; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; RAE ASL, 1994, CLIN NEUROPATHOL, V13, P17; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Tomasevic G, 1998, MOL BRAIN RES, V60, P168, DOI 10.1016/S0169-328X(98)00173-9; BRAIN ATLAS DOMESTIC	25	644	685	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1243	1249		10.1126/science.1136281	http://dx.doi.org/10.1126/science.1136281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17303719				2022-12-24	WOS:000244564700041
J	Mwaluko, G; Wringe, A; Todd, J; Glynn, JR; Crampin, AC; Jaffar, S; Kalluvya, S; Zaba, B				Mwaluko, Gabriel; Wringe, Alison; Todd, James; Glynn, Judith R.; Crampin, Amelia C.; Jaffar, Shabbar; Kalluvya, Samuel; Zaba, Basia			Use of data from HIV counselling and testing services for HIV surveillance in Africa	LANCET			English	Article									Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1E 7HT, England; Tanzania Netherlands Project Support HIV AIDS Con, Mwanza, Tanzania; Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Karonga Prevent Study, London WC1E 7HT, England; Uganda Virus Res Inst, MRC Programme AIDS, Entebbe, Uganda; Bugando Univ, Coll Hlth Sci, HIV AIDS Unit, Mwanza, Tanzania; Natl Inst Med Res, TAZAMA Project, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; National Institute of Medical Research	Wringe, A (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, Keppel St, London WC1E 7HT, England.	alison.wringe@lshtm.ac.uk		Jaffar, Shabbar/0000-0002-9615-1588; Crampin, Amelia/0000-0002-1513-4330; Todd, Jim/0000-0001-5918-4914	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; Diaz T, 2005, AIDS, V19, pS1, DOI 10.1097/01.aids.0000172871.80723.3e; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; *UN REP TANZ MIN H, 2003, HIV AIDS CAR TREATM	6	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					612	613		10.1016/S0140-6736(07)60281-5	http://dx.doi.org/10.1016/S0140-6736(07)60281-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307108				2022-12-24	WOS:000244368000035
J	Kawaguchi, R; Yu, JM; Honda, J; Hu, J; Whitelegge, J; Ping, PP; Wiita, P; Bok, D; Sun, H				Kawaguchi, Riki; Yu, Jiamei; Honda, Jane; Hu, Jane; Whitelegge, Julian; Ping, Peipei; Wiita, Patrick; Bok, Dean; Sun, Hui			A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A	SCIENCE			English	Article							EPITHELIAL-CELLS; ESTER FORMATION; MICE LACKING; ACID; TRANSPORT; LECITHIN; GENE; ACYLTRANSFERASE; ACCUMULATION; LESSONS	Vitamin A has diverse biological functions. It is transported in the blood as a complex with retinol binding protein ( RBP), but the molecular mechanism by which vitamin A is absorbed by cells from the vitamin A-RBP complex is not clearly understood. We identified in bovine retinal pigment epithelium cells STRA6, a multitransmembrane domain protein, as a specific membrane receptor for RBP. STRA6 binds to RBP with high affinity and has robust vitamin A uptake activity from the vitamin A-RBP complex. It is widely expressed in embryonic development and in adult organ systems. The RBP receptor represents a major physiological mediator of cellular vitamin A uptake.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Semel Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020	Ping, Peipei/0000-0003-3583-3881	NATIONAL EYE INSTITUTE [T32EY007026] Funding Source: NIH RePORTER; NEI NIH HHS [5T32EY07026] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Biesalski HK, 2003, MOL ASPECTS MED, V24, P431, DOI 10.1016/S0098-2997(03)00039-6; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; CHEN CC, 1977, J BIOL CHEM, V252, P5216; DOWLING JE, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1066-78; DRAGER UC, 2006, SCI STKE, pPE10; Evans R M, 1994, Harvey Lect, V90, P105; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Hagen E, 1999, J NUTR BIOCHEM, V10, P345, DOI 10.1016/S0955-2863(99)00013-3; HELLER J, 1975, J BIOL CHEM, V250, P3613; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1990, P NATL ACAD SCI USA, V87, P4265, DOI 10.1073/pnas.87.11.4265; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; OTTONELLO S, 1987, J BIOL CHEM, V262, P3975; PASUTTO F, IN PRESS AM J HUM GE; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; RASK L, 1976, J BIOL CHEM, V251, P6360; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; SIVAPRASADARAO A, 1994, BIOCHEM J, V300, P437, DOI 10.1042/bj3000437; Sivaprasadarao A., 1994, Vitamin A in health and disease., P87; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sommer A, 1997, NAT MED, V3, P1061, DOI 10.1038/nm1097-1061; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Szeto W, 2001, CANCER RES, V61, P4197; Vahlquist A., 1994, Vitamin A in health and disease., P365; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	41	574	595	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					820	825		10.1126/science.1136244	http://dx.doi.org/10.1126/science.1136244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17255476				2022-12-24	WOS:000244069000062
J	Shaw, RM; Fay, AJ; Puthenveedu, MA; von Zastrow, M; Jan, YN; Jan, LY				Shaw, Robin M.; Fay, Alex J.; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Jan, Yuh-Nung; Jan, Lily Y.			Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions	CELL			English	Article							ADULT-RAT CARDIOMYOCYTES; N-CADHERIN; PLASMA-MEMBRANE; HUMAN-FIBROBLASTS; BETA-CATENIN; BORDER ZONE; CONNEXIN43; ADHESION; DYNEIN; EB1	Gap junctions are intercellular channels that connect the cytoplasms of adjacent cells. For gap junctions to properly control organ formation and electrical synchronization in the heart and the brain, connexin-based hemichannels must be correctly targeted to cell-cell borders. While it is generally accepted that gap junctions form via lateral diffusion of hemichannels following microtubule-mediated delivery to the plasma membrane, we provide evidence for direct targeting of hemichannels to cell-cell junctions through a pathway that is dependent on microtubules; through the adherens-junction proteins N-cadherin and beta-catenin through the microtubule plus-end-tracking protein (+TIP) EB1; and through its interacting protein p150(Glued). Based on live cell microscopy that includes fluorescence recovery after photobleaching (FRAP), total internal reflection fluorescence (TIRF), deconvolution, and siRNA knockdown, we propose that preferential tethering of microtubule plus ends at the adherens junction promotes delivery of connexin hemichannels directly to the cell-cell border. These findings support an unanticipated mechanism for protein delivery to points of cell-cell contact.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231; Shaw, Robin/0000-0001-7429-6092; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, P01DA010154, R01DA010711, R37DA010711] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL075449-01A1, K08 HL075449, HL 075449, K08 HL075449-02] Funding Source: Medline; NIDA NIH HHS [DA 10154, DA 10711] Funding Source: Medline; NIMH NIH HHS [MH 065334] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; DAVIDSON JS, 1984, EXP CELL RES, V155, P406, DOI 10.1016/0014-4827(84)90201-5; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Frenzel EM, 1996, DEV BIOL, V179, P1, DOI 10.1006/dbio.1996.0237; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gros DB, 1996, BIOESSAYS, V18, P719, DOI 10.1002/bies.950180907; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hertig CM, 1996, J CELL SCI, V109, P11; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Ko KS, 2001, J CELL SCI, V114, P1155; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Kostin S, 1999, CIRC RES, V85, P154, DOI 10.1161/01.RES.85.2.154; Krutovskikh V, 2002, SEMIN CANCER BIOL, V12, P267, DOI 10.1016/S1044-579X(02)00013-5; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Matsushita T, 1999, CIRC RES, V85, P1046; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Musil LS, 1990, CURR OPIN CELL BIOL, V2, P875, DOI 10.1016/0955-0674(90)90086-T; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Peters NS, 1997, CIRCULATION, V95, P988; Reinecke H, 2004, HUM GENE THER, V15, P627, DOI 10.1089/1043034041361253; Schuyler SC, 2001, J CELL SCI, V114, P247; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Shaw RM, 1997, CIRC RES, V81, P727; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Williams EJ, 2000, MOL CELL NEUROSCI, V15, P456, DOI 10.1006/mcne.2000.0847	54	343	357	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					547	560		10.1016/j.cell.2006.12.037	http://dx.doi.org/10.1016/j.cell.2006.12.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289573	Green Accepted, Bronze			2022-12-24	WOS:000244842700020
J	Willis, SN; Fletcher, JI; Kaufmann, T; van Delft, MF; Chen, L; Czabotar, PE; Ierino, H; Lee, EF; Fairlie, WD; Bouillet, P; Strasser, A; Kluck, RM; Adams, JM; Huang, DCS				Willis, Simon N.; Fletcher, Jamie I.; Kaufmann, Thomas; van Delft, Mark F.; Chen, Lin; Czabotar, Peter E.; Ierino, Helen; Lee, Erinna F.; Fairlie, W. Douglas; Bouillet, Philippe; Strasser, Andreas; Kluck, Ruth M.; Adams, Jerry M.; Huang, David C. S.			Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak	SCIENCE			English	Article							BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; FAMILY-MEMBERS; CELL-DEATH; X-L; BIM; PUMA; RESPONSES; DOMAINS; HELIX	A central issue in the regulation of apoptosis by the Bcl-2 family is whether its BH3-only members initiate apoptosis by directly binding to the essential cell-death mediators Bax and Bak, or whether they can act indirectly, by engaging their pro-survival Bcl-2-like relatives. Contrary to the direct-activation model, we show that Bax and Bak can mediate apoptosis without discernable association with the putative BH3-only activators (Bim, Bid, and Puma), even in cells with no Bim or Bid and reduced Puma. Our results indicate that BH3-only proteins induce apoptosis at least primarily by engaging the multiple pro-survival relatives guarding Bax and Bak.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au	Adams, Jerry M/E-1199-2013; Fletcher, Jamie/V-4667-2019; Strasser, Andreas/C-7581-2013; Huang, David C. S./C-7586-2013; Bouillet, Philippe/E-1241-2013; Lee, Erinna/N-1523-2015; Fairlie, Walter/M-8401-2015; Kluck, Ruth M/C-8413-2013	Strasser, Andreas/0000-0002-5020-4891; Huang, David C. S./0000-0002-3101-4873; Bouillet, Philippe/0000-0002-9012-6058; Lee, Erinna/0000-0003-1255-9808; Fairlie, Walter/0000-0002-2498-1160; Kluck, Ruth M/0000-0002-7101-1925; Adams, Jerry/0000-0002-4360-8628; Fletcher, Jamie/0000-0003-2949-9469; van Delft, Mark/0000-0002-3866-4318; Czabotar, Peter/0000-0002-2594-496X; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [CA80188, CA43540] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cuconati A, 2002, J VIROL, V76, P4547, DOI 10.1128/JVI.76.9.4547-4558.2002; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Shindler KS, 1997, J NEUROSCI, V17, P3112; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	24	901	942	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					856	859		10.1126/science.1133289	http://dx.doi.org/10.1126/science.1133289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289999				2022-12-24	WOS:000244069000072
J	Royo-Torres, R; Cobos, A; Alcala, L				Royo-Torres, Rafael; Cobos, Alberto; Alcala, Luis			A giant European dinosaur and a new sauropod clade	SCIENCE			English	Article								Fossils of a giant sauropod dinosaur, Turiasaurus riodevensis, have been recovered from terrestrial deposits of the Villar del Arzobispo Formation (Jurassic-Cretaceous boundary) of Riodeva (Teruel Province, Spain). Its humerus length ( 1790 millimeters) and estimated mass ( 40 to 48 metric tons) indicate that it may have been the most massive terrestrial animal in Europe and one of the largest in the world. Phylogenetic analysis indicates that the fossil represents a member of a hitherto unrecognized group of primitive European eusauropods that evolved in the Jurassic.	Fdn Conjurito Paleontol Tereul Dinopolis, E-44002 Teruel, Spain		Royo-Torres, R (corresponding author), Fdn Conjurito Paleontol Tereul Dinopolis, Ave Sagunto, E-44002 Teruel, Spain.	royo@dinopolis.com	Alcalá, Luis/A-7413-2009; Alcalá, Luis/P-5793-2014; Torres, Rafael Royo/AAE-3183-2019	Alcalá, Luis/0000-0002-6369-6186; Torres, Rafael Royo/0000-0001-5116-3000; Cobos, Alberto/0000-0001-9162-334X				[Anonymous], 1999, REV MUSEO ARGENTINE, V5, P13; Barco Jose Luis, 2005, Naturaleza Aragonesa, V15, P4; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Buffetaut Eric, 1994, Revue de Paleobiologie Volume Special, V7, P17; Casanovas Maria Lourdes, 2001, Paleontologia i Evolucio, V32-33, P99; Fezer R., 1988, Arbeiten aus dem Institut fuer Geologie und Palaeontologie an der Universitaet Stuttgart Neue Folge, V84, P1; Gillette D.D., 1991, Journal of Vertebrate Paleontology, V11, P417; Lapparent A. F., 1957, Memorias Servicos Geologicos Portugal NS, V2, P1; Luquetti AO, 2005, REV SOC BRAS MED TRO, V38, P27; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; Naish D, 2004, CRETACEOUS RES, V25, P787, DOI 10.1016/j.cretres.2004.07.002; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Paul G.S., 1988, HUNTERIA, V2, P1; Royo-Torres R., 2005, Geogaceta, V38, P23; ROYOTORRES R, 2004, GEOTEMAS, V6, P59; Sanchez-Hernandez B, 2005, ZOOTAXA, P1; Sanchez-Hernandez B, 2006, ZOOTAXA, P63, DOI 10.11646/zootaxa.1201.1.3; SANZ J L, 1987, Estudios Geologicos (Madrid), P45; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; You HL, 2004, ACTA GEOL SIN-ENGL, V78, P907; YOUNG CC, 1972, VERT PALEONTOL PALEO, V8, P1	27	99	105	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1925	1927		10.1126/science.1132885	http://dx.doi.org/10.1126/science.1132885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185599	Green Submitted			2022-12-24	WOS:000242996800048
J	Jin, RS; Rummel, A; Binz, T; Brunger, AT				Jin, Rongsheng; Rummel, Andreas; Binz, Thomas; Brunger, Axel T.			Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity	NATURE			English	Article							H-CC-DOMAIN; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; THERMODYNAMICS; TRANSLOCATION; MEMBRANES; TOXINS	Botulinum neurotoxins (BoNTs) are produced by Clostridium botulinum and cause the neuroparalytic syndrome of botulism. With a lethal dose of 1 ng kg(-1), they pose a biological hazard to humans and a serious potential bioweapon threat(1). BoNTs bind with high specificity at neuromuscular junctions and they impair exocytosis of synaptic vesicles containing acetylcholine through specific proteolysis of SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors), which constitute part of the synaptic vesicle fusion machinery(2,3). The molecular details of the toxin-cell recognition have been elusive. Here we report the structure of a BoNT in complex with its protein receptor: the receptor-binding domain of botulinum neurotoxin serotype B (BoNT/B) bound to the luminal domain of synaptotagmin II, determined at 2.15 angstrom resolution. On binding, a helix is induced in the luminal domain which binds to a saddle-shaped crevice on a distal tip of BoNT/B. This crevice is adjacent to the non-overlapping ganglioside-binding site of BoNT/B. Synaptotagmin II interacts with BoNT/B with nanomolar affinity, at both neutral and acidic endosomal pH. Biochemical and neuronal ex vivo studies of structure-based mutations indicate high specificity and affinity of the interaction, and high selectivity of BoNT/B among synaptotagmin I and II isoforms. Synergistic binding of both synaptotagmin and ganglioside imposes geometric restrictions on the initiation of BoNT/B translocation after endocytosis. Our results provide the basis for the rational development of preventive vaccines or inhibitors against these neurotoxins.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Hannover Medical School; Hannover Medical School	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Rummel, Andreas/I-7449-2013; Jin, Rongsheng/M-7797-2013	Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Brunger, Axel/0000-0001-5121-2036				Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; HABERMANN E, 1980, N-S ARCH PHARMACOL, V311, P33, DOI 10.1007/BF00500299; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jayaraman S, 2005, BIOCHEM BIOPH RES CO, V330, P97, DOI 10.1016/j.bbrc.2005.02.123; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; PANG ZP, IN PRESS J NEUROSCI; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; RUMMEL A, IN PRESS P NATL ACAD; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005	30	188	199	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1092	1095		10.1038/nature05387	http://dx.doi.org/10.1038/nature05387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167421				2022-12-24	WOS:000242971100061
J	Wilcox, AJ; Lie, RT; Solvoll, K; Taylor, J; McConnaughey, DR; Abyholm, F; Vindenes, H; Vollset, SE; Drevon, CA				Wilcox, Allen J.; Lie, Rov Terje; Solvoll, Kari; Taylor, Jack; McConnaughey, D. Robert; Abyholm, Frank; Vindenes, Hallvard; Vollset, Stein Emil; Drevon, Christian A.			Folic acid supplements and risk of facial clefts: national population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; OROFACIAL CLEFTS	Objective To explore the role of folic acid supplements, dietary folates, and multivitamins in the prevention of facial clefts. Design National population based case-control study. Setting Infants born 1996-2001 in Norway. Participants 377 infants with cleft lip with or without cleft palate; 196 infants with cleft palate alone; 763 controls. Main outcome measures Association of facial clefts with maternal intake of folic acid supplements, multivitamins, and folates in diet. Results Folic acid supplementation during early pregnancy (>= 400 mu g/day) was associated with a reduced risk of isolated cleft lip with or without cleft palate after adjustment for multivitamins, smoking, and other potential confounding factors (adjusted odds ratio 0.61, 95% confidence interval 0.39 to 0.96). Independent of supplements, diets rich in fruits, vegetables, and other high folate containing foods reduced the risk somewhat (adjusted odds ratio 0.75, 0.50 to 1.11). The lowest risk of cleft lip was among women with folate rich diets who also took folic acid supplements and multivitamins (0.36, 0.17 to 0.77). Folic acid provided no protection against cleft palate alone (1.07, 0.56 to 2.03). Conclusions Folic acid supplements during early pregnancy seem to reduce the risk of isolated cleft lip (with or without cleft palate) by about a third. Other vitamins and dietary factors may provide additional benefit.	NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; Univ Bergen, Dept Publ Hlth & Primary Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway; Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; WESTAT Corp, Durham, NC USA; Univ Oslo, Rikshosp, Dept Plast Surg, N-0027 Oslo, Norway; Haukeland Hosp, Dept Plast Surg, N-5021 Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; University of Oslo; Westat; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilcox@niehs.nih.gov	Wilcox, Allen J/C-7723-2019; Drevon, Christian A/F-6012-2010; taylor, jack a/C-7154-2019	Wilcox, Allen J/0000-0002-3376-1311; taylor, jack a/0000-0001-5303-6398	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049033, Z01ES049027] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andersen LF, 2003, EUR J CLIN NUTR, V57, P279, DOI 10.1038/sj.ejcn.1601519; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Christensen K., 2002, CLEFT LIP PALATE ORI, P101; Hayes C, 1996, AM J EPIDEMIOL, V143, P1229, DOI 10.1093/oxfordjournals.aje.a008710; Itikala PR, 2001, TERATOLOGY, V63, P79, DOI 10.1002/1096-9926(200102)63:2&lt;79::AID-TERA1013&gt;3.0.CO;2-3; MOSSEY PA, 2002, CLEFT LIP PALATE ORI, P170; MUNGER RG, 2002, CLEFT LIP PALATE ORI, P170; NES M, 1992, EUR J CLIN NUTR, V46, P809; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; SOLVOLL K, 1993, SCAND J NUTR, V37, P150; van Rooij IALM, 2004, PREV MED, V39, P689, DOI 10.1016/j.ypmed.2004.02.036; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070	14	226	245	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					464	467		10.1136/bmj.39079.618287.0B	http://dx.doi.org/10.1136/bmj.39079.618287.0B			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17259187	Green Published, Bronze			2022-12-24	WOS:000244802000033
J	Zhou, TQ; Xu, L; Dey, B; Hessell, AJ; Van Ryk, D; Xiang, SH; Yang, XZ; Zhang, MY; Zwick, MB; Arthos, J; Burton, DR; Dimitrov, DS; Sodroski, J; Wyatt, R; Nabel, GJ; Kwong, PD				Zhou, Tongqing; Xu, Ling; Dey, Barna; Hessell, Ann J.; Van Ryk, Donald; Xiang, Shi-Hua; Yang, Xinzhen; Zhang, Mei-Yun; Zwick, Michael B.; Arthos, James; Burton, Dennis R.; Dimitrov, Dimiter S.; Sodroski, Joseph; Wyatt, Richard; Nabel, Gary J.; Kwong, Peter D.			Structural definition of a conserved neutralization epitope on HIV-1 gp120	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; RECEPTOR; RECOGNITION; ANTIGEN; PROTEIN; DOMAIN; IDENTIFICATION; REGIONS	The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 angstrom resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Hessell, Ann/0000-0001-7471-9366	NATIONAL CANCER INSTITUTE [Z01BC010701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005022, U19AI067854, Z01AI000883, Z01AI005078, Z01AI005068] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [U19 AI067854-03, U19 AI067854] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; BURTON DR, 1997, AIDS SA, V11, P587; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fleury D, 2000, PROTEINS, V40, P572; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LI Y, 2006, AIDS VACCINE 2006; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; PROFY AT, 1990, J IMMUNOL, V144, P4641; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	50	627	659	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					732	737		10.1038/nature05580	http://dx.doi.org/10.1038/nature05580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301785	Green Published			2022-12-24	WOS:000244205200037
J	Steinbrook, R				Steinbrook, Robert			Thailand and the compulsory licensing of efavirenz	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV					rsteinbrook@attglobal.net						Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; World Health Organization, 2006, PROGR GLOB ACC HIV A; World Health Organization, 2006, ANT THER HIV INF AD	4	29	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					544	546		10.1056/NEJMp068297	http://dx.doi.org/10.1056/NEJMp068297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287474				2022-12-24	WOS:000244012700002
J	Uchida, K; Beck, DC; Yamamoto, T; Berclaz, P; Abe, S; Staudt, MK; Carey, BC; Filippi, M; Wert, SE; Denson, LA; Puchalski, JT; Hauck, DM; Trapnell, BC				Uchida, Kanji; Beck, David C.; Yamamoto, Takashi; Berclaz, Pierre-Yves; Abe, Shuichi; Staudt, Margaret K.; Carey, Brenna C.; Filippi, Marie-Dominique; Wert, Susan E.; Denson, Lee A.; Puchalski, Jonathan T.; Hauck, Diane M.; Trapnell, Bruce C.			GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; MACROPHAGE DIFFERENTIATION; AUTOIMMUNE-DISEASE; BONE-MARROW; PU.1; MICE; LUNG; PHAGOCYTOSIS; INNATE; ACTIVATION	BACKGROUND: Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in patients with pulmonary alveolar proteinosis and that GM-CSF autoantibodies cause the dysfunction. METHODS: We studied 12 subjects with pulmonary alveolar proteinosis, 61 healthy control subjects, and 12 control subjects with either cystic fibrosis or end-stage liver disease. We also studied GM-CSF(sup -/-) mice and wild-type mice. We evaluated basal neutrophil functions, neutrophil functions after priming by GM-CSF to augment antimicrobial functions, and the effects of highly purified GM-CSF autoantibodies on neutrophil functions in vitro and in vivo. RESULTS: Neutrophils from subjects with pulmonary alveolar proteinosis had normal ultrastructure and differentiation markers but impaired basal functions and antimicrobial functions after GM-CSF priming. GM-CSF(sup -/-) mice also had reduced basal neutrophil functions, but functions after GM-CSF priming were unimpaired. The neutrophil dysfunction characteristic of pulmonary alveolar proteinosis was reproduced in a dose-dependent fashion in blood specimens from healthy control subjects after incubation with affinity-purified GM-CSF autoantibodies isolated from patients with pulmonary alveolar proteinosis. The injection of mouse GM-CSF antibodies into wild-type mice also caused neutrophil dysfunction. CONCLUSIONS: The antimicrobial functions of neutrophils are impaired in patients with pulmonary alveolar proteinosis, owing to the presence of GM-CSF autoantibodies. The effects of these autoantibodies show that GM-CSF is an essential regulator of neutrophil functions.	Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Trapnell, BC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Rm 4029,TCHRF,3333 Burnet Ave, Cincinnati, OH 45229 USA.	bruce.trapnell@cchmc.org			NCRR NIH HHS [RR019498] Funding Source: Medline; NHLBI NIH HHS [HL69459, HL071823] Funding Source: Medline; NICHD NIH HHS [T32HD043005] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD043005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071823, R01HL069459] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; CLARK RA, 2005, CURRENT PROTOCOLS IM, P2; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; DeForge LE, 2000, J IMMUNOL METHODS, V245, P79, DOI 10.1016/S0022-1759(00)00279-9; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; ENGLISH D, 1992, BLOOD, V80, P776; FLEISCHMANN J, 1986, BLOOD, V68, P708; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; GRAVES V, 1993, BLOOD, V81, P1668; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; HASSAN NF, 1988, J LEUKOCYTE BIOL, V43, P317, DOI 10.1002/jlb.43.4.317; Hellmich B, 2002, ARTHRITIS RHEUM, V46, P2384, DOI 10.1002/art.10497; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; Krinner EM, 2007, MOL IMMUNOL, V44, P916, DOI 10.1016/j.molimm.2006.03.020; Mann BS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-59; Meager A, 1999, IMMUNOLOGY, V97, P526; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Rosenbloom AJ, 2005, CHEST, V127, P2139, DOI 10.1378/chest.127.6.2139; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Seymour John F, 2004, Treat Respir Med, V3, P229, DOI 10.2165/00151829-200403040-00003; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; TREWEEKE AT, 1994, J LEUKOCYTE BIOL, V55, P612, DOI 10.1002/jlb.55.5.612; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	38	187	197	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					567	579		10.1056/NEJMoa062505	http://dx.doi.org/10.1056/NEJMoa062505			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287477				2022-12-24	WOS:000244012700005
J	Boudker, O; Ryan, RM; Yernool, D; Shimamoto, K; Gouaux, E				Boudker, Olga; Ryan, Renae M.; Yernool, Dinesh; Shimamoto, Keiko; Gouaux, Eric			Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter	NATURE			English	Article							SCANNING MUTAGENESIS REVEALS; AMINO-ACID TRANSPORTER; GLUTAMATE TRANSPORTERS; REENTRANT LOOP; GLT-1; NA+; EXPRESSION; CLONING; GENE; COTRANSPORT	Secondary transporters are integral membrane proteins that catalyse the movement of substrate molecules across the lipid bilayer by coupling substrate transport to one or more ion gradients, thereby providing a mechanism for the concentrative uptake of substrates. Here we describe crystallographic and thermodynamic studies of Glt(Ph), a sodium (Na+)-coupled aspartate transporter, defining sites for aspartate, two sodium ions and D, L-threo-beta-benzyloxyaspartate, an inhibitor. We further show that helical hairpin 2 is the extracellular gate that controls access of substrate and ions to the internal binding sites. At least two sodium ions bind in close proximity to the substrate and these sodium-binding sites, together with the sodium-binding sites in another sodium-coupled transporter, LeuT, define an unwound alpha-helix as the central element of the ion-binding motif, a motif well suited to the binding of sodium and to participation in conformational changes that accompany ion binding and unbinding during the transport cycle.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Suntory Inst Bioorgan Res, Osaka 6188503, Japan	Columbia University; Columbia University; Howard Hughes Medical Institute; Suntory Holdings Ltd	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Ryan, Renae/AAC-3540-2021; Gouaux, Eric/Y-4370-2019	Ryan, Renae/0000-0002-8680-4610; Gouaux, Eric/0000-0002-8549-2360				ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; ENGELKE T, 1989, J BACTERIOL, V171, P5551, DOI 10.1128/jb.171.10.5551-5560.1989; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Kanner BI, 2002, BBA-BIOENERGETICS, V1555, P92, DOI 10.1016/S0005-2728(02)00260-8; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Lauger P., 1991, ELECTROGENIC ION PUM; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Mudring AV, 2005, INORG CHEM, V44, P6240, DOI 10.1021/ic050547k; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Ogawa W, 1998, J BACTERIOL, V180, P6749, DOI 10.1128/JB.180.24.6749-6752.1998; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUICK M, 2002, TRANSMEMBRANE TRANSP; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Slotboom DJ, 2001, TRENDS BIOCHEM SCI, V26, P534, DOI 10.1016/S0968-0004(01)01925-9; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yurgel SN, 2005, J BACTERIOL, V187, P1161, DOI 10.1128/JB.187.3.1161-1172.2005; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; ZERANGUE N, 1995, J BIOL CHEM, V270, P6433, DOI 10.1074/jbc.270.12.6433; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	45	386	393	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					387	393		10.1038/nature05455	http://dx.doi.org/10.1038/nature05455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17230192				2022-12-24	WOS:000243689500030
J	Frith, L				Frith, Lucy			HIV self-testing: a time to revise current policy	LANCET			English	Article							HOME; NORMALIZATION; PREFERENCES; COLLECTION; PREVENTION		Univ Liverpool, Div Primary Care, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Frith, L (corresponding author), Univ Liverpool, Div Primary Care, Whelan Bldg,Brownlow Hill, Liverpool L69 3GB, Merseyside, England.	L.J.Frith@liverpool.ac.uk	Frith, Lucy/AAW-6711-2020	Frith, Lucy/0000-0002-8506-0699				[Anonymous], 2000, CAN MED ASSOC J, V162, P1545; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; *BRIT ASS SEX HLTH, 2005, UK NAT GUID HIV TEST; De Cock KM, 1998, BMJ-BRIT MED J, V316, P290, DOI 10.1136/bmj.316.7127.290; *FDA, 2005, APPR VAL OV THE COUN; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Phillips KA, 2003, AM J PREV MED, V24, P340, DOI 10.1016/S0749-3797(03)00019-9; Rogstad KE, 2003, SEX TRANSM INFECT, V79, P243, DOI 10.1136/sti.79.3.243; Rosenbrock R, 2000, SOC SCI MED, V50, P1607, DOI 10.1016/S0277-9536(99)00469-4; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Spielberg F, 2001, SEX TRANSM DIS, V28, P51, DOI 10.1097/00007435-200101000-00012; Spielberg F, 2003, HOME SELF TESTING HI; *UK DEP HLTH, 2004, CHOOS HLTH MAK HLTH; *UK GEN MED COUNC, 2000, ANT TEST HIV; *UK HUM GEN COMM, 2005, NONC DNA TEST; US Food and Drug Administration, 2004, FDA APPR 1 OR FLUID; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	18	38	39	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					243	245		10.1016/S0140-6736(07)60113-5	http://dx.doi.org/10.1016/S0140-6736(07)60113-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	128XG	17240291				2022-12-24	WOS:000243692400033
J	Chaudhuri, O; Parekh, SH; Fletcher, DA				Chaudhuri, Ovijit; Parekh, Sapun H.; Fletcher, Daniel A.			Reversible stress softening of actin networks	NATURE			English	Article							ARP2/3 COMPLEX; DENDRITIC ORGANIZATION; MECHANICAL-PROPERTIES; CROSS-LINKING; CELLS; FILAMENTS; MICRORHEOLOGY; MICROTUBULES; ELASTICITY; MOTILITY	The mechanical properties of cells play an essential role in numerous physiological processes. Organized networks of semiflexible actin filaments determine cell stiffness and transmit force during mechanotransduction, cytokinesis, cell motility and other cellular shape changes(1-3). Although numerous actin-binding proteins have been identified that organize networks, the mechanical properties of actin networks with physiological architectures and concentrations have been difficult to measure quantitatively. Studies of mechanical properties in vitro have found that crosslinked networks of actin filaments formed in solution exhibit stress stiffening arising from the entropic elasticity of individual filaments or crosslinkers resisting extension(4-8). Here we report reversible stress-softening behaviour in actin networks reconstituted in vitro that suggests a critical role for filaments resisting compression. Using a modified atomic force microscope to probe dendritic actin networks ( like those formed in the lamellipodia of motile cells), we observe stress stiffening followed by a regime of reversible stress softening at higher loads. This softening behaviour can be explained by elastic buckling of individual filaments under compression that avoids catastrophic fracture of the network. The observation of both stress stiffening and softening suggests a complex interplay between entropic and enthalpic elasticity in determining the mechanical properties of actin networks.	Univ Calif Berkeley, UC San Francisco UC Berkeley Joint Grad Grp Bioen, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fletcher, DA (corresponding author), Univ Calif Berkeley, UC San Francisco UC Berkeley Joint Grad Grp Bioen, Berkeley, CA 94720 USA.	fletch@berkeley.edu	Ladoux, Benoit/A-9879-2013	Chaudhuri, Ovijit/0000-0002-9287-3401	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074751, R01GM072736] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072736-05, R01 GM072736, R01 GM074751-01A2, R01 GM074751] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Coughlin MF, 1998, J BIOMECH ENG-T ASME, V120, P770, DOI 10.1115/1.2834892; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tseng Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258104; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	30	292	303	6	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					295	298		10.1038/nature05459	http://dx.doi.org/10.1038/nature05459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230186	Green Accepted			2022-12-24	WOS:000243504700040
J	Zanetti, R; Rosso, S				Zanetti, Roberto; Rosso, Stefano			Levodopa and the risk of melanoma	LANCET			English	Editorial Material							PARKINSONS-DISEASE; MALIGNANT-MELANOMA; L-DOPA; SMOKING		Piedmont Canc Registry CPO, I-10123 Turin, Italy		Zanetti, R (corresponding author), Piedmont Canc Registry CPO, I-10123 Turin, Italy.	roberto.zanetti@cpo.it						DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; GURNEY H, 1991, J INVEST DERMATOL, V96, P85, DOI 10.1111/1523-1747.ep12515896; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; *MEDL PLUS, LEV SYST; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008; SHOHAT B, 1975, EXPERIENTIA, V31, P110, DOI 10.1007/BF01924707; SKIBBA JL, 1972, ARCH PATHOL, V93, P556; Zanetti R, 2006, MELANOMA RES, V16, P201, DOI 10.1097/01.cmr.0000215043.61306.d7	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					257	258		10.1016/S0140-6736(07)60125-1	http://dx.doi.org/10.1016/S0140-6736(07)60125-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258651				2022-12-24	WOS:000243912000009
J	Bendell, J				Bendell, Johanna			Optimum chemotherapy for metastatic colorectal cancer	LANCET			English	Editorial Material							FLUOROURACIL PLUS LEUCOVORIN; RANDOMIZED CONTROLLED-TRIAL; OXALIPLATIN; IRINOTECAN; INTERGROUP; GERCOR; BOLUS		Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Bendell, J (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	bende007@mc.duke.edu						deGramont A, 1997, J CLIN ONCOL, V15, P808, DOI 10.1200/JCO.1997.15.2.808; FALCONE A, 2006, J CLIN ONCOL S, V24, P3513; FUCHS C, 2006, J CLIN ONCOL, V24, P3506; Goldberg RM, 2006, J CLIN ONCOL, V24, P3347, DOI 10.1200/JCO.2006.06.1317; Goldberg RM, 2002, J CLIN ONCOL, V20, P4591, DOI 10.1200/JCO.2002.03.039; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; HOCHSTER H, 2006, 2006 GASTR CANC S SA; Maindrault-Goebel F., 2006, J CLIN ONCOL, V24, P3504, DOI [10.1200/jco.2006.24.18_suppl.3504, DOI 10.1200/JCO.2006.24.18_SUPPL.3504]; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113	11	7	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2039	2041		10.1016/S0140-6736(06)69818-8	http://dx.doi.org/10.1016/S0140-6736(06)69818-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161715				2022-12-24	WOS:000242663700006
J	Tilman, D; Hill, J; Lehman, C				Tilman, David; Hill, Jason; Lehman, Clarence			Carbon-negative biofuels from low-input high-diversity grassland biomass	SCIENCE			English	Article							ECOSYSTEM; ENERGY; CROPS; SWITCHGRASS; BIODIESEL; DYNAMICS; NITROGEN; ETHANOL	Biofuels derived from low-input high-diversity (LIHD) mixtures of native grassland perennials can provide more usable energy, greater greenhouse gas reductions, and less agrichemical pollution per hectare than can corn grain ethanol or soybean biodiesel. High-diversity grasslands had increasingly higher bioenergy yields that were 238% greater than monoculture yields after a decade. LIHD biofuels are carbon negative because net ecosystem carbon dioxide sequestration (4.4 megagram hectare(-1) year(-1) of carbon dioxide in soil and roots) exceeds fossil carbon dioxide release during biofuel production (0.32 megagram hectare(-1) year(-1)). Moreover, LIHD biofuels can be produced on agriculturally degraded lands and thus need to neither displace food production nor cause loss of biodiversity via habitat destruction.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Hill, Jason/A-8919-2008; Tilman, David/ABD-5309-2021	Hill, Jason/0000-0001-7609-6713; 				Berndes G, 2002, GLOBAL ENVIRON CHANG, V12, P253, DOI 10.1016/S0959-3780(02)00040-7; Camill P, 2004, ECOL APPL, V14, P1680, DOI 10.1890/03-5273; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fedoroff NV, 1999, P NATL ACAD SCI USA, V96, P5903, DOI 10.1073/pnas.96.11.5903; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gallagher PW, 2003, ENVIRON RESOUR ECON, V24, P335, DOI 10.1023/A:1023630823210; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Mann M, 2001, CLEAN PROD PROCESS, V3, P81, DOI DOI 10.1007/S100980100109; Outlaw J, 2005, AGR PRODUCER CONSUME; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; *US DEP EN EN INF, 2006, DOEEIA0484; *USDA NAT AGR STAT, 2006, AGR CHEM US 2004 200; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Zhang Y, 2003, BIORESOURCE TECHNOL, V89, P1, DOI 10.1016/S0960-8524(03)00040-3	28	1224	1263	17	676	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1598	1600		10.1126/science.1133306	http://dx.doi.org/10.1126/science.1133306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158327				2022-12-24	WOS:000242624600042
J	Hitchins, MP; Wong, JJL; Suthers, G; Suter, CM; Martin, DIK; Hawkins, NJ; Ward, RL				Hitchins, Megan P.; Wong, Justin J. L.; Suthers, Graerne; Suter, Catherine M.; Martin, David I. K.; Hawkins, Nicholas J.; Ward, Robyn L.			Brief report: Inheritance of a cancer-associated MLH1 germ-line epimutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA METHYLATION; PROMOTER HYPERMETHYLATION; EPIGENETIC INHERITANCE; PATERNAL GENOME; MOUSE; GENE; ALLELE; HUMAN-CHROMOSOME-15; DEMETHYLATION	Persons who have hypermethylation of one allele of MLH1 in somatic cells throughout the body (a germ-line epimutation) have a predisposition for the development of cancer in a pattern typical of hereditary nonpolyposis colorectal cancer. By studying the families of two such persons, we found evidence that the epimutation was transmitted from a mother to her son but was erased in his spermatozoa. The affected maternal allele was inherited by three other siblings from these two families, but in those offspring the allele had reverted to the normal active state. These findings demonstrate a novel pattern of inheritance of cancer susceptibility and are consistent with transgenerational epigenetic inheritance.	St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; Womens & Childrens Hospital Australia; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ward, RL (corresponding author), St Vincents Hosp, Dept Med Oncol, Victoria St, Darlinghurst, NSW 2010, Australia.	robyn@unsw.edu.au	Ward, Robyn L/I-2313-2013; Wong, Justin/AAE-7986-2020; Hawkins, Nicholas J/A-8461-2008; Hitchins, Megan/GXH-4566-2022	Ward, Robyn L/0000-0002-6877-8906; Wong, Justin/0000-0002-7038-5079; Hawkins, Nicholas J/0000-0002-2204-3189; 				Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Gazzoli I, 2002, CANCER RES, V62, P3925; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hegde M, 2005, J MOL DIAGN, V7, P525, DOI 10.1016/S1525-1578(10)60584-3; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lynch HT, 2005, ONCOLOGY-NY, V19, P455; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; MORALES P, 1991, HUM REPROD, V6, P401; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; *NAT CTR BIOT INF, UNISTS DAT; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268	25	300	321	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					697	705		10.1056/NEJMoa064522	http://dx.doi.org/10.1056/NEJMoa064522			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301300				2022-12-24	WOS:000244193300007
J	Dhallan, R; Guo, X; Emche, S; Damewood, M; Bayliss, P; Cronin, M; Barry, J; Betz, J; Franz, K; Gold, K; Vallecillo, B; Varney, J				Dhallan, Ravinder; Guo, Xin; Emche, Sarah; Damewood, Marian; Bayliss, Philip; Cronin, Michael; Barry, Julie; Betz, Jordan; Franz, Kara; Gold, Katie; Vallecillo, Brett; Varney, John			A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study	LANCET			English	Article							CELLS; PLASMA; CIRCULATION	Background Use of free fetal DNA to diagnose fetal chromosomal abnormalities has been hindered by the inability to distinguish fetal DNA from maternal DNA. Our aim was to establish whether single nucleotide polymorphisms (SNPs) can be used to distinguish fetal DNA from maternal DNA-and to determine the number of fetal chromosomes-in maternal blood samples. Methods Formaldehyde-treated blood samples from 60 pregnant women and the stated biological fathers were analysed. Maternal plasma fractions were quantified at multiple SNPs, and the ratio of the unique fetal allele signal to the combined maternal and fetal allele signal calculated. The mean ratios of SNPs on chromosomes 13 and 21 were compared to test for potential fetal chromosomal abnormalities. Findings The mean proportion of free fetal DNA was 34.0% (median 32.5%, range 17.0-93-8). We identified three samples with significant differences in the fetal DNA ratios for chromosome 13 and chromosome 21,. indicative of trisomy 21; the remaining 57 samples were deemed to be normal. Amniocentesis or newborn reports from the clinical sites confirmed that the copy number of fetal chromosomes 13 and 21 was established correctly for 58 of the 60 samples, identifying 56 of the 57 normal samples, and two of the three trisomy 21 samples. Of the incorrectly identified samples, one was a false negative and one was a false positive. The sensitivity and positive predictive value were both 66.7% (95% CI 12.5-98.2) and the specificity and negative predictive values were both 98.2% (89.4-99.9). Interpretation The copy number of chromosomes of interest can be directly established from maternal plasma. Such a non-invasive prenatal test could provide a useful complement to currently used screening tests.	Ravgen Inc, Columbia, MD 21045 USA; York Hosp Wellspan Hlth, Dept Obstet & Gynecol, York, PA USA; Lancaster Gen Women & Babies Hosp, Dept Maternal Fetal Med, Lancaster, PA USA; Whyte Hirschboeck Dudek SC, Madison, WI USA		Dhallan, R (corresponding author), Ravgen Inc, 9241 Rumsey Rd, Columbia, MD 21045 USA.	rdhallan@ravgen.com	Betz, Jordan F/A-8833-2010	Betz, Jordan F/0000-0002-1257-2204				ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Alfirevic Z, 2004, BMJ-BRIT MED J, V329, P811, DOI 10.1136/bmj.329.7470.811; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Amicucci P, 2000, CLIN CHEM, V46, P301; Avent ND, 2006, PRENATAL DIAG, V26, P598, DOI 10.1002/pd.1493; Benn PA, 2004, OBSTET GYNECOL, V103, P1255, DOI 10.1097/01.AOG.0000127008.14792.14; Berkowitz RL, 2006, OBSTET GYNECOL, V107, P715, DOI 10.1097/01.AOG.0000201976.00299.d2; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; d'Ercole C, 2003, CHILD NERV SYST, V19, P444, DOI 10.1007/s00381-003-0788-z; de Graaf IM, 1999, PRENATAL DIAG, V19, P648, DOI 10.1002/(SICI)1097-0223(199907)19:7<648::AID-PD600>3.0.CO;2-X; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; DHALLAN RS, 2005, Patent No. 6977162; DHALLAN RS, 2004, Patent No. 10661165; Fuchs KM, 2005, SEMIN PERINATOL, V29, P267, DOI 10.1053/j.semperi.2005.05.003; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Papp C, 2003, CURR OPIN OBSTET GYN, V15, P159, DOI 10.1097/00001703-200304000-00011; Pont-Kingdon G, 2003, CLIN CHEM, V49, P1087, DOI 10.1373/49.7.1087; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; Torricelli F, 2001, CLIN CHEM LAB MED, V39, P494, DOI 10.1515/CCLM.2001.082; Wilson RD, 2005, J OBSTET GYNAECOL CA, V27, P54, DOI 10.1016/S1701-2163(16)30173-6	25	89	174	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					474	481		10.1016/S0140-6736(07)60115-9	http://dx.doi.org/10.1016/S0140-6736(07)60115-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292767				2022-12-24	WOS:000244188300030
J	Kurella, M; Covinsky, KE; Collins, AJ; Chertow, GM				Kurella, Manjula; Covinsky, Kenneth E.; Collins, Alan J.; Chertow, Glenn M.			Octogenarians and nonagenarians starting dialysis in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; DECISION-MAKING; INITIATION; SURVIVAL; HEMODIALYSIS; PREVALENCE; VALIDATION; COHORT	Background: The elderly constitute the fastest-growing segment of the end-stage renal disease (ESRD) population, but the epidemiology and outcomes of dialysis among the very elderly, that is, those 80 years of age and older, have not been previously examined at a national level. Objective: To describe recent trends in the incidence and outcomes of octogenarians and nonagenarians starting dialysis. Design: Observational study. Setting: U.S. Renal Data System, a comprehensive, national registry of patients with ESRD. Participants: Octogenarians and nonagenarians initiating dialysis between 1996 and 2003. Measurements: Rates of dialysis initiation and survival. Results: The number of octogenarians and nonagenarians starting dialysis increased from 7054 persons in 1996 to 13 577 persons in 2003, corresponding to an average annual increase in dialysis initiation of 9.8%. After we accounted for population growth, the rate of dialysis initiation increased by 57% (rate ratio, 1.57 [95% CI, 1.53 to 1.62]) between 1996 and 2003. One-year mortality for octogenarians and nonagenarians after dialysis initiation was 46%. Compared with octogenarians and nonagenarians initiating dialysis in 1996, those starting dialysis in 2003 had a higher glomerular filtration rate and less morbidity related to chronic kidney disease but no difference in 1-year survival. Clinical characteristics strongly associated with death were older age, nonambulatory status, and more comorbid conditions. Limitations: Survival of patients with incident ESRD who did not begin dialysis could not be assessed. Conclusions: The number of octogenarians and nonagenarians initiating dialysis has increased considerably over the past decade, while overall survival for patients on dialysis remains modest. Estimates of prognosis based on patient characteristics, when considered in conjunction with individual values and preferences, may aid in dialysis decision making for the very elderly.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA 94143 USA; US Renal Data Syst, Minneapolis, MN USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Kurella, M (corresponding author), Univ Calif San Francisco, Div Nephrol, UCSF Laurel Heights,Suite 430,3333 Calif St, San Francisco, CA 94143 USA.	manjula.kurella@ucsf.edu	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479; Chertow, Glenn/0000-0002-7599-0534	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG029812] Funding Source: NIH RePORTER; NIA NIH HHS [K24 AG029812] Funding Source: Medline; NIDDK NIH HHS [R01 DK01005, R01 DK58411] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; BURNS A, 2005, AM SOC NEPHR REN WEE; Centers for Disease Control and Prevention, NAT CTR HLTH STAT NC; CHESTER AC, 1979, ARCH INTERN MED, V139, P1001, DOI 10.1001/archinte.139.9.1001; Collins AJ, 2005, AM J KIDNEY DIS, V45, pV, DOI 10.1053/j.ajkd.2004.10.009; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McDonald S, 2005, ADV CHRONIC KIDNEY D, V12, P32, DOI 10.1053/j.ackd.2004.10.011; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Munshi SK, 2001, NEPHROL DIAL TRANSPL, V16, P128, DOI 10.1093/ndt/16.1.128; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Peri UN, 2001, NEPHROL DIAL TRANSPL, V16, P2201, DOI 10.1093/ndt/16.11.2201; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Rohrich B, 1996, NEPHROL DIAL TRANSPL, V11, P2412, DOI 10.1093/oxfordjournals.ndt.a027205; Smith C, 2003, NEPHRON CLIN PRACT, V95, pC40, DOI 10.1159/000073708; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Vandelli L, 1996, NEPHROL DIAL TRANSPL, V11, P89	25	399	419	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					177	183		10.7326/0003-4819-146-3-200702060-00006	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283348				2022-12-24	WOS:000243957400003
J	Lim, MLM; Land, MF; Li, DQ				Lim, Matthew L. M.; Land, Michael F.; Li, Daiqin			Sex-specific UV and fluorescence signals in jumping spiders	SCIENCE			English	Article							SALTICIDAE; ARANEAE; SENSITIVITY		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England; Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China	National University of Singapore; University of Sussex; Hubei University	Li, DQ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslidq@nus.edu.sg	Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013; Lim, Matthew LM/D-4154-2011; Lim, Matthew/Q-7406-2019	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Lim, Matthew LM/0000-0002-0888-3595; Lim, Matthew/0000-0002-0888-3595				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Land M.F., 1985, P53; Lim MLM, 2006, BIOL J LINN SOC, V89, P397, DOI 10.1111/j.1095-8312.2006.00704.x; Lim MLM, 2006, J COMP PHYSIOL A, V192, P871, DOI 10.1007/s00359-006-0126-5; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X	8	108	113	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					481	481		10.1126/science.1134254	http://dx.doi.org/10.1126/science.1134254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255504				2022-12-24	WOS:000243726600036
J	Gostin, LO				Gostin, Lawrence O.			Law as a tool to facilitate healthier lifestyles and prevent obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; PUBLIC-HEALTH; PREVALENCE; OVERWEIGHT; ADULTS; INCOME		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], FREQ ASK QUEST WHO G; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007; BURROS M, 2006, NY TIMES        1007; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Epstein RA, 2005, GEORGETOWN LAW J, V93, P1361; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Frieden TR, 2004, AM J PUBLIC HEALTH, V94, P2059, DOI 10.2105/AJPH.94.12.2059; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; *HLTH CAN, TRANSFORMING FOOD SU; Institute of Medicine, 2005, DIET REF INT EN CARB; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Jacobson MF, 2000, AM J PUBLIC HEALTH, V90, P854, DOI 10.2105/AJPH.90.6.854; Mair J.S., 2005, USE ZONING RESTRICT; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; *NAT REST ASS, STAT FRIV LAWS LEG; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Perdue WC, 2003, AM J PUBLIC HEALTH, V93, P1390, DOI 10.2105/AJPH.93.9.1390; *TRUST AM HLTH, 2004, F FAT OB POL ARE FAI; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *US GOV ACC OFF, 2003, GAO03506; *WHO REG OFF EUR, EUR CHART COUNT OB	23	86	86	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2007	297	1					87	90		10.1001/jama.297.1.87	http://dx.doi.org/10.1001/jama.297.1.87			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	123BS	17200479	Green Published			2022-12-24	WOS:000243271900025
J	Gregori, L; Gurgel, PV; Lathrop, JT; Edwardson, P; Lambert, BC; Carbonell, RG; Burton, SJ; Hammond, DJ; Rohwer, RG				Gregori, Luisa; Gurgel, Patrick V.; Lathrop, Julia T.; Edwardson, Peter; Lambert, Brian C.; Carbonell, Ruben G.; Burton, Steven J.; Hammond, David J.; Rohwer, Robert G.			Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; TRANSFUSION; COMPONENTS; TESTS	Background Transmissible spongiform encephalopathies (TSE) can be contracted through blood transfusion. Selective adsorption of the causative agent from donated blood might be one of the best ways of managing this risk. In our study, affinity resin L13, which reduces brain-derived infectivity spiked into human red blood cell concentrate by around 4 log(10)ID(50), and its equivalent, L13A, produced on a manufacturing scale, were assessed for their ability to remove TSE infectivity endogenously present in blood. Methods 500 mL of scrapie-infected hamster whole blood was leucoreduced at full scale before passage through the affinity resins. Infectivity of whole blood, leucoreduced whole blood (challenge), and the recovered blood from each flow-through was measured by limiting dilution titration. Findings Leutcoreduction removed 72% of input infectivity. 15 of 99 animals were infected by the challenge, whereas none of the 96 or 100 animals inoculated with the final flow-throughs from either resin developed the disease after 540 days. The limit of detection of the bioassay was 0 center dot 2 infectious doses per mL. The overall reduction of the challenge infectivity was more than 1 center dot 22 log(10)ID. The results showed removal of endogenous TSE infectivity from leucoreduced whole blood by affinity ligands. The same resins adsorb normal and abnormal prion protein from human infections with variant, sporadic, and familial Creutzfeldt-jakob disease, in the presence of blood components. Interpretation TSE affinity ligands, when incorporated into appropriate devices, can be used to mitigate the risks from TSE-infected blood, blood products, and other materials exposed to TSE infectivity.	Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; ProMet BioSci Ltd, Cambridge, England; Amer Red Cross Biomed R&D, Plasma Derivat Dept, Rockville, MD USA; N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); American Red Cross; University of North Carolina; North Carolina State University	Rohwer, RG (corresponding author), Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	rrohwer@umaryland.edu	Gurgel, Patrick/M-9749-2019; Gurgel, Patrick/C-2181-2008					BAUMBACH GA, 1992, BIOPHARM         MAY, P24; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 2005, VOX SANG, V89, P63, DOI 10.1111/j.1423-0410.2005.00683.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, TRANSFUSION, V46, P1152, DOI 10.1111/j.1537-2995.2006.00865.x; HAMMOND D, Patent No. 2004050851; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; MacGregor I, 1999, VOX SANG, V77, P88; Minor PD, 2004, VOX SANG, V86, P164, DOI 10.1111/j.0042-9007.2004.00411.x; *NAT CREUTZF JAK D, 2006, VAR CREUTZF JAK DIS; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; *US DEP HHS, 2002, GUID IND REV PREV ME; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	19	70	73	1	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2006	368	9554					2226	2230		10.1016/S0140-6736(06)69897-8	http://dx.doi.org/10.1016/S0140-6736(06)69897-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189034				2022-12-24	WOS:000243076800030
J	Cromie, GA; Hyppa, RW; Taylor, AF; Zakharyevich, K; Hunter, N; Smith, GR				Cromie, Gareth A.; Hyppa, Randy W.; Taylor, Andrew F.; Zakharyevich, Kseniya; Hunter, Neil; Smith, Gerald R.			Single Holliday junctions are intermediates of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE CONVERSION; CROSSING-OVER; FISSION YEAST; REPLICATION ORIGINS; DNA-DAMAGE; S.-POMBE	Crossing-over between homologous chromosomes facilitates their accurate segregation at the first division of meiosis. Current models for crossing-over invoke an intermediate in which homologs are connected by two crossed-strand structures called Holliday junctions. Such double Holliday junctions are a prominent intermediate in Saccharomyces cerevisiae meiosis, where they form preferentially between homologs rather than between sister chromatids. In sharp contrast, we find that single Holliday junctions are the predominant intermediate in Schizosaccharomyces pombe meiosis. Furthermore, these single Holliday junctions arise preferentially between sister chromatids rather than between homologs. We show that Mus81 is required for Holliday junction resolution, providing further in vivo evidence that the structure-specific endonuclease Mus81-Eme1 is a Holliday junction resolvase. To reconcile these observations, we present a unifying recombination model applicable for both meiosis and mitosis in which single Holliday junctions arise from single- or double-strand breaks, lesions postulated by previous models to initiate recombination.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Fred Hutchinson Cancer Center; University of California System; University of California Davis; University of California System; University of California Davis	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	NIGMS NIH HHS [R01 GM074223, R56 GM031693, R01 GM031693, R01 GM074223-02, GM074223, GM031693, R01 GM031693-25] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031693, R56GM031693, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DEVEAUX LC, 1992, GENETICS, V130, P251; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; GRIMM C, 1994, GENETICS, V136, P41; Her C, 2001, MAMM GENOME, V12, P73, DOI 10.1007/s003350010231; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; MUNZ P, 1994, GENETICS, V137, P701; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHUCHERT P, 1988, GENETICS, V119, P507; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Smith GR, 2003, GENETICS, V165, P2289; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	48	154	162	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1167	1178		10.1016/j.cell.2006.09.050	http://dx.doi.org/10.1016/j.cell.2006.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174892	Green Accepted, Bronze			2022-12-24	WOS:000242991000015
J	Shepherd, CB				Shepherd, Charles B.			Shark cartilage in the water - Effective legislation is already in place but is not being properly used	BRITISH MEDICAL JOURNAL			English	Letter												charlesbshepherd@lineone.net						Campbell D, 1997, BRIT MED J, V315, P625; DYER O, 1994, BRIT MED J, V308, P158, DOI 10.1136/bmj.308.6922.158; Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.725162.3A	http://dx.doi.org/10.1136/bmj.39051.725162.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158403	Green Published			2022-12-24	WOS:000243009600031
J	Holland, RA; Thorup, K; Vonhof, MJ; Cochran, WW; Wikelski, M				Holland, Richard A.; Thorup, Kasper; Vonhof, Maarten J.; Cochran, William W.; Wikelski, Martin			Navigation - Bat orientation using Earth's magnetic field	NATURE			English	Article							PIGEONS; CUES		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Copenhagen, Inst Biol, Ctr Macroecol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen, Denmark; Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	Princeton University; University of Leeds; University of Copenhagen; University of Copenhagen; Western Michigan University; Illinois Natural History Survey	Holland, RA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rahollan@princeton.edu	Holland, Richard A/A-6107-2010; Thorup, Kasper/A-4835-2013	Holland, Richard A/0000-0003-4495-8061; Thorup, Kasper/0000-0002-0320-0601				Berthold P, 2001, AUK, V2nd; Bonadona F, 2000, J EXP BIOL, V203, P207; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; MICHENER MC, 1967, J EXP BIOL, V47, P99; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Neuweiler G., 2000, BIOL BATS; Simmons JA., 1995, HEARING BATS SPRINGE, P146; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487	8	107	116	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					702	702		10.1038/444702a	http://dx.doi.org/10.1038/444702a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151656				2022-12-24	WOS:000242581100043
J	Liu, KJ; Arron, JR; Stankunas, K; Crabtree, GR; Longaker, MT				Liu, Karen J.; Arron, Joseph R.; Stankunas, Kryn; Crabtree, Gerald R.; Longaker, Michael T.			Chemical rescue of cleft palate and midline defects in conditional GSK-3 beta mice	NATURE			English	Article							MODEL	Glycogen synthase kinase-3 beta (GSK-3 beta) has integral roles in a variety of biological processes, including development, diabetes, and the progression of Alzheimer's disease(1-4). As such, a thorough understanding of GSK-3 beta function will have a broad impact on human biology and therapeutics. Because GSK-3 beta interacts with many different pathways, its specific developmental roles remain unclear(5). We have discovered a genetic requirement for GSK-3 beta in midline development. Homozygous null mice display cleft palate, incomplete fusion of the ribs at the midline and bifid sternum as well as delayed sternal ossification. Using a chemically regulated allele of GSK-3 beta ( ref. 6), we have defined requirements for GSK-3 beta activity during discrete temporal windows in palatogenesis and skeletogenesis. The rapamycin-dependent allele of GSK-3 beta produces GSK-3 beta fused to a tag, FRB* (FKBP/rapamycin binding), resulting in a rapidly destabilized chimaeric protein. In the absence of drug, GSK-3 beta(FRB*/FRB*) mutants appear phenotypically identical to GSK-3 beta(-/-) mutants. In the presence of drug, GSK-3 beta FRB* is rapidly stabilized, restoring protein levels and activity(6). Using this system, mutant phenotypes were rescued by restoring endogenous GSK-3 beta activity during two distinct periods in gestation. This technology provides a powerful tool for defining windows of protein function during development.	Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Liu, KJ (corresponding author), Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England.	karen.liu@kcl.ac.uk; longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Arron, Joseph/0000-0001-7677-9979				Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; CHEN JM, 1952, J ANAT, V86, P373; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FLAKE AW, 1987, J PEDIATR SURG, V22, P816, DOI 10.1016/S0022-3468(87)80643-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; SHARPE PM, 1988, J CELL SCI, P195; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X	20	111	113	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					79	82		10.1038/nature05557	http://dx.doi.org/10.1038/nature05557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17293880				2022-12-24	WOS:000244525600041
J	England, R; de Lay, P; Greener, R; Izazola, JA				England, Roger; de lay, Paul; Greener, Robert; Izazola, Jose Antonio			Are we spending too much on HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UNAIDS, Evaluat Dept, CH-1211 Geneva, Switzerland	UNAIDS		roger.england@healthsystemsworkshop.org; communications@unaids.org							0	63	63	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2007	334	7589					344	345		10.1136/bmj.39113.402361.94	http://dx.doi.org/10.1136/bmj.39113.402361.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141EJ	17303881	Green Published			2022-12-24	WOS:000244560400029
J	Specht, S; Hoerauf, A				Specht, Sabine; Hoerauf, Achim			Does helminth elimination promote or prevent malaria?	LANCET			English	Editorial Material							FILARIAL NEMATODES; IMMUNE-RESPONSES; PARASITE GROWTH; CELLS; IMMUNOMODULATION; MODULATION; INFECTION; PROTECT		Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany.	hoerauf@parasit.meb.uni-bonn.de						BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; Chatterjee S, 2001, TROP MED INT HEALTH, V6, P578, DOI 10.1046/j.1365-3156.2001.00758.x; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Marshall FA, 2005, J IMMUNOL, V175, P5817, DOI 10.4049/jimmunol.175.9.5817; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; WHO, 2005, MILL DEV GOALS EV IS	16	19	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					446	447		10.1016/S0140-6736(07)60210-4	http://dx.doi.org/10.1016/S0140-6736(07)60210-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292747				2022-12-24	WOS:000244188300008
J	Hossain, P; Kawar, B; Nahas, ME				Hossain, Parvez; Kawar, Bisher; Nahas, Meguid El			Obesity and diabetes in the developing world - A growing challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Sheffield, Sheffield Kidney Inst, Acad Nephrol Unit, Sheffield, S Yorkshire, England	University of Sheffield	Hossain, P (corresponding author), Univ Sheffield, Sheffield Kidney Inst, Acad Nephrol Unit, Sheffield, S Yorkshire, England.							Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lee G, 2003, SEMIN NEPHROL, V23, P107, DOI 10.1053/snep.2003.50009; WHO, 2006, WORLD HLTH REPORT 20; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	5	1380	1418	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					213	215		10.1056/NEJMp068177	http://dx.doi.org/10.1056/NEJMp068177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126BV	17229948				2022-12-24	WOS:000243488100003
J	Shen, JS; Tareste, DC; Paumet, F; Rothman, JE; Melia, TJ				Shen, Jingshi; Tareste, David C.; Paumet, Fabienne; Rothman, James E.; Melia, Thomas J.			Selective activation of cognate SNAREpins by Sec1/Munc18 proteins	CELL			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; T-SNARE; SYNTAXIN; EXOCYTOSIS; COMPLEX; SPECIFICITY; BINDS; GOLGI	Sec1/Muncl 8 (SM) proteins are required for every step of intracellular membrane fusion, but their molecular mechanism of action has been unclear. In this work, we demonstrate a fundamental role of the SM protein: to act as a stimulatory subunit of its cognate SNARE fusion machinery. In a reconstituted system, mammalian SNARE pairs assemble between bilayers to drive a basal fusion reaction. Munc18-1/nSec1, a synaptic SM protein required for neurotransmitter release, strongly accelerates this reaction through direct contact with both t- and v-SNAREs. Munc18-1 accelerates fusion only for the cognate SNAREs for exocytosis, therefore enhancing fusion specificity.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Rothman, JE (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jr2269@columbia.edu; tm2176@columbia.edu	Tareste, David/P-9249-2019; Tareste, David/L-2639-2017	Tareste, David/0000-0002-8744-7598; Tareste, David/0000-0002-8744-7598; SHEN, JINGSHI/0000-0001-9595-1148; Paumet, Fabienne/0000-0003-4466-6966				Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; BRENNER S, 1974, GENETICS, V77, P71; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Graham ME, 1997, J NEUROCHEM, V69, P2369; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SCHEKMAN R, 2004, CELL, V116, pS19; Schekman Randy, 2004, Cell, VS116, pS13, DOI 10.1016/S0092-8674(03)00972-3; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Williams AL, 2004, MOL BIOL CELL, V15, P162, DOI 10.1091/mbc.E03-07-0535; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	70	349	365	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					183	195		10.1016/j.cell.2006.12.016	http://dx.doi.org/10.1016/j.cell.2006.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218264	Bronze			2022-12-24	WOS:000244420400022
J	Weber, F; Xu, YM; Zhang, L; Patocs, A; Shen, L; Platzer, P; Eng, C				Weber, Frank; Xu, Yaomin; Zhang, Li; Patocs, Attila; Shen, Lei; Platzer, Petra; Eng, Charis			Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTATE-CANCER-AGGRESSIVENESS; FIELD CANCERIZATION; TUMOR PROGRESSION; BREAST-CANCER; STROMA; EXPRESSION; PROTEIN; EPITHELIUM; LUNG; DIFFERENTIATION	Context Carcinogens associated with head and neck squamous cell carcinoma (SCC) genesis should inflict genomic alterations not only on the epithelium but also the mesenchyme of the aerodigestive tract. Therefore, the apparently nonmalignant stroma surrounding the tumor epithelium can acquire genomic alterations and contribute to cancer initiation and progression. Objectives To determine compartment-specific loci of loss of heterozygosity or allelic imbalance (LOH/AI) and to identify which genomic alterations restricted to the stroma cell population contribute to aggressiveness of head and neck SCC disease. Design, Setting, and Patients Tumor epithelium and surrounding stroma were isolated from 122 US patients with oral cavity and oropharyngeal or hypopharyngeal SCC and subjected to whole-genome LOH/AI analysis using 366 microsatellite markers. Samples, collected between 2001 and 2004, were pulled and transferred in batches of 10 to 30 between 2002 and 2005. Laser capture microdissection DNA extraction and technical genotyping occurred on a rolling model between 2002 and November 2005. Main Outcome Measures Compartment-specific frequency and distribution of LOH/AI were determined, and hot spots of genomic alterations identified. Compartment-specific LOH/AI events were correlated with presenting clinicopathologic characteristics. Results Tumor-associated stroma of head and neck SCC from smokers were found to have a high degree of genomic alterations. A correlation between tumor aggressiveness could be found for a specific set of 5 loci. Three stroma-specific loci (D4S2417, D3S360, and D19555) were associated with tumor size (pT) and regional nodal metastases (pN). Furthermore, 2 epithelial-specific LOH/AI hot spots were positively correlated with pN status and clinical stage. Conclusions Stroma-specific genetic alterations are associated with smoking-related head and neck SCC genesis. These findings suggest novel prognostic or diagnostic biomarkers and identify potential new molecular targets for therapeutic and preventive intervention.	Cleveland Clin Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Sect Stat Genet, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Ohio State Univ, Div Biostat, Sch Publ Hlth, Columbus, OH 43210 USA; Case Western Reserve Univ, Dept Stat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Weber, Frank/A-1883-2012	Weber, Frank/0000-0002-0995-667X; Eng, Charis/0000-0002-3693-5145; Patocs, Attila/0000-0001-7506-674X				*AM CANC SOC, 2006, OR CANC FACTS FIG; [Anonymous], 2006, SEER CANC STAT REV 1; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bockmuhl U, 2002, GENE CHROMOSOME CANC, V33, P29, DOI 10.1002/gcc.1209.abs; Bockmuhl U, 1998, HEAD NECK-J SCI SPEC, V20, P145, DOI 10.1002/(SICI)1097-0347(199803)20:2<145::AID-HED8>3.0.CO;2-2; Braakhuis BJM, 2005, SEMIN CANCER BIOL, V15, P113, DOI 10.1016/j.semcancer.2004.08.004; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Climent J, 2002, CLIN CANCER RES, V8, P3863; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Dai MS, 2002, J BIOL CHEM, V277, P26327, DOI 10.1074/jbc.M201834200; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Edlund M, 2004, J CELL BIOCHEM, V91, P686, DOI 10.1002/jcb.10702; FARAWAY JJ, 2006, EXTENDING LINEAR MOD, V1; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gotte A, 2005, ADV OTO-RHINO-LARYNG, V62, P38; GREEN FL, 1997, AJCC CANC STAGING MA; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Horvath B, 2005, HEAD NECK-J SCI SPEC, V27, P585, DOI 10.1002/hed.20188; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Leng K, 2006, J ORAL PATHOL MED, V35, P19, DOI 10.1111/j.1600-0714.2005.00365.x; Marsh DJ, 1997, CANCER RES, V57, P500; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Riccil F, 2005, CANCER BIOL THER, V4, P302, DOI 10.4161/cbt.4.3.1501; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; Rosenthal E, 2004, MOL CARCINOGEN, V40, P116, DOI 10.1002/mc.20024; Slager SL, 2003, AM J HUM GENET, V72, P759, DOI 10.1086/368230; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tran Y, 1998, ONCOGENE, V17, P3499, DOI 10.1038/sj.onc.1202258; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Williams HK, 2000, J CLIN PATHOL-MOL PA, V53, P165, DOI 10.1136/mp.53.4.165; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Worsham MJ, 2006, ARCH OTOLARYNGOL, V132, P409, DOI 10.1001/archotol.132.4.409; XU Y, 2005, C NONP INF PROB APPL	51	71	74	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					187	195		10.1001/jama.297.2.187	http://dx.doi.org/10.1001/jama.297.2.187			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213402	Bronze			2022-12-24	WOS:000243355900028
J	Ribeil, JA; Zermati, Y; Vandekerckhove, J; Cathelin, S; Kersual, J; Dussiot, M; Coulon, S; Moura, IC; Zeuner, A; Kirkegaard-Sorensen, T; Varet, B; Solary, E; Garrido, C; Hermine, O				Ribeil, Jean-Antoine; Zermati, Yael; Vandekerckhove, Julie; Cathelin, Severine; Kersual, Joelle; Dussiot, Michael; Coulon, Severine; Moura, Ivan Cruz; Zeuner, Ann; Kirkegaard-Sorensen, Thomas; Varet, Bruno; Solary, Eric; Garrido, Carmen; Hermine, Olivier			Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; NEGATIVE REGULATION; CASPASE ACTIVATION; APAF-1 APOPTOSOME; CELL-SURVIVAL; CYTOCHROME-C; MATURATION; PROLIFERATION; PROGENITORS	Caspase-3 is activated during both terminal differentiation and erythropoietin-starvation-induced apoptosis of human erythroid precursors. The transcription factor GATA-1, which performs an essential function in erythroid differentiation(1,2) by positively regulating promoters of erythroid and anti-apoptotic genes(3-6), is cleaved by caspases in erythroid precursors undergoing cell death upon erythropoietin starvation or engagement of the death receptor Fas(7,8). In contrast, by an unknown mechanism, GATA-1 remains uncleaved when these cells undergo terminal differentiation upon stimulation with Epo(9-11). Here we show that during differentiation, but not during apoptosis, the chaperone protein Hsp70 protects GATA-1 fromcaspase-mediated proteolysis. At the onset of caspase activation, Hsp70 co-localizes and interacts with GATA-1 in the nucleus of erythroid precursors undergoing terminal differentiation. In contrast, erythropoietin starvation induces the nuclear export of Hsp70 and the cleavage of GATA-1. In an in vitro assay, Hsp70 protects GATA-1 from caspase-3-mediated proteolysis through its peptide-binding domain. The use of RNA-mediated interference to decrease the Hsp70 content of erythroid precursors cultured in the presence of erythropoietin leads to GATA-1 cleavage, a decrease in haemoglobin content, downregulation of the expression of the anti-apoptotic protein Bcl-X-L, and cell death by apoptosis. These effects are abrogated by the transduction of a caspase-resistant GATA-1 mutant. Thus, in erythroid precursors undergoing terminal differentiation, Hsp70 prevents active caspase-3 from cleaving GATA-1 and inducing apoptosis.	Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France; INSERM, UMR 517, F-21079 Dijon, France; Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; Danish Canc Soc, Inst Canc Biol, Dept Apoptosis, DK-2100 Copenhagen, Denmark; Univ Paris 05, Assistance Publ Hop Paris, F-75270 Paris, France; Fac Med, Dept Hematol, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Superiore di Sanita (ISS); Danish Cancer Society; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hermine, O (corresponding author), Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France.	zermati@igr.fr; hermine@necker.fr	Ribeil, Jean-Antoine/F-7896-2017; Ribeil, Jean-Antoine/AAK-7979-2020; Garrido, carmen/G-1633-2018; Zeuner, Ann/K-8607-2016; Garrido, Carolina/GWM-5557-2022; Hermine, Olivier/Q-7072-2018; Moura, Ivan C/A-9510-2013; Zeuner, Ann/A-8529-2010; Cruz Moura, Ivan/A-9510-2013	Ribeil, Jean-Antoine/0000-0002-5733-9123; Ribeil, Jean-Antoine/0000-0002-4549-4783; Garrido, carmen/0000-0003-1368-1493; Moura, Ivan C/0000-0002-2977-0354; Zeuner, Ann/0000-0002-8295-3715; Solary, Eric/0000-0002-8629-1341; Hermine, Olivier/0000-0003-2574-3874; Cruz Moura, Ivan/0000-0002-8418-2803				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WINNING RS, 1988, DEV BIOL, V128, P111, DOI 10.1016/0012-1606(88)90272-2; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	24	202	216	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					102	105		10.1038/nature05378	http://dx.doi.org/10.1038/nature05378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167422				2022-12-24	WOS:000243225100044
J	Bethard, S				Bethard, Suzanne			Taking my poison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sbethard@stanford.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2657	2658		10.1001/jama.296.22.2657	http://dx.doi.org/10.1001/jama.296.22.2657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164443				2022-12-24	WOS:000242765700001
J	Erkko, H; Xia, B; Nikkilae, J; Schleutker, J; Syrjaekoski, K; Mannermaa, A; Kallioniemi, A; Pylkas, K; Karppinen, SM; Rapakko, K; Miron, A; Sheng, Q; Li, GL; Mattila, H; Bell, DW; Haber, DA; Grip, M; Reiman, M; Jukkola-Vuorinen, A; Mustonen, A; Kere, J; Aaltonen, LA; Kosma, VM; Kataja, V; Soini, Y; Drapkin, RI; Livingston, DM; Winqvist, R				Erkko, Hannele; Xia, Bing; Nikkilae, Jenni; Schleutker, Johanna; Syrjaekoski, Kirsi; Mannermaa, Arto; Kallioniemi, Anne; Pylkas, Katri; Karppinen, Sanna-Maria; Rapakko, Katrin; Miron, Alexander; Sheng, Qing; Li, Guilan; Mattila, Henna; Bell, Daphne W.; Haber, Daniel A.; Grip, Mervi; Reiman, Mervi; Jukkola-Vuorinen, Arja; Mustonen, Aki; Kere, Juha; Aaltonen, Lauri A.; Kosma, Veli-Matti; Kataja, Vesa; Soini, Ylermi; Drapkin, Ronny I.; Livingston, David M.; Winqvist, Robert			A recurrent mutation in PALB2 in Finnish cancer families	NATURE			English	Article							SENSITIVE GEL-ELECTROPHORESIS; BREAST; BRCA2	BRCA1, BRCA2 and other known susceptibility genes account for less than half of the detectable hereditary predisposition to breast cancer(1-3). Other relevant genes therefore remain to be discovered. Recently a new BRCA2-binding protein, PALB2, was identified(4). The BRCA2-PALB2 interaction is crucial for certain key BRCA2 DNA damage response functions as well as its tumour suppression activity(4). Here we show, by screening for PALB2 mutations in Finland that a frameshift mutation, c.1592delT, is present at significantly elevated frequency in familial breast cancer cases compared with ancestry-matched population controls. The truncated PALB2 protein caused by this mutation retained little BRCA2-binding capacity and was deficient in homologous recombination and crosslink repair. Further screening of c.1592delT in unselected breast cancer individuals revealed a roughly fourfold enrichment of this mutation in patients compared with controls. Most of the mutation-positive unselected cases had a familial pattern of disease development. In addition, one multigenerational prostate cancer family that segregated the c.1592delT truncation allele was observed. These results indicate that PALB2 is a breast cancer susceptibility gene that, in a suitably mutant form, may also contribute to familial prostate cancer development.	Univ Kuopio, Inst Clin Med, FIN-70211 Kuopio, Finland; Karolinska Inst, Dept Biosci, SE-17177 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, SE-17177 Huddinge, Sweden; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Kuopio Univ Hosp, Dept Clin Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70211 Kuopio, Finland; Univ Tampere, Inst Med technol, Canc Genet Lab, FIN-33520 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Oulu Univ Hosp, FIN-90029 OYS, Finland; Univ Oulu, Dept Pathol, Oulu, Finland; Univ Oulu, Dept Oncol, Oulu, Finland; Univ Oulu, Dept Surg, Oulu, Finland; Univ Oulu, Dept Clin Genet, Oulu, Finland	University of Eastern Finland; Karolinska Institutet; Karolinska Institutet; University of Helsinki; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; Tampere University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Winqvist, R (corresponding author), Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland.	david_livingston@dfci.harvard.edu; robert.winqvist@oulu.fi	Aaltonen, Lauri/A-5375-2010; Drapkin, Ronny/E-9944-2016; Kere, Juha/AAX-9117-2021; xin, xp/C-7350-2009; Kere, Juha/A-9179-2008	Aaltonen, Lauri/0000-0001-6839-4286; Drapkin, Ronny/0000-0002-6912-6977; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Kataja, Vesa/0000-0003-4846-4843; Winqvist, Robert/0000-0003-0932-9104; Schleutker, Johanna/0000-0002-1863-0305; Pylkas, Katri/0000-0002-2449-0521; Kallioniemi, Anne/0000-0003-3552-8158; Karppinen, Sanna/0000-0001-6233-9075				Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Borg A, 2001, SEMIN CANCER BIOL, V11, P375, DOI 10.1006/scbi.2001.0393; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	16	339	348	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					316	319		10.1038/nature05609	http://dx.doi.org/10.1038/nature05609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17287723				2022-12-24	WOS:000244892900045
J	Hinson, JT; Fantin, VR; Schonberger, J; Breivik, N; Siem, G; McDonough, B; Sharma, P; Keogh, I; Godinho, R; Santos, F; Esparza, A; Nicolau, Y; Selvaag, E; Cohen, BH; Hoppel, CL; Tranebjaerg, L; Eavey, RD; Seidman, JG; Seidman, CE				Hinson, J. Travis; Fantin, Valeria R.; Schoenberger, Jost; Breivik, Noralv; Siem, Geir; McDonough, Barbara; Sharma, Pankaj; Keogh, Ivan; Godinho, Ricardo; Santos, Felipe; Esparza, Alfonso; Nicolau, Yamileth; Selvaag, Edgar; Cohen, Bruce H.; Hoppel, Charles L.; Tranebjaerg, Lisbeth; Eavey, Roland D.; Seidman, J. G.; Seidman, Christine E.			Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; SENSORINEURAL HEARING-LOSS; LETHAL METABOLIC-DISORDER; PILI TORTI; GRACILE SYNDROME; IRON OVERLOAD; PROTEIN; COMPLEX; MEMBRANE; DISEASE	Background: The Bjornstad syndrome, an autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by mutation of a previously unidentified gene on chromosome 2q34-36. Methods: Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and D2S2244 revealed BCS1L mutations. Functional analyses elucidated how BCS1L mutations cause the Bjornstad syndrome. Results: BCS1L encodes a member of the AAA family of ATPases that is necessary for the assembly of complex III in the mitochondria. In addition to the Bjornstad syndrome, BCS1L mutations cause complex III deficiency and the GRACILE syndrome, which in neonates are lethal conditions that have multisystem and neurologic manifestations typifying severe mitochondrial disorders. Patients with the Bjornstad syndrome have mutations that alter residues involved in protein-protein interactions, whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from the crystal structure of a related AAA-family ATPase. Biochemical studies provided evidence to support this model: complex III deficiency mutations prevented ATP-dependent assembly of BCS1L-associated complexes. All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species. However, only mutations associated with complex III deficiency increased mitochondrial content, which further increased the production of reactive oxygen species. Conclusions: BCS1L mutations cause disease phenotypes ranging from highly restricted pili torti and sensorineural hearing loss (the Bjornstad syndrome) to profound multisystem organ failure (complex III deficiency and the GRACILE syndrome). All BCS1L mutations disrupted the assembly of mitochondrial respirasomes (the basic unit for respiration in human mitochondria), but the clinical expression of the mutations was correlated with the production of reactive oxygen species. Mutations that cause the Bjornstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Wurzburg, Wurzburg, Germany; Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; Aalesund Hosp, Alesund, Norway; Hammersmith Hosp, London, England; Univ London Imperial Coll Sci Technol & Med, London, England; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Pontificia Univ Catholica Minas Gerais, Belo Horizonte, MG, Brazil; Univ Washington, Seattle, WA 98195 USA; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Cleveland Clin, Brain Tumor Inst, Cleveland, OH 44106 USA; Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA; Univ Copenhagen, Inst Med Biochem & Genet, Copenhagen, Denmark; Univ Tromso Hosp, N-9012 Tromso, Norway	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wurzburg; Imperial College London; Imperial College London; Harvard University; Massachusetts Eye & Ear Infirmary; Pontificia Universidade Catolica de Minas Gerais; University of Washington; University of Washington Seattle; University of Copenhagen; Bispebjerg Hospital; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Copenhagen; UiT The Arctic University of Tromso; University Hospital of North Norway	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Room 256 NRB,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	sharma, pankaj/HGE-4423-2022; KEOGH, IVAN J/M-2704-2016	KEOGH, IVAN J/0000-0001-6358-6377; Santos, Felipe/0000-0002-3523-665X				Armstrong JS, 2004, J BIOL CHEM, V279, P50420, DOI 10.1074/jbc.M408882200; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; *CEL GEN, 2005, CEL DISC SYST; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HILL JE, 1986, YEAST, V2, P13; KREGEL KC, IN PRESS AM J PHYSL; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; *NAT HUM GEN RES I, 2005, DBSNP DAT SINGL NUCL; Neto JFL, 1998, AM J HUM GENET, V62, P1107, DOI 10.1086/301837; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Ronchese F, 1932, ARCH DERMATOL SYPH, V26, P98, DOI 10.1001/archderm.1932.01450030101015; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Selvaag E, 2000, EUR J DERMATOL, V10, P91; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; WALKER B, 1994, PROTEIN ENG, V7, P91, DOI 10.1093/protein/7.1.91; Wenchich L, 2003, PHYSIOL RES, V52, P781; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	33	135	143	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					809	819		10.1056/NEJMoa055262	http://dx.doi.org/10.1056/NEJMoa055262			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314340				2022-12-24	WOS:000244326700007
J	Tyson, JJ				Tyson, John J.			Bringing cartoons to life	NATURE			English	Editorial Material									Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tyson, JJ (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.		Tyson, John J/A-2942-2014	Tyson, John J/0000-0001-7560-6013				Goldbeter A., 1996, BIOCH OSCILLATIONS C; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016	4	21	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					823	823		10.1038/445823a	http://dx.doi.org/10.1038/445823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314960				2022-12-24	WOS:000244341200024
J	Prytkova, TR; Kurnikov, IV; Beratan, DN				Prytkova, Tatiana R.; Kurnikov, Igor V.; Beratan, David N.			Coupling coherence distinguishes structure sensitivity in protein electron transfer	SCIENCE			English	Article							TRANSFER RATES; BIOLOGICAL MOLECULES; TRANSFER PATHWAYS; DYNAMICS; INTERFERENCE; INTERFACE; MEDIA	Quantum mechanical analysis of electron tunneling in nine thermally fluctuating cytochrome b(562) derivatives reveals two distinct protein-mediated coupling limits. A structure-insensitive regime arises for redox partners coupled through dynamically averaged multiple-coupling pathways (in seven of the nine derivatives) where heme-edge coupling leads to the multiple-pathway regime. A structure-dependent limit governs redox partners coupled through a dominant pathway (in two of the nine derivatives) where axial-ligand coupling generates the single-pathway limit and slower rates. This two-regime paradigm provides a unified description of electron transfer rates in 26 ruthenium-modified heme and blue-copper proteins, as well as in numerous photosynthetic proteins.	Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA	Duke University	Beratan, DN (corresponding author), Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA.	david.beratan@duke.edu	Beratan, David N/C-5098-2011	Beratan, David N/0000-0003-4758-8676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Babini E, 2000, J AM CHEM SOC, V122, P4532, DOI 10.1021/ja994472t; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Hoffman BM, 2005, P NATL ACAD SCI USA, V102, P3564, DOI 10.1073/pnas.0408767102; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Improta R, 2006, CHEMPHYSCHEM, V7, P1211, DOI 10.1002/cphc.200600069; Jones ML, 2002, J PHYS CHEM A, V106, P2002, DOI 10.1021/jp0133743; Kang SA, 2005, P NATL ACAD SCI USA, V102, P15465, DOI 10.1073/pnas.0505176102; Kawatsu T, 2002, J PHYS CHEM B, V106, P11356, DOI 10.1021/jp026035y; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCLENDON G, 1992, CHEM REV, V92, P481, DOI 10.1021/cr00011a007; Nishioka H, 2005, J PHYS CHEM B, V109, P1978, DOI 10.1021/jp046282x; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Prytkova TR, 2007, P NATL ACAD SCI USA, V104, P802, DOI 10.1073/pnas.0605319104; Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491; Ramirez BE, 1995, P NATL ACAD SCI USA, V92, P11949, DOI 10.1073/pnas.92.26.11949; Regan JJ, 1999, ADV CHEM PHYS, V107, P497; Skourtis SS, 1999, ADV CHEM PHYS, V106, P377, DOI 10.1002/9780470141656.ch8; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; STUCHEBRUKHOV AA, 1995, J PHYS CHEM-US, V99, P7581, DOI 10.1021/j100019a044; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Troisi A, 2003, J CHEM PHYS, V119, P5782, DOI 10.1063/1.1601600; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Winkler JR, 1999, PURE APPL CHEM, V71, P1753, DOI 10.1351/pac199971091753; Zheng YJ, 2003, J PHYS CHEM B, V107, P7288, DOI 10.1021/jp027092u; [No title captured]	33	158	159	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					622	625		10.1126/science.1134862	http://dx.doi.org/10.1126/science.1134862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272715	Green Accepted, Green Published			2022-12-24	WOS:000243909400036
J	Guo, DG; Tan, YC; Wang, DW; Madhusoodanan, KS; Zheng, Y; Maack, T; Zhang, JJ; Huang, XY				Guo, Dagang; Tan, Ying-cai; Wang, Dawei; Madhusoodanan, K. S.; Zheng, Yi; Maack, Thomas; Zhang, J. Jillian; Huang, Xin-Yun			A Rac-cGMP signaling pathway	CELL			English	Article							GUANYLATE-CYCLASE ACTIVITY; CYCLIC-GMP; KINASE; ACTIVATION; GROWTH; PAK1; MEMBRANE; RECEPTOR; COMPLEX; ORGANIZATION	The small GTPase Rac and the second messenger cGMP (guanosine 3',5'-cyclic monophosphate) are critical regulators of diverse cell functions. When activated by extracellular signals via membrane signaling receptors, Rac executes its functions through engaging downstream effectors such as p21-activated kinase (PAK), a serine/threonine protein kinase. However, the molecular mechanism by which membrane signaling receptors regulate cGMP levels is not known. Here we have uncovered a signaling pathway linking Rac to the increase of cellular cGMP. We show that Rac uses PAK to directly activate transmembrane guanylyl cyclases (GCs), leading to increased cellular cGMP levels. This Rac/PAK/GC/cGMP pathway is involved in platelet-derived growth factor-induced fibroblast cell migration and lamellipodium formation. Our findings connect two important regulators of cellular physiological functions and provide a general mechanism for diverse receptors to modulate physiological responses through elevating cellular cGMP levels.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; Univ Cincinnati, Childrens Hosp, Res Fdn, Div Expt Hematol, Cincinnati, OH 45229 USA	Cornell University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu	Maack, Thomas/AAN-7878-2020; Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIA NIH HHS [AG23202, R01 AG023202, AG14563, R01 AG014563] Funding Source: Medline; NIGMS NIH HHS [R01 GM084191, R01 GM056904, GM56904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904, R01GM084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023202, R01AG014563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; BENTLEY JK, 1986, CELL, V45, P281, DOI 10.1016/0092-8674(86)90392-2; Birnby DA, 2000, GENETICS, V155, P85; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; COFFEY RG, 1988, J IMMUNOL, V140, P2695; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; ESTENSEN RD, 1973, NATURE, V245, P458, DOI 10.1038/245458a0; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hou YL, 2004, CELL SIGNAL, V16, P1061, DOI 10.1016/j.cellsig.2004.03.002; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Lucas KA, 2000, PHARMACOL REV, V52, P375; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MANEER E, 1997, MOL CELL BIOL, V17, P1129; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; SCHEVING LA, 1985, ENDOCRINOLOGY, V116, P332, DOI 10.1210/endo-116-1-332; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schmidt H, 2002, J CELL BIOL, V159, P489, DOI 10.1083/jcb.200207058; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	81	87	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					341	355		10.1016/j.cell.2006.11.048	http://dx.doi.org/10.1016/j.cell.2006.11.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254971	Green Accepted, Bronze			2022-12-24	WOS:000244420500018
J	Braiteh, F; Cohen, PR; Kurzrock, R				Braiteh, Fadi; Cohen, Philip R.; Kurzrock, Razelle			CAT scan reveals BAT sign	LANCET			English	Editorial Material									Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase Program 1, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Dermatol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Braiteh, F (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Phase Program 1, 1515 Holcombe Blvd, Houston, TX 77030 USA.	fbraiteh@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020					[Anonymous], 2005, GRAYS ANATOMY ANATOM, V39th; Rogers LF, 2003, AM J ROENTGENOL, V180, P1501, DOI 10.2214/ajr.180.6.1801501	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					217	217		10.1016/S0140-6736(07)60110-X	http://dx.doi.org/10.1016/S0140-6736(07)60110-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240288				2022-12-24	WOS:000243692400030
J	Wolfson, LJ; Strebel, PM; Gacic-Dobo, M; Hoekstra, EJ; McFarland, JW; Hersh, BS				Wolfson, Lara J.; Strebel, Peter M.; Gacic-Dobo, Marta; Hoekstra, Edward J.; McFarland, Jeffrey W.; Hersh, Bradley S.		Measles Initiative	Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study	LANCET			English	Article							UPPER RIVER DIVISION; CHILD-MORTALITY; RESPIRATORY-INFECTIONS; VACCINATION CAMPAIGN; CASE-FATALITY; RURAL AREA; DEATHS; ERADICATION; COMMUNITY; OUTBREAK	Background In 2002, the UN General Assembly Special Session on Children adopted a goal to reduce deaths owing to measles by half by the end of 2005, compared with 1999 estimates. We describe efforts and progress made towards this goal. Methods We assessed trends in immunisation against measles on the basis of national implementation of the WHO/UNICEF comprehensive strategy for measles mortality reduction, and the provision of a second opportunity for measles immunisation. We used a natural history model to evaluate trends in mortality due to measles. Results Between 1999 and 2005, according to our model mortality owing to measles was reduced by 60%, from an estimated 873 000 deaths (uncertainty bounds 634000-1140 000) in 1999 to 345 000 deaths (247 000-458 000) in 2005. The largest percentage reduction in estimated measles mortality during this period was in the western Pacific region (81%), followed by Africa (75%) and the eastern Mediterranean region (62%). Africa achieved the largest total reduction, contributing 72% of the global reduction in measles mortality. Nearly 7.5 million deaths from measles were prevented through immunisation between 1999 and 2005, with supplemental immunisation activities and improved routine immunisation accounting for 2.3 million of these prevented deaths. Interpretation The achievement of the 2005 global measles mortality reduction goal is evidence of what can be accomplished for child survival in countries with high childhood mortality when safe, cost-effective, and affordable interventions are backed by country-level political commitment and an effective international partnership.	WHO, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland; WHO, Dept Immunisat Vaccines & Biol, CH-1211 Geneva 27, Switzerland; UNICEF, New York, NY USA; US Ctr Dis Control & Prevent, Phnom Penh, Cambodia	World Health Organization; World Health Organization; UNICEF	Wolfson, LJ (corresponding author), WHO, Initiat Vaccine Res, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	wolfsonl@who.int	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368				ANDERSON R M, 1991; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P130; Antunes JLF, 2002, B WORLD HEALTH ORGAN, V80, P391; ASSAAD F, 1983, REV INFECT DIS, V5, P452; ATKINSON WL, 1991, SEMIN PEDIATR INFECT, V2, P100; Awasthi Shally, 1996, Indian Journal of Pediatrics, V63, P363, DOI 10.1007/BF02751529; BAGENHOLM GC, 1989, ANN TROP PAEDIATR, V9, P75, DOI 10.1080/02724936.1989.11748602; BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Baqui AH, 2001, ACTA PAEDIATR, V90, P682, DOI 10.1080/080352501750258775; BARCLAY AJG, 1987, BMJ-BRIT MED J, V294, P296; BARKIN RM, 1975, AM J EPIDEMIOL, V102, P341, DOI 10.1093/oxfordjournals.aje.a112170; BHATIA S, 1989, STUD FAMILY PLANN, V20, P136, DOI 10.2307/1966568; BHUIYA A, 1987, SOC SCI MED, V24, P439, DOI 10.1016/0277-9536(87)90217-6; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; BLACK FL, 1959, J IMMUNOL, V83, P74; Brenzel L, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P389; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BURSTROM B, 1993, SCAND J INFECT DIS, V25, P763, DOI 10.3109/00365549309008576; CHEN RT, 1994, INT J EPIDEMIOL, V23, P185, DOI 10.1093/ije/23.1.185; CHOUDHARY S R, 1989, Indian Pediatrics, V26, P544; Christensen R., 1990, LOG LINEAR MODELS; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; Clements C. J., 2004, GLOBAL EPIDEMIOLOGY; CUTTS FT, 1995, BIOLOGICALS, V23, P95; de Quadros CA, 2004, B WORLD HEALTH ORGAN, V82, P134; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; DEFRANCISCO A, 1993, ANN TROP PAEDIATR, V13, P345, DOI 10.1080/02724936.1993.11747669; degli Atti MLC, 2006, VACCINE, V24, P1332, DOI 10.1016/j.vaccine.2005.09.031; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; EKANEM EE, 1994, TROP GEOGR MED, V46, P305; FAUVEAU V, 1991, INT J EPIDEMIOL, V20, P729, DOI 10.1093/ije/20.3.729; *GAVI, IFFIM PROGR OV; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; Gounder C, 1998, HEALTH POLICY PLANN, V13, P212, DOI 10.1093/heapol/13.3.212; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; HAMMERSLEY J.M., 1964, MONTE CARLO METHODS; Hedrich AW, 1933, AM J HYG, V17, P613, DOI 10.1093/oxfordjournals.aje.a117929; Henao-Restrepo AM, 2003, J INFECT DIS, V187, pS15, DOI 10.1086/368273; HETHCOTE HW, 1995, MODELS INFECTIOUS HU, P215; HINMAN AR, 1982, REV INFECT DIS, V4, P933; Hirve S, 1997, Indian Pediatr, V34, P995; Hodges M, 1998, West Afr J Med, V17, P95; HOPKINS DR, 1982, LANCET, V1, P1396; Hussain A, 1999, TROP MED INT HEALTH, V4, P758, DOI 10.1046/j.1365-3156.1999.00485.x; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kabir Z, 2002, J TROP PEDIATRICS, V48, P178, DOI 10.1093/tropej/48.3.178; Kadane JB, 1998, J ROY STAT SOC D-STA, V47, P3; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; KHAN AJ, 1990, B WORLD HEALTH ORGAN, V68, P577; LANGMUIR AD, 1962, AM J DIS CHILD, V103, P224, DOI 10.1001/archpedi.1962.02080020236005; Lindsey J.K., 2000, APPL GEN LINEAR MODE; McCullagh P, 1989, GEN LINEAR MODELS; *MEASL PARTN, 2005, MEASL INV CAS 2; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; MIRZA NM, 1990, E AFR MED J, V67, P823; MOLBAK K, 1992, T ROY SOC TROP MED H, V86, P216, DOI 10.1016/0035-9203(92)90580-6; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; *PAHO, 2005, SCI TECHN PUBL PAHO, V605; PANDEY MR, 1991, LANCET, V338, P993, DOI 10.1016/0140-6736(91)91847-N; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; PISON G, 1993, INT J EPIDEMIOL, V22, P72, DOI 10.1093/ije/22.1.72; PREBLUD SR, 1982, JAMA-J AM MED ASSOC, V247, P1134, DOI 10.1001/jama.247.8.1134; Reddaiah V. P., 1992, Indian Journal of Pediatrics, V59, P567, DOI 10.1007/BF02832992; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Samb B, 1997, AM J EPIDEMIOL, V145, P51, DOI 10.1093/oxfordjournals.aje.a009031; SHAMEBO D, 1991, J TROP PEDIATRICS, V37, P254, DOI 10.1093/tropej/37.5.254; Slutsker L, 1996, AM J TROP MED HYG, V55, P77, DOI 10.4269/ajtmh.1996.55.77; SMEDMAN L, 1986, ANN TROP PAEDIATR, V6, P67, DOI 10.1080/02724936.1986.11748414; SNYDER MJ, 1962, AM J DIS CHILD, V103, P250, DOI 10.1001/archpedi.1962.02080020262012; SPENCER H C, 1987, Annals of Tropical Medicine and Parasitology, V81, P36; SPIKA JS, 1989, ANN TROP PAEDIATR, V9, P33, DOI 10.1080/02724936.1989.11748592; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Stittelaar Koert J, 2002, Expert Rev Vaccines, V1, P151, DOI 10.1586/14760584.1.2.151; Strebel P, 2003, J INFECT DIS, V187, pS1, DOI 10.1086/368226; SUTRISNA B, 1993, LANCET, V342, P787, DOI 10.1016/0140-6736(93)91545-W; UN, MILL DEV GOALS; UNICEF, 2002, WORLD FIT CHILDR; UNPD, 2005, WORLD POP PROSP 2004; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; *WHO, 1974, HDB RES, V1, P1; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P365; *WHO, 2003, 5220 WHO; *WHO, 2002, STAT WORLDS VACC IMM; *WHO, 2005, WHO VACC PREV DIS MO; *WHO UNICEF, 2005, GLOB IMM VIS STRAT; WHO (World Health Organization), 2004, WKLY EPIDEMIOL REC; World Health Organization, MEASL REP CAS; World Health Organization, WHO UNICEF EST NAT I; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization United Nations Children's Fund, 2001, MEASL MORT RED REG E; Yameogo KR, 2005, INT J EPIDEMIOL, V34, P556, DOI 10.1093/ije/dyi001	98	180	189	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2007	369	9557					191	200		10.1016/S0140-6736(07)60107-X	http://dx.doi.org/10.1016/S0140-6736(07)60107-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240285				2022-12-24	WOS:000243692400027
J	Lohse, N; Hansen, ABE; Pedersen, G; Kronborg, G; Gerstoft, J; Sorensen, HT; Vaeth, M; Obel, N				Lohse, Nicolai; Hansen, Ann-Brit Eg; Pedersen, Gitte; Kronborg, Gifte; Gerstoft, Jan; Sorensen, Henrik Toft; Vaeth, Michael; Obel, Niels			Survival of persons with and without HIV infection in Denmark, 1995-2005	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; GENERAL-POPULATION; COHORT; INDIVIDUALS; DEMOGRAPHICS; EUROSIDA; DEATH; RISK	Background: The expected survival of HIV-infected patients is of major public health interest. Objective: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. Design: Population-based cohort study. Setting: All HIV-infected persons receiving care in Denmark from 1995 to 2005. Patients: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. Measurements: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. Results: 3990 HIV-infected patients and 379 872 persons from the general population were included in the study, yielding 22 744 (median, 5.8 y/person) and 2 689 287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. Limitations: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. Conclusions: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.	Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark; Univ So Denmark, Odense, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Univ Aarhus, Aarhus, Denmark; Hvidovre Univ Hosp, Hvidovre, Denmark; Rigshosp, DK-2100 Copenhagen, Denmark; Boston Univ, Boston, MA 02215 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Aarhus University; University of Copenhagen; Rigshospitalet; University of Copenhagen; Boston University	Lohse, N (corresponding author), Odense Univ Hosp, Dept Infect Dis, Sdr Blvd 29, DK-5000 Odense C, Denmark.	nl@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Kronborg, Gitte/E-4757-2010; Lohse, Nicolai/ABE-5884-2020; Hansen, Ann-Brit/ABA-1921-2020; Vaeth, Michael/T-6882-2017	Sorensen, Henrik Toft/0000-0003-4299-7040; Vaeth, Michael/0000-0002-0134-5006; Lohse, Nicolai/0000-0001-8403-8759; Hansen, Ann-Brit Eg/0000-0003-4228-3822				Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Christensen P B, 1998, Ugeskr Laeger, V160, P3529; Dorrucci M, 2005, AIDS, V19, P331; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Jaggy C, 2003, LANCET, V362, P877, DOI 10.1016/S0140-6736(03)14307-3; Jensen-Fangel S, 2004, AIDS, V18, P89, DOI 10.1097/00002030-200401020-00011; Jensen-Fangel S, 2001, SCAND J INFECT DIS, V33, P765, DOI 10.1080/003655401317074590; Keiser O, 2004, AIDS, V18, P1835, DOI 10.1097/00002030-200409030-00013; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; Lohse N, 2005, AIDS, V19, P815, DOI 10.1097/01.aids.0000168976.51843.9f; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lohse N, 2004, SCAND J INFECT DIS, V36, P738, DOI 10.1080/00365540410020974a; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; *NAT CTR HLTH STAT, 2002, UN STAT LIF TABL; Press N, 2002, JAIDS-J ACQ IMM DEF, V31, pS112, DOI 10.1097/00126334-200212153-00005; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; van Sighem A, 2005, JAIDS-J ACQ IMM DEF, V40, P212, DOI 10.1097/01.qai.0000165911.97085.d0; Zwahlen M, 2005, INT J EPIDEMIOL, V34, P130, DOI 10.1093/ije./dyh402	21	561	589	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					87	95		10.7326/0003-4819-146-2-200701160-00003	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227932				2022-12-24	WOS:000243901000002
J	Wilcken, B; Haas, M; Joy, P; Wiley, V; Chaplin, M; Black, C; Fletcher, J; McGill, J; Boneh, A				Wilcken, Bridget; Haas, Marion; Joy, Pamela; Wiley, Veronica; Chaplin, Meredyth; Black, Carly; Fletcher, Janice; McGill, Jim; Boneh, Avihu			Outcome of neonatal screening for medium-chain aryl-CoA dehydrogenase deficiency in Australia: a cohort study	LANCET			English	Article							TANDEM MASS-SPECTROMETRY; INBORN-ERRORS; CLINICAL SYMPTOMS; METABOLISM; MUTATION; IDENTIFICATION; POPULATION; EXPERIENCE; NEWBORNS	Background Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the disorder thought most to justify neonatal screening by tandem-mass spectrometry because, without screening, there seems to be substantial morbidity and mortality. Our aim was to assess the overall effectiveness of neonatal screening for MCAD deficiency in Australia. Methods We identified MCAD-deficient patients from a total population of 2495000 Australian neonates (810000 screened) born between April 1, 1994, and March 31, 2004. Those from a cohort of 1995000 (460000 screened) were followed up for at least 4 years, and we recorded number of deaths and severe episodes, medical and neuropsychological outcome, and hospital admissions within the screened and unscreened groups. Findings In cohorts aged at least 4 years there were 35 MCAD-deficient patients in those not screened (2.28 per 100 000 total population) and 24 in the screened population (5.2 per 100000). We estimated that patients with this disorder in the unscreened cohort remained undiagnosed. Before 4 years of age, three screened patients had an episode of severe decompensation (including one neonatal death) versus 23 unscreened patients (including five deaths). At the most conservative estimate, relative risk of an adverse event was 0.44 (95% CI 0.13-1.45). In the larger cohort the relative risk (screened vs unscreened) of an adverse event by age 2 years was 0.26 (95% CI 0.07-0.97), also a conservative estimate. 38 of 52 living patients had neuropsychological testing, with no suggestions of significant differences in general cognitive outcome between the groups. Interpretation Screening is effective in patients with MCAD deficiency since early diagnosis reduces deaths and severe adverse events in children up to the age of 4 years.	Childrens Hosp Westmead, Westmead, NSW 2145, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia; Womens & Childrens Hosp, Adelaide, SA, Australia; Royal Childrens Hosp, Brisbane, Qld, Australia; Univ Melbourne, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic, Australia	University of Sydney; University of Sydney; University of Technology Sydney; Womens & Childrens Hospital Australia; Royal Children's Hospital Brisbane; University of Melbourne; Murdoch Children's Research Institute	Wilcken, B (corresponding author), Childrens Hosp Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.	bridgetw@chw.edu.au	Haas, Marion Ruth/H-2732-2017					Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Derks TGJ, 2006, J PEDIATR-US, V148, P665, DOI 10.1016/j.jpeds.2005.12.028; Dezateux C, 2003, EUR J PEDIATR, V162, pS25, DOI 10.1007/s00431-003-1346-0; Ensenauer R, 2005, GENET MED, V7, P339, DOI 10.1097/01.GIM.0000164548.54482.9D; Frazier DM, 2006, J INHERIT METAB DIS, V29, P76, DOI 10.1007/s10545-006-0228-9; Grosse SD, 2006, GENET MED, V8, P205, DOI 10.1097/01.gim.0000204472.25153.8d; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; *MAT CHILD HLTH BU, 2005, NEWB SCREEN UN SCREE; MATSUBARA Y, 1991, LANCET, V338, P552, DOI 10.1016/0140-6736(91)91110-G; Nennstiel-Ratzel U, 2005, MOL GENET METAB, V85, P157, DOI 10.1016/j.ymgme.2004.12.010; Pandor A, 2004, HEALTH TECHNOL ASSES, V8, P1; Pollitt RI, 1997, HEALTH TECHNOL ASSES, V1, pi; Pollitt RJ, 1998, ARCH DIS CHILD, V79, P116, DOI 10.1136/adc.79.2.116; Pourfarzam M, 2001, LANCET, V358, P1063, DOI 10.1016/S0140-6736(01)06199-2; ROE CR, 2005, METABOLIC MOL BASES, P2297; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; SEYMOUR CA, 2001, HEALTH TECHNOL ASSES, V1, P23; Sparrow S., 2016, VINELAND ADAPTIVE BE; Tanaka K., 1992, Human Mutation, V1, P271, DOI 10.1002/humu.1380010402; TOUMA EH, 1992, ARCH DIS CHILD, V67, P142, DOI 10.1136/adc.67.1.142; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Waisbren SE, 2002, J INHERIT METAB DIS, V25, P599, DOI 10.1023/A:1022003726224; WILCKEN B, 1994, ARCH DIS CHILD, V70, P410, DOI 10.1136/adc.70.5.410; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wiley V, 1999, ACTA PAEDIATR, V88, P48, DOI 10.1080/080352599750029376; Wilson CJ, 1999, ARCH DIS CHILD, V80, P459, DOI 10.1136/adc.80.5.459; Woodcock R. W., 2001, WOODCOCK JOHNSON; ZIADEH R, 1995, PEDIATR RES, V37, P675, DOI 10.1203/00006450-199505000-00021; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	30	117	120	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					37	42		10.1016/S0140-6736(07)60029-4	http://dx.doi.org/10.1016/S0140-6736(07)60029-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125AK	17208640				2022-12-24	WOS:000243413700027
J	Pasrija, S; Sharma, N				Pasrija, Shikha; Sharma, Nayantara			Images in clinical medicine: Benign diffuse breast hyperplasia during pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tagore Garden, New Delhi 110027, India		Pasrija, S (corresponding author), Tagore Garden, New Delhi 110027, India.	shikhapasrija@hotmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2771	2771		10.1056/NEJMicm040539	http://dx.doi.org/10.1056/NEJMicm040539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192543				2022-12-24	WOS:000243110500010
J	Yang, YX; Lewis, JD; Epstein, S; Metz, DC				Yang, Yu-Xiao; Lewis, James D.; Epstein, Solomon; Metz, David C.			Long-term proton pump inhibitor therapy and risk of hip fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							L-LACTIC ACID; ORAL CORTICOSTEROIDS; CALCIUM-ABSORPTION; BONE-RESORPTION; K+-ATPASE; OMEPRAZOLE; OSTEOPOROSIS; POPULATION; H+; CARBONATE	Context Proton pump inhibitors (PPIs) may interfere with calcium absorption through induction of hypochlorhydria but they also may reduce bone resorption through inhibition of osteoclastic vacuolar proton pumps. Objective To determine the association between PPI therapy and risk of hip fracture. Design, Setting, and Patients A nested case-control study was conducted using the General Practice Research Database (1987-2003), which contains information on patients in the United Kingdom. The study cohort consisted of users of PPI therapy and nonusers of acid suppression drugs who were older than 50 years. Cases included all patients with an incident hip fracture. Controls were selected using incidence density sampling, matched for sex, index date, year of birth, and both calendar period and duration of up-to-standard follow-up before the index date. For comparison purposes, a similar nested case-control analysis for histamine 2 receptor antagonists was performed. Main Outcome Measure The risk of hip fractures associated with PPI use. Results There were 13 556 hip fracture cases and 135 386 controls. The adjusted odds ratio (AOR) for hip fracture associated with more than 1 year of PPI therapy was 1.44 (95% confidence interval [CI], 1.30-1.59). The risk of hip fracture was significantly increased among patients prescribed long-term high-dose PPIs ( AOR, 2.65; 95% CI, 1.80-3.90; P <. 001). The strength of the association increased with increasing duration of PPI therapy ( AOR for 1 year, 1.22 [ 95% CI, 1.15-1.30]; 2 years, 1.41 [ 95% CI, 1.28-1.56]; 3 years, 1.54 [ 95% CI, 1.37-1.73]; and 4 years, 1.59 [ 95% CI, 1.39-1.80]; P <. 001 for all comparisons). Conclusion Long-term PPI therapy, particularly at high doses, is associated with an increased risk of hip fracture.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA; Doylestown Hosp Res Ctr, Dept Med, Doylestown, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Yang, YX (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 722 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	yangy@mail.med.upenn.edu	yang, yx/GZM-0464-2022		NIDDK NIH HHS [K08 DK062978] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062978] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLINN GW, 1984, J CLIN INVEST, V73, P640, DOI 10.1172/JCI111254; Chonan O, 1998, J NUTR SCI VITAMINOL, V44, P473, DOI 10.3177/jnsv.44.473; Chonan O, 1998, J NUTR SCI VITAMINOL, V44, P869, DOI 10.3177/jnsv.44.869; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956; Dawson-Hughes B, 2002, OSTEOPOROSIS INT, V13, P657, DOI 10.1007/s001980200089; DONALDSON LJ, 1990, J EPIDEMIOL COMMUN H, V44, P241, DOI 10.1136/jech.44.3.241; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; GOERSS JB, 1992, J BONE MINER RES, V7, P573; Hollowell J, 1997, Popul Trends, P36; IVANOVIC.P, 1967, ANN INTERN MED, V66, P917, DOI 10.7326/0003-4819-66-5-917; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Johansson S, 2003, ALIMENT PHARM THER, V18, P973, DOI 10.1046/j.1365-2036.2003.01798.x; LANDAHL S, 1992, CLIN PHARMACOKINET, V23, P469, DOI 10.2165/00003088-199223060-00006; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; MIZUNASHI K, 1993, CALCIFIED TISSUE INT, V53, P21, DOI 10.1007/BF01352010; NILAS L, 1985, GUT, V26, P252, DOI 10.1136/gut.26.3.252; Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6; O'Connell MB, 2005, AM J MED, V118, P778, DOI 10.1016/j.amjmed.2005.02.007; *OFF NAT STAT, 1996, STUD MED POP SUBJ, V60; Perry J, 1978, OXMIS PROBLEM CODES; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476, DOI 10.7326/0003-4819-139-6-200309160-00010; SERFATYLACROSNIERE C, 1995, J AM COLL NUTR, V14, P364; SHEIKH MS, 1987, NEW ENGL J MED, V317, P532, DOI 10.1056/NEJM198708273170903; Shin JM, 2004, J AM CHEM SOC, V126, P7800, DOI 10.1021/ja049607w; TUUKKANEN J, 1986, CALCIFIED TISSUE INT, V38, P123, DOI 10.1007/BF02556841; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; ZAIDI M, 1990, BIOSCIENCE REP, V10, P547, DOI 10.1007/BF01116615	37	833	886	1	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2947	2953		10.1001/jama.296.24.2947	http://dx.doi.org/10.1001/jama.296.24.2947			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190895	Bronze			2022-12-24	WOS:000243069000026
J	Pennington, DJ; Silva-Santos, B; Silberzahn, T; Escorcio-Correia, M; Woodward, MJ; Roberts, SJ; Smith, AL; Dyson, PJ; Hayday, AC				Pennington, Daniel J.; Silva-Santos, Bruno; Silberzahn, Tobias; Escorcio-Correia, Monica; Woodward, Martin J.; Roberts, Scott J.; Smith, Adrian L.; Dyson, P. Julian; Hayday, Adrian C.			Early events in the thymus affect the balance of effector and regulatory T cells	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; ALPHA-BETA; ANTIGEN 4; TOLERANCE; LINEAGE; GENE; INFLAMMATION; PROGENITORS; ENRICHMENT; SELECTION	In cellular immunology the critical balance between effector and regulatory mechanisms is highlighted by serious immunopathologies attributable to mutations in Foxp3, a transcription factor required for a major subset of regulatory T (T(R)) cells(1-3). Thus, many studies have focused on the developmental origin of T(R) cells, with the prevailing view that they emerge in the thymus from late-stage T-cell progenitors whose T-cell receptors (TCRs) engage high affinity (agonist) ligands(4-6). This study questions the completeness of that interpretation. Here we show that without any obvious effect on TCR-mediated selection, the normal differentiation of mouse gamma delta T cells into potent cytolytic and interferon-gamma-secreting effector cells is switched towards an aggregate regulatory phenotype by limiting the capacity of CD4(+) CD8(+) T-cell progenitors to influence in trans early gamma delta cell progenitors. Unexpectedly, we found that the propensity of early TCR-alpha beta(+) progenitors to differentiate into Foxp3 1 T(R) cells is also regulated in trans by CD4(+) CD8(+) T-cell progenitor cells, before agonist selection.	Guys Hosp, Kings Coll London Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Queen Mary Coll, London & Barts Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; Inst Child Hlth, Mol Haematol & Canc Biol Unit, Camelia Botnar Labs, London WC1N 1EH, England; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; Inst Anim Hlth, Compton Lab, Newbury RG20 7NN, Berks, England; Hammersmith Hosp, Imperial Coll, Div Med, London W12 0HS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; Universidade de Lisboa; University of London; University College London; Yale University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Imperial College London	Pennington, DJ (corresponding author), Guys Hosp, Kings Coll London Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	d.pennington@qmul.ac.uk; adrian.hayday@kcl.ac.uk	England, Philip C/A-1920-2010	England, Philip C/0000-0002-9024-8901; Smith, Adrian/0000-0002-7657-6191; Silva-Santos, Bruno/0000-0003-4141-9302; HAYDAY, ADRIAN/0000-0002-9495-5793; Escorcio Correia Wang, Monica/0000-0002-9205-1993; Pennington, Daniel/0000-0001-7889-9923	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001048, BBS/E/I/00001160] Funding Source: Medline; Wellcome Trust [071534] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Carter JD, 2005, J IMMUNOL, V174, P6627, DOI 10.4049/jimmunol.174.11.6627; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lerman MA, 2004, J IMMUNOL, V173, P236, DOI 10.4049/jimmunol.173.1.236; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; WISE E, UNPUB J IMMUNOL; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069	30	84	86	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1073	1077		10.1038/nature06051	http://dx.doi.org/10.1038/nature06051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17190001				2022-12-24	WOS:000242971100057
J	Schapira, A				Schapira, Allan			DDT: a polluted debate in malaria control	LANCET			English	Editorial Material												a.schapira@bluewin.ch	Schapira, Allan/AAZ-8116-2020					[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; *GLOB MAL PROGR, 2006, IND RES SPRAY US IND; *PEST ACT NETW N A, 2006, GLOB COAL HLTH TOX E; Schapira A, 2004, NATURE, V432, P439, DOI 10.1038/432439b; STOSSEL J, 2006, HOORAY DDTS LIFE SAV; *WHO, 2006, WHO GIV IND US DDT C	7	14	14	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2111	2113		10.1016/S0140-6736(06)69812-7	http://dx.doi.org/10.1016/S0140-6736(06)69812-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174693				2022-12-24	WOS:000242856900006
J	Wakabayashi, Y; Mao, JH; Brown, K; Girardi, M; Balmain, A				Wakabayashi, Yuichi; Mao, Jian-Hua; Brown, Ken; Girardi, Michael; Balmain, Allan			Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice	NATURE			English	Article							BASAL-CELL CARCINOMAS; HUMAN HOMOLOG; SKIN TUMORS; SIGNALING PATHWAY; INDUCED APOPTOSIS; SONIC HEDGEHOG; DROSOPHILA; MUTATIONS; CANCER; RAS	Mice of the C57BL/6 strain are resistant to the development of skin squamous carcinomas (SCCs) induced by an activated Ras oncogene, whereas FVB/N mice are highly susceptible(1). The genetic basis of this difference in phenotype is unknown. Here we show that susceptibility to SCC is under the control of a carboxyterminal polymorphism in the mouse Ptch gene. F-1 hybrids between C57BL/6 and FVB/N strains ((B6FVB)F-1) are resistant to Ras-induced SCCs, but resistance can be overcome either by elimination of the C57BL/6 Ptch allele (Ptch(B6)) or by overexpression of the FVB/N Ptch allele (Ptch(FVB)) in the epidermis of K5Hras-transgenic (B6FVB) F-1 hybrid mice. The human Patched (PTCH) gene is a classical tumour suppressor gene for basal cell carcinomas and medulloblastomas, the loss of which causes increased signalling through the Sonic Hedgehog (SHH) pathway(2-5). SCCs that develop in Ptch(B6+/-) mice do not lose the wild-type Ptch gene or show evidence of increased SHH signalling. Although Ptch(FVB) overexpression can promote SCC formation, continued expression is not required for tumour maintenance, suggesting a role at an early stage of tumour cell lineage commitment. The Ptch polymorphism affects Hras-induced apoptosis, and binding to Tid1, the mouse homologue of the Drosophila l( 2) tid tumour suppressor gene. We propose that Ptch occupies a critical niche in determining basal or squamous cell lineage, and that both tumour types can arise from the same target cell depending on carcinogen exposure and host genetic background.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Glasgow, CRC Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Glasgow; Yale University; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Girardi, Michael/0000-0003-1887-9343				ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Canamasas I, 2003, J BIOL CHEM, V278, P30952, DOI 10.1074/jbc.M304225200; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guerrero I, 2003, SCIENCE, V301, P774, DOI 10.1126/science.1088625; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Li XX, 2005, BLOOD, V105, P3465, DOI 10.1182/blood-2004-06-2483; Mao JH, 2003, CURR OPIN GENET DEV, V13, P14, DOI 10.1016/S0959-437X(03)00005-4; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tarunina M, 2004, MOL CELL BIOL, V24, P10792, DOI 10.1128/MCB.24.24.10792-10801.2004; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Unden AB, 1996, CANCER RES, V56, P4562; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	29	89	90	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					761	765		10.1038/nature05489	http://dx.doi.org/10.1038/nature05489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17230190				2022-12-24	WOS:000244205200044
J	Nicholls, SJ; Tuzcu, EM; Sipahi, I; Grasso, AW; Schoenhagen, P; Hu, T; Wolski, K; Crowe, T; Desai, MY; Hazen, SL; Kapadia, SR; Nissen, SE				Nicholls, Stephen J.; Tuzcu, E. Murat; Sipahi, Ilke; Grasso, Adam W.; Schoenhagen, Paul; Hu, Tingfei; Wolski, Kathy; Crowe, Tim; Desai, Milind Y.; Hazen, Stanley L.; Kapadia, Samir R.; Nissen, Steven E.			Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-A-I; C-REACTIVE PROTEIN; HEART-DISEASE; SECONDARY PREVENTION; INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; ESTER TRANSFER; THERAPY; HDL	Context Statins reduce low-density lipoprotein cholesterol (LDL-C) levels and slow progression of coronary atherosclerosis. However, no data exist describing the relationship between statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and disease progression. Objective To investigate the relationship between changes in LDL-C and HDL-C levels and atheroma burden. Design, Setting, and Patients Post-hoc analysis combining raw data from 4 prospective randomized trials ( performed in the United States, North America, Europe, and Australia between 1999 and 2005), in which 1455 patients with angiographic coronary disease underwent serial intravascular ultrasonography while receiving statin treatment for 18 months or for 24 months. Ultrasound analysis was performed in the same core laboratory for all of the studies. Main Outcome Measure Relationship between changes in lipoprotein levels and coronary artery atheroma volume. Results During statin therapy, mean (SD) LDL-C levels were reduced from 124.0 (38.3) mg/dL (3.2 [0.99] mmol/L) to 87.5 (28.8) mg/dL (2.3 [0.75] mmol/L) (a 23.5% decrease; P <. 001), and HDL-C levels increased from 42.5 (11.0) mg/dL(1.1 [0.28] mmol/L) to 45.1 (11.4) mg/dL(1.2 [0.29] mmol/L)(a 7.5% increase; P <. 001). The ratio of LDL-C to HDL-C was reduced from a mean ( SD) of 3.0 ( 1.1) to 2.1 (0.9) (a 26.7% decrease; P <. 001). These changes were accompanied by a mean ( SD) increase in percent atheroma volume from 39.7% (9.8%) to 40.1% (9.7%) ( a 0.5% [3.9%] increase; P=. 001) and a mean ( SD) decrease in total atheroma volume of 2.4 (23.6) mm(3) ( P <. 001). In univariate analysis, mean levels and treatment-mediated changes in LDL-C, total cholesterol, non-HDL cholesterol, apolipoprotein B, and ratio of apolipoprotein B to apolipoprotein A-I were significantly correlated with the rate of atherosclerotic progression, whereas treatment-mediated changes in HDL-C were inversely correlated with atheroma progression. In multivariate analysis, mean levels of LDL-C ( beta coefficient, 0.11 [95% confidence interval, 0.07-0.15]) and increases in HDL-C( beta coefficient,- 0.26[ 95% confidence interval,- 0.41 to - 0.10]) remained independent predictors of atheroma regression. Substantial atheroma regression ( >= 5% reduction in atheroma volume) was observed in patients with levels of LDL-C less than the mean( 87.5 mg/dL) during treatment and percentage increases of HDL-C greater than the mean( 7.5%; P <. 001). No significant differences were found with regard to clinical events. Conclusions Statin therapy is associated with regression of coronary atherosclerosis when LDL-C is substantially reduced and HDL-C is increased by more than 7.5%. These findings suggest that statin benefits are derived from both reductions in atherogenic lipoprotein levels and increases in HDL-C, although it remains to be determined whether the atherosclerotic regression associated with these changes in lipid levels will translate to meaningful reductions in clinical events and improved clinical outcomes.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin, Dept Diagnost Radiol, Cleveland, OH 44195 USA; Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nicholls, SJ (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Mail Code JJ65,9500 Euclid Ave, Cleveland, OH 44195 USA.	nichols1@ccf.org	SIPAHI, ILKE/K-9745-2013; Schoenhagen, Paul/A-2808-2012; Hazen, Stanley L/ABD-5845-2021	SIPAHI, ILKE/0000-0001-8581-9557; Schoenhagen, Paul/0000-0002-7751-5243; Nicholls, Stephen/0000-0002-9668-4368				Aikawa M, 2001, CIRCULATION, V103, P276; AMAUD C, 2005, ARTERIOSCLER THROMB, V25, P1231, DOI DOI 10.1161/01.ATV.0000163840.63685.0; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/14656566.4.11.1901; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guerin M, 2000, ARTERIOSCL THROM VAS, V20, P189, DOI 10.1161/01.ATV.20.1.189; Jensen LO, 2004, CIRCULATION, V110, P265, DOI 10.1161/01.CIR.0000135215.75876.41; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Steiner G, 2001, LANCET, V357, P905; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	43	541	573	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					499	508		10.1001/jama.297.5.499	http://dx.doi.org/10.1001/jama.297.5.499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284700				2022-12-24	WOS:000243999100027
J	Huttenlocher, A; Horwitz, AR				Huttenlocher, Anna; Horwitz, Alan Rick			Wound healing with electric potential	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI USA; Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Virginia	Huttenlocher, A (corresponding author), Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA.							Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	5	48	51	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					303	304		10.1056/NEJMcibr066496	http://dx.doi.org/10.1056/NEJMcibr066496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229960				2022-12-24	WOS:000243488100016
J	Wilson, JF				Wilson, Jennifer Fisher			Facing an uncertain climate	ANNALS OF INTERNAL MEDICINE			English	News Item							HUMAN HEALTH					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kovats RS, 2000, CLIMATE CHANGE HUMAN; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; McMichael A. J, 1996, WHOEHG967; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; MCMICHAEL AJ, 2006, CLIMATE CHANGE HUMAN; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Stern N. H., 2006, STERN REV EC CLIMATE; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1	12	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					153	156		10.7326/0003-4819-146-2-200701160-00022	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131WF	17227946				2022-12-24	WOS:000243901000017
J	Ueki, Y; Lin, CY; Senoo, M; Ebihara, T; Agata, N; Onji, M; Saheki, Y; Kawai, T; Mukherjee, PM; Reichenberger, E; Olsen, BR				Ueki, Yasuyoshi; Lin, Chin-Yu; Senoo, Makoto; Ebihara, Takeshi; Agata, Naoki; Onji, Masahiro; Saheki, Yasunori; Kawai, Toshihisa; Mukherjee, Padma M.; Reichenberger, Ernst; Olsen, Bjorn R.			Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice	CELL			English	Article							ADAPTER PROTEIN 3BP2; COLONY-STIMULATING FACTOR; TYROSINE KINASE; KAPPA-B; TRANSCRIPTION FACTOR; ANTIGEN RECEPTOR; LINKER REGION; IMMUNE-SYSTEM; ACTIVATION; SYK	While studies of the adaptor SH3BP2 have implicated a role in receptor-mediated signaling in mast cells and lymphocytes, they have failed to identify its function or explain why SH3BP2 missense mutations cause bone loss and inflammation in patients with cherubism. We demonstrate that Sh3bp2 "cherubism" mice exhibit trabecular bone loss, TNF-alpha-dependent systemic inflammation, and cortical bone erosion. The mutant phenotype is lymphocyte independent and can be transferred to mice carrying wild-type Sh3bp2 alleles through mutant fetal liver cells. Mutant myeloid cells show increased responses to M-CSF and RANKL stimulation, and, through mechanisms of increased ERK 1/2 and SYK phosphorylation/activation, they form macrophages that express high levels of TNF-alpha and osteoclasts; that are unusually large. M-CSF and RANKL stimulation of myeloid cells that overexpress wild-type SH3BP2 results in similar large osteoclasts. This indicates that the mutant phenotype reflects gain of SH3BP2 function and suggests that SH3BP2 is a critical regulator of myeloid cell responses to M-CSF and RANKL stimulation.	Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Forsyth Inst, Dept Immunol, Boston, MA 02115 USA; Univ Connecticut, Ctr Hlth, Ctr Restorat Med & Skeletal Dev, Dept Oral Rehabil Biomat & Skeletal Dev, Farmington, CT 06030 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Forsyth Institute; University of Connecticut	Olsen, BR (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.	bjorn_olsen@hms.harvard.edu	Ebihara, Takeshi/GYU-7579-2022; Saheki, Yasunori/D-5430-2016	Saheki, Yasunori/0000-0002-1229-6668; Senoo, Makoto/0000-0002-0155-0683	NIAMS NIH HHS [AR36820, AR36819] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036819, R01AR036819, R01AR036820, R37AR036820] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHITU V, 2005, CURR OPIN IMMUNOL, V17, P1; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Foucault I, 2003, J BIOL CHEM, V278, P7146, DOI 10.1074/jbc.M209509200; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Jimi E, 2005, IMMUNOL REV, V208, P80, DOI 10.1111/j.0105-2896.2005.00329.x; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Law CL, 1996, MOL CELL BIOL, V16, P1305; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zollino M, 2000, AM J MED GENET, V94, P254, DOI 10.1002/1096-8628(20000918)94:3<254::AID-AJMG13>3.0.CO;2-7	38	139	146	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					71	83		10.1016/j.cell.2006.10.047	http://dx.doi.org/10.1016/j.cell.2006.10.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218256	Bronze			2022-12-24	WOS:000244420400014
J	Keidan, J				Keidan, Jane			Medicine and the media - Sucked into the Herceptin maelstrom	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Elizabeth Hosp, Kings Lynn NHS Trust, Kings Lynn, England		Keidan, J (corresponding author), Queen Elizabeth Hosp, Kings Lynn NHS Trust, Kings Lynn, England.	Jane.Keidan@qehkl.nhs.uk							0	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 6	2007	334	7583					18	18		10.1136/bmj.39080.481551.47	http://dx.doi.org/10.1136/bmj.39080.481551.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125CH	17204797	Green Published			2022-12-24	WOS:000243418600029
J	Davies, KE; Grounds, MD				Davies, Kay E.; Grounds, Miranda D.			Treating muscular dystrophy with stem cells?	CELL			English	Editorial Material							MUSCLE; MESOANGIOBLASTS	There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.	Univ Oxford, MRC Funct Genet Unit, Oxford, England; Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia	University of Oxford; University of Western Australia	Davies, KE (corresponding author), Univ Oxford, MRC Funct Genet Unit, Oxford, England.	kay.davies@anat.ox.ac.uk		Grounds, Miranda/0000-0002-4530-9402				De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Lee-Pullen TF, 2005, IUBMB LIFE, V57, P731, DOI 10.1080/15216540500352748; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; RADLEY H, 2006, INT J BIOCHEM CELL B, DOI DOI 10.1016/BIOCEL.2006.09.009; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SHARMA KR, 1993, NEUROLOGY, V43, P527, DOI 10.1212/WNL.43.3_Part_1.527; Stupka N, 2004, ACTA NEUROPATHOL, V107, P299, DOI 10.1007/s00401-003-0807-x	10	31	34	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1304	1306		10.1016/j.cell.2006.12.010	http://dx.doi.org/10.1016/j.cell.2006.12.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190595	Bronze			2022-12-24	WOS:000243690000010
J	Vrieseling, E; Arber, S				Vrieseling, Eline; Arber, Silvia			Target-induced transcriptional control of dendritic patterning and connectivity in motor neurons by the ETS gene Pea3	CELL			English	Article							LUMBOSACRAL SPINAL-CORD; SENSORY NEURONS; MOTONEURONS; POOLS; SPECIFICATION; INNERVATION; AFFERENTS; ARBORIZATION; EXPRESSION; BULLFROG	The apposition of axon terminals and dendrites, is critical for the control of neuronal activation, but how distinct neuronal subpopulations establish selective dendrite patterns and acquire specific presynaptic inputs remains unclear. Spinal motor neuron (MN) pools project to specific target muscles and are activated by selective synaptic inputs from group la proprioceptive afferents (IaPAs). Here, we show that MN pools with radially projecting dendrites respond to sensory stimulation with monosynaptic latency and are strikingly different from MN pools with dendrites that avoid the central gray matter, which are only activated through indirect connections. We provide genetic evidence that the induction of the ETS transcription factor Pea3 by GDNF is essential in two cervical MN pools to control dendrite patterning and selectivity of IaPA connectivity. These findings suggest that target-induced transcriptional programs control MN dendrite orientation and play a crucial role in the establishment of sensory-motor connections in the spinal cord.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Pecho-Vrieseling, Eline/AAP-7239-2020	Arber, Silvia/0000-0002-6261-250X; Pecho-Vrieseling, Eline/0000-0001-6712-775X				Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BALDISSERA F, 1981, HDB PHYSL INTEGRATIO; BAULAC M, 1981, ACTA ANAT, V109, P209; BLASER PF, 1990, DEV BRAIN RES, V57, P139, DOI 10.1016/0165-3806(90)90193-3; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; Brown AG, 1981, ORG SPINAL CORD; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V; FRANK E, 1988, STRATEGIES SELECTIVE; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KALB RG, 1994, DEVELOPMENT, V120, P3063; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LICHTMAN JW, 1984, J NEUROSCI, V4, P1754; LICHTMAN JW, 1984, J NEUROSCI, V4, P1745; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mears SC, 1997, J NEUROSCI, V17, P3128; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; OKADO N, 1990, ANAT EMBRYOL, V182, P113; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SZEKELY G, 1980, ACTA BIOL ACAD SCI H, V31, P305; Wenner P, 1995, J NEUROSCI, V15, P8191; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	43	134	136	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1439	1452		10.1016/j.cell.2006.10.042	http://dx.doi.org/10.1016/j.cell.2006.10.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190606	Bronze			2022-12-24	WOS:000243690000022
J	Aziz, MA; Wright, A; Laszlo, A; De Muynck, A; Portaels, F; Van Deun, A; Wells, C; Nunn, P; Blanc, L; Raviglione, M				Aziz, Mohamed Abdel; Wright, Abigail; Laszlo, Adalbert; De Muynck, Aime; Portaels, Francois; Van Deun, Armand; Wells, Charles; Nunn, Paul; Blanc, Leopold; Raviglione, Mario		WHO Int Union Against Tub	Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis	LANCET			English	Article							TUBERCULOSIS-CONTROL; MYCOBACTERIA; SENSITIVITY; HEALTH; TRENDS	Background The burden of tuberculosis is compounded by drug-resistant forms of the disease. This study aimed to analyse data on antituberculosis drug resistance gathered by the WHO and International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Methods Data on drug susceptibility testing for four antituberculosis drugs-isoniazid, rifampicin, ethambutol, and streptomycin-were gathered in the third round of the Global Project (1999-2002) from surveys or ongoing surveillance in 79 countries or geographical settings. These data were combined with those from the first two rounds of the project and analyses were done. Countries that participated followed a standardised set of guidelines to ensure comparability both between and within countries. Findings The median prevalence of resistance to any of the four antituberculosis drugs in new cases of tuberculosis identified in 76 countries or geographical settings was 10.2% (range 0.0-57.1). The median prevalence of multidrug resistance in new cases was 1.0% (range 0.0-14.2). Kazakhstan, Tomsk Oblast (Russia), Karakalpakstan (Uzbekistan), Estonia, Israel, the Chinese provinces Liaoning and Henan, Lithuania, and Latvia reported prevalence of multidrug resistance above 6.5%. Trend analysis showed a significant increase in the prevalence of multidrug resistance in new cases in Tomsk Oblast (p<0.0001). Hong Kong (p=0.01) and the USA (p=0.0002) reported significant decreasing trends in multidrug resistance in new cases of tuberculosis. Interpretation Multidrug resistance represents a serious challenge for tuberculosis control in countries of the former Soviet Union and in some provinces of China. Gaps in coverage of the Global Project are substantial, and baseline information is urgently required from several countries with high tuberculosis burden to develop appropriate control interventions.	WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Raviglione, M (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva, Switzerland.	raviglionem@who.int	ROBERT, Jérôme/C-3993-2011	ROBERT, Jérôme/0000-0002-9380-0570; RAVIGLIONE, Mario/0000-0002-9331-2067				CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cohn DL, 1997, CLIN INFECT DIS   S1, V24, P121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CROFTON J, 1948, BMJ-BRIT MED J, V2, P1009, DOI 10.1136/bmj.2.4588.1009; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; *HONG KONG GOV TUB, 1964, TUBERCLE, V45, P77; KOCHI A, 1993, RES MICROBIOL, V73, P219; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; MITCHISON DA, 1950, THORAX, V4, P144; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; *PHS COOP INV, 1964, AM RESP DIS, V89, P327; PYLE MM, 1947, P STAFF M MAYO CLIN, V22, P465; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; RAVIGLIONE MC, 1997, AIDS, V11, P115; Siddiqi S. H., 1996, BACTEC 460TB SYSTEM; VESTAL AL, 1967, SCAND J RESPIR DIS, V48, P142; WHO, 2003, WHOCDSCSRRMD20033; *WHO, 2005, WHOHTMTB2005349; WHO, 2000, WHOCDSTB2000279; WHO, 2001, WHOCDSCSRDRS20012; *WHOIUATLD, 2000, WHOCDSTB200278 IUATL; *WHOIUATLD, 1997, WHOTB97229 IUATLD; *WHOIUATLD, 2004, WHOHTMTB2004343 IUAT; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTM2006361; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	38	251	274	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2142	2154		10.1016/S0140-6736(06)69863-2	http://dx.doi.org/10.1016/S0140-6736(06)69863-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174706				2022-12-24	WOS:000242856900022
J	Tsushima, Y; Sasaki, Y; Watanabe, T				Tsushima, Yoshiaki; Sasaki, Yuka; Watanabe, Takeo			Greater disruption due to failure of inhibitory control on an ambiguous distractor	SCIENCE			English	Article							PREFRONTAL CORTEX; DISSOCIATION; BLINDNESS	Considerable evidence indicates that a stimulus that is subthreshold, and thus consciously invisible, influences brain activity and behavioral performance. However, it is not clear how subthreshold stimuli are processed in the brain. We found that a task-irrelevant subthreshold coherent motion led to a stronger disturbance in task performance than did suprathreshold motion. With the subthreshold motion, activity in the visual cortex measured by functional magnetic resonance imaging was higher, but activity in the lateral prefrontal cortex was lower, than with suprathreshold motion. These results suggest that subthreshold irrelevant signals are not subject to effective inhibitory control.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA; CALTECH, ERATO, Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA	Boston University; Harvard University; Massachusetts General Hospital; California Institute of Technology	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	takeo@bu.edu		Tsushima, Yoshiaki/0000-0001-7818-4602; Sasaki, Yuka/0000-0002-0061-0250	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980, R21EY017737] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline; NEI NIH HHS [R01 EY015980, R21 EY017737] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Callan AM, 2005, NEUROIMAGE, V28, P553, DOI 10.1016/j.neuroimage.2005.06.031; Chun MM, 1997, J EXP PSYCHOL HUMAN, V23, P738, DOI 10.1037/0096-1523.23.3.738; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mack A., 1998, INATTENTIONAL BLINDN; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Niedeggen M, 2002, COGNITIVE BRAIN RES, V13, P241, DOI 10.1016/S0926-6410(01)00122-7; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sahraie A, 2001, VISION RES, V41, P1613, DOI 10.1016/S0042-6989(01)00065-7; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	30	124	125	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1786	1788		10.1126/science.1133197	http://dx.doi.org/10.1126/science.1133197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170308				2022-12-24	WOS:000242833600062
J	Schmidt, AR; Ragazzi, E; Coppellotti, O; Roghi, G				Schmidt, Alexander R.; Ragazzi, Eugenio; Coppellotti, Olimpia; Roghi, Guido			A microworld in Triassic amber	NATURE			English	Article							ALPS		Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; Univ Padua, Dept Pharmacol & Anaesthesiol, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; CNR, Inst Geosci & Earth Resources, I-35137 Padua, Italy; Univ Padua, Dept Geol Paleontol & Geophys, I-35137 Padua, Italy	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); University of Padua	Schmidt, AR (corresponding author), Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany.	alexander.schmidt@museum.hu-berlin.de	Ragazzi, Eugenio/ACX-1875-2022	Ragazzi, Eugenio/0000-0002-0390-6823				Dorfelt H, 2006, PALAEONTOLOGY, V49, P1013, DOI 10.1111/j.1475-4983.2006.00582.x; Dorfelt H, 2000, HOPPEA DENKSCHRIFTEN, V61, P785; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Roghi G, 2006, PALAIOS, V21, P143, DOI 10.2110/palo.2005.p05-68; Roghi G, 2004, REV PALAEOBOT PALYNO, V132, P1, DOI 10.1016/j.revpalbo.2004.03.001; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; SCHONBORN WILFRIED, 1962, LIMNOLOGICA, V1, P111; WAGGONER BM, 1994, LETHAIA, V27, P77, DOI 10.1111/j.1502-3931.1994.tb01559.x	9	76	79	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					835	835		10.1038/444835a	http://dx.doi.org/10.1038/444835a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167469	Bronze			2022-12-24	WOS:000242805400033
J	Baker, DW; Persell, SD; Thompson, JA; Soman, NS; Burgner, KM; Liss, D; Kmetik, KS				Baker, David W.; Persell, Stephen D.; Thompson, Jason A.; Soman, Neilesh S.; Burgner, Karen M.; Liss, David; Kmetik, Karen S.			Automated review of electronic health records to assess quality of care for outpatients with heart failure	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; PRACTICE GUIDELINES; PITFALLS	Background: Electronic health records (EHRs) may be used to assess quality of care. Objective: To evaluate the accuracy of automated review of EHR data to measure quality of care for outpatients with heart failure. Design: Observational study of quality of care for heart failure comparing automated review of EHR data with automated review followed by manual review of electronic notes for patients with apparent quality deficits (hybrid review). Setting: An academic general internal medicine clinic with several years' experience using a commercial EHR. Patients: 517 adults with a qualifying International Classification of Diseases, Ninth Revision, diagnosis of heart failure in their EHR data and 2 or more clinic visits over the past 18 months. Measurements: Left ventricular ejection fraction (LVEF), prescription of a G-blocker and an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB) for patients with left ventricular systolic dysfunction (LVEF < 0.40) and prescription of warfarin for patients with comorbid atrial fibrillation. Results: Performance based on automated review of EHR data was similar to that based on hybrid review for assessing LVEF measurement (94.6% vs. 97.3%), prescription of beta-blockers (90.9% vs. 92.8%), and prescription of ACE inhibitors or ARBs (93.9% vs. 98.7%). However, performance based on automated review was lower than that based on hybrid review for prescription of warfarin for atrial fibrillation (70.4% vs. 93.6%), primarily because automated review did not detect documentation of accepted reasons for not prescribing warfarin. Limitations: The findings may not be applicable to other practices and other EHRs. The authors used EHR data to identify eligible patients, so the study may have excluded some patients with heart failure. Patient charts were manually reviewed only if a provider appeared to fail a quality measure on automated review and did not determine the sensitivity and specificity of automated review according to standard definitions. Conclusions: Automated review of EHR data to measure the quality of care of outpatients with heart failure missed many exclusion criteria for medications documented only in providers' notes. As a result, it sometimes underestimated performance on medication-based quality measures.	Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Baker, DW (corresponding author), 676 N St,Clair St,Suite 200, Chicago, IL 60611 USA.	dwbaker@northwestern.edu		Liss, David/0000-0001-5505-2922	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS013690] Funding Source: NIH RePORTER; AHRQ HHS [5 U18 HS013690] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM MED ASS, 2006, CPT 2 COD; [Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Borzecki AM, 2004, AM J MANAG CARE, V10, P473; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; *CTR MED MED SERV, 2006, QUAL IN GEN INF; *CTR MED MED SERV, 2006, PHSY FOC QUAL IN; *DOQIT, 2006, DOCT OFF QUAL INF TE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; Institute of Medicine, 2002, LEAD EX COORD GOV RO; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555; *MED PAYM ADV COMM, 2003, REP C VAR INN MED; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; Parameswaran AC, 2005, AM HEART J, V149, P921, DOI 10.1016/j.ahj.2004.07.026; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; *PHYS CONS PERF IM, 2006, PERF MEAS HEART FAIL; Santell JP, 2006, JT COMM J QUAL PATIE, V32, P225, DOI 10.1016/S1553-7250(06)32029-6; *SNOMED, 2006, SYST NOM MED CLIN TE; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466	23	66	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					270	277		10.7326/0003-4819-146-4-200702200-00006	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310051				2022-12-24	WOS:000244271000005
J	Heinze, S; Homberg, U				Heinze, Stanley; Homberg, Uwe			Maplike representation of celestial E-vector orientations in the brain of an insect	SCIENCE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; LIGHT-SENSITIVE NEURONS; ANTERIOR OPTIC TUBERCLE; TETHERED FLYING LOCUSTS; CENTRAL COMPLEX; HEAD-DIRECTION; DROSOPHILA-MELANOGASTER; POLARIZATION VISION; CONNECTIONS; CORTEX	For many insects, the polarization pattern of the blue sky serves as a compass cue for spatial navigation. E-vector orientations are detected by photoreceptors in a dorsal rim area of the eye. Polarized-light signals from both eyes are finally integrated in the central complex, a brain area consisting of two subunits, the protocerebral bridge and the central body. Here we show that a topographic representation of zenithal E-vector orientations underlies the columnar organization of the protocerebral bridge in a locust. The maplike arrangement is highly suited to signal head orientation under the open sky.	Univ Marburg, Dept Biol, D-35032 Marburg, Germany	Philipps University Marburg	Homberg, U (corresponding author), Univ Marburg, Dept Biol, D-35032 Marburg, Germany.	homberg@staff.uni-marburg.de	Homberg, Uwe/AFH-8214-2022; Heinze, Stanley/I-4440-2019	Homberg, Uwe/0000-0002-8229-7236; Heinze, Stanley/0000-0002-8145-3348				Batschelet E, 1981, CIRCULAR STAT BIOL; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; Homberg U, 1997, J COMP NEUROL, V386, P329; Horvath G., 2004, POLARIZED LIGHT ANIM; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Mappes M, 2007, J COMP PHYSIOL A, V193, P43, DOI 10.1007/s00359-006-0166-x; Mittelstaedt H, 2000, BIOL CYBERN, V83, P261, DOI 10.1007/s004220000169; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; PFEIFFER K, P 6 M GERM NEUR SOC, P218; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; Wehner R, 2001, J EXP BIOL, V204, P2589; WILLIAMS JLD, 1975, J ZOOL, V176, P67; Zar JH, 1999, BIOSTATISTICAL ANAL	25	240	249	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					995	997		10.1126/science.1135531	http://dx.doi.org/10.1126/science.1135531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303756				2022-12-24	WOS:000244229800044
J	Park, HH; Logette, E; Raunser, S; Cuenin, S; Walz, T; Tschopp, J; Wu, H				Park, Hyun Ho; Logette, Emmanuelle; Raunser, Stefan; Cuenin, Solange; Walz, Thomas; Tschopp, Jurg; Wu, Hao			Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex	CELL			English	Article							MUTATIONAL ANALYSIS; PROVIDES INSIGHTS; CELL-DEATH; CASPASE-2; PROTEIN; APOPTOSIS; ACTIVATION; PIDD; SUPERFAMILY; MODEL	Proteins of the death domain (DD) superfamily mediate assembly of oligomeric signaling complexes for the activation of caspases and kinases via unknown mechanisms. Here we report the crystal structure of the PIDD DD and RAIDD DD complex, which forms the core of the caspase-2-activating complex PIDDo-some. Although RAIDD DD and PIDD DD are monomers, they assemble into a complex that comprises seven RAIDD DDs and five PIDD DDs. Despite the use of an asymmetric assembly mechanism, all DDs in the complex are in quasi-equivalent environments. The structure provided eight unique asymmetric interfaces, which can be classified into three types. These three types of interactions together cover a majority of the DD surface. Mutagenesis on almost all interfaces leads to disruption of the assembly, resulting in defective caspase-2 activation. The three types of interactions may represent most, if not all, modes of interactions in the DD superfamily for assembling complexes of different stoichiometry.	Univ Cordoba, Weill Med Coll, New York, NY 10021 USA; Univ Cordoba, Grad Sch Med Sci, New York, NY 10021 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Cornell University; University of Lausanne; Harvard University; Harvard Medical School	Wu, H (corresponding author), Univ Cordoba, Weill Med Coll, New York, NY 10021 USA.	haowu@med.cornell.edu	park, hyun ho/D-2627-2011; Raunser, Stefan/AHE-1573-2022	Walz, Thomas/0000-0003-2606-2835; Raunser, Stefan/0000-0001-9373-3016; park, hyun ho/0000-0001-9928-0847	NIAID NIH HHS [R01 AI050872, R01 AI050872-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pick R, 2006, BIOCHEM BIOPH RES CO, V349, P1329, DOI 10.1016/j.bbrc.2006.08.176; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Salvesen GS, 2002, ESSAYS BIOCHEM, V38, P9, DOI 10.1042/bse0380009; Sandu C, 2005, J BIOL CHEM, V280, P31974, DOI 10.1074/jbc.M506938200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; Telliez JB, 2000, J MOL BIOL, V300, P1323, DOI 10.1006/jmbi.2000.3899; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thakar J, 2006, PROTEINS, V63, P413, DOI 10.1002/prot.20895; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	44	208	210	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					533	546		10.1016/j.cell.2007.01.019	http://dx.doi.org/10.1016/j.cell.2007.01.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289572	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000244842700019
J	Komiyama, T; Sweeney, LB; Schuldiner, O; Garcia, KC; Luo, LQ				Komiyama, Takaki; Sweeney, Lora B.; Schuldiner, Oren; Garcia, K. Christopher; Luo, Liqun			Graded expression of Semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons	CELL			English	Article							REPULSIVE GUIDANCE MOLECULE; DROSOPHILA ANTENNAL LOBE; TRANSMEMBRANE SEMAPHORIN; WIRING SPECIFICITY; AXON GUIDANCE; BRANCH EXTENSION; RETINAL AXONS; RECEPTOR; SYSTEM; MAP	Gradients of axon guidance molecules instruct the formation of continuous neural maps, such as the retinotopic map in the vertebrate visual system. Here we show that molecular gradients can also instruct the formation of a discrete neural map. In the fly olfactory system, axons of 50 classes of olfactory receptor neurons (ORNs) and dendrites of 50 classes of projection neurons (PNs) form one-to-one connections at discrete units called glomeruli. We provide expression, loss- and gain-of-function data to demonstrate that the levels of transmembrane Semaphorin-la (Sema-la), acting cell-autonomously as a receptor or part of a receptor complex, direct the dendritic targeting of PNs along the dorsolateral to ventromedial axis of the antennal lobe. Sema-1a also regulates PN axon targeting in higher olfactory centers. Thus, graded expression of Sema-1a contributes to connection specificity from ORNs to PNs and then to higher brain centers, ensuring proper representation of olfactory information in the brain.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Komiyama, Takaki/0000-0001-9609-4600; Sweeney, Lora/0000-0001-9242-5601; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cramer KS, 2005, HEARING RES, V206, P42, DOI 10.1016/j.heares.2004.11.024; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KOMIYAMA T, 2007, IN PRESS CURR BIOL; Kumanogoh A, 2004, CELL MOL LIFE SCI, V61, P292, DOI 10.1007/s00018-003-3257-7; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCGUIRE SE, 2004, SCI STKE, V220, P16; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	57	132	134	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					399	410		10.1016/j.cell.2006.12.028	http://dx.doi.org/10.1016/j.cell.2006.12.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254975	Bronze			2022-12-24	WOS:000244420500022
J	Keller, LP; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Busemann, H; Brucato, JR; Burchell, M; Colangeli, L; d'Hendecourt, L; Djouadi, Z; Ferrini, G; Flynn, G; Franchi, IA; Fries, M; Grady, MM; Graham, GA; Grossemy, F; Kearsley, A; Matrajt, G; Nakamura-Messenger, K; Mennella, V; Nittler, L; Palumbo, ME; Stadermann, FJ; Tsou, P; Rotundi, A; Sandford, SA; Snead, C; Steele, A; Wooden, D; Zolensky, M				Keller, Lindsay P.; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Don E.; Busemann, Henner; Brucato, John R.; Burchell, Mark; Colangeli, Luigi; d'Hendecourt, Louis; Djouadi, Zahia; Ferrini, Gianluca; Flynn, George; Franchi, Ian A.; Fries, Marc; Grady, Monica M.; Graham, Giles A.; Grossemy, Faustine; Kearsley, Anton; Matrajt, Graciela; Nakamura-Messenger, Keiko; Mennella, Vito; Nittler, Larry; Palumbo, Maria E.; Stadermann, Frank J.; Tsou, Peter; Rotundi, Alessandra; Sandford, Scott A.; Snead, Christopher; Steele, Andrew; Wooden, Diane; Zolensky, Mike			Infrared spectroscopy of comet 81P/Wild 2 samples returned by Stardust	SCIENCE			English	Article							DIFFUSE INTERSTELLAR-MEDIUM; ORGANIC-MATTER; DUST; SPECTROPHOTOMETRY; MINERALOGY	Infrared spectra of material captured from comet 81P/Wild 2 by the Stardust spacecraft reveal indigenous aliphatic hydrocarbons similar to those in interplanetary dust particles thought to be derived from comets, but with longer chain lengths than those observed in the diffuse interstellar medium. Similarly, the Stardust samples contain abundant amorphous silicates in addition to crystalline silicates such as olivine and pyroxene. The presence of crystalline silicates in Wild 2 is consistent with mixing of solar system and interstellar matter. No hydrous silicates or carbonate minerals were detected, which suggests a lack of aqueous processing of Wild 2 dust.	NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Osserv Astrofis Catania, INAF, I-95123 Catania, Italy; Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NR, Kent, England; Novaetech SRL, I-80125 Naples, Italy; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Milton Keynes MK7 6AA, Bucks, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; NASA, Lyndon B Johnson Space Ctr, Engn Sci Contract Grp, Houston, TX 77058 USA; Washington Univ, Space Sci Lab, St Louis, MO 63160 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Napoli Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Washington; University of Washington Seattle; Carnegie Institution for Science; Istituto Nazionale Astrofisica (INAF); University of Kent; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley	Keller, LP (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Mail Code KR, Houston, TX 77058 USA.	lindsay.p.keller@nasa.gov	Baratta, Giuseppe/AAY-6188-2021; Steele, Andrew/A-3573-2013; Bajt, Sasa/G-2228-2010; Matrajt, Graciela/A-4812-2017; Bajt, Sasa/O-4695-2019; 1.4, ALS Beamline/I-1886-2014; Appourchaux, Thierry/F-4692-2010	Steele, Andrew/0000-0001-9643-2841; Bajt, Sasa/0000-0002-7163-7602; Zolensky, Michael/0000-0002-3181-1303; Colangeli, Luigi/0000-0001-6801-9152; Brucato, John Robert/0000-0002-4738-5521; Baratta, Giuseppe/0000-0002-3688-160X; Mennella, Vito/0000-0001-9525-895X; Grady, Monica/0000-0002-4055-533X; Burchell, Mark/0000-0002-2680-8943; Palumbo, MariaElisabetta/0000-0002-9122-491X; Rotundi, Alessandra/0000-0001-5467-157X; Busemann, Henner/0000-0002-0867-6908				Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 2004, TREATISE GEOCHEMISTR, V1, P1121; BREGMAN JD, 1988, ASTROPHYS J, V334, P1044, DOI 10.1086/166896; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P616; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Dartois E, 2004, ASTRON ASTROPHYS, V423, P549, DOI 10.1051/0004-6361:20047067; DISANTI MA, 1995, ICARUS, V116, P1, DOI 10.1006/icar.1995.1110; Dorschner J, 1995, ASTRON ASTROPHYS REV, V6, P271, DOI 10.1007/BF00873686; EHRENFREUND P, 1991, ASTRON ASTROPHYS, V252, P712; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; FLYNN GJ, 2003, WORKSH COM DUST ASTR; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Harker DE, 2002, ASTROPHYS J, V580, P579, DOI 10.1086/343091; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KELLER LP, 2004, LUNAR PLANET SCI, V35, P1985; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2005, ASTROPHYS J, V633, P534, DOI 10.1086/447764; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Molster FJ, 2003, LECT NOTES PHYS, V609, P121; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1172; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Rietmeijer F.J.M., 1998, PLANETARY MAT, V36; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Whittet DCB, 1997, ASTROPHYS J, V490, P729, DOI 10.1086/304914; Wooden DH, 1999, ASTROPHYS J, V517, P1034, DOI 10.1086/307206; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	145	146	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1728	1731		10.1126/science.1135796	http://dx.doi.org/10.1126/science.1135796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170293				2022-12-24	WOS:000242833600045
J	Azaele, S; Pigolotti, S; Banavar, JR; Maritan, A				Azaele, Sandro; Pigolotti, Simone; Banavar, Jayanth R.; Maritan, Amos			Dynamical evolution of ecosystems	NATURE			English	Article							NEUTRAL THEORY; VEGETATION DYNAMICS; SPECIES ABUNDANCE; BETA-DIVERSITY; FOREST; COMMUNITIES; MODEL	The assembly of an ecosystem such as a tropical forest depends crucially on the species interaction network, and the deduction of its rules is a formidably complex problem(1). In spite of this, many recent studies(2-16) using Hubbell's neutral theory of biodiversity and biogeography(2) have demonstrated that the resulting emergent macroscopic behaviour of the ecosystem at or near a stationary state shows a surprising simplicity reminiscent of many physical systems(17). Indeed the symmetry postulate(2), that the effective birth and death rates are species-independent within a single trophic level, allows one to make analytical predictions for various static distributions such as the relative species abundance(3-12), beta-diversity(13-15) and the species - area relationship(16). In contrast, there have only been a few studies of the dynamics and stability of tropical rain forests(18-20). Here we consider the dynamical behaviour of a community, and benchmark it against the exact predictions of a neutral model near or at stationarity. In addition to providing a description of the relative species abundance, our analysis leads to a quantitative understanding of the species turnover distribution and extinction times, and a measure of the temporal scales of neutral evolution. Our model gives a very good description of the large quantity of data collected in Barro Colorado Island in Panama in the period 1990 - 2000 with just three ecologically relevant parameters and predicts the dynamics of extinction of the existing species.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Padua; University of Copenhagen; Niels Bohr Institute	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Azaele, Sandro/N-1137-2013; Azaele, Sandro/AAN-8986-2020; Pigolotti, Simone/AAU-2395-2021; Azaele, Sandro/B-2444-2008	Azaele, Sandro/0000-0002-5153-4833; Azaele, Sandro/0000-0002-5153-4833; Pigolotti, Simone/0000-0002-6157-6906; Maritan, Amos/0000-0002-3535-7873				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; FOSTER DR, 1993, ECOLOGY, V74, P982, DOI 10.2307/1940468; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Pigolotti S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011916; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	29	85	87	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					926	928		10.1038/nature05320	http://dx.doi.org/10.1038/nature05320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167485				2022-12-24	WOS:000242805400055
J	Hafner, M; Schmitz, A; Grune, I; Srivatsan, SG; Paul, B; Kolanus, W; Quast, T; Kremmer, E; Bauer, I; Famulok, M				Hafner, Markus; Schmitz, Anton; Gruene, Imke; Srivatsan, Seergazhi G.; Paul, Bianca; Kolanus, Waldemar; Quast, Thomas; Kremmer, Elisabeth; Bauer, Inga; Famulok, Michael			Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; NUCLEOTIDE-EXCHANGE FACTOR; GTP-BINDING PROTEINS; GUANINE-NUCLEOTIDE; BREFELDIN-A; ARF; MICE; DISRUPTION; ACTIVATION; MECHANISM	G proteins are an important class of regulatory switches in all living systems. They are activated by guanine nucleotide exchange factors (GEFs), which facilitate the exchange of GDP for GTP(1,2). This activity makes GEFs attractive targets for modulating disease-relevant G-protein-controlled signalling networks(3-5). GEF inhibitors are therefore of interest as tools for elucidating the function of these proteins and for therapeutic intervention; however, only one small molecule GEF inhibitor, brefeldin A (BFA), is currently available(6-9). Here we used an aptamer displacement screen to identify SecinH3, a small molecule antagonist of cytohesins. The cytohesins are a class of BFA-resistant small GEFs for ADP-ribosylation factors (ARFs), which regulate cytoskeletal organization(10), integrin activation(11) or integrin signalling(12). The application of SecinH3 in human liver cells showed that insulin-receptor-complex-associated cytohesins are required for insulin signalling. SecinH3-treated mice show increased expression of gluconeogenic genes, reduced expression of glycolytic, fatty acid and ketone body metabolism genes in the liver, reduced liver glycogen stores, and a compensatory increase in plasma insulin. Thus, cytohesin inhibition results in hepatic insulin resistance. Because insulin resistance is among the earliest pathological changes in type 2 diabetes, our results show the potential of chemical biology for dissecting the molecular pathogenesis of this disease.	Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, D-53121 Bonn, Germany; Univ Bonn, Lab Mol Immunol, LIMES Program Unit Mol Immune & Cell Biol, D-53115 Bonn, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, D-81377 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Famulok, M (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	m.famulok@uni-bonn.de	Hafner, Markus/O-7100-2018	Hafner, Markus/0000-0002-4336-6518				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	30	195	205	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					941	944		10.1038/nature05415	http://dx.doi.org/10.1038/nature05415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167487				2022-12-24	WOS:000242805400059
J	Leduc, G; Vidal, L; Tachikawa, K; Rostek, F; Sonzogni, C; Beaufort, L; Bard, E				Leduc, Guillaume; Vidal, Laurence; Tachikawa, Kazuyo; Rostek, Frauke; Sonzogni, Corinne; Beaufort, Luc; Bard, Edouard			Moisture transport across Central America as a positive feedback on abrupt climatic changes	NATURE			English	Article							SCALE CHANGES; RAPID CHANGES; ATLANTIC; OCEAN; SALINITY; TEMPERATURE; SIMULATIONS; CIRCULATION; SEDIMENTS	Moisture transport from the Atlantic to the Pacific ocean across Central America leads to relatively high salinities in the North Atlantic Ocean(1) and contributes to the formation of North Atlantic Deep Water(2). This deep water formation varied strongly between Dansgaard/ Oeschger interstadials and Heinrich events millennial- scale abrupt warm and cold events, respectively, during the last glacial period(3). Increases in the moisture transport across Central America have been proposed to coincide with northerly shifts of the Intertropical Convergence Zone and with Dansgaard/ Oeschger interstadials, with opposite changes for Heinrich events(4). Here we reconstruct sea surface salinities in the eastern equatorial Pacific Ocean over the past 90,000 years by comparing palaeotemperature estimates from alkenones and Mg/Ca ratios with foraminiferal oxygen isotope ratios that vary with both temperature and salinity. We detect millennial- scale fluctuations of sea surface salinities in the eastern equatorial Pacific Ocean of up to two to four practical salinity units. High salinities are associated with the southward migration of the tropical Atlantic Intertropical Convergence Zone, coinciding with Heinrich events and with Greenland stadials(5). The amplitudes of these salinity variations are significantly larger on the Pacific side of the Panama isthmus, as inferred from a comparison of our data with a palaeoclimate record from the Caribbean basin(6). We conclude that millennial-scale fluctuations of moisture transport constitute an important feedback mechanism for abrupt climate changes, modulating the North Atlantic freshwater budget and hence North Atlantic Deep Water formation.	Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, F-13545 Aix En Provence 04, France	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Leduc, G (corresponding author), Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, Europole Arbois,BP 80, F-13545 Aix En Provence 04, France.	leduc@cerege.fr; bard@cerege.fr	Vidal, Laurence/C-1860-2019; Beaufort, Luc/AAH-5305-2021; Beaufort, Luc/ABG-2289-2021; Sonzogni, Corinne/AAG-5816-2019; Leduc, Guillaume/A-8930-2008; Bard, Edouard/G-7717-2014	Beaufort, Luc/0000-0001-6055-9373; 				Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Bard E, 2002, PHYS TODAY, V55, P32, DOI 10.1063/1.1537910; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; Benway HM, 2004, EARTH PLANET SC LETT, V224, P493, DOI 10.1016/j.epsl.2004.05.014; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Ivanochko TS, 2005, EARTH PLANET SC LETT, V235, P302, DOI 10.1016/j.epsl.2005.04.002; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Liu WT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005300; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Masson S, 2001, PHYS CHEM EARTH PT B, V26, P137, DOI 10.1016/S1464-1909(00)00230-6; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Mignot J, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002005; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Schmidt MW, 2006, NATURE, V443, P561, DOI 10.1038/nature05121; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schmittner A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000633; Sonzogni C, 1997, QUATERNARY RES, V47, P344, DOI 10.1006/qres.1997.1885; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Vidal L, 2004, DEV PALEOENVIRON RES, V6, P31; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	28	170	175	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					908	911		10.1038/nature05578	http://dx.doi.org/10.1038/nature05578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314978				2022-12-24	WOS:000244341200047
J	Robinson, DJ; O'Neill, D				Robinson, David J.; O'Neill, Desmond			Access to health care records after death - Balancing confidentiality with appropriate disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL CONFIDENTIALITY		Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland.	arhc@amnch.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Annas GJ, 2005, NEW ENGL J MED, V352, P501, DOI 10.1056/NEJMlim042648; Behnke SH, 1998, J AM ACAD PSYCHIATRY, V26, P639; Billings J A, 1999, J Palliat Med, V2, P33, DOI 10.1089/jpm.1999.2.33; BISHOP L, 2005, NATL CONSUMER HEALTH; Caulfield H, 1998, Nurs Stand, V13, P47; Comijs HC, 1998, J AM GERIATR SOC, V46, P885, DOI 10.1111/j.1532-5415.1998.tb02724.x; deCinque N, 2004, J PAEDIATR CHILD H, V40, P131, DOI 10.1111/j.1440-1754.2004.00313.x; Dimond Bridgit, 2005, Br J Nurs, V14, P391; Glen S, 1997, NURS ETHICS, V4, P403; Kipnis K, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160500506308; Lucassen AM, 2004, BMJ-BRIT MED J, V328, P952, DOI 10.1136/bmj.328.7445.952; McGuire W., 1978, CG JUNG SPEAKING INT; medical council, 2004, GUID ETH COND BEH; Phukan JFM, 2004, IR J MED SCI S1, V173, P47; RHODES H, 2003, PROTECTING PATIENT I; Sankar P, 2003, J GEN INTERN MED, V18, P659, DOI 10.1046/j.1525-1497.2003.20823.x; WORTHINGTON R, 2004, BMJ             0420	17	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					634	636		10.1001/jama.297.6.634	http://dx.doi.org/10.1001/jama.297.6.634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135TU	17299198				2022-12-24	WOS:000244177400026
J	Pinton, P; Rimessi, A; Marchi, S; Orsini, F; Migliaccio, E; Giorgio, M; Contursi, C; Minucci, S; Mantovani, F; Wieckowski, MR; Del Sal, G; Pelicci, PG; Rizzuto, R				Pinton, Paolo; Rimessi, Alessandro; Marchi, Saverio; Orsini, Francesca; Migliaccio, Enrica; Giorgio, Marco; Contursi, Cristina; Minucci, Saverio; Mantovani, Fiamma; Wieckowski, Mariusz R.; Del Sal, Giannino; Pelicci, Pier Giuseppe; Rizzuto, Rosario			Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66(Shc)	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; CA2+ SIGNALS; APOPTOSIS; MECHANISM	The 66-kilodalton isoform of the growth factor adapter Shc (p66(Shc)) translates oxidative damage into cell death by acting as reactive oxygen species (ROS) producer within mitochondria. However, the signaling link between cellular stress and mitochondrial proapoptotic activity of p66(Shc) was not known. We demonstrate that protein kinase C beta, activated by oxidative conditions in the cell, induces phosphorylation of p66Shc and triggers mitochondrial accumulation of the protein after it is recognized by the prolyl isomerase Pin1. Once imported, p66(Shc) causes alterations of mitochondrial Ca2+ responses and three-dimensional structure, thus inducing apoptosis. These data identify a signaling route that activates an apoptotic inducer shortening the life span and could be a potential target of pharmacological approaches to inhibit aging.	Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, ICSI, I-44100 Ferrara, Italy; Univ Ferrara, Emilia Romagna Lab Genom & Biotechnol, I-44100 Ferrara, Italy; European Inst Oncol, Dept Expt Oncol, Milan, Italy; FIRC, Inst Mol Oncol, Milan, Italy; Congenia SrL, Milan, Italy; Consorzio Interuniv Biotechnol, Lab Nazl, Trieste, Italy; Univ Trieste, Dept Biochim Biofis Chim Macromol, I-34127 Trieste, Italy; Polish Acad Sci, M Nencki Inst Expt Biol, Dept Cellular Biochem, PL-00901 Warsaw, Poland; Univ Milan, Dept Med & Surg, I-20122 Milan, Italy	University of Ferrara; University of Ferrara; University of Ferrara; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Trieste; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Milan	Rizzuto, R (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy.	r.rizzuto@unife.it	Minucci, Saverio/J-9669-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; rimessi, alessandro/O-3335-2019; Rizzuto, Rosario/B-6312-2008; Pinton, Paolo/J-8025-2012; Migliaccio, Enrica/AAQ-8880-2020; Marchi, Saverio/K-5997-2016; Giorgio, Marco/I-9425-2012; Marchi, Saverio/AAK-3308-2021; Rimessi, Alessandro/K-5420-2016	rimessi, alessandro/0000-0001-7091-5765; Pinton, Paolo/0000-0001-7108-6508; Marchi, Saverio/0000-0003-2708-1843; Giorgio, Marco/0000-0002-5842-6042; Marchi, Saverio/0000-0003-2708-1843; Rimessi, Alessandro/0000-0001-7091-5765; Wieckowski, Mariusz/0000-0003-0789-4521; DEL SAL, GIANNINO/0000-0003-2185-6003; Rizzuto, Rosario/0000-0001-7044-5097	Telethon [GGP05284] Funding Source: Medline	Telethon(Fondazione Telethon)		Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bootman MD, 2001, J CELL SCI, V114, P2213; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gonindard C, 1997, CELL BIOL TOXICOL, V13, P141, DOI 10.1023/A:1007321227010; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2004, J CELL BIOL, V165, P223, DOI 10.1083/jcb.200311061; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120	20	389	413	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					659	663		10.1126/science.1135380	http://dx.doi.org/10.1126/science.1135380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272725				2022-12-24	WOS:000243909400047
J	Scott, LM; Tong, W; Levine, RL; Scott, MA; Beer, PA; Stratton, MR; Futreal, PA; Erber, WN; McMullin, MF; Harrison, CN; Warren, AJ; Gilliland, DG; Lodish, HF; Green, AR				Scott, Linda M.; Tong, Wei; Levine, Ross L.; Scott, Mike A.; Beer, Philip A.; Stratton, Michael R.; Futreal, P. Andrew; Erber, Wendy N.; McMullin, Mary Frances; Harrison, Claire N.; Warren, Alan J.; Gilliland, D. Gary; Lodish, Harvey F.; Green, Anthony R.			JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE JAK2; V617F MUTATION; MYELOPROLIFERATIVE-DISORDERS; ESSENTIAL THROMBOCYTHEMIA; DIAGNOSTIC-CRITERIA; ACTIVATING MUTATION; MYELOID METAPLASIA; MYELOFIBROSIS; DISEASE; JAK2V617F	BACKGROUND: The V617F mutation, which causes the substitution of phenylalanine for valine at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. However, the molecular basis of these myeloproliferative disorders in patients without the V617F mutation is unclear. METHODS: We searched for new mutations in members of the JAK and signal transducer and activator of transcription (STAT) gene families in patients with V617F-negative polycythemia vera or idiopathic erythrocytosis. The mutations were characterized biochemically and in a murine model of bone marrow transplantation. RESULTS: We identified four somatic gain-of-function mutations affecting JAK2 exon 12 in 10 V617F-negative patients. Those with a JAK2 exon 12 mutation presented with an isolated erythrocytosis and distinctive bone marrow morphology, and several also had reduced serum erythropoietin levels. Erythroid colonies could be grown from their blood samples in the absence of exogenous erythropoietin. All such erythroid colonies were heterozygous for the mutation, whereas colonies homozygous for the mutation occur in most patients with V617F-positive polycythemia vera. BaF3 cells expressing the murine erythropoietin receptor and also carrying exon 12 mutations could proliferate without added interleukin-3. They also exhibited increased phosphorylation of JAK2 and extracellular regulated kinase 1 and 2, as compared with cells transduced by wild-type JAK2 or V617F JAK2. Three of the exon 12 mutations included a substitution of leucine for lysine at position 539 of JAK2. This mutation resulted in a myeloproliferative phenotype, including erythrocytosis, in a murine model of retroviral bone marrow transplantation. CONCLUSIONS: JAK2 exon 12 mutations define a distinctive myeloproliferative syndrome that affects patients who currently receive a diagnosis of polycythemia vera or idiopathic erythrocytosis.	Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes Natl Hlth Serv Trust, Cambridge, England; Whitehead Inst Biomed Res, Cambridge, England; MIT, Cambridge, England; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA; Wellcome Trust Sanger Inst, Hinxton, England; Queens Univ Belfast, Belfast, Antrim, North Ireland; St Thomas Hosp, London, England	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Wellcome Trust Sanger Institute; Queens University Belfast; Guy's & St Thomas' NHS Foundation Trust	Green, AR (corresponding author), Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	McMullin, Mary Frances/AAG-6078-2021; Erber, Wendy/A-1955-2012; levine, ross/AAE-7658-2019; McMullin, Mary F/AAF-6472-2020; Scott, Linda/D-9777-2012	McMullin, Mary Frances/0000-0002-0773-0204; Scott, Linda/0000-0003-0334-1479; Erber, Wendy/0000-0002-1028-9376; Green, Anthony/0000-0002-9795-0218; Tong, Wei/0000-0001-9951-2273; Beer, Philip/0000-0003-3056-5419	Medical Research Council [MC_U105161083, G0300497] Funding Source: Medline; NCI NIH HHS [P01 CA066996, K01 CA115679] Funding Source: Medline; NHLBI NIH HHS [P01 HL032262] Funding Source: Medline; NIDDK NIH HHS [P01 DK050654] Funding Source: Medline; Wellcome Trust [077012] Funding Source: Medline; MRC [G0300497, MC_U105161083] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K01CA115679, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Horn T, 2006, J MOL DIAGN, V8, P299, DOI 10.2353/jmoldx.2006.050128; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	34	888	988	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					459	468		10.1056/NEJMoa065202	http://dx.doi.org/10.1056/NEJMoa065202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267906	Green Accepted, Bronze			2022-12-24	WOS:000243860700006
J	Tombola, F; Pathak, MM; Gorostiza, P; Isacoff, EY				Tombola, Francesco; Pathak, Medha M.; Gorostiza, Pau; Isacoff, Ehud Y.			The twisted ion-permeation pathway of a resting voltage-sensing domain	NATURE			English	Article							FOCUSED ELECTRIC-FIELD; SHAKER K+ CHANNEL; POTASSIUM CHANNEL; TRANSMEMBRANE MOVEMENT; SENSOR; PORE; DISPLACEMENT; ACTIVATION; MECHANISM; MODELS	Proteins containing voltage-sensing domains (VSDs) translate changes in membrane potential into changes in ion permeability or enzymatic activity(1-3). In channels, voltage change triggers a switch in conformation of the VSD, which drives gating in a separate pore domain, or, in channels lacking a pore domain, directly gates an ion pathway within the VSD4,5. Neither mechanism is well understood(6). In the Shaker potassium channel, mutation of the first arginine residue of the S4 helix to a smaller uncharged residue makes the VSD permeable to ions ('omega current') in the resting conformation ('S4 down')(7). Here we perform a structure-guided perturbation analysis of the omega conductance to map its VSD permeation pathway. We find that there are four omega pores per channel, which is consistent with one conduction path per VSD. Permeating ions from the extracellular medium enter the VSD at its peripheral junction with the pore domain, and then plunge into the core of the VSD in a curved conduction pathway. Our results provide a model of the resting conformation of the VSD.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Tombola, Francesco/C-7311-2011; Gorostiza, Pau/Q-2544-2015; isacoff, ehud/AAP-1459-2020; Tombola, Francesco/ABA-6002-2020	Gorostiza, Pau/0000-0002-7268-5577; Tombola, Francesco/0000-0002-9315-0352; Isacoff, Ehud Y./0000-0003-4775-9359				Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Minor DL, 2006, NAT STRUCT MOL BIOL, V13, P388, DOI 10.1038/nsmb0506-388; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; YU FH, 2004, SCI STKE; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	25	114	115	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					546	549		10.1038/nature05396	http://dx.doi.org/10.1038/nature05396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17187057				2022-12-24	WOS:000243867300045
J	Grimmler, M; Wang, YF; Mund, T; Cilensek, Z; Keidel, EM; Waddell, MB; Jakel, H; Kullmann, M; Kriwacki, RW; Hengst, L				Grimmler, Matthias; Wang, Yuefeng; Mund, Thomas; Cilensek, Zoran; Keidel, Eva-Maria; Waddell, M. Brett; Jaekel, Heidelinde; Kullmann, Michael; Kriwacki, Richard W.; Hengst, Ludger			Cdk-inhibitory activity and stability of p27(Kip1) are directly regulated by oncogenic tyrosine kinases	CELL			English	Article							MYELOGENOUS LEUKEMIA-CELLS; DEPENDENT KINASES; UBIQUITIN LIGASE; CYCLIN-A; P27; PHOSPHORYLATION; PROGRESSION; DEGRADATION; ACTIVATION; PATHWAY	P27(Kip1) controls cell proliferation by binding to and regulating the activity of cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are regulated through direct phosphorylation by tyrosine kinases. A conserved tyrosine residue (Y88) in the Cdk-binding domain of p27 can be phosphorylated by the Src-family kinase Lyn and the oncogene product BCR-ABL. Y88 phosphorylation does not prevent p27 binding to cyclin A/Cdk2. Instead, it causes phosphorylated Y88 and the entire inhibitory 3(10)-helix of p27 to be ejected from the Cdk2 active site, thus restoring partial Cdk activity. Importantly, this allows Y88-phosphorylated p27 to be efficiently phosphorylated on threonine 187 by Cdk2 which in turn promotes its SCF-Skp2-dependent degradation. This direct link between transforming tyrosine kinases and p27 may provide an explanation for Cdk kinase activities observed in p27 complexes and for premature p27 elimination in cells that have been transformed by activated tyrosine kinases.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Innsbruck; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, RW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org; ludger.hengst@i-med.ac.at	WANG, YUE/GWQ-9256-2022; Kriwacki, Richard/N-8154-2018; Kullmann, Michael Keith/AGY-4711-2022	Kriwacki, Richard/0000-0002-9798-6018; Grimmler, Matthias/0000-0003-2860-3391; Hengst, Ludger/0000-0002-0605-0223; Kullmann, Michael Keith/0000-0003-3567-3806; Mund, Thomas/0000-0002-3957-1105	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014675] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, R01 CA82491] Funding Source: Medline; NCRR NIH HHS [RR014675] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Coutts M, 2000, ONCOGENE, V19, P801, DOI 10.1038/sj.onc.1203398; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dong F, 1998, MOL BIOL CELL, V9, P2081, DOI 10.1091/mbc.9.8.2081; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; HALL M, 1995, ONCOGENE, V11, P1581; Hallek M, 1997, EXP HEMATOL, V25, P1367; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; Wang YF, 2005, CHEMBIOCHEM, V6, P2242, DOI 10.1002/cbic.200500260; Waugh DS, 1996, J BIOMOL NMR, V8, P184; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753	42	266	276	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					269	280		10.1016/j.cell.2006.11.047	http://dx.doi.org/10.1016/j.cell.2006.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254966	Bronze			2022-12-24	WOS:000244420500013
J	Kesselheim, AS; Avorn, J				Kesselheim, Aaron S.; Avorn, Jerry			The role of litigation in defining drug risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	PHS HHS [6T32HP1101] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Avorn J, 2005, POWERFUL MED BENEFIT; BACIU A, 2006, FUTURE DRUG SAFETY P; BERENSON A, 2003, NY TIMES        0921, pA1; Berenson Alex, 2006, N Y Times Web, pC2; BRENT RL, 1995, REPROD TOXICOL, V9, P337, DOI 10.1016/0890-6238(95)00020-B; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; DeAngelis CD, 2006, JAMA-J AM MED ASSOC, V296, P996, DOI 10.1001/jama.296.8.jed60051; Food and Drug Administration HHS, 2006, Fed Regist, V71, P3921; FR (Federal Register), 1985, FED REGISTER, V50, P7452; Harris G., 2005, NY TIMES 0225, pA1; JOHANNES L, 1997, WALL ST J       1211, pA1; JOHANNES L, 1999, WALL ST J       0928, pA1; KAY J, 2003, MIAMI DAILY BUS 0226; Koller EA, 2002, PHARMACOTHERAPY, V22, P841, DOI 10.1592/phco.22.11.841.33629; Struve Catherine T, 2005, Yale J Health Policy Law Ethics, V5, P587; U.S. Food and Drug Administration, 2004, FDA PUBL HLTH ADV WO; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; 2004, PUBLIC CITIZEN WORST	18	49	50	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					308	311		10.1001/jama.297.3.308	http://dx.doi.org/10.1001/jama.297.3.308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227983				2022-12-24	WOS:000243472300027
J	Schade, R; Andersohn, F; Suissa, S; Haverkamp, W; Garbe, E				Schade, Rene; Andersohn, Frank; Suissa, Samy; Haverkamp, Wilhelm; Garbe, Edeltraut			Dopamine agonists and the risk of cardiac-valve regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVULAR HEART-DISEASE; PRACTICE RESEARCH DATABASE; PARKINSONS-DISEASE; 5-HT2B RECEPTORS; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; MULTIPLE CLASSES; PERGOLIDE; FENFLURAMINE	BACKGROUND: Case reports and echocardiographic studies suggest that the ergot-derived dopamine agonists pergolide and cabergoline, used in the treatment of Parkinson's disease and the restless legs syndrome, may increase the risk of cardiac-valve regurgitation. METHODS: We used data from the United Kingdom General Practice Research Database to identify a population-based cohort comprising 11,417 subjects 40 to 80 years of age who were prescribed antiparkinsonian drugs between 1988 and 2005. We conducted a nested case-control analysis within this cohort in which each patient with newly diagnosed cardiac-valve regurgitation was matched with up to 25 control subjects from the cohort, according to age, sex, and year of entry into the cohort. Incidence-rate ratios for cardiac-valve regurgitation with the use of different dopamine agonists were estimated by conditional logistic-regression analysis. RESULTS: Of 31 case patients with newly diagnosed cardiac-valve regurgitation, 6 were currently exposed to pergolide, 6 were currently exposed to cabergoline, and 19 had not been exposed to any dopamine agonist within the previous year. The rate of cardiac-valve regurgitation was increased with current use of pergolide (incidence-rate ratio, 7.1; 95% confidence interval [CI], 2.3 to 22.3) and cabergoline (incidence-rate ratio, 4.9; 95% CI, 1.5 to 15.6), but not with current use of other dopamine agonists. CONCLUSIONS: In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.	Charite Univ Med Berlin, Dept Clin Pharmacol, Berlin, Germany; Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany; McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol,McGill Pharmacoepidemiol Res U, Montreal, PQ, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; Royal Victoria Hospital	Schade, R (corresponding author), Charite Univ Med Berlin, Dept Clin Pharmacol, Charite Campus Mitte, Berlin, Germany.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Chung EJ, 2006, MOVEMENT DISORD, V21, P586, DOI 10.1002/mds.20813; Committee on Safety of Medicines, 2003, CURRENT PROBLEMS PHA, V29, P7; Dhawan V, 2005, J NEURAL TRANSM, V112, P661, DOI 10.1007/s00702-005-0289-1; Earley CJ, 2003, NEW ENGL J MED, V348, P2103, DOI 10.1056/NEJMcp021288; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; Horvath J, 2004, MOVEMENT DISORD, V19, P656, DOI 10.1002/mds.20201; Jahnichen S, 2005, EUR J PHARMACOL, V513, P225, DOI 10.1016/j.ejphar.2005.03.010; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Peralta C, 2006, MOVEMENT DISORD, V21, P1109, DOI 10.1002/mds.20887; Pinero A, 2005, NEW ENGL J MED, V353, P1976, DOI 10.1056/NEJM200511033531822; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Rothman RB, 2000, CIRCULATION, V102, P2836; Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7	25	501	515	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					29	38		10.1056/NEJMoa062222	http://dx.doi.org/10.1056/NEJMoa062222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202453				2022-12-24	WOS:000243209600006
J	Golinko, MS				Golinko, Michael S.			A bump in the neck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												msg1@alum.mit.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2901	2902		10.1001/jama.296.24.2901	http://dx.doi.org/10.1001/jama.296.24.2901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190881				2022-12-24	WOS:000243069000001
J	Jalan, R; Williams, R; Bernuau, J				Jalan, Rajiv; Williams, Roger; Bernuau, Jacques			Paracetarnol: are therapeutic doses entirely safe?	LANCET			English	Editorial Material							ACUTE LIVER-FAILURE; ACETAMINOPHEN		UCL, UCL Inst Hepatol, London WC1E 6HX, England; Hop Beaujon, APHP, Pole Malad Appareil Digest, Clichy, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Jalan, R (corresponding author), UCL, UCL Inst Hepatol, London WC1E 6HX, England.	r.j.jalan@ucl.ac.uk						Bernuau JR, 2004, HEPATOLOGY, V40, p499A; CRITCHLEY JAJH, 1986, BRIT J CLIN PHARMACO, V22, P649, DOI 10.1111/j.1365-2125.1986.tb02953.x; KWAN D, 1995, DIGEST DIS SCI, V40, P1951, DOI 10.1007/BF02208663; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Moynihan R, 2002, BRIT MED J, V325, P678, DOI 10.1136/bmj.325.7366.678; OGRADY JG, 1993, LANCET, V342, P273; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Polson J, 2006, GASTROENTEROLOGY, V130, pA772; PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002; *US FOOD DRUG ADM, 2006, CDER 2002 M DOC AUG; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; Yaghi Cesar, 2006, Gastroenterol Clin Biol, V30, P763, DOI 10.1016/S0399-8320(06)73311-5; Yin OQP, 2001, INT J PHARM, V222, P305, DOI 10.1016/S0378-5173(01)00712-8	13	39	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2195	2196		10.1016/S0140-6736(06)69874-7	http://dx.doi.org/10.1016/S0140-6736(06)69874-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189017				2022-12-24	WOS:000243076800009
J	Ridgway, J; Zhang, G; Wu, Y; Stawicki, S; Liang, WC; Chanthery, Y; Kowalski, J; Watts, RJ; Callahan, C; Kasman, I; Singh, M; Chien, M; Tan, C; Hongo, JAS; de Sauvage, F; Plowman, G; Yan, MH				Ridgway, John; Zhang, Gu; Wu, Yan; Stawicki, Scott; Liang, Wei-Ching; Chanthery, Yvan; Kowalski, Joe; Watts, Ryan J.; Callahan, Christopher; Kasman, Ian; Singh, Mallika; Chien, May; Tan, Christine; Hongo, Jo-Anne S.; de Sauvage, Fred; Plowman, Greg; Yan, Minhong			Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis	NATURE			English	Article							ENDOTHELIAL-CELL FUNCTION; VASCULAR DEVELOPMENT; UP-REGULATION; VEGF; DIFFERENTIATION; EXPRESSION; ANTIBODIES; LETHALITY; ARTERIAL; PATHWAY	Haploinsufficiency of DII4, a vascular-specific Notch ligand, has shown that it is essential for embryonic vascular development and arteriogenesis(1-3). Mechanistically, it is unclear how the DII4-mediated Notch pathway contributes to complex vascular processes that demand meticulous coordination of multiple signalling pathways. Here we show that DII4-mediated Notch signalling has a unique role in regulating endothelial cell proliferation and differentiation. Neutralizing DII4 with a DII4-selective antibody rendered endothelial cells hyperproliferative, and caused defective cell fate specification or differentiation both in vitro and in vivo. In addition, blocking DII4 inhibited tumour growth in several tumour models. Remarkably, antibodies against DII4 and antibodies against vascular endothelial growth factor (VEGF) had paradoxically distinct effects on tumour vasculature. Our data also indicate that DII4-mediated Notch signalling is crucial during active vascularization, but less important for normal vessel maintenance. Furthermore, unlike blocking Notch signalling globally, neutralizing DII4 had no discernable impact on intestinal goblet cell differentiation(4,5), supporting the idea that DII4-mediated Notch signalling is largely restricted to the vascular compartment. Therefore, targeting DII4 might represent a broadly efficacious and well-tolerated approach for the treatment of solid tumours.	Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; Genentech Inc, Antibody Engn, San Francisco, CA 94080 USA; Genentech Inc, Pathol, San Francisco, CA 94080 USA; Genentech Inc, Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, MH (corresponding author), Genentech Inc, Tumor Biol & Angiogenesis, 1 DNA Way, San Francisco, CA 94080 USA.	minhong@gene.com	Plowman, Greg/O-8032-2019; PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X				Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	22	762	875	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1083	1087		10.1038/nature05313	http://dx.doi.org/10.1038/nature05313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183323				2022-12-24	WOS:000242971100059
J	Barclay, RL; Vicari, JJ; Doughty, AS; Johanson, JF; Greenlaw, RL				Barclay, Robert L.; Vicari, Joseph J.; Doughty, Andrea S.; Johanson, John F.; Greenlaw, Roger L.			Colonoscopic withdrawal times and adenoma detection during screening colonoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER INCIDENCE; FLEXIBLE SIGMOIDOSCOPY; MISS RATES; POLYPECTOMY; PREVENTION; EFFICACY; RECOMMENDATIONS; SURVEILLANCE; VARIABILITY; PERFORMANCE	BACKGROUND: Colonoscopy is commonly used to screen for neoplasia. To assess the performance of screening colonoscopy in everyday practice, we conducted a study of the rates of detection of adenomas and the amount of time taken to withdraw the colonoscope among endoscopists in a large community-based practice. METHODS: During a 15-month period, 12 experienced gastroenterologists performed 7882 colonoscopies, of which 2053 were screening examinations in subjects who had not previously undergone colonoscopy. We recorded the numbers, sizes, and histologic features of the neoplastic lesions detected during screening, as well as the duration of insertion and of withdrawal of the colonoscope during the procedure. We compared rates of detection of neoplastic lesions among gastroenterologists who had mean colonoscopic withdrawal times of less than 6 minutes with the rates of those who had mean withdrawal times of 6 minutes or more. According to experts, 6 minutes is the minimum length of time to allow adequate inspection during instrument withdrawal. RESULTS: Neoplastic lesions (mostly adenomatous polyps) were detected in 23.5% of screened subjects. There were large differences among gastroenterologists in the rates of detection of adenomas (range of the mean number of lesions per subject screened, 0.10 to 1.05; range of the percentage of subjects with adenomas, 9.4 to 32.7%) and in their times of withdrawal of the colonoscope from the cecum to the anus (range, 3.1 to 16.8 minutes for procedures during which no polyps were removed). As compared with colonoscopists with mean withdrawal times of less than 6 minutes, those with mean withdrawal times of 6 minutes or more had higher rates of detection of any neoplasia (28.3% vs. 11.8%, P<0.001) and of advanced neoplasia (6.4% vs. 2.6%, P=0.005). CONCLUSIONS: In this large community-based gastroenterology practice, we observed greater rates of detection of adenomas among endoscopists who had longer mean times for withdrawal of the colonoscope. The effect of variation in withdrawal times on lesion detection and the prevention of colorectal cancer in the context of widespread colonoscopic screening is not known. Ours was a preliminary study, so the generalizability and implications for clinical practice need to be determined by future studies.	Rockford Gastroenterol Associates, Rockford, IL 61107 USA; Univ Illinois, Coll Med, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Barclay, RL (corresponding author), Rockford Gastroenterol Associates, 401 Roxbury Rd, Rockford, IL 61107 USA.	drbarclay@rockfordgi.com	Wilkins, Thad/G-2541-2010					Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Barclay RL, 2004, GASTROINTEST ENDOSC, V60, P527, DOI 10.1016/S0016-5107(04)01857-7; Beam CA, 2003, J NATL CANCER I, V95, P282, DOI 10.1093/jnci/95.4.282; Bresalier R, 2002, SLEISENGER FORDTRANS, P2215; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Gupta DK, 2001, ACTA CYTOL, V45, P697, DOI 10.1159/000328290; Halligan S, 2003, CLIN RADIOL, V58, P948, DOI 10.1016/S0009-9260(03)00317-9; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Itzkowitz SH, 2002, SLEISENGER FORDTRANS, P2175; LEE YS, 1988, DIS COLON RECTUM, V31, P291, DOI 10.1007/BF02554363; Lieberman D, 2004, ANN INTERN MED, V141, P401, DOI 10.7326/0003-4819-141-5-200409070-00018; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pinsky PF, 2005, CLIN GASTROENTEROL H, V3, P792, DOI 10.1053/S1542-3565(05)00286-7; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sanchez W, 2004, AM J GASTROENTEROL, V99, P1941, DOI 10.1111/j.1572-0241.2004.40569.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	25	987	1021	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2533	2541		10.1056/NEJMoa055498	http://dx.doi.org/10.1056/NEJMoa055498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167136				2022-12-24	WOS:000242778800005
J	Rapp, M; Seppala, S; Granseth, E; von Heijne, G				Rapp, Mikaela; Seppala, Susanna; Granseth, Erik; von Heijne, Gunnar			Emulating membrane protein evolution by rational design	SCIENCE			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; X-RAY-STRUCTURE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; CRYSTAL-STRUCTURE; ABC TRANSPORTER; EMRE; MECHANISM; TOPOLOGY; SELECTIVITY	How do integral membrane proteins evolve in size and complexity? Using the small multidrug-resistance protein EmrE from Escherichia coli as a model, we experimentally demonstrated that the evolution of membrane proteins composed of two homologous but oppositely oriented domains can occur in a small number of steps: An original dual-topology protein evolves, through a gene-duplication event, to a heterodimer formed by two oppositely oriented monomers. This simple evolutionary pathway can explain the frequent occurrence of membrane proteins with an internal pseudo-two-fold symmetry axis in the plane of the membrane.	Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Rapp, Mikaela/0000-0002-4401-9518; Seppala, Susanna/0000-0002-2983-3669				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	27	103	104	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1282	1284		10.1126/science.1135406	http://dx.doi.org/10.1126/science.1135406			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17255477				2022-12-24	WOS:000244564700051
J	Stanger, BZ; Tanaka, AJ; Melton, DA				Stanger, Ben Z.; Tanaka, Akemi J.; Melton, Douglas A.			Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; BETA-CATENIN; GROWTH; DIFFERENTIATION; COMPLEMENTATION; EPITHELIUM; LINEAGE; FGF10	The determinants of vertebrate organ size are poorly understood, but the process is thought to depend heavily on growth factors and other environmental cues. In the blood and central nervous system, for example, organ mass is determined primarily by growth-factor-regulated cell proliferation and apoptosis to achieve a final target size. Here, we report that the size of the mouse pancreas is constrained by an intrinsic programme established early in development, one that is essentially not subject to growth compensation. Specifically, final pancreas size is limited by the size of the progenitor cell pool that is set aside in the developing pancreatic bud. By contrast, the size of the liver is not constrained by reductions in the progenitor cell pool. These findings show that progenitor cell number, independently of regulation by growth factors, can be a key determinant of organ size.	Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Melton, DA (corresponding author), Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bstanger@mail.med.upenn.edu; dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Stanger, Ben/0000-0003-0410-4037				Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KALTHOFF K, 1996, ANAL BIOL DEV; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Liegeois NJ, 1996, P NATL ACAD SCI USA, V93, P1303, DOI 10.1073/pnas.93.3.1303; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Offield MF, 1996, DEVELOPMENT, V122, P983; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Twitty VC, 1931, J EXP ZOOL, V59, P61, DOI 10.1002/jez.1400590105; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw; WOLPERT L, 1981, BRIT MED BULL, V37, P215, DOI 10.1093/oxfordjournals.bmb.a071705	42	266	272	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					886	891		10.1038/nature05537	http://dx.doi.org/10.1038/nature05537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259975				2022-12-24	WOS:000244341200042
J	Zheng, Z; Chen, TG; Li, XL; Haura, E; Sharma, A; Bepler, G				Zheng, Zhong; Chen, Tingan; Li, Xueli; Haura, Eric; Sharma, Anupama; Bepler, Gerold			DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTASE SUBUNIT M1; PHASE-III TRIAL; RIBONUCLEOTIDE REDUCTASE; PROTEIN EXPRESSION; GEMCITABINE; CISPLATIN; SURVIVAL; MUTATIONS; PTEN; SUPPRESSION	Background: RRM1, the regulatory subunit of ribonucleotide reductase, is involved in carcinogenesis, tumor progression, and the response of non-small-cell lung cancer to treatment. Methods: We developed an automated quantitative determination of the RRM1 protein in routinely processed histologic specimens. In these specimens, we measured the expression of RRM1 and two other proteins that are relevant to non-small-cell lung cancer: the excision repair cross-complementation group 1 (ERCC1) protein and the phosphatase and tensin homologue (PTEN). We compared the results with the clinical outcomes in 187 patients with early-stage non-small-cell lung cancer who had received only surgical treatment. Results: RRM1 expression correlated with the expression of ERCC1 (P < 0.001) but not with the expression of PTEN (P=0.37). The median disease-free survival exceeded 120 months in the group of patients with tumors that had high expression of RRM1 and was 54.5 months in the group with low expression of RRM1 (hazard ratio for disease progression or death in the high-expression group, 0.46; P=0.004). The overall survival was more than 120 months for patients with tumors with high expression of RRM1 and 60.2 months for those with low expression of RRM1 (hazard ratio for death, 0.61; P=0.02). Among these 187 patients, the survival advantage was limited to the 30% of patients with tumors that had a high expression of both RRM1 and ERCC1. Conclusions: RRM1 and ERCC1 are determinants of survival after surgical treatment of early-stage, non-small-cell lung cancer.	H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Bepler, G (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, MRC-4W,Rm 4046,12902 Magnolia Dr, Tampa, FL 33612 USA.	beplerg@moffitt.usf.edu			NCI NIH HHS [R21-CA110487, R01-CA102726] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102726, R21CA110487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2002, J CLIN ONCOL, V20, P1353, DOI 10.1200/JCO.20.5.1353; BEPLER G, 2006, ASCO 2006 ED BOOK, P431; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bertheau P, 1998, J CLIN PATHOL, V51, P370, DOI 10.1136/jcp.51.5.370; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; CARBONE DP, 1994, CHEST, V106, pS377, DOI 10.1378/chest.106.6.377S; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Gridelli C, 2003, J CLIN ONCOL, V21, P3025, DOI 10.1200/JCO.2003.06.099; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Pitterle DM, 1999, MAMM GENOME, V10, P916, DOI 10.1007/s003359901114; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Rosell R, 2005, J CLIN ONCOL, V23, p621S; RUCKDESCHEL JC, 2004, CLIN ONCOLOGY, P1649; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Treat J, 2005, J CLIN ONCOL, V23, p627S; Tsao MS, 2006, NEW ENGL J MED, V355, P1746; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736	32	397	436	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					800	808		10.1056/NEJMoa065411	http://dx.doi.org/10.1056/NEJMoa065411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314339	Bronze			2022-12-24	WOS:000244326700006
J	O'Donnell, MJ; Kearon, C; Johnson, J; Robinson, M; Zondag, M; Turpie, I; Turpie, AG				O'Donnell, Martin J.; Kearon, Clive; Johnson, Judy; Robinson, Marlene; Zondag, Michelle; Turpie, Irene; Turpie, Alexander G.			Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							PERIOPERATIVE MANAGEMENT; ELECTIVE SURGERY; ENOXAPARIN; PATIENT; THERAPY	Background: Preoperative low-molecular-weight heparin (LMWH) is often used when warfarin therapy is interrupted for surgery. Objective: To determine the preoperative anticoagulant activity of LMWH following a standardized "bridging" regimen. Design: Prospective cohort study. Setting: Single university hospital. Patients: Consecutive patients who had warfarin therapy interrupted before an invasive procedure. Intervention: Enoxaparin, 1 mg/kg of body weight, twice daily. The last dose was administered the evening before surgery. Measurements: Blood anti-factor Xa heparin levels measured shortly before surgery. Results: Preoperative anti-Xa heparin levels were obtained in 80 patients at an average of 14 hours after the last dose of enoxaparin was administered. The average anti-Xa heparin level was 0.6 U/mL. The anti-Xa heparin level, measured shortly before surgery, was 0.5 U/mL or greater in 54 (68%) patients and 1.0 U/mL or greater in 13 (16%) patients. A shorter interval since the last dose (P < 0.001) and a higher body mass index (P = 0.001) were associated with higher preoperative anti-Xa heparin levels. Limitations: The small sample size limits accurate estimates of the frequency of the clinical outcomes. A single regimen of LMWH was evaluated. Conclusions: Anti-Xa heparin levels often remain high at the time of surgery if a last dose of a twice-daily regimen of LMWH is given the evening before surgery.	McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; Hamilton Hlth Sci Fdn, Hamilton, ON, Canada	McMaster University	O'Donnell, MJ (corresponding author), McMaster Univ, Henderson Res Ctr, 70 Wing,Room 220,711 Concess St, Hamilton, ON L8V 1C3, Canada.	odonnm@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020	O'Donnell, Martin/0000-0002-7347-7761				Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Becker RC, 2002, AM HEART J, V143, P753, DOI 10.1067/mhj.2002.120774; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Douketis JD, 2004, ARCH INTERN MED, V164, P1319, DOI 10.1001/archinte.164.12.1319; Douketis JD, 2002, THROMB HAEMOSTASIS, V88, P37; Douketis JD, 2000, CAN J CARDIOL, V16, P326; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; Garcia DA, 2005, J THROMB THROMBOLYS, V18, P199, DOI 10.1007/s11239-005-0346-5; Heit JA, 2001, J THROMB THROMBOLYS, V12, P81, DOI 10.1023/A:1012746729537; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Montalescot G, 2004, CIRCULATION, V110, P392, DOI 10.1161/01.CIR.0000136830.65073.C7; O'Donnell M, 2006, CLIN GERIATR MED, V22, P199, DOI 10.1016/j.cger.2005.09.008; Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x; Turpie AG, 2004, BLOOD, V104, p202A, DOI 10.1182/blood.V104.11.703.703; Wilson SJ, 2001, HAEMOSTASIS, V31, P42	16	71	74	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					184	187		10.7326/0003-4819-146-3-200702060-00007	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283349				2022-12-24	WOS:000243957400004
J	Coombes, R				Coombes, Rebecca			Is killing pain worth the risk? MPs argue that the regulator went too far when it banned co-proxamol	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					186	187		10.1136/bmj.39104.415961.68	http://dx.doi.org/10.1136/bmj.39104.415961.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255610	Green Published			2022-12-24	WOS:000244027600031
J	Yeung, RSM				Yeung, Rae S. M.			Phenotype and coronary outcome in Kawasaki's disease	LANCET			English	Editorial Material							ASSOCIATION; ANEURYSMS		Univ Toronto, Hosp Sick Children, Dept Paediat, Div Rheumatol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Yeung, RSM (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Rheumatol, Toronto, ON M5G 1X8, Canada.	rae.yeung@sickkids.ca		Yeung, Rae/0000-0003-2361-725X				Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7; Benseler SM, 2006, ANN RHEUM DIS, V65, P245; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; BURNS JC, 1991, J PEDIATR-US, V118, P680, DOI 10.1016/S0022-3476(05)80026-5; DANIELS SR, 1987, AM J DIS CHILD, V141, P205, DOI 10.1001/archpedi.1987.04460020095035; Gong GWK, 2006, J PEDIATR-US, V148, P800, DOI 10.1016/j.jpeds.2006.01.039; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KOREN G, 1986, J PEDIATR-US, V108, P388, DOI 10.1016/S0022-3476(86)80878-2; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Rowley A H, 1991, Adv Pediatr, V38, P51; Sung RYT, 2006, PEDIATR INFECT DIS J, V25, P521, DOI 10.1097/01.inf.0000215263.96289.1c	12	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					85	87		10.1016/S0140-6736(07)60045-2	http://dx.doi.org/10.1016/S0140-6736(07)60045-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126TK	17223454				2022-12-24	WOS:000243538200007
J	Mitro, N; Mak, PA; Vargas, L; Godio, C; Hampton, E; Molteni, V; Kreusch, A; Saez, E				Mitro, Nico; Mak, Puiying A.; Vargas, Leo; Godio, Cristina; Hampton, Eric; Molteni, Valentina; Kreusch, Andreas; Saez, Enrique			The nuclear receptor LXR is a glucose sensor	NATURE			English	Article							ELEMENT-BINDING PROTEIN-1C; X-RECEPTOR; LIVER; METABOLISM; ALPHA; TRANSCRIPTION; MICE; HOMEOSTASIS; LIPOGENESIS; DEFICIENCY	The liver has a central role in glucose homeostasis, as it has the distinctive ability to produce and consume glucose(1). On feeding, glucose influx triggers gene expression changes in hepatocytes to suppress endogenous glucose production and convert excess glucose into glycogen or fatty acids to be stored in adipose tissue(2). This process is controlled by insulin, although debate exists as to whether insulin acts directly or indirectly on the liver(3). In addition to stimulating pancreatic insulin release, glucose also regulates the activity of ChREBP, a transcription factor that modulates lipogenesis(4). Here we describe another mechanism whereby glucose determines its own fate: we show that glucose binds and stimulates the transcriptional activity of the liver X receptor (LXR), a nuclear receptor that coordinates hepatic lipid metabolism. D-Glucose and D-glucose-6-phosphate are direct agonists of both LXR-alpha and LXR-beta. Glucose activates LXR at physiological concentrations expected in the liver and induces expression of LXR target genes with efficacy similar to that of oxysterols, the known LXR ligands. Cholesterol homeostasis genes that require LXR for expression are upregulated in liver and intestine of fasted mice re-fed with a glucose diet, indicating that glucose is an endogenous LXR ligand. Our results identify LXR as a transcriptional switch that integrates hepatic glucose metabolism and fatty acid synthesis.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Saez, E (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Hopkins Dr, San Diego, CA 92121 USA.	esaez@scripps.edu		Godio, Cristina/0000-0003-2639-6368; Mitro, Nico/0000-0002-5000-3619				Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fehr M, 2004, J FLUORESC, V14, P603, DOI 10.1023/B:JOFL.0000039347.94943.99; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Moore MC, 2003, BEST PRACT RES CL EN, V17, P343, DOI 10.1016/S1521-690X(03)00036-8; Parks EJ, 2002, P NUTR SOC, V61, P281, DOI 10.1079/PNS2002148; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	24	411	439	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					219	223		10.1038/nature05449	http://dx.doi.org/10.1038/nature05449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17187055				2022-12-24	WOS:000243384300054
J	Canfield, DE; Poulton, SW; Narbonne, GM				Canfield, Don E.; Poulton, Simon W.; Narbonne, Guy M.			Late-Neoproterozoic deep-ocean oxygenation and the rise of animal life	SCIENCE			English	Article							MISTAKEN POINT; SNOWBALL; IRON; PRESERVATION; ORIGIN	Because animals require oxygen, an increase in late-Neoproterozoic oxygen concentrations has been suggested as a stimulus for their evolution. The iron content of deep-sea sediments shows that the deep ocean was anoxic and ferruginous before and during the Gaskiers glaciation 580 million years ago and that it became oxic afterward. The first known members of the Ediacara biota arose shortly after the Gaskiers glaciation, suggesting a causal link between their evolution and this oxygenation event. A prolonged stable oxic environment may have permitted the emergence of bilateral motile animals some 25 million years later.	Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada	University of Southern Denmark; University of Southern Denmark; Newcastle University - UK; Queens University - Canada	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, Campusvej 55, DK-5230 Odense M, Denmark.	dec@biology.sdu.dk	Narbonne, Guy M/I-7518-2012; Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X	Natural Environment Research Council [NE/C518465/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BOWRING SA, 2003, ASTROBIOLOGY, V2, P112; Broecker W.S., 1982, TRACERS SEA, V690; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARDINER S, 1988, CAN J EARTH SCI, V25, P1579, DOI 10.1139/e88-151; Gorjan P, 2000, PRECAMBRIAN RES, V100, P151, DOI 10.1016/S0301-9268(99)00073-X; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halverson Galen P., 2006, V27, P231; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hurtgen MT, 2006, EARTH PLANET SC LETT, V245, P551, DOI 10.1016/j.epsl.2006.03.026; Knoll AH, 2006, LETHAIA, V39, P13, DOI 10.1080/00241160500409223; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Knoll AH, 2003, LIFE YOUNG PLANET 1; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; MISRA SB, 1971, GEOL SOC AM BULL, V82, P979, DOI 10.1130/0016-7606(1971)82[979:SADHOL]2.0.CO;2; Narbonne G., 2005, N AM PAL CONV FIELD; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 2001, B5 GEOL ASS CAN; Olcott AN, 2006, GEOCHIM COSMOCHIM AC, V70, pA456, DOI 10.1016/j.gca.2006.06.918; Olcott AN, 2005, SCIENCE, V310, P471, DOI 10.1126/science.1115769; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; RUNNEGAR B, 1991, GLOBAL PLANET CHANGE, V97, P97; SCOTESE CR, 2001, PALEOMAP PROJECT, V51; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; WILLIAMS H, 1979, GEOL SURV CAN MEM, V389; Wood DA, 2003, CAN J EARTH SCI, V40, P1375, DOI 10.1139/E03-048; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	37	661	734	9	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					92	95		10.1126/science.1135013	http://dx.doi.org/10.1126/science.1135013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17158290				2022-12-24	WOS:000243259100042
J	Greenaway, C; Dongier, P; Boivin, JF; Tapiero, B; Miller, M; Schwartzman, K				Greenaway, Christina; Dongier, Pierre; Boivin, Jean-Francois; Tapiero, Bruce; Miller, Mark; Schwartzman, Kevin			Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees	ANNALS OF INTERNAL MEDICINE			English	Article							VISITING FRIENDS; UNITED-STATES; EPIDEMIOLOGY; ELIMINATION	Background: Despite effective vaccination programs for measles, mumps, and rubella in the United States and Canada, outbreaks continue to occur in susceptible subgroups, such as foreign-born persons. Objective: To determine the susceptibility of newly arrived immigrants and refugees to measles, mumps, and rubella. Design: Seroprevalence study. etting: Two hospitals and three community clinics in Montreal, Quebec, Canada. Patients: 1480 adult immigrants and refugees who were recruited from October 2002 to December 2004. Measurements: Sociodemographic and clinical data and serology for measles, mumps, and rubella. Results: Thirty-six percent (range, 22% to 54%) of the study population was nonimmune to at least 1 of the 3 diseases. This proportion varied by age, sex, and region of origin. In multivariate analysis and after adjustment for region of origin, age, and socioeconomic factors, immigrant women had higher odds (odds ratio, 2.1) of being immune to measles (95% CI, 1.2 to 3.8) and an odds ratio of 1.7 of being nonimmune to rubella (CI, 1.2 to 2.6) compared with immigrant men. Limitations: The results from the community-based convenience sample of immigrants may not be generalizable to all immigrant populations. Conclusions: Many new immigrants and refugees, particularly women, are susceptible to measles, mumps, or rubella and may benefit from targeted vaccination programs.	McGill Univ, Sir Mortimer B Davis Jewish Hosp, Cote des Neiges Local Community Hlth Ctr, Div Infect Dis, Montreal, PQ H3T 1E2, Canada; Hop St Justine, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal	Greenaway, C (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Hosp, Cote des Neiges Local Community Hlth Ctr, Div Infect Dis, 3755 Cote St Catherine Rd,Room G-143, Montreal, PQ H3T 1E2, Canada.	ca.greenaway@mcgill.ca						Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Barnett ED, 2002, CLIN INFECT DIS, V35, P403, DOI 10.1086/341772; *CAN NAT REP IMM, 1999, PEADIAT CHILD HL SC, V4, pC5; *CDC, TECHN INSTR PAN PHYS; Gershman K., 2006, Morbidity and Mortality Weekly Report, V55, P559; *IMM QUEB GOV QUEB, 2001, PORTR IMM POP 2001 C; King A, 2004, J INFECT DIS, V189, pS236, DOI 10.1086/378499; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; Papania MJ, 2004, J INFECT DIS, V189, pS61, DOI 10.1086/381557; Reef SE, 2002, JAMA-J AM MED ASSOC, V287, P464, DOI 10.1001/jama.287.4.464; *STAT CAN, 2001, IMM CIT 2001 CENS OT; U.S. Census Bureau, 2000 CENS POP HOUS; United Nations, 2002, INT MIGR REP 2002; *WHO, 2004, WHO VACC PREV DIS MO; Willis Bayo C., 2005, Morbidity and Mortality Weekly Report, V54, P1; 1994, MMWR MORB MORTAL WKL, V43, P391; 1994, MMWR MORB MORTAL WKL, V43, P397	19	33	33	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					20	W4		10.7326/0003-4819-146-1-200701020-00005	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200218				2022-12-24	WOS:000247893300003
J	Sandblad, L; Busch, KE; Tittmann, P; Gross, H; Brunner, D; Hoenger, A				Sandblad, Linda; Busch, Karl Emanuel; Tittmann, Peter; Gross, Heinz; Brunner, Damian; Hoenger, Andreas			The Schizosaccharomyces pombe EB1 homolog Mal3p binds and stabilizes the microtubule lattice seam	CELL			English	Article							END-TRACKING PROTEINS; 3-DIMENSIONAL STRUCTURE; STRUCTURAL INSIGHTS; BETA-TUBULIN; IN-VITRO; KINESIN; TIP1P; DECORATION; COOPERATE; DYNAMICS	End binding 1 (EB1) proteins are highly conserved regulators of microtubule dynamics. Using electron microscopy (EM) and high-resolution surface shadowing we have studied the microtubule-binding properties of the fission yeast EB1 homolog Mal3p. This allowed for a direct visualization of Mal3p bound on the surface of microtubules. Mal3p particles usually formed a single line on each microtubule along just one of the multiple grooves that are formed by adjacent protofilaments. We provide structural data showing that the alignment of Mal3p molecules coincides with the microtubule lattice seam as well as data suggesting that Mal3p not only binds but also stabilizes this seam. Accordingly, Mal3p stabilizes microtubules through a specific interaction with what is potentially the weakest part of the microtubule in a way not previously demonstrated. Our findings further suggest that microtubules exhibit two distinct reaction platforms on their surface that can independently interact with target structures such as microtubule-associated proteins, motors, kinetochores, or membranes.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; ETH, Swiss Fed Inst Technol, Electron Microscopy Ctr, CH-8093 Zurich, Switzerland; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder	Brunner, D (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	brunner@embl.de; andreas.hoenger@colorado.edu	Brunner, Damian/F-2024-2011	Busch, Karl Emanuel/0000-0001-7886-3226; Brunner, Damian/0000-0001-5250-492X; Hoenger, Andreas/0000-0001-9176-6658				AFZELIUS BA, 1990, J CELL SCI, V95, P207; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; AMOS LA, 1979, NATURE, V279, P607, DOI 10.1038/279607a0; AMOS LA, 1974, J CELL SCI, V14, P523; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Austin JR, 2005, J CELL SCI, V118, P3895, DOI 10.1242/jcs.02512; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; BEURON F, 2001, STRUCTURAL ANAL MICR, V164; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Chretien D, 1996, STRUCTURE, V4, P1031, DOI 10.1016/S0969-2126(96)00110-4; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Dias DP, 1999, J MOL BIOL, V287, P287, DOI 10.1006/jmbi.1999.2597; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GROSS H, 1990, 12TH P INT C MICR, V1, P510; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Hoenger A, 2000, BIOL CHEM, V381, P1001, DOI 10.1515/BC.2000.123; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; KIKKAWA M, 1994, J CELL BIOL, V127, P1965, DOI 10.1083/jcb.127.6.1965; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; MANDELKOW EM, 1985, J MOL BIOL, V181, P123, DOI 10.1016/0022-2836(85)90330-4; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; SMITH PR, 1977, J ULTRA MOL STRUCT R, V61, P124, DOI 10.1016/S0022-5320(77)90011-9; SONG YH, 1995, J CELL BIOL, V128, P81, DOI 10.1083/jcb.128.1.81; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sosa H, 1996, J MOL BIOL, V260, P743, DOI 10.1006/jmbi.1996.0434; SU LK, 1995, CANCER RES, V55, P2972; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042	47	123	125	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1415	1424		10.1016/j.cell.2006.11.025	http://dx.doi.org/10.1016/j.cell.2006.11.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190604	Bronze			2022-12-24	WOS:000243690000020
J	Aylwin, CJ; Konig, TC; Brennan, NW; Shirley, PJ; Davies, G; Walsh, MS; Brohi, K				Aylwin, Christopher J.; Koenig, Thomas C.; Brennan, Nora W.; Shirley, Peter J.; Davies, Gareth; Walsh, Michael S.; Brohi, Karim			Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005	LANCET			English	Article							TERRORIST BOMBINGS; TRAUMA CARE; INJURIES; MANAGEMENT; CITY	Background The terrorist bombings in London on July 7, 2005, produced the largest mass casualty event in the UK since World War 2. The aim of this study was to analyse the prehospital and in-hospital response to the incident and identify system processes that optimise resource use and reduce critical mortality. Methods This study was a retrospective analysis of the London-wide prehospital response and the in-hospital response of one academic trauma Centre. Data for injuries, outcome, triage, patient flow, and resource use were obtained by the review of emergency services and hospital records. Findings There were 775 casualties and 56 deaths, 53 at scene. 55 patients were triaged to priority dispatch and 20 patients were critically injured. Critical mortality was low at 15% and not due to poor availability of resources. Over-triage rates were reduced where advanced prehospital teams did initial scene triage. The Royal London Hospital received 194 casualties, 27 arrived as seriously injured. Maximum surge rate was 18 seriously injured patients per hour and resuscitation room capacity was reached within 15 min. 17 patients needed surgery and 264 units of blood products were used in the first 15 h, close to the hospital's routine daily blood use. Interpretation Critical mortality was reduced by rapid advanced major incident management and seems unrelated to over-triage. Hospital surge capacity can be maintained by repeated effective triage and implementing a hospital-wide damage control philosophy, keeping investigations to a minimum, and transferring patients rapidly to definitive care.	Royal London Hosp, Dept Trauma Surg, London E1 1BB, England; Royal London Hosp, Dept Intens Care Med, London E1 1BB, England; Royal London Hosp, Dept Emergency Med & Prehosp Care, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital	Brohi, K (corresponding author), Royal London Hosp, Dept Trauma Surg, London E1 1BB, England.	karim@trauma.org						[Anonymous], EMERGO TRAIN SYSTEM; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biancolini CA, 1999, J TRAUMA, V47, P728, DOI 10.1097/00005373-199910000-00019; Christie P M, 1998, J Med Syst, V22, P289; Cushman JG, 2003, J TRAUMA, V54, P147, DOI 10.1097/00005373-200301000-00018; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; FRYKBERG ER, 1987, MIL MED, V152, P563; Hirshberg A, 1999, J TRAUMA, V47, P545, DOI 10.1097/00005373-199909000-00020; Hirshberg A, 2001, ANN EMERG MED, V37, P647, DOI 10.1067/mem.2001.115650; Hirshberg A, 2005, J TRAUMA, V58, P686, DOI 10.1097/01.TA.0000159243.70507.86; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Lockey DJ, 2005, RESUSCITATION, V66, pIX, DOI 10.1016/j.resuscitation.2005.07.005; *LOND EM SERV LIAI, MAJ INC PROC MAN; Mackway-Jones K, 2019, MAJOR INCIDENT MEDIC, V2; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813; *WHO, 2005, WHO ANN REP HLTH ACT	20	270	279	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2219	2225		10.1016/S0140-6736(06)69896-6	http://dx.doi.org/10.1016/S0140-6736(06)69896-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189033				2022-12-24	WOS:000243076800029
J	Abu-Raddad, LJ; Patnaik, P; Kublin, JG				Abu-Raddad, Laith J.; Patnaik, Padmaja; Kublin, James G.			Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLINICAL EPISODES; ADULTS; TRANSMISSION; REPLICATION; UGANDA; TUBERCULOSIS; ACTIVATION; INDUCTION; COHORT	Mounting evidence has revealed pathological interactions between HIV and malaria in dually infected patients, but the public health implications of the interplay have remained unclear. A transient almost one-log elevation in HIV viral load occurs during febrile malaria episodes; in addition, susceptibility to malaria is enhanced in HIV-infected patients. A mathematical model applied to a setting in Kenya with an adult population of roughly 200,000 estimated that, since 1980, the disease interaction may have been responsible for 8,500 excess HIV infections and 980,000 excess malaria episodes. Co-infection might also have facilitated the geographic expansion of malaria in areas where HIV prevalence is high. Hence, transient and repeated increases in HIV viral load resulting from recurrent co-infection with malaria may be an important factor in promoting the spread of HIV in sub-Saharan Africa.	Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Univ Washington, Int Hlth Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA.	laith@scharp.org; jkublin@fhcrc.org	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Kublin, James/0000-0003-1279-3741	NIAID NIH HHS [P30 AI 27757] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2004, MAL HIV INT THEIR IM; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P199; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Froebel K, 2004, PARASITE IMMUNOL, V26, P213, DOI 10.1111/j.0141-9838.2004.00701.x; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; *JOINT UN PROGR HI, AIDS EP UP 2005; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Quigley MA, 2005, TROP MED INT HEALTH, V10, P894, DOI 10.1111/j.1365-3156.2005.01461.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Whitworth JAG, 2005, LANCET, V365, P196; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	28	309	321	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1603	1606		10.1126/science.1132338	http://dx.doi.org/10.1126/science.1132338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158329				2022-12-24	WOS:000242624600044
J	Creel, S; Christianson, D; Liley, S; Winnie, JA				Creel, Scott; Christianson, David; Liley, Stewart; Winnie, John A., Jr.			Predation risk affects reproductive physiology and demography of elk	SCIENCE			English	Article							NATIONAL-PARK; YELLOWSTONE; WOLVES		Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Creel, S (corresponding author), Montana State Univ, Dept Ecol, 310 Lewis Hall, Bozeman, MT 59717 USA.	screel@montana.edu						Barber Shannon M., 2005, Yellowstone Science, V13, P37; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P306; Varley N, 2006, ECOL MODEL, V193, P315, DOI 10.1016/j.ecolmodel.2005.09.001; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1	10	382	389	3	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					960	960		10.1126/science.1135918	http://dx.doi.org/10.1126/science.1135918			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303746				2022-12-24	WOS:000244229800033
J	Hsu, YC; Chern, JJ; Cai, Y; Liu, MY; Choi, KW				Hsu, Ya-Chieh; Chern, Joshua J.; Cai, Yi; Liu, Mingyao; Choi, Kwang-Wook			Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase	NATURE			English	Article							CONTROLLED TUMOR PROTEIN; CELL-GROWTH; DIRECT TARGET; RHEB GTPASE; ACTIVATION; EXCHANGE; HOMOLOG; TSC1; SIZE	Cellular growth and proliferation are coordinated during organogenesis. Misregulation of these processes leads to pathological conditions such as cancer. Tuberous sclerosis (TSC) is a benign tumour syndrome caused by mutations in either TSC1 or TSC2 tumour suppressor genes. Studies in Drosophila and other organisms have identified TSC signalling as a conserved pathway for growth control. Activation of the TSC pathway is mediated by Rheb (Ras homologue enriched in brain), a Ras superfamily GTPase(1,2). Rheb is a direct target of TSC2 and is negatively regulated by its GTPase-activating protein activity(3-5). However, molecules required for positive regulation of Rheb have not been identified. Here we show that a conserved protein, translationally controlled tumour protein ( TCTP), is an essential new component of the TSC - Rheb pathway. Reducing Drosophila TCTP (dTCTP) levels reduces cell size, cell number and organ size, which mimics Drosophila Rheb (dRheb) mutant phenotypes. dTCTP is genetically epistatic to Tsc1 and dRheb, but acts upstream of dS6k, a downstream target of dRheb. dTCTP directly associates with dRheb and displays guanine nucleotide exchange activity with it in vivo and in vitro. Human TCTP (hTCTP) shows similar biochemical properties compared to dTCTP and can rescue dTCTP mutant phenotypes, suggesting that the function of TCTP in the TSC pathway is evolutionarily conserved. Our studies identify TCTP as a direct regulator of Rheb and a potential therapeutic target for TSC disease.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Choi, KW (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	kchoi@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Liu, Mingyao/0000-0001-7339-5048				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Guo XG, 2003, J BIOL CHEM, V278, P13207, DOI 10.1074/jbc.M208896200; Huang H, 1999, DEVELOPMENT, V126, P5365; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stowers RS, 1999, GENETICS, V152, P1631; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; von Lintig FC, 2000, ONCOGENE, V19, P4029, DOI 10.1038/sj.onc.1203741; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	235	251	2	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					785	788		10.1038/nature05528	http://dx.doi.org/10.1038/nature05528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301792				2022-12-24	WOS:000244205200049
J	Knight, ZA; Shokat, KM				Knight, Zachary A.; Shokat, Kevan M.			Chemical genetics: Where genetics and pharmacology meet	CELL			English	Article							INSULIN-RESISTANCE; PRESSURE-OVERLOAD; CATALYTIC SUBUNIT; PROTEIN-KINASE; RECEPTOR; 3-KINASE; GAMMA; ACTIVATION; P110-ALPHA; PI3K-GAMMA		Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu		Knight, Zachary/0000-0001-7621-1478				Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOBAYASHI M, 1983, FEBS LETT, V163, P50, DOI 10.1016/0014-5793(83)81160-0; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Stern Bodo, 1996, Trends in Genetics, V12, P345, DOI 10.1016/0168-9525(96)10036-6; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200	23	191	196	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					425	430		10.1016/j.cell.2007.01.021	http://dx.doi.org/10.1016/j.cell.2007.01.021			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289560	Bronze			2022-12-24	WOS:000244842700007
J	Reddy, KS				Reddy, K. Srinath			The preventive polypill - Much promise, insufficent evidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE		Publ Hlth Fdn India, New Delhi, India; All India Inst Med Sci, New Delhi, India	Public Health Foundation of India; All India Institute of Medical Sciences (AIIMS) New Delhi	Reddy, KS (corresponding author), Publ Hlth Fdn India, New Delhi, India.							Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Wald NJ, 2003, BRIT MED J, V327, P586	3	35	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					212	212		10.1056/NEJMp068219	http://dx.doi.org/10.1056/NEJMp068219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229947				2022-12-24	WOS:000243488100002
J	Hawkes, N				Hawkes, Nigel			Body politic - Fat chance of hitting obesity targets	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2007	334	7584					71	71		10.1136/bmj.39086.625822.59	http://dx.doi.org/10.1136/bmj.39086.625822.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	127DZ	17218708	Green Published			2022-12-24	WOS:000243566800025
J	Baumann, C; Korner, R; Hofmann, K; Nigg, EA				Baumann, Christoph; Koerner, Roman; Hofmann, Kay; Nigg, Erich A.			PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; PROTEIN PHOSPHATASE 2A; CELL-CYCLE CHECKPOINT; POLO-LIKE KINASES; TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; MITOTIC CHECKPOINT; BUDDING YEAST; BOX DOMAIN; KINETOCHORE	We identify PICH (PIk1 -interacting checkpoint "helicase"), a member of the SNF2 ATPase family, as an interaction partner and substrate of PIk1. Following phosphorylation of PICH on the Cdk1 site T1 063, PIk1 is recruited to PICH and controls its localization. Starting in prometaphase, PICH accumulates at kinetochores and inner centromeres. Moreover, it decorates threads that form during metaphase before increasing in length and progressively diminishing during anaphase. PICH-positive threads connect sister kinetochores and are dependent on tension, sensitive to DNase, and exacerbated in response to premature loss of cohesins or inhibition of topoisomerase II, suggesting that they represent stretched centromeric chromatin. Depletion of PICH causes the selective loss of Mad2 from kinetochores and completely abrogates the spindle checkpoint, resulting in massive chromosome missegregation. These data identify PICH as a novel essential component of checkpoint signaling. We propose that PICH binds to catenated centromere-related DNA to monitor tension developing between sister kinetochores.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Miltenyi Biotec GmbH, Bioinformat Grp, D-50829 Cologne, Germany	Max Planck Society; Miltenyi Biotec	Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.	nigg@biochem.mpg.de	Körner, Roman/G-8565-2011; Hofmann, Kay/D-6714-2011	Körner, Roman/0000-0001-9285-9290; Hofmann, Kay/0000-0002-2289-9083; nigg, erich/0000-0003-4835-5719				Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Owen-Hughes T, 2006, E SCHERING RES FDN W, V57, P47; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; YANAGIDA N, 1995, BIOESSAYS, V17, P519, DOI 10.1002/bies.950170608; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	54	251	261	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					101	114		10.1016/j.cell.2006.11.041	http://dx.doi.org/10.1016/j.cell.2006.11.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218258	Bronze			2022-12-24	WOS:000244420400016
J	Okie, S				Okie, Susan			Sex, drugs, prisons, and HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2006, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2006.00101.X; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; MARUSCHAK LM, 2006, HIV PRISONS 2004; 2006, MMWR MORB MORTAL WKL, V55, P421	5	37	38	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2007	356	2					105	108		10.1056/NEJMp068277	http://dx.doi.org/10.1056/NEJMp068277			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	124NE	17215526	Bronze			2022-12-24	WOS:000243373700001
J	Montanez, IP; Tabor, NJ; Niemeier, D; DiMichele, WA; Frank, TD; Fielding, CR; Isbell, JL; Birgenheier, LP; Rygel, MC				Montanez, Isabel P.; Tabor, Neil J.; Niemeier, Deb; DiMichele, William A.; Frank, Tracy D.; Fielding, Christopher R.; Isbell, John L.; Birgenheier, Lauren P.; Rygel, Michael C.			CO2-forced climate and vegetation instability during late paleozoic deglaciation	SCIENCE			English	Article							ATMOSPHERIC CO2; ISOTOPIC COMPOSITION; CARBON-DIOXIDE; NORTH-AMERICA; GLACIATION; RECORD; OXYGEN; EVOLUTION; PALEOCLIMATE; DELTA-O-18	The late Paleozoic deglaciation is the vegetated Earth's only recorded icehouse-to-greenhouse transition, yet the climate dynamics remain enigmatic. By using the stable isotopic compositions of soil-formed minerals, fossil-plant matter, and shallow-water brachiopods, we estimated atmospheric partial pressure of carbon dioxide (pCO(2)) and tropical marine surface temperatures during this climate transition. Comparison to southern Gondwanan glacial records documents covariance between inferred shifts in pCO(2), temperature, and ice volume consistent with greenhouse gas forcing of climate. Major restructuring of paleotropical flora in western Euramerica occurred in step with climate and pCO(2) shifts, illustrating the biotic impact associated with past CO2-forced turnover to a permanent ice-free world.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; So Methodist Univ, Dept Geol Sci, Dallas, TX 75275 USA; Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Wisconsin, Dept Geosci, Milwaukee, WI 53201 USA	University of California System; University of California Davis; Southern Methodist University; University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Milwaukee	Montanez, IP (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	montanez@geology.ucdavis.edu	DiMichele, William/K-4301-2012	Rygel, Michael/0000-0002-6453-6205; Birgenheier, Lauren/0000-0001-6951-0939; Montanez, Isabel/0000-0003-0492-3796; Frank, Tracy/0000-0002-8422-7389				Arens NC, 2000, PALEOBIOLOGY, V26, P137, DOI 10.1666/0094-8373(2000)026&lt;0137:CCPFRT&gt;2.0.CO;2; Bangert B, 1999, J AFR EARTH SCI, V29, P33, DOI 10.1016/S0899-5362(99)00078-0; Banks M.R., 1981, EARTHS PREPLEISTOCEN, P495; Beck WC, 2005, GEOCHIM COSMOCHIM AC, V69, P3493, DOI 10.1016/j.gca.2005.02.003; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; CECIL C.B., 2003, SEPM SPECIAL PUBLICA, V77, P151; Cerling TE, 1999, PALAEOWEATHERING PAL, V27, P43, DOI DOI 10.1002/9781444304190.CH2; Dickins JM, 1996, PALAEOGEOGR PALAEOCL, V125, P185, DOI 10.1016/S0031-0182(96)00030-2; DIMICHELE WA, 1992, EVOLUTION, V46, P807, DOI 10.1111/j.1558-5646.1992.tb02086.x; DiMichele WA, 2000, PALAIOS, V15, P524, DOI 10.2307/3515616; DiMichele WA, 2006, GEOL SOC AM SPEC PAP, V399, P223, DOI 10.1130/2006.2399(11); Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; Frakes L. A, 1992, CLIMATE MODES PHANER; GONZALEZ CR, 1990, PALAEOGEOGR PALAEOCL, V79, P275, DOI 10.1016/0031-0182(90)90022-Y; Gradstein F., 2005, GEOLOGIC TIME SCALE, DOI [10.1017/CBO9780511536045, DOI 10.1017/CBO9780511536045]; Isbell J.L., 2003, GEOLOGICAL SOC AM SP, V370, P5; Jones AT, 2004, GEOLOGY, V32, P153, DOI 10.1130/G20112.1; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Korte C, 2005, PALAEOGEOGR PALAEOCL, V224, P333, DOI 10.1016/j.palaeo.2005.03.015; Kump LR, 2005, NATURE, V436, P333, DOI 10.1038/436333a; Kump LR, 2002, NATURE, V419, P188, DOI 10.1038/nature01087; Lopez-Gamundi O. R, 1997, LATE GLACIAL POSTGLA, P147; MAMAY SH, 1992, AM J BOT, V79, P1092, DOI 10.2307/2445207; MAMAY SH, 1967, 575C US GEOL SURV, P120; Mii HS, 1999, GEOL SOC AM BULL, V111, P960, DOI 10.1130/0016-7606(1999)111<0960:CISONA>2.3.CO;2; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Panchuk KM, 2006, J SEDIMENT RES, V76, P200, DOI 10.2110/jsr.2006.017; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ross C. A., 1988, SOC ECON PALEONT MIN, P227, DOI 10.2110/pec.88.01.0227; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; Saltzman MR, 2003, GEOLOGY, V31, P151, DOI 10.1130/0091-7613(2003)031<0151:LPIAOG>2.0.CO;2; Scheffler K, 2003, GEOLOGY, V31, P605, DOI 10.1130/0091-7613(2003)031<0605:GCDCGO>2.0.CO;2; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stollhofen H, 2000, PALAEOGEOGR PALAEOCL, V161, P127, DOI 10.1016/S0031-0182(00)00120-6; Tabor NJ, 2005, PALAEOGEOGR PALAEOCL, V223, P127, DOI 10.1016/j.palaeo.2005.04.009; Tabor NJ, 2004, SEDIMENTOLOGY, V51, P851, DOI 10.1111/j.1365-3091.2004.00655.x; Tabor NJ, 2004, GEOCHIM COSMOCHIM AC, V68, P1503, DOI 10.1016/S0016-7037(03)00497-6; TABOR NJ, IN PRESS EARTH PLANE; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Visser JNJ, 1997, SEDIMENTOLOGY, V44, P507, DOI 10.1046/j.1365-3091.1997.d01-35.x; Winguth AME, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000646; YAPP CJ, 1992, NATURE, V355, P342, DOI 10.1038/355342a0; Zhang H, 1999, ACTA GEOL SIN-ENGL, V73, P111	47	393	409	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					87	91		10.1126/science.1134207	http://dx.doi.org/10.1126/science.1134207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204648	Green Published			2022-12-24	WOS:000243259100041
J	Temple, R; Stockbridge, NL				Temple, Robert; Stockbridge, Norman L.			BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective	ANNALS OF INTERNAL MEDICINE			English	Article							ISOSORBIDE DINITRATE; MORTALITY; HYDRALAZINE; RACE	Critics of the U. S. Food and Drug Administration (FDA) approval of the fixed combination of hydralazine hydrochloride, 37.5 mg, and isosorbide dinitrate, 20 mg, for treating heart failure in black patients have suggested that data were insufficient to distinguish treatment effects in black and white people; that distinctions based on race, rather than pathophysiology, were scientifically unreasonable; and that a "race-based" approval could be a commercial ploy to avoid a more expensive and prolonged full evaluation of a drug. The criticisms acknowledge that data supporting the approval came from a well-designed clinical trial in which self-identified black patients with heart failure who took hydralazine hydrochloride-isosorbide dinitrate with standard therapy experienced a statistically significant 43% (95% CI, 11% to 63%) reduction in mortality compared with those who took only the standard therapy. The criticisms do not always recognize that the decision to conduct the trial in only black patients reflected careful analyses of 2 previous trials in racially mixed patient populations that compared hydralazine hydrochloride-isosorbide dinitrate with placebo or with enalapril. Both trials showed little or no overall effect of hydralazine hydrochloride-isosorbide dinitrate in the mostly white patient population but hinted at a substantial effect in subsets of black patients. Perhaps most critically, the criticisms do not appreciate the urgency of strong scientific evidence of a substantial survival benefit in black patients. A serious attempt to avoid race-based approval by mandating study of a mixed population to identify a possible white patient-responder subset, particularly without a plausible hypothesis as to what that subset might be, would have required years of work, many thousands of patients, and wholly unreasonable delay in approval of a treatment whose effectiveness had been well-documented in the group for which it was intended.	US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Temple, R (corresponding author), US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	robert.temple@fda.hhs.gov						[Anonymous], 1990, Lancet, V336, P1; Avorn J, 2005, NEW ENGL J MED, V353, P969, DOI 10.1056/NEJMp058174; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Food and Drug Administration, 1988, GUID FORM CONT CLIN; Food and Drug Administration HHS, 2006, Fed Regist, V71, P3921; Haga SB, 2006, J AM COLL CARDIOL, V48, P12, DOI 10.1016/j.jacc.2006.04.017; Harty L, 2006, J CLIN PHARMACOL, V46, P405, DOI 10.1177/0091270005286028; JUST H, 1995, CIRCULATION S1, V92, P722; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; *NITROMED INC, 2005, BIDIL; PACKER M, 1993, CIRCULATION, V88, P301; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Perry G, 1997, NEW ENGL J MED, V336, P525; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; TEMPLE RJ, 1994, COMMUN STAT THEORY, V23, P499, DOI 10.1080/03610929408831269; U.S. Food and Drug Administration, 1993, Fed Regist, V58, P39406; *US FDA, 1989, GUID STUD DRUGS LIK; *US FDA, 2005, P US FDA CTR DRUG EV; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	26	81	81	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					57	W9		10.7326/0003-4819-146-1-200701020-00010	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200223				2022-12-24	WOS:000247893300008
J	Collier, J				Collier, Joe			Getting new drugs to market: how individuals,could do this without leaving their desks	BRITISH MEDICAL JOURNAL			English	Editorial Material									St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England	St Georges University London	Collier, J (corresponding author), St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England.	jcollier@sgul.ac.uk						Henry D, 2002, LANCET, V360, P1590, DOI 10.1016/S0140-6736(02)11527-3; JACK A, 2006, FINANCIAL TIMES 0929	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1315	1317		10.1136/bmj.39055.610764.47	http://dx.doi.org/10.1136/bmj.39055.610764.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185722	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000243160700020
J	Wong, YN; Mitra, N; Hudes, G; Localio, R; Schwartz, JS; Wan, F; Montagnet, C; Armstrong, K				Wong, Yu-Ning; Mitra, Nandita; Hudes, Gary; Localio, Russell; Schwartz, J. Sanford; Wan, Fei; Montagnet, Chantal; Armstrong, Katrina			Survival associated with treatment vs observation of localized prostate cancer in elderly men (Reprinted from JAMA, vol 296, 2006)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARING RADICAL PROSTATECTOMY; QUALITY-OF-LIFE; CONSERVATIVE MANAGEMENT; OUTCOMES; COMORBIDITY; POPULATION; BIAS; SUBCLASSIFICATION; INTERVENTION; CARCINOMA	Context Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial. Objective To estimate the association between treatment ( with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer. Design and Setting Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data. Patients At total of 44 630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well-or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end ( December 31, 2002). Patients were classified as having received treatment ( n= 32 022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation ( n= 12 608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded. Main Outcome Measure Overall survival. Results At the end of the 12-year study period, 4663 men ( 37%) in the observational group and 7639 men ( 23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders ( tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment ( hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men ( aged 75-80 years at diagnosis), black men, and men with low- risk disease. Conclusions This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.	Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; Univ Penn, Dept Biostat & Epidemiol, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Wong, YN (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Y_Wong@fccc.edu			NATIONAL CANCER INSTITUTE [R25CA057708, P50CA105641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022255] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA105641, R25 CA057708] Funding Source: Medline; NCRR NIH HHS [K30 RR022255] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; Beissner RS, 2002, UROLOGY, V59, P721, DOI 10.1016/S0090-4295(02)01531-5; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; BRIGANTI A, 2006, EUR UROL, V175, P721; Chang KP, 2004, J BONE MINER RES, V19, P532, DOI 10.1359/JBMR.040109; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Donovan J, 2003, Health Technol Assess, V7, P1; Etzioni R, 2002, J NATL CANCER I, V94, P981; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Harlan SR, 2003, J UROLOGY, V170, P1804, DOI 10.1097/01.ju.0000091641.34674.11; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Houterman S, 2006, CRIT REV ONCOL HEMAT, V58, P60, DOI 10.1016/j.critrevonc.2005.08.003; Kim-Sing C, 2004, INT J RADIAT ONCOL, V60, P463, DOI 10.1016/j.ijrobp.2004.03.004; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4; MITRA N, 2005, U PENNSYLVANIA BIOST; *NAT COMPR CANC NE, 2006, PROST CANC CLIN PRAC; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8; WONG YN, 2006, 4A7A, V296	36	225	226	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2683	2693		10.1001/jama.296.22.2683	http://dx.doi.org/10.1001/jama.296.22.2683			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164454	Bronze			2022-12-24	WOS:000242765700023
J	Sato, T; Atomi, H; Imanaka, T				Sato, Takaaki; Atomi, Haruyuki; Imanaka, Tadayuki			Archaeal type IIIRuBisCOs function in a pathway for AMP metabolism	SCIENCE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; PYROCOCCUS-KODAKARAENSIS KOD1; METHIONINE SALVAGE PATHWAY; HYPERTHERMOPHILIC ARCHAEON; BISPHOSPHATE CARBOXYLASE/OXYGENASE; MAXIMUM-LIKELIHOOD; RUBISCO; PROTEIN; FIXATION	The type III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) present in the archaeon Thermococcus kodakaraensis was found to participate in adenosine 5'-monophosphate ( AMP) metabolism, a role that is distinct from that of classical RuBisCOs of the Calvin-Benson-Bassham cycle. Genes annotated as thymidine phosphorylase (deoA) and eucaryal translation initiation factor 2B (e2b2) were found to encode AMP phosphorylase and ribose-1,5-bisphosphate isomerase, respectively. These enzymes supplied the RuBisCO substrate, ribulose-1,5-bisphosphate, from AMP and phosphate. Archaea with type III RuBisCOs all harbor both DeoA and the corresponding E2b2 homologs. In this pathway, adenine was released from AMP and the phosphoribose moiety entered central-carbon metabolism.	Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kyoto University	Imanaka, T (corresponding author), Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426				Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Schiffer A, 2006, BIOCHEMISTRY-US, V45, P2960, DOI 10.1021/bi0521689; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; WALTER MR, 1990, J BIOL CHEM, V265, P14016; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147	26	151	158	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1003	1006		10.1126/science.1135999	http://dx.doi.org/10.1126/science.1135999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303759				2022-12-24	WOS:000244229800047
J	Sharp, D				Sharp, David			A device before its time	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Charette F, 2006, NATURE, V444, P551, DOI 10.1038/444551a; Freeth T, 2006, NATURE, V444, P587, DOI 10.1038/nature05357; HANCOCK G, 1996, FINGERPRINTS GODS QU, P389; PRICE DJD, 1959, SCI AM           JUN; *WIK, BAGHD BATT; WRIGHT MT, UNDERSTANDING ANTIKY	6	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					176	176		10.1016/S0140-6736(07)60089-0	http://dx.doi.org/10.1016/S0140-6736(07)60089-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240272				2022-12-24	WOS:000243692400011
J	Butler, SJ; Vickery, JA; Norris, K				Butler, S. J.; Vickery, J. A.; Norris, K.			Farmland biodiversity and the footprint of agriculture	SCIENCE			English	Article							GENETICALLY-MODIFIED CROPS; AGRI-ENVIRONMENT SCHEMES; CONSERVATION; DECLINES; BRITAIN; IMPACTS; ECOLOGY; BIRDS	Sustainable development requires the reconciliation of demands for biodiversity conservation and increased agricultural production. Assessing the impact of novel farming practices on biodiversity and ecosystem services is fundamental to this process. Using farmland birds as a model system, we present a generic risk assessment framework that accurately predicts each species' current conservation status and population growth rate associated with past changes in agriculture. We demonstrate its value by assessing the potential impact on biodiversity of two controversial land uses, genetically modified herbicide-tolerant crops and agri-environment schemes. This framework can be used to guide policy and land management decisions and to assess progress toward sustainability targets.	Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England; British Trust Ornithol, Thetford IP24 2PU, Norfolk, England	University of Reading; British Trust for Ornithology	Butler, SJ (corresponding author), Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England.	s.j.butler@reading.ac.uk	Butler, Simon/H-1703-2011	Butler, Simon/0000-0002-5111-5639				*ACRE, 2006, MAN FOOTPR AGR COMP; Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; *DEFR, 2005, ENTR LEV STEW HDB; Freckleton RP, 2004, P ROY SOC B-BIOL SCI, V271, P325, DOI 10.1098/rspb.2003.2603; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; GREEN RE, 2004, SCIENCE         1223, DOI DOI 10.1126/SCIENCE.1106049; Gregory R.D., 2003, Ornis Hungarica, V12-13, P11; Gregory Richard D., 2002, British Birds, V95, P410; Hails RS, 2002, NATURE, V418, P685, DOI 10.1038/nature01016; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Norris K, 2004, P ROY SOC B-BIOL SCI, V271, P123, DOI 10.1098/rspb.2003.2576; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Perry JN, 2004, NATURE, V428, P313, DOI 10.1038/nature02374; *RUR DEV SERV STRA, 2006, ES OPT UPT REP; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Whitfield J, 2006, NATURE, V439, P908, DOI 10.1038/439908a; Zeki S, 2003, PHILOS T ROY SOC B, V358, P1775, DOI 10.1098/rstb.2003.1412	27	295	309	6	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					381	384		10.1126/science.1136607	http://dx.doi.org/10.1126/science.1136607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234947				2022-12-24	WOS:000243535400043
J	Ferrer, M; Golyshina, OV; Beloqui, A; Golyshin, PN; Timmis, KN				Ferrer, Manuel; Golyshina, Olga V.; Beloqui, Ana; Golyshin, Peter N.; Timmis, Kenneth N.			The cellular machinery of Ferroplasma acidiphilum is iron-protein-dominated	NATURE			English	Article							SOUTHERN-OCEAN; WALL-LACKING; SP-NOV.; ENVIRONMENTS; PROKARYOTES; CLUSTERS; ARCHAEA; ACID	Ferroplasma is a genus of the Archaea, one of the three branches of the tree of life, and belongs to the order Thermoplasmatales ( Euryarchaeota), which contains the most acidophilic microbes yet known. Ferroplasma species live in acid mine drainage, acidic pools and environments containing sulphidic ores such as pyrite and characterized by pH values of 0 - 2 and high concentrations of ferrous iron and other heavy metals(1-3). F. acidiphilum strain Y-T is a chemoautotroph that grows optimally at pH 1.7 and gains energy by oxidizing ferrous iron and carbon by the fixation of carbon dioxide(1). Here we show that 86% of 189 investigated cellular proteins of F. acidiphilum are iron-metalloproteins. These include proteins with deduced structural, chaperone and catalytic roles, not described as iron-metalloproteins in any other organism so far investigated. The iron atoms in the proteins seem to organize and stabilize their three-dimensional structures, to act as 'iron rivets'. Analysis of proteins of the phylogenetic neighbour Picrophilus torridus and of the habitat neighbour Acidithiobacillus ferrooxidans revealed far fewer and only typical metalloproteins. F. acidiphilum therefore has a currently unique iron-protein-dominated cellular machinery and biochemical phylogeny.	CSIC, Inst Catalysis, Madrid 28049, Spain; HZI Helmholtz Ctr Infect Res, Dept Environm Microbiol, D-38124 Braunschweig, Germany; Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; University of Essex	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Madrid 28049, Spain.	mferrer@icp.csic.es	Beloqui, Ana/C-4512-2012; Ferrer, Manuel/K-4535-2014	Beloqui, Ana/0000-0002-7693-4163; Ferrer, Manuel/0000-0003-4962-4714; Golyshin, Peter/0000-0002-5433-0350; Golyshina, Olga/0000-0001-5132-6850				Agarwalla S, 2004, J BIOL CHEM, V279, P34123, DOI 10.1074/jbc.M405702200; BLOCHL E, 1992, P NATL ACAD SCI USA, V89, P8117, DOI 10.1073/pnas.89.17.8117; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Ferrer M, 2005, BIOCHEM J, V391, P269, DOI 10.1042/BJ20050346; Giometti CS, 2003, PROTEOMICS, V3, P777, DOI 10.1002/pmic.200300406; Golyshina OV, 2000, INT J SYST EVOL MICR, V50, P997, DOI 10.1099/00207713-50-3-997; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; WACHTERSHAUSER G, 2002, SCIENCE, V296, P1982; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	17	78	81	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					91	94		10.1038/nature05362	http://dx.doi.org/10.1038/nature05362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203061				2022-12-24	WOS:000243225100042
J	Heathcote, E				Heathcote, Edwin			Maggie's Centres	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Heathcote, E (corresponding author), Financial Times, London, England.	edwinheathcote@hotmail.com							0	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1304	1305		10.1136/bmj.39062.614132.55	http://dx.doi.org/10.1136/bmj.39062.614132.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185717	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000243160700015
J	Ibrahim, F; Rohr, J; Jeong, WJ; Hesson, J; Cerutti, H				Ibrahim, Fadia; Rohr, Jennifer; Jeong, Won-Joong; Hesson, Jennifer; Cerutti, Heriberto			Untemplated oligoadenylation promotes degradation of RISC-cleaved transcripts	SCIENCE			English	Article							RNAS; EXOSOME; COMPLEX		Univ Nebraska, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Cerutti, H (corresponding author), Univ Nebraska, Lincoln, NE 68588 USA.	hcerutti@unl.edu		Ibrahim, Fadia/0000-0002-4344-765X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062915] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062915-06, GM62915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	7	72	79	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1893	1893		10.1126/science.1135268	http://dx.doi.org/10.1126/science.1135268			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185594	Green Submitted			2022-12-24	WOS:000242996800038
J	Lifson, AR; Rybicki, SL				Lifson, Alan R.; Rybicki, Sarah L.			Routine opt-out HIV testing	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION		Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lifson, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	lifso001@umn.edu						Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CA STD HIV PREV T, ASK SCREEN INT RISK; Cunningham WE, 2006, MED CARE, V44, P1038, DOI 10.1097/01.mlr.0000242942.17968.69; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Gielen AC, 1997, WOMEN HEALTH, V25, P19, DOI 10.1300/J013v25n03_02; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Lo B, 2000, J ACQ IMMUN DEF SYND, V25, pS136, DOI 10.1097/00126334-200012152-00008; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; *MONT MED CTR AD A, ASS CONS TEST SUPP	10	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					539	540		10.1016/S0140-6736(07)60249-9	http://dx.doi.org/10.1016/S0140-6736(07)60249-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307085				2022-12-24	WOS:000244368000007
J	Rubino, A; Roskell, N; Tennis, P; Mines, D; Weich, S; Andrews, E				Rubino, Annalisa; Roskell, Neil; Tennis, Pat; Mines, Daniel; Weich, Scott; Andrews, Elizabeth			Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; ANTIDEPRESSANTS; PLACEBO; DEPRESSION; TRIALS; SSRIS	Objective To compare the risk of suicide in adults using the antidepressant venlafaxine with the risk of suicide in adult using citalopram, fluoxetine, and dothiepin. Design Retrospective cohort study. Setting UK General Practice Research Database. Participants 219088 patients, aged 18-89 years, who were prescribed venlafaxine, citalopram, fluoxetine, or dothiepin from 1995 to 2005. Main outcome measures Completed suicide and attempted suicide. Results Venlafaxine users had a higher burden of risk factors for suicide, including previous suicide attempts and proxies for severe depression or depression that was difficult to treat. In the analysis for completed suicides, unadjusted and adjusted hazard ratios for venlafaxine compared with citalopram were 2.44 (95% confidence interval 1.12 to 5.31) and 1.70 (0.76 to 3.80), for venlafaxine compared with fluoxetine were 2.85 (1.37 to 5.94) and 1.63 (0.74 to 3.59), and for venlafaxine compared with dothiepin were 2.54 (1.07 to 6.02) and 1.31 (0.53 to 3.25). Compared with other study drugs, venlafaxine was also associated with an increased risk of attempted suicide, but adjustment for measured confounders substantially reduced the hazard ratios. Conclusions Venlafaxine use was consistently associated with higher risk of suicide compared with citalopram, fluoxetine, and dothiepin. Venlafaxine users had a higher burden of suicide risk factors, however, and adjustment for measured confounders substantially reduced the excess risks. Since the secondary data used in this analysis allowed only indirect and partial measurements of potential confounders, it is possible that residual confounding explains much, if not all, of the observed excess risk.	RTI Hlth Solut, Manchester M15 6SE, Lancs, England; RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Res Triangle Pk, NC USA; Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Research Triangle Institute; Research Triangle Institute; University of Warwick	Rubino, A (corresponding author), RTI Hlth Solut, Manchester Sci Pk, Manchester M15 6SE, Lancs, England.	arubino@rti.org		Mines, Daniel/0000-0002-9134-2836; Andrews, Elizabeth B./0000-0003-1131-5983				Collins MH, 2001, PEDIATR TRANSPLANT, V5, P250, DOI 10.1034/j.1399-3046.2001.005004250.x; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Egberts ACG, 1997, J CLIN PSYCHOPHARM, V17, P149, DOI 10.1097/00004714-199706000-00002; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mines D, 2005, PHARMACOEPIDEM DR S, V14, P367, DOI 10.1002/pds.1095; Plunkett A, 2001, AMBUL PEDIATR, V1, P262, DOI 10.1367/1539-4409(2001)001<0262:SRFCSA>2.0.CO;2; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothman KJ, 2003, EPIDEMIOLOGY, V14, P55, DOI 10.1097/00001648-200301000-00014; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Simon TR, 2002, SUICIDE LIFE-THREAT, V32, P42, DOI 10.1521/suli.32.1.42.22181; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	23	77	85	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					242	245		10.1136/bmj.39041.445104.BE	http://dx.doi.org/10.1136/bmj.39041.445104.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17164297	Bronze, Green Published			2022-12-24	WOS:000244172400029
J	Greenamyre, JT				Greenamyre, J. Timothy			Huntington's disease - Making connections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEURODEGENERATION; DEFECTS		Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greenamyre, JT (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.		Greenamyre, J. Timothy/B-4049-2011	Greenamyre, J. Timothy/0000-0003-3468-7878				Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	7	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					518	520		10.1056/NEJMcibr067022	http://dx.doi.org/10.1056/NEJMcibr067022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267914				2022-12-24	WOS:000243860700016
J	Irion, U; St Johnston, D				Irion, Uwe; St Johnston, Daniel			bicoid RNA localization requires specific binding of an endosomal sorting complex	NATURE			English	Article							MESSENGER-RNA; ESCRT-II; DROSOPHILA EMBRYO; ANTERIOR LOCALIZATION; DEPENDENT MANNER; PROTEIN; STAUFEN; GENE; TRANSPORT; OOCYTES	bicoid messenger RNA localizes to the anterior of the Drosophila egg, where it is translated to form a morphogen gradient of Bicoid protein that patterns the head and thorax of the embryo. Although bicoid was the first localized cytoplasmic determinant to be identified(1-4), little is known about how the mRNA is coupled to the microtubule-dependent transport pathway that targets it to the anterior, and it has been proposed that the mRNA is recognized by a complex of many redundant proteins, each of which binds to the localization element in the 3' untranslated region (UTR) with little or no specificity(5). Indeed, the only known RNA-binding protein that co-localizes with bicoid mRNA is Staufen, which binds non-specifically to double-stranded RNA in vitro(6,7). Here we show that mutants in all subunits of the ESCRT-II complex (VPS22, VPS25 and VPS36) abolish the final Staufen-dependent step in bicoid mRNA localization. ESCRT-II is a highly conserved component of the pathway that sorts ubiquitinated endosomal proteins into internal vesicles(8,9), and functions as a tumour-suppressor by removing activated receptors from the cytoplasm(10,11). However, the role of ESCRT-II in bicoid localization seems to be independent of endosomal sorting, because mutations in ESCRT-I and III components do not affect the targeting of bicoid mRNA. Instead, VPS36 functions by binding directly and specifically to stem-loop V of the bicoid 39 UTR through its amino-terminal GLUE domain(12), making it the first example of a sequence-specific RNA-binding protein that recognizes the bicoid localization signal. Furthermore, VPS36 localizes to the anterior of the oocyte in a bicoid-mRNA-dependent manner, and is required for the subsequent recruitment of Staufen to the bicoid complex. This function of ESCRT-II as an RNA-binding complex is conserved in vertebrates and may clarify some of its roles that are independent of endosomal sorting.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	Irion, Uwe/ABC-8635-2020; St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Irion, Uwe/0000-0003-2823-5840	Cancer Research UK [A14492] Funding Source: Medline; Wellcome Trust [092096, 049818] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; FROHNHOFER HG, 1987, GENE DEV, V1, P880, DOI 10.1101/gad.1.8.880; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; MACDONALD PM, 1991, GENE DEV, V5, P2455, DOI 10.1101/gad.5.12b.2455; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moon WJ, 2004, CURR BIOL, V14, P1957, DOI 10.1016/j.cub.2004.10.023; Putz U, 1996, NUCLEIC ACIDS RES, V24, P4838, DOI 10.1093/nar/24.23.4838; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STJOHNSTON D, 1989, DEVELOPMENT S, V107, P131; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	30	140	146	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					554	558		10.1038/nature05503	http://dx.doi.org/10.1038/nature05503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268469	Green Accepted			2022-12-24	WOS:000243867300047
J	Ives, A; Saunders, C; Bulsara, M; Semmens, J				Ives, Angela; Saunders, Christobel; Bulsara, Max; Semmens, James			Pregnancy after breast cancer: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WESTERN-AUSTRALIA; CARCINOMA; PROGNOSIS; SURVIVAL; OUTCOMES; WOMEN	Objectives To identify women who survived breast cancer and subsequently conceived and to determine the rate of pregnancy (proportion), management, outcome of the cancer, and outcome of the first subsequent pregnancy. Design Population based descriptive study with cases identified from the Western Australian data linkage system and validated by review of medical charts. Supplementary data obtained from hospital and clinician records. Setting Western Australia, 1982-2003. Participants Women aged <45 with a diagnosis of breast cancer who subsequently conceived. Main outcome measures Pregnancy outcome and rate, survival, time from diagnosis to pregnancy. Results Sixty two (54%) women with a diagnosis of breast cancer who subsequently conceived did so less than two years after their diagnosis: 29 of them had an abortion, 27 had a live birth, and six miscarried. Within a proportional hazards regression model subsequent pregnancy was associated with improved overall survival (hazard ratio 0.59, 95% confidence interval 0.37 to 0.95). When the model was stratified by time from diagnosis subsequent pregnancy was associated with improved overall survival in women who waited at least 24 months to conceive (0.48, 0.27 to 0.83) and a non-significant protective effect was seen for women who waited at least six months to become pregnant. Conclusions Our study does not support the current medical advice given to premenopausal women with a diagnosis of breast cancer to wait two years before attempting to conceive. This recommendation may be valid for women who are receiving treatment or have systemic disease at diagnosis, but for women with localised disease early conception, six months after completing treatment, is unlikely to reduce survival.	Univ Western Australia, Sch Surg & Pathol, Crawley, WA, Australia; Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; Curtin Univ Technol, Sch Publ Hlth, Bentley, WA 6845, Australia	University of Western Australia; University of Western Australia; Curtin University	Ives, A (corresponding author), Univ Western Australia, Sch Surg & Pathol, M507, Crawley, WA, Australia.	angela.ives@uwa.edu.au	Ives, Angela D/H-5113-2014; Bulsara, Max/A-5966-2008; Saunders, Christobel M/H-5779-2014	Bulsara, Max/0000-0002-8033-6123; Saunders, Christobel M/0000-0003-2281-9829; Ives, Angela Denise/0000-0001-5734-0821				Blakely LJ, 2004, CANCER-AM CANCER SOC, V100, P465, DOI 10.1002/cncr.11929; Clark R M, 1989, Clin Oncol (R Coll Radiol), V1, P11, DOI 10.1016/S0936-6555(89)80004-4; CLARK RM, 1978, INT J RADIAT ONCOL, V4, P693, DOI 10.1016/0360-3016(78)90196-7; GUINEE VF, 1994, LANCET, V343, P1587; Gwyn K, 2001, ONCOLOGY-NY, V15, P39; HARVEY JC, 1981, SURG GYNECOL OBSTET, V153, P723; HOLLEB AI, 1962, SURG GYNECOL OBSTET, V115, P65; Ives Angela, 2002, Aust Fam Physician, V31, P929; Kroman N, 1997, LANCET, V350, P319, DOI 10.1016/S0140-6736(97)03052-3; McEvoy SP, 2004, MED J AUSTRALIA, V181, P305, DOI 10.5694/j.1326-5377.2004.tb06294.x; *NAT CTR CLASS, 2000, INT STAT CLASS DIS R; National Coding Centre, 1995, AUSTR VERS INT CLASS; NUGENT P, 1985, ARCH SURG-CHICAGO, V120, P1221; Peters MV, 1968, PROGNOSTIC FACTORS B, P65; PETREK JA, 1994, CANCER-AM CANCER SOC, V74, P528, DOI 10.1002/cncr.2820741342; Reichman B S, 1994, J Natl Cancer Inst Monogr, P125; RIBEIRO G, 1986, BRIT J SURG, V73, P607, DOI 10.1002/bjs.1800730805; RIBEIRO GG, 1977, BRIT MED J, V2, P1524, DOI 10.1136/bmj.2.6101.1524; SANKILA R, 1994, AM J OBSTET GYNECOL, V170, P818, DOI 10.1016/S0002-9378(94)70290-X; Semmens JB, 1998, AUST NZ J SURG, V68, P397, DOI 10.1111/j.1445-2197.1998.tb04786.x; Singh KL, 2005, HUM REPROD UPDATE, V11, P69, DOI 10.1093/humupd/dmh052; SUTTON R, 1990, CANCER, V65, P847, DOI 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A; Velentgas P, 1999, CANCER, V85, P2424, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4	23	164	174	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					194	196B		10.1136/bmj.39035.667176.55	http://dx.doi.org/10.1136/bmj.39035.667176.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17158581	Green Published			2022-12-24	WOS:000244027600035
J	Barabash, S; Fedorov, A; Lundin, R; Sauvaud, JA				Barabash, Stas; Fedorov, Andrei; Lundin, Rickard; Sauvaud, Jean-Andre			Martian atmospheric erosion rates	SCIENCE			English	Article							MARS; PLASMA; ENVIRONMENT; EVOLUTION; ASPERA-3; OUTFLOW; EXPRESS	Mars was once wet but is now dry, and the fate of its ancient carbon dioxide atmosphere is one of the biggest puzzles in martian planetology. We have measured the current loss rate due to the solar wind interaction for different species: Q(O+) = 1.6 . 10(23) per second = 4 grams per second ( g s(-1)), Q(O-2(+)) = 1.5 . 10(23) s(-1) = 8 g s(-1), and Q(CO2+) = 8 . 10(22) s(-1) = 6 g s(-1) in the energy range of 30 to 30,000 electron volts per charge. These rates can be propagated backward over a period of 3.5 billion years, resulting in the total removal of 0.2 to 4 millibar of carbon dioxide and a few centimeters of water. The escape rate is low, and thus one has to continue searching for water reservoirs and carbon dioxide stores on or beneath the planetary surface and investigate other escape channels.	Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France		Barabash, S (corresponding author), Swedish Inst Space Phys, Box 812, S-98128 Kiruna, Sweden.	stas@irf.se						Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; BARABASH S, 2004, ESA SPECIAL PUBLICAT, P121; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Carlsson E, 2006, ICARUS, V182, P320, DOI 10.1016/j.icarus.2005.09.020; DUBININ E, 1993, J GEOPHYS RES-SPACE, V98, P3991, DOI 10.1029/92JA02233; Dubinin E, 2006, ICARUS, V182, P343, DOI 10.1016/j.icarus.2005.08.023; Fedorov A, 2006, ICARUS, V182, P329, DOI 10.1016/j.icarus.2005.09.021; Fox JL, 1997, GEOPHYS RES LETT, V24, P2901, DOI 10.1029/97GL52842; Kallio E, 1996, J GEOPHYS RES-SPACE, V101, P11133, DOI 10.1029/96JA00164; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Lundin R, 2004, SCIENCE, V305, P1933, DOI 10.1126/science.1101860; LUNDIN R, 1990, GEOPHYS RES LETT, V17, P873, DOI 10.1029/GL017i006p00873; Ma YJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010367; MCKAY CP, 1989, REV GEOPHYS, V27, P189, DOI 10.1029/RG027i002p00189; Modolo R, 2005, ANN GEOPHYS-GERMANY, V23, P433, DOI 10.5194/angeo-23-433-2005; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VENGIN M, 1991, PLANET SPACE SCI, V39, P131	18	213	217	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					501	503		10.1126/science.1134358	http://dx.doi.org/10.1126/science.1134358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255508				2022-12-24	WOS:000243726600042
J	Sinclair, AH; Schofield, PR				Sinclair, Andrew H.; Schofield, Peter R.			Human embryonic stem cell research: An Australian perspective	CELL			English	Editorial Material							DONATION	A conscience vote of individual parliamentarians in the Australian government last month regarding amendments to current legislation regulating human embryonic stem cell research yielded a surprising outcome. Despite opposition by the Australian Prime Minister, the Senate and House of Representatives voted to adopt the recommendations of the Lockhart Review and approve human somatic cell nuclear transfer, thus providing a consistent national policy for all researchers in Australia.	Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Prince Wales Med Res Inst, Sydney, NSW 2031, Australia; Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Prince Wales Medical Research Institute; University of New South Wales Sydney	Sinclair, AH (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	andrew.sinclair@mcri.edu.au; p.schofield@unsw.edu.au	Sinclair, Andrew H/A-3598-2010; Schofield, Peter/C-9669-2011	Sinclair, Andrew H/0000-0003-2741-7992; Schofield, Peter/0000-0003-2967-9662				Leeton J, 2004, AUST NZ J OBSTET GYN, V44, P495, DOI 10.1111/j.1479-828X.2004.00305.x; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	4	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					221	223		10.1016/j.cell.2007.01.008	http://dx.doi.org/10.1016/j.cell.2007.01.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254957	Bronze			2022-12-24	WOS:000244420500004
J	Abramson, J; Wright, JM				Abramson, J.; Wright, J. M.			Are lipid-lowering guidelines evidence-based?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; WOMEN; MEN		Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut & Med, Vancouver, BC V6T 1Z3, Canada; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	University of British Columbia; Harvard University	Wright, JM (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut & Med, Vancouver, BC V6T 1Z3, Canada.	jmwright@interchange.ubc.ca						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; JAUCA C, 2003, INT SOC DRUG B NEWSL, V17, P7; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; National Cholesterol Education Program (NCEP), 2002, 3 NCEP; Savoie I, 2002, J CLIN EPIDEMIOL, V55, P95, DOI 10.1016/S0895-4356(01)00436-X; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243	8	93	95	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2007	369	9557					168	169		10.1016/S0140-6736(07)60084-1	http://dx.doi.org/10.1016/S0140-6736(07)60084-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240267				2022-12-24	WOS:000243692400006
J	Fomenko, DE; Xing, WB; Adair, BM; Thomas, DJ; Gladyshev, VN				Fomenko, Dmitri E.; Xing, Weibing; Adair, Blakely M.; Thomas, David J.; Gladyshev, Vadim N.			High-throughput identification of catalytic redox-active cysteine residues	SCIENCE			English	Article							SELENOCYSTEINE INSERTION; ESCHERICHIA-COLI; PROTEIN; METHYLTRANSFERASE; OXIDATION; INSIGHT; CLUSTER	Cysteine (Cys) residues often play critical roles in proteins; however, identification of their specific functions has been limited to case-by-case experimental approaches. We developed a procedure for high-throughput identification of catalytic redox-active Cys in proteins by searching for sporadic selenocysteine-Cys pairs in sequence databases. This method is independent of protein family, structure, and taxon. We used it to selectively detect the majority of known proteins with redox-active Cys and to make additional predictions, one of which was verified. Rapid accumulation of sequence information from genomic and metagenomic projects should allow detection of many additional oxidoreductase families as well as identification of redox-active Cys in these proteins.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; US EPA, Expt Toxicol Div, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill; United States Environmental Protection Agency	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER; NIA NIH HHS [AG021518] Funding Source: Medline; NIGMS NIH HHS [GM061603] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair BM, 2005, ENVIRON CHEM, V2, P161, DOI 10.1071/EN05054; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Fetrow JS, 2001, PROTEIN SCI, V10, P1005, DOI 10.1110/ps.49201; Fomenko DE, 2003, BIOCHEMISTRY-US, V42, P11214, DOI 10.1021/bi034459s; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Madadi-Kahkesh S, 2001, EUR J BIOCHEM, V268, P2566, DOI 10.1046/j.1432-1327.2001.02141.x; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161	22	147	152	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					387	389		10.1126/science.1133114	http://dx.doi.org/10.1126/science.1133114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234949	Green Submitted			2022-12-24	WOS:000243535400045
J	Dahn, RD; Davis, MC; Pappano, WN; Shubin, NH				Dahn, Randall D.; Davis, Marcus C.; Pappano, William N.; Shubin, Neil H.			Sonic hedgehog function in chondrichthyan fins and the evolution of appendage patterning	NATURE			English	Article							RETINOIC ACID; PECTORAL FIN; POLARIZING ACTIVITY; POLYODON-SPATHULA; LIMB; EXPRESSION; ZEBRAFISH; RANGE; SHH; ENHANCER	The genetic mechanisms regulating tetrapod limb development are well characterized, but how they were assembled during evolution and their function in basal vertebrates is poorly understood. Initial studies report that chondrichthyans, the most primitive extant vertebrates with paired appendages, differ from ray-finned fish and tetrapods in having Sonic hedgehog (Shh)-independent patterning of the appendage skeleton(1). Here we demonstrate that chondrichthyans share patterns of appendage Shh expression, Shh appendage-specific regulatory DNA, and Shh function with ray-finned fish and tetrapods(2-10). These studies demonstrate that some aspects of Shh function are deeply conserved in vertebrate phylogeny, but also highlight how the evolution of Shh regulation may underlie major morphological changes during appendage evolution.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Field Museum Nat Hist, Chicago, IL 60605 USA	University of Chicago; Howard Hughes Medical Institute; Johns Hopkins University; Field Museum of Natural History (Chicago)	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Pappano, William/0000-0003-2848-2219; Davis, Marcus/0000-0002-2462-0138				AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BEMIS WE, 1992, J MORPHOL, V213, P47, DOI 10.1002/jmor.1052130106; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Hoffman L, 2002, INT J DEV BIOL, V46, P949; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Maas SA, 2005, DEV DYNAM, V232, P345, DOI 10.1002/dvdy.20254; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Prince VE, 1998, DEVELOPMENT, V125, P407; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; Vandersea MW, 1998, DEV GENES EVOL, V208, P61, DOI 10.1007/s004270050155	21	102	107	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					311	314		10.1038/nature05436	http://dx.doi.org/10.1038/nature05436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17187056				2022-12-24	WOS:000243504700044
J	Szutorisz, H; Georgiou, A; Tora, L; Dillon, N				Szutorisz, Henrietta; Georgiou, Andrew; Tora, Laszlo; Dillon, Niall			The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells	CELL			English	Article							RNA-POLYMERASE-II; PROTEIN-DEGRADATION; REGULATORY PARTICLE; 20S PROTEASOME; CHROMATIN; COMPLEX; COACTIVATOR; RECRUITMENT; TURNOVER; DOMAIN	The ability of stem cells to activate different gene expression programs requires the choreographed assembly of trans-acting factors at enhancers and promoters during cell differentiation. In this study, we show that the proteasome acts on specific regulatory regions in embryonic stem (ES) cells to prevent incorrect transcriptional initiation. Chemical or siRNA-mediated inhibition of proteasome activity results in increased transcription factor and RNA polymerase II binding and leads to activation of cryptic promoters. Analysis of the binding profiles of different proteasome subunits in normal ES cells and following RNAi knockdown of individual subunits provides evidence for a targeted assembly of the 26S proteasome at specific regulatory elements. Our results suggest that the proteasome promotes a dynamic turnover of transcription factor and Pol II binding at tissue-specific gene domains in ES cells, thereby restricting permissive transcriptional activity and keeping the genes in a potentiated state, ready for activation at later stages.	Univ London Imperial Coll Sci & Technol, Gene Regulat & Chromatin Grp, MRC Clin Sci Ctr, Fac Med, London W12 0NN, England; ULP, INSERM, IGBMC, CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Szutorisz, H (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	henrietta.szutorisz@csc.mrc.ac.uk; niall.dillon@csc.mrc.ac.uk	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250	MRC [MC_U120036884] Funding Source: UKRI; Medical Research Council [MC_U120036884] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; AUID KL, 2006, CELL, V21, P861; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Minaee S, 2005, MOL IMMUNOL, V42, P1283, DOI 10.1016/j.molimm.2005.01.003; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perry P, 2004, CELL CYCLE, V3, P1645; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	42	96	99	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1375	1388		10.1016/j.cell.2006.10.045	http://dx.doi.org/10.1016/j.cell.2006.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190601	Bronze			2022-12-24	WOS:000243690000017
J	Sethi, D; Racioppi, F; Baumgarten, I; Bertollini, R				Sethi, Dinesh; Racioppi, Francesca; Baumgarten, Inge; Bertollini, Roberto			Reducing inequalities from injuries in Europe	LANCET			English	Article							ALCOHOL-CONSUMPTION; SOCIOECONOMIC INEQUALITIES; EASTERN-EUROPE; PUBLIC-HEALTH; GLOBAL BURDEN; POLICY-MAKING; CHILD INJURY; SOCIAL-CLASS; MORTALITY; RUSSIA	Injuries cause 9% of deaths and 14% of ill health in the WHO European Region. This problem is neglected; injuries are often seen as part of everyday life. However, although western Europe has good safety levels, death and disability from injury are rising in eastern Europe. People in low-to-middle-income countries in the Region are 3.6 times more likely to die from injuries than those in high-income countries. Economic and political change have led to unemployment, income inequalities, increased traffic, reduced restrictions on alcohol, and loss of social support. Risks such as movement of vulnerable populations and transfer of lifestyles and products between countries also need attention. In many countries, the public-health response has been inadequate, yet the cost is devastating to individuals and health-service budgets. More than half a million lives could be saved annually in the Region if recent knowledge could be used to prevent injuries and thus redress social injustice in this area.	WHO European Ctr Environm & Hlth, Special Programme Hlth & Environm, WHO Reg Off Europe, Accid Transport & Hlth, I-00187 Rome, Italy; WHO Reg Off Europe, Special Programme Hlth & Environm, Copenhagen, Denmark; WHO Reg Off Europe, Violence Prevent, Copenhagen, Denmark	World Health Organization; World Health Organization	Sethi, D (corresponding author), WHO European Ctr Environm & Hlth, Special Programme Hlth & Environm, WHO Reg Off Europe, Accid Transport & Hlth, I-00187 Rome, Italy.	din@ecr.euro.who.int		Racioppi, Francesca/0000-0002-7287-9603				*AD HOC COMM, 1996, AD HOC COMM HLTH RES; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Bauer Robert, 2005, Int J Inj Contr Saf Promot, V12, P57, DOI 10.1080/15660970412331289715; Bobak M, 1999, ANN EPIDEMIOL, V9, P335; Boland M, 2005, INJURY PREV, V11, P38, DOI 10.1136/ip.2004.005371; Breen J, 2004, BRIT MED J, V328, P888, DOI 10.1136/bmj.328.7444.888; Chenet L, 2001, INT J EPIDEMIOL, V30, P743, DOI 10.1093/ije/30.4.743; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Coker RJ, 2004, LANCET, V363, P1389, DOI 10.1016/S0140-6736(04)16053-4; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; *DEP TRANSP, 2004, BACKGR PARTN DEM PRO; Department of Health, 1999, RED HLTH IN ACT REP; DIMITROV P, 2004, OVERVIEW ENV HLTH EF; *EUR C MIN TRANSP, 2006, ROAD SAF PERF NAT PE; *EUR COMM, 2001, CONS MEMB STAT EL PR; European Commission, 2001, WHIT PAP EUR TRANSP; FOXCROFT DR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003024; *FRENCH NAT OBS RO, FRANC REC DEV ROAD S; Fustukian S., 2002, HLTH POLICY GLOBALIS, P208; *GOV RUSS FED, FED TARG PROGR ENH R; GUSTAFSSON LH, 1979, PAEDIATRICIAN, V8, P181; HIBBEL B, 2004, 2003 ESPAD REPORT AL; Holder Y, 2001, INJURY SURVEILLANCE; HOWSON CP, 1998, ADLV, V351, P586; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; JENKINS R, 2005, BMJ-BRIT MED J, V34, P1203; KOUPILOVA I, 2002, 29 EUR ENV AG, P130; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; LAFLAMME L, 1998, SOCIAL INEQUALITY IN; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Macintyre S, 2003, BRIT MED J, V326, P5, DOI 10.1136/bmj.326.7379.5; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; MCALLISTER JFO, 2005, TIME            1219; McKee M, 2000, LANCET, V356, P665, DOI 10.1016/S0140-6736(00)02616-7; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; McKee M, 1999, ALCOHOL ALCOHOLISM, V34, P824, DOI 10.1093/alcalc/34.6.824; McKee M, 2004, BRIT MED J, V329, P1428, DOI 10.1136/bmj.329.7480.1428; Mckee M, 2005, ADDICTION, V100, P1205, DOI 10.1111/j.1360-0443.2005.01162.x; McKee M, 2004, BRIT MED J, V328, P1025, DOI 10.1136/bmj.328.7447.1025; MCKEE M, 2005, INT J EPIDEMIOL, V1093, P1; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Miller TR, 2000, MED CARE, V38, P562, DOI 10.1097/00005650-200006000-00003; *MIN HLTH, 2003, MORT POP RUSS FED 20; Mock C, 2005, B WORLD HEALTH ORGAN, V83, P294; MULRHAD N, 2004, GAMBIT C P GDANSK; *NAT CTR INJ PREV, 2000, WORK PREV CONTR INJ; Nemtsov A, 2003, DRUG ALCOHOL DEPEN, V71, P161, DOI 10.1016/S0376-8716(03)00094-2; Nemtsov AV, 1998, ADDICTION, V93, P1501, DOI 10.1046/j.1360-0443.1998.931015016.x; Peden M, 2002, INJURY LEADING CAUSE; Peden M., 2004, WORLD REPORT ROAD TR; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Powles JW, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-116; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Racioppi F., 2004, PREVENTING ROAD TRAF; Rehm J, 2004, COMP QUANTIFICATION, P959; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; Roberts I, 2004, INJURY PREV, V10, P65, DOI 10.1136/ip.2004.005140; Room R, 2005, ADDICTION, V100, P579, DOI 10.1111/rp10.1017-S1367943003213238; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Ross L, 2001, J VIROL METHODS, V96, P1, DOI 10.1016/S0166-0934(00)00275-5; SETHI D, 1999, HLTH MORTALITY ISSUE, P412; SETHI D, IN PRESS INJURIES VI; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; *SURESTART, ACC INJ; *TEACH VIP, 2005, US MAN; Towner Elizabeth, 2005, Int J Inj Contr Saf Promot, V12, P79, DOI 10.1080/15660970500073682; *UN, 2004, 58289 UN; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Walby S., 2004, COST DOMESTIC VIOLEN; Watt K, 2004, ADDICTION, V99, P1262, DOI 10.1111/j.1360-0443.2004.00823.x; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; *WHO, 2005, MORT 67 CAUS DEATH A; *WHO, 2003, WHA5624 WHO; WHO, 2004, WHA5710 WHO; *WHO, 2005, STAT INF SYST WHOSIS; *WHO, GBD EST; WHO, 2000, EUR ALC ACT PLAN 200, piii; *WHO EUR MIN C MEN, MENT HLTH ACT PLAN E; *WHO REG COMM, 2005, EURRC5510 WHO REG CO; *WHO REG COMM EUR, 2005, EURRC55R9 WHO REG CO; Wilkinson RG, 2003, SOCIAL DETERMINANTS; *WORLD BANK, 2002, TRANS 1 10 YEARS AN; World Bank, 2005, DYING TOO YOUNG ADDR; *WORLD BANK, 2002, COUNTR CLASS CLASS E; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 1996, WHA4925 WHO; ZWI A, 2002, POVERTY INEQUALITY H, P263	90	49	52	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2243	2250		10.1016/S0140-6736(06)68895-8	http://dx.doi.org/10.1016/S0140-6736(06)68895-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	120HY	17189036				2022-12-24	WOS:000243076800032
J	Gibbs, SJ; Bown, PR; Sessa, JA; Bralower, TJ; Wilson, PA				Gibbs, Samantha J.; Bown, Paul R.; Sessa, Jocelyn A.; Bralower, Timothy J.; Wilson, Paul A.			Nannoplankton extinction and origination across the Paleocene-Eocene Thermal Maximum	SCIENCE			English	Article							OCEAN; CARBON; SEA; ACIDIFICATION; METHANE; RISE; END	The Paleocene-Eocene Thermal Maximum (PETM, similar to 55 million years ago) was an interval of global warming and ocean acidification attributed to rapid release and oxidation of buried carbon. We show that the onset of the PETM coincided with a prominent increase in the origination and extinction of calcareous phytoplankton. Yet major perturbation of the surface-water saturation state across the PETM was not detrimental to the survival of most calcareous nannoplankton taxa and did not impart a calcification or ecological bias to the pattern of evolutionary turnover. Instead, the rate of environmental change appears to have driven turnover, preferentially affecting rare taxa living close to their viable limits.	Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; UCL, Dept Earth Sci, London WC1E 6BT, England; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	NERC National Oceanography Centre; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gibbs, SJ (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	sxg@noc.soton.ac.uk	Bown, Paul/C-5235-2011	Bown, Paul/0000-0001-6777-4463; Sessa, Jocelyn A./0000-0003-1509-5519; Wilson, Paul/0000-0001-6425-8906	Natural Environment Research Council [NE/C002407/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000662; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; COLOSIMO AB, 2006, P OC DRILL PROGR SCI, V0198; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Houghton J. T., 2001, CLIMATE CHANGE 2001; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; NORRIS RD, 2000, DEEP TIME PALEOBIOLO, P236; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; Wilson E. O., 1994, DIVERSITY LIFE; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	24	141	148	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1770	1773		10.1126/science.1133902	http://dx.doi.org/10.1126/science.1133902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170303				2022-12-24	WOS:000242833600057
J	Paliwal, S; Iglesias, PA; Campbell, K; Hilioti, Z; Groisman, A; Levchenko, A				Paliwal, Saurabh; Iglesias, Pablo A.; Campbell, Kyle; Hilioti, Zoe; Groisman, Alex; Levchenko, Andre			MAPK-mediated bimodal gene expression and adaptive gradient sensing in yeast	NATURE			English	Article							PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; POSITIVE FEEDBACK; ESCHERICHIA-COLI; KINASE; KSS1; HYSTERESIS; GROWTH; DIFFERENTIATION	The mating pathway in Saccharomyces cerevisiae has been the focus of considerable research effort, yet many quantitative aspects of its regulation still remain unknown. Using an integrated approach involving experiments in microfluidic chips and computational modelling, we studied gene expression and phenotypic changes associated with the mating response under well-defined pheromone gradients. Here we report a combination of switch-like and graded pathway responses leading to stochastic phenotype determination in a specific range of pheromone concentrations. Furthermore, we show that these responses are critically dependent on mitogen-activated protein kinase (MAPK)-mediated regulation of the activity of the pheromone-response-specific transcription factor, Ste12, as well as on the autoregulatory feedback of Ste12. In particular, both the switch-like characteristics and sensitivity of gene expression in shmooing cells to pheromone concentration were significantly diminished in cells lacking Kss1, one of the MAP kinases activated in the mating pathway. In addition, the dynamic range of gradient sensing of Kss1-deficient cells was reduced compared with wild type. We thus provide unsuspected functional significance for this kinase in regulation of the mating response.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Whitehead Inst Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Elect Engn & Comp Engn, Baltimore, MD 21218 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Johns Hopkins University; University of California System; University of California San Diego	Levchenko, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	agroisman@ucsd.edu; alev@jhu.edu	Groisman, Alexander/AAU-7843-2021; Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X; HILIOTI, ZOE/0000-0003-4330-0129	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [R01 GM072024] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Colman-Lerner A, 2006, NATURE, V439, P502, DOI 10.1038/nature04476; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Farley FW, 1999, GENETICS, V151, P1425; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guthrie C., 1991, METHODS ENZYMOLOGY G; Isbister CM, 2003, J NEUROSCI, V23, P193; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; MOORE SA, 1983, J BIOL CHEM, V258, P3849; NINFA AJ, 2004, SCI STKE, V232, pPE20; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113	31	222	227	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					46	51		10.1038/nature05561	http://dx.doi.org/10.1038/nature05561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17310144				2022-12-24	WOS:000244525600033
J	Cai, HQ; Yu, S; Menon, S; Cai, YY; Lazarova, D; Fu, CM; Reinisch, K; Hay, JC; Ferro-Novick, S				Cai, Huaqing; Yu, Sidney; Menon, Shekar; Cai, Yiying; Lazarova, Darina; Fu, Chunmei; Reinisch, Karin; Hay, Jesse C.; Ferro-Novick, Susan			TRAPPI tethers COPII vesicles by binding the coat subunit Sec23	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; FUSION; PROTEIN; DOCKING; INTERMEDIATE; HYDROLYSIS; COMPLEXES; SITES	The budding of endoplasmic reticulum (ER)-derived vesicles is dependent on the COPII coat complex(1). Coat assembly is initiated when Sar1-GTP recruits the cargo adaptor complex, Sec23/Sec24, by binding to its GTPase-activating protein ( GAP) Sec23 (ref. 2). This leads to the capture of transmembrane cargo by Sec24 (refs 3, 4) before the coat is polymerized by the Sec13/Sec31 complex(5). The initial interaction of a vesicle with its target membrane is mediated by tethers(6). We report here that in yeast and mammalian cells the tethering complex TRAPPI ( ref. 7) binds to the coat subunit Sec23. This event requires the Bet3 subunit. In vitro studies demonstrate that the interaction between Sec23 and Bet3 targets TRAPPI to COPII vesicles to mediate vesicle tethering. We propose that the binding of TRAPPI to Sec23 marks a coated vesicle for fusion with another COPII vesicle or the Golgi apparatus. An implication of these findings is that the intracellular destination of a transport vesicle may be determined in part by its coat and its associated cargo.	Howard Hughes Med Inst, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Howard Hughes Medical Institute; Yale University; University of Montana System; University of Montana	Ferro-Novick, S (corresponding author), Howard Hughes Med Inst, New Haven, CT 06519 USA.	susan.ferronovick@yale.edu	Bin Sidney Yu, Siu/R-4936-2018	Bin Sidney Yu, Siu/0000-0001-9643-2729; Cai, Huaqing/0000-0001-8434-6639	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080616] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Menon S, 2006, BIOCHEM BIOPH RES CO, V350, P669, DOI 10.1016/j.bbrc.2006.09.096; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425; Peyroche A, 2001, METHOD ENZYMOL, V329, P290; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	28	185	197	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					941	944		10.1038/nature05527	http://dx.doi.org/10.1038/nature05527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287728				2022-12-24	WOS:000244341200055
J	Garcia-Bassets, I; Kwon, YS; Telese, F; Prefontaine, GG; Hutt, KR; Cheng, CS; Ju, BG; Ohgi, KA; Wang, J; Escoubet-Lozach, L; Rose, DW; Glass, CK; Fu, XD; Rosenfeld, MG				Garcia-Bassets, Ivan; Kwon, Young-Soo; Telese, Francesca; Prefontaine, Gratien G.; Hutt, Kasey R.; Cheng, Christine S.; Ju, Bong-Gun; Ohgi, Kenneth A.; Wang, Jianxun; Escoubet-Lozach, Laure; Rose, David W.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors	CELL			English	Article							THYROID-HORMONE RECEPTOR; ANDROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ESTROGEN-RECEPTOR; CO-REPRESSOR; INDEPENDENT ACTIVATION; CHROMATIN-STRUCTURE; LYSINE METHYLATION; SIGNALING PATHWAY; BREAST-CANCER	Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases (HMTs) to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals. This strategy, based at least in part on an HMT-dependent inhibitory histone code, imposes a requirement for specific histone demethylases, including LSD1, to permit ligand- and signal-dependent activation of regulated gene expression. These events link an inhibitory methylation component of the histone code to a broadly used strategy that circumvents pathological constitutive gene induction by physiologically regulated transcription factors.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu; xdfu@ucsd.edu; mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Telese, Francesca/0000-0003-3877-0628; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL CANCER INSTITUTE [R33CA114184, R01CA097134, R01CA052599] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R37DK039949, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA052599, CA52599, R01 CA097134, CA97134, R33 CA114184, CA114184] Funding Source: Medline; NHGRI NIH HHS [R01 HG003119, HG003119] Funding Source: Medline; NIDDK NIH HHS [R37 DK039949, DK39949, P30 DK063491, DK063491, R01 DK039949] Funding Source: Medline; NINDS NIH HHS [NS34934, R01 NS034934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CULIG Z, 1994, CANCER RES, V54, P5474; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Du Y, 2001, CANCER RES, V61, P8094; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Gazzerro P, 2006, EXP CELL RES, V312, P340, DOI 10.1016/j.yexcr.2005.11.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He LS, 1998, CANCER RES, V58, P4238; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	74	348	375	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					505	518		10.1016/j.cell.2006.12.038	http://dx.doi.org/10.1016/j.cell.2006.12.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289570	Green Accepted, Bronze			2022-12-24	WOS:000244842700017
J	Pillitteri, LJ; Sloan, DB; Bogenschutz, NL; Torii, KU				Pillitteri, Lynn Jo; Sloan, Daniel B.; Bogenschutz, Naomi L.; Torii, Keiko U.			Termination of asymmetric cell division and differentiation of stomata	NATURE			English	Article							MYOD FAMILY; SELAGINELLA; POLARITY	Stomata consist of a pair of guard cells that mediate gas and water-vapour exchange between plants and the atmosphere. Stomatal precursor cells - meristemoids - possess a transient stem-cell-like property and undergo several rounds of asymmetric divisions before further differentiation. Here we report that the Arabidopsis thaliana basic helix - loop - helix ( bHLH) protein MUTE is a key switch for meristemoid fate transition. In the absence of MUTE, meristemoids abort after excessive asymmetric divisions and fail to differentiate stomata. Constitutive overexpression of MUTE directs the entire epidermis to adopt guard cell identity. MUTE has two paralogues: FAMA, a regulator of guard cell morphogenesis, and SPEECHLESS (SPCH). We show that SPCH directs the first asymmetric division that initiates stomatal lineage. Together, SPCH, MUTE and FAMA bHLH proteins control stomatal development at three consecutive steps: initiation, meristemoid differentiation and guard cell morphogenesis. Our findings highlight the roles of closely related bHLHs in cell type differentiation in plants and animals.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST)	Torii, KU (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ktorii@u.washington.edu	TORII, KEIKO U./A-6041-2013; Sloan, Daniel/D-4152-2011	TORII, KEIKO U./0000-0002-6168-427X; Sloan, Daniel/0000-0002-3618-0897				Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; BROWN RC, 1985, AM J BOT, V72, P1914, DOI 10.2307/2443608; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; DENGLER NG, 1983, AM J BOT, V70, P193, DOI 10.2307/2443263; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Geisler MJ, 2003, PLANTA, V216, P571; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; POETHIG RS, 2006, ENHANCER TRAPS; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3	24	323	360	6	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					501	505		10.1038/nature05467	http://dx.doi.org/10.1038/nature05467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183267				2022-12-24	WOS:000243867300035
J	Johnson, MD; Oldach, D; Delwiche, CF; Stoecker, DK				Johnson, Matthew D.; Oldach, David; Delwiche, Charles F.; Stoecker, Diane K.			Retention of transcriptionally active cryptophyte nuclei by the ciliate Myrionecta rubra	NATURE			English	Article							MESODINIUM-RUBRUM; GENE-TRANSFER; ULTRASTRUCTURE; CHLOROPLASTS; CRYPTOMONAD; DINOFLAGELLATE; ENDOSYMBIONT; NUCLEOMORPH; CILIOPHORA; ALGAE	It is well documented that organelles can be retained and used by predatory organisms, but in most cases such sequestrations are limited to plastids of algal prey(1). Furthermore, sequestrations of prey organelles are typically highly ephemeral(2) as a result of the inability of the organelle to remain functional in the absence of numerous nuclear-encoded genes involved in its regulation, division and function(3). The marine photosynthetic ciliate Myrionecta rubra (Lohmann 1908) Jankowski 1976 ( the same as Mesodinium rubrum)(4) is known to possess organelles of cryptophyte origin(5-9), which has led to debate concerning their status as permanent symbiotic or temporary sequestered fixtures(5-13). Recently, M. rubra has been shown to steal plastids ( that is, chloroplasts) from the cryptomonad, Geminigera cryophila, and prey nuclei were observed to accumulate after feeding(10). Here we show that cryptophyte nuclei in M. rubra are retained for up to 30 days, are transcriptionally active and service plastids derived from multiple cryptophyte cells. Expression of a cryptophyte nuclear-encoded gene involved in plastid function declined in M. rubra as the sequestered nuclei disappeared from the population. Cytokinesis, plastid performance and their replication are dependent on recurrent stealing of cryptophyte nuclei. Karyoklepty ( from Greek karydi, kernel; kleftis, thief) represents a previously unknown evolutionary strategy for acquiring biochemical potential.	Univ Maryland, Horn Point Environm Lab, Ctr Environm Sci, Cambridge, MD 21613 USA; Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; Univ Maryland, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Johnson, MD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	johnson@marine.rutgers.edu	Delwiche, Charles F/C-6549-2008; stoecker, diane k/F-9341-2013; Johnson, Matthew/B-4344-2012	Delwiche, Charles F/0000-0001-7854-8584; Johnson, Matthew/0000-0003-4853-2674				BLACKBOURN DJ, 1973, J PROTOZOOL, V20, P286, DOI 10.1111/j.1550-7408.1973.tb00877.x; Deane JA, 2000, PROTIST, V151, P239, DOI 10.1078/1434-4610-00022; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; GILLOTT MA, 1980, J PHYCOL, V16, P558; GOFF LJ, 1995, PLANT CELL, V7, P1899; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hansen PJ, 2006, MAR BIOL RES, V2, P169, DOI 10.1080/17451000600719577; HIBBERD DJ, 1977, J MAR BIOL ASSOC UK, V57, P45, DOI 10.1017/S0025315400021226; Johnson MD, 2006, J PHYCOL, V42, P1235, DOI 10.1111/j.1529-8817.2006.00275.x; Johnson MD, 2004, PROTIST, V155, P347, DOI 10.1078/1434461041844222; Johnson MD, 2005, AQUAT MICROB ECOL, V39, P303, DOI 10.3354/ame039303; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYNN DH, 2000, ILLUSTRATED GUIDE PR, P477; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Miller PE, 1998, J PHYCOL, V34, P371, DOI 10.1046/j.1529-8817.1998.340371.x; OAKLEY BR, 1978, BIOSYSTEMS, V10, P361, DOI 10.1016/0303-2647(78)90019-9; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; STOECKER DK, 1990, MAR BIOL, V107, P491, DOI 10.1007/BF01313434; TAYLOR FJR, 1971, J FISH RES BOARD CAN, V28, P391, DOI 10.1139/f71-052; TAYLOR FJR, 1969, NATURE, V224, P819, DOI 10.1038/224819a0; WILCOX LW, 1984, J PHYCOL, V20, P236, DOI 10.1111/j.0022-3646.1984.00236.x	24	146	152	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					426	428		10.1038/nature05496	http://dx.doi.org/10.1038/nature05496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251979				2022-12-24	WOS:000243689500039
J	Center, JR; Bliue, D; Nguyen, TV; Eisman, JA				Center, Jacqueline R.; Bliue, Dana; Nguyen, Tuan V.; Eisman, John A.			Risk of subsequent fracture after low-trauma fracture in men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OSTEOPOROTIC FRACTURES; LIMB FRACTURES; ELDERLY-MEN; DUBBO; METAANALYSIS; MANAGEMENT; INCREASE; FOREARM; SPINE	Context There are few published long-term data on absolute risk of subsequent fracture ( refracture) following initial low-trauma fracture in women and fewer in men. Objective To examine long-term risk of subsequent fracture following initial osteoporotic fracture in men and women. Design, Setting, and Participants Prospective cohort study (Dubbo Osteoporosis Epidemiology Study) in Australia of 2245 community-dwelling women and 1760 men aged 60 years or older followed up for 16 years from July 1989 through April 2005. Main Outcome Measure Incidence of first ( initial) fracture and incidence of subsequent fracture according to sex, age group, and time since first fracture. Relative risk was determined by comparing risk of subsequent fracture with risk of initial fracture. Results There were 905 women and 337 men with an initial fracture, of whom 253 women and 71 men experienced a subsequent fracture. Relative risk (RR) of subsequent fracture in women was 1.95 (95% confidence interval [CI], 1.70-2.25) and in men was 3.47 ( 95% CI, 2.68-4.48). As a result, absolute risk of subsequent fracture was similar in women and men and at least as great as the initial fracture risk for a woman 10 years older. Thus, women and men aged 60 to 69 years had absolute refracture rates of 36/1000 person-years ( 95% CI, 26-48/1000) and 37/1000 person-years ( 95% CI, 23-59/1000), respectively. The increase in absolute fracture risk remained for up to 10 years, by which time 40% to 60% of surviving women and men experienced a subsequent fracture. All fracture locations apart from rib ( men) and ankle ( women) resulted in increased subsequent fracture risk, with highest RRs following hip ( RR, 9.97; 95% CI, 1.38-71.98) and clinical vertebral ( RR, 15.12; 95% CI, 6.06-37.69) fractures in younger men. In multivariate analyses, femoral neck bone mineral density, age, and smoking were predictors of subsequent fracture in women and femoral neck bone mineral density, physical activity, and calcium intake were predictors in men. Conclusion After an initial low-trauma fracture, absolute risk of subsequent fracture was similar for men and women. This increased risk occurred for virtually all clinical fractures and persisted for up to 10 years.	Univ New S Wales, Bone & Mineral Res Program, Garvan Inst Med Res, St Vincents Hosp, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Center, JR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	j.center@garvan.org.au	Nguyen, Tuan V/B-6147-2008; Nguyen, Tuan V./AAD-9503-2020; Center, Jacqueline/AAY-8712-2021; Bliuc, Dana/Y-7240-2018; Eisman, John A/C-2886-2014	Nguyen, Tuan V/0000-0002-3246-6281; Nguyen, Tuan V./0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Bliuc, Dana/0000-0001-9682-2313; 				Bliuc D, 2005, OSTEOPOROSIS INT, V16, P977, DOI 10.1007/s00198-004-1788-x; Briancon D, 2004, JOINT BONE SPINE, V71, P128, DOI 10.1016/S1297-319X(03)00060-5; *CARY NC, 2006, SAS 9 1 3 PROCEDURES; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; CENTER JR, 2003, INT C MET BON DIS CO; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Eisman J, 2004, J BONE MINER RES, V19, P1969, DOI 10.1359/JBMR.040905; Ettinger B, 2003, ARCH INTERN MED, V163, P2741, DOI 10.1001/archinte.163.22.2741; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Hasselman CT, 2003, J BONE JOINT SURG AM, V85A, P820, DOI 10.2106/00004623-200305000-00008; Ismail AA, 2006, OSTEOPOROSIS INT, V17, P41, DOI 10.1007/s00198-005-1887-3; Johnell O, 2001, OSTEOPOROSIS INT, V12, P207, DOI 10.1007/s001980170131; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; LAURITZEN JB, 1993, ACTA ORTHOP SCAND, V64, P297, DOI 10.3109/17453679308993629; LORD SR, 1994, MED J AUSTRALIA, V160, P684, DOI 10.5694/j.1326-5377.1994.tb125905.x; Majumdar SR, 2005, ARCH INTERN MED, V165, P905, DOI 10.1001/archinte.165.8.905; Majumdar SR, 2004, ANN INTERN MED, V141, P366, DOI 10.7326/0003-4819-141-5-200409070-00011; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Nguyen ND, 2005, J BONE MINER RES, V20, P1921, DOI 10.1359/JBMR.050520; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Port L, 2003, OSTEOPOROSIS INT, V14, P780, DOI 10.1007/s00198-003-1452-x; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P624, DOI 10.1007/s001980200084; VANHELDEN S, 2005, OSTEOPOROUS INT, V24, P24	30	435	452	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2007	297	4					387	394		10.1001/jama.297.4.387	http://dx.doi.org/10.1001/jama.297.4.387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128GE	17244835				2022-12-24	WOS:000243645400024
J	Gillson, L; Hoffman, MT				Gillson, Lindsey; Hoffman, M. Timm			Rangeland ecology in a changing world	SCIENCE			English	Editorial Material							NONEQUILIBRIUM; ECOSYSTEMS	A synthesis of differnt models for assessing the balance between vegetation and livestock numbers in grazing lands may help policy-makers integrate human and ecosystem needs.	Univ Cape Town, Inst Plant Conservat, Dept Bot, ZA-7701 Rondebosch, South Africa	University of Cape Town	Gillson, L (corresponding author), Univ Cape Town, Inst Plant Conservat, Dept Bot, ZA-7701 Rondebosch, South Africa.	lindsey.gillson@uct.ac.za	Hoffman, Timm/K-4937-2016; Gillson, Lindsey/AAR-6531-2020	Hoffman, Timm/0000-0002-5843-2397; Gillson, Lindsey/0000-0001-9607-6760				Behnke R.H., 1993, RANGE ECOLOGY DISEQU; Benjaminsen TA, 2006, ANN ASSOC AM GEOGR, V96, P524, DOI 10.1111/j.1467-8306.2006.00704.x; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Campbell BM, 2006, ECOL ECON, V60, P75, DOI 10.1016/j.ecolecon.2006.05.010; Chambers FM, 1999, J APPL ECOL, V36, P719, DOI 10.1046/j.1365-2664.1999.00435.x; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Gross JE, 2006, ENVIRON MODELL SOFTW, V21, P1264, DOI 10.1016/j.envsoft.2005.04.024; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Janssen MA, 2004, J ENVIRON ECON MANAG, V47, P140, DOI 10.1016/S0095-0696(03)00069-X; Li BL, 2002, ACTA BIOTHEOR, V50, P141, DOI 10.1023/A:1016562208170; Reynolds JF, 2002, GLOBAL DESERTIFICATI, P1; SCOONES I, 1999, ANNU REV ANTHROPOL, V28, P479, DOI DOI 10.1146/ANNUREV.ANTHR0.28.1.479; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Vetter S, 2005, J ARID ENVIRON, V62, P321, DOI 10.1016/j.jaridenv.2004.11.015; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492	18	114	123	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					53	54		10.1126/science.1136577	http://dx.doi.org/10.1126/science.1136577			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122WU	17204634				2022-12-24	WOS:000243259100027
J	Yudushkin, IA; Schleifenbaum, A; Kinkhabwala, A; Neel, BG; Schultz, C; Bastiaens, PIH				Yudushkin, Ivan A.; Schleifenbaum, Andreas; Kinkhabwala, Ali; Neel, Benjamin G.; Schultz, Carsten; Bastiaens, Philippe I. H.			Live-cell Imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B	SCIENCE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; ENDOPLASMIC-RETICULUM; INSULIN-RECEPTOR; PHOSPHORYLATION; DEPHOSPHORYLATION; SPECIFICITY; GRADIENTS; PEPTIDES	Endoplasmic reticulum-localized protein-tyrosine phosphatase PTP1B terminates growth factor signal transduction by dephosphorylation of receptor tyrosine kinases (RTKs). But how PTP1B allows for RTK signaling in the cytoplasm is unclear. In order to test whether PTP1B activity is spatially regulated, we developed a method based on Forster resonant energy transfer for imaging enzyme-substrate (ES) intermediates in live cells. We observed the establishment of a steady-state ES gradient across the cell. This gradient exhibited robustness to cell-to-cell variability, growth factor activation, and RTK localization, which demonstrated spatial regulation of PTP1B activity. Such regulation may be important for generating distinct cellular environments that permit RTK signal transduction and that mediate its eventual termination.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02115 USA	European Molecular Biology Laboratory (EMBL); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bastiaen@embl.de	Yudushkin, Ivan/ABH-9204-2020	Yudushkin, Ivan/0000-0002-6637-027X; Schultz, Carsten/0000-0002-5824-2171	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK60838] Funding Source: Medline; PHS HHS [R37 49152] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Nguyen A, 2004, NAT BIOTECHNOL, V22, P993, DOI 10.1038/nbt997; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Vazquez ME, 2003, J AM CHEM SOC, V125, P10150, DOI 10.1021/ja0351847; Verveer P.J., 2001, METHODS CELLULAR IMA, P273; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224	25	111	117	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					115	119		10.1126/science.1134966	http://dx.doi.org/10.1126/science.1134966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204654				2022-12-24	WOS:000243259100050
J	Swanson, SJ; Snider, C; Braden, CR; Boxrud, D; Wunschmann, A; Rudroff, JA; Lockett, J; Smith, KE				Swanson, Stephen J.; Snider, Cynthia; Braden, Christopher R.; Boxrud, David; Wuenschmann, Arno; Rudroff, Jo Ann; Lockett, Jana; Smith, Kirk E.			Multidrug-resistant Salmonella enterica serotype typhimurium associated with pet rodents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	43rd Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 06-09, 2005	San Francisco, CA	Infect Dis Soc Amer			NONTYPHOIDAL SALMONELLA; COLONIZATION RESISTANCE; UNITED-STATES; INFECTIONS; ILLNESS; FEED; MICE; TRANSPORTATION; OUTBREAK; BURDEN	BACKGROUND: An estimated 1.4 million salmonella infections occur annually in the United States. The majority of these infections are foodborne, but many are acquired by contact with animals. In August 2004, isolates of Salmonella enterica serotype Typhimurium, which were indistinguishable from one another by pulsed-field gel electrophoresis (PFGE), were obtained from eight hamsters from a Minnesota pet distributor. We conducted an investigation to determine whether human cases of salmonella could be linked to this rodent-borne strain. METHODS: To identify cases of human infection with S. enterica serotype Typhimurium potentially related to pet rodents, we reviewed salmonella PFGE patterns submitted to the National Molecular Subtyping Network for Foodborne Disease Surveillance. Patients with isolates matching the hamster strain were interviewed about exposure to pet rodents. Implicated rodents were traced to pet stores, distributors, and breeders. RESULTS: We identified matching S. enterica serotype Typhimurium isolates from 28 patients in whom the onset of illness occurred between December 2003 and September 2004. Of 22 patients (or in the case of children, their parents) interviewed, 13 patients (59%) in 10 states reported exposure to pet hamsters, mice, or rats, and 2 (9%) had secondary infections. The median age of the 15 patients with primary or secondary rodent exposure was 16 years, and 6 patients (40%) were hospitalized. Thirteen associated pet stores supplied by seven distributors were identified in 10 states. No single source of the rodents was identified. The outbreak strain of S. enterica serotype Typhimurium was cultured from a patient's pet mouse and from seven hamsters from pet stores. Closely related S. enterica serotype Typhimurium isolates were cultured from rodent cages and reusable transport containers at a pet distributor. Human, rodent, and environmental isolates were resistant to ampicillin, chloramphenicol, streptomycin, sulfisoxazole, and tetracycline. CONCLUSIONS: Pet rodents probably are an underrecognized source of human salmonella infection.	Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA USA; Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Publ Hlth Lab, St Paul, MN USA; Minnesota Dept Hlth, Acute Dis Invest & Control Sect, St Paul, MN USA; Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; Missouri Dept Hlth & Senior Serv, Jefferson City, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities	Swanson, SJ (corresponding author), Hennepin Cty Med Ctr, Dept Pediat, Mail Code G7,701 Pk Ave, Minneapolis, MN 55415 USA.	stephen.swanson@co.hennepin.mn.us						*AM VET MED ASS, 2004, JUD THER US ANT SCHA; Bartram MT, 1940, J INFECT DIS, V67, P222, DOI 10.1093/infdis/67.3.222; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; FISH NA, 1968, CAN MED ASSOC J, V99, P418; Foodborne and Diarrheal Diseases Branch DoBaMD; National Center for Infectious Diseases Centers for Disease Control and Prevention, 2000, STAND MOL SUBT FOODB; Gupte AR, 2003, APPL ENVIRON MICROB, V69, P6669, DOI 10.1128/AEM.69.11.6669-6675.2003; HABERMANN RT, 1958, J NATL CANCER I, V20, P933; Healing T D, 1991, CDR (Lond Engl Rev), V1, pR114; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Isaacson RE, 1999, AM J VET RES, V60, P1155; LATOUR PB, 1981, AM J VET RES, V42, P2105; Lawson AJ, 2002, EMERG INFECT DIS, V8, P434; LIPSKY S, 1995, JAMA-J AM MED ASSOC, V274, P294; Martin LJ, 2004, J INFECT DIS, V189, P377, DOI 10.1086/381270; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; MILLER CP, 1963, J INFECT DIS, V113, P59, DOI 10.1093/infdis/113.1.59; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; OWEN RA, 1983, AM J VET RES, V44, P46; PETRIE GF, 1910, P ROY SOC MED, V4, P70; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; SPARROW S, 1980, J SMALL ANIM PRACT, V21, P1, DOI 10.1111/j.1748-5827.1980.tb01208.x; STEFFEN EK, 1983, LAB ANIM SCI, V33, P454; VANDERWAAIJ D, 1968, J INFECT DIS, V118, P32, DOI 10.1093/infdis/118.1.32; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Welch H, 1941, AM J PUBLIC HEALTH N, V31, P332, DOI 10.2105/AJPH.31.4.332; WILLIAMS JE, 1978, AVIAN DIS, V22, P742, DOI 10.2307/1589652; Woodward DL, 1997, J CLIN MICROBIOL, V35, P2786, DOI 10.1128/JCM.35.11.2786-2790.1997; 2000, MMWR MORB MORTAL WKL, V49, P297; 2001, MMWR MORB MORTAL WKL, V50, P701; 2003, MMWR MORB MORTAL WKL, V52, P1206; 2005, MMWR MORB MORTAL WKL, V54, P429	35	56	65	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					21	28		10.1056/NEJMoa060465	http://dx.doi.org/10.1056/NEJMoa060465			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202452				2022-12-24	WOS:000243209600005
J	Zanettini, R; Antonini, A; Gatto, G; Gentile, R; Tesei, S; Pezzoli, G				Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianni			Valvular heart disease and the use of dopamine agonists for Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITRAL REGURGITATION; 5-HT2B RECEPTORS; PERGOLIDE; VALVE; DETERMINANTS; VALVULOPATHY; FENFLURAMINE; DYSFUNCTION; PREVALENCE	BACKGROUND: Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease. METHODS: We performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for Parkinson's disease (pergolide, 64 patients; cabergoline, 49; and non-ergot-derived dopamine agonists, 42) and 90 control subjects. Valve regurgitation was assessed according to American Society of Echocardiography recommendations. The mitral-valve tenting area was also measured and used as a quantitative index for leaflet stiffening and apical displacement of leaflet coaptation. RESULTS: Clinically important regurgitation (moderate to severe, grade 3 to 4) in any valve was found with significantly greater frequency in patients taking pergolide (23.4%) or cabergoline (28.6%) but not in patients taking non-ergot-derived dopamine agonists (0%), as compared with control subjects (5.6%). The relative risk for moderate or severe valve regurgitation in the pergolide group was 6.3 for mitral regurgitation (P=0.008), 4.2 for aortic regurgitation (P=0.01), and 5.6 for tricuspid regurgitation (P=0.16); corresponding relative risks in the cabergoline group were 4.6 (P=0.09), 7.3 (P<0.001), and 5.5 (P=0.12). The mean mitral tenting area was significantly greater in ergot-treated patients and showed a linear relationship with the severity of mitral regurgitation. Patients treated with ergot derivatives who had grade 3 to 4 regurgitation of any valve had received a significantly higher mean cumulative dose of pergolide or cabergoline than had patients with lower grades. CONCLUSIONS: The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non-ergot-derived dopamine agonists, as compared with control subjects. These findings should be considered in evaluating the risk-benefit ratio of treatment with ergot derivatives.	Ist Clin Perfezionamento, Cardiac Rehabil Unit, I-20126 Milan, Italy; Ist Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy		Zanettini, R (corresponding author), Ist Clin Perfezionamento, Cardiac Rehabil Unit, Via Bignami 1, I-20126 Milan, Italy.	cardriab@icp.mi.it	Antonini, Angelo/H-9726-2019	Antonini, Angelo/0000-0003-1040-2807; Pezzoli, Gianni/0000-0003-4665-6710				Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Botero M, 2002, J CLIN ANESTH, V14, P57, DOI 10.1016/S0952-8180(01)00353-1; Chaudhuri KR, 2004, MOVEMENT DISORD, V19, P1522, DOI 10.1002/mds.20330; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; Horvath J, 2004, MOVEMENT DISORD, V19, P656, DOI 10.1002/mds.20201; Jahnichen S, 2005, EUR J PHARMACOL, V513, P225, DOI 10.1016/j.ejphar.2005.03.010; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Pinero A, 2005, NEW ENGL J MED, V353, P1976, DOI 10.1056/NEJM200511033531822; Rascol O, 2004, MOVEMENT DISORD, V19, P611, DOI 10.1002/mds.20202; REDFIELD MM, 1992, ANN INTERN MED, V117, P50, DOI 10.7326/0003-4819-117-1-50; Rothman RB, 2000, CIRCULATION, V102, P2836; Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; Srichai MB, 2005, ANN THORAC SURG, V80, P170, DOI 10.1016/j.athoracsur.2005.01.068; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	19	575	593	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					39	46		10.1056/NEJMoa054830	http://dx.doi.org/10.1056/NEJMoa054830			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202454	Bronze			2022-12-24	WOS:000243209600007
J	Fonarow, GC; Abraham, WT; Albert, NM; Stough, WG; Gheorghiade, M; Greenberg, BH; O'Connor, CM; Pieper, K; Sun, JL; Yancy, C; Young, JB				Fonarow, Gregg C.; Abraham, William T.; Albert, Nancy M.; Stough, Wendy Gattis; Gheorghiade, Mihai; Greenberg, Barry H.; O'Connor, Christopher M.; Pieper, Karen; Sun, Jie Lena; Yancy, Clyde; Young, James B.		OPTIMIZE-HF Investigators	Association between performance measures and clinical outcomes for patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; MORTALITY; CARVEDILOL; INFARCTION; RATES	Context Assessment of quality of care in heart failure has focused on the development and use of process-based performance measures, with the presumption that these processes are associated with improved clinical outcomes. However, this link remains largely untested. Objective To examine the relationship between current American College of Cardiology/ American Heart Association (ACC/AHA) performance measures for patients hospitalized with heart failure and relevant clinical outcomes. Design, Setting, and Patients The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure, a registry and performance improvement program for patients hospitalized with heart failure. Sixty- to ninety-day postdischarge follow-up data were prospectively collected from 5791 patients at 91 US hospitals in a prespecified 10% sample between March 2003 and December 2004. Mean patient age was 72.0 years, 51% were male, 78% were white, and 42% had ischemic etiology. Multivariable and propensity-adjusted analyses were performed to assess the process-outcome relationship for each performance measure in eligible patients. Additionally, we evaluated the process-outcome link of a potential performance measure for beta-blockade at discharge among eligible patients hospitalized with heart failure. Main Outcome Measures Sixty- to ninety-day mortality and combined mortality/ rehospitalization rates. Results Mortality during follow-up was 8.6% and mortality/ rehospitalization was 36.2%. None of the 5 ACC/AHA heart failure performance measures was significantly associated with reduced early mortality risk, and only angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use at discharge was associated with 60- to 90-day postdischarge mortality or rehospitalization. beta-Blockade at the time of hospital discharge, currently not a heart failure performance measure, was strongly associated with reduced risk of mortality ( hazard ratio, 0.48; 95% confidence interval, 0.30-0.79; P=.004) and mortality/ rehospitalization during follow-up. Conclusions Current heart failure performance measures, aside from prescription of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker at discharge, have little relationship to patient mortality and combined mortality/ rehospitalization in the first 60 to 90 days after discharge. Additional measures and better methods for identifying and validating heart failure performance measures may be needed to accurately assess and improve care of patients with heart failure.	Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Ohio State Univ, Columbus, OH 43210 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Duke Univ, Med Ctr, Durham, NC USA; Duke Clin Res Inst, Durham, NC USA; Campbell Univ, Sch Pharm, Dept Clin Res, Res Triangle Pk, NC USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; Duke University; Duke University; Campbell University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Diego; Baylor University; Baylor University Medical Center	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014; Stough, Wendy G/R-4287-2016	Fonarow, Gregg C/0000-0002-3192-8093; Stough, Wendy G/0000-0001-8290-1205				American Heart Association, 2006, HEART DIS STROK STAT; [Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Bufalino V, 2006, CIRCULATION, V113, P1151, DOI 10.1161/CIRCULATIONAHA.105.171760; Fonarow GC, 2004, AM J CARDIOL, V93, p77B, DOI 10.1016/j.amjcard.2004.01.030; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Granger CB, 2005, AM J MED, V118, P858, DOI 10.1016/j.amjmed.2005.01.070; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hjalmarson A, 1999, LANCET, V353, P2001; Houston TK, 2005, AM J MED, V118, P269, DOI 10.1016/j.amjmed.2004.12.007; Hunt SA, ACC AHA 2005 GUIDELI; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P2647; *JOINT COMM ACCR H, 2006, SPEC MAN NAT HOSP QU; *JOINT COMM ACCR H, 2006, FACTS ORYX HOSP COR; Koelling TM, 2004, AM HEART J, V147, P74, DOI 10.1016/j.ahj.2003.07.021; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 2000, CIRCULATION, V101, pE122, DOI 10.1161/01.CIR.101.12.e122; Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010; Lechat P, 1999, LANCET, V353, P9; Luthi JC, 2002, INT J QUAL HEALTH C, V14, P15, DOI 10.1093/intqhc/14.1.15; Luthi JC, 2003, INT J QUAL HEALTH C, V15, P413, DOI 10.1093/intqhc/mzg055; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Rich Michael W, 2002, Heart Fail Rev, V7, P89; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Shivkumar K, 1996, PROG CARDIOVASC DIS, V38, P337, DOI 10.1016/S0033-0620(96)80018-1; Spertus JA, 2005, J AM COLL CARDIOL, V45, P1147, DOI 10.1016/j.jacc.2005.03.011	34	382	387	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2007	297	1					61	70		10.1001/jama.297.1.61	http://dx.doi.org/10.1001/jama.297.1.61			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123BS	17200476				2022-12-24	WOS:000243271900022
J	Patrick, JH; Keenan, MAE				Patrick, John H.; Keenan, Mary Ann E.			Gait analysis to assist walking after stroke	LANCET			English	Editorial Material							DEFORMITY; FOOT		Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England; Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania	Patrick, JH (corresponding author), Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England.	John.Patrick@rjah.nhs.uk	Keenan, Mary Ann/ABB-1551-2020					Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; *DAN NAT I HLTH, 2002, DAN NAT HLTH POP FOR; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gage Jr, 2004, CLIN DEV MED, P238; Jorgensen HS, 1999, STROKE, V30, P930, DOI 10.1161/01.STR.30.5.930; NENE AV, 2005, GAIT POST S, V22, pS18; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Takahashi S, 2002, J BONE JOINT SURG BR, V84B, P978, DOI 10.1302/0301-620X.84B7.12905	8	22	25	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					256	257		10.1016/S0140-6736(07)60124-X	http://dx.doi.org/10.1016/S0140-6736(07)60124-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258650				2022-12-24	WOS:000243912000008
J	Kuo, CT; Mirzadeh, Z; Soriano-Navarro, M; Rasin, M; Wang, D; Shen, J; Sestan, N; Garcia-Verdugo, J; Alvarez-Buylla, A; Jan, LY; Jan, YN				Kuo, Chay T.; Mirzadeh, Zaman; Soriano-Navarro, Mario; Rasin, Mladen; Wang, Denan; Shen, Jie; Sestan, Nenad; Garcia-Verdugo, Jose; Alvarez-Buylla, Arturo; Jan, Lily Y.; Jan, Yuh-Nung			Postnatal deletion of numb/numblike reveals repair and remodeling capacity in the subventricular neurogenic niche	CELL			English	Article							PROGENITOR-CELL MAINTENANCE; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; ADULT BRAIN; CORTICAL NEUROGENESIS; NEURONAL MIGRATION; SONIC HEDGEHOG; NUMB; MOUSE; ZONE	Neural stem cells are retained in the postnatal subventricular zone (SVZ), a specialized neurogenic niche with unique cytoarchitecture and cell-cell contacts. Although the SVZ stem cells continuously regenerate, how they and the niche respond to local changes is unclear. Here we generated nestin-creER(tm) transgenic mice with inducible Cre recombinase in the SVZ and removed Numb/Numblike, key regulators of embryonic neurogenesis from postnatal SVZ progenitors and ependymal cells. This resulted in severe damage to brain lateral ventricle integrity and identified roles for Numb/Numblike in regulating ependymal wall integrity and SVZ neuroblast survival. Surprisingly, the ventricular damage was eventually repaired: SVZ reconstitution and ventricular wall remodeling were mediated by progenitors that escaped Numb deletion. Our results show a self-repair mechanism in the mammalian brain and may have implications for both niche plasticity in other areas of stem cell biology and the therapeutic use of neural stem cells in neurodegenerative diseases.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; Univ Valencia, Unidad Asociada Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46013, Spain; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Prince Felipe Research Center; University of Valencia; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Soriano Navarro, Mario/0000-0002-7245-2095	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200, R37NS040929, R01NS028478, R29NS028478, R37NS028478] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD045481] Funding Source: Medline; NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R01 NS047200, 5 R01 NS047200, R37 NS040929, NS28478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chambers CB, 2001, DEVELOPMENT, V128, P689; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Morhenn VB, 2004, EXP DERMATOL, V13, P505, DOI 10.1111/j.0906-6705.2004.00186.x; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shen Q, 2002, DEVELOPMENT, V129, P4843; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	41	168	182	2	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1253	1264		10.1016/j.cell.2006.10.041	http://dx.doi.org/10.1016/j.cell.2006.10.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174898	Green Accepted, Bronze			2022-12-24	WOS:000242991000021
J	Nelson, CD; Perry, SJ; Regier, DS; Prescott, SM; Topham, MK; Lefkowitz, RJ				Nelson, Christopher D.; Perry, Stephen J.; Regier, Debra S.; Prescott, Stephen M.; Topham, Matthew K.; Lefkowitz, Robert J.			Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins	SCIENCE			English	Article							PHOSPHATIDIC-ACID; KINASE-ZETA; TRANSFORMED CELLS; CLATHRIN ADAPTER; TRANSLOCATION; PROTEIN; ENDOCYTOSIS; MECHANISM; COMPLEX; CLONING	Seven-transmembrane receptor (7TMR) signaling is transduced by second messengers such as diacylglycerol (DAG) generated in response to the heterotrimeric guanine nucleotide-binding protein G(q) and is terminated by receptor desensitization and degradation of the second messengers. We show that beta-arrestins coordinate both processes for the G(q)-coupled M1 muscarinic receptor. beta-Arrestins physically interact with diacylglycerol kinases (DGKs), enzymes that degrade DAG. Moreover, beta-arrestins are essential for conversion of DAG to phosphatidic acid after agonist stimulation, and this activity requires recruitment of the beta-arrestin-DGK complex to activated 7TMRs. The dual function of beta-arrestins, limiting production of diacylglycerol (by receptor desensitization) while enhancing its rate of degradation, is analogous to their ability to recruit adenosine 3',5'-monophosphate phosphodiesterases to G(s)-coupled beta(2)-adrenergic receptors. Thus, beta-arrestins can serve similar regulatory functions for disparate classes of 7TMRs through structurally dissimilar enzymes that degrade chemically distinct second messengers.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL CANCER INSTITUTE [R01CA095463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NCI NIH HHS [CA95463] Funding Source: Medline; NHLBI NIH HHS [HL70631, HL16037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; KATO H, 1988, BIOCHEM BIOPH RES CO, V154, P959, DOI 10.1016/0006-291X(88)90233-1; KATO M, 1987, J BIOL CHEM, V262, P5696; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; STERNWEIS PC, 1992, PHILOS T ROY SOC B, V336, P35, DOI 10.1098/rstb.1992.0041; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; VANDERBEND RL, 1994, J BIOL CHEM, V269, P4098	20	110	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					663	666		10.1126/science.1134562	http://dx.doi.org/10.1126/science.1134562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272726				2022-12-24	WOS:000243909400048
J	Janson, ME; Loughlin, R; Loiodice, I; Fu, CH; Brunner, D; Nedelec, FJ; Tran, PT				Janson, Marcel E.; Loughlin, Rose; Loiodice, Isabelle; Fu, Chuanhai; Brunner, Damian; Nedelec, Francois J.; Tran, Phong T.			Crosslinkers and motors organize dynamic microtubules to form stable bipolar arrays in fission yeast	CELL			English	Article							SPINDLE MIDZONE FORMATION; SELF-ORGANIZATION; INTERPHASE MICROTUBULES; POLARITY ORIENTATION; BUNDLING ACTIVITY; MITOTIC SPINDLES; ACTIN-FILAMENTS; GAMMA-TUBULIN; KINESIN; CELLS	Microtubule (MI) nucleation not only occurs from centrosomes, but also in large part from dispersed nucleation sites. The subsequent sorting of short MTs into networks like the mitotic spindle requires molecular motors that laterally slide overlapping MTs and bundling proteins that statically connect MTs. How bundling proteins interfere with MT sliding is unclear. In bipolar MT bundles in fission yeast, we found that the bundler ase1p localized all along the length of antiparallel MTs, whereas the motor klp2p (kinesin-14) accumulated only at MT plus ends. Consequently, sliding forces could only overcome resistant bundling forces for short, newly nucleated MTs, which were transported to their correct position within bundles. Ase1p thus regulated sliding forces based on polarity and overlap length, and computer simulations showed these mechanisms to be sufficient to generate stable bipolar bundles. By combining motor and bundling proteins, cells can thus dynamically organize stable regions of overlap between cytoskeletal filaments.	Univ Penn, Philadelphia, PA 19104 USA; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	University of Pennsylvania; European Molecular Biology Laboratory (EMBL)	Nedelec, FJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	nedelec@embl.de; tranp@mail.med.upenn.edu	Tran, Phong/GZA-8504-2022; Nedelec, Francois J/H-3317-2011; Tran, Phong/F-1357-2015; Nedelec, Francois/AAC-1673-2019; Brunner, Damian/F-2024-2011; Fu, Chuanhai/G-8303-2016; Fu, Chuanhai/E-1479-2011	Nedelec, Francois J/0000-0002-8141-5288; Tran, Phong/0000-0002-2410-2277; Nedelec, Francois/0000-0002-8141-5288; Fu, Chuanhai/0000-0003-4354-3796; Brunner, Damian/0000-0001-5250-492X				Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.e04-10-0935; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Hizlan D, 2006, J STRUCT BIOL, V153, P73, DOI 10.1016/j.jsb.2005.10.007; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1997, J CELL SCI, V110, P2373; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	41	162	165	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					357	368		10.1016/j.cell.2006.12.030	http://dx.doi.org/10.1016/j.cell.2006.12.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254972	Bronze			2022-12-24	WOS:000244420500019
J	't Hoen, EFM; Dukes, MNG				't Hoen, Ellen F. M.; Dukes, M. N. Graham			Compensation for diethylstilbestrol injury	LANCET			English	Editorial Material									Univ Amsterdam, Amsterdam Sch Social Sci Res, NL-1012 CX Amsterdam, Netherlands; Univ Oslo, N-0316 Oslo, Norway	University of Amsterdam; University of Oslo	't Hoen, EFM (corresponding author), Univ Amsterdam, Amsterdam Sch Social Sci Res, NL-1012 CX Amsterdam, Netherlands.	ellen.t.hoen@orange.fr		't Hoen, Ellen/0000-0003-4477-6866				BUITENDIJK S, 1984, 13 EUR S CLIN PHARM; *DES, 2005, REP RUL GOV COMP INJ; DIECKMANN WJ, 1953, AM J OBSTET GYNECOL, V66, P1062; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Dukes M. N. G., 2005, LAW ETHICS PHARM IND; *GRANT CHEM CO INC, 1957, AM J OBSTET GYNECOL; Hatch EE, 2006, AM J EPIDEMIOL, V164, P682, DOI 10.1093/aje/kwj257; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; *US NCI, DES RES UPD 1999 CUR	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2007	369	9557					173	174		10.1016/S0140-6736(07)60087-7	http://dx.doi.org/10.1016/S0140-6736(07)60087-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	128XG	17240270				2022-12-24	WOS:000243692400009
J	Liu, R; Wang, XH; Chen, GY; Dalerba, P; Gurney, A; Hoey, T; Sherlock, G; Lewicki, J; Shedden, K; Clarke, MF				Liu, Rui; Wang, Xinhao; Chen, Grace Y.; Dalerba, Piero; Gurney, Austin; Hoey, Timothy; Sherlock, Gavin; Lewicki, John; Shedden, Kerby; Clarke, Michael F.			The prognostic role of a gene signature from tumorigenic breast-cancer cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPRESSION SIGNATURE; IDENTIFICATION; METASTASIS; SURVIVAL; PATTERNS; THERAPY	BACKGROUND: Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 (CD44+CD24-/low) that have higher tumorigenic capacity than other subtypes of cancer cells. METHODS: We compared the gene-expression profile of CD44+CD24-/low tumorigenic breast-cancer cells with that of normal breast epithelium. Differentially expressed genes were used to generate a 186-gene ``invasiveness'' gene signature (IGS), which was evaluated for its association with overall survival and metastasis-free survival in patients with breast cancer or other types of cancer. RESULTS: There was a significant association between the IGS and both overall and metastasis-free survival (P<0.001, for both) in patients with breast cancer, which was independent of established clinical and pathological variables. When combined with the prognostic criteria of the National Institutes of Health, the IGS was used to stratify patients with high-risk early breast cancer into prognostic categories (good or poor); among patients with a good prognosis, the 10-year rate of metastasis-free survival was 81%, and among those with a poor prognosis, it was 57%. The IGS was also associated with the prognosis in medulloblastoma (P=0.004), lung cancer (P=0.03), and prostate cancer (P=0.01). The prognostic power of the IGS was increased when combined with the wound-response (WR) signature. CONCLUSIONS: The IGS is strongly associated with metastasis-free survival and overall survival for four different types of tumors. This genetic signature of tumorigenic breast-cancer cells was even more strongly associated with clinical outcomes when combined with the WR signature in breast cancer.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; Oncomed Pharmaceut, Mountain View, CA USA; Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Liu, R (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.		Dalerba, Piero/E-2543-2018; Sherlock, Gavin J/B-1831-2009; Sherlock, Gavin J/E-9110-2012	Dalerba, Piero/0000-0002-8815-4981; Sherlock, Gavin/0000-0002-1692-4983	NATIONAL CANCER INSTITUTE [T32CA009357, U54CA126524, R01CA104987] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009357, CA126524, CA104987] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P6890, DOI 10.1073/pnas.1131491100; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	18	773	839	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					217	226		10.1056/NEJMoa063994	http://dx.doi.org/10.1056/NEJMoa063994			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229949	Bronze			2022-12-24	WOS:000243488100004
J	Van Dyke, T				Van Dyke, Terry			p53 and tumor suppression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DNA-DAMAGE		Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Van Dyke, T (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA.							Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595	4	22	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					79	81		10.1056/NEJMcibr066301	http://dx.doi.org/10.1056/NEJMcibr066301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202460				2022-12-24	WOS:000243209600014
J	Vanhollebeke, B; Truc, P; Poelvoorde, P; Pays, A; Joshi, PP; Katti, R; Jannin, JG; Pays, E				Vanhollebeke, Benoit; Truc, Philippe; Poelvoorde, Philippe; Pays, Annette; Joshi, Prashant P.; Katti, Ravindra; Jannin, Jean G.; Pays, Etienne			Brief report: Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN SERUM; RHODESIENSE; RESISTANCE; PROTEIN; INDIA; GENE	Humans have innate immunity against Trypanosoma brucei brucei that is known to involve apolipoprotein L-I (APOL1). Recently, a case of T. evansi infection in a human was identified in India. We investigated whether the APOL1 pathway was involved in this occurrence. The serum of the infected patient was found to have no trypanolytic activity, and the finding was linked to the lack of APOL1, which was due to frameshift mutations in both APOL1 alleles. Trypanolytic activity was restored by the addition of recombinant APOL1. The lack of APOL1 explained the patient's infection with T. evansi.	Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Inst Rech Dev, Unite Rech Trypanosomoses Africaines 117, Montpellier, France; Govt Med Coll, Dept Med, Nagpur, Maharashtra, India; Directorate Hlth Serv, Bombay, Maharashtra, India; WHO, Communicable Dis Control Prevent & Eradicat, CH-1211 Geneva, Switzerland	Universite Libre de Bruxelles; Institut de Recherche pour le Developpement (IRD); World Health Organization	Pays, E (corresponding author), Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, 12 Rue Professeurs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be		Vanhollebeke, Benoit/0000-0002-0353-365X				Gibson WC, 2005, PARASITOLOGY, V131, P143, DOI 10.1017/S0031182005007560; HAWKING F, 1978, T ROY SOC TROP MED H, V72, P405, DOI 10.1016/0035-9203(78)90136-0; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Joshi PP, 2006, T ROY SOC TROP MED H, V100, P989, DOI 10.1016/j.trstmh.2005.11.003; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Juyal P. D., 1998, Journal of Parasitic Diseases, V22, P67; LAVERAN A, 1912, TRYPANOSOMES TRPANOS, P379; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; TRUC P, IN PRESS INFECT GENE; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	13	131	141	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2752	2756		10.1056/NEJMoa063265	http://dx.doi.org/10.1056/NEJMoa063265			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192540				2022-12-24	WOS:000243110500007
J	Johnson, C; Goodman, NW				Johnson, Chris; Goodman, Neville W.			Time to stop sniffing the air: snapshot survey	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Goodman, NW (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.	nev.w.goodman@bris.ac.uk						Cattermole GN, 2002, ANAESTHESIA, V57, P411; GOLDSACK N, 1999, STUDENT BMJ, V7; LIM SL, 1994, ANAESTHESIA, V49, P255; Pinnock C, 1999, FUNDAMENTALS ANAESTH, P49	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1295	1296		10.1136/bmj.39015.726690.47	http://dx.doi.org/10.1136/bmj.39015.726690.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185713	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000243160700011
J	Cookson, MR; Hardy, J				Cookson, Mark R.; Hardy, John			Clinical implications of basic research: The persistence of memory	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UBIQUITIN		NIA, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.		Cookson, Mark/AAW-2516-2021; Hardy, John/C-2451-2009	Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000953, ZIAAG000953] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Selkoe DJ, 2002, SCIENCE, V298, P963; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2697	2698		10.1056/NEJMcibr065999	http://dx.doi.org/10.1056/NEJMcibr065999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182998				2022-12-24	WOS:000242956200015
J	Levi, Z; Rozen, P; Hazazi, R; Vilkin, A; Waked, A; Maoz, E; Birkenfeld, S; Leshno, M; Niv, Y				Levi, Zohar; Rozen, Paul; Hazazi, Rachel; Vilkin, Alex; Waked, Amal; Maoz, Eran; Birkenfeld, Shlomo; Leshno, Moshe; Niv, Yaron			A quantitative immunochemical fecal occult blood test for colorectal neoplasia	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE-CHARACTERISTICS; CHINESE POPULATION; CANCER; COLONOSCOPY; QUANTIFICATION; ADENOMAS; RISK	Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening are not specific for human hemoglobin and have low sensitivity. Automated-development, immunochemical FOBT is quality-controlled, is specific for human hemoglobin, and does not require diet restriction. Objectives: To measure the sensitivity and specificity of quantitative immunochernical fecal hemoglobin measurements for detection of cancer and advanced adenoma in patients undergoing colonoscopy, to determine fecal hemoglobin thresholds that give the highest posttest probability for neoplasia, and to determine the number of immunochemical FOBTs needed. Design: Prospective, cross-sectional study. Setting: Ambulatory endoscopy services of the main health medical organization in Tel Aviv, Israel. Participants: 1000 consecutive ambulatory patients-some asymptornatic but at increased risk for colorectal neoplasia and some symptomatic-who were undergoing elective colonoscopy and volunteered to prepare immunochemical FOBTs. Intervention: The hemoglobin content of 3 bowel movements was measured, and the highest value was compared with colonoscopy findings. Measurements: Sensitivity, specificity, predictive values, likelihood ratios, and 95% Cls of fecal hemoglobin measurements for clinically significant neoplasia, their relationship to the amount of fecal hemoglobin measured, and the number of immunochemical FOBTs performed. Results: Colonoscopy identified clinically significant neoplasia in 91 patients (cancer in 17 patients and advanced adenomas in 74 patients). Using 3 immunochemical FOBTs and a hemoglobin threshold of 75 ng/mL of buffer, sensitivity and specificity were 94.1% (95% Cl, 82.9% to 100.0%) and 87.5% (Cl, 85.4% to 89.6%), respectively, for cancer and 67% (Cl, 57.4% to 76.7%) and 91.4% (Cl, 89.6% to 93.2%), respectively, for any clinically significant neoplasia. Limitations: The fecal sampling method is standardized, but the sample size depends on fecal consistency. Some patients were tested while discontinuing aspirin and anticoagulant therapies. Study patients were at increased risk, and results might not apply to average-risk populations. Conclusions: Quantitative immunochemical FOBT has good sensitivity and specificity for detection of clinically significant neoplasia. Test performance in screening average-risk populations is not known.	Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; Clalit Hlth Serv, Tel Aviv, Israel; Clalit Hlth Serv, Bat Yam, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Clalit Health Services; Clalit Health Services; Tel Aviv University	Rozen, P (corresponding author), Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, 39 Jabotinsky St, IL-49100 Petah Tiqwa, Israel.	paulro@clalit.org.il		Levi, Zohar/0000-0003-2456-8891				Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Castiglione G, 2000, J MED SCREEN, V7, P35, DOI 10.1136/jms.7.1.35; Castiglione G, 2002, J MED SCREEN, V9, P99, DOI 10.1136/jms.9.3.99; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Crotta S, 2004, EUR J GASTROEN HEPAT, V16, P33, DOI 10.1097/00042737-200401000-00006; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fattah ASMA, 1998, HEPATO-GASTROENTEROL, V45, P712; Fenocchi E, 2006, EUR J CANCER PREV, V15, P384, DOI 10.1097/00008469-200610000-00002; Haug U, 2005, CANCER EPIDEM BIOMAR, V14, P422, DOI 10.1158/1055-9965.EPI-04-0411; Kunii Y, 2004, DIGEST DIS SCI, V49, P1899, DOI 10.1007/s10620-004-9590-3; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Levi Z, 2006, ALIMENT PHARM THER, V24, P1475, DOI 10.1111/j.1365-2036.2006.03152.x; Levi Z, 2006, ALIMENT PHARM THER, V23, P1359, DOI 10.1111/j.1365-2036.2006.02898.x; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; McCarthy DM, 2005, CLIN GASTROENTEROL H, V3, P1071, DOI 10.1016/S1542-3565(05)00851-7; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakama H, 2000, EUR J CANCER, V36, P647, DOI 10.1016/S0959-8049(00)00020-4; Nakama H, 2001, EUR J CANCER, V37, P398, DOI 10.1016/S0959-8049(00)00387-7; Nakama H, 1998, HEPATO-GASTROENTEROL, V45, P1579; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; NIV Y, 1990, J CLIN GASTROENTEROL, V12, P393, DOI 10.1097/00004836-199008000-00007; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rozen P, 2006, MED SCI MONITOR, V12, pMT27; Rozen P, 1997, DIGEST DIS SCI, V42, P2064, DOI 10.1023/A:1018866400973; Rozen P, 2000, CANCER-AM CANCER SOC, V89, P46; Saito H, 2000, ONCOL REP, V7, P815; Selinger RRE, 2003, AM J MED, V114, P64, DOI 10.1016/S0002-9343(02)01350-5; SOX HC, 1988, MED DECIS MAKING, P142; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; Wong BCY, 2003, ALIMENT PHARM THER, V18, P941, DOI 10.1046/j.1365-2036.2003.01783.x; Wong WM, 2003, CANCER-AM CANCER SOC, V97, P2420, DOI 10.1002/cncr.11369; Young GP, 2002, AM J GASTROENTEROL, V97, P2499, DOI 10.1111/j.1572-0241.2002.06046.x; YOUNG GP, 2004, PRACT GASTROENTEROL, V18, P46; Young GP, 2005, COLORECTAL CANC CLIN, P97	38	255	266	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					244	255		10.7326/0003-4819-146-4-200702200-00003	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310048				2022-12-24	WOS:000244271000002
J	Galbraith, CG; Yamada, KM; Galbraith, JA				Galbraith, Catherine G.; Yamada, Kenneth M.; Galbraith, James A.			Polymerizing actin fibers position integrins primed to probe for adhesion sites	SCIENCE			English	Article							CELL-MIGRATION; GROWTH CONES; MOTILITY; CYTOSKELETON; LAMELLIPODIA; FIBROBLASTS; LINKAGES; PROTEINS; LOCOMOTION; MOVEMENTS	Migrating cells extend protrusions, probing the surrounding matrix in search of permissive sites to form adhesions. We found that actin fibers polymerizing along the leading edge directed local protrusions and drove synchronous sideways movement of beta(1) integrin adhesion receptors. These movements lead to the clustering and positioning of conformationally activated, but unligated, beta(1) integrins along the leading edge of fibroblast lamellae and growth cone filopodia. Thus, rapid actin-based movement of primed integrins along the leading edge suggests a "sticky fingers" mechanism to probe for new adhesion sites and to direct migration.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	kyamada@dir.nidcr.nih.gov		Yamada, Kenneth/0000-0003-1512-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002551, Z01NS002551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Danuser G, 2000, BIOPHYS J, V79, P191, DOI 10.1016/S0006-3495(00)76283-7; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	26	210	216	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					992	995		10.1126/science.1137904	http://dx.doi.org/10.1126/science.1137904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303755	Green Submitted			2022-12-24	WOS:000244229800043
J	Sprangers, R; Kay, LE				Sprangers, Remco; Kay, Lewis E.			Quantitative dynamics and binding studies of the 20S proteasome by NMR	NATURE			English	Article							MOLECULAR-WEIGHT PROTEINS; 723-RESIDUE ENZYME; METHYL-GROUPS; SPECTROSCOPY; RELAXATION; DEGRADATION; RESOLUTION; COMPLEX; ASSIGNMENTS; PARTICLE	The machinery used by the cell to perform essential biological processes is made up of large molecular assemblies. One such complex, the proteasome, is the central molecular machine for removal of damaged and misfolded proteins from the cell. Here we show that for the 670-kilodalton 20S proteasome core particle it is possible to overcome the molecular weight limitations that have traditionally hampered quantitative nuclear magnetic resonance (NMR) spectroscopy studies of such large systems. This is achieved by using an isotope labelling scheme where isoleucine, leucine and valine methyls are protonated in an otherwise highly deuterated background in concert with experiments that preserve the lifetimes of the resulting NMR signals. The methodology has been applied to the 20S core particle to reveal functionally important motions and interactions by recording spectra on complexes with molecular weights of up to a megadalton. Our results establish that NMR spectroscopy can provide detailed insight into supra-molecular structures over an order of magnitude larger than those routinely studied using methodology that is generally applicable.	Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Kay, LE (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca						Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Kwon YD, 2004, J MOL BIOL, V335, P233, DOI 10.1016/j.jmb.2003.08.029; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Tugarinov V, 2005, BIOCHEMISTRY-US, V44, P15970, DOI 10.1021/bi0519809; Tugarinov V, 2005, J AM CHEM SOC, V127, P8214, DOI 10.1021/ja0508830; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	29	386	394	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					618	622		10.1038/nature05512	http://dx.doi.org/10.1038/nature05512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237764				2022-12-24	WOS:000244039400037
J	Yu, JK; Satou, Y; Holland, ND; Shin-I, T; Kohara, Y; Satoh, N; Bronner-Fraser, M; Holland, LZ				Yu, Jr-Kai; Satou, Yutaka; Holland, Nicholas D.; Shin-, Tadasu, I; Kohara, Yuji; Satoh, Noriyuki; Bronner-Fraser, Marianne; Holland, Linda Z.			Axial patterning in cephalochordates and the evolution of the organizer	NATURE			English	Article							TWISTED GASTRULATION; AMPHIOXUS EMBRYOS; NEURAL INDUCTION; XENOPUS EMBRYOS; HEAD ORGANIZER; GENE; MESODERM; ANTAGONISM; EXPRESSION; PHYLOGENY	The organizer of the vertebrate gastrula is an important signalling centre that induces and patterns dorsal axial structures. Although a topic of long-standing interest, the evolutionary origin of the organizer remains unclear. Here we show that the gastrula of the cephalochordate amphioxus expresses dorsal/ventral (D/V) patterning genes (for example, bone morphogenetic proteins (BMPs), Nodal and their antagonists) in patterns reminiscent of those of their vertebrate orthlogues, and that amphioxus embryos, like those of vertebrates, are ventralized by exogenous BMP protein. In addition, Wnt-antagonists (for example, Dkks and sFRP2-like) are expressed anteriorly, whereas Wnt genes themselves are expressed posteriorly, consistent with a role for Wnt signalling in anterior/posterior (A/P) patterning. These results suggest evolutionary conservation of the mechanisms for both D/V and A/P patterning of the early gastrula. In light of recent phylogenetic analyses placing cephalochordates basally in the chordate lineage, we propose that separate signalling centres for patterning the D/V and A/P axes may be an ancestral chordate character.	Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA; Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Genet, Shizuoka 4118540, Japan; CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; California Institute of Technology	Holland, LZ (corresponding author), Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA.	lzholland@ucsd.edu	Yu, Jr-Kai/H-4822-2019; Satou, Yutaka/K-7131-2012; Satou, Yutaka/AAJ-2194-2021; Satoh, Nori/C-4123-2009	Yu, Jr-Kai/0000-0001-8591-0529; Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Satoh, Nori/0000-0002-4480-3572; Bronner, Marianne/0000-0003-4274-1862				Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; DALE L, 1992, DEVELOPMENT, V115, P573; Darras S, 2001, DEV BIOL, V236, P271, DOI 10.1006/dbio.2001.0339; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Gerhart J, 2001, INT J DEV BIOL, V45, P133; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Holland LZ, 2005, DEV DYNAM, V233, P1430, DOI 10.1002/dvdy.20473; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Hufton AL, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-27; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; Kourakis MJ, 2005, TRENDS GENET, V21, P506, DOI 10.1016/j.tig.2005.07.002; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Langeland JA, 2006, INT J BIOL SCI, V2, P110; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Neidert AH, 2000, EVOL DEV, V2, P303, DOI 10.1046/j.1525-142x.2000.00073.x; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nikaido M, 1997, MECH DEVELOP, V61, P75, DOI 10.1016/S0925-4773(96)00625-9; Passamaneck YJ, 2005, DEV DYNAM, V233, P1, DOI 10.1002/dvdy.20300; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Schubert M., 2003, WNT SIGNALING DEV, P210; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; TUNG TC, 1962, SCI SINICA, V11, P805; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x; Zhang SC, 1997, DEV GENES EVOL, V206, P532, DOI 10.1007/s004270050083	39	186	195	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					613	617		10.1038/nature05472	http://dx.doi.org/10.1038/nature05472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17237766				2022-12-24	WOS:000244039400036
J	Jacobson, PD; Parmet, WE				Jacobson, Peter D.; Parmet, Wendy E.			A new era of unapproved drugs - The case of Abigail Alliance v Von Eschenbach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RATES		Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, Ann Arbor, MI 48109 USA; Northeastern Univ, Sch Law, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Northeastern University	Jacobson, PD (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, 109 Observ, Ann Arbor, MI 48109 USA.	pdj@umich.edu						*AB ALL, AB STOR; Costanza ME, 1995, CLIN CANCER RES, V1, P699; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Mayer M, 2006, CLIN TRIALS, V3, P149, DOI 10.1191/1740774506cn144oa; PILON R, 2006, WALL STREET J   0603, P9; 2005, WALL STREET J   1115, pA22	8	41	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					205	208		10.1001/jama.297.2.205	http://dx.doi.org/10.1001/jama.297.2.205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213404				2022-12-24	WOS:000243355900030
J	Ding, B; Seeman, NC				Ding, Baoquan; Seeman, Nadrian C.			Operation of a DNA robot arm inserted into a 2D DNA crystalline substrate	SCIENCE			English	Article							NANOSCALE; DESIGN	The success of nanorobotics requires the precise placement and subsequent operation of specific nanomechanical devices at particular locations. The structural programmability of DNA makes it a particularly attractive system for nanorobotics. We have developed a cassette that enables the placement of a robust, sequence-dependent DNA robot arm within a two-dimensional (2D) crystalline DNA array. The cassette contains the device, an attachment site, and a reporter of state. We used atomic force microscopy to demonstrate that the rotary device is fully functional after insertion. Thus, a nanomechanical device can operate within a fixed frame of reference.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			NIGMS NIH HHS [R37 GM029554] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Carbone A, 2002, P NATL ACAD SCI USA, V99, P12577, DOI 10.1073/pnas.202418299; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Sherman WB, 2006, BIOPHYS J, V90, P4546, DOI 10.1529/biophysj.105.080390; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a	12	182	184	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1583	1585		10.1126/science.1131372	http://dx.doi.org/10.1126/science.1131372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158323	Green Accepted			2022-12-24	WOS:000242624600037
J	Malin, MC; Edgett, KS; Posiolova, LV; McColley, SM; Dobrea, EZN				Malin, Michael C.; Edgett, Kenneth S.; Posiolova, Liliya V.; McColley, Shawn M.; Dobrea, Eldar Z. Noe			Present-day impact cratering rate and contemporary gully activity on Mars	SCIENCE			English	Article							MARTIAN GULLIES; ORBITER CAMERA; GLOBAL SURVEYOR; CARBON-DIOXIDE; SURFACE RUNOFF; LIQUID WATER; CONSTRAINTS; METEOROIDS; CHRONOLOGY; ATMOSPHERE	The Mars Global Surveyor Mars Orbiter Camera has acquired data that establish the present-day impact cratering rate and document new deposits formed by downslope movement of material in mid-latitude gullies on Mars. Twenty impacts created craters 2 to 150 meters in diameter within an area of 21.5 x 10(6) square kilometers between May 1999 and March 2006. The values predicted by models that scale the lunar cratering rate to Mars are close to the observed rate, implying that surfaces devoid of craters are truly young and that as yet unrecognized processes of denudation must be operating. The new gully deposits, formed since August 1999, are light toned and exhibit attributes expected from emplacement aided by a fluid with the properties of liquid water: relatively long, extended, digitate distal and marginal branches, diversion around obstacles, and low relief. The observations suggest that liquid water flowed on the surface of Mars during the past decade.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				Caplinger MA, 2001, J GEOPHYS RES-PLANET, V106, P23595, DOI 10.1029/2000JE001341; CEPLECHA Z, 1993, ASTRON ASTROPHYS, V279, P615; Ceplecha Z, 1995, EARTH MOON PLANETS, V68, P107, DOI 10.1007/BF00671501; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; Gaidos EJ, 2001, ICARUS, V153, P218, DOI 10.1006/icar.2001.6649; GAULT DE, 1970, RADIO SCI, V5, P273, DOI 10.1029/RS005i002p00273; Gilmore MS, 2002, GEOLOGY, V30, P1107, DOI 10.1130/0091-7613(2002)030<1107:ROAIFO>2.0.CO;2; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HEIDMANN JL, 2004, ICARUS, V168, P285; HEIDMANN JL, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2004JE002261; Hoffman N, 2002, ASTROBIOLOGY, V2, P313, DOI 10.1089/153110702762027899; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HORZ F, 2004, LUNAR PLANET SCI, V35, P1116; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; McEwen AS, 2006, ANNU REV EARTH PL SC, V34, P535, DOI 10.1146/annurev.earth.34.031405.125018; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; Mellon MT, 2001, J GEOPHYS RES-PLANET, V106, P23165, DOI 10.1029/2000JE001424; MELOSH HJ, 1981, MULTIRING BASINS, P29; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Popova O, 2003, METEORIT PLANET SCI, V38, P905, DOI 10.1111/j.1945-5100.2003.tb00287.x; Shoemaker E. M., 1965, 32700 JET PROP LAB, P75; Stewart ST, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001465; Sullivan R, 2001, J GEOPHYS RES-PLANET, V106, P23607, DOI 10.1029/2000JE001296; Treiman AH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001900; [No title captured]	32	323	327	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1573	1577		10.1126/science.1135156	http://dx.doi.org/10.1126/science.1135156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158321				2022-12-24	WOS:000242624600034
J	Sakakura, A; Ukai, A; Ishihara, K				Sakakura, Akira; Ukai, Atsushi; Ishihara, Kazuaki			Enantioselective halocyclization of polyprenoids induced by nucleophilic phosphoramidites	NATURE			English	Article							MARINE NATURAL-PRODUCTS; CYCLIZATION; TERPENES	Polycyclic bio-active natural products that contain halogen atoms have been isolated from a number of different marine organisms(1). The biosynthesis of these natural products appears to be initiated by an electrophilic halogenation reaction at a carbon - carbon double bond(2-4) via a mechanism that is similar to a proton-induced olefin polycyclization(5-8). Enzymes such as haloperoxidases generate an electrophilic halonium ion ( or its equivalent), which reacts with the terminal carbon - carbon double bond of the polyprenoid, enantioselectively inducing a cyclization reaction that produces a halogenated polycyclic terpenoid. Use of an enantioselective halocyclization reaction is one possible way to chemically synthesize these halogenated cyclic terpenoids; although several brominated cyclic terpenoids have been synthesized via a diastereoselective halocyclization reaction that uses stoichiometric quantities of a brominating reagent(9-12), the enantioselective halocyclization of isoprenoids induced by a chiral promoter has not yet been reported. Here we report the enantioselective halocyclization of simple polyprenoids using a nucleophilic promoter. Achiral nucleophilic phosphorus compounds are able to promote the diastereoselective halocyclization reaction to give a halogenated cyclic product in excellent yields. Moreover, chiral phosphoramidites promote the enantioselective halocyclization of simple polyprenoids with N-iodosuccinimide to give iodinated cyclic products in up to 99% enantiomeric excess and diastereomeric excess. To the best of our knowledge, this is the first successful example of the enantioselective halopolycyclization of polyprenoids.	Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Sakakura, Akira/A-6319-2013	Sakakura, Akira/0000-0002-2995-1251				Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Carter-Franklin JN, 2003, J AM CHEM SOC, V125, P3688, DOI 10.1021/ja029271v; Cui XL, 2000, J ORG CHEM, V65, P5653, DOI 10.1021/jo000449a; Fukuzumi T, 2006, J FLUORINE CHEM, V127, P548, DOI 10.1016/j.jfluchem.2006.01.004; GONZALEZ AG, 1976, TETRAHEDRON LETT, V17, P137; Grossman RB, 1998, CAN J CHEM, V76, P1233, DOI 10.1139/cjc-76-9-1233; Haas J, 2002, ORG LETT, V4, P297, DOI 10.1021/ol0171113; Huang AX, 1999, J AM CHEM SOC, V121, P9999, DOI 10.1021/ja992411p; Ishibashi H, 2004, J AM CHEM SOC, V126, P11122, DOI 10.1021/ja0472026; JOHNSON WS, 1976, BIOORG CHEM, V5, P51, DOI 10.1016/0045-2068(76)90016-X; Kang SH, 2003, J AM CHEM SOC, V125, P15748, DOI 10.1021/ja0369921; WOLINSKY LE, 1976, J ORG CHEM, V41, P597, DOI 10.1021/jo00866a003; YAMAGUCHI Y, 1985, TETRAHEDRON LETT, V26, P343, DOI 10.1016/S0040-4039(01)80813-3; YAMAMURA S, 1977, TETRAHEDRON LETT, P2171; Yarnell A, 2006, CHEM ENG NEWS, V84, P12, DOI 10.1021/cen-v084n012.p012; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhang Y, 2004, J AM CHEM SOC, V126, P15038, DOI 10.1021/ja0454485	18	324	324	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					900	903		10.1038/nature05553	http://dx.doi.org/10.1038/nature05553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	138CR	17314976				2022-12-24	WOS:000244341200045
J	Wan, YSY; Flavell, RA				Wan, Yisong Y.; Flavell, Richard A.			Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; SCURFY MOUSE; INTERLEUKIN-2; INFLAMMATION; CD25(+); PROTEIN	The naturally occurring regulatory T cell (T-R) is the pivotal cell type that maintains self-tolerance and exerts active immune suppression. The development and function of T-R cells is controlled by Foxp3 (refs 1, 2), a lack of which results in loss of T-R cells and massive multi-organ autoimmunity in scurfy mice and IPEX ( immune dysregulation, polyendocrinopathy, enteropathy, X-linked) patients(3,4). It is generally thought that, through a binary mechanism, Foxp3 expression serves as an on-and-off switch to regulate positively the physiology of T-R cells; however, emerging evidence associates decreased Foxp3 expression in T-R cells with various immune disorders(5-7). We hypothesized that Foxp3 regulates T(R)cell development and function in a dose-dependent, nonbinary manner, and that decreased Foxp3 expression can cause immune disease. Here, by generating a mouse model in which endogenous Foxp3 gene expression is attenuated in T-R cells, we show that decreased Foxp3 expression results in the development of an aggressive autoimmune syndrome similar to that of scurfy mice, but does not affect thymic development, homeostatic expansion/maintenance or transforming-growth-factor-beta-induced de novo generation of Foxp3-expressing cells. The immune-suppressive activities of T cells with attenuated Foxp3 expression were nearly abolished in vitro and in vivo, whereas their anergic properties in vitro were maintained. This was accompanied by decreased expression of T(R)cell 'signature genes'. Notably, T cells expressing decreased Foxp3 preferentially became T-helper 2 (T(H)2)-type effectors even in a T(H)1-polarizing environment. These cells instructed T(H)2 differentiation of conventional T cells, which contributed to the immune diseases observed in these mice. Thus, decreased Foxp3 expression causes immune disease by subverting the suppressive function of T-R cells and converting T-R cells into effector cells; these findings are important for understanding the regulation of T-R cell function and the aetiology of various human immune diseases.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 300 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Wan, Yisong/ABE-1200-2021	Wan, Yisong/0000-0003-4346-9717				Balandina A, 2005, BLOOD, V105, P735, DOI 10.1182/blood-2003-11-3900; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	27	660	710	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					766	770		10.1038/nature05479	http://dx.doi.org/10.1038/nature05479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17220876	Bronze			2022-12-24	WOS:000244205200045
J	Willett, WC; Collins, FS; Manolio, TA				Willett, Walter C.; Collins, Francis S.; Manolio, Teri A.			Merging and emerging cohorts	NATURE			English	Editorial Material							PROSTATE-CANCER; GENE; BREAST		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Willett, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	walter.willett@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [R01 CA092447] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Feigelson HS, 2006, CANCER RES, V66, P2468, DOI 10.1158/0008-5472.CAN-05-3574; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; LANGHOLZ B, 1999, MONOGR NATL CANC I, V26, P39; National Heart Lung and Blood Institute, NAT HEART LUNG BLOOD; Samet JM, 1998, EPIDEMIOL REV, V20, P1; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Spivey A, 2006, ENVIRON HEALTH PERSP, V114, pA466, DOI 10.1289/ehp.114-a466; Watts G, 2006, BRIT MED J, V332, P1052	11	56	61	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					257	258		10.1038/445257a	http://dx.doi.org/10.1038/445257a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230171				2022-12-24	WOS:000243504700021
J	Wadman, M				Wadman, Meredith			When the party's over	NATURE			English	News Item																		Wadman M, 2005, NATURE, V437, P618, DOI 10.1038/437618a; [No title captured]	2	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					13	13		10.1038/445013a	http://dx.doi.org/10.1038/445013a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203035				2022-12-24	WOS:000243225100009
J	Mehta, MP; Baross, JA				Mehta, Mausmi P.; Baross, John A.			Nitrogen fixation at 92 degrees C by a hydrothermal vent archaeon	SCIENCE			English	Article							MIDOCEAN RIDGE SUBSEAFLOOR; METHANOSARCINA-BARKERI 227; FUNCTIONAL-ORGANIZATION; STRUCTURAL GENES; EVOLUTION; SEA; DIVERSITY; PROTEINS; HABITAT; CLONING	A methanogenic archaeon isolated from deep-sea hydrothermal vent fluid was found to reduce N-2 to NH3 at up to 92 degrees C, which is 28 degrees C higher than the current upper temperature limit of biological nitrogen fixation. The 16S ribosomal RNA gene of the hyperthermophilic nitrogen fixer, designated FS406-22, was 99% similar to that of non-nitrogen fixing Methanocaldococcus jannaschii DSM 2661. At its optimal growth temperature of 90 degrees C, FS406-22 incorporated N-15(2) and expressed nifH messenger RNA. This increase in the temperature limit of nitrogen fixation could reveal a broader range of conditions for life in the subseafloor biosphere and other nitrogen-limited ecosystems than previously estimated.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mehta, MP (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	mausmi@alum.mit.edu						Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; BELAY N, 1984, NATURE, V312, P286, DOI 10.1038/312286a0; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Butterfield DA, 2004, GEOPH MONOG SERIES, V144, P269, DOI 10.1029/144GM17; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; CHIEN YT, 1994, J BACTERIOL, V176, P6590, DOI 10.1128/JB.176.21.6590-6598.1994; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dodsworth JA, 2006, P NATL ACAD SCI USA, V103, P9779, DOI 10.1073/pnas.0602278103; GILBERT LA, 2004, THESIS U WASHINGTON; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; KENNICUTT MC, 1995, MICR EXTREM UNUSUAL, P275; Leigh JA, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P7; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Pruis MJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013977; RAU GH, 1981, NATURE, V289, P484, DOI 10.1038/289484a0; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SOUILLARD N, 1989, MOL MICROBIOL, V3, P541, DOI 10.1111/j.1365-2958.1989.tb00200.x; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; [No title captured]	28	151	160	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1783	1786		10.1126/science.1134772	http://dx.doi.org/10.1126/science.1134772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170307				2022-12-24	WOS:000242833600061
J	Lewis, RF; Carey, JP				Lewis, Richard F.; Carey, John P.			Abnormal eye movements associated with unilateral loss of vestibular function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Lewis, RF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	richard_lewis@meei.harvard.edu							0	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					E26	E26		10.1056/NEJMicm031134	http://dx.doi.org/10.1056/NEJMicm031134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167131				2022-12-24	WOS:000242778800010
J	Pallansch, MA; Sandhu, HS				Pallansch, Mark A.; Sandhu, Hardeep S.			The eradication of polio - Progress and challenges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pallansch, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.							[Anonymous], 2006, MMWR MORB MORTAL WKL, V55, P145; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210	3	49	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2508	2511		10.1056/NEJMp068200	http://dx.doi.org/10.1056/NEJMp068200			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167133	Bronze			2022-12-24	WOS:000242778800002
J	Brueckner, F; Hennecke, U; Carell, T; Cramer, P				Brueckner, Florian; Hennecke, Ulrich; Carell, Thomas; Cramer, Patrick			CPD damage recognition by transcribing RNA polymerase II	SCIENCE			English	Article							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMER; SYN THYMINE DIMER; ELONGATION COMPLEX; STRUCTURAL BASIS; DNA-DAMAGE; COCKAYNE-SYNDROME; YEAST; RESOLUTION	Cells use transcription-coupled repair (TCR) to efficiently eliminate DNA lesions such as ultraviolet light-induced cyclobutane pyrimidine dimers (CPDs). Here we present the structure-based mechanism for the first step in eukaryotic TCR, CPD-induced stalling of RNA polymerase (Pol)II. A CPD in the transcribed strand slowly passes a translocation barrier and enters the polymerase active site. The CPD 5'-thymine then directs uridine misincorporation into messenger RNA, which blocks translocation. Artificial replacement of the uridine by adenosine enables CPD bypass; thus, Pol II stalling requires CPD-directed misincorporation. In the stalled complex, the lesion is inaccessible, and the polymerase conformation is unchanged. This is consistent with nonallosteric recruitment of repair factors and excision of a lesion-containing DNA fragment in the presence of Pol II.	Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Carell, T (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany.	thomas.carell@cup.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Hennecke, Ulrich/A-7723-2010; Carell, Thomas/G-4799-2012	Hennecke, Ulrich/0000-0002-4904-6793; Carell, Thomas/0000-0001-7898-2831				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Tornaletti S, 1997, J BIOL CHEM, V272, P31719, DOI 10.1074/jbc.272.50.31719; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Verhage RA, 1997, MOL GEN GENET, V254, P284, DOI 10.1007/s004380050417; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	28	180	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					859	862		10.1126/science.1135400	http://dx.doi.org/10.1126/science.1135400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290000	Green Published			2022-12-24	WOS:000244069000073
J	Himmel, ME; Ding, SY; Johnson, DK; Adney, WS; Nimlos, MR; Brady, JW; Foust, TD				Himmel, Michael E.; Ding, Shi-You; Johnson, David K.; Adney, William S.; Nimlos, Mark R.; Brady, John W.; Foust, Thomas D.			Biomass recalcitrance: Engineering plants and enzymes for biofuels production	SCIENCE			English	Editorial Material							DILUTE-SULFURIC-ACID; HYDROGEN-BONDING SYSTEM; SYNCHROTRON X-RAY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CORN STOVER; PRETREATMENT; HYDROLYSIS; XYLAN; CELLULOSOMES	Lignocellulosic biomass has long been recognized as a potential sustainable source of mixed sugars for fermentation to biofuels and other biomaterials. Several technologies have been developed during the past 80 years that allow this conversion process to occur, and the clear objective now is to make this process cost-competitive in today's markets. Here, we consider the natural resistance of plant cell walls to microbial and enzymatic deconstruction, collectively known as "biomass recalcitrance." It is this property of plants that is largely responsible for the high cost of lignocellulose conversion. To achieve sustainable energy production, it will be necessary to overcome the chemical and structural properties that have evolved in biomass to prevent its disassembly.	Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA; Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Himmel, ME (corresponding author), Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA.	mike_himmel@nrel.gov	Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021; Johnson, David K/G-4959-2011	DING, SHIYOU/0000-0002-1102-1507; Johnson, David K/0000-0003-4815-8782; Foust, Thomas/0000-0002-3995-8254				Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Esteghlalian A, 1997, BIORESOURCE TECHNOL, V59, P129, DOI 10.1016/S0960-8524(97)81606-9; European Commission, 2006, BIOF EUR UN VIS 2030; Faaij APC, 2006, ENERG POLICY, V34, P322, DOI 10.1016/j.enpol.2004.03.026; GAUSS W, 1976, Patent No. 39909444; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 1997, ACS SYM SER, V666, P2; HOUGHTON J, 2005, BREAKING BIOL BARRIE; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; KIM SB, 1987, BIOTECHNOL BIOENG S, V17, P71; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Liu CG, 2004, IND ENG CHEM RES, V43, P2781, DOI 10.1021/ie030754x; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MALONEY MT, 1985, BIOTECHNOL BIOENG, V27, P355, DOI 10.1002/bit.260270321; Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nonhebel S, 2005, RENEW SUST ENERG REV, V9, P191, DOI 10.1016/j.rser.2004.02.003; *OBP, 2005, MULT PROGR PLAN 2007; PERLACK RD, 2005, TM2005 ORNL; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SHIANG M, 1991, BIOTECHNOL PROGR, V7, P315, DOI 10.1021/bp00010a005; SUN Y, IN PRESS BIORESOUR T; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; TORGET R, 1992, APPL BIOCHEM BIOTECH, V34-5, P115, DOI 10.1007/BF02920538; TORGET R, 1991, BIORESOURCE TECHNOL, V35, P239, DOI 10.1016/0960-8524(91)90120-9; *US DEP EN OFF BIO, 2006, 30 X 30 WORKSH WASH; *USDA NAT RES CONS, 2003, NAT RES INV 2001 ANN; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043	39	3217	3398	37	1690	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					804	807		10.1126/science.1137016	http://dx.doi.org/10.1126/science.1137016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289988				2022-12-24	WOS:000244069000056
J	Allen, CDC; Okada, T; Tang, HL; Cyster, JG				Allen, Christopher D. C.; Okada, Takaharu; Tang, H. Lucy; Cyster, Jason G.			Imaging of germinal center selection events during affinity maturation	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PROLIFERATION; OPINION; MEMORY; ZONE	The germinal center ( GC) is an important site for the generation and selection of B cells bearing high-affinity antibodies, yet GC cell migration and interaction dynamics have not been directly observed. Using two-photon microscopy of mouse lymph nodes, we revealed that GC B cells are highly motile and extend long cell processes. They transited between GC dark and light zones and divided in both regions, although these B cells resided for only several hours in the light zone where antigen is displayed. GC B cells formed few stable contacts with GC T cells despite frequent encounters, and T cells were seen to carry dead B cell blebs. On the basis of these observations, we propose a model in which competition for T cell help plays a more dominant role in the selection of GC B cells than previously appreciated.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Okada, T (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Takaharu.Okada@ucsf.edu; Jason.Cyster@ucsf.edu	Okada, Takaharu/N-7931-2015	Allen, Christopher/0000-0002-1879-9047				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ryser JE, 1999, NUCL MED BIOL, V26, P673, DOI 10.1016/S0969-8051(99)00042-6; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012	17	569	579	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					528	531		10.1126/science.1136736	http://dx.doi.org/10.1126/science.1136736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185562				2022-12-24	WOS:000243726600051
J	Goldenfeld, N; Woese, C				Goldenfeld, Nigel; Woese, Carl			Biology's next revolution	NATURE			English	Editorial Material									Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Goldenfeld, N (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.							Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103	4	170	181	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					369	369		10.1038/445369a	http://dx.doi.org/10.1038/445369a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251963	Green Submitted			2022-12-24	WOS:000243689500021
J	Loque, D; Lalonde, S; Looger, LL; von Wiren, N; Frommer, WB				Loque, D.; Lalonde, S.; Looger, L. L.; von Wiren, N.; Frommer, W. B.			A cytosolic trans-activation domain essential for ammonium uptake	NATURE			English	Article							TRANSPORTER AMTB; PLASMA-MEMBRANE; AUTOINHIBITORY DOMAIN; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; NH4+; IDENTIFICATION; PROTEIN; EXPRESSION; MECHANISM	Polytopic membrane proteins are essential for cellular uptake and release of nutrients. To prevent toxic accumulation, rapid shut-off mechanisms are required. Here we show that the soluble cytosolic carboxy terminus of an oligomeric ammonium transporter from Arabidopsis thaliana serves as an allosteric regulator essential for function; mutations in the C-terminal domain, conserved between bacteria, fungi and plants, led to loss of transport activity. When co-expressed with intact transporters, mutants inactivated functional subunits, but left their stability unaffected. Co-expression of two inactive transporters, one with a defective pore, the other with an ablated C terminus, reconstituted activity. The crystal structure of an Archaeoglobus fulgidus ammonium transporter (AMT)(1) suggests that the C terminus interacts physically with cytosolic loops of the neighbouring subunit. Phosphorylation of conserved sites in the C terminus(2) are proposed as the cognate control mechanism. Conformational coupling between monomers provides a mechanism for tight regulation, for increasing the dynamic range of sensing and memorizing prior events, and may be a general mechanism for transporter regulation.	Carnegie Inst Washington, Stanford, CA 94305 USA; Univ Hohenheim, Inst Plant Nutr, D-70593 Stuttgart, Germany	Carnegie Institution for Science; University Hohenheim	Frommer, WB (corresponding author), Carnegie Inst Washington, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Loque, Dominique/A-8153-2008; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; von Wiren, Nicolaus/0000-0002-4966-425X				Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Conroy MJ, 2004, EMBO REP, V5, P1153, DOI 10.1038/sj.embor.7400296; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Schulze Waltraud X, 2003, BMC Biochem, V4, P3, DOI 10.1186/1471-2091-4-3; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	30	205	219	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					195	198		10.1038/nature05579	http://dx.doi.org/10.1038/nature05579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17293878				2022-12-24	WOS:000244718100042
J	Schwickert, TA; Lindquist, RL; Shakhar, G; Livshits, G; Skokos, D; Kosco-Vilbois, MH; Dustin, ML; Nussenzweig, MC				Schwickert, Tanja A.; Lindquist, Randall L.; Shakhar, Guy; Livshits, Geulah; Skokos, Dimitris; Kosco-Vilbois, Marie H.; Dustin, Michael L.; Nussenzweig, Michel C.			In vivo imaging of germinal centres reveals a dynamic open structure	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; ANTIGEN; SELECTION; (4-HYDROXY-3-NITROPHENYL)ACETYL; ACTIVATION; MICROSCOPY; MECHANISM	Germinal centres are specialized structures wherein B lymphocytes undergo clonal expansion, class switch recombination, antibody gene diversification and affinity maturation. Three to four antigen-specific B cells colonize a follicle to establish a germinal centre and become rapidly dividing germinal-centre centroblasts that give rise to dark zones(1-4). Centroblasts produce non-proliferating centrocytes that are thought to migrate to the light zone of the germinal centre, which is rich in antigen-trapping follicular dendritic cells and CD4(+) T cells(5-7). It has been proposed that centrocytes are selected in the light zone on the basis of their ability to bind cognate antigen(5-8). However, there have been no studies of germinal-centre dynamics or the migratory behaviour of germinal-centre cells in vivo. Here we report the direct visualization of B cells in lymph node germinal centres by two-photon laser-scanning microscopy in mice. Nearly all antigen-specific B cells participating in a germinal-centre reaction were motile and physically restricted to the germinal centre but migrated bidirectionally between dark and light zones. Notably, follicular B cells were frequent visitors to the germinal-centre compartment, suggesting that all B cells scan antigen trapped in germinal centres. Consistent with this observation, we found that high-affinity antigen-specific B cells can be recruited to an ongoing germinal-centre reaction. We conclude that the open structure of germinal centres enhances competition and ensures that rare high-affinity B cells can participate in antibody responses.	NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY 10016 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NovImmune SA, CH-1211 Geneva 4, Switzerland	New York University; New York University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; NovImmune SA	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA.	mikeroscope@nyc.rr.com; nussen@rockefeller.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019	Dustin, Michael/0000-0003-4983-6389; Schwickert, Tanja/0000-0002-3371-2376				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FOSSUM S, 1983, SCAND J IMMUNOL, V17, P551; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; HANNA MG, 1964, LAB INVEST, V13, P95; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; KOSCO MH, 1992, J IMMUNOL, V148, P2331; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; SZAKAL AK, 1988, J IMMUNOL, V140, P341	30	349	351	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					83	87		10.1038/nature05573	http://dx.doi.org/10.1038/nature05573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17268470				2022-12-24	WOS:000244525600042
J	Marson, A; Kretschmer, K; Frampton, GM; Jacobsen, ES; Polansky, JK; Maclsaac, KD; Levine, SS; Fraenkel, E; von Boehmer, H; Young, RA				Marson, Alexander; Kretschmer, Karsten; Frampton, Garrett M.; Jacobsen, Elizabeth S.; Polansky, Julia K.; Maclsaac, Kenzie D.; Levine, Stuart S.; Fraenkel, Ernest; von Boehmer, Harald; Young, Richard A.			Foxp3 occupancy and regulation of key target genes during T-cell stimulation	NATURE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; TRANSCRIPTION; SCURFIN; ENTEROPATHY; EXPRESSION; PROTEIN	Foxp3(+) CD4(+) CD25(+) regulatory T (T-reg) cells are essential for the prevention of autoimmunity(1,2). T-reg cells have an attenuated cytokine response to T-cell receptor stimulation, and can suppress the proliferation and effector function of neighbouring T cells(3,4). The forkhead transcription factor Foxp3 ( forkhead box P3) is selectively expressed in T-reg cells, is required for T-reg development and function, and is sufficient to induce a Treg phenotype in conventional CD4(+) CD25(-) T cells(5-8). Mutations in Foxp3 cause severe, multi-organ autoimmunity in both human and mouse(9-11). FOXP3 can cooperate in a DNA-binding complex with NFAT ( nuclear factor of activated T cells) to regulate the transcription of several known target genes(12). However, the global set of genes regulated directly by Foxp3 is not known and consequently, how this transcription factor controls the gene expression programme for T-reg function is not understood. Here we identify Foxp3 target genes and report that many of these are key modulators of T-cell activation and function. Remarkably, the predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on T-cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function of T-reg cells, because overactive variants of some target genes are known to be associated with autoimmune disease.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Harald_von_Boehmer@dfci.harvard.edu; young@wi.mit.edu	Young, Richard A/F-6495-2012; Kretschmer, Karsten/E-8174-2010; Polansky-Biskup, Julia K./J-5937-2017	Young, Richard A/0000-0001-8855-8647; Kretschmer, Karsten/0000-0001-6770-4078; Polansky-Biskup, Julia K./0000-0003-4727-2540; Fraenkel, Ernest/0000-0001-9249-8181; Levine, Stuart/0000-0001-7363-562X; Frampton, Garrett/0000-0002-2361-2750	NATIONAL CANCER INSTITUTE [P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA109901, P01 CA109901-067138] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668-04A1, R01 HG002668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Myers LM, 2005, TRENDS IMMUNOL, V26, P440, DOI 10.1016/j.it.2005.06.003; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	30	551	598	0	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					931	935		10.1038/nature05478	http://dx.doi.org/10.1038/nature05478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17237765	Green Accepted			2022-12-24	WOS:000244341200053
J	Sladek, R; Rocheleau, G; Rung, J; Dina, C; Shen, L; Serre, D; Boutin, P; Vincent, D; Belisle, A; Hadjadj, S; Balkau, B; Heude, B; Charpentier, G; Hudson, TJ; Montpetit, A; Pshezhetsky, AV; Prentki, M; Posner, BI; Balding, DJ; Meyre, D; Polychronakos, C; Froguel, P				Sladek, Robert; Rocheleau, Ghislain; Rung, Johan; Dina, Christian; Shen, Lishuang; Serre, David; Boutin, Philippe; Vincent, Daniel; Belisle, Alexandre; Hadjadj, Samy; Balkau, Beverley; Heude, Barbara; Charpentier, Guillaume; Hudson, Thomas J.; Montpetit, Alexandre; Pshezhetsky, Alexey V.; Prentki, Marc; Posner, Barry I.; Balding, David J.; Meyre, David; Polychronakos, Constantin; Froguel, Philippe			A genome-wide association study identifies novel risk loci for type 2 diabetes	NATURE			English	Article							TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; NUCLEAR FACTOR-4-ALPHA GENE; ENZYME IDE GENE; POPULATION-STRUCTURE; INSULIN-SECRETION; LARGE-SCALE; SUSCEPTIBILITY; GLUCOSE; POLYMORPHISMS; VARIANTS	Type 2 diabetes mellitus results from the interaction of environmental factors with a combination of genetic variants, most of which were hitherto unknown. A systematic search for these variants was recently made possible by the development of high-density arrays that permit the genotyping of hundreds of thousands of polymorphisms. We tested 392,935 single-nucleotide polymorphisms in a French case - control cohort. Markers with the most significant difference in genotype frequencies between cases of type 2 diabetes and controls were fast-tracked for testing in a second cohort. This identified four loci containing variants that confer type 2 diabetes risk, in addition to confirming the known association with the TCF7L2 gene. These loci include a non-synonymous polymorphism in the zinc transporter SLC30A8, which is expressed exclusively in insulin-producing beta-cells, and two linkage disequilibrium blocks that contain genes potentially involved in beta-cell development or function (IDE - KIF11 - HHEX and EXT2 - ALX4). These associations explain a substantial portion of disease risk and constitute proof of principle for the genome-wide approach to the elucidation of complex genetic traits.	McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Med, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; Univ Hosp, F-86021 Poitiers, France; INSERM, U780, IFR69, F-94807 Villejuif, France; Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, F-91100 Corbeil Essonnes, France; Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; Montreal Diabet Res Ctr, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Mol Nutr Unit, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Ctr Hosp, Montreal, PQ H3C 3J7, Canada; Polypeptide Hormone Lab, Montreal, PQ H3A 2B2, Canada; Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ London Imperial Coll Sci & Technol, Sect Genom Med, London W12 0NN, England; Hammersmith Hosp, London W12 0HS, England	McGill University; McGill University; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Sud Francilien; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Imperial College London; Imperial College London; Imperial College London	Polychronakos, C (corresponding author), McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada.	Constantin.Polychronakos@McGill.ca	Balding, David/G-9898-2011; Heude, Barbara/G-3095-2016; FROGUEL, Philippe/O-6799-2017; Polychronakos, Constantin/B-8151-2008; Heude, Barbara/GLU-9626-2022; Dina, Christian R/D-3535-2015; Meyre, David/D-7315-2011; Sladek, Robert/R-2391-2019; Posner, Barry/B-6733-2008; Shen, Lishuang/B-3040-2013	Balding, David/0000-0002-1480-6115; Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Heude, Barbara/0000-0002-1565-1629; Dina, Christian R/0000-0002-7722-7348; Meyre, David/0000-0003-4850-7444; Sladek, Robert/0000-0002-2730-1204; A, Pshezhetsky/0000-0002-6612-1062; Polychronakos, Constantin/0000-0002-7624-6635; Rung, Johan/0000-0001-5875-8429; Shen, Lishuang/0000-0002-0436-0199; Hudson, Thomas/0000-0002-1376-4849				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Florez JC, 2006, DIABETES, V55, P128, DOI 10.2337/diabetes.55.1.128; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Groves CJ, 2003, DIABETES, V52, P1300, DOI 10.2337/diabetes.52.5.1300; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	50	2220	2346	0	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					881	885		10.1038/nature05616	http://dx.doi.org/10.1038/nature05616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17293876				2022-12-24	WOS:000244341200041
J	Mignot, T; Shaevitz, JW; Hartzell, PL; Zusman, DR				Mignot, Tam; Shaevitz, Joshua W.; Hartzell, Patricia L.; Zusman, David R.			Evidence that focal adhesion complexes power bacterial gliding motility	SCIENCE			English	Article								The bacterium Myxococcus xanthus has two motility systems: S motility, which is powered by type IV pilus retraction, and A motility, which is powered by unknown mechanism(s). We found that A motility involved transient adhesion complexes that remained at fixed positions relative to the substratum as cells moved forward. Complexes assembled at leading cell poles and dispersed at the rear of the cells. When cells reversed direction, the A-motility clusters relocalized to the new leading poles together with S-motility proteins. The Frz chemosensory system coordinated the two motility systems. The dynamics of protein cluster localization suggest that intracellular motors and force transmission by dynamic focal adhesions can power bacterial motility.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Idaho; University of Idaho	Mignot, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	tmignot@berkeley.edu; zusman@berkeley.edu		Mignot, Tam/0000-0003-4338-9063	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075242, R01GM020509] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM020509, R01 GM075242-03, GM20509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; GODWIN SL, 1989, J BACTERIOL, V171, P4589, DOI 10.1128/jb.171.9.4589-4594.1989; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wolgemuth CW, 2005, BIOPHYS J, V89, P945, DOI 10.1529/biophysj.105.062513; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004	13	171	175	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					853	856		10.1126/science.1137223	http://dx.doi.org/10.1126/science.1137223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289998	Green Accepted			2022-12-24	WOS:000244069000071
J	McFall-Ngai, M				McFall-Ngai, Margaret			Adaptive immunity - Care for the community	NATURE			English	Editorial Material									Univ Wisconsin, Symbiosis Cluster, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	McFall-Ngai, M (corresponding author), Univ Wisconsin, Symbiosis Cluster, Madison, WI 53706 USA.							Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Weng L, 2006, GENOME RES, V16, P316, DOI 10.1101/gr.3676406	4	248	253	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					153	153		10.1038/445153a	http://dx.doi.org/10.1038/445153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215830				2022-12-24	WOS:000243384300032
J	Tylianakis, JM; Tscharntke, T; Lewis, OT				Tylianakis, Jason M.; Tscharntke, Teja; Lewis, Owen T.			Habitat modification alters the structure of tropical host-parasitoid food webs	NATURE			English	Article							BIOLOGICAL-CONTROL; LAND-USE; COMMUNITY; DIVERSITY; DESCRIPTORS; STABILITY; SERVICES; GRADIENT; INSECTS; BEES	Global conversion of natural habitats to agriculture has led to marked changes in species diversity and composition(1). However, it is less clear how habitat modification affects interactions among species(2). Networks of feeding interactions ( food webs) describe the underlying structure of ecological communities, and might be crucially linked to their stability and function(3-7). Here, we analyse 48 quantitative food webs(8,9) for cavity-nesting bees, wasps and their parasitoids across five tropical habitat types. We found marked changes in food-web structure(10,11) across the modification gradient, despite little variation in species richness. The evenness of interaction frequencies declined with habitat modification, with most energy flowing along one or a few pathways in intensively managed agricultural habitats. In modified habitats there was a higher ratio of parasitoid to host species and increased parasitism rates, with implications for the important ecosystem services, such as pollination and biological control, that are performed by host bees and wasps(12). The most abundant parasitoid species was more specialized in modified habitats, with reduced attack rates on alternative hosts. Conventional community descriptors failed to discriminate adequately among habitats, indicating that perturbation of the structure and function of ecological communities might be overlooked in studies that do not document and quantify species interactions. Altered interaction structure therefore represents an insidious and functionally important hidden effect of habitat modification by humans.	Univ Gottingen, D-37073 Gottingen, Germany; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Gottingen; University of Oxford	Tylianakis, JM (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8020, New Zealand.	jason.tylianakis@canterbury.ac.nz	Tylianakis, Jason/B-6634-2011; Lewis, Owen T/B-9531-2011; Tscharntke, Teja/N-5123-2014	Tylianakis, Jason/0000-0001-7402-5620; Lewis, Owen/0000-0001-7935-6111				Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Goldwasser L, 1997, ECOLOGY, V78, P41; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; JANZEN DH, 1974, NAT HIST, V83, P48; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2002, ECOL LETT, V5, P37, DOI 10.1046/j.1461-0248.2002.00280.x; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tylianakis JM, 2006, ECOLOGY, V87, P3047, DOI 10.1890/0012-9658(2006)87[3047:DEFASO]2.0.CO;2; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003	30	617	641	10	457	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					202	205		10.1038/nature05429	http://dx.doi.org/10.1038/nature05429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215842				2022-12-24	WOS:000243384300050
J	Haag-Liautard, C; Dorris, M; Maside, X; Macaskill, S; Halligan, DL; Charlesworth, B; Keightley, PD				Haag-Liautard, Cathy; Dorris, Mark; Maside, Xulio; Macaskill, Steven; Halligan, Daniel L.; Charlesworth, Brian; Keightley, Peter D.			Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila	NATURE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; EVOLUTION; RECOMBINATION; ACCUMULATION; FITNESS; DNA; INSERTIONS; SEX	Spontaneous mutations are the source of genetic variation required for evolutionary change, and are therefore important for many aspects of evolutionary biology. For example, the divergence between taxa at neutrally evolving sites in the genome is proportional to the per nucleotide mutation rate, u (ref. 1), and this can be used to date speciation events by assuming a molecular clock. The overall rate of occurrence of deleterious mutations in the genome each generation (U) appears in theories of nucleotide divergence and polymorphism(2), the evolution of sex and recombination(3), and the evolutionary consequences of inbreeding(2). However, estimates of U based on changes in allozymes(4) or DNA sequences(5) and fitness traits are discordant(6-8). Here we directly estimate u in Drosophila melanogaster by scanning 20 million bases of DNA from three sets of mutation accumulation lines by using denaturing high-performance liquid chromatography(9). From 37 mutation events that we detected, we obtained a mean estimate for u of 8.4 x 10(-9) per generation. Moreover, we detected significant heterogeneity in u among the three mutation-accumulation-line genotypes. By multiplying u by an estimate of the fraction of mutations that are deleterious in natural populations of Drosophila(10), we estimate that U is 1.2 per diploid genome. This high rate suggests that selection against deleterious mutations may have a key role in explaining patterns of genetic variation in the genome, and help to maintain recombination and sexual reproduction.	Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Keightley, PD (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keightley.drosmutrate@spambob.net	Maside, Xulio/AAU-8864-2020; Maside, Xulio/AAA-6551-2019; Halligan, Daniel/H-4459-2011	Maside, Xulio/0000-0002-4494-8616; Halligan, Daniel/0000-0003-4726-6343	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Crow J.F., 1983, Genetics and Biology of Drosophila, V3c, P1; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Fernandez J, 1996, GENETICS, V143, P829; Fry JD, 2004, GENETICS, V166, P797, DOI 10.1534/genetics.166.2.797; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Houle D, 2004, GENET RES, V83, P7, DOI 10.1017/S0016672303006505; Keightley PD, 1999, GENETICS, V153, P515; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Kimura MA, 1985, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Maside X, 2001, GENET RES, V78, P121, DOI 10.1017/S0016672301005201; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; MUKAI T, 1977, P NATL ACAD SCI USA, V74, P2514, DOI 10.1073/pnas.74.6.2514; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; Oefner PJ, 2002, J CHROMATOGR B, V782, P27, DOI 10.1016/S1570-0232(02)00700-6; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Ravnik-Glavac M, 2002, HUM MUTAT, V19, P374, DOI 10.1002/humu.10065; Salathe M, 2006, ECOL LETT, V9, P941, DOI 10.1111/j.1461-0248.2006.00942.x; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; WOODRUFF RC, 1984, HEREDITY, V53, P223, DOI 10.1038/hdy.1984.78	30	280	282	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					82	85		10.1038/nature05388	http://dx.doi.org/10.1038/nature05388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203060				2022-12-24	WOS:000243225100040
J	Ahmed, MF; Ahuja, S; Alauddin, M; Hug, SJ; Lloyd, JR; Pfaff, A; Pichler, T; Saltikov, C; Stute, M; van Geen, A				Ahmed, M. F.; Ahuja, S.; Alauddin, M.; Hug, S. J.; Lloyd, J. R.; Pfaff, A.; Pichler, T.; Saltikov, C.; Stute, M.; van Geen, A.			Epidemiology - Ensuring safe drinking water in Bangladesh	SCIENCE			English	Editorial Material							CHILDRENS INTELLECTUAL FUNCTION; GROUNDWATER DYNAMICS; WEST-BENGAL; ARAIHAZAR; EXPOSURE; RELIABILITY; AQUIFERS; RELEASE; SHALLOW		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Bangladesh Univ Engn & Technol, Dhaka 1000, Bangladesh; Ahuja Consulting, Calabash, NC 28467 USA; Wagner Coll, Dept Chem, Staten Isl, NY 10301 USA; Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, CH-8600 Dubendorf, Switzerland; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Columbia Univ, Earth Inst, New York, NY 10027 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA	Columbia University; Bangladesh University of Engineering & Technology (BUET); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Manchester; Columbia University; State University System of Florida; University of South Florida; University of California System; University of California Santa Cruz; Columbia University	van Geen, A (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	avangeen@ldeo.columbia.edu		Thomas, Pichler/0000-0003-3327-2451; Lloyd, Jonathan/0000-0002-0719-0498	Engineering and Physical Sciences Research Council [GR/S30207/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmed M.F., 2005, RISK ASSESSMENT ARSE; CHAKRABORTY AK, 1987, INDIAN J MED RES, V85, P326; Charlet L, 2006, ELEMENTS, V2, P91, DOI 10.2113/gselements.2.2.91; Dhar RK, 1997, CURR SCI INDIA, V73, P48; Gelman A, 2004, RISK ANAL, V24, P1597, DOI 10.1111/j.0272-4332.2004.00553.x; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Hossain MA, 2005, ENVIRON SCI TECHNOL, V39, P4300, DOI 10.1021/es048703u; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kinniburgh D. G., 2001, WC0019 BGS; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Polizzotto ML, 2005, P NATL ACAD SCI USA, V102, P18819, DOI 10.1073/pnas.0509539103; Ravenscroft P, 2005, HYDROGEOL J, V13, P727, DOI 10.1007/s10040-003-0314-0; Sarker M. M. H, 2005, REPORT DEV ARSENIC D; SCHOENFELD A, 2006, THESIS COLUMBIA U NE; van Geen A, 2006, SCI TOTAL ENVIRON, V367, P769, DOI 10.1016/j.scitotenv.2006.01.030; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Williams PN, 2005, ENVIRON SCI TECHNOL, V39, P5531, DOI 10.1021/es0502324; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	22	205	207	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1687	1688		10.1126/science.1133146	http://dx.doi.org/10.1126/science.1133146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170279				2022-12-24	WOS:000242833600030
J	Cox, JJ; Reimann, F; Nicholas, AK; Thornton, G; Roberts, E; Springell, K; Karbani, G; Jafri, H; Mannan, J; Raashid, Y; Al-Gazali, L; Hamamy, H; Valente, EM; Gorman, S; Williams, R; McHale, DP; Wood, JN; Gribble, FM; Woods, CG				Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey			An SCN9A channelopathy causes congenital inability to experience pain	NATURE			English	Article							CLOSED-STATE INACTIVATION; NA(V)1.7 SODIUM-CHANNELS; OF-FUNCTION MUTATION; ALPHA-SUBUNIT; INDIFFERENCE; INSENSITIVITY; EXPRESSION; CURRENTS; PN1	The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the alpha-subunit of the voltage-gated sodium channel, Na(v)1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Na(v)1.7 with sodium channel beta(1) and beta(2) subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.	Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 OXY, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 OXY, England; St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Gene Tech Lab 146 1, Lahore, Pakistan; Fatima Jinah Med Coll, Dept Paediat, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; CSS Mendel, I-00168 Rome, Italy; IRCCS CSS, San Giovanni Rotondo, Italy; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; Pfizer Ltd, Global Res & Dev, Sandwich Labs, Sandwich CT13 9NJ, Kent, England; UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; United Arab Emirates University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Pfizer; University of London; University College London	Woods, CG (corresponding author), Addenbrookes Hosp, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 OXY, England.	cw347@cam.ac.uk	Valente, Enza Maria/G-2942-2017; woods, christopher g/A-1361-2010; Cox, James/R-1910-2016	Valente, Enza Maria/0000-0002-0600-6820; Reimann, Frank/0000-0001-9399-6377; Gribble, Fiona/0000-0002-4232-2898; Nicholas, Adeline/0000-0002-7124-629X	MRC [G9717869] Funding Source: UKRI; Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust [057964, 071187] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Blair NT, 2002, J NEUROSCI, V22, P10277; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dearborn GV, 1932, J NERV MENT DIS, V75, P612; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; DYCK PJ, 1983, BRAIN, V106, P373, DOI 10.1093/brain/106.2.373; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Klein CJ, 2003, ANN NEUROL, V53, P417, DOI 10.1002/ana.10469; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; LANDRIEU P, 1990, ANN NEUROL, V27, P574, DOI 10.1002/ana.410270520; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	28	1041	1170	5	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					894	898		10.1038/nature05413	http://dx.doi.org/10.1038/nature05413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167479	Green Accepted			2022-12-24	WOS:000242805400048
J	Wegener, KL; Partridge, AW; Han, J; Pickford, AR; Liddington, RC; Ginsberg, MH; Campbell, ID				Wegener, Kate L.; Partridge, Anthony W.; Han, Jaewon; Pickford, Andrew R.; Liddington, Robert C.; Ginsberg, Mark H.; Campbell, Iain D.			Structural basis of integrin activation by talin	CELL			English	Article							MEMBRANE-PROXIMAL REGION; LIGAND-BINDING AFFINITY; FERM DOMAIN; TRANSMEMBRANE DOMAIN; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; CYTOPLASMIC FACE; PROTEIN; LINKAGE; COMPLEX	Regulation of integrin affinity (activation) is essential for metazoan development and for many pathological processes. Binding of the talin phosphotyrosine-binding (PTB) domain to integrin beta subunit cytoplasmic domains (tails) causes activation, whereas numerous other PTB-domain-containing proteins bind integrins without activating them. Here we define the structure of a complex between talin and the membrane-proximal integrin beta 3 cytoplasmic domain and identify specific contacts between talin and the integrin tail required for activation. We used structure-based mutagenesis to engineer talin and beta 3 variants that interact with comparable affinity to the wild-type proteins but inhibit integrin activation by competing with endogenous talin. These results reveal the structural basis of talin's unique ability to activate integrins, identify an interaction that could aid in the design of therapeutics to block integrin activation, and enable engineering of cells with defects in the activation of multiple classes of integrins.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Burnham Inst, Ctr Canc, Program Cell Adhes, La Jolla, CA 92037 USA; Univ Portsmouth, Portsmouth PO1 2DY, Hants, England	University of Oxford; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Portsmouth	Ginsberg, MH (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	mhginsberg@ucsd.edu; iain.campbell@bioch.ox.ac.uk	Wegener, Kate/E-5077-2010; Pickford, Andy/AGB-6901-2022	Wegener, Kate/0000-0002-1562-6060; Ginsberg, Mark/0000-0002-5685-5417; Pickford, Andy/0000-0002-7237-0030	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Baker EK, 1997, P NATL ACAD SCI USA, V94, P1973, DOI 10.1073/pnas.94.5.1973; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bersch B, 2003, J BIOMOL NMR, V27, P57, DOI 10.1023/A:1024746306675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; REDFIELD C, 1991, BIOCHEMISTRY-US, V30, P11029, DOI 10.1021/bi00110a004; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799	47	506	521	2	54	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					171	182		10.1016/j.cell.2006.10.048	http://dx.doi.org/10.1016/j.cell.2006.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218263	Bronze			2022-12-24	WOS:000244420400021
J	Acquisti, C; Kleffe, J; Collins, S				Acquisti, Claudia; Kleffe, Juergen; Collins, Sinead			Oxygen content of transmembrane proteins over macroevolutionary time scales	NATURE			English	Article							AMINO-ACID-COMPOSITION; MEMBRANE-PROTEINS; EVOLUTION; GENOMES; ORGANISMS; EUKARYOTES; PROTEOMES; TOPOLOGY; MODEL; LIFE	We observe that the time of appearance of cellular compartmentalization correlates with atmospheric oxygen concentration. To explore this correlation, we predict and characterize the topology of all transmembrane proteins in 19 taxa and correlate differences in topology with historical atmospheric oxygen concentrations. Here we show that transmembrane proteins, individually and as a group, were probably selectively excluding oxygen in ancient ancestral taxa, and that this constraint decreased over time when atmospheric oxygen levels rose. As this constraint decreased, the size and number of communication-related transmembrane proteins increased. We suggest the hypothesis that atmospheric oxygen concentrations affected the timing of the evolution of cellular compartmentalization by constraining the size of domains necessary for communication across membranes.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Inst Mol Biol & Biochem, D-14195 Berlin, Germany	Max Planck Society	Acquisti, C (corresponding author), Arizona State Univ, Ctr Evolutionary Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA.	Claudia.Acquisti.1@asu.edu	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				AITCHISON J, 1986, STAT ANAL COMPOSITIO, P154; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; ANDERSON JS, IN PRESS MAJOR TRANS; Baudouin-Cornu P, 2004, J BIOL CHEM, V279, P5421, DOI 10.1074/jbc.M306415200; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Berner RA, 1999, P NATL ACAD SCI USA, V96, P10955, DOI 10.1073/pnas.96.20.10955; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Elser JJ, 2006, MOL BIOL EVOL, V23, P1946, DOI 10.1093/molbev/msl068; Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hasenfuss I, 2002, J ZOOL SYST EVOL RES, V40, P65, DOI 10.1046/j.1439-0469.2002.00180.x; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll AH, 2003, LIFE YOUNG PLANET 1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lio P, 2003, GENE, V317, P29, DOI 10.1016/S0378-1119(03)00666-8; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Martin W, 2003, IUBMB LIFE, V55, P193, DOI 10.1080/1521654031000141231; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; SCHOPF J.W., 1992, PROTEROZOIC BIOSPHER; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tamames J, 1996, FEBS LETT, V389, P96, DOI 10.1016/0014-5793(96)00527-3; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	34	52	55	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					47	52		10.1038/nature05450	http://dx.doi.org/10.1038/nature05450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17183269	Green Published			2022-12-24	WOS:000243225100032
J	Ruby, JG; Jan, C; Player, C; Axtell, MJ; Lee, W; Nusbaum, C; Ge, H; Bartel, DP				Ruby, J. Graham; Jan, Calvin; Player, Christopher; Axtell, Michael J.; Lee, William; Nusbaum, Chad; Ge, Hui; Bartel, David P.			Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C-elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; GERM-LINE; INTERFERENCE; POLYMERASE; GENES; IDENTIFICATION; MECHANISMS; PROTEIN; DSRNA	We sequenced 400,000 small RNAs from Caenorhabditis elegans. Another 18 microRNA (miRNA) genes were identified, thereby extending to 112 our tally of confidently identified miRNA genes in C. elegans. Also observed were thousands of endogenous siRNAs generated by RNA-directed RNA polymerases acting preferentially on transcripts associated with spermatogenesis and transposons. In addition, a third class of nematode small RNAs, called 21 U-RNAs, was discovered. 21 U-RNAs are precisely 21 nucleotides long, begin with a uridine 5'-monophosphate but are diverse in their remaining 20 nucleotides, and appear modified at their 3'-terminal ribose. 21 U-RNAs originate from more than 5700 genomic loci dispersed in two broad regions of chromosome IV-primarily between protein-coding genes or within their introns. These loci share a large upstream motif that enables accurate prediction of additional 21 U-RNAs. The motif is conserved in other nematodes, presumably because of its importance for producing these diverse, autonomously expressed, small RNAs (dasRNAs).	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; PAK J, 2006, IN PRESS SCIENCE; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	58	704	870	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1193	1207		10.1016/j.cell.2006.10.040	http://dx.doi.org/10.1016/j.cell.2006.10.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174894	Bronze, Green Submitted			2022-12-24	WOS:000242991000017
J	Piccirillo, SGM; Reynolds, BA; Zanetti, N; Lamorte, G; Binda, E; Broggi, G; Brem, H; Olivi, A; Dimeco, F; Vescovi, AL				Piccirillo, S. G. M.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L.			Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells	NATURE			English	Article							NEURAL STEM-CELLS; TGF-BETA; CNS; CANCER; DIFFERENTIATION; IDENTIFICATION; PRECURSORS; APOPTOSIS; SMAD; BMPS	Transformed, oncogenic precursors, possessing both defining neural-stem-cell properties and the ability to initiate intracerebral tumours, have been identified in human brain cancers(1). Here we report that bone morphogenetic proteins (BMPs), amongst which BMP4 elicits the strongest effect, trigger a significant reduction in the stem-like, tumour-initiating precursors of human glioblastomas (GBMs). Transient in vitro exposure to BMP4 abolishes the capacity of transplanted GBM cells to establish intracerebral GBMs. Most importantly, in vivo delivery of BMP4 effectively blocks the tumour growth and associated mortality that occur in 100% of mice after intracerebral grafting of human GBM cells. We demonstrate that BMPs activate their cognate receptors (BMPRs) and trigger the Smad signalling cascade in cells isolated from human glioblastomas ( GBMs). This is followed by a reduction in proliferation, and increased expression of markers of neural differentiation, with no effect on cell viability. The concomitant reduction in clonogenic ability, in the size of the CD133(+) population and in the growth kinetics of GBM cells indicates that BMP4 reduces the tumour-initiating cell pool of GBMs. These findings show that the BMP - BMPR signalling system - which controls the activity of normal brain stem cells(2,3) - may also act as a key inhibitory regulator of tumour-initiating, stem-like cells from GBMs and the results also identify BMP4 as a novel, non-cytotoxic therapeutic effector, which may be used to prevent growth and recurrence of GBMs in humans.	Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; Univ Milano Bicocca, StemGen Spa, Unit Canc Stem Cell Biol, I-20126 Milan, Italy; Univ Queensland, Queensland Brain Inst, Lab Neural Stem Cell Biol, Brisbane, Qld, Australia; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Natl Neurol Inst C Besta, I-20133 Milan, Italy; Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA	University of Milano-Bicocca; University of Milano-Bicocca; University of Queensland; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; Johns Hopkins University	Vescovi, AL (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy.	vescovi@tin.it	Olivi, Alessandro/K-6531-2016; Vescovi, Angelo Luigi/A-4919-2015; Binda, Elena/B-2650-2017; Zanetti, Nadia/AAK-4682-2021; DiMeco, Francesco/Z-5431-2019; DiMeco, Francesco/Q-3785-2016	Olivi, Alessandro/0000-0002-4489-7564; Vescovi, Angelo Luigi/0000-0002-1742-4112; Binda, Elena/0000-0002-8750-2905; Zanetti, Nadia/0000-0003-1485-8983; Lamorte, Giuseppe/0000-0001-9377-7537; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992; DiMeco, Francesco/0000-0001-6213-5793				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker FG, 1998, NEUROSURGERY, V42, P709, DOI 10.1097/00006123-199804000-00013; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weiss S, 1996, J NEUROSCI, V16, P7599	30	907	954	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					761	765		10.1038/nature05349	http://dx.doi.org/10.1038/nature05349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151667				2022-12-24	WOS:000242581100061
J	Stranger, BE; Forrest, MS; Dunning, M; Ingle, CE; Beazley, C; Thorne, N; Redon, R; Bird, CP; de Grassi, A; Lee, C; Tyler-Smith, C; Carter, N; Scherer, SW; Tavare, S; Deloukas, P; Hurles, ME; Dermitzakis, ET				Stranger, Barbara E.; Forrest, Matthew S.; Dunning, Mark; Ingle, Catherine E.; Beazley, Claude; Thorne, Natalie; Redon, Richard; Bird, Christine P.; de Grassi, Anna; Lee, Charles; Tyler-Smith, Chris; Carter, Nigel; Scherer, Stephen W.; Tavare, Simon; Deloukas, Panagiotis; Hurles, Matthew E.; Dermitzakis, Emmanouil T.			Relative impact of nucleotide and copy number variation on gene expression phenotypes	SCIENCE			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; DELETION; POLYMORPHISMS; LANDSCAPE; DISEASE; LOCUS; YEAST	Extensive studies are currently being performed to associate disease susceptibility with one form of genetic variation, namely, single-nucleotide polymorphisms (SNPs). In recent years, another type of common genetic variation has been characterized, namely, structural variation, including copy number variants (CNVs). To determine the overall contribution of CNVs to complex phenotypes, we have performed association analyses of expression levels of 14,925 transcripts with SNPs and CNVs in individuals who are part of the International HapMap project. SNPs and CNVs captured 83.6% and 17.7% of the total detected genetic variation in gene expression, respectively, but the signals from the two types of variation had little overlap. Interrogation of the genome for both types of variants may be an effective way to elucidate the causes of complex phenotypes and disease in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Oncol, Canc Res UK, Cambridge Res Inst,Li Ka Shing Ctr, Cambridge CB2 0RE, England; CNR, Ist Tecnol Biomed, Sez Bari, I-70126 Bari, Italy; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, MaRS Ctr, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA	Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk; md4@sanger.ac.uk	Scherer, Stephen W./B-3785-2013; Dermitzakis, Emmanouil/B-7687-2013; Deloukas, Panos/B-2922-2013; De Grassi, Anna/AAE-6036-2020; Redon, Richard/F-3303-2014	Scherer, Stephen W./0000-0002-8326-1999; Deloukas, Panos/0000-0001-9251-070X; De Grassi, Anna/0000-0001-7273-4263; Redon, Richard/0000-0001-7751-2280; Dunning, Mark/0000-0002-8853-9435; Fosker, Christine/0000-0002-3799-9474; Forrest, Matthew/0000-0002-2141-0303; Stranger, Barbara/0000-0001-9021-7331	Wellcome Trust [077014, 076113, 065535, 077009, 077046] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dermitzakis ET, 2006, MAMM GENOME, V17, P503, DOI 10.1007/s00335-006-0005-y; Doerge RW, 1996, GENETICS, V142, P285; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P357, DOI 10.1007/978-1-59745-039-3_25; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	28	1298	1376	0	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					848	853		10.1126/science.1136678	http://dx.doi.org/10.1126/science.1136678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289997	Green Accepted			2022-12-24	WOS:000244069000070
J	Pan, F; Sun, L; Kardian, DB; Whartenby, KA; Pardoll, DM; Liu, JO				Pan, Fan; Sun, Luo; Kardian, David B.; Whartenby, Katharine A.; Pardoll, Drew M.; Liu, Jun O.			Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin	NATURE			English	Article							T-CELL-ACTIVATION; IDENTIFICATION; STIMULATION; LYMPHOCYTES; SELECTION; GTPASES; P21RAS; KINASE; FAMILY; CABIN1	Feedback regulation of adaptive immunity is a fundamental mechanism for controlling the overall output of different signal transduction pathways, including that mediated by the T-cell antigen receptor (TCR)(1). Calcineurin(2-4) and Ras(5-7) are known to have essential functions during T-cell activation. However, how the calcineurin signalling pathway is terminated in the process is still largely unknown. Although several endogenous inhibitors of calcineurin have been reported(8-13), none fulfils the criteria of a feedback inhibitor, as their expression is not responsive to TCR signalling. Here we identify an endogenous inhibitor of calcineurin, named Carabin, which also inhibits the Ras signalling pathway through its intrinsic Ras GTPase-activating protein (GAP) activity. Expression of Carabin is upregulated on TCR signalling in a manner that is sensitive to inhibitors of calcineurin, indicating that Carabin constitutes part of a negative regulatory loop for the intracellular TCR signalling pathway. Knockdown of Carabin by short interfering RNA led to a significant enhancement of interleukin-2 production by antigen-specific T cells in vitro and in vivo. Thus, Carabin is a negative feedback inhibitor of the calcineurin signalling pathway that also mediates crosstalk between calcineurin and Ras.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu						Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Anderson DH, 2005, METHOD ENZYMOL, V403, P552, DOI 10.1016/S0076-6879(05)03048-X; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Cui Y, 2003, NAT MED, V9, P952, DOI 10.1038/nm882; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu Jun O, 2005, Sci STKE, V2005, pre1; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	27	44	49	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					433	436		10.1038/nature05476	http://dx.doi.org/10.1038/nature05476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17230191				2022-12-24	WOS:000243689500041
J	Taylor, S; Barragan, A; Su, C; Fux, B; Fentress, SJ; Tang, K; Beatty, WL; El Hajj, H; Jerome, M; Behnke, MS; White, M; Wootton, JC; Sibley, LD				Taylor, S.; Barragan, A.; Su, C.; Fux, B.; Fentress, S. J.; Tang, K.; Beatty, W. L.; El Hajj, H.; Jerome, M.; Behnke, M. S.; White, M.; Wootton, J. C.; Sibley, L. D.			A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii	SCIENCE			English	Article							PARASITOPHOROUS VACUOLE; INTRACELLULAR PARASITE; STRAINS; INFECTION; REVEALS; OVERPRODUCTION; RECOMBINATION; TRANSMISSION; APOPTOSIS; LINEAGES	Toxoplasma gondii strains differ dramatically in virulence despite being genetically very similar. Genetic mapping revealed two closely adjacent quantitative trait loci on parasite chromosome VIIa that control the extreme virulence of the type I lineage. Positional cloning identified the candidate virulence gene ROP18, a highly polymorphic serine-threonine kinase that was secreted into the host cell during parasite invasion. Transfection of the virulent ROP18 allele into a nonpathogenic type III strain increased growth and enhanced mortality by 4 to 5 logs. These attributes of ROP18 required kinase activity, which revealed that secretion of effectors is a major component of parasite virulence.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA; Karolinska Inst, Swedish Inst Infect Dis Control, Dept Med, S-14186 Stockholm, Sweden; Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Stockholm, Sweden; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Univ Montpellier 2, UMR 5539, CNRS, F-34095 Montpellier 5, France; Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Washington University (WUSTL); Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Tennessee System; University of Tennessee Knoxville; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA.	sibley@borcim.wustl.edu	White, Michael/A-4978-2012; Barragan, Antonio/P-6278-2015; Sibley, L. David/C-4616-2008; Behnke, Michael S/R-8839-2016; Barragan, Antonio/AAL-8618-2020; Fux, Blima/AAO-2941-2020; Su, Chunlei/M-1892-2013	Barragan, Antonio/0000-0001-7746-9964; Behnke, Michael S/0000-0002-4668-8109; Barragan, Antonio/0000-0001-7746-9964; Su, Chunlei/0000-0001-8392-7108; Fux, Blima/0000-0002-5038-3551	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059176, R01AI036629, R01AI044600] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000026] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [P20 RR-020185] Funding Source: Medline; NIAID NIH HHS [AI059176, AI44600, AI36629] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; ELHAJJ H, IN PRESS PLOS PATHOG; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Joynson DH, 2001, TOXOPLASMOSIS COMPRE; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099	29	394	426	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1776	1780		10.1126/science.1133643	http://dx.doi.org/10.1126/science.1133643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170305				2022-12-24	WOS:000242833600059
J	Striemer, CC; Gaborski, TR; McGrath, JL; Fauchet, PM				Striemer, Christopher C.; Gaborski, Thomas R.; McGrath, James L.; Fauchet, Philippe M.			Charge- and size-based separation of macromolecules using ultrathin silicon membranes	NATURE			English	Article							MOLECULAR-TRANSPORT; ULTRAFILTRATION; CRYSTALLIZATION; NANOCOMPOSITE; DIFFUSION	Commercial ultrafiltration and dialysis membranes have broad pore size distributions and are over 1,000 times thicker than the molecules they are designed to separate, leading to poor size cutoff properties, filtrate loss within the membranes, and low transport rates(1,2). Nanofabricated membranes have great potential in molecular separation applications by offering more precise structural control(3,4), yet transport is also limited by micrometre-scale thicknesses(5). This limitation can be addressed by a new class of ultrathin nanostructured membranes where the membrane is roughly as thick (similar to 10 nm) as the molecules being separated, but membrane fragility and complex fabrication have prevented the use of ultrathin membranes for molecular separations(1). Here we report the development of an ultrathin porous nanocrystalline silicon (pnc-Si) membrane using straightforward silicon fabrication techniques that provide control over average pore sizes from approximately 5 nm to 25 nm. Our pnc-Si membranes can retain proteins while permitting the transport of small molecules at rates an order of magnitude faster than existing materials, separate differently sized proteins under physiological conditions, and separate similarly sized molecules carrying different charges. Despite being only 15 nm thick, pnc-Si membranes that are free-standing over 40,000 mu m(2) can support a full atmosphere of differential pressure without plastic deformation or fracture. By providing efficient, low-loss macromolecule separations, pnc-Si membranes are expected to enable a variety of new devices, including membrane-based chromatography systems and both analytical and preparative microfluidic systems that require highly efficient separations.	Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA; Univ Rochester, Dept Biomed Engn, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Striemer, CC (corresponding author), Univ Rochester, Dept Elect & Comp Engn, 601 Elmwood Ave, Rochester, NY 14627 USA.	striemer@ece.rochester.edu	Gaborski, Thomas/F-4306-2012	McGrath, James/0000-0003-2017-8335				BERG HC, 1993, RANDOM WALKS BIOL, P34; Grom GF, 2000, NATURE, V407, P358, DOI 10.1038/35030062; Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212; Karlsson D, 2002, BIOTECHNOL PROGR, V18, P1423, DOI 10.1021/bp0255659; Ku JR, 2004, LANGMUIR, V20, P2030, DOI 10.1021/la0357662; Kuiper S, 1998, J MEMBRANE SCI, V150, P1, DOI 10.1016/S0376-7388(98)00197-5; Lee SB, 2002, J AM CHEM SOC, V124, P11850, DOI 10.1021/ja027494f; Letant SE, 2003, NAT MATER, V2, P391, DOI 10.1038/nmat888; Li QY, 1997, J MEMBRANE SCI, V136, P181, DOI 10.1016/S0376-7388(97)00159-2; Mace CR, 2006, ANAL CHEM, V78, P5578, DOI 10.1021/ac060473+; Martin F, 2005, J CONTROL RELEASE, V102, P123, DOI 10.1016/j.jconrel.2004.09.024; Ouyang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196069; Palik E. D., 1985, HDB OPTICAL CONSTANT, DOI 10.1016/C2009-0-20920-2; Pujar NS, 1998, J CHROMATOGR A, V796, P229, DOI 10.1016/S0021-9673(97)01003-0; REISMAN A, 1979, J ELECTROCHEM SOC, V126, P1406, DOI 10.1149/1.2129289; Spinella C, 1998, J APPL PHYS, V84, P5383, DOI 10.1063/1.368873; Tong HD, 2004, NANO LETT, V4, P283, DOI 10.1021/nl0350175; Yamaguchi A, 2004, NAT MATER, V3, P337, DOI 10.1038/nmat1107; Zacharias M, 1999, APPL PHYS LETT, V74, P2614, DOI 10.1063/1.123914; Zacharias M, 2001, PHYSICA E, V11, P245, DOI 10.1016/S1386-9477(01)00212-0	20	598	628	9	420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					749	753		10.1038/nature05532	http://dx.doi.org/10.1038/nature05532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301789				2022-12-24	WOS:000244205200041
J	Rivera, MN; Kim, WJ; Wells, J; Driscoll, DR; Brannigan, BW; Han, M; Kim, JC; Feinberg, AP; Gerald, WL; Vargas, SO; Chin, L; Iafrate, AJ; Bell, DW; Haber, DA				Rivera, Miguel N.; Kim, Woo Jae; Wells, Julie; Driscoll, David R.; Brannigan, Brian W.; Han, Moonjoo; Kim, James C.; Feinberg, Andrew P.; Gerald, William L.; Vargas, Sara O.; Chin, Lynda; Iafrate, A. John; Bell, Daphne W.; Haber, Daniel A.			An X chromosome gene, WTX, is commonly inactivated in Wilms tumor	SCIENCE			English	Article							FANCONI-ANEMIA; HUMAN GENOME; CANCER; KIDNEY; MUTATIONS	Wilms tumor is a pediatric kidney cancer associated with inactivation of the WT1 tumor-suppressor gene in 5 to 10% of cases. Using a high-resolution screen for DNA copy-number alterations in Wilms tumor, we identified somatic deletions targeting a previously uncharacterized gene on the X chromosome. This gene, which we call WTX, is inactivated in approximately one-third of Wilms tumors (15 of 51 tumors). Tumors with mutations in WTX lack WT1 mutations, and both genes share a restricted temporal and spatial expression pattern in normal renal precursors. In contrast to biallelic inactivation of autosomal tumor-suppressor genes, WTX is inactivated by a monoallelic "single-hit" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females.	Massachusetts Gen Hosp, Ctr Canc, Harvard Med Ctr, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Mol Med, Baltimore, MD 21205 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Harvard Med Ctr, Boston, MA 02114 USA.	haber@helix.mgh.harvard.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R37CA058596, P50CA101942, R37CA054358, T32CA009216, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA054358, R37 CA054358-17, P01-CA101942, T32-CA009216, R01 CA054358, R37-CA058596] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Heard E, 1999, MOL CELL BIOL, V19, P3156; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Maiti S, 2000, CANCER RES, V60, P6288; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Rahman N, 2004, NAT GENET, V36, P1142, DOI 10.1038/ng1104-1142; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Yuan E, 2005, MOL CANCER RES, V3, P493, DOI 10.1158/1541-7786.MCR-05-0082	22	244	300	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					642	645		10.1126/science.1137509	http://dx.doi.org/10.1126/science.1137509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17204608				2022-12-24	WOS:000243909400042
J	Koelle, K; Cobey, S; Grenfell, B; Pascual, M				Koelle, Katia; Cobey, Sarah; Grenfell, Bryan; Pascual, Mercedes			Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans	SCIENCE			English	Article							SEQUENCE SPACE; VIRUS; PROTEIN; DYNAMICS; HEMAGGLUTININ; EMERGENCE; MORTALITY; MODEL; DRIFT; IDENTIFICATION	Human influenza A ( subtype H3N2) is characterized genetically by the limited standing diversity of its hemagglutinin and antigenically by clusters that emerge and replace each other within 2 to 8 years. By introducing an epidemiological model that allows for differences between the genetic and antigenic properties of the virus's hemagglutinin, we show that these patterns can arise from cluster-specific immunity alone. Central to the formulation is a genotype-to-phenotype mapping, based on neutral networks, with antigenic phenotypes, not genotypes, determining the degree of strain cross-immunity. The model parsimoniously explains well-known, as well as previously unremarked, features of interpandemic influenza dynamics and evolution. It captures the observed boom-and-bust pattern of viral evolution, with periods of antigenic stasis during which genetic diversity grows, and with episodic contraction of this diversity during cluster transitions.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Penn State Univ, Dept Biol, Mueller Lab 208, Eberly Coll Sci, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Koelle, K (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2019 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	kkoelle@psu.edu						Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Barnett L, 1998, FROM ANIM ANIMAT, P18; Bastolla U, 1999, J THEOR BIOL, V200, P49, DOI 10.1006/jtbi.1999.0975; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; GREENE SK, 2004, P INT C OPT CONTR IN, V5, P795; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; KAUFFMAN SA, 1991, J THEOR BIOL, V149, P467, DOI 10.1016/S0022-5193(05)80094-3; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; MEIKLEJOHN G, 1978, J INFECT DIS, V138, P618, DOI 10.1093/infdis/138.5.618; Nakajima K, 2005, J VIROL, V79, P6472, DOI 10.1128/JVI.79.10.6472-6477.2005; Nakajima S, 2000, VIROLOGY, V274, P220, DOI 10.1006/viro.2000.0453; Newman MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1333, DOI 10.1098/rspb.1998.0438; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; Schuster P, 1999, PHYSICA D, V133, P427, DOI 10.1016/S0167-2789(99)00076-7; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X; vanNimwegen E, 1997, PHYS LETT A, V229, P144, DOI 10.1016/S0375-9601(97)00192-8; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, P223; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	49	334	345	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1898	1903		10.1126/science.1132745	http://dx.doi.org/10.1126/science.1132745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185596				2022-12-24	WOS:000242996800040
J	Lincoln, GA; Clarke, IJ; Hut, RA; Hazlerigg, DG				Lincoln, Gerald A.; Clarke, Iain J.; Hut, Roelof A.; Hazlerigg, David G.			Characterizing a mammalian circannual pacemaker	SCIENCE			English	Article							BEETLE ANTHRENUS-VERBASCI; PITUITARY-GLAND; PROLACTIN SECRETION; REPRODUCTIVE RHYTHM; MELATONIN SIGNAL; SYRIAN-HAMSTER; SEASONAL TIMER; CYCLES; PHOTOPERIOD; SHEEP	Many species express endogenous cycles in physiology and behavior that allow anticipation of the seasons. The anatomical and cellular bases of these circannual rhythms have not been defined. Here, we provide strong evidence using an in vivo Soay sheep model that the circannual regulation of prolactin secretion, and its associated biology, derive from a pituitary-based timing mechanism. Circannual rhythm generation is seen as the product of the interaction between melatonin-regulated timer cells and adjacent prolactin- secreting cells, which together function as an intrapituitary "pacemaker-slave" timer system. These new insights open the way for a molecular analysis of long-term timing mechanisms.	Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH3 9EW, Midlothian, Scotland; Queens Med Res Inst, Edinburgh, Midlothian, Scotland; Univ Groningen, Dept Chronobiol, Haren, Netherlands; Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Edinburgh; University of Edinburgh; University of Groningen; Monash University; University of Aberdeen	Lincoln, GA (corresponding author), Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH3 9EW, Midlothian, Scotland.	g.lincoln@hrsu.mrc.ac.uk	Hut, Roelof A./I-3483-2012	Clarke, Iain/0000-0002-6613-2757	Medical Research Council [G0600678] Funding Source: Medline; MRC [G0600678] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bockers TM, 1997, ENDOCRINOLOGY, V138, P4101, DOI 10.1210/en.138.10.4101; Carmichael M S, 1986, J Biol Rhythms, V1, P277, DOI 10.1177/074873048600100402; GWINNER E, 2001, FRONTIERS LIFE, V4, P193; Gwinner E., 1986, CIRCANNUAL RHYTHMS E; Hazlerigg DG, 2004, CURR BIOL, V14, P334, DOI 10.1016/j.cub.2004.01.057; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Johnston JD, 2003, FASEB J, V17, P810, DOI 10.1096/fj.02-0837com; Johnston JD, 2003, GEN COMP ENDOCR, V134, P182, DOI 10.1016/S0016-6480(03)00248-X; KARSCH FJ, 1989, BIOL REPROD, V41, P1034, DOI 10.1095/biolreprod41.6.1034; Kondo N, 2006, CELL, V125, P161, DOI 10.1016/j.cell.2006.03.017; LEDERC GM, 2005, ENDOCRINOLOGY, V146, P2782; Lincoln G, 1999, ADV EXP MED BIOL, V460, P137; Lincoln GA, 2005, ENDOCRINOLOGY, V146, P3782, DOI 10.1210/en.2005-0132; Lincoln GA, 2003, BIOL REPROD, V69, P1416, DOI 10.1095/biolreprod.103.017673; Lincoln GA, 1997, BIOL REPROD, V57, P460, DOI 10.1095/biolreprod57.2.460; LINCOLN GA, 1989, J REPROD FERTIL, V85, P687, DOI 10.1530/jrf.0.0850687; LINCOLN GA, 1994, J NEUROENDOCRINOL, V6, P251, DOI 10.1111/j.1365-2826.1994.tb00580.x; Lincoln GA, 1998, COMP BIOCHEM PHYS C, V119, P283, DOI 10.1016/S0742-8413(98)00017-6; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; MARTINET L, 1992, J REPROD FERTIL, V95, P325, DOI 10.1530/jrf.0.0950325; McFerran DW, 2001, ENDOCRINOLOGY, V142, P3255, DOI 10.1210/en.142.7.3255; Miyazaki Y, 2005, J COMP PHYSIOL A, V191, P883, DOI 10.1007/s00359-005-0012-6; Nisimura T, 2002, BIOL RHYTHM RES, V33, P255, DOI 10.1076/brhm.33.3.255.8264; PENGELLY ET, 1974, CIRCANNUAL CLOCKS, P89; Stirland JA, 2001, J NEUROENDOCRINOL, V13, P147, DOI 10.1046/j.1365-2826.2001.00611.x; THRUN LA, 1995, J BIOL RHYTHM, V10, P42, DOI 10.1177/074873049501000104; Williams LM, 1997, J NEUROENDOCRINOL, V9, P639, DOI 10.1046/j.1365-2826.1997.00625.x; WOODFILL CJI, 1994, BIOL REPROD, V50, P965, DOI 10.1095/biolreprod50.4.965; Zucker Irving, 2001, Handbook of Behavioral Neurobiology, V12, P509	29	171	171	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1941	1944		10.1126/science.1132009	http://dx.doi.org/10.1126/science.1132009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185605				2022-12-24	WOS:000242996800054
J	Nackley, AG; Shabalina, SA; Tchivileva, IE; Satterfield, K; Korchynskyi, O; Makarov, SS; Maixner, W; Diatchenko, L				Nackley, A. G.; Shabalina, S. A.; Tchivileva, I. E.; Satterfield, K.; Korchynskyi, O.; Makarov, S. S.; Maixner, W.; Diatchenko, L.			Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure	SCIENCE			English	Article							PAIN PATIENTS; GENE; COMT; POLYMORPHISMS; TRANSLATION; PREDICTION; PATTERN	Catechol-O-methyltransferase (COMT) is a key regulator of pain perception, cognitive function, and affective mood. Three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous position, code for differences in COMT enzymatic activity and are associated with pain sensitivity. Haplotypes divergent in synonymous changes exhibited the largest difference in COMT enzymatic activity, due to a reduced amount of translated protein. The major COMT haplotypes varied with respect to messenger RNA local stem-loop structures, such that the most stable structure was associated with the lowest protein levels and enzymatic activity. Site-directed mutagenesis that eliminated the stable structure restored the amount of translated protein. These data highlight the functional significance of synonymous variations and suggest the importance of haplotypes over single-nucleotide polymorphisms for analysis of genetic variations.	Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Univ N Carolina, Thurston Arthrit Ctr, Chapel Hill, NC 27599 USA; Attagene Inc, Res Triangle Pk, NC 27560 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; University of North Carolina; University of North Carolina Chapel Hill	Diatchenko, L (corresponding author), Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA.	lbdiatch@email.unc.edu	Korchynskyi, Olexandr/ADA-6398-2022; Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473; Korchynskyi, Olexandr/0000-0002-4557-4003	NIDCR NIH HHS [R01 DE016558] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Funke B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-19; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Mannisto PT, 1999, PHARMACOL REV, V51, P593; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Puga I, 2005, ENDOCRINOLOGY, V146, P2210, DOI 10.1210/en.2004-1366; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; SCHMITTGEN TD, 1994, J BIOL CHEM, V269, P16269; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	682	783	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1930	1933		10.1126/science.1131262	http://dx.doi.org/10.1126/science.1131262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185601				2022-12-24	WOS:000242996800050
J	Seelig, G; Soloveichik, D; Zhang, DY; Winfree, E				Seelig, Georg; Soloveichik, David; Zhang, David Yu; Winfree, Erik			Enzyme-free nucleic acid logic circuits	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; DNA; RIBOREGULATORS; MACHINE	Biological organisms perform complex information processing and control tasks using sophisticated biochemical circuits, yet the engineering of such circuits remains ineffective compared with that of electronic circuits. To systematically create complex yet reliable circuits, electrical engineers use digital logic, wherein gates and subcircuits are composed modularly and signal restoration prevents signal degradation. We report the design and experimental implementation of DNA-based digital logic circuits. We demonstrate AND, OR, and NOT gates, signal restoration, amplification, feedback, and cascading. Gate design and circuit construction is modular. The gates use single-stranded nucleic acids as inputs and outputs, and the mechanism relies exclusively on sequence recognition and strand displacement. Biological nucleic acids such as microRNAs can serve as inputs, suggesting applications in biotechnology and bioengineering.	CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Winfree, E (corresponding author), CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523				Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Hagiya M, 2006, NAT COMP SER, P293, DOI 10.1007/3-540-30296-4_18; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; MULLER DE, 1963, ASYNCHRONOUS LOGICS, P289; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Von Neumann J., 1956, ANN MATH STUD, V34, P43; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Yurke B, 1999, BIOSYSTEMS, V52, P165, DOI 10.1016/S0303-2647(99)00043-X	22	1033	1110	31	524	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1585	1588		10.1126/science.1132493	http://dx.doi.org/10.1126/science.1132493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158324				2022-12-24	WOS:000242624600038
J	Carlton, JM; Hirt, RP; Silva, JC; Delcher, AL; Schatz, M; Zhao, Q; Wortman, JR; Bidwell, SL; Alsmark, UCM; Besteiro, S; Sicheritz-Ponten, T; Noel, CJ; Dacks, JB; Foster, PG; Simillion, C; Van de Peer, Y; Miranda-Saavedra, D; Barton, GJ; Westrop, GD; Muller, S; Dessi, D; Fiori, PL; Ren, QH; Paulsen, I; Zhang, HB; Bastida-Corcuera, FD; Simoes-Barbosa, A; Brown, MT; Hayes, RD; Mukherjee, M; Okumura, CY; Schneider, R; Smith, AJ; Vanacova, S; Villalvazo, M; Haas, BJ; Pertea, M; Feldblyum, TV; Utterback, TR; Shu, CL; Osoegawa, K; de Jong, PJ; Hrdy, I; Horvathova, L; Zubacova, Z; Dolezal, P; Malik, SB; Logsdon, JM; Henze, K; Gupta, A; Wang, CC; Dunne, RL; Upcroft, JA; Upcroft, P; White, O; Salzberg, SL; Tang, P; Chiu, CH; Lee, YS; Embley, TM; Coombs, GH; Mottram, JC; Tachezy, J; Fraser-Liggett, CM; Johnson, PJ				Carlton, Jane M.; Hirt, Robert P.; Silva, Joana C.; Delcher, Arthur L.; Schatz, Michael; Zhao, Qi; Wortman, Jennifer R.; Bidwell, Shelby L.; Alsmark, U. Cecilia M.; Besteiro, Sebastien; Sicheritz-Ponten, Thomas; Noel, Christophe J.; Dacks, Joel B.; Foster, Peter G.; Simillion, Cedric; Van de Peer, Yves; Miranda-Saavedra, Diego; Barton, Geoffrey J.; Westrop, Gareth D.; Mueller, Sylke; Dessi, Daniele; Fiori, Pier Luigi; Ren, Qinghu; Paulsen, Ian; Zhang, Hanbang; Bastida-Corcuera, Felix D.; Simoes-Barbosa, Augusto; Brown, Mark T.; Hayes, Richard D.; Mukherjee, Mandira; Okumura, Cheryl Y.; Schneider, Rachel; Smith, Alias J.; Vanacova, Stepanka; Villalvazo, Maria; Haas, Brian J.; Pertea, Mihaela; Feldblyum, Tamara V.; Utterback, Terry R.; Shu, Chung-Li; Osoegawa, Kazutoyo; de Jong, Pieter J.; Hrdy, Ivan; Horvathova, Lenka; Zubacova, Zuzana; Dolezal, Pavel; Malik, Shehre-Banoo; Logsdon, John M., Jr.; Henze, Katrin; Gupta, Arti; Wang, Ching C.; Dunne, Rebecca L.; Upcroft, Jacqueline A.; Upcroft, Peter; White, Owen; Salzberg, Steven L.; Tang, Petrus; Chiu, Cheng-Hsun; Lee, Ying-Shiung; Embley, T. Martin; Coombs, Graham H.; Mottram, Jeremy C.; Tachezy, Jan; Fraser-Liggett, Claire M.; Johnson, Patricia J.			Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis	SCIENCE			English	Article							ENTAMOEBA-HISTOLYTICA; TRITRICHOMONAS-FETUS; STRUCTURAL BASIS; DNA CONTENT; EUKARYOTES; CELLS; IDENTIFICATION; RESISTANCE; EVOLUTION; PROTEINS	We describe the genome sequence of the protist Trichomonas vaginalis, a sexually transmitted human pathogen. Repeats and transposable elements comprise about two-thirds of the similar to 160-megabase genome, reflecting a recent massive expansion of genetic material. This expansion, in conjunction with the shaping of metabolic pathways that likely transpired through lateral gene transfer from bacteria, and amplification of specific gene families implicated in pathogenesis and phagocytosis of host proteins may exemplify adaptations of the parasite during its transition to a urogenital environment. The genome sequence predicts previously unknown functions for the hydrogenosome, which support a common evolutionary origin of this unusual organelle with mitochondria.	Inst Genom Res, Rockville, MD 20850 USA; Univ Newcastle, Div Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; Univ Glasgow, Div Infect & Immun, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland; Tech Univ Denmark, Ctr Biol Sequence Anal, Biocentrum DTU, DK-2800 Lyngby, Denmark; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Antwerp VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; Univ Dundee, Sch Life Sci Res, Dundee DD1 5EH, Scotland; Univ Sassari, Dept Biomed Sci, Div Exptl & Clin Microbiol, I-07100 Sassari, Italy; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; J Craig Venter Joint Technol Ctr, Rockville, MD 20850 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Charles Univ Prague, Dept Parasitol, Fac Sci, CR-12844 Prague, Czech Republic; Univ Iowa, Dept Biol Sci, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA; Univ Dusseldorf, Inst Bot, D-402225 Dusseldorf, Germany; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Chang Gung Univ, Bioinformat Ctr, Mol Med Res Ctr, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Med Genom Ctr, Tao Yuan 333, Taiwan; Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	J. Craig Venter Institute; Newcastle University - UK; University System of Maryland; University of Maryland College Park; University of Glasgow; University of Glasgow; Technical University of Denmark; University of Calgary; Natural History Museum London; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Dundee; University of Sassari; University of California System; University of California Los Angeles; J. Craig Venter Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Charles University Prague; University of Iowa; Heinrich Heine University Dusseldorf; University of California System; University of California San Francisco; University of Queensland; QIMR Berghofer Medical Research Institute; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Strathclyde	Carlton, JM (corresponding author), NYU, Dept Med Parasitol, Sch Med, New York, NY 10011 USA.	jane.carlton@med.nyu.edu	Salzberg, Steven/Q-6514-2019; Paulsen, Ian T/K-3832-2012; Barton, Geoffrey J/C-6267-2011; Schatz, Michael/L-2690-2019; Pertea, Mihaela/AAT-2705-2021; Barton, Geoffrey/N-1037-2019; Salzberg, Steven L/F-6162-2011; Van de Peer, Yves/D-4388-2009; Dolezal, Pavel/V-1907-2017; Alsmark, Cecilia/AAO-1330-2021; Van de Peer, Yves/AAE-7666-2019; Silva, Joana/GVT-6441-2022; Vanacova, Stepanka/D-6858-2012; Miranda-Saavedra, Diego/C-2707-2012; Silva, Joana/GYQ-9526-2022; Besteiro, Sébastien/F-3622-2014; Hirt, Robert/R-5429-2017; Hrdý, Ivan/K-8931-2017; Logsdon, John M/B-7812-2009; Horváthová, Lenka/AAC-3119-2021; Malik, Shehre-Banoo/A-1385-2009; Fiori, Pier Luigi/GVU-9300-2022; Vanacova, Stepanka/AGO-9953-2022; Dacks, Joel/AAE-3308-2021; Sicheritz-Ponten, Thomas/A-4325-2017	Salzberg, Steven/0000-0002-8859-7432; Paulsen, Ian T/0000-0001-9015-9418; Schatz, Michael/0000-0002-4118-4446; Pertea, Mihaela/0000-0003-0762-8637; Barton, Geoffrey/0000-0002-9014-5355; Salzberg, Steven L/0000-0002-8859-7432; Van de Peer, Yves/0000-0003-4327-3730; Dolezal, Pavel/0000-0003-1285-9026; Van de Peer, Yves/0000-0003-4327-3730; Vanacova, Stepanka/0000-0001-8807-0684; Besteiro, Sébastien/0000-0003-1853-1494; Hirt, Robert/0000-0002-3760-9958; Hrdý, Ivan/0000-0002-5595-9177; Horváthová, Lenka/0000-0001-7618-8669; Fiori, Pier Luigi/0000-0001-6190-612X; Vanacova, Stepanka/0000-0001-8807-0684; Dacks, Joel/0000-0003-4520-5694; Fraser, Claire/0000-0003-1462-2428; Mottram, Jeremy/0000-0001-5574-3766; Embley, Thomas Martin/0000-0002-1484-340X; Foster, Peter/0000-0003-0194-9237; Simillion, Cedric/0000-0002-2026-6741; DESSI', Daniele/0000-0001-5713-741X; Malik, Shehre-Banoo/0000-0003-0833-0648; Westrop, Gareth/0000-0002-8011-6219; Tang, Petrus/0000-0002-2779-0116; Hayes, Richard/0000-0002-5236-7918; Bastida, Felix/0000-0003-1036-9787; Wortman, Jennifer/0000-0002-8713-1227; Sicheritz-Ponten, Thomas/0000-0001-6615-1141	MRC [G9722968, G0000508] Funding Source: UKRI; Medical Research Council [G9722968(65078), G9722968, G0000508(56841), G0000508] Funding Source: Medline; NIAID NIH HHS [U01 AI050913-02, U01 AI050913-01A1, UO1 AI50913-01, U01 AI050913] Funding Source: Medline; NLM NIH HHS [R01 LM007938, R01 LM006845, R01 LM007938-04, R01 LM006845-08] Funding Source: Medline; Wellcome Trust [072031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050913] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007938, R01LM006845] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; BEACH DH, 1991, MOL BIOCHEM PARASIT, V44, P97, DOI 10.1016/0166-6851(91)90225-U; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Davis PH, 2006, MOL BIOCHEM PARASIT, V145, P111, DOI 10.1016/j.molbiopara.2005.08.017; DIAS FBP, 1992, MICROBIOS, V71, P55; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FIORI PL, 1993, FEMS MICROBIOL LETT, V109, P13, DOI 10.1111/j.1574-6968.1993.tb06136.x; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Honigberg B.M., 1990, P5; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Kleydman Y, 2004, MICROBIOL-SGM, V150, P1139, DOI 10.1099/mic.0.26939-0; Kutisova K, 2005, PARASITOLOGY, V131, P309, DOI 10.1017/S0031182005008000; Kwon DH, 2001, ANTIMICROB AGENTS CH, V45, P2609, DOI 10.1128/AAC.45.9.2609-2615.2001; Land KM, 2004, MOL MICROBIOL, V51, P115, DOI 10.1046/j.1365-2958.2003.03791.x; LEHKER MW, 1990, J EXP MED, V171, P2165, DOI 10.1084/jem.171.6.2165; Leiros HKS, 2004, J BIOL CHEM, V279, P55840, DOI 10.1074/jbc.M408044200; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LOWE PN, 1986, MOL BIOCHEM PARASIT, V21, P65, DOI 10.1016/0166-6851(86)90080-0; MUILER M, 1998, EVOLUTIONARY RELATIO, P109; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Rendon-Maldonado JG, 1998, EXP PARASITOL, V89, P241, DOI 10.1006/expr.1998.4297; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Schmid G, 2001, J REPROD MED, V46, P545; Schumacher MA, 2003, CELL, V115, P413, DOI 10.1016/S0092-8674(03)00887-0; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; TURNER AC, 1988, EXP PARASITOL, V67, P47, DOI 10.1016/0014-4894(88)90007-0; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; World Health Organization, 2001, GLOB PREV INC SEL CU; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; ZUO X, 1995, MICROBIOL-UK, V141, P2637, DOI 10.1099/13500872-141-10-2637	40	595	631	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					207	212		10.1126/science.1132894	http://dx.doi.org/10.1126/science.1132894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218520	Green Accepted			2022-12-24	WOS:000243407400037
J	Jones, WD; Cayirlioglu, P; Kadow, IG; Vosshall, LB				Jones, Walton D.; Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Vosshall, Leslie B.			Two chemosensory receptors together mediate carbon dioxide detection in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MELANOGASTER; RESPONSES; BEHAVIOR; NEURONS; MOSQUITOS; SENSILLA; OXYGEN	Blood-feeding insects, including the malaria mosquito Anopheles gambiae, use highly specialized and sensitive olfactory systems to locate their hosts. This is accomplished by detecting and following plumes of volatile host emissions, which include carbon dioxide (CO2)(1). CO2 is sensed by a population of olfactory sensory neurons in the maxillary palps of mosquitoes(2,3) and in the antennae of the more genetically tractable fruitfly, Drosophila melanogaster(4). The molecular identity of the chemosensory CO2 receptor, however, remains unknown. Here we report that CO2-responsive neurons in Drosophila co-express a pair of chemosensory receptors, Gr21a and Gr63a, at both larval and adult life stages. We identify mosquito homologues of Gr21a and Gr63a, GPRGR22 and GPRGR24, and show that these are co-expressed in A. gambiae maxillary palps. We show that Gr21a and Gr63a together are sufficient for olfactory CO2-chemosensation in Drosophila. Ectopic expression of Gr21a and Gr63a together confers CO2 sensitivity on CO2-insensitive olfactory neurons, but neither gustatory receptor alone has this function. Mutant flies lacking Gr63a lose both electrophysiological and behavioural responses to CO2. Knowledge of the molecular identity of the insect olfactory CO2 receptors may spur the development of novel mosquito control strategies designed to take advantage of this unique and critical olfactory pathway. This in turn could bolster the worldwide fight against malaria and other insect-borne diseases.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	leslie@mail.rockefeller.edu	Jones, Walton/A-2417-2011	Jones, Walton/0000-0001-8642-627X; Grunwald Kadow, Ilona/0000-0002-9085-4274; Vosshall, Leslie/0000-0002-6060-8099				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	440	467	11	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					86	90		10.1038/nature05466	http://dx.doi.org/10.1038/nature05466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167414				2022-12-24	WOS:000243225100041
J	Botuyan, MV; Lee, J; Ward, IM; Kim, JE; Thompson, JR; Chen, JJ; Mer, G				Botuyan, Maria Victoria; Lee, Joseph; Ward, Irene M.; Kim, Ja-Eun; Thompson, James R.; Chen, Junjie; Mer, Georges			Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair	CELL			English	Article							DOUBLE-STRAND BREAKS; CHECKPOINT PROTEIN CRB2; TANDEM BRCT DOMAINS; H4 LYS-20; LYSINE METHYLATION; HISTIDINE KINASES; CRYSTAL-STRUCTURE; SILENT CHROMATIN; TUDOR DOMAIN; H3 TAIL	Histone lysine methylation has been linked to the recruitment of mammalian DNA repair factor 53BP1 and putative fission yeast homolog Crb2 to DNA double-strand breaks (DSBs), but how histone recognition is achieved has not been established. Here we demonstrate that this link occurs through direct binding of 53BP1 and Crb2 to histone H4. Using X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, we show that, despite low amino acid sequence conservation, both 53BP1 and Crb2 contain tandem tudor domains that interact with histone H4 specifically dimethylated at Lys20 (W-K20me2). The structure of 53BP1/H4-K20me2 complex uncovers a unique five-residue 53BP1 binding cage, remarkably conserved in the structure of Crb2, that best accommodates a dimethyllysine but excludes a trimethyllysine, thus explaining the methylation state-specific recognition of H4-K20. This study reveals an evolutionarily conserved molecular mechanism of targeting DNA repair proteins to DSBs by direct recognition of H4-K20me2.	Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Physiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA.	junjie.chen@yale.edu; mer.georges@mayo.edu	Mer, Georges/AAT-4946-2021; Kim, Ja-Eun/AAI-1896-2020	Mer, Georges/0000-0002-1900-1578; Kim, Ja-Eun/0000-0002-9132-1277	NCI NIH HHS [R01 CA109449, CA100109, R01 CA100109] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109449, R01CA100109] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Du LL, 2004, J BIOL CHEM, V279, P38409, DOI 10.1074/jbc.M403326200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FUJITAKI JM, 1981, BIOCHEMISTRY-US, V20, P3658, DOI 10.1021/bi00515a055; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; MAVRI J, 1994, PROTEINS, V18, P381, DOI 10.1002/prot.340180408; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; SMITH DL, 1973, NATURE, V246, P103, DOI 10.1038/246103a0; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905	53	747	769	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1361	1373		10.1016/j.cell.2006.10.043	http://dx.doi.org/10.1016/j.cell.2006.10.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190600	Green Accepted, Bronze			2022-12-24	WOS:000243690000016
J	Saeij, JPJ; Boyle, JP; Coller, S; Taylor, S; Sibley, LD; Brooke-Powell, ET; Ajioka, JW; Boothroyd, JC				Saeij, J. P. J.; Boyle, J. P.; Coller, S.; Taylor, S.; Sibley, L. D.; Brooke-Powell, E. T.; Ajioka, J. W.; Boothroyd, J. C.			Polymorphic secreted kinases are key virulence factors in toxoplasmosis	SCIENCE			English	Article							POPULATION BIOLOGY; PARASITE GENOTYPE; GONDII; STRAINS; RECOMBINATION; LINEAGES; DISEASE; GENOME; IL-12; HOST	The majority of known Toxoplasma gondii isolates from Europe and North America belong to three clonal lines that differ dramatically in their virulence, depending on the host. To identify the responsible genes, we mapped virulence in F-1 progeny derived from crosses between type II and type III strains, which we introduced into mice. Five virulence ( VIR) loci were thus identified, and for two of these, genetic complementation showed that a predicted protein kinase (ROP18 and ROP16, respectively) is the key molecule. Both are hypervariable rhoptry proteins that are secreted into the host cell upon invasion. These results suggest that secreted kinases unique to the Apicomplexa are crucial in the host-pathogen interaction.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Stanford University; Washington University (WUSTL); University of Cambridge	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	Sibley, L. David/C-4616-2008	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NIAID NIH HHS [1R01AI045806-01A1, AI41014, AI059176, R01 AI021423, AI30230, AI36629, AI21423, AI05093, R01 AI036629, R01 AI021423-20, F32AI60306] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059176, R01AI036629, R01AI045806, Z01AI005093, R37AI021423, R01AI021423, R01AI041014, F32AI060306] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; ELHAJJ H, IN PRESS PLOS PATHOG; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Honore S, 2000, PATHOL BIOL, V48, P541; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; SAEIJ JP, IN PRESS NATURE; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, MOL BIOCHEM PARASIT, V51, P291, DOI 10.1016/0166-6851(92)90079-Y; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wille U, 2002, INFECT IMMUN, V70, P6940, DOI 10.1128/IAI.70.12.6940-6947.2002	26	410	436	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1780	1783		10.1126/science.1133690	http://dx.doi.org/10.1126/science.1133690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170306	Green Accepted			2022-12-24	WOS:000242833600060
J	Shima, K; Isoda, M; Mushiake, H; Tanji, J				Shima, Keisetsu; Isoda, Masaki; Mushiake, Hajime; Tanji, Jun			Categorization of behavioural sequences in the prefrontal cortex	NATURE			English	Article							SUPPLEMENTARY MOTOR AREA; TEMPORAL ORGANIZATION; NEURONAL-ACTIVITY; MULTIPLE MOVEMENTS; MONKEY; REPRESENTATION; DAMAGE; CELLS	Although it has long been thought that the prefrontal cortex of primates is involved in the integrative regulation of behaviours(1-4), the neural architecture underlying specific aspects of cognitive behavioural planning has yet to be clarified(5-8). If subjects are required to remember a large number of complex motor sequences and plan to execute each of them individually, categorization of the sequences according to the specific temporal structure inherent in each subset of sequences serves to facilitate higher-order planning based on memory. Here we show, using these requirements, that cells in the lateral prefrontal cortex selectively exhibit activity for a specific category of behavioural sequences, and that categories of behaviours, embodied by different types of movement sequences, are represented in prefrontal cells during the process of planning. This cellular activity implies the generation of neural representations capable of storing structured event complexes at an abstract level, exemplifying the development of macro-structured action knowledge in the lateral prefrontal cortex(9).	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan; Tamagawa Univ Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan	Tohoku University	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan.	tanji@lab.tamagawa.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; BARONE P, 1989, EXP BRAIN RES, V78, P447; Dominey PF, 1998, J COGNITIVE NEUROSCI, V10, P734, DOI 10.1162/089892998563130; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fuster J.M., 1989, PREFRONTAL CORTEX; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GREEN DM, 1966, SIGNAL DETECTION THE; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; PASSINGHAM PE, 1993, FRONTAL LOBES VOLUNT; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sirigu A, 1995, ANN NY ACAD SCI, V769, P277, DOI 10.1111/j.1749-6632.1995.tb38145.x; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8	30	148	150	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					315	318		10.1038/nature05470	http://dx.doi.org/10.1038/nature05470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183266				2022-12-24	WOS:000243504700045
J	Beukeboom, LW; Kamping, A; Louter, M; Pijnacker, LP; Katju, V; Ferree, PM; Werren, JH				Beukeboom, Leo W.; Kamping, Albert; Louter, Marina; Pijnacker, Laas P.; Katju, Vaishali; Ferree, Patrick M.; Werren, John H.			Haploid females in the parasitic wasp Nasonia vitripennis	SCIENCE			English	Article									Univ Groningen, Ctr Ecol & Evolut Studies, NL-9750 AA Haren, Netherlands; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of Groningen; University of Rochester; University of California System; University of California Santa Cruz	Beukeboom, LW (corresponding author), Univ Groningen, Ctr Ecol & Evolut Studies, POB 14, NL-9750 AA Haren, Netherlands.	l.w.beukeboom@rug.nl	Beukeboom, L.W./D-1808-2012	Louter, Marina/0000-0002-9368-512X; Werren, John/0000-0001-9353-2070	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 RO1 GM070026-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411	4	28	33	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					206	206		10.1126/science.1133388	http://dx.doi.org/10.1126/science.1133388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218519	Green Submitted			2022-12-24	WOS:000243407400036
J	Maerkl, SJ; Quake, SR				Maerkl, Sebastian J.; Quake, Stephen R.			A systems approach to measuring the binding energy landscapes of transcription factors	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA; DISCOVERY; RECOGNITION; NETWORK; MOTIFS; SITES; MAX	A major goal of systems biology is to predict the function of biological networks. Although network topologies have been successfully determined in many cases, the quantitative parameters governing these networks generally have not. Measuring affinities of molecular interactions in high-throughput format remains problematic, especially for transient and low-affinity interactions. We describe a high-throughput microfluidic platform that measures such properties on the basis of mechanical trapping of molecular interactions. With this platform we characterized DNA binding energy landscapes for four eukaryotic transcription factors; these landscapes were used to test basic assumptions about transcription factor binding and to predict their in vivo function.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; CALTECH, Pasadena, CA 91125 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; California Institute of Technology	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr, Stanford, CA 94305 USA.	quake@stanford.edu	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268				BAKER RE, 1990, MOL CELL BIOL, V10, P2458, DOI 10.1128/MCB.10.6.2458; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Carroll AS, 2001, P NATL ACAD SCI USA, V98, P12578, DOI 10.1073/pnas.211195798; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent NA, 2004, J BIOL CHEM, V279, P27116, DOI 10.1074/jbc.M403818200; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	36	409	439	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					233	237		10.1126/science.1131007	http://dx.doi.org/10.1126/science.1131007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218526	Green Submitted			2022-12-24	WOS:000243407400045
J	Palike, H; Norris, RD; Herrle, JO; Wilson, PA; Coxall, HK; Lear, CH; Shackleton, NJ; Tripati, AK; Wade, BS				Paelike, Heiko; Norris, Richard D.; Herrle, Jens O.; Wilson, Paul A.; Coxall, Helen K.; Lear, Caroline H.; Shackleton, Nicholas J.; Tripati, Aradhna K.; Wade, Bridget S.			The heartbeat of the oligocene climate system	SCIENCE			English	Article							SEDIMENTS ODP SITE-1218; INSOLATION QUANTITIES; ANTARCTIC GLACIATION; CALCITE COMPENSATION; MIOCENE BOUNDARY; ATMOSPHERIC CO2; CARBON-DIOXIDE; CALIBRATION; MYR; CONSTRAINTS	A 13-million-year continuous record of Oligocene climate from the equatorial Pacific reveals a pronounced "heartbeat" in the global carbon cycle and periodicity of glaciations. This heartbeat consists of 405,000-, 127,000-, and 96,000- year eccentricity cycles and 1.2-million-year obliquity cycles in periodically recurring glacial and carbon cycle events. That climate system response to intricate orbital variations suggests a fundamental interaction of the carbon cycle, solar forcing, and glacial events. Box modeling shows that the interaction of the carbon cycle and solar forcing modulates deep ocean acidity as well as the production and burial of global biomass. The pronounced 405,000- year eccentricity cycle is amplified by the long residence time of carbon in the oceans.	Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3AT, S Glam, Wales; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	NERC National Oceanography Centre; University of Southampton; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Alberta; Cardiff University; University of Cambridge; Rutgers State University New Brunswick	Palike, H (corresponding author), Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	H.Palike@soton.ac.uk	Wade, Bridget S/F-4987-2014; Palike, Heiko/A-6560-2008; Tripati, Aradhna/C-9419-2011; Lear, Caroline/D-2582-2009; Herrle, Jens O/B-9088-2008	Wade, Bridget S/0000-0002-7245-8614; Palike, Heiko/0000-0003-3386-0923; Tripati, Aradhna/0000-0002-1695-1754; Wilson, Paul/0000-0001-6425-8906; Lear, Caroline/0000-0002-7533-4430; Coxall, Helen/0000-0002-2843-2898	Natural Environment Research Council [NE/D000343/1] Funding Source: researchfish; NERC [NE/D000343/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Billups K, 2004, EARTH PLANET SC LETT, V224, P33, DOI 10.1016/j.epsl.2004.05.004; Broecker W.S., 1982, TRACERS SEA, V690; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; GHIL M, 2002, REV GEOPHYS, V40; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; Lanci L, 2005, EARTH PLANET SC LETT, V237, P617, DOI 10.1016/j.epsl.2005.07.004; Lanci L, 2004, EARTH PLANET SC LETT, V226, P207, DOI 10.1016/j.epsl.2004.07.025; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Loutre MF, 2004, EARTH PLANET SC LETT, V221, P1, DOI 10.1016/S0012-821X(04)00108-6; LYLE M, 2002, INIT REP P OCEAN DRI, V199; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; OPDYKE BN, 1992, GEOLOGY, V20, P733, DOI 10.1130/0091-7613(1992)020<0733:ROTCRH>2.3.CO;2; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Palike H, 2004, GEOLOGY, V32, P929, DOI 10.1130/G20750.1; Palike H, 2000, EARTH PLANET SC LETT, V182, P1, DOI 10.1016/S0012-821X(00)00229-6; PALIKE H, 2005, SCI RES P OCEAN DRIL, V199; PALIKE H, IN PRESS QUAT SCI RE; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pekar SF, 2002, GEOLOGY, V30, P903, DOI 10.1130/0091-7613(2002)030<0903:CBEEFB>2.0.CO;2; Raffi I, 1999, PHILOS T R SOC A, V357, P1975, DOI 10.1098/rsta.1999.0410; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; TRIPATI A, 2006, SCI RES P OCEAN DRIL, V199; Van Simaeys S, 2005, GEOLOGY, V33, P709, DOI 10.1130/G21634.1; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Wade BS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001042; WALKER JCG, 1992, GLOBAL PLANET CHANGE, V97, P151, DOI 10.1016/0921-8181(92)90009-Y; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	36	438	474	11	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1894	1898		10.1126/science.1133822	http://dx.doi.org/10.1126/science.1133822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185595	Green Published, Green Accepted			2022-12-24	WOS:000242996800039
J	Munger, KL; Levin, LI; Hollis, BW; Howard, NS; Ascherio, A				Munger, Kassandra L.; Levin, Lynn I.; Hollis, Bruce W.; Howard, Noel S.; Ascherio, Alberto			Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-D DEFICIENCY; AUTOIMMUNE; EXPOSURE; ENCEPHALOMYELITIS; PREVALENCE; PREVENTION; MECHANISMS; SYMPTOMS; SUNLIGHT; DISEASE	Context Epidemiological and experimental evidence suggests that high levels of vitamin D, a potent immunomodulator, may decrease the risk of multiple sclerosis. There are no prospective studies addressing this hypothesis. Objective To examine whether levels of 25-hydroxyvitamin D are associated with risk of multiple sclerosis. Design, Setting, and Participants Prospective, nested case-control study among more than 7 million US military personnel who have serum samples stored in the Department of Defense Serum Repository. Multiple sclerosis cases were identified through Army and Navy physical disability databases for 1992 through 2004, and diagnoses were confirmed by medical record review. Each case (n= 257) was matched to 2 controls by age, sex, race/ethnicity, and dates of blood collection. Vitamin D status was estimated by averaging 25-hydroxyvitamin D levels of 2 or more serum samples collected before the date of initial multiple sclerosis symptoms. Main Outcome Measures Odds ratios of multiple sclerosis associated with continuous or categorical levels (quantiles or a priori - defined categories) of serum 25-hydroxyvitamin D within each racial/ethnic group. Results Among whites ( 148 cases, 296 controls), the risk of multiple sclerosis significantly decreased with increasing levels of 25-hydroxyvitamin D ( odds ratio [ OR] for a 50-nmol/L increase in 25-hydroxyvitamin D, 0.59; 95% confidence interval, 0.36-0.97). In categorical analyses using the lowest quintile ( < 63.3 nmol/L) as the reference, the ORs for each subsequent quintile were 0.57, 0.57, 0.74, and 0.38 (P=. 02 for trend across quintiles). Only the OR for the highest quintile, corresponding to 25-hydroxyvitamin D levels higher than 99.1 nmol/L, was significantly different from 1.00 ( OR, 0.38; 95% confidence interval, 0.19-0.75; P=. 006). The inverse relation with multiple sclerosis risk was particularly strong for 25-hydroxyvitamin D levels measured before age 20 years. Among blacks and Hispanics ( 109 cases, 218 controls), who had lower 25-hydroxyvitamin D levels than whites, no significant associations between vitamin D and multiple sclerosis risk were found. Conclusion The results of our study suggest that high circulating levels of vitamin D are associated with a lower risk of multiple sclerosis.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; Dept Navy, Navy Council Review Boards, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,3rd Floor, Boston, MA 02115 USA.	aascheri@hsph.harvard.edu			NINDS NIH HHS [NS042194, NS46635] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046635, R01NS042194] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; Aubin F, 2003, EUR J DERMATOL, V13, P515; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BLISS CI, 1958, CONN AGRIC EXPT ST B, P615; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Compston Alastair, 2002, Curr Neurol Neurosci Rep, V2, P259, DOI 10.1007/s11910-002-0085-3; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; GOLDBERG P, 1974, INT J ENVIRON STUD, V6, P19, DOI 10.1080/00207237408709630; HAUSER SL, 1984, J IMMUNOL, V132, P1276; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2004, AM J CLIN NUTR, V79, P362; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; LEIBOWITZ U, 1967, BRAIN, V90, P871, DOI 10.1093/brain/90.4.871; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Lucas RM, 2006, PROG BIOPHYS MOL BIO, V92, P140, DOI 10.1016/j.pbiomolbio.2006.02.019; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; *NAT WEATH SERV CL, 2006, UV IND ANN TIM SER; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER CM, 1995, J NEUROL NEUROSUR PS, V58, P253, DOI 10.1136/jnnp.58.2.253-a; RAHMANIYAN M, 2005, VITAMIN D, V1, P769; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; SUTHERLAND JM, 1962, BRAIN, V85, P149, DOI 10.1093/brain/85.1.149; Van Den SK, 2004, NEUROEPIDEMIOLOGY PR, P188; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; ZADSHIR A, 2005, ETHN DIS S5, V15, DOI DOI 10.1136/JMG.2004.024083	47	1267	1298	2	100	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2832	2838		10.1001/jama.296.23.2832	http://dx.doi.org/10.1001/jama.296.23.2832			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179460	Bronze			2022-12-24	WOS:000242826400025
J	Sibert, J; Hampton, J; Kleiber, P; Maunder, M				Sibert, John; Hampton, John; Kleiber, Pierre; Maunder, Mark			Biomass, size, and trophic status of top predators in the Pacific Ocean	SCIENCE			English	Article								Fisheries have removed at least 50 million tons of tuna and other top-level predators from the Pacific Ocean pelagic ecosystem since 1950, leading to concerns about a catastrophic reduction in population biomass and the collapse of oceanic food chains. We analyzed all available data from Pacific tuna fisheries for 1950-2004 to provide comprehensive estimates of fishery impacts on population biomass and size structure. Current biomass ranges among species from 36 to 91% of the biomass predicted in the absence of fishing, a level consistent with or higher than standard fisheries management targets. Fish larger than 175 centimeters fork length have decreased from 5% to approximately 1% of the total population. The trophic level of the catch has decreased slightly, but there is no detectable decrease in the trophic level of the population. These results indicate substantial, though not catastrophic, impacts of fisheries on these top-level predators and minor impacts on the ecosystem in the Pacific Ocean.	Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; Secretariat Pacific Community, Ocean Fisheries Programme, Noumea 98848, New Caledonia; NOAA, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96822 USA; Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Sibert, J (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	sibert@hawaii.edu						Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005	1	174	179	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1773	1776		10.1126/science.1135347	http://dx.doi.org/10.1126/science.1135347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170304				2022-12-24	WOS:000242833600058
J	Xu, YH; Xing, YN; Chen, Y; Chao, Y; Lin, Z; Fan, E; Yu, JW; Strack, S; Jeffrey, PD; Shi, YG				Xu, Yanhui; Xing, Yongna; Chen, Yu; Chao, Yang; Lin, Zheng; Fan, Eugene; Yu, Jong W.; Strack, Stefan; Jeffrey, Philip D.; Shi, Yigong			Structure of the protein phosphatase 2A holoenzyme	CELL			English	Article							B56-GAMMA REGULATORY SUBUNIT; PP2A CATALYTIC SUBUNIT; A-ALPHA SUBUNIT; MOLECULAR-CLONING; TRUNCATED ISOFORM; B-SUBUNITS; CARBOXYL METHYLATION; REDUCED EXPRESSION; TUMOR-ANTIGENS; BETA	Protein Phosphatase 2A (PP2A) plays an essential role in many aspects of cellular physiology. The PP2A holoenzyme consists of a heterodimeric core enzyme, which comprises a scaffolding subunit and a catalytic subunit, and a variable regulatory subunit. Here we report the crystal structure of the heterotrimeric PP2A holoenzyme involving the regulatory subunit B'/B56/PR61. Surprisingly, the B'/PR61 subunit has a HEAT-like (huntingtin-elongation-A subunit-TOR-like) repeat structure, similar to that of the scaffolding subunit. The regulatory B'/B56/ PR61 subunit simultaneously interacts with the catalytic subunit as well as the conserved ridge of the scaffolding subunit. The carboxyterminus of the catalytic subunit recognizes a surface groove at the interface between the B'/B56/ PR61 subunit and the scaffolding subunit. Compared to the scaffolding subunit in the PP2A core enzyme, formation of the holoenzyme forces the scaffolding subunit to undergo pronounced conformational rearrangements. This structure reveals significant ramifications for understanding the function and regulation of PP2A.	Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA; Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	Princeton University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Xu, Yanhui/D-5119-2019	Jeffrey, Philip/0000-0002-4351-5341; Strack, Stefan/0000-0002-6175-7280; Shi, Yigong/0000-0003-2030-168X				ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; CHO US, 2006, NATURE; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ito A, 2003, AM J PATHOL, V162, P81, DOI 10.1016/S0002-9440(10)63800-X; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1992, J BIOL CHEM, V267, P21864; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Suzuki K, 2003, INT J ONCOL, V23, P1263; TAKATA K, 2000, BREED RES, V2, P11; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	50	329	352	1	59	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1239	1251		10.1016/j.cell.2006.11.033	http://dx.doi.org/10.1016/j.cell.2006.11.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174897	Bronze			2022-12-24	WOS:000242991000020
J	Guy, J; Gan, J; Selfridge, J; Cobb, S; Bird, A				Guy, Jacky; Gan, Jian; Selfridge, Jim; Cobb, Stuart; Bird, Adrian			Reversal of neurological defects in a mouse model of Rett syndrome	SCIENCE			English	Article							CPG-BINDING PROTEIN-2; MECP2; NEURONS; MICE; DISORDER; DNA	Rett syndrome is an autism spectrum disorder caused by mosaic expression of mutant copies of the X-linked MECP2 gene in neurons. However, neurons do not die, which suggests that this is not a neurodegenerative disorder. An important question for future therapeutic approaches to this and related disorders concerns phenotypic reversibility. Can viable but defective neurons be repaired, or is the damage done during development without normal MeCP2 irrevocable? Using a mouse model, we demonstrate robust phenotypic reversal, as activation of MeCP2 expression leads to striking loss of advanced neurological symptoms in both immature and mature adult animals.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Edinburgh; University of Glasgow	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	a.bird@ed.ac.uk		Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Gan, Jian/0000-0002-0155-6241	Wellcome Trust [077224] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995	15	825	854	2	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1143	1147		10.1126/science.1138389	http://dx.doi.org/10.1126/science.1138389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17289941	Green Accepted			2022-12-24	WOS:000244387600042
J	Forest, F; Grenyer, R; Rouget, M; Davies, TJ; Cowling, RM; Faith, DP; Balmford, A; Manning, JC; Proches, S; van der Bank, M; Reeves, G; Hedderson, TAJ; Savolainen, V				Forest, Felix; Grenyer, Richard; Rouget, Mathieu; Davies, T. Jonathan; Cowling, Richard M.; Faith, Daniel P.; Balmford, Andrew; Manning, John C.; Proches, Serban; van der Bank, Michelle; Reeves, Gail; Hedderson, Terry A. J.; Savolainen, Vincent			Preserving the evolutionary potential of floras in biodiversity hotspots	NATURE			English	Article							CAPE FLORA; PLANT DIVERSITY; CONSERVATION; RADIATION; RICHNESS; HISTORY	One of the biggest challenges for conservation biology is to provide conservation planners with ways to prioritize effort. Much attention has been focused on biodiversity hotspots(1). However, the conservation of evolutionary process is now also acknowledged as a priority in the face of global change(2). Phylogenetic diversity (PD) is a biodiversity index that measures the length of evolutionary pathways that connect a given set of taxa(3,4). PD therefore identifies sets of taxa that maximize the accumulation of 'feature diversity'. Recent studies, however, concluded that taxon richness is a good surrogate for PD5-9. Here we show taxon richness to be decoupled from PD, using a biome-wide phylogenetic analysis of the flora of an undisputed biodiversity hotspot - the Cape of South Africa. We demonstrate that this decoupling has real-world importance for conservation planning. Finally, using a database of medicinal and economic plant use(10), we demonstrate that PD protection is the best strategy for preserving feature diversity in the Cape. We should be able to use PD to identify those key regions that maximize future options, both for the continuing evolution of life on Earth and for the benefit of society.	Kirstenbosch Res Ctr, S African Natl Biodivers Inst, ZA-7735 Claremont, South Africa; Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; S African Natl Biodivers Inst, Biodivers Planning Unit, ZA-0001 Pretoria, South Africa; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Nelson Mandela Metropolitan Univ, Dept Bot, ZA-6031 Port Elizabeth, South Africa; Australian Museum, Sydney, NSW 2010, Australia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Ctr Invas Biol, ZA-7602 Matieland, South Africa; Univ Johannesburg, Dept Bot & Plant Biotechnol, ZA-2006 Auckland Pk, South Africa	South African National Biodiversity Institute; University of Cape Town; Royal Botanic Gardens, Kew; South African National Biodiversity Institute; University of Virginia; University System of Georgia; University of Georgia; Nelson Mandela University; Australian Museum; University of Cambridge; Stellenbosch University; University of Johannesburg	Forest, F (corresponding author), Kirstenbosch Res Ctr, S African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa.	f.forest@kew.org; v.savolainen@kew.org	Cowling, Richard/AFU-6261-2022; Procheş, Şerban/A-2044-2008; Rouget, Mathieu/B-7249-2008; Hedderson, Terry/AAD-8614-2021	Procheş, Şerban/0000-0002-3415-6930; Rouget, Mathieu/0000-0003-1836-7727; Rouget, Mathieu/0000-0002-6172-3152; Balmford, Andrew/0000-0002-0144-3589; Savolainen, Vincent/0000-0001-5350-9984				Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cowling R. M., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P273; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Cowling RM, 1999, J BIOGEOGR, V26, P367, DOI 10.1046/j.1365-2699.1999.00275.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; Goldblatt P, 2002, MOL PHYLOGENET EVOL, V25, P341, DOI 10.1016/S1055-7903(02)00235-X; GOLDBLATT P, 2000, CONSPECTUS CAPE FLOR; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; LINDER HP, 1994, S AFR J SCI, V90, P329; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Midley G. F., 2001, J MEDITERRANEAN ECOL, V2, P137, DOI DOI 10.1111/EVO.12573; MOOERS AO, 2005, PHYLOGENY CONSERVATI; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Polasky S, 2001, BIOL CONSERV, V97, P99, DOI 10.1016/S0006-3207(00)00103-8; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; *SURV EC PLANTS AR, 1999, SEPASAL DAT; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Torres NM, 2004, GENET MOL BIOL, V27, P511, DOI 10.1590/S1415-47572004000400008; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	30	643	675	11	393	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					757	760		10.1038/nature05587	http://dx.doi.org/10.1038/nature05587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301791				2022-12-24	WOS:000244205200043
J	Gavin, MA; Rasmussen, JP; Fontenot, JD; Vasta, V; Manganiello, VC; Beavo, JA; Rudensky, AY				Gavin, Marc A.; Rasmussen, Jeffrey P.; Fontenot, Jason D.; Vasta, Valeria; Manganiello, Vincent C.; Beavo, Joseph A.; Rudensky, Alexander Y.			Foxp3-dependent programme of regulatory T-cell differentiation	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; HELPER-CELLS; INFLAMMATION; ACTIVATION; RECEPTORS	Regulatory CD4(+) T cells (T-R cells), the development of which is critically dependent on X-linked transcription factor Foxp3 ( forkhead box P3), prevent self-destructive immune responses(1). Despite its important role, molecular and functional features conferred by Foxp3 to T-R precursor cells remain unknown. It has been suggested that Foxp3 expression is required for both survival of T-R precursors as well as their inability to produce interleukin (IL)-2 and independently proliferate after T-cell-receptor engagement, raising the possibility that such 'anergy' and T-R suppressive capacity are intimately linked(2-4). Here we show, by dissociating Foxp3-dependent features from those induced by the signals preceding and promoting its expression in mice, that the latter signals include several functional and transcriptional hallmarks of T-R cells. Although its function is required for T-R cell suppressor activity, Foxp3 to a large extent amplifies and fixes pre-established molecular features of T-R cells, including anergy and dependence on paracrine IL-2. Furthermore, Foxp3 solidifies T-R cell lineage stability through modification of cell surface and signalling molecules, resulting in adaptation to the signals required to induce and maintain T-R cells. This adaptation includes Foxp3-dependent repression of cyclic nucleotide phosphodiesterase 3B, affecting genes responsible for T-R cell homeostasis.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; NHLBI, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rudensky, AY (corresponding author), Amgen Corp, Seattle, WA 98101 USA.	aruden@u.washington.edu		Rasmussen, Jeffrey/0000-0001-6997-3773	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540, Z01HL002540] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; WILLIAMS LM, IN PRESS NATURE IMMU; Yegutkin GG, 2006, J BIOL CHEM, V281, P29441, DOI 10.1074/jbc.M602480200; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Zhang W, 2000, BLOOD, V95, P3380, DOI 10.1182/blood.V95.11.3380.011k25_3380_3386; ZHENG Y, NATURE IN PRESS	23	872	926	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					771	775		10.1038/nature05543	http://dx.doi.org/10.1038/nature05543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17220874	Bronze			2022-12-24	WOS:000244205200046
J	Berg, RW; Alaburda, A; Hounsgaard, J				Berg, Rune W.; Alaburda, Aidas; Hounsgaard, Jorn			Balanced inhibition and excitation drive spike activity in spinal half-centers	SCIENCE			English	Article							NEURONS IN-VIVO; NETWORK ACTIVITY; CORTICAL-NEURONS; SYNAPTIC INPUT; CONDUCTANCE; CORD; MOTONEURONS; VARIABILITY; MODULATION; MODELS	Many limb movements are composed of alternating flexions and extensions. However, the underlying spinal network mechanisms remain poorly defined. Here, we show that the intensity of synaptic excitation and inhibition in limb motoneurons varies in phase rather than out of phase during rhythmic scratchlike network activity in the turtle. Inhibition and excitation peak with the total neuron conductance during the depolarizing waves of scratch episodes. Furthermore, spike activity is driven by depolarizing synaptic transients rather than pacemaker properties. These findings show that balanced excitation and inhibition and irregular firing are fundamental motifs in certain spinal network functions.	Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; Vilnius State Univ, Fac Nat Sci, Dept Biochem & Biophys, LT-03101 Vilnius, Lithuania	University of Copenhagen; Vilnius University	Hounsgaard, J (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark.	j.hounsgaard@mfi.ku.dk	Berg, Rune W/C-9717-2014; Berg, Rune W./X-7293-2019	Berg, Rune W/0000-0001-6376-9368; Berg, Rune W./0000-0001-6376-9368; hounsgaard, jorn/0000-0003-1523-0485				Alaburda A, 2005, J NEUROSCI, V25, P6316, DOI 10.1523/JNEUROSCI.0843-05.2005; Alaburda A, 2003, J NEUROSCI, V23, P8625; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Diba K, 2004, J NEUROSCI, V24, P9723, DOI 10.1523/JNEUROSCI.1721-04.2004; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; JANKOWSKA E, 1965, NATURE, V206, P198, DOI 10.1038/206198a0; KEIFER J, 1983, BRAIN RES, V266, P148, DOI 10.1016/0006-8993(83)91318-5; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherrington C., 1947, INTEGRATIVE ACTION N, V2nd; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	29	181	181	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					390	393		10.1126/science.1134960	http://dx.doi.org/10.1126/science.1134960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234950				2022-12-24	WOS:000243535400046
J	Stukel, TA; Fisher, ES; Wennberg, DE; Alter, DA; Gottlieb, DJ; Vermeulen, MJ				Stukel, Therese A.; Fisher, Elliott S.; Wennberg, David E.; Alter, David A.; Gottlieb, Daniel J.; Vermeulen, Marian J.			Analysis of observational studies in the presence of treatment selection bias - Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ANGIOGRAPHY; REGIONAL-VARIATIONS; ELDERLY-PATIENTS; THROMBOLYTIC THERAPY; MEDICARE PATIENTS; OUTCOMES; REGRESSION; RISK; STRATEGIES	Context Comparisons of outcomes between patients treated and untreated in observational studies may be biased due to differences in patient prognosis between groups, often because of unobserved treatment selection biases. Objective To compare 4 analytic methods for removing the effects of selection bias in observational studies: multivariable model risk adjustment, propensity score risk adjustment, propensity-based matching, and instrumental variable analysis. Design, Setting, and Patients A national cohort of 122 124 patients who were elderly ( aged 65-84 years), receiving Medicare, and hospitalized with acute myocardial infarction ( AMI) in 1994-1995, and who were eligible for cardiac catheterization. Baseline chart reviews were taken from the Cooperative Cardiovascular Project and linked to Medicare health administrative data to provide a rich set of prognostic variables. Patients were followed up for 7 years through December 31, 2001, to assess the association between long-term survival and cardiac catheterization within 30 days of hospital admission. Main Outcome Measure Risk-adjusted relative mortality rate using each of the analytic methods. Results Patients who received cardiac catheterization (n = 73 238) were younger and had lower AMI severity than those who did not. After adjustment for prognostic factors by using standard statistical risk-adjustment methods, cardiac catheterization was associated with a 50% relative decrease in mortality ( for multivariable model risk adjustment: adjusted relative risk [RR], 0.51; 95% confidence interval [CI], 0.50-0.52; for propensity score risk adjustment: adjusted RR, 0.54; 95% CI, 0.53-0.55; and for propensity-based matching: adjusted RR, 0.54; 95% CI, 0.52-0.56). Using regional catheterization rate as an instrument, instrumental variable analysis showed a 16% relative decrease in mortality ( adjusted RR, 0.84; 95% CI, 0.79-0.90). The survival benefits of routine invasive care from randomized clinical trials are between 8% and 21%. Conclusions Estimates of the observational association of cardiac catheterization with long-term AMI mortality are highly sensitive to analytic method. All standard risk-adjustment methods have the same limitations regarding removal of unmeasured treatment selection biases. Compared with standard modeling, instrumental variable analysis may produce less biased estimates of treatment effects, but is more suited to answering policy questions than specific clinical questions.	Inst Clin Evaluat Sci, Toronto, ON, Canada; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Vet Adm Outcomes Grp, White River Jct, VT USA; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; St Michaels Hosp, Toronto Rehabil Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Toronto Rehabil Inst, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Dartmouth College; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Maine Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	stukel@ices.on.ca	Potter, Joseph E/A-3122-2008	Stukel, Therese/0000-0002-2951-1360	NIA NIH HHS [P01 AG019783-06, P01 AG019783, 1P01-AG19783-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; Harrell FE, 2001, REGRESSION MODELING; Harris KM, 1998, HEALTH SERV RES, V33, P1337; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; LANDRUM MB, 2001, HLTH SERV OUTCOMES R, V2, P221, DOI DOI 10.1023/A:1020367111374; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Parsons L, REDUCING BIAS PROPEN; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; *STAT CORP, 2004, STATA STAT SOFTW REL; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; U.S. Food and Drug Administration U.S. Department of Health and Human Services, FDA PUBL HLTH ADV DE; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wooldridge J.M., 2000, INTRO ECONOMETRICS M	42	590	604	3	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2007	297	3					278	285		10.1001/jama.297.3.278	http://dx.doi.org/10.1001/jama.297.3.278			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125VT	17227979	Green Accepted, Bronze			2022-12-24	WOS:000243472300022
J	Ferraz, G; Nichols, JD; Hines, JE; Stouffer, PC; Bierregaard, RO; Lovejoy, TE				Ferraz, Goncalo; Nichols, James D.; Hines, James E.; Stouffer, Philip C.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.			A large-scale deforestation experiment: Effects of patch area and isolation on Amazon birds	SCIENCE			English	Article								As compared with extensive contiguous areas, small isolated habitat patches lack many species. Some species disappear after isolation; others are rarely found in any small patch, regardless of isolation. We used a 13-year data set of bird captures from a large landscape-manipulation experiment in a Brazilian Amazon forest to model the extinction-colonization dynamics of 55 species and tested basic predictions of island biogeography and metapopulation theory. From our models, we derived two metrics of species vulnerability to changes in isolation and patch area. We found a strong effect of area and a variable effect of isolation on the predicted patch occupancy by birds.	Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, BR-69011 Manaus, Amazonas, Brazil; US Fish & Wildlife Serv, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; Louisiana State Univ, AgCenter, Baton Rouge, LA 70803 USA; Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; H John Heinz III Ctr Sci Econ Environm, Washington, DC 20004 USA	Institute Nacional de Pesquisas da Amazonia; United States Department of the Interior; US Fish & Wildlife Service; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Charlotte	Ferraz, G (corresponding author), Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, BR-69011 Manaus, Amazonas, Brazil.	gferraz@inpa.gov.br	stouffer, phil/AAF-7281-2020; Ferraz, Gonçalo/C-3860-2008	Ferraz, Gonçalo/0000-0001-8748-0462				Bierregaard R., 2001, LESSONS AMAZONIA ECO; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cohn-Haft Mario, 1997, Ornithological Monographs, V48, P205; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gascon Claude, 2001, P31; Hanski I., 1999, METAPOPULATION ECOLO; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2004, PRESENCE VERSION 2 0; LAURANCE WF, 2006, EMERGING THREATS TRO; MAC ARTHUR ROBERT H., 1967; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Van Houtan KS, 2006, EVOL ECOL RES, V8, P129	16	219	225	6	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					238	241		10.1126/science.1133097	http://dx.doi.org/10.1126/science.1133097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218527	Green Submitted			2022-12-24	WOS:000243407400046
J	Jin, D; Liu, HX; Hirai, H; Torashima, T; Nagai, T; Lopatina, O; Shnayder, NA; Yamada, K; Noda, M; Seike, T; Fujita, K; Takasawa, S; Yokoyama, S; Koizumi, K; Shiraishi, Y; Tanaka, S; Hashii, M; Yoshihara, T; Higashida, K; Islam, MS; Yamada, N; Hayashi, K; Noguchi, N; Kato, I; Okamoto, H; Matsushima, A; Salmina, A; Munesue, T; Shimizu, N; Mochida, S; Asano, M; Higashida, H				Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro			CD38 is critical for social behaviour by regulating oxytocin secretion	NATURE			English	Article							CYCLIC-ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; RELEASE; CA2+; RECOGNITION; BRAIN; NEUROPEPTIDES; NEUROBIOLOGY; TRANSDUCTION; VASOPRESSIN	CD38, a transmembrane glycoprotein with ADP-ribosyl cyclase activity, catalyses the formation of Ca2+ signalling molecules, but its role in the neuroendocrine system is unknown. Here we show that adult CD38 knockout (CD38(-/-)) female and male mice show marked defects in maternal nurturing and social behaviour, respectively, with higher locomotor activity. Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38(-/-) mice. Replacement of OT by subcutaneous injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38(-/-) mice. Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38(-/-) mice; this was mimicked by CD38 metabolite antagonists in CD38(+/+) mice. These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviours, and may be an element in neurodevelopmental disorders.	Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Anat, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan; Japan Sci & Technol Agcy, SORST, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Nat Sci & Technol, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Pathophysiol, Fukuoka 8128582, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Adv Biol Sci Regenerat, Sendai, Miyagi 9808575, Japan; Kanazawa Univ Hosp, Cent Clin Lab, Kanazawa, Ishikawa 9208641, Japan; Kanazawa Univ Hosp, Dept Psychiat, Kanazawa, Ishikawa 9208641, Japan; Toyama Univ, Sch Med, Dept Biochem, Toyama 9300194, Japan; Nanao Natl Hosp, Nanao 9208531, Japan; Krasnoyarsk State Med Acad, Dept Med Chem & Biochem, Krasnoyarsk 660022, Russia; Tokyo Med Univ, Dept Physiol, Tokyo, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Kyushu University; Tohoku University; Tohoku University; Kanazawa University; Kanazawa University; University of Toyama; Krasnoyarsk State Medical University; Tokyo Medical University	Higashida, H (corresponding author), Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan.	haruhiro@med.kanazawa-u.ac.jp	Salmina, Alla B./L-7977-2013; Hirai, Hirokazu/ABP-1143-2022; Lopatina, Olga/I-9610-2014; Noda, Mami/AAC-3949-2020; Yamada, Kiyofumi/I-7487-2014; Nagai, Taku/I-7507-2014; Shnayder, Natalia/M-7084-2014; Sokabe, Masahiro/I-1565-2012; higashida, haruhiro/L-3773-2015	Lopatina, Olga/0000-0002-7884-2721; Yamada, Kiyofumi/0000-0002-5280-5180; Nagai, Taku/0000-0001-5050-7748; Shnayder, Natalia/0000-0002-2840-837X; Hirai, Hirokazu/0000-0002-0721-4293; higashida, haruhiro/0000-0002-1779-0606				Argiolas A, 2005, PROG NEUROBIOL, V76, P1, DOI 10.1016/j.pneurobio.2005.06.002; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BELIN V, 1986, J PHYSIOL-LONDON, V377, P369, DOI 10.1113/jphysiol.1986.sp016192; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; Higashida H, 2001, PHARMACOL THERAPEUT, V90, P283, DOI 10.1016/S0163-7258(01)00142-5; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lim MM, 2005, INT J DEV NEUROSCI, V23, P235, DOI 10.1016/j.ijdevneu.2004.05.006; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; OuYang W, 2004, BRAIN RES, V1024, P203, DOI 10.1016/j.brainres.2004.07.068; POPIK P, 1992, PSYCHOPHARMACOLOGY, V106, P71, DOI 10.1007/BF02253591; Russell JA, 2003, FRONT NEUROENDOCRIN, V24, P27, DOI 10.1016/S0091-3022(02)00104-8; Sasaki N, 2005, CELL CALCIUM, V37, P45, DOI 10.1016/j.ceca.2004.06.007; Soares SM, 2005, ENDOCRINOLOGY, V146, P2186, DOI 10.1210/en.2004-1298; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	44	478	485	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					41	45		10.1038/nature05526	http://dx.doi.org/10.1038/nature05526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287729				2022-12-24	WOS:000244525600032
J	Xin, HW; Liu, D; Wan, M; Safari, A; Kim, H; Sun, W; O'Connor, MS; Zhou, SY				Xin, Huawei; Liu, Dan; Wan, Ma; Safari, Amin; Kim, Hyeung; Sun, Wen; O'Connor, Matthew S.; Zhou Songyang			TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase	NATURE			English	Article							END-BINDING-PROTEIN; DNA-DAMAGE; LENGTH REGULATOR; COMPLEX; MAINTENANCE; SUBUNIT; PROTECTION; TERMINI; ENZYME; YEAST	Telomere dysfunction may result in chromosomal abnormalities, DNA damage responses, and even cancer(1). Early studies in lower organisms have helped to establish the crucial role of telomerase and telomeric proteins in maintaining telomere length and protecting telomere ends(2-7). In Oxytricha nova, telomere G-overhangs are protected by the TEBP-alpha/beta heterodimer(3,4). Human telomeres contain duplex telomeric repeats with 3' single-stranded G-overhangs, and may fold into a t-loop structure that helps to shield them from being recognized as DNA breaks(8,9). Additionally, the TEBP-alpha homologue, POT1, which binds telomeric single-stranded DNA (ssDNA)(10), associates with multiple telomeric proteins ( for example, TPP1, TIN2, TRF1, TRF2 and RAP1) to form the six-protein telosome/shelterin(11,12) and other subcomplexes. These telomeric protein complexes in turn interact with diverse pathways to form the telomere interactome(13) for telomere maintenance. However, the mechanisms by which the POT1-containing telosome communicates with telomerase to regulate telomeres remain to be elucidated. Here we demonstrate that TPP1 is a putative mammalian homologue of TEBP-beta and contains a predicted amino-terminal oligonucleotide/ oligosaccharide binding (OB) fold. TPP1-POT1 association enhanced POT1 affinity for telomeric ssDNA. In addition, the TPP1 OB fold, as well as POT1 - TPP1 binding, seemed critical for POT1-mediated telomerelength control and telomere-end protection in human cells. Disruption of POT1 - TPP1 interaction by dominant negative TPP1 expression or RNA interference (RNAi) resulted in telomerelength alteration and DNA damage responses. Furthermore, we offer evidence that TPP1 associates with the telomerase in a TPP1-OB-fold-dependent manner, providing a physical link between telomerase and the telosome/shelterin complex. Our findings highlight the critical role of TPP1 in telomere maintenance, and support a yin - yang model in which TPP1 and POT1 function as a unit to protect human telomeres, by both positively and negatively regulating telomerase access to telomere DNA.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.tmc.edu						Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Chadwick D., 1997, TELOMERES TELOMERASE; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; FANG GW, 1993, P NATL ACAD SCI USA, V90, P6056, DOI 10.1073/pnas.90.13.6056; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Shore D, 1997, BIOL CHEM, V378, P591; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10	30	377	391	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					559	562		10.1038/nature05469	http://dx.doi.org/10.1038/nature05469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237767				2022-12-24	WOS:000243867300048
J	Swallen, SF; Kearns, KL; Mapes, MK; Kim, YS; McMahon, RJ; Ediger, MD; Wu, T; Yu, L; Satija, S				Swallen, Stephen F.; Kearns, Kenneth L.; Mapes, Marie K.; Kim, Yong Seol; McMahon, Robert J.; Ediger, M. D.; Wu, Tian; Yu, Lian; Satija, Sushil			Organic glasses with exceptional thermodynamic and kinetic stability	SCIENCE			English	Article							SUPERCOOLED LIQUIDS; STRUCTURAL RELAXATION; AROMATIC HYDROCARBONS; PHYSICAL PROPERTIES; HEAT-CAPACITY; TRANSITION; TEMPERATURE; FORMERS; PARADOX	Vapor deposition has been used to create glassy materials with extraordinary thermodynamic and kinetic stability and high density. For glasses prepared from indomethacin or 1,3-bis-(1-naphthyl)-5(2-naphthyl) benzene, stability is optimized when deposition occurs on substrates at a temperature of 50 K below the conventional glass transition temperature. We attribute the substantial improvement in thermodynamic and kinetic properties to enhanced mobility within a few nanometers of the glass surface during deposition. This technique provides an efficient means of producing glassy materials that are low on the energy landscape and could affect technologies such as amorphous pharmaceuticals.	Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institute of Standards & Technology (NIST) - USA	Ediger, MD (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	ediger@chem.wisc.edu	Ediger, Mark/AGZ-4130-2022; McMahon, Robert J./AAR-3868-2020	Ediger, Mark/0000-0003-4715-8473; 				Angell CA, 1997, J RES NATL INST STAN, V102, P171, DOI 10.6028/jres.102.013; Bell RC, 2003, J AM CHEM SOC, V125, P5176, DOI 10.1021/ja0291437; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Huang DH, 2003, J CHEM PHYS, V119, P3590, DOI 10.1063/1.1599271; Ishii K, 2003, J PHYS CHEM B, V107, P876, DOI 10.1021/jp0260604; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Kovacs AJ, 1963, FORTSCH HOCHPOLYM FO, V3, P394, DOI DOI 10.1007/BFB0050366; MAGILL JH, 1967, J CHEM PHYS, V47, P2802, DOI 10.1063/1.1712301; Matyushov DV, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949211; PLAZEK DJ, 1966, J CHEM PHYS, V45, P3038, DOI 10.1063/1.1728059; Richert R, 2003, J CHEM PHYS, V118, P1828, DOI 10.1063/1.1531587; Saksaengwijit A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.235701; Speedy RJ, 2003, BIOPHYS CHEM, V105, P411, DOI 10.1016/S0301-4622(03)00105-4; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; STILLINGER FH, 1988, J CHEM PHYS, V88, P7818, DOI 10.1063/1.454295; Swallen SF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191492; TAKEDA K, 1995, J PHYS CHEM-US, V99, P1602, DOI 10.1021/j100005a035; Tanaka H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025701; Tanaka H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011505; TURNBULL D, 1981, METALL TRANS A, V12, P695, DOI 10.1007/BF02648333; Whitaker CM, 1996, J PHYS CHEM-US, V100, P1081, DOI 10.1021/jp9529329	27	547	550	6	294	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					353	356		10.1126/science.1135795	http://dx.doi.org/10.1126/science.1135795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158289				2022-12-24	WOS:000243535400034
J	Doyle, M; Fookes, M; Ivens, A; Mangan, MW; Wain, J; Dorman, CJ				Doyle, Marie; Fookes, Maria; Ivens, Al; Mangan, Michael W.; Wain, John; Dorman, Charles J.			An H-NS-like stealth protein aids horizontal DNA transmission in bacteria	SCIENCE			English	Article							PLASMID; SEQUENCE; GENES; COLI; LER; R27; SFH	The Sfh protein is encoded by self-transmissible plasmids involved in human typhoid and is closely related to the global regulator H-NS. We have found that Sfh provides a stealth function that allows the plasmids to be transmitted to new bacterial hosts with minimal effects on their fitness. Introducing the plasmid without the sfh gene imposes a mild H-NS- phenotype and a severe loss of fitness due to titration of the cellular pool of H-NS by the A+T-rich plasmid. This stealth strategy seems to be used widely to aid horizontal DNA transmission and has important implications for bacterial evolution.	Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland; Wellcome Trust Res Labs, Sanger Inst, Cambridge CB10 1SA, England	Trinity College Dublin; Wellcome Trust Sanger Institute	Dorman, CJ (corresponding author), Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland.	cjdorman@tcd.ie	Wain, John/B-3446-2013; Dorman, Charles J/N-9867-2015; Dorman, Charles/P-3481-2019	Wain, John/0000-0002-1257-1148; Dorman, Charles J/0000-0002-6018-9170; Dorman, Charles/0000-0002-6018-9170; Ivens, Al/0000-0002-0112-3876; Mangan, Michael/0000-0001-9428-0397	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beloin C, 2003, MOL GENET GENOMICS, V270, P66, DOI 10.1007/s00438-003-0897-0; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Dahlberg C, 2003, GENETICS, V165, P1641; Deighan P, 2003, MOL MICROBIOL, V48, P1401, DOI 10.1046/j.1365-2958.2003.03515.x; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Forns N, 2005, J BACTERIOL, V187, P3950, DOI 10.1128/JB.187.12.3950-3959.2005; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; More MI, 1996, J BACTERIOL, V178, P4392, DOI 10.1128/jb.178.15.4392-4399.1996; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; TIETZE E, 1994, J BASIC MICROB, V34, P105, DOI 10.1002/jobm.3620340206; Wain J, 2004, T ROY SOC TROP MED H, V98, P423, DOI 10.1016/j.trstmh.2003.10.015; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003	21	161	162	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					251	252		10.1126/science.1137550	http://dx.doi.org/10.1126/science.1137550			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218529				2022-12-24	WOS:000243407400050
J	Wang, TJ; Gona, P; Larson, MG; Tofler, GH; Levy, D; Newton-Cheh, C; Jacques, PF; Rifai, N; Selhub, J; Robins, SJ; Benjamin, EJ; D'Agostino, RB; Vasan, RS				Wang, Thomas J.; Gona, Philimon; Larson, Martin G.; Tofler, Geoffrey H.; Levy, Daniel; Newton-Cheh, Christopher; Jacques, Paul F.; Rifai, Nader; Selhub, Jacob; Robins, Sander J.; Benjamin, Emelia J.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Multiple biomarkers for the prediction of first major cardiovascular events and death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR; DENSITY-LIPOPROTEIN CHOLESTEROL; BRAIN NATRIURETIC PEPTIDE; CONVENTIONAL RISK-FACTORS; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); FOLLOW-UP; PLASMA	BACKGROUND: Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events. METHODS: We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, d-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio. RESULTS: During follow-up (median, 7.4 years), 207 participants died and 169 had a first major cardiovascular event. In Cox proportional-hazards models adjusting for conventional risk factors, the following biomarkers most strongly predicted the risk of death (each biomarker is followed by the adjusted hazard ratio per 1 SD increment in the log values): B-type natriuretic peptide level (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine level (1.20), and renin level (1.17). The biomarkers that most strongly predicted major cardiovascular events were B-type natriuretic peptide level (adjusted hazard ratio, 1.25 per 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20). Persons with ``multimarker'' scores (based on regression coefficients of significant biomarkers) in the highest quintile as compared with those with scores in the lowest two quintiles had elevated risks of death (adjusted hazard ratio, 4.08; P<0.001) and major cardiovascular events (adjusted hazard ratio, 1.84; P=0.02). However, the addition of multimarker scores to conventional risk factors resulted in only small increases in the ability to classify risk, as measured by the C statistic. CONCLUSIONS: For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, Boston, MA 02114 USA; Framingham Heart Dis Epidemiol Study, Framingham, MA USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Royal N Shore Hosp, Sydney, NSW, Australia; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer Dept Agr, Boston, MA 02111 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston Med Ctr, Prevent Med & Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Div Endocrinol Nutr & Diabet, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; Boston University; Royal North Shore Hospital; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital; Harvard Medical School; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Wang, TJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, GRB-800,55 Fruit St, Boston, MA 02114 USA.	tjwang@partners.org	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Gona, Philimon/K-1477-2019; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336; Robins, Sander/0000-0002-3735-8415	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, R01HL076784, K24HL004334, R01HL048157] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195, K23-HL-074077, R01-HL-076784, R01-HL-48157, 2K24-HL-04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman MH, 1997, AM J HYPERTENS, V10, P1, DOI 10.1016/S0895-7061(96)00301-9; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P2848; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hoekstra T, 2004, THROMB HAEMOSTASIS, V91, P861, DOI 10.1160/TH03-08-0546; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; KANNEL WB, 1987, NIH PUBLICATION; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	989	1070	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2631	2639		10.1056/NEJMoa055373	http://dx.doi.org/10.1056/NEJMoa055373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182988				2022-12-24	WOS:000242956200004
J	Kieffer, SW; Lu, XL; Bethke, CM; Spencer, JR; Marshak, S; Navrotsky, A				Kieffer, Susan W.; Lu, Xinli; Bethke, Craig M.; Spencer, John R.; Marshak, Stephen; Navrotsky, Alexandra			A clathrate reservoir hypothesis for Enceladus' south polar plume	SCIENCE			English	Article							GAS-PRODUCTION; HYDRATE; ICE; WELL	We hypothesize that active tectonic processes in the south polar terrain of Enceladus, the 500-kilometer-diameter moon of Saturn, are creating fractures that cause degassing of a clathrate reservoir to produce the plume documented by the instruments on the Cassini spacecraft. Advection of gas and ice transports energy, supplied at depth as latent heat of clathrate decomposition, to shallower levels, where it reappears as latent heat of condensation of ice. The plume itself, which has a discharge rate comparable to Old Faithful Geyser in Yellowstone National Park, probably represents small leaks from this massive advective system.	Univ Illinois, Dept Geol, Urbana, IL 61801 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Calif Davis, Thermochem Facil, Davis, CA 95616 USA; Univ Calif Davis, NEAT, ORU, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; University of California System; University of California Davis	Kieffer, SW (corresponding author), Univ Illinois, Dept Geol, 1301 W Green St, Urbana, IL 61801 USA.	skieffer@uiuc.edu						Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hong H, 2003, J CAN PETROL TECHNOL, V42, P45, DOI 10.2118/03-11-05; Ji C, 2001, CHEM ENG SCI, V56, P5801, DOI 10.1016/S0009-2509(01)00265-2; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; KIEFFER SW, 1989, REV GEOPHYS, V27, P28; Kuhs WF, 1997, J INCLUS PHENOM MOL, V29, P65, DOI 10.1023/A:1007960217691; Laufer D, 2005, ICARUS, V178, P248, DOI 10.1016/j.icarus.2005.04.019; Longhi J, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002552; Lu X, 2004, THESIS U AUCKLAND AU; Lu XL, 2006, GEOTHERMICS, V35, P409, DOI 10.1016/j.geothermics.2006.07.001; Lu XL, 2005, GEOTHERMICS, V34, P389, DOI 10.1016/j.geothermics.2005.05.001; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MILLER SL, 1969, SCIENCE, V165, P489, DOI 10.1126/science.165.3892.489; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Sloan E. D., 1997, CLATHRATE HYDRATES N; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tian F.H., UNPUB; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wilder JW, 2002, J PHYS CHEM B, V106, P6298, DOI 10.1021/jp014256i	21	115	117	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1764	1766		10.1126/science.1133519	http://dx.doi.org/10.1126/science.1133519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170301				2022-12-24	WOS:000242833600055
J	Ohlstein, B; Spradling, A				Ohlstein, Benjamin; Spradling, Allan			Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential Notch signaling	SCIENCE			English	Article							SELF-RENEWAL; NICHE; MAINTENANCE; DIVISION; EXOCYST	The adult Drosophila midgut contains multipotent intestinal stem cells (ISCs) scattered along its basement membrane that have been shown by lineage analysis to generate both enterocytes and enteroendocrine cells. ISCs containing high levels of cytoplasmic Delta-rich vesicles activate the canonical Notch pathway and down-regulate Delta within their daughters, a process that programs these daughters to become enterocytes. ISCs that express little vesiculate Delta, or are genetically impaired in Notch signaling, specify their daughters to become enteroendocrine cells. Thus, ISCs control daughter cell fate by modulating Notch signaling over time. Our studies suggest that ISCs actively coordinate cell production with local tissue requirements by this mechanism.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090078] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R56 DK090078] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	21	463	473	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					988	992		10.1126/science.1136606	http://dx.doi.org/10.1126/science.1136606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303754				2022-12-24	WOS:000244229800042
J	Vergassola, M; Villermaux, E; Shraiman, BI				Vergassola, Massimo; Villermaux, Emmanuel; Shraiman, Boris I.			'Infotaxis' as a strategy for searching without gradients	NATURE			English	Article							FINE-SCALE STRUCTURE; ODOR PLUMES; INSECT ORIENTATION; MOBILE ROBOT; PHEROMONE; CHEMOTAXIS; TRACKING; MOTHS	Chemotactic bacteria rely on local concentration gradients to guide them towards the source of a nutrient(1). Such local cues pointing towards the location of the source are not always available at macroscopic scales because mixing in a flowing medium breaks up regions of high concentration into random and disconnected patches. Thus, animals sensing odours in air or water detect them only intermittently as patches sweep by on the wind or currents(2-6). A macroscopic searcher must devise a strategy of movement based on sporadic cues and partial information. Here we propose a search algorithm, which we call 'infotaxis', designed to work under such conditions. Any search process can be thought of as acquisition of information on source location; for infotaxis, information plays a role similar to concentration in chemotaxis. The infotaxis strategy locally maximizes the expected rate of information gain. We demonstrate its efficiency using a computational model of odour plume propagation and experimental data on mixing flows(7). Infotactic trajectories feature 'zigzagging' and 'casting' paths similar to those observed in the flight of moths(8). The proposed search algorithm is relevant to the design of olfactory robots(9-11), but the general idea of infotaxis can be applied more broadly in the context of searching with sparse information.	Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Inst Pasteur, CNRS, URA 2171, F-75724 Paris 15, France; Univ Aix Marseille 1, F-13384 Marseille, France	University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite	Shraiman, BI (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.	shraiman@kitp.ucsb.edu		Vergassola, Massimo/0000-0002-7212-8244; Villermaux, Emmanuel/0000-0001-5130-4862				Balkovsky E, 2002, P NATL ACAD SCI USA, V99, P12589, DOI 10.1073/pnas.192393499; Belanger JH, 1998, J COMP PHYSIOL A, V183, P345, DOI 10.1007/s003590050261; Berg B.C., 1993, RANDOM WALKS BIOL; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; COVER TM, 1991, SERIES TELECOMMUNICA; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; Farrell JA, 2005, IEEE J OCEANIC ENG, V30, P428, DOI 10.1109/JOE.2004.838066; Farrell JA, 2003, IEEE T SYST MAN CY B, V33, P850, DOI 10.1109/TSMCB.2003.810873; Grasso FW, 2000, ROBOT AUTON SYST, V30, P115, DOI 10.1016/S0921-8890(99)00068-8; Hansson B.S., 1999, INSECT OLFACTION; Ishida H, 2005, IEEE SENS J, V5, P537, DOI 10.1109/JSEN.2004.839597; Ishida H, 1996, SENSOR ACTUAT B-CHEM, V33, P115, DOI 10.1016/0925-4005(96)01907-7; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kennedy JS, 1983, PHYSIOL ENTOMOL, V27, P58; Kuwana Y, 1999, BIOSENS BIOELECTRON, V14, P195, DOI 10.1016/S0956-5663(98)00106-7; Li W, 2001, ADAPT BEHAV, V9, P143, DOI 10.1177/10597123010093003; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Marques L, 2006, AUTON ROBOT, V20, P183, DOI 10.1007/s10514-006-7536-7; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; PANG S, IN PRESS IEEE T SY B; Payne T.L., 1986, MECH INSECT OLFACTIO; Russell R.A., 1999, ODOR DETECTION MOBIL; Russell RA, 2003, ROBOT AUTON SYST, V45, P83, DOI 10.1016/S0921-8890(03)00120-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Villermaux E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.184501; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a	31	478	494	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					406	409		10.1038/nature05464	http://dx.doi.org/10.1038/nature05464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251974				2022-12-24	WOS:000243689500034
J	Mizuno, D; Tardin, C; Schmidt, CF; MacKintosh, FC				Mizuno, Daisuke; Tardin, Catherine; Schmidt, C. F.; MacKintosh, F. C.			Nonequilibrium mechanics of active cytoskeletal networks	SCIENCE			English	Article							2-POINT MICRORHEOLOGY; MYOSIN; VISCOELASTICITY; ELASTICITY; MOTION; MODULI	Cells both actively generate and sensitively react to forces through their mechanical framework, the cytoskeleton, which is a nonequilibrium composite material including polymers and motor proteins. We measured the dynamics and mechanical properties of a simple three-component model system consisting of myosin II, actin filaments, and cross-linkers. In this system, stresses arising from motor activity controlled the cytoskeletal network mechanics, increasing stiffness by a factor of nearly 100 and qualitatively changing the viscoelastic response of the network in an adenosine triphosphate-dependent manner. We present a quantitative theoretical model connecting the large-scale properties of this active gel to molecular force generation.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Univ Gottingen, Fak Phys, Inst Phys 3, D-37077 Gottingen, Germany	Vrije Universiteit Amsterdam; University of Gottingen	MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	cfs@nat.vu.nl; fcm@nat.vu.nl	MacKintosh, Fred C/A-9450-2008; Schmidt, Christoph F/G-3787-2011; 水野, 大介/O-1812-2018; MacKintosh, Frederick/AAB-9332-2021	MacKintosh, Fred C/0000-0002-2607-9541; Schmidt, Christoph F/0000-0003-2864-6973; 水野, 大介/0000-0001-7749-3681; MacKintosh, Frederick/0000-0002-2607-9541				Bray D, 2001, CELL MOVEMENTS MOL M; Buchanan M, 2005, MACROMOLECULES, V38, P8840, DOI 10.1021/ma0500990; Caspi A, 1998, PHYS REV LETT, V80, P1106, DOI 10.1103/PhysRevLett.80.1106; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; HAYASHI T, 1975, J BIOCHEM-TOKYO, V78, P1031, DOI 10.1093/oxfordjournals.jbchem.a130980; Hough LA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021906; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307; Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mizuno D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.088104; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	26	651	657	3	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					370	373		10.1126/science.1134404	http://dx.doi.org/10.1126/science.1134404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234946				2022-12-24	WOS:000243535400040
J	Brouilette, SW; Moore, JS; D McMahon, A; Thompson, JR; Ford, I; Shepherd, J; Packard, CJ; Samani, NJ				Brouilette, Scott W.; Moore, Jasbir S.; D McMahon, Alex; Thompson, John R.; Ford, Ian; Shepherd, James; Packard, Chris J.; Samani, Nilesh J.		W Scotland Coronary Prevention Stu	Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study	LANCET			English	Article							WHITE BLOOD-CELLS; ATHEROSCLEROSIS; ENDOTHELIUM; MORTALITY; THERAPY; PLAQUES	Background Inter-individual differences in biological ageing could affect susceptibility to coronary heart disease. Our aim was to determine whether mean leucocyte telomere length is a predictor of the development of coronary heart disease. Methods We compared telomere lengths at recruitment in 484 individuals in the West of Scotland Primary Prevention Study (WOSCOPS) who went on to develop coronary heart disease events with those from 1058 matched controls who remained event free. We also investigated whether there was any association between telomere length and observed clinical benefit of statin treatment in WOSCOPS. Findings Mean telomere length decreased with age by 9% per decade (95% CI 3.6-14.1; p=0.001) in controls; much the same trend was seen in cases (-5.9% per decade, -3.1 to 14.1; p=0.1902). Individuals in the middle and the lowest tertiles of telomere length were more at risk of developing a coronary heart disease event than were individuals in the highest tertile (odds ratio [OR] for coronary heart disease: 1.51, 95% CI 1.15-1.98; p=0.0029 in the middle tertile; 1.44, 1.10-1.90, p=0.0090 in the lowest). In placebo-treated patients, the risk of coronary heart disease was almost double in those in the lower two tertiles of telomere length compared with those in the highest tertile (1.93, 1.33-2.80, p=0.0005 in the middle tertile; 1.94, 1.33-2.84, p=0.0006 in the lowest). By contrast, in patients treated with pravastatin, the increased risk with shorter telomeres was substantially attenuated (1.12, 0.75-1.69, p=0.5755 in the middle tertile; 1.02, 0.68-1.52, p=0.9380 in the lowest). Interpretation Mean leucocyte telomere length is a predictor of future coronary heart disease events in middle-aged, high-risk men and could identify individuals who would benefit most from statin treatment. Our findings lend support to the hypothesis that differences in biological ageing might contribute to the risk-and variability in age of onset-of coronary heart disease.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Vasc Biochem, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; University of Glasgow; University of Glasgow	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Clin Sci Wing,Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Ford, Ian/ABE-6145-2020					ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; [Anonymous], 1995, Am J Cardiol, V76, P485; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; BURRIG KF, 1991, ARTERIOSCLER THROMB, V11, P1678, DOI 10.1161/01.ATV.11.6.1678; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; DAVIES MJ, 1988, BRIT HEART J, V60, P459; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrison D, 1998, Can J Cardiol, V14 Suppl D, p30D; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	579	602	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2007	369	9556					107	114		10.1016/S0140-6736(07)60071-3	http://dx.doi.org/10.1016/S0140-6736(07)60071-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126TK	17223473				2022-12-24	WOS:000243538200029
J	Hellstrom, M; Phng, LK; Hofmann, JJ; Wallgard, E; Coultas, L; Lindblom, P; Alva, J; Nilsson, AK; Karlsson, L; Gaiano, N; Yoon, K; Rossant, J; Iruela-Arispe, ML; Kalen, M; Gerhardt, H; Betsholtz, C				Hellstroem, Mats; Phng, Li-Kun; Hofmann, Jennifer J.; Wallgard, Elisabet; Coultas, Leigh; Lindblom, Per; Alva, Jackelyn; Nilsson, Ann-Katrin; Karlsson, Linda; Gaiano, Nicholas; Yoon, Keejung; Rossant, Janet; Iruela-Arispe, M. Luisa; Kalen, Mattias; Gerhardt, Holger; Betsholtz, Christer			Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GAMMA-SECRETASE; BRANCHING MORPHOGENESIS; VASCULAR DEVELOPMENT; ARTERIAL; MOUSE; MATURATION; LETHALITY	In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A(1,2). VEGF-A is also essential for the induction of endothelial tip cells(2), but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4) -Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using gamma-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4 - Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene(3-5), and indicates that modulators of Dll4 or Notch signalling, such as gamma-secretase inhibitors developed for Alzheimer's disease, might find usage as pharmacological regulators of angiogenesis.	Angiogenet Sweden AB, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, SE-17177 Stockholm, Sweden; Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2A 3PX, England; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD 21205 USA	Karolinska Institutet; Karolinska Institutet; Cancer Research UK; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University	Hellstrom, M (corresponding author), Angiogenet Sweden AB, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	mats.hellstrom@ki.se; holger.gerhardt@cancer.org.uk	Gerhardt, Holger/G-4610-2011; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Phng, Li-Kun/L-7346-2013; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yoon, Keejung/0000-0002-2361-9039; Hellstrom, Mats/0000-0002-7088-9533; Gerhardt, Holger/0000-0001-9228-7472				Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shutter JR, 2000, GENE DEV, V14, P1313; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	30	1203	1278	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					776	780		10.1038/nature05571	http://dx.doi.org/10.1038/nature05571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259973				2022-12-24	WOS:000244205200047
J	Collins, FS				Collins, Francis S.		Int Mouse Knockout Consortium	A mouse for all reasons	CELL			English	Editorial Material							MULTIPURPOSE; ALLELES; GENOME	Three major mouse knockout programs are underway worldwide, working together to mutate all protein-encoding genes in the mouse using a combination of gene trapping and gene targeting in mouse embryonic stem (ES) cells. Although the current emphasis is on production of this valuable resource, there are significant efforts to facilitate program coordination, to enhance the availability of this resource, and to plan for future efforts in mouse genetics research.	Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Tech Univ Munich, GSF, Natl Res Ctr Environm & Hlth, D-8000 Munich, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich		francisc@mail.nih.gov	Lefebvre, Louis/O-9309-2016; Nagy, Andras/G-6465-2013	Lefebvre, Louis/0000-0001-5664-9480; Nagy, Andras/0000-0003-4311-0413				Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	9	324	354	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					9	13		10.1016/j.cell.2006.12.018	http://dx.doi.org/10.1016/j.cell.2006.12.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218247	Bronze			2022-12-24	WOS:000244420400005
J	Gottar, M; Gobert, V; Matskevich, AA; Reichhart, JM; Wang, CS; Butt, TM; BeIvin, M; Hoffmann, JA; Ferrandon, D				Gottar, Marie; Gobert, Vanessa; Matskevich, Alexey A.; Reichhart, Jean-Marc; Wang, Chengshu; Butt, Tariq M.; BeIvin, Marcia; Hoffmann, Jules A.; Ferrandon, Dominique			Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors	CELL			English	Article							POSITIVE BACTERIAL-INFECTIONS; GRAM-NEGATIVE BACTERIA; IMMUNE-RESPONSE; METARHIZIUM-ANISOPLIAE; ANTIMICROBIAL PEPTIDE; DEFICIENT DROSOPHILA; MANDUCA-SEXTA; TOLL PATHWAY; HOST-DEFENSE; PROTEIN	The Drosophila immune system discriminates between various types of infections and activates appropriate signal transduction pathways to combat the invading microorganisms. The Toll pathway is required for the host response against fungal and most Gram-positive bacterial infections. The sensing of Gram-positive bacteria is mediated by the pattern recognition receptors PGRP-SA and GNBP1 that cooperate to detect the presence of infections in the host. Here, we report that GNBP3 is a pattern recognition receptor that is required for the detection of fungal cell wall components. Strikingly, we find that there is a second, parallel pathway acting jointly with GNBP3. The Drosophila Persephone protease activates the Toll pathway when proteolytically matured by the secreted fungal virulence factor PR1. Thus, the detection of fungal infections in Drosophila relies both on the recognition of invariant microbial patterns and on monitoring the effects of virulence factors on the host.	CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA; Univ Wales Swansea, Dept Biol Sci, Swansea SA2 8PP, W Glam, Wales	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.; Swansea University	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466; FERRANDON, Dominique/0000-0001-7680-7773; Butt, Tariq/0000-0002-8789-9543	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI44220, P01 AI044220-08, P01 AI044220] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Roberts D.W., 1981, BIOL CONIDIAL FUNGI, P201; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; STLEGER RJ, 1992, EUR J BIOCHEM, V204, P991, DOI 10.1111/j.1432-1033.1992.tb16721.x; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang CS, 2002, FEMS MICROBIOL LETT, V213, P251, DOI 10.1111/j.1574-6968.2002.tb11314.x	47	299	311	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1425	1437		10.1016/j.cell.2006.10.046	http://dx.doi.org/10.1016/j.cell.2006.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190605	Green Accepted, Bronze			2022-12-24	WOS:000243690000021
J	Clutton-Brock, TH; Hodge, SJ; Spong, G; Russell, AF; Jordan, NR; Bennett, NC; Sharpe, LL; Manser, MB				Clutton-Brock, T. H.; Hodge, S. J.; Spong, G.; Russell, A. F.; Jordan, N. R.; Bennett, N. C.; Sharpe, L. L.; Manser, M. B.			Intrasexual competition and sexual selection in cooperative mammals	NATURE			English	Article							FEMALE; DOMINANCE; EVOLUTION; BEHAVIOR; RANK	In most animals, the sex that invests least in its offspring competes more intensely for access to the opposite sex and shows greater development of secondary sexual characters than the sex that invests most(1,2). However, in some mammals where females are the primary care-givers, females compete more frequently or intensely with each other than males(3-5). A possible explanation is that, in these species, the resources necessary for successful female reproduction are heavily concentrated and intrasexual competition for breeding opportunities is more intense among females than among males. Intrasexual competition between females is likely to be particularly intense in cooperative breeders where a single female monopolizes reproduction in each group(6). Here, we use data from a twelve-year study of wild meerkats (Suricata suricatta), where females show high levels of reproductive skew, to show that females gain greater benefits from acquiring dominant status than males and traits that increase competitive ability exert a stronger influence on their breeding success. Females that acquire dominant status also develop a suite of morphological, physiological and behavioural characteristics that help them to control other group members. Our results show that sex differences in parental investment are not the only mechanism capable of generating sex differences in reproductive competition and emphasize the extent to which competition for breeding opportunities between females can affect the evolution of sex differences and the operation of sexual selection.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Uppsala Univ, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Cambridge; University of Pretoria; Uppsala University; University of Sheffield; Stellenbosch University; University of Zurich	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk	Bennett, Nigel Charles/E-4238-2010	Bennett, Nigel Charles/0000-0001-9748-2947; Jordan, Neil/0000-0002-0712-8301; Spong, Goran/0000-0002-1246-5046	Natural Environment Research Council [NE/C511348/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersson Malte, 1994; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BRETT RA, 1991, REPROD NAKED MOLE RA, P67; Buston P, 2003, BEHAV ECOL, V14, P576, DOI 10.1093/beheco/arg036; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Clutton-Brock TH, 2004, ANIM BEHAV, V68, P1029, DOI 10.1016/j.anbehav.2003.10.024; CLUTTONBROCK TH, 2004, SEXUAL SELECTION PRI; Darwin G., 1871, P423; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENGH A, 2002, SOCIAL COMPLEXITY; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; Faulkes Christopher G., 1997, P302; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; FRICKE H, 1977, NATURE, V266, P830, DOI 10.1038/266830a0; Griffin AS, 2003, BEHAV ECOL, V14, P472, DOI 10.1093/beheco/arg040; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; O'Riain MJ, 2000, P NATL ACAD SCI USA, V97, P13194, DOI 10.1073/pnas.97.24.13194; Scantlebury M, 2002, P ROY SOC B-BIOL SCI, V269, P2147, DOI 10.1098/rspb.2002.2108; Shellman-Reeve Janet S., 1997, P52; Sherman PW, 2002, J ZOOL, V258, P307, DOI 10.1017/S0952836902001437; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	30	225	227	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1065	1068		10.1038/nature05386	http://dx.doi.org/10.1038/nature05386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183322				2022-12-24	WOS:000242971100055
J	Tyzio, R; Cossart, R; Khalilov, I; Minlebaev, M; Hubner, CA; Represa, A; Ben-Ari, Y; Khazipov, R				Tyzio, Roman; Cossart, Rosa; Khalilov, Ilgam; Minlebaev, Marat; Huebner, Christian A.; Represa, Alfonso; Ben-Ari, Yehezkel; Khazipov, Rustem			Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery	SCIENCE			English	Article							EXCITATORY ACTIONS; NEONATAL HIPPOCAMPUS; NEURONS; CELLS; OSCILLATIONS; VASOPRESSIN; SYNAPSES; CHANNELS; SEIZURES; SLICES	We report a signaling mechanism in rats between mother and fetus aimed at preparing fetal neurons for delivery. In immature neurons, gamma-aminobutyric acid (GABA) is the primary excitatory neurotransmitter. We found that, shortly before delivery, there is a transient reduction in the intracellular chloride concentration and an excitatory-to-inhibitory switch of GABA actions. These events were triggered by oxytocin, an essential maternal hormone for labor. In vivo administration of an oxytocin receptor antagonist before delivery prevented the switch of GABA actions in fetal neurons and aggravated the severity of anoxic episodes. Thus, maternal oxytocin inhibits fetal neurons and increases their resistance to insults during delivery.	Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, F-13273 Marseille 09, France; Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, D-20251 Hamburg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Hamburg	Ben-Ari, Y (corresponding author), Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, Campus Sci Luminy,Boite Postale 13, F-13273 Marseille 09, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015; Represa, Alfonso/M-7383-2016; Hübner, Christian/A-2950-2017; Khazipov, Roustem/M-1834-2016; Cossart, Rosa/AAT-7934-2020; MINLEBAEV, Marat/B-4927-2015; MINLEBAEV, Marat/R-4794-2019; Cossart, Rosa/E-7674-2014	Khalilov, Ilgam/0000-0002-9468-4778; Represa, Alfonso/0000-0002-5096-8939; Hübner, Christian/0000-0002-1030-4943; Khazipov, Roustem/0000-0002-6763-2841; Cossart, Rosa/0000-0003-2111-6638; MINLEBAEV, Marat/0000-0002-0722-7027; MINLEBAEV, Marat/0000-0002-0722-7027; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Maric D, 1998, EUR J NEUROSCI, V10, P2532, DOI 10.1046/j.1460-9568.1998.00284.x; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; Serradeil-Le Gal C, 2004, J PHARMACOL EXP THER, V309, P414, DOI 10.1124/jpet.103.061200; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 1999, J NEUROSCI, V19, P10372; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Volpe J., 2017, VOLPES NEUROLOGY NEW, V6th edn; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	32	328	340	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1788	1792		10.1126/science.1133212	http://dx.doi.org/10.1126/science.1133212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170309	Green Published			2022-12-24	WOS:000242833600063
J	Driscoll, R; Hudson, A; Jackson, SP				Driscoll, Robert; Hudson, Amanda; Jackson, Stephen P.			Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56	SCIENCE			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; CHECKPOINT; REPAIR; INSTABILITY; INTEGRITY; NETWORK; HST3	Posttranslational modifications of the histone octamer play important roles in regulating responses to DNA damage. Here, we reveal that Saccharomyces cerevisiae Rtt109p promotes genome stability and resistance to DNA-damaging agents, and that it does this by functionally cooperating with the histone chaperone Asf1p to maintain normal chromatin structure. Furthermore, we show that, as for Asf1p, Rtt109p is required for histone H3 acetylation on lysine 56 (K56) in vivo. Moreover, we show that Rtt109p directly catalyzes this modification in vitro in a manner that is stimulated by Asf1p. These data establish Rtt109p as a member of a new class of histone acetyltransferases and show that its actions are critical for cell survival in the presence of DNA damage during S phase.	Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 	Biotechnology and Biological Sciences Research Council [BBS/S/D/2004/12546] Funding Source: Medline; Cancer Research UK [A5290] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		AGUILERA A, 1989, GENETICS, V122, P503; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	19	342	347	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					649	652		10.1126/science.1135862	http://dx.doi.org/10.1126/science.1135862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272722	Green Accepted			2022-12-24	WOS:000243909400044
J	Hu, K; Ji, L; Applegate, KT; Danuser, G; Waterman-Storer, CM				Hu, Ke; Ji, Lin; Applegate, Kathryn T.; Danuser, Gaudenz; Waterman-Storer, Clare M.			Differential transmission of actin motion within focal adhesions	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; CELL-MIGRATION; STRESS FIBERS; ALPHA-ACTININ; PROTEIN; CYTOSKELETON; VINCULIN; TALIN; CONTRACTILITY; ASSOCIATION	Cell migration requires the transmission of motion generated in the actin cytoskeleton to the extracellular environment through a complex assembly of proteins in focal adhesions. We developed correlational fluorescent speckle microscopy to measure the coupling of focal-adhesion proteins to actin filaments. Different classes of focal-adhesion structural and regulatory molecules exhibited varying degrees of correlated motions with actin filaments, indicating hierarchical transmission of actin motion through focal adhesions. Interactions between vinculin, talin, and actin filaments appear to constitute a slippage interface between the cytoskeleton and integrins, generating a molecular clutch that is regulated during the morphodynamic transitions of cell migration.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Waterman-Storer, CM (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	gdanuser@scripps.edu; waterman@scripps.edu		Waterman, Clare/0000-0001-6142-6775; Danuser, Gaudenz/0000-0001-8583-2014	NIGMS NIH HHS [GM67230, U54GM64346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM067230, U01GM067230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schlaepfer DD, 1996, CELL STRUCT FUNCT, V21, P445, DOI 10.1247/csf.21.445; Tanaka T, 1996, FEBS LETT, V399, P53, DOI 10.1016/S0014-5793(96)01280-X; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3	26	389	395	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					111	115		10.1126/science.1135085	http://dx.doi.org/10.1126/science.1135085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204653				2022-12-24	WOS:000243259100049
J	Lee, HK; Lund, JM; Ramanathan, B; Mizushima, N; Iwasaki, A				Lee, Heung Kyu; Lund, Jennifer M.; Ramanathan, Balaji; Mizushima, Noboru; Iwasaki, Akiko			Autophagy-dependent viral recognition by plasmacytoid dendritic cells	SCIENCE			English	Article							SINGLE-STRANDED RNA; RIG-I; ANTIVIRAL RESPONSES; DEGRADATION; 3-KINASE	Plasmacytoid dendritic cells (pDCs) detect viruses in the acidified endosomes by means of Toll-like receptors (TLRs). Yet, pDC responses to certain single-stranded RNA (ssRNA) viruses occur only after live viral infection. We present evidence here that the recognition of such viruses by TLR7 requires transport of cytosolic viral replication intermediates into the lysosome by the process of autophagy. In addition, autophagy was found to be required for the production of interferon-alpha by pDCs. These results support a key role for autophagy in mediating ssRNA virus detection and interferon-alpha secretion by pDCs and suggest that cytosolic replication intermediates of viruses serve as pathogen signatures recognized by TLR7.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; Tokyo Med & Dent Univ, Dept Cell Physiol, Grad Sch, Tokyo, Japan; Tokyo Med & Dent Univ, Dept Cell Physiol, Fac Med, Tokyo, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Japan	Yale University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	iwasaki@yale.edu	Mizushima, Noboru/C-3635-2009; Lee, Heung Kyu/C-2073-2011; Iwasaki, Akiko/Z-1591-2019	Mizushima, Noboru/0000-0002-6258-6444; Lee, Heung Kyu/0000-0002-3977-1510; Iwasaki, Akiko/0000-0002-7824-9856; Lund, Jennifer/0000-0003-3284-979X	NIAID NIH HHS [AI054359, AI064705, AI07019] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI064705] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	29	699	735	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1398	1401		10.1126/science.1136880	http://dx.doi.org/10.1126/science.1136880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17272685				2022-12-24	WOS:000244752200030
J	Chu, I; Sun, J; Arnaout, A; Kahn, H; Hanna, W; Narod, S; Sun, P; Tan, CK; Hengst, L; Slingerland, J				Chu, Isabel; Sun, Jun; Arnaout, Angel; Kahn, Harriette; Hanna, Wedad; Narod, Steven; Sun, Ping; Tan, Cheng-Keat; Hengst, Ludger; Slingerland, Joyce			p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2	CELL			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN-BREAST-CANCER; MEDIATED G(1) ARREST; CELL-CYCLE; DEPENDENT-KINASE; TYROSINE KINASE; C-SRC; ESTROGEN-RECEPTOR; CDK INHIBITOR; FACTOR-BETA	The kinase inhibitor p27(Kip1) regulates the G, cell cycle phase. Here, we present data indicating that the oncogenic kinase Src regulates p27 stability through phosphorylation of p27 at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs the Cdk2 inhibitory action of p27 and reduces its steady-state binding to cyclin E-Cdk2 to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show reduced p27 and observe a correlation between Src activation and reduced nuclear p27 in 482 primary human breast cancers. Importantly, we report that in tamoxifen-resistant breast cancer cell lines, Src inhibition can increase p27 levels and restore tamoxifen sensitivity. These data provide a new rationale for Src inhibitors in cancer therapy.	Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; Univ Toronto, Dept Pathol & Lab Med, Toronto, ON M4N 3M5, Canada; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria	University of Miami; University of Miami; University of Toronto; University of Innsbruck	Slingerland, J (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Narod, Steven A/AAA-6112-2022	Hengst, Ludger/0000-0002-0605-0223	NATIONAL CANCER INSTITUTE [R01CA105118, R01CA123415] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105118, R01-CA105118, R01 CA123415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen T, 2006, ANTI-CANCER DRUG, V17, P123, DOI 10.1097/00001813-200602000-00002; Chu I, 2005, CANCER RES, V65, P18; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Florenes VA, 1996, ONCOGENE, V13, P2447; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lenferink AEG, 2000, P NATL ACAD SCI USA, V97, P9609, DOI 10.1073/pnas.160564197; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NICHOLSON S, 1990, J STEROID BIOCHEM, V37, P811, DOI 10.1016/0960-0760(90)90424-J; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Ple PA, 2004, J MED CHEM, V47, P871, DOI 10.1021/jm030317k; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Riley D, 2001, ONCOGENE, V20, P5941, DOI 10.1038/sj.onc.1204826; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200	64	286	301	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					281	294		10.1016/j.cell.2006.11.049	http://dx.doi.org/10.1016/j.cell.2006.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254967	Green Accepted, Bronze			2022-12-24	WOS:000244420500014
J	Tothova, Z; Kollipara, R; Huntly, BJ; Lee, BH; Castrillon, DH; Cullen, DE; McDowell, EP; Lazo-Kallanian, S; Williams, IR; Sears, C; Armstrong, SA; Passegue, E; DePinho, RA; Gilliland, DG				Tothova, Zuzana; Kollipara, Ramya; Huntly, Brian J.; Lee, Benjamin H.; Castrillon, Diego H.; Cullen, Dana E.; McDowell, Elizabeth P.; Lazo-Kallanian, Suzan; Williams, Ifor R.; Sears, Christopher; Armstrong, Scott A.; Passegue, Emmanuelle; DePinho, Ronald A.; Gilliland, D. Gary			FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress	CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROLIFERATION; ACTIVATION; PROGENITOR; PROTEIN; KINASE	To understand the role of FoxO family members in hematopoiesis, we conditionally deleted FoxO1, FoxO3, and FoxO4 in the adult hematopoietic system. FoxO-deficient mice exhibited myeloid lineage expansion, lymphoid developmental abnormalities, and a marked decrease of the lineage-negative Sca-1(+), c-Kit(+) (LSK) compartment that contains the short- and long-term hematopoietic stem cell (HSC) populations. FoxO-deficient bone marrow had defective long-term repopulating activity that correlated with increased cell cycling and apoptosis of HSC. Notably, there was a marked context-dependent increase in reactive oxygen species (ROS) in FoxO-deficient HSC compared with wild-type HSC that correlated with changes in expression of genes that regulate ROS. Furthermore, in vivo treatment with the antioxidative agent N-acetyl-L-cysteine resulted in reversion of the FoxO-deficient HSC phenotype. Thus, FoxO proteins play essential roles in the response to physiologic oxidative stress and thereby mediate quiescence and enhanced survival in the HSC compartment, a function that is required for its long-term regenerative potential.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Robert A & Renee E Belfer Fdn Inst Innovat Canc S, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Cambridge, Med Res Inst, Dept Haematol, Cambridge CB2 2XY, England; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Cambridge; Emory University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco	Gilliland, DG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA.	ggilliland@rics.bwh.harvard.edu	huntly, brian JP/E-6725-2014; Williams, Ifor R/D-3648-2011	huntly, brian JP/0000-0003-0312-161X; Williams, Ifor R/0000-0002-8810-2911; Passegue, Emmanuelle/0000-0002-3516-297X; DePinho, Ronald/0000-0002-5625-577X	MRC [G116/187] Funding Source: UKRI; Medical Research Council [G116/187] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	43	1182	1231	2	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					325	339		10.1016/j.cell.2007.01.003	http://dx.doi.org/10.1016/j.cell.2007.01.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254970	Bronze			2022-12-24	WOS:000244420500017
J	Sergina, NV; Rausch, M; Wang, DH; Blair, J; Hann, B; Shokat, KM; Moasser, MM				Sergina, Natalia V.; Rausch, Megan; Wang, Donghui; Blair, Jimmy; Hann, Byron; Shokat, Kevan M.; Moasser, Mark M.			Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3	NATURE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EGFR; BREAST-CANCER CELLS; ZD1839 IRESSA; TUMOR-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; NEU ONCOGENE; IN-VIVO; PROTEIN; GEFITINIB	Oncogenic tyrosine kinases have proved to be promising targets for the development of highly effective anticancer drugs. However, tyrosine kinase inhibitors (TKIs) against the human epidermal growth factor receptor ( HER) family show only limited activity against HER2-driven breast cancers, despite effective inhibition of epidermal growth factor receptor (EGFR) and HER2 in vivo(1-8). The reasons for this are unclear. Signalling in trans is a key feature of this multimember family and the critically important phosphatidylinositol-3- OH kinase ( PI( 3) K)/Akt pathway is driven predominantly through transphosphorylation of the kinase-inactive HER3 (refs 9, 10). Here we show that HER3 and consequently PI( 3) K/Akt signalling evade inhibition by current HER-family TKIs in vitro and in tumours in vivo. This is due to a compensatory shift in the HER3 phosphorylation - dephosphorylation equilibrium, driven by increased membrane HER3 expression driving the phosphorylation reaction and by reduced HER3 phosphatase activity impeding the dephosphorylation reaction. These compensatory changes are driven by Akt-mediated negative-feedback signalling. Although HER3 is not a direct target of TKIs, HER3 substrate resistance undermines their efficacy and has thus far gone undetected. The experimental abrogation of HER3 resistance by small interfering RNA knockdown restores potent pro-apoptotic activity to otherwise cytostatic HER TKIs, re-affirming the oncogene-addicted nature of HER2-driven tumours and the therapeutic promise of this oncoprotein target. However, because HER3 signalling is buffered against an incomplete inhibition of HER2 kinase, much more potent TKIs or combination strategies are required to silence oncogenic HER2 signalling effectively. The biologic marker with which to assess the efficacy of HER TKIs should be the transphosphorylation of HER3 rather than autophosphorylation.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Moasser, MM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mmoasser@medicine.ucsf.edu		Blair, Jimmy/0000-0003-0303-5981	NATIONAL CANCER INSTITUTE [R01CA122216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA122216, R01 CA122216-01A1] Funding Source: Medline; NIAID NIH HHS [R01 AI044009] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akita RW, 2003, SEMIN ONCOL, V30, P15, DOI 10.1016/S0093-7754(03)00187-8; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; BACUS SS, 2003, P AM SOC CLIN ONCOL, V22; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; BLACKWELL K, 2004, P AM SOC CLIN ONCOL, V23; BURRIS HA, 2003, BREAST CANC RES T S1, V82; Campiglio M, 2004, J CELL PHYSIOL, V198, P259, DOI 10.1002/jcp.10411; CAMPOS SM, 2004, P AM SOC CLIN ONCOL, V23; DEES EC, 2004, P AM SOC CLIN ONCOL, V23; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; Huron DR, 2003, CLIN CANCER RES, V9, P1267; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KIM HH, 1994, J BIOL CHEM, V269, P24747; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moasser MM, 2001, CANCER RES, V61, P7184; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Moulder SL, 2001, CANCER RES, V61, P8887; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; She QB, 2003, CLIN CANCER RES, V9, P4340; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsou HR, 2001, J MED CHEM, V44, P2719, DOI 10.1021/jm0005555; WINER E, 2002, BREAST CANC RES T S1, V76	30	750	809	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					437	441		10.1038/nature05474	http://dx.doi.org/10.1038/nature05474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17206155	Green Accepted			2022-12-24	WOS:000243689500042
J	Tanaka, S; Umemori, T; Hirai, K; Muramatsu, S; Kamimura, Y; Araki, H				Tanaka, Seiji; Umemori, Toshiko; Hirai, Kazuyuki; Muramatsu, Sachiko; Kamimura, Yoichiro; Araki, Hiroyuki			CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DNA; RE-REPLICATION; PROTEIN-KINASE; CELL-CYCLE; COMPLEX; GINS; PROGRESSION; INTERACTS; DPB11	In eukaryotic cells, cyclin-dependent kinases (CDKs) have an important involvement at various points in the cell cycle. At the onset of S phase, active CDK is essential for chromosomal DNA replication(1), although its precise role is unknown. In budding yeast ( Saccharomyces cerevisiae), the replication protein Sld2 (ref. 2) is an essential CDK substrate(3), but its phospho-mimetic form (Sld2-11D) alone neither affects cell growth(4) nor promotes DNA replication in the absence of CDK activity(4), suggesting that other essential CDK substrates promote DNA replication. Here we show that both an allele of CDC45 (JET1) and high-copy DPB11, in combination with Sld2-11D, separately confer CDK-independent DNA replication. Although Cdc45 is not an essential CDK substrate, CDK-dependent phosphorylation of Sld3, which associates with Cdc45 ( ref. 5), is essential and generates a binding site for Dpb11. Both the JET1 mutation and high-copy DPB11 by-pass the requirement for Sld3 phosphorylation in DNA replication. Because phosphorylated Sld2 binds to the carboxy-terminal pair of BRCT domains in Dpb11 ( ref. 4), we propose that Dpb11 connects phosphorylated Sld2 and Sld3 to facilitate interactions between replication proteins, such as Cdc45 and GINS. Our results demonstrate that CDKs regulate interactions between BRCT-domain-containing replication proteins and other phosphorylated proteins for the initiation of chromosomal DNA replication; similar regulation may take place in higher eukaryotes.	Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; CREST, Kawaguchi, Saitama 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Yata 1111 Mishima, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Kamimura, Yoichiro/M-2585-2017; Tanaka, Seiji/Q-8601-2019	Tanaka, Seiji/0000-0003-3882-3494; Hirai, Kazuyuki/0000-0003-1640-3667				ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Schwob Etienne, 2006, V47, P295; Sivaprasad Umasundari, 2006, V47, P63; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Walter Johannes C., 2006, V47, P89; ZEGERMAN P, 2006, NATURE          1213, DOI DOI 10.1038/NATURE05432	29	337	339	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					328	332		10.1038/nature05465	http://dx.doi.org/10.1038/nature05465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167415				2022-12-24	WOS:000243504700048
J	Wetzel, C; Hu, J; Riethmacher, D; Benckendorff, A; Harder, L; Eilers, A; Moshourab, R; Kozlenkov, A; Labuz, D; Caspani, O; Erdmann, B; Machelska, H; Heppenstall, PA; Lewin, GR				Wetzel, Christiane; Hu, Jing; Riethmacher, Dieter; Benckendorff, Anne; Harder, Lena; Eilers, Andreas; Moshourab, Rabih; Kozlenkov, Alexey; Labuz, Dominika; Caspani, Ombretta; Erdmann, Bettina; Machelska, Halina; Heppenstall, Paul A.; Lewin, Gary R.			A stomatin-domain protein essential for touch sensation in the mouse	NATURE			English	Article							SENSING ION CHANNELS; SENSORY NEURONS; C-ELEGANS; MEMBRANE-PROTEIN; RECEPTOR NEURONS; MECHANOSENSATION; PAIN; RAT; MECHANORECEPTOR; LOCALIZATION	Touch and mechanical pain are first detected at our largest sensory surface, the skin. The cell bodies of sensory neurons that detect such stimuli are located in the dorsal root ganglia, and subtypes of these neurons are specialized to detect specific modalities of mechanical stimuli. Molecules have been identified that are necessary for mechanosensation in invertebrates but so far not in mammals. In Caenorhabditis elegans, mec-2 is one of several genes identified in a screen for touch insensitivity and encodes an integral membrane protein with a stomatin homology domain(1). Here we show that about 35% of skin mechanoreceptors do not respond to mechanical stimuli in mice with a mutation in stomatin-like protein 3 (SLP3, also called Stoml3), a mammalian mec-2 homologue that is expressed in sensory neurons. In addition, mechanosensitive ion channels found in many sensory neurons do not function without SLP3. Tactile-driven behaviours are also impaired in SLP3 mutant mice, including touch-evoked pain caused by neuropathic injury. SLP3 is therefore indispensable for the function of a subset of cutaneous mechanoreceptors, and our data support the idea that this protein is an essential subunit of a mammalian mechanotransducer.	Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; Charite Univ Med Berlin, D-13125 Berlin, Germany; Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; Charite Univ Med Berlin, Klin Anaesthesiol & Operat Med, D-12200 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany.	glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011; Riethmacher, Dieter/AAB-8690-2022; Riethmacher, Dieter/AAP-2227-2021; Hu, Jing/G-2092-2011; Riethmacher, Dieter/A-6242-2010	Riethmacher, Dieter/0000-0002-4206-5529; Machelska, Halina/0000-0001-6315-2958; Caspani, Ombretta/0000-0002-9700-3149; Lewin, Gary/0000-0002-2890-6352; Wetzel, Christiane/0000-0003-0587-8018; moshourab, rabih/0000-0002-9180-8472				Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Fricke B, 2003, ANAT EMBRYOL, V207, P1, DOI 10.1007/s00429-003-0324-7; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Manni A, 2004, SOIL SEDIMENT CONTAM, V13, P391, DOI 10.1080/10588330490466003; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2	29	175	184	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					206	209		10.1038/nature05394	http://dx.doi.org/10.1038/nature05394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17167420				2022-12-24	WOS:000243384300051
J	Radoshitzky, SR; Abraham, J; Spiropoulou, CF; Kuhn, JH; Nguyen, D; Li, WH; Nagel, J; Schmidt, PJ; Nunberg, JH; Andrews, NC; Farzan, M; Choe, H				Radoshitzky, Sheli R.; Abraham, Jonathan; Spiropoulou, Christina F.; Kuhn, Jens H.; Nguyen, Dan; Li, Wenhui; Nagel, Jane; Schmidt, Paul J.; Nunberg, Jack H.; Andrews, Nancy C.; Farzan, Michael; Choe, Hyeryun			Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses	NATURE			English	Article							ALPHA-DYSTROGLYCAN; ENDOTHELIUM; VIRUSES; CELLS; JUNIN; ANTIBODIES; BIOLOGY; BINDING; ENTRY	At least five arenaviruses cause viral haemorrhagic fevers in humans. Lassa virus, an Old World arenavirus, uses the cellular receptor alpha-dystroglycan to infect cells(1). Machupo, Guanarito, Junin and Sabia viruses are New World haemorrhagic fever viruses that do not use alpha-dystroglycan(2). Here we show a specific, high-affinity association between transferrin receptor 1 (TfR1) and the entry glycoprotein ( GP) of Machupo virus. Expression of human TfR1, but not human transferrin receptor 2, in hamster cell lines markedly enhanced the infection of viruses pseudotyped with the GP of Machupo, Guanarito and Junin viruses, but not with those of Lassa or lymphocytic choriomeningitis viruses. An anti-TfR1 antibody efficiently inhibited the replication of Machupo, Guanarito, Junin and Sabia viruses, but not that of Lassa virus. Iron depletion of culture medium enhanced, and iron supplementation decreased, the efficiency of infection by Junin and Machupo but not Lassa pseudoviruses. These data indicate that TfR1 is a cellular receptor for New World haemorrhagic fever arenaviruses.	Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany; Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Div Hematol Oncol, Boston, MA 02115 USA; Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Centers for Disease Control & Prevention - USA; Free University of Berlin; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Montana System; University of Montana	Choe, H (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA.	hyeryun.choe@childrens.harvard.edu	Radoshitzky, Sheli S/F-2766-2019; Kuhn, Jens H./B-7615-2011; Radoshitzky, Sheli/L-8410-2019	Kuhn, Jens H./0000-0002-7800-6045; Radoshitzky, Sheli/0000-0001-8976-8056; Li, Wenhui/0000-0003-1305-7404; Andrews, Nancy/0000-0003-0243-4462; Farzan, Michael/0000-0002-2990-5319	NIAID NIH HHS [R01 AI074879] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; Andrews N C, 1999, Curr Opin Hematol, V6, P61, DOI 10.1097/00062752-199903000-00001; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BUCHMEIER MJ, 1987, J VIROL, V61, P982, DOI 10.1128/JVI.61.4.982-985.1987; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Castilla V, 1996, ARCH VIROL, V141, P1307, DOI 10.1007/BF01718832; Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2002, CURR TOP MICROBIOL, V262, P111; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MATTIA E, 1984, J BIOL CHEM, V259, P2689; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, pV; Oldstone MBA, 2002, CURR TOP MICROBIOL, V262, pV; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; Peters CJ, 2002, CRIT CARE MED, V30, pS268, DOI 10.1097/00003246-200205001-00016; Raya G, 2001, CLIN CHEM LAB MED, V39, P1162, DOI 10.1515/CCLM.2001.183; Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; SODA R, 1984, BLOOD, V63, P270; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Templeton DM, 2003, BBA-GEN SUBJECTS, V1619, P113, DOI 10.1016/S0304-4165(02)00497-X; WARD JH, 1982, J BIOL CHEM, V257, P317; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	30	300	313	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					92	96		10.1038/nature05539	http://dx.doi.org/10.1038/nature05539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287727	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000244525600044
J	Monje-Casas, F; Prabhu, VR; Lee, BH; Boselli, M; Amon, A				Monje-Casas, Fernando; Prabhu, Vineet R.; Lee, Brian H.; Boselli, Monica; Amon, Angelika			Kinetochore orientation during meiosis is controlled by Aurora B and the monopolin complex	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CENTROMERIC COHESION; PROTEIN-KINASE; CHROMOSOME SEGREGATION; BUDDING YEAST; MEIOTIC RECOMBINATION; SPINDLE; AIR-2; PHOSPHORYLATION	Kinetochores of sister chromatids attach to microtubules emanating from the same pole (coorientation) during meiosis I and microtubules emanating from opposite poles (biorientation) during meiosis II. We find that the Aurora B kinase IpI1 regulates kinetochore-microtubule attachment during both meiotic divisions and that a complex known as the monopolin complex ensures that the protein kinase coorients sister chromatids during meiosis I. Furthermore, the defining of conditions sufficient to induce sister kinetochore coorientation during mitosis provides insight into monopolin complex function. The monopolin complex joins sister kinetochores independently of cohesins, the proteins that hold sister chromatids together. We propose that this function of the monopolin complex helps Aurora B coorient sister chromatids during meiosis I.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Monje-Casas, Fernando/M-3062-2014	Monje-Casas, Fernando/0000-0002-3587-2373; Amon, Angelika/0000-0001-9837-0314; Lee, Brian/0000-0003-2497-5139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062207, GM62207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; XU L, 1998, MOL CELL BIOL, V12, P6572; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	45	101	103	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					477	490		10.1016/j.cell.2006.12.040	http://dx.doi.org/10.1016/j.cell.2006.12.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289568	Bronze, Green Accepted			2022-12-24	WOS:000244842700015
J	Han, JH; Zhou, H; Horazdovsky, B; Zhang, KL; Xu, RM; Zhang, ZG				Han, Junhong; Zhou, Hui; Horazdovsky, Bruce; Zhang, Kangling; Xu, Rui-Ming; Zhang, Zhiguo			Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; REPAIR; MAINTENANCE; COMPLEXES; INTEGRITY; NETWORK; HST3	Acetylation of histone H3 lysine 56 (H3-K56) occurs in S phase, and cells lacking H3-K56 acetylation are sensitive to DNA-damaging agents. However, the histone acetyltransferase (HAT) that catalyzes global H3-K56 acetylation has not been found. Here we show that regulation of Ty1 transposition gene product 109 (Rtt109) is an H3-K56 HAT. Cells lacking Rtt109 or expressing rtt109 mutants with alterations at a conserved aspartate residue lose H3-K56 acetylation and exhibit increased sensitivity toward genotoxic agents, as well as elevated levels of spontaneous chromosome breaks. Thus, Rtt109, which shares no sequence homology with any other known HATs, is a unique HAT that acetylates H3-K56.	Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Calif Riverside, Mass Spectrometry Facil, Riverside, CA 92521 USA; NYU, Sch Med, Struct Biol Program,Skirball Inst Biomed, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Mayo Clinic; University of California System; University of California Riverside; New York University; New York University	Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	Zhang.Zhiguo@mayo.edu	Han, Junhong/L-5264-2013; xu, rui/GRX-5734-2022	Han, Junhong/0000-0002-3371-8698				Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Marmorstein Ronen, 2004, Novartis Found Symp, V259, P78; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	26	327	331	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					653	655		10.1126/science.1133234	http://dx.doi.org/10.1126/science.1133234			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272723				2022-12-24	WOS:000243909400045
J	Kicheva, A; Pantazis, P; Bollenbach, T; Kalaidzidis, Y; Bittig, T; Julicher, F; Gonzalez-Gaitan, M				Kicheva, Anna; Pantazis, Periklis; Bollenbach, Tobias; Kalaidzidis, Yannis; Bittig, Thomas; Juelicher, Frank; Gonzalez-Gaitan, Marcos			Kinetics of morphogen gradient formation	SCIENCE			English	Article							WING IMAGINAL DISC; FLUORESCENT PROTEIN; PHOTOBLEACHING RECOVERY; DROSOPHILA DPP; CELLS; ENDOCYTOSIS; DIFFUSION; TRAFFICKING; RECEPTORS; MOBILITY	In the developing fly wing, secreted morphogens such as Decapentaplegic (Dpp) and Wingless (Wg) form gradients of concentration providing positional information. Dpp forms a longer-range gradient than Wg. To understand how the range is controlled, we measured the four key kinetic parameters governing morphogen spreading: the production rate, the effective diffusion coefficient, the degradation rate, and the immobile fraction. The four parameters had different values for Dpp versus Wg. In addition, Dynamin-dependent endocytosis was required for spreading of Dpp, but not Wg. Thus, the cellular mechanisms of Dpp and Wingless spreading are different: Dpp spreading requires endocytic, intracellular trafficking.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; University of Geneva; University of Geneva; Max Planck Society; Lomonosov Moscow State University	Julicher, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 109, D-01307 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@biochem.unige.ch	Julicher, Frank/B-1828-2009; Kalaidzidis, Yannis/H-3094-2016; Bollenbach, Tobias/AAK-3206-2020; Pantazis, Periklis/AAR-1795-2021	Julicher, Frank/0000-0003-4731-9185; Kalaidzidis, Yannis/0000-0002-6137-1193; Bollenbach, Tobias/0000-0003-4398-476X; Pantazis, Periklis (Laki)/0000-0002-8367-9332; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; BASLER K, 1994, TRENDS GENET, V10, P187; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	23	285	288	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					521	525		10.1126/science.1135774	http://dx.doi.org/10.1126/science.1135774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255514				2022-12-24	WOS:000243726600049
J	Marquez, LM; Redman, RS; Rodriguez, RJ; Roossinck, MJ				Marquez, Luis M.; Redman, Regina S.; Rodriguez, Russell J.; Roossinck, Marilyn J.			A virus in a fungus in a plant: Three-way symbiosis required for thermal tolerance	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; HYPOVIRULENCE; DISRUPTION; CONVERSION; VIRULENCE	A mutualistic association between a fungal endophyte and a tropical panic grass allows both organisms to grow at high soil temperatures. We characterized a virus from this fungus that is involved in the mutualistic interaction. Fungal isolates cured of the virus are unable to confer heat tolerance, but heat tolerance is restored after the virus is reintroduced. The virus-infected fungus confers heat tolerance not only to its native monocot host but also to a eudicot host, which suggests that the underlying mechanism involves pathways conserved between these two groups of plants.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; US Geol Survey, Seattle, WA 98115 USA	Noble Research Institute; University of Washington; University of Washington Seattle; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey	Roossinck, MJ (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	mroossinck@noble.org						Ahn IP, 2001, MOL PLANT MICROBE IN, V14, P496, DOI 10.1094/MPMI.2001.14.4.496; ANAGNOSTAKIS SL, 1979, PHYTOPATHOLOGY, V69, P1226, DOI 10.1094/Phyto-69-1226; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; GHABRIAL SA, 1994, ADV VIRUS RES, V43, P303, DOI 10.1016/S0065-3527(08)60052-4; Kuznetsov YG, 2006, VIROLOGY, V352, P329, DOI 10.1016/j.virol.2006.04.008; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Redman RS, 1999, MOL PLANT MICROBE IN, V12, P969, DOI 10.1094/MPMI.1999.12.11.969; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Zabalgogeazcoa I, 1998, MYCOL RES, V102, P914, DOI 10.1017/S0953756297005819; Zhou T, 1997, PHYTOPATHOLOGY, V87, P147, DOI 10.1094/PHYTO.1997.87.2.147; [No title captured]	16	505	570	13	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					513	515		10.1126/science.1136237	http://dx.doi.org/10.1126/science.1136237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255511				2022-12-24	WOS:000243726600046
J	Bibbins-Domingo, K; Gupta, R; Na, B; Wu, AHB; Schiller, NB; Whooley, MA				Bibbins-Domingo, Kirsten; Gupta, Reena; Na, Beeya; Wu, Alan H. B.; Schiller, Nelson B.; Whooley, Mary A.			N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; PROGNOSTIC VALUE; VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK; FAILURE; PREDICTORS; PREVENTION; COMMITTEE	Context Identification of individuals at high risk for cardiovascular events is important for the optimal use of primary and secondary prevention measures. Objective To determine whether plasma levels of amino terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) predict cardiovascular events or death independent of other available prognostic tests. Design, Setting, and Participants Prospective cohort study (2000-2002) of 987 individuals in California with stable coronary heart disease in the Heart and Soul Study, who were followed up for a mean of 3.7 (range, 0.1-5.3) years. Main Outcome Measures The association of baseline NT-proBNP levels with death or cardiovascular events (myocardial infarction, stroke, or heart failure). Traditional clinical risk factors, echocardiographic measures, ischemia, other biomarkers, and New York Heart Association classification were adjusted for to determine whether NT-proBNP levels were independent of other prognostic factors. Receiver operating characteristic (ROC) curves were used to assess the incremental prognostic value of adding NT-proBNP level to these other measures. Results A total of 256 participants (26.2%) had a cardiovascular event or died. Each increasing quartile of NT-proBNP level (range of quartile 1, 8.06-73.95 pg/mL; quartile 2, 74-174.5 pg/mL; quartile 3, 175.1-459 pg/mL; quartile 4, >= 460 pg/mL) was associated with a greater risk of cardiovascular events or death, ranging from 23 of 247 (annual event rate, 2.6%) in the lowest quartile to 134 of 246 (annual event rate, 19.6%) in the highest quartile (unadjusted hazard ratio [HR] for quartile 4 vs quartile 1, 7.8; 95% confidence interval [CI], 5.0-12.1; P < .001). Each SD increase in log NT-proBNP level (1.3 pg/mL) was associated with a 2.3-fold increased rate of adverse cardiovascular outcomes (unadjusted HR, 2.3; 95% CI, 2.0-2.6; P < .001), and this association persisted after adjustment for all of the other prognostic measures (adjusted HR, 1.7; 95% CI, 1.3-2.2; P < .001). The addition of NT-proBNP level to standard clinical assessment and complete echocardiographic parameters significantly improved the area under the ROC curves for predicting subsequent adverse cardiovascular outcomes (0.80 for clinical risk factors and echocardiographic parameters plus log NT-proBNP vs 0.76 for clinical risk factors and echocardiographic parameters only; P = .006). Conclusions Elevated levels of NT-proBNP predict cardiovascular morbidity and mortality, independent of other prognostic markers, and identify at-risk individuals even in the absence of systolic or diastolic dysfunction by echocardiography. Level of NT-proBNP may help guide risk stratification of high-risk individuals, such as those with coronary heart disease.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; San Francisco Vet Adm Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-95095, N01HC95095, R01 HL079235, R01 HL079235-01A1] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Ndrepepa G, 2005, CIRCULATION, V112, P2102, DOI 10.1161/CIRCULATIONAHA.105.550715; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 2005, AM J CARDIOL, V95, P24, DOI 10.1016/j.amjcard.2004.08.058; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Schnabel R, 2005, EUR HEART J, V26, P241, DOI 10.1093/eurheartj/ehi036; Tsutamoto T, 1997, CIRCULATION, V96, P509; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	28	209	222	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					169	176		10.1001/jama.297.2.169	http://dx.doi.org/10.1001/jama.297.2.169			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17213400	Green Accepted, Bronze			2022-12-24	WOS:000243355900026
J	Lee, JY; Yang, W				Lee, Jae Young; Yang, Wei			UvrD helicase unwinds DNA one base pair at a time by a two-part power stroke	CELL			English	Article							ESCHERICHIA-COLI UVRD; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; REP HELICASE; STEP-SIZE; ATP HYDROLYSIS; RECBCD ENZYME; PCRA HELICASE; GENE-PRODUCT; DUPLEX DNA	Helicases use the energy derived from nucleoside triphosphate hydrolysis to unwind double helices in essentially every metabolic pathway involving nucleic acids. Earlier crystal structures have suggested that DNA helicases translocate along a single-stranded DNA in an inchworm fashion, We report here a series of crystal structures of the UvrD helicase complexed with DNA and ATP hydrolysis intermediates. These structures reveal that ATP binding alone leads to unwinding of 1 base pair by directional rotation and translation of the DNA duplex, and ADP and Pi release leads to translocation of the developing single strand. Thus DNA unwinding is achieved by a two-part power stroke in a combined wrench-and-inchworm mechanism. The rotational angle and translational distance of DNA define the unwinding step to be 1 base pair per ATP hydrolyzed. Finally, a gateway for ssDNA translocation and an alternative strand-displacement mode may explain the varying step sizes reported previously.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [Z01 DK036119-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036119] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P33, DOI 10.1111/j.1432-1033.1977.tb11780.x; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; HICKSON ID, 1983, MOL GEN GENET, V190, P265, DOI 10.1007/BF00330649; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; LOHMAN TM, 2003, ENERGY COUPLING MOL, P304; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1987, J BIOL CHEM, V262, P2066; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; OGAWA H, 1968, MOL GEN GENET, V101, P227, DOI 10.1007/BF00271625; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; RICHET E, 1976, J BIOL CHEM, V251, P808; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; VANDEPUT.P, 1965, MUTAT RES, V2, P97, DOI 10.1016/0027-5107(65)90041-2; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P783, DOI 10.1073/pnas.71.3.783; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998	52	293	295	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1349	1360		10.1016/j.cell.2006.10.049	http://dx.doi.org/10.1016/j.cell.2006.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190599	Green Accepted, Bronze			2022-12-24	WOS:000243690000015
J	Martins, CP; Brown-Swigart, L; Evan, GI				Martins, Carla P.; Brown-Swigart, Lamorna; Evan, Gerard I.			Modeling the therapeutic efficacy of p53 restoration in tumors	CELL			English	Article							DNA-DAMAGE; C-MYC; INDUCED TUMORIGENESIS; P53-DEFICIENT MICE; SMALL MOLECULES; APOPTOSIS; LYMPHOMAGENESIS; SUPPRESSOR; ACTIVATION; CANCER	Although restoration of p53 function is an attractive tumor-specific therapeutic strategy, it remains unclear whether p53 loss is required only for transition through early bottlenecks in tumorigenesis or also for maintenance of established tumors. To explore the efficacy of p53 reinstatement as a tumor therapy, we used a reversibly switchable p53 knockin (KI) mouse model that permits modulation of p53 status from wild-type to knockout, at will. Using the well-characterized E mu-myc lymphoma model, we show that p53 is spontaneously activated when restored in established E mu-myc lymphomas in vivo, triggering rapid apoptosis and conferring a significant increase in survival. Nonetheless, reimposition of p53 function potently selects for emergence of p53-resistant tumors through inactivation of p19(ARF) or p53. Our study provides important insights into the nature and timing of p53-activating signals in established tumors and how resistance to p53 evolves, which will aid in the optimization of p53-based tumor therapies.	Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA100193] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100193] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; CHRISTOPHOROU M, 2006, IN PRESS NATURE, P53; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Del Toro Gustavo, 2005, Clin Adv Hematol Oncol, V3, P54; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HSU B, 1995, ONCOGENE, V11, P175; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Khan SH, 2000, P NATL ACAD SCI USA, V97, P3266, DOI 10.1073/pnas.050560997; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; MOORE JP, 1987, ONCOGENE RES, V2, P65; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Ring D, 2001, J SHOULDER ELB SURG, V10, P501, DOI 10.1067/mse.2001.118414; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sigal A, 2000, CANCER RES, V60, P6788; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vassilev LT, 2005, J MED CHEM, V48, P4491, DOI 10.1021/jm058174k; Vater CA, 1996, ONCOGENE, V13, P739; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	478	494	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1323	1334		10.1016/j.cell.2006.12.007	http://dx.doi.org/10.1016/j.cell.2006.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17182091	Bronze			2022-12-24	WOS:000243690000013
J	Behrenfeld, MJ; O'Malley, RT; Siegel, DA; McClain, CR; Sarmiento, JL; Feldman, GC; Milligan, AJ; Falkowski, PG; Letelier, RM; Boss, ES				Behrenfeld, Michael J.; O'Malley, Robert T.; Siegel, David A.; McClain, Charles R.; Sarmiento, Jorge L.; Feldman, Gene C.; Milligan, Allen J.; Falkowski, Paul G.; Letelier, Ricardo M.; Boss, Emmanuel S.			Climate-driven trends in contemporary ocean productivity	NATURE			English	Article							EL-NINO; EQUATORIAL PACIFIC; EXPORT PRODUCTION; WORLDS OCEANS; PERIOD	Contributing roughly half of the biosphere's net primary production (NPP)(1,2), photosynthesis by oceanic phytoplankton is a vital link in the cycling of carbon between living and inorganic stocks. Each day, more than a hundred million tons of carbon in the form of CO2 are fixed into organic material by these ubiquitous, microscopic plants of the upper ocean, and each day a similar amount of organic carbon is transferred into marine ecosystems by sinking and grazing. The distribution of phytoplankton biomass and NPP is defined by the availability of light and nutrients ( nitrogen, phosphate, iron). These growth-limiting factors are in turn regulated by physical processes of ocean circulation, mixed-layer dynamics, upwelling, atmospheric dust deposition, and the solar cycle. Satellite measurements of ocean colour provide a means of quantifying ocean productivity on a global scale and linking its variability to environmental factors. Here we describe global ocean NPP changes detected from space over the past decade. The period is dominated by an initial increase in NPP of 1,930 teragrams of carbon a year (Tg C yr(-1)), followed by a prolonged decrease averaging 190 Tg C yr(-1). These trends are driven by changes occurring in the expansive stratified low-latitude oceans and are tightly coupled to coincident climate variability. This link between the physical environment and ocean biology functions through changes in upper-ocean temperature and stratification, which influence the availability of nutrients for phytoplankton growth. The observed reductions in ocean productivity during the recent post-1999 warming period provide insight on how future climate change can alter marine food webs.	Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Oregon State Univ, Coll Oceanog & Atmospher Sci, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	Oregon State University; Oregon State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Maine System; University of Maine Orono	Behrenfeld, MJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu	Letelier, Ricardo/A-6953-2009; Boss, Emmanuel/C-5765-2009; Boss, Emmanuel/AAF-2336-2019; Siegel, David A/C-5587-2008; Smith, Christa/G-3187-2010	Letelier, Ricardo/0000-0003-3376-4026; Boss, Emmanuel/0000-0002-8334-9595; Boss, Emmanuel/0000-0002-8334-9595; 				Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Le Quere C, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000920; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; MOREL A, 1989, LIMNOL OCEANOGR, V34, P1545, DOI 10.4319/lo.1989.34.8.1545; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Siegel DA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002527; Turk D, 2001, SCIENCE, V293, P471, DOI 10.1126/science.1056449; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2; Wolter K, 1993, P 17 CLIM DIAGN WORK, P52	26	1484	1543	51	1104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					752	755		10.1038/nature05317	http://dx.doi.org/10.1038/nature05317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151666				2022-12-24	WOS:000242581100059
J	Mitchell, GF; Vasan, RS; Keyes, MJ; Parise, H; Wang, TJ; Larson, MG; D'Agostino, RB; Kannel, WB; Levy, D; Benjamin, EJ				Mitchell, Gary F.; Vasan, Ramachandran S.; Keyes, Michelle J.; Parise, Helen; Wang, Thomas J.; Larson, Martin G.; D'Agostino, Ralph B., Sr.; Kannel, William B.; Levy, Daniel; Benjamin, Emelia J.			Pulse pressure and risk of new-onset atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATRIURETIC PEPTIDE LEVELS; SYSTOLIC HYPERTENSION; DIASTOLIC DYSFUNCTION; BLOOD-PRESSURE; HEART-FAILURE; HEALTHY-MEN; FRAMINGHAM; POPULATION; ADULTS; AGE	Context Atrial fibrillation (AF) is responsible for considerable morbidity and mortality, making identification of modifiable risk factors a priority. Increased pulse pressure, a reflection of aortic stiffness, increases cardiac load and may increase AF risk. Objective To examine relations between pulse pressure and incident AF. Design, Setting, and Participants Prospective, community-based observational cohort in Framingham, Mass, including 5331 Framingham Heart Study participants aged 35 years and older and initially free from AF (median age, 57 years; 55% women). Main Outcome Measures Incident AF. Results AF developed in 698 participants (13.1%) a median of 12 years after pulse pressure assessment. Cumulative 20-year AF incidence rates were 5.6% for pulse pressure of 40 mm Hg or less (25th percentile) and 23.3% for pulse pressure greater than 61 mm Hg (75th percentile). In models adjusted for age, sex, baseline and time-dependent change in mean arterial pressure, and clinical risk factors for AF (body mass index, smoking, valvular disease, diabetes, electrocardiographic left ventricular hypertrophy, hypertension treatment, and prevalent myocardial infarction or heart failure), pulse pressure was associated with increased risk for AF (adjusted hazard ratio [HR], 1.26 per 20-mm Hg increment; 95% confidence interval [CI], 1.12-1.43; P < .001). In contrast, mean arterial pressure was unrelated to incident AF (adjusted HR, 0.96 per 10-mm Hg increment; 95% CI, 0.88-1.05; P = .39). Systolic pressure was related to AF (HR, 1.14 per 20-mm Hg increment; 95% CI, 1.04-1.25; P = .006); however, if diastolic pressure was added, model fit improved and the diastolic relation was inverse (adjusted HR, 0.87 per 10-mm Hg increment; 95% CI, 0.78-0.96; P = .01), consistent with a pulse pressure effect. Among patients with interpretable echocardiographic images, the association between pulse pressure and AF persisted in models that adjusted for baseline left atrial dimension, left ventricular mass, and left ventricular fractional shortening (adjusted HR, 1.23; 95% CI, 1.09-1.39; P = .001). Conclusion Pulse pressure is an important risk factor for incident AF in a community-based sample. Further research is needed to determine whether interventions that reduce pulse pressure will limit the growing incidence of AF.	Cardiovasc Engn Inc, Waltham, MA 02453 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA; NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 51 Sawyer Rd,Suite 100, Waltham, MA 02453 USA.	garyfmitchell@mindspring.com	Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Parise, Helen/0000-0001-7761-4973; Benjamin, Emelia/0000-0003-4076-2336	NHLBI NIH HHS [N01-HC-25195, K24-HL-04334, R01-HL60040, R01-HL70100] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL060040, R01HL070100] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eijsbouts SCM, 2003, J CARDIOVASC ELECTR, V14, P269, DOI 10.1046/j.1540-8167.2003.02280.x; Gardin JM, 1997, HYPERTENSION, V29, P1095, DOI 10.1161/01.HYP.29.5.1095; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Huang JL, 2003, BASIC RES CARDIOL, V98, P16, DOI 10.1007/s00395-003-0385-z; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kannel W., 1987, SOME RISK FACTORS RE; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Kato J, 2002, HYPERTENS RES, V25, P887; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Mitchell GF, 1997, CIRCULATION, V96, P4254; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; OKIN PM, 2006, JAMA-J AM MED ASSOC, V26, P1242; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Psaty BM, 1997, CIRCULATION, V96, P2455; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAS Institute Inc, 1999, SAS STAT US GUID VER; SAVAGE DD, 1987, HYPERTENSION, V9, P40; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Vasan RS, 2003, AM J CARDIOL, V91, P1079, DOI 10.1016/S0002-9149(03)00152-8; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173; ZILE MR, 1990, PROG CARDIOVASC DIS, V32, P333, DOI 10.1016/0033-0620(90)90020-3	42	253	260	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					709	715		10.1001/jama.297.7.709	http://dx.doi.org/10.1001/jama.297.7.709			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17312290				2022-12-24	WOS:000244291100022
J	Macpherson, LJ; Dubin, AE; Evans, MJ; Marr, F; Schultz, PG; Cravatt, BF; Patapoutian, A				Macpherson, Lindsey J.; Dubin, Adrienne E.; Evans, Michael J.; Marr, Felix; Schultz, Peter G.; Cravatt, Benjamin F.; Patapoutian, Ardem			Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines	NATURE			English	Article							CLICK CHEMISTRY; S-NITROSYLATION; COLD; KEAP1; PROTEIN; ELECTROPHILE; NOCICEPTION; REACTIVITY; SENSATION; INDUCERS	The nervous system senses peripheral damage through nociceptive neurons that transmit a pain signal(1,2). TRPA1 is a member of the Transient Receptor Potential (TRP) family of ion channels and is expressed in nociceptive neurons(3-5). TRPA1 is activated by a variety of noxious stimuli, including cold temperatures, pungent natural compounds, and environmental irritants(6-11). How such diverse stimuli activate TRPA1 is not known. We observed that most compounds known to activate TRPA1 are able to covalently bind cysteine residues. Here we use click chemistry to show that derivatives of two such compounds, mustard oil and cinnamaldehyde, covalently bind mouse TRPA1. Structurally unrelated cysteine-modifying agents such as iodoacetamide (IA) and (2-aminoethyl) methanethiosulphonate ( MTSEA) also bind and activate TRPA1. We identified by mass spectrometry fourteen cytosolic TRPA1 cysteines labelled by IA, three of which are required for normal channel function. In excised patches, reactive compounds activated TRPA1 currents that were maintained at least 10 min after washout of the compound in calcium-free solutions. Finally, activation of TRPA1 by disulphide-bond-forming MTSEA is blocked by the reducing agent dithiothreitol (DTT). Collectively, our data indicate that covalent modification of reactive cysteines within TRPA1 can cause channel activation, rapidly signalling potential tissue damage through the pain pathway.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Macpherson, Lindsey/0000-0002-1089-3733				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fearon IM, 1999, J PHYSIOL-LONDON, V514, P629, DOI 10.1111/j.1469-7793.1999.629ad.x; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wood JN, 1997, ANNU REV PHYSIOL, V59, P457, DOI 10.1146/annurev.physiol.59.1.457; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	31	857	903	4	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					541	545		10.1038/nature05544	http://dx.doi.org/10.1038/nature05544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237762				2022-12-24	WOS:000243867300044
J	Dudziak, D; Kamphorst, AO; Heidkamp, GF; Buchholz, VR; Trumpfheller, C; Yamazaki, S; Cheong, C; Liu, K; Lee, HW; Park, CG; Steinman, RM; Nussenzweig, MC				Dudziak, Diana; Kamphorst, Alice O.; Heidkamp, Gordon F.; Buchholz, Veit R.; Trumpfheller, Christine; Yamazaki, Sayuri; Cheong, Cheolho; Liu, Kang; Lee, Han-Woong; Park, Chae Gyu; Steinman, Ralph M.; Nussenzweig, Michel C.			Differential antigen processing by dendritic cell subsets in vivo	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; CROSS-PRESENTATION; LYMPH-NODE; T-CELLS; CD8(+); MOUSE; COMPLEXES; PROTEOLYSIS; ACTIVATION; RECEPTOR	Dendritic cells (DCs) process and present self and foreign antigens to induce tolerance or immunity. In vitro models suggest that induction of immunity is controlled by regulating the presentation of antigen, but little is known about how DCs control antigen presentation in vivo. To examine antigen processing and presentation in vivo, we specifically targeted antigens to two major subsets of DCs by using chimeric monoclonal antibodies. Unlike CD8(+) DCs that express the cell surface protein CD205, CD8(-) DCs, which are positive for the 33D1 antigen, are specialized for presentation on major histocompatibility complex (MHC) class II. This difference in antigen processing is intrinsic to the DC subsets and is associated with increased expression of proteins involved in MHC processing.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Yonsei University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Steinman, Ralph/F-7729-2012; Buchholz, Veit R./AAF-6966-2021; Dudziak, Diana/B-2432-2017	Buchholz, Veit R./0000-0003-0441-3913; Park, Chae Gyu/0000-0003-1906-1308; Dudziak, Diana/0000-0001-9358-134X; Kamphorst, Alice/0000-0002-9230-9501				Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	27	1018	1042	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					107	111		10.1126/science.1136080	http://dx.doi.org/10.1126/science.1136080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204652				2022-12-24	WOS:000243259100048
J	Lam, YC; Bowman, AB; Jafar-Neiad, P; Lim, J; Richman, R; Fryer, JD; Hyun, ED; Duvick, LA; Brr, HT; Botas, J; Zoghbi, HY				Lam, Yung C.; Bowman, Aaron B.; Jafar-Neiad, Paymaan; Lim, Janghoo; Richman, Ronald; Fryer, John D.; Hyun, Eric D.; Duvick, Lisa A.; Brr, Harry T.; Botas, Juan; Zoghbi, Huda Y.			ATAXIN-1 interacts with the repressor capicua in its native complex to cause SCA1 neuropathology	CELL			English	Article							BULBAR MUSCULAR-ATROPHY; HISTONE ACETYLTRANSFERASE ACTIVITY; TRANSGENIC MOUSE MODEL; DISEASE GENE HOMOLOG; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; MEDIATES NEURODEGENERATION; EMBRYONIC LETHALITY; EXPANDED ATAXIN-7; AXH DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is one of several neurodegenerative diseases caused by expansion of a polyglutamine tract in the disease protein, in this case, ATAXIN-1 (ATXN1). A key question in the field is whether neurotoxicity is mediated by aberrant, novel interactions with the expanded protein or whether its wild-type functions are augmented to a deleterious degree. We examined soluble protein complexes from mouse cerebellum and found that the majority of wild-type and expanded ATXN1 assembles into large stable complexes containing the transcriptional repressor Capicua. ATXN1 directly binds Capicua and modulates Capicua repressor activity in Drosophila and mammalian cells, and its loss decreases the steady-state level of Capicua. Interestingly, the S776A mutation, which abrogates the neurotoxicity of expanded ATXN1, substantially reduces the association of mutant ATXN1 with Capicua in vivo. These data provide insight into the function of ATXN1 and suggest that SCA1 neuropathology depends on native, not novel, protein interactions.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Bowman, Aaron/0000-0001-8728-3346; Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022920, R01NS022920, R01NS027699, R01NS045667] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064] Funding Source: Medline; NINDS NIH HHS [NS45667, NS22920, NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atkey MR, 2006, DEVELOPMENT, V133, P2115, DOI 10.1242/dev.02369; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen SM, 2004, HUM MOL GENET, V13, P53, DOI 10.1093/hmg/ddh005; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Jimenez G, 2000, GENE DEV, V14, P224; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 2003, SCI STKE, V207, pPE48; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matsumoto T, 2005, J BIOCHEM, V138, P105, DOI 10.1093/jb/mvi118; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roch F, 2002, DEVELOPMENT, V129, P993; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Strom AL, 2005, NEUROBIOL DIS, V20, P646, DOI 10.1016/j.nbd.2005.04.018; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	55	226	232	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1335	1347		10.1016/j.cell.2006.11.038	http://dx.doi.org/10.1016/j.cell.2006.11.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190598	Bronze			2022-12-24	WOS:000243690000014
J	Watts, PC; Buley, KR; Boardman, W; Ciofi, C; GibsonO, R				Watts, Phillip C.; Buley, Kevin R.; Boardman, Wayne; Ciofi, Claudio; GibsonO, Richard			Parthenogenesis in komodo dragons	NATURE			English	Article							EXTINCTION		Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; N England Zool Soc, Chester Zoo, Upton By Chester CH2 1LH, England; Zool Soc London, London NW1 4RY, England; Univ Florence, Dept Anim Biol & Genet, I-50125 Florence, Italy	University of Liverpool; Zoological Society of London; University of Florence	Watts, PC (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.	p.c.watts@liv.ac.uk	Boardman, Wayne S.J/J-6479-2013; Boardman, Wayne/ABE-7528-2020; Watts, Phill/G-7257-2011; Ciofi, Claudio/AAH-9461-2019	Boardman, Wayne/0000-0002-1746-0682; Watts, Phillip/0000-0001-7755-187X; CIOFI, CLAUDIO/0000-0001-8537-8659				AVISE JC, 1992, EVOL BIOL, V26, P225; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 1998, MOL ECOL, V7, P134; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; HALVERSON J, 2002, BIOL CONSERVATION KO, P165; Lenk P, 2005, AMPHIBIA-REPTILIA, V26, P507, DOI 10.1163/156853805774806296; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sherratt TN, 2005, NATURE, V435, P1039, DOI 10.1038/4351039a; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL	10	100	105	1	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1021	1022		10.1038/4441021a	http://dx.doi.org/10.1038/4441021a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183308				2022-12-24	WOS:000242971100041
J	Schussler, A; Martin, H; Cohen, D; Fitz, M; Wipf, D				Schuessler, Arthur; Martin, Holger; Cohen, David; Fitz, Michael; Wipf, Daniel			Characterization of a carbohydrate transporter from symbiotic glomeromycotan fungi	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; GLOMUS-INTRARADICES; CARBON; PHYLOGENY; HYPHAE; GENOME; ROOTS; GENES	The symbiotic relationships between mycorrhizal fungi and plants have an enormous impact on terrestrial ecosystems(1). Most common are the arbuscular mycorrhizas, formed by fungi belonging to the phylum Glomeromycota(2). Arbuscular mycorrhizal fungi facilitate the uptake of soil nutrients by plants(3) and in exchange obtain carbohydrates, thus representing a large sink(4) for atmospheric plant-fixed CO2. However, how carbohydrates are transported through the symbiotic interface is still unknown. Here we report the characterization of the first known glomeromycotan monosaccharide transporter, GpMST1, by exploiting the unique symbiosis of a glomeromycotan fungus (Geosiphon pyriformis) with cyanobacteria(5). The GpMST1 gene has a very low GC content and contains six introns with unusual boundaries. GpMST1 possesses twelve predicted transmembrane domains and functions as a proton cotransporter with highest affinity for glucose, then mannose, galactose and fructose. It belongs to an as yet uncharacterized phylogenetic monosaccharide transporter clade. This initial characterization of a new transporter family involved in fungal symbiosis will lead to a better understanding of carbon flows in terrestrial environments.	Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Univ Bonn, IZMB, NWG Transport Mycorrhiza, D-53115 Bonn, Germany	Technical University of Darmstadt; University of Bonn	Schussler, A (corresponding author), Dept Biol 1, Bereich Genet, Maria Ward Str 1A, D-80638 Munich, Germany.	arthur.schuessler@lrz.uni-muenchen.de	Schüßler, Arthur/F-1681-2011	Wipf, Daniel/0000-0001-7197-5612; Cohen, David/0000-0002-0320-8865; Fitz, Michael/0000-0001-9192-0280				Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; BONFANTE P, 2001, MYCOTA, V9, P45; GARCIA M, 2006, 5 INT C MYC 23 27 JU, P200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gould G.W., 1997, FACILITATIVE GLUCOSE, P1; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hildebrandt U, 2006, FEMS MICROBIOL LETT, V254, P258, DOI 10.1111/j.1574-6968.2005.00027.x; KLUGE M, 1991, PLANTA, V185, P311, DOI 10.1007/BF00201049; KNOBLAUCH M, 1995, THESIS, P1; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Marx J, 2004, SCIENCE, V304, P234, DOI 10.1126/science.304.5668.234; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Sawaki H, 2001, FEMS MICROBIOL LETT, V195, P109, DOI 10.1111/j.1574-6968.2001.tb10506.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2002, PLANT SOIL, V244, P75, DOI 10.1023/A:1020238728910; Schussler A, 2005, SOIL BIOL, V4, P271; Schussler A, 1996, PROTOPLASMA, V190, P53, DOI 10.1007/BF01281194; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Solaiman MDZ, 1997, NEW PHYTOL, V136, P533, DOI 10.1046/j.1469-8137.1997.00757.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; VELA GM, 2006, 5 INT C MYC 23 27 JU, P40; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wipf D, 2003, GENOME, V46, P177, DOI [10.1139/g02-121, 10.1139/G02-121]	25	95	108	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					933	936		10.1038/nature05364	http://dx.doi.org/10.1038/nature05364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167486				2022-12-24	WOS:000242805400057
J	Kimchi-Sarfaty, C; Oh, JM; Kim, IW; Sauna, ZE; Calcagno, AM; Ambudkar, SV; Gottesman, MM				Kimchi-Sarfaty, Chava; Oh, Jung Mi; Kim, In-Wha; Sauna, Zuben E.; Calcagno, Anna Maria; Ambudkar, Suresh V.; Gottesman, Michael M.			A "silent" polymorphism in the MDR1 gene changes substrate specificity	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; SINGLE-NUCLEOTIDE POLYMORPHISMS; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; MESSENGER-RNA; IN-VIVO; EXPRESSION; LINKAGE		NCI, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, MM (corresponding author), US FDA, Ctr Biol Evaluat & Res, 29 Lincoln Dr,Room 316, Bethesda, MD 20892 USA.	kimchi@cber.fda.gov; jmoh@snu.ac.kr; mgottesman@nih.gov	Ambudkar, Suresh V/L-1317-2016; Calcagno, Anna Maria/A-5617-2012; Sauna, Zuben E./AAA-7149-2019	Calcagno, Anna Maria/0000-0002-0804-2753; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010030, ZIABC010030] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Bercovitch L, 2004, J AM ACAD DERMATOL, V51, pS13, DOI 10.1016/j.jaad.2004.01.015; Brunak S, 1996, PROTEINS, V25, P237, DOI 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Frittitta L, 2001, DIABETES, V50, P1952, DOI 10.2337/diabetes.50.8.1952; Goto M, 2002, PHARMACOGENETICS, V12, P451, DOI 10.1097/00008571-200208000-00005; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gribar JJ, 2000, J MEMBRANE BIOL, V173, P203, DOI 10.1007/s002320001020; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Perloff MD, 2001, BRIT J PHARMACOL, V134, P1601, DOI 10.1038/sj.bjp.0704399; Ruth A, 2001, BIOCHEMISTRY-US, V40, P4332, DOI 10.1021/bi001373f; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; SIEMION IZ, 1994, BIOSYSTEMS, V33, P139, DOI 10.1016/0303-2647(94)90053-1; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Xie T, 1998, FEBS LETT, V434, P93	29	1856	2111	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					525	528		10.1126/science.1135308	http://dx.doi.org/10.1126/science.1135308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185560	Green Published			2022-12-24	WOS:000243726600050
J	Keays, DA; Tian, G; Poirier, K; Huang, GJ; Siebold, C; Cleak, J; Oliver, PL; Fray, M; Harvey, RJ; Molnar, Z; Pinon, MC; Dear, N; Valdar, W; Brown, SDM; Davies, KE; Rawlins, JNP; Cowan, NJ; Nolan, P; Chelly, J; Flint, J				Keays, David A.; Tian, Guoling; Poirier, Karine; Huang, Guo-Jen; Siebold, Christian; Cleak, James; Oliver, Peter L.; Fray, Martin; Harvey, Robert J.; Molnar, Zoltan; Pinon, Maria C.; Dear, Neil; Valdar, William; Brown, Steve D. M.; Davies, Kay E.; Rawlins, J. Nicholas P.; Cowan, Nicholas J.; Nolan, Patrick; Chelly, Jamel; Flint, Jonathan			Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans	CELL			English	Article							CEREBELLAR HYPOPLASIA; CORTICAL DEVELOPMENT; BETA-TUBULIN; GENE; DOUBLECORTIN; PROTEIN; CHAPERONIN; MOUSE; HETERODIMER; HIPPOCAMPUS	The development of the mammalian brain is dependent on extensive neuronal migration. Mutations in mice and humans that affect neuronal migration result in abnormal lamination of brain structures with associated behavioral deficits. Here, we report the identification of a hyperactive N-ethyl-N-nitrosourea (ENU)induced mouse mutant with abnormalities in the laminar architecture of the hippocampus and cortex, accompanied by impaired neuronal migration. We show that the causative mutation lies in the guanosine triphosphate (GTP) binding pocket of alpha-1 tubulin (Tuba 1) and affects tubulin heterodimer formation. Phenotypic similarity with existing mouse models of lissencephaly led us to screen a cohort of patients with developmental brain anomalies. We identified two patients with cle novo mutations in TUBA3, the human homolog of Tubal. This study demonstrates the utility of ENU mutagenesis in the mouse as a means to discover the basis of human neurodevelopmental disorders.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; MRC, Funct Genet Unit, Oxford OX1 3QX, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Paris 05, Fac Med Rene Descartes, Inst Cochin, INSERM,Unite 567,CNRS,UMR 8104, F-75014 Paris, France	University of Oxford; Wellcome Centre for Human Genetics; New York University; MRC Harwell; University of London; University College London; University of London School of Pharmacy; University of Oxford; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	jf@well.ox.ac.uk	Harvey, Robert/D-3994-2016; Oliver, Peter/F-1453-2010; Chelly, Jamel/J-7528-2015; Nolan, Patrick/W-3918-2019; POIRIER, Karine/N-3009-2018; Molnar, Zoltan/J-7281-2012; Valdar, William/AAE-4354-2019	Harvey, Robert/0000-0001-5956-6664; Chelly, Jamel/0000-0002-0939-8719; Nolan, Patrick/0000-0001-5550-0334; POIRIER, Karine/0000-0002-7928-2906; Molnar, Zoltan/0000-0002-6852-6004; Huang, Guo-Jen/0000-0002-6392-2155; Oliver, Peter/0000-0003-3347-2461; Flint, Jonathan/0000-0002-9427-4429	MRC [MC_U137761449, MC_U142684173, MC_UP_1502/1, G0300200, MC_U142684175, MC_U142684172] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047234] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1502/1, MC_U142684175, MC_U142684172, MC_U142684173, MC_U137761449, G0300200] Funding Source: Medline; NIDDK NIH HHS [R01 DK047234, R01 DK47234] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; BASTEN CJ, 1996, PLANT GENOME, V4; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Buhot MC, 2001, BEHAV NEUROSCI, V115, P455, DOI 10.1037/0735-7044.115.2.455; CHURCHILL GA, 1994, GENETICS, V138, P963; Corbo JC, 2002, J NEUROSCI, V22, P7548; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; des Portes V, 1998, CELL, V92, P51; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; Farr SA, 2002, PHYSIOL BEHAV, V76, P531, DOI 10.1016/S0031-9384(02)00749-7; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; GU W, 1989, MOL CELL BIOL, V9, P3418, DOI 10.1128/MCB.9.8.3418; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Huang GJ, 2005, NEUROPSYCHOPHARMACOL, V30, P231, DOI 10.1038/sj.npp.1300609; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Leventer RJ, 2005, J CHILD NEUROL, V20, P307, DOI 10.1177/08830738050200040701; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Pinheiro J, 2001, MIXED EFFECTS MODELS; QIU S, 2005, NEUROBIOLOGY LEARNIN, V85, P228; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takahashi T, 1999, J NEUROSCI, V19, P10357; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Tian GL, 2006, P NATL ACAD SCI USA, V103, P13491, DOI 10.1073/pnas.0602798103; Vega LR, 1998, MOL BIOL CELL, V9, P2349, DOI 10.1091/mbc.9.9.2349; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WILLINS DA, 1995, GENETICS, V141, P1287; ZENG ZB, 1994, GENETICS, V136, P1457	46	318	325	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					45	57		10.1016/j.cell.2006.12.017	http://dx.doi.org/10.1016/j.cell.2006.12.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218254	Green Published, hybrid			2022-12-24	WOS:000244420400012
J	Wassarman, KM; Saecker, RM				Wassarman, Karen M.; Saecker, Ruth M.			Synthesis-mediated release of a small RNA inhibitor of RNA polymerase	SCIENCE			English	Article							ESCHERICHIA-COLI; LID ELEMENT; TRANSCRIPTION; ELONGATION; PROMOTER; REGULATORS; STRAND	Noncoding small RNAs regulate gene expression in all organisms, in some cases through direct association with RNA polymerase ( RNAP). Here we report that the mechanism of 6S RNA inhibition of transcription is through specific, stable interactions with the active site of Escherichia coli RNAP that exclude promoter DNA binding. In fact, the DNA-dependent RNAP uses bound 6S RNA as a template for RNA synthesis, producing 14- to 20-nucleotide RNA products (pRNA). These results demonstrate that 6S RNA is functionally engaged in the active site of RNAP. Synthesis of pRNA destabilizes 6S RNA-RNAP complexes leading to release of the pRNA-6S RNA hybrid. In vivo, 6S RNA-directed RNA synthesis occurs during outgrowth from the stationary phase and likely is responsible for liberating RNAP from 6S RNA in response to nutrient availability.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, KM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	wassarman@bact.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023467, R37GM023467, R01GM067955] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23467, R01 GM067955, GM67955] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN CR, 1994, P NATL ACAD SCI USA, V91, P3784, DOI 10.1073/pnas.91.9.3784; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; BIEBRICH.CK, 1973, P NATL ACAD SCI USA, V70, P934, DOI 10.1073/pnas.70.3.934; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pelchat M, 2002, BIOCHEMISTRY-US, V41, P6561, DOI 10.1021/bi025595k; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Trotochaud AE, 2006, J BACTERIOL, V188, P3936, DOI 10.1128/JB.00079-06; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wettich A, 2001, BIOCHEMISTRY-US, V40, P3308, DOI 10.1021/bi002756g; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337	25	132	135	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1601	1603		10.1126/science.1134830	http://dx.doi.org/10.1126/science.1134830			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158328				2022-12-24	WOS:000242624600043
J	Shen, QH; Saijo, Y; Mauch, S; Biskup, C; Bieri, S; Keller, B; Seki, H; Ulker, B; Somssich, IE; Schulze-Lefert, P				Shen, Qian-Hua; Saijo, Yusuke; Mauch, Stefan; Biskup, Christoph; Bieri, Stephane; Keller, Beat; Seki, Hikaru; Uelker, Bekir; Somssich, Imre E.; Schulze-Lefert, Paul			Nuclear activity of MLA immune receptors links isolate-specific and basal disease-resistance responses	SCIENCE			English	Article							WRKY TRANSCRIPTION FACTORS; POWDERY MILDEW FUNGUS; PSEUDOMONAS-SYRINGAE; SIGNALING PATHWAYS; DNA-BINDING; MAP KINASE; BARLEY; ARABIDOPSIS; PLANT; PROTEINS	Plant immune responses are triggered by pattern recognition receptors that detect conserved pathogen-associated molecular patterns (PAMPs) or by resistance ( R) proteins recognizing isolate-specific pathogen effectors. We show that in barley, intracellular mildew A (MLA) R proteins function in the nucleus to confer resistance against the powdery mildew fungus. Recognition of the fungal avirulence A10 effector by MLA10 induces nuclear associations between receptor and WRKY transcription factors. The identified WRKY proteins act as repressors of PAMP-triggered basal defense. MLA appears to interfere with the WRKY repressor function, thereby de-repressing PAMP-triggered basal defense. Our findings reveal a mechanism by which these polymorphic immune receptors integrate distinct pathogen signals.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	Max Planck Society; Friedrich Schiller University of Jena; University of Zurich	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Shen, Qian-Hua/D-2734-2013; Bruening, Stefan/B-8505-2011; Seki, Hikaru/C-9730-2017; Somssich, Imre/GLT-3738-2022; Keller, Beat/K-3093-2019; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008	Shen, Qian-Hua/0000-0002-9446-3086; Somssich, Imre/0000-0003-3066-5794; Keller, Beat/0000-0003-2379-9225; 				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Eckey C, 2004, PLANT MOL BIOL, V55, P1, DOI 10.1007/s11103-004-0275-2; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Halterman DA, 2004, PLANT J, V38, P215, DOI 10.1111/j.1365-313X.2004.02032.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	34	527	577	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1098	1103		10.1126/science.1136372	http://dx.doi.org/10.1126/science.1136372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17185563	Green Published			2022-12-24	WOS:000244387600029
J	Markert, S; Arndt, C; Felbeck, H; Becher, D; Sievert, SM; Hugler, M; Albrecht, D; Robidart, J; Bench, S; Feldman, RA; Hecker, M; Schweder, T				Markert, Stephanie; Arndt, Cordelia; Felbeck, Horst; Becher, Dorte; Sievert, Stefan M.; Huegler, Michael; Albrecht, Dirk; Robidart, Julie; Bench, Shellie; Feldman, Robert A.; Hecker, Michael; Schweder, Thomas			Physiological proteomics of the uncultured endosymbiont of Riftia pachyptila	SCIENCE			English	Article							DEEP-SEA VENTS; CHEMOAUTOTROPHIC SYMBIONTS; CARBON FIXATION; PURIFICATION; TROPHOSOME; BACTERIA; ANIMALS; JONES; WORM	The bacterial endosymbiont of the deep-sea tube worm Riftia pachyptila has never been successfully cultivated outside its host. In the absence of cultivation data, we have taken a proteomic approach based on the metagenome sequence to study the metabolism of this peculiar microorganism in detail. As one result, we found that three major sulfide oxidation proteins constitute similar to 12% of the total cytosolic proteome, which highlights the essential role of these enzymes for the symbiont's energy metabolism. Unexpectedly, the symbiont uses the reductive tricarboxylic acid cycle in addition to the previously identified Calvin cycle for CO2 fixation.	Scripps Inst Oceanog, La Jolla, CA 92093 USA; Inst Marine Biotechnol, D-17489 Greifswald, Germany; Max Planck Inst Infect Biol, D-10117 Berlin, Germany; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Greifswald, D-17487 Greifswald, Germany; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Synbio Corp, Menlo Pk, CA 94025 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Max Planck Society; Woods Hole Oceanographic Institution; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California Santa Cruz	Schweder, T (corresponding author), Scripps Inst Oceanog, La Jolla, CA 92093 USA.	schweder@uni-greifswald.de	Hügler, Michael/A-9155-2018; Bench, Shellie R/E-7679-2010; Markert, Stephanie/AAL-5591-2021; Becher, Doerte/B-4454-2015	Hügler, Michael/0000-0002-2820-0333; Markert, Stephanie/0000-0003-0923-3305; Becher, Doerte/0000-0002-9630-5735; Schweder, Thomas/0000-0002-7213-3596; Robidart, Julie/0000-0001-9805-3570; Sievert, Stefan/0000-0002-9541-2707				BLUM J, 1984, ARCH BIOCHEM BIOPHYS, V228, P617, DOI 10.1016/0003-9861(84)90030-4; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; DISTEL DL, 1988, J EXP ZOOL, V247, P1, DOI 10.1002/jez.1402470102; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; Felbeck Horst, 1988, Oceanologica Acta Special Issue, V8, P131; FISHER CR, 1989, BIOL BULL, V177, P372, DOI 10.2307/1541597; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Nelson D.C., 1995, DEEP SEA HYDROTHERMA, P125; Pflugfelder B, 2005, MAR BIOL, V146, P895, DOI 10.1007/s00227-004-1500-x; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; SCHEDEL M, 1979, ARCH MICROBIOL, V121, P29, DOI 10.1007/BF00409202; Sorgo A, 2002, MAR ECOL PROG SER, V231, P115, DOI 10.3354/meps231115; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; WILMOT DB, 1990, MAR BIOL, V106, P273, DOI 10.1007/BF01314811	18	153	159	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					247	250		10.1126/science.1132913	http://dx.doi.org/10.1126/science.1132913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218528	Green Submitted			2022-12-24	WOS:000243407400049
J	Noguera-Troise, I; Daly, C; Papadopoulos, NJ; Coetzee, S; Boland, P; Gale, NW; Lin, HC; Yancopoulos, GD; Thurston, G				Noguera-Troise, Irene; Daly, Christopher; Papadopoulos, Nicholas J.; Coetzee, Sandra; Boland, Pat; Gale, Nicholas W.; Lin, Hsin Chieh; Yancopoulos, George D.; Thurston, Gavin			Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis	NATURE			English	Article							CLINICAL-TRIALS; VEGF-TRAP; NOTCH; VASCULATURE; MOUSE; EXPRESSION; RESISTANCE; LETHALITY; THERAPY; PROTEIN	Tumour growth requires accompanying expansion of the host vasculature, with tumour progression often correlated with vascular density. Vascular endothelial growth factor (VEGF) is the best-characterized inducer of tumour angiogenesis. We report that VEGF dynamically regulates tumour endothelial expression of Delta-like ligand 4 (Dll4), which was previously shown to be absolutely required for normal embryonic vascular development. To define Dll4 function in tumour angiogenesis, we manipulated this pathway in murine tumour models using several approaches. Here we show that blockade resulted in markedly increased tumour vascularity, associated with enhanced angiogenic sprouting and branching. Paradoxically, this increased vascularity was non-productive - as shown by poor perfusion and increased hypoxia, and most importantly, by decreased tumour growth - even for tumours resistant to anti-VEGF therapy. Thus, VEGF-induced Dll4 acts as a negative regulator of tumour angiogenesis; its blockade results in a striking uncoupling of tumour growth from vessel density, presenting a novel therapeutic approach even for tumours resistant to anti-VEGF therapies.	Regeneron Pharmaceut Inc, Res Labs, Tarrytown, NY 10591 USA	Regeneron	Thurston, G (corresponding author), Regeneron Pharmaceut Inc, Res Labs, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	Gavin.Thurston@Regeneron.com	Wang, Zegen/H-3018-2011	Thurston, Gavin/0000-0002-4105-5919; Daly, Christopher/0000-0003-3800-8174				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karsan A, 2005, CAN J PHYSIOL PHARM, V83, P14, DOI 10.1139/Y04-125; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Laskin JJ, 2005, ONCOLOGY-NY, V19, P1671; Lee CG, 2000, CANCER RES, V60, P5565; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Rudge JS, 2005, COLD SH Q B, V70, P411, DOI 10.1101/sqb.2005.70.052; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	34	802	914	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1032	1037		10.1038/nature05355	http://dx.doi.org/10.1038/nature05355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183313				2022-12-24	WOS:000242971100046
J	Bermejo, M; Rodriguez-Teijeiro, JD; Illera, G; Barroso, A; Vila, C; Walsh, PD				Bermejo, Magdalena; Rodriguez-Teijeiro, Jose Domingo; Illera, German; Barroso, Alex; Vila, Carles; Walsh, Peter D.			Ebola outbreak killed 5000 gorillas	SCIENCE			English	Article							DECLINE; VIRUS		Ecosyst Forestiers Afrique Cent ECOFAC, Libreville, Gabon; Univ Barcelona, Dept Anim Biol, ES-08028 Barcelona, Spain; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	University of Barcelona; Max Planck Society	Bermejo, M (corresponding author), Ecosyst Forestiers Afrique Cent ECOFAC, Box Postale 15115, Libreville, Gabon.	magda_bermejo@yahoo.es	Rodríguez-Teijeiro, José Domingo/AAV-7830-2021; Vila, Carles/H-4893-2013; Rodriguez-Teijeiro, Jose D/G-2768-2016	Rodríguez-Teijeiro, José Domingo/0000-0001-7787-9293; Vila, Carles/0000-0002-4206-5246; Rodriguez-Teijeiro, Jose D/0000-0001-7787-9293				Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Oates JF, 2006, PRIMATES, V47, P102, DOI 10.1007/s10329-005-0149-5; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Sleeman JM, 2004, ORYX, V38, P136, DOI 10.1017/S0030605304000237; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	7	254	268	17	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1564	1564		10.1126/science.1133105	http://dx.doi.org/10.1126/science.1133105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158318				2022-12-24	WOS:000242624600031
J	Muchhala, N				Muchhala, Nathan			Nectar bat stows huge tongue in its rib cage	NATURE			English	Article							POLLINATION		Univ Miami, Dept Biol, Coral Gables, FL 33143 USA	University of Miami	Muchhala, N (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33143 USA.	muchhala@bio.miami.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Self, Casey J/B-6871-2011					CHAN LK, 1995, J MAMMAL, V76, P472, DOI 10.2307/1382356; Darwin C., 1877, VARIOUS CONTRIVANCES; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fleming T.H., 2005, CONTRIBUCIONES MASTO, P163; Griffiths TA., 1982, AM MUS NOVIT, V2742, P1, DOI DOI 10.1097/; Herrel A, 2001, J EXP BIOL, V204, P3621; Muchhala N, 2005, J MAMMAL, V86, P457, DOI 10.1644/1545-1542(2005)86[457:ANSOAC]2.0.CO;2; Peikert-Holle T., 1985, BLUTEN FLEDERMAUSE; STILES FG, 1978, AM ZOOL, V18, P715; von Helversen O, 2003, BAT ECOLOGY, P346; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032	11	61	62	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					701	702		10.1038/444701a	http://dx.doi.org/10.1038/444701a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151655				2022-12-24	WOS:000242581100042
J	Hansen, SK; Rainey, PB; Haagensen, JAJ; Molin, S				Hansen, Susse Kirkelund; Rainey, Paul B.; Haagensen, Janus A. J.; Molin, Soren			Evolution of species interactions in a biofilm community	NATURE			English	Article							MICROBIAL BIOFILMS; PSEUDOMONAS-PUTIDA; DIVERSITY; BIODIVERSITY; COEXISTENCE; ENVIRONMENT; COMPETITION; ADAPTATION; DYNAMICS; ECOLOGY	Biofilms are spatially structured communities of microbes whose function is dependent on a complex web of symbiotic interactions(1,2). Localized interactions within these assemblages are predicted to affect the coexistence of the component species(3-5), community structure(6) and function(7-10), but there have been few explicit empirical analyses of the evolution of interactions(11). Here we show, with the use of a two-species community, that selection in a spatially structured environment leads to the evolution of an exploitative interaction. Simple mutations in the genome of one species caused it to adapt to the presence of the other, forming an intimate and specialized association. The derived community was more stable and more productive than the ancestral community. Our results show that evolution in a spatially structured environment can stabilize interactions between species, provoke marked changes in their symbiotic nature and affect community function.	Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Tech Univ Denmark, Infect Microbiol Grp, Biocentrum DTU, DK-2800 Lyngby, Denmark	University of Auckland; Technical University of Denmark	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	p.rainey@auckland.ac.nz	Rainey, Paul/A-3207-2008; Albers, Pieter/I-2563-2017	Rainey, Paul/0000-0003-0879-5795; Molin, Soren/0000-0002-7973-2639				An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Kareiva, 1997, SPATIAL ECOLOGY; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; LAM JS, 2004, PSEUDOMONAS, V3, P3; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moller S, 1996, APPL ENVIRON MICROB, V62, P4632; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thompson JN, 1994, COEVOLUTIONARY PROCE; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2	30	370	382	7	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					533	536		10.1038/nature05514	http://dx.doi.org/10.1038/nature05514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268468				2022-12-24	WOS:000243867300042
J	Yamashita, YM; Mahowald, AP; Perlin, JR; Fuller, MT				Yamashita, Yukiko M.; Mahowald, Anthony P.; Perlin, Julie R.; Fuller, Margaret T.			Asymmetric inheritance of mother versus daughter centrosome in stem cell division	SCIENCE			English	Article							DROSOPHILA; PROTEIN	Adult stem cells often divide asymmetrically to produce one self-renewed stem cell and one differentiating cell, thus maintaining both populations. The asymmetric outcome of stem cell divisions can be specified by an oriented spindle and local self-renewal signals from the stem cell niche. Here we show that developmentally programmed asymmetric behavior and inheritance of mother and daughter centrosomes underlies the stereotyped spindle orientation and asymmetric outcome of stem cell divisions in the Drosophila male germ line. The mother centrosome remains anchored near the niche while the daughter centrosome migrates to the opposite side of the cell before spindle formation.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Chicago; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Room 5403,210 Washtenaw Ave, Ann Arbor, MI 48183 USA.	yukikomy@umich.edu; fuller@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987; Yamashita, Yukiko/0000-0001-5541-0216	NIDDK NIH HHS [P01 DK053074, P01 DK53074] Funding Source: Medline; NIGMS NIH HHS [R01 GM080501] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tracey WD, 2000, GENETICS, V154, P273; TUTINA N, 2001, SCIENCE, V294, P2546; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	13	397	413	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					518	521		10.1126/science.1134910	http://dx.doi.org/10.1126/science.1134910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255513	Green Accepted			2022-12-24	WOS:000243726600048
J	Not, F; Valentin, K; Romari, K; Lovejoy, C; Massana, R; Tobe, K; Vaulot, D; Medlin, LK				Not, Fabrice; Valentin, Klaus; Romari, Khadidja; Lovejoy, Connie; Massana, Ramon; Toebe, Kerstin; Vaulot, Daniel; Medlin, Linda K.			Picobiliphytes: A marine picoplanktonic algal group with unknown affinities to other eukaryotes	SCIENCE			English	Article							COASTAL SITE; 18S RDNA; DIVERSITY	Environmental sequencing has revealed unimagined diversity among eukaryotic picoplankton. A distinct picoplanktonic algal group, initially detected from 18S ribosomal DNA ( rDNA) sequences, was hybridized with rRNA lambda-targeted (rRNA-targeted) probes, detected by tyramide signal amplification-fluorescent in situ hybridization, and showed an organelle-like body with orange fluorescence indicative of phycobilins. Using this fluorescence signal, cells were sorted by flow cytometry and probed. Hybridized cells contained a 4',6'-diamidino-2-phenylindole-stained organelle resembling a plastid with a nucleomorph. This suggests that they may be secondary endosymbiotic algae. Pending the isolation of living cells and their formal description, these algae have been termed picobiliphytes.	CNRS, Stn Biol Roscoff, CNRS, UMR 7144, F-29682 Roscoff, France; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Univ Laval, Quebec Ocean, Dept Biol, Ste Foy, PQ G1K 7P4, Canada; Inst Ciencies Mar, Barcelona 08003, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Laval University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Not, F (corresponding author), Inst Ciencies Mar, Passeig Martim Barceloneta 37-49, Barcelona 08003, Spain.	not@icm.csic.es; lkmedlin@awi-bremerhaven.de	Massana, Ramon/F-4205-2016; Vaulot, Daniel/T-6649-2019; medlin, linda k/G-4820-2010; Lovejoy, Connie/A-3756-2008; Valentin, Klaus/G-5862-2014	Vaulot, Daniel/0000-0002-0717-5685; Lovejoy, Connie/0000-0001-8027-2281; Valentin, Klaus/0000-0001-7401-9423; Massana, Ramon/0000-0001-9172-5418				Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; MCFADDEN G, 1995, TRENDS ECOL EVOL, V10, P12, DOI 10.1016/S0169-5347(00)88954-5; MEDLIN LK, 2006, MICROB ECOL, V167, P1432; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049	17	153	160	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					253	255		10.1126/science.1136264	http://dx.doi.org/10.1126/science.1136264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218530	Green Published			2022-12-24	WOS:000243407400051
J	Xu, Y; Toh, KL; Jones, CR; Shin, JY; Fu, YH; Ptacek, LJ				Xu, Y.; Toh, K. L.; Jones, C. R.; Shin, J. -Y.; Fu, Y. -H.; Ptacek, L. J.			Modeling of a human circadian mutation yields insights into clock regulation by PER2	CELL			English	Article							MOLECULAR ANALYSIS; GENE-EXPRESSION; CKI-EPSILON; PHOSPHORYLATION; PERIOD; MPER2; TRANSCRIPTION; DELTA; DROSOPHILA; COMPONENT	Circadian rhythms are endogenous oscillations of physiological and behavioral phenomena with period length of -24 hr. A mutation in human Period 2 (hPER2), a gene crucial for resetting the central clock in response to light, is associated with familial advanced sleep phase syndrome (FASPS), an autosomal dominant condition with early morning awakening and early sleep times. The FASPS hPER2 S662G mutation resulted in PER2 being hypophosphorylated by casein kinase I (CKI) in vitro. We generated transgenic mice carrying the FASPS hPER2 S662G mutation and faithfully recapitulate the human phenotype. We show that phosphorylation at S662 leads to increased PER2 transcription and suggest that phosphorylation at another site leads to PER2 degradation. Altering CK1 delta dosage modulates the S662 phenotype demonstrating that CK1 delta can regulate period through PER2 in vivo. Modeling a naturally occurring human variant in mice has yielded novel insights into PER2 regulation.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	yhf@neugenes.org; ljp@ucsf.edu	Xu, Ying/A-3009-2013; Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059596] Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; [Anonymous], [No title captured], DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177]; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Campbell S, 2000, SCIENCE, V288, P1174, DOI 10.1126/science.288.5469.1174; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	41	282	292	5	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2007	128	1					59	70		10.1016/j.cell.2006.11.043	http://dx.doi.org/10.1016/j.cell.2006.11.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218255	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000244420400013
J	Mason, MF; Norton, MI; Van Horn, JD; Wegner, DM; Grafton, ST; Macrae, CN				Mason, Malia F.; Norton, Michael I.; Van Horn, John D.; Wegner, Daniel M.; Grafton, Scott T.; Macrae, C. Neil			Wandering minds: The default network and stimulus-independent thought	SCIENCE			English	Article							BRAIN ACTIVITY; MEMORY; CONSCIOUSNESS; SELF; MODE; FMRI	Despite evidence pointing to a ubiquitous tendency of human minds to wander, little is known about the neural operations that support this core component of human cognition. Using both thought sampling and brain imaging, the current investigation demonstrated that mind-wandering is associated with activity in a default network of cortical regions that are active when the brain is "at rest." In addition, individuals' reports of the tendency of their minds to wander were correlated with activity in this network.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Harvard Univ, Harvard Business Sch, Boston, MA 02163 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Dartmouth College; Harvard University; Harvard University; University of Aberdeen	Mason, MF (corresponding author), Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	malia@nmr.mgh.harvard.edu	Macrae, Neil/C-4761-2008; Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Van Horn, John Darrell/0000-0003-1537-0816	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033504] Funding Source: NIH RePORTER; NIMH NIH HHS [MH49127] Funding Source: Medline; NINDS NIH HHS [R01 NS050614, R01 NS033504] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damasio A. R., 1983, NEUROPSYCHOLOGY HUMA, P85; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klinger E., 1971, STRUCTURE FUNCTIONS; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schooler JW, 2004, THINKING AND SEEING, P203; Schooler JW, 2002, TRENDS COGN SCI, V6, P339, DOI 10.1016/S1364-6613(02)01949-6; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Singer J. L., 1972, FUNCTION NATURE IMAG, P175; SINGER JL, 1962, INT J SOC PSYCHIATR, V8, P272, DOI 10.1177/002076406200800404; Singer JL., 1966, DAYDREAMING; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wegner DM, 1997, CARN S COGN, P295	27	1860	1898	6	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					393	395		10.1126/science.1131295	http://dx.doi.org/10.1126/science.1131295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126SI	17234951	Green Submitted, Green Accepted			2022-12-24	WOS:000243535400047
J	Wallace, HAC; Marques-Kranc, F; Richardson, M; Luna-Crespo, F; Sharpe, JA; Hughes, J; Wood, WG; Higgs, DR; Smith, AJH				Wallace, Helen A. C.; Marques-Kranc, Fatima; Richardson, Melville; Luna-Crespo, Francisco; Sharpe, Jackie A.; Hughes, Jim; Wood, William G.; Higgs, Douglas R.; Smith, Andrew J. H.			Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence	CELL			English	Article							EMBRYONIC STEM-CELLS; BACTERIAL ARTIFICIAL CHROMOSOMES; GENE-EXPRESSION; ES CELLS; REGULATORY ELEMENTS; GLOBIN CLUSTER; RECOMBINATION; DNA; MICE; IDENTIFICATION	We have devised a strategy (called recombinase-mediated genomic replacement, RMGR) to allow the replacement of large segments (> 100 kb) of the mouse genome with the equivalent human syntenic region. The technique involves modifying a mouse ES cell chromosome and a human BAC by inserting heterotypic lox sites to flank the proposed exchange interval and then using Cre recombinase to achieve segmental exchange. We have demonstrated the feasibility of this approach by replacing the mouse alpha globin regulatory domain with the human syntenic region and generating homozygous mice that produce only human a globin chains. Furthermore, modified ES cells can be used iteratively for functional studies, and here, as an example, we have used RMGR to produce an accurate mouse model of human alpha thalassemia. RMGR has general applicability and will overcome limitations inherent in current transgenic technology when studying the expression of human genes and modeling human genetic diseases.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Oxford, John Radcliffe Hosp, MRC, Weatherall Inst Mol Med,Mol Haematol Unit, Oxford OX3 9DS, England	University of Edinburgh; University of Oxford	Smith, AJH (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	andrew.smith@ed.ac.uk		Higgs, Douglas/0000-0003-3579-8705	Medical Research Council [G0300058B] Funding Source: researchfish; MRC [MC_U137961145, MC_U137961144] Funding Source: UKRI; Medical Research Council [MC_U137961144, MC_U137961145] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Anguita E, 2001, P NATL ACAD SCI USA, V98, P12114, DOI 10.1073/pnas.201413098; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bethke B, 1997, NUCLEIC ACIDS RES, V25, P2828, DOI 10.1093/nar/25.14.2828; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; COLLEDGE WH, 1995, NAT GENET, V10, P445, DOI 10.1038/ng0895-445; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kielman MF, 1996, GENOMICS, V32, P341, DOI 10.1006/geno.1996.0128; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Nagy A., 2003, MANIPULATING MOUSE E; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; PASZTY C, 1995, NAT GENET, V11, P33, DOI 10.1038/ng0995-33; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Shen W, 2005, MOL BIOTECHNOL, V31, P181, DOI 10.1385/MB:31:3:181; Smith AJH, 2002, ONCOGENE, V21, P4521, DOI 10.1038/sj.onc.1205530; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564	37	120	151	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					197	209		10.1016/j.cell.2006.11.044	http://dx.doi.org/10.1016/j.cell.2006.11.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218265	Bronze			2022-12-24	WOS:000244420400023
J	Hwang, HW; Wentzel, EA; Mendell, JT				Hwang, Hun-Way; Wentzel, Erik A.; Mendell, Joshua T.			A hexanucleotide element directs microRNA nuclear import	SCIENCE			English	Article							BIOGENESIS; TARGETS; SIRNAS; MIRNAS	MicroRNAs ( miRNAs) negatively regulate partially complementary target messenger RNAs. Target selection in animals is dictated primarily by sequences at the miRNA 5' end. We demonstrated that despite their small size, specific miRNAs contain additional sequence elements that control their posttranscriptional behavior, including their subcellular localization. We showed that human miR-29b, in contrast to other studied animal miRNAs, is predominantly localized to the nucleus. The distinctive hexanucleotide terminal motif of miR-29b acts as a transferable nuclear localization element that directs nuclear enrichment of miRNAs or small interfering RNAs to which it is attached. Our results indicate that miRNAs sharing common 5' sequences, considered to be largely redundant, might have distinct functions because of the influence of cis-acting regulatory motifs.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA.	jmendell@jhmi.edu		Hwang, Hun-Way/0000-0003-0522-1577				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806	16	514	557	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2007	315	5808					97	100		10.1126/science.1136235	http://dx.doi.org/10.1126/science.1136235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204650				2022-12-24	WOS:000243259100044
J	Catania, KC				Catania, Kenneth C.			Olfaction - Underwater 'sniffing' by semi-aquatic mammals	NATURE			English	Article							EVOLUTION		Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu						Catania KC, 2000, BRAIN BEHAV EVOLUT, V56, P146, DOI 10.1159/000047201; ESTES JA, 1989, CARNIVORE BEHAV ECOL, V1, P242; Howell A.B., 1930, AQUAT MAMM; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; REPENNING CA, 1976, SYST ZOOL, V25, P375, DOI 10.2307/2412512; Sanchez-Villagra MR, 2002, MAMMALIA, V66, P93, DOI 10.1515/mamm.2002.66.1.93; STEPHAN H, 1984, Z ZOOL SYST EVOL, V22, P328; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	9	44	45	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1024	1025		10.1038/4441024a	http://dx.doi.org/10.1038/4441024a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183311				2022-12-24	WOS:000242971100044
J	Alper, H; Moxley, J; Nevoigt, E; Fink, GR; Stephanopoulos, G				Alper, Hal; Moxley, Joel; Nevoigt, Elke; Fink, Gerald R.; Stephanopoulos, Gregory			Engineering yeast transcription machinery for improved ethanol tolerance and production	SCIENCE			English	Article							TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POLYMERASE-II; STRESS; MECHANISM; GROWTH; SAGA; DNA	Global transcription machinery engineering (gTME) is an approach for reprogramming gene transcription to elicit cellular phenotypes important for technological applications. Here we show the application of gTME to Saccharomyces cerevisiae for improved glucose/ethanol tolerance, a key trait for many biofuels programs. Mutagenesis of the transcription factor Spt15p and selection led to dominant mutations that conferred increased tolerance and more efficient glucose conversion to ethanol. The desired phenotype results from the combined effect of three separate mutations in the SPT15 gene [ serine substituted for phenylalanine ( Phe(177)Ser) and, similarly, Tyr(195)His, and Lys(218)Arg]. Thus, gTME can provide a route to complex phenotypes that are not readily accessible by traditional methods.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Berlin Univ Technol, Dept Microbiol & Genet, D-13353 Berlin, Germany; MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Technical University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Room 56-469, Cambridge, MA 02139 USA.	gregstep@mit.edu	Nevoigt, Elke/F-5887-2010		NIGMS NIH HHS [GM035010] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010, R37GM035010] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER HHS, 2006, THESIS MIT; Bai FW, 2004, J BIOTECHNOL, V110, P287, DOI 10.1016/j.jbiotec.2004.01.017; Cakar ZP, 2005, FEMS YEAST RES, V5, P569, DOI 10.1016/j.femsyr.2004.10.010; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Furukawa K, 2004, J BIOSCI BIOENG, V98, P107, DOI [10.1016/S1389-1723(04)70250-9, 10.1263/jbb.98.107]; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Klejman MP, 2005, NUCLEIC ACIDS RES, V33, P5426, DOI 10.1093/nar/gki850; Kou HP, 2003, MOL CELL BIOL, V23, P3186, DOI 10.1128/MCB.23.9.3186-3201.2003; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Nozawa M, 2002, J BIOSCI BIOENG, V93, P288, DOI 10.1263/jbb.93.288; OCONNOR GM, 1992, BIOTECHNOL BIOENG, V39, P293, DOI 10.1002/bit.260390307; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STININGER B, 2005, APPL MICROBIAL BIOTE, DOI DOI 10.1007/S00253-006-0435-1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; THATIPAMALA R, 1992, BIOTECHNOL BIOENG, V40, P289, DOI 10.1002/bit.260400213; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359	27	562	680	5	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1565	1568		10.1126/science.1131969	http://dx.doi.org/10.1126/science.1131969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158319				2022-12-24	WOS:000242624600032
J	Sane, SP; Dieudonne, A; Willis, MA; Daniel, TL				Sane, Sanjay P.; Dieudonne, Alexandre; Willis, Mark A.; Daniel, Thomas L.			Antennal mechanosensors mediate flight control in moths	SCIENCE			English	Article							AGLAIS-URTICAE L; CURRENT SENSE-ORGANS; MECHANICAL-PROPERTIES; BLOWFLY CALLIPHORA; LOCUSTA-MIGRATORIA; VISUAL CONTROL; L-LEPIDOPTERA; ORGANIZATION; EQUILIBRIUM; MOVEMENT	Flying insects have evolved sophisticated sensory capabilities to achieve rapid course control during aerial maneuvers. Among two-winged insects such as houseflies and their relatives, the hind wings are modified into club-shaped, mechanosensory halteres, which detect Coriolis forces and thereby mediate flight stability during maneuvers. Here, we show that mechanosensory input from the antennae serves a similar role during flight in hawk moths, which are four-winged insects. The antennae of flying moths vibrate and experience Coriolis forces during aerial maneuvers. The antennal vibrations are transduced by individual units of Johnston's organs at the base of their antennae in a frequency range characteristic of the Coriolis input. Reduction of the mechanical input to Johnston's organs by removing the antennal flagellum of these moths severely disrupted their flight stability, but reattachment of the flagellum restored their flight control. The antennae thus play a crucial role in maintaining flight stability of moths.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; Case Western Reserve University	Sane, SP (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	sane@u.washington.edu						Chan WP, 1998, SCIENCE, V280, P289, DOI 10.1126/science.280.5361.289; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Dayan P., 2005, THEORETICAL NEUROSCI; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; GEWECKE M, 1980, J COMP PHYSIOL, V139, P357, DOI 10.1007/BF00610466; Gewecke M., 1974, P100; GEWECKE M, 1970, NATURE, V225, P1263, DOI 10.1038/2251263a0; GEWECKE M, 1981, J COMP PHYSIOL, V145, P249, DOI 10.1007/BF00605037; HEINZEL HG, 1987, J COMP PHYSIOL A, V161, P671, DOI 10.1007/BF00605008; Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767; NALBACH G, 1994, J COMP PHYSIOL A, V175, P695; NALBACH G, 1993, J COMP PHYSIOL A, V173, P293, DOI 10.1007/BF00212693; NIEHAUS M, 1978, ZOOMORPHOLOGIE, V91, P19, DOI 10.1007/BF00994151; NIEHAUS M, 1981, J COMP PHYSIOL, V145, P257, DOI 10.1007/BF00605038; OLBERG RM, 1981, J COMP PHYSIOL, V141, P327, DOI 10.1007/BF00609935; PIX W, 1993, NATURWISSENSCHAFTEN, V80, P371, DOI 10.1007/BF01138795; PRINGLE JWS, 1948, PHILOS T ROY SOC B, V233, P347, DOI 10.1098/rstb.1948.0007; Robert D, 2002, J INSECT PHYSIOL, V48, P189, DOI 10.1016/S0022-1910(01)00163-9; Sane SP, 2006, J EXP BIOL, V209, P43, DOI 10.1242/jeb.01958; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Schneider D., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P287; VANDEBERG JS, 1971, J MORPHOL, V133, P439, DOI 10.1002/jmor.1051330407; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P553, DOI 10.1098/rstb.1986.0018; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; WIGGLESWORTH VB, 1946, NATURE, V157, P655, DOI 10.1038/157655a0	26	200	210	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					863	866		10.1126/science.1133598	http://dx.doi.org/10.1126/science.1133598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290001				2022-12-24	WOS:000244069000074
J	Prochnow, C; Bransteitter, R; Klein, MG; Goodman, MF; Chen, XJS				Prochnow, Courtney; Bransteitter, Ronda; Klein, Michael G.; Goodman, Myron F.; Chen, Xiaojiang S.			The APOBEC-2 crystal structure and functional implications for the deaminase AID	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; ANTIVIRAL ACTIVITY; EDITING ENZYMES; RESOLUTION; MUTATIONS; MECHANISM; FAMILY; HIV-1; DNA	APOBEC-2 (APO2) belongs to the family of apolipoprotein B messenger RNA-editing enzyme catalytic ( APOBEC) polypeptides, which deaminates mRNA and single-stranded DNA(1,2). Different APOBEC members use the same deamination activity to achieve diverse human biological functions. Deamination by an APOBEC protein called activation-induced cytidine deaminase ( AID) is critical for generating high-affinity antibodies(3), and deamination by APOBEC-3 proteins can inhibit retrotransposons and the replication of retroviruses such as human immunodeficiency virus and hepatitis B virus(4-7). Here we report the crystal structure of APO2. APO2 forms a rod-shaped tetramer that differs markedly from the square-shaped tetramer of the free nucleotide cytidine deaminase, with which APOBEC proteins share considerable sequence homology. In APO2, two long alpha-helices of a monomer structure prevent the formation of a square-shaped tetramer and facilitate formation of the rod-shaped tetramer via head-to-head interactions of two APO2 dimers. Extensive sequence homology among APOBEC family members allows us to test APO2 structure-based predictions using AID. We show that AID deamination activity is impaired by mutations predicted to interfere with oligomerization and substrate access. The structure suggests how mutations in patients with hyper-IgM-2 syndrome inactivate AID, resulting in defective antibody maturation.	Univ So Calif, Los Angeles, CA 90089 USA	University of Southern California	Chen, XJS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu						Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bransteitter R, 2006, J BIOL CHEM, V281, P16833, DOI 10.1074/jbc.R600006200; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Franca R, 2006, MED SCI MONITOR, V12, pRA92; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pham P, 2005, BIOCHEMISTRY-US, V44, P2703, DOI 10.1021/bi047481+; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; Teng BB, 1999, J LIPID RES, V40, P623; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WANG J, IN PRESS J BIOL CHEM; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	28	163	175	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					447	451		10.1038/nature05492	http://dx.doi.org/10.1038/nature05492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17187054				2022-12-24	WOS:000243689500044
J	Farooqi, IS; Wangensteen, T; Collins, S; Kimber, W; Matarese, G; Keogh, JM; Lank, E; Bottomley, B; Lopez-Fernandez, J; Ferraz-Amaro, I; Dattani, MT; Ercan, O; Myhre, AG; Retterstol, L; Stanhope, R; Edge, JA; McKenzie, S; Lessan, N; Ghodsi, M; De Rosa, V; Perna, F; Fontana, S; Barroso, I; Undlien, DE; O'Rahilly, S				Farooqi, I. Sadaf; Wangensteen, Teresia; Collins, Stephan; Kimber, Wendy; Matarese, Giuseppe; Keogh, Julia M.; Lank, Emma; Bottomley, Bill; Lopez-Fernandez, Judith; Ferraz-Amaro, Ivan; Dattani, Mehul T.; Ercan, Oya; Myhre, Anne Grethe; Retterstol, Lars; Stanhope, Richard; Edge, Julie A.; McKenzie, Sheila; Lessan, Nader; Ghodsi, Maryam; De Rosa, Veronica; Perna, Francesco; Fontana, Silvia; Barroso, Ines; Undlien, Dag E.; O'Rahilly, Stephen			Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY-ONSET OBESITY; BODY-MASS INDEX; MORBID-OBESITY; MISSENSE MUTATION; METABOLIC-RATE; HYPOGONADISM; DYSFUNCTION; HUMANS; GROWTH; ASSOCIATION	BACKGROUND: A single family has been described in which obesity results from a mutation in the leptin-receptor gene (LEPR), but the prevalence of such mutations in severe, early-onset obesity has not been systematically examined. METHODS: We sequenced LEPR in 300 subjects with hyperphagia and severe early-onset obesity, including 90 probands from consanguineous families, and investigated the extent to which mutations cosegregated with obesity and affected receptor function. We evaluated metabolic, endocrine, and immune function in probands and affected relatives. RESULTS: Of the 300 subjects, 8 (3%) had nonsense or missense LEPR mutations -- 7 were homozygotes, and 1 was a compound heterozygote. All missense mutations resulted in impaired receptor signaling. Affected subjects were characterized by hyperphagia, severe obesity, alterations in immune function, and delayed puberty due to hypogonadotropic hypogonadism. Serum leptin levels were within the range predicted by the elevated fat mass in these subjects. Their clinical features were less severe than those of subjects with congenital leptin deficiency. CONCLUSIONS: The prevalence of pathogenic LEPR mutations in a cohort of subjects with severe, early-onset obesity was 3%. Circulating levels of leptin were not disproportionately elevated, suggesting that serum leptin cannot be used as a marker for leptin-receptor deficiency. Congenital leptin-receptor deficiency should be considered in the differential diagnosis in any child with hyperphagia and severe obesity in the absence of developmental delay or dysmorphism.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Cambridge, England; Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, London, England; John Radcliffe Hosp, Oxford OX3 9DU, England; Royal London Hosp, London E1 1BB, England; Univ Oslo, Ulleval Univ Hosp, Oslo, Norway; Rikshosp Radiumhosp Med Ctr, Oslo, Norway; Univ Naples Federico 2, Naples, Italy; CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; Hosp Univ Canarias, Tenerife, Spain; Istanbul Univ, Cerrahpasa Med Fac, Fatih Istanbul, Turkey; Univ Tehran Med Sci, Shariati Hosp, Tehran, Iran	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Oxford; Barts Health NHS Trust; Royal London Hospital; University of Oslo; University of Oslo; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universidad de la Laguna; Istanbul University; Istanbul University - Cerrahpasa; Tehran University of Medical Sciences	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge Inst Med Res, Hills Rd,Box 232, Cambridge CB2 2QQ, England.	isf20@cam.ac.uk	Ghodsi, Maryam/HGB-1575-2022; Ghodsi, Masoud/A-9403-2017; O'Rahilly, Stephen/ABF-6509-2020; Ercan, Oya/A-9654-2018; Matarese, Giuseppe/AAO-4077-2021; Ferraz-Amaro, Ivan/X-1489-2019; Farooqi, Ismaa Sadaf/AAZ-3046-2020; De Rosa, Veronica/K-6534-2016; ercan, oya/AAS-5035-2020; DATTANI, MEHUL/C-5401-2008; collins, stephan c/P-4409-2016	Ghodsi, Maryam/0000-0001-8940-3970; Ghodsi, Masoud/0000-0002-9127-8635; O'Rahilly, Stephen/0000-0003-2199-4449; Ercan, Oya/0000-0001-7397-2837; Matarese, Giuseppe/0000-0001-9429-0616; Ferraz-Amaro, Ivan/0000-0003-0197-5267; De Rosa, Veronica/0000-0002-9477-0991; collins, stephan c/0000-0002-1533-3380; Barroso, Ines/0000-0001-5800-4520; PERNA, Francesco/0000-0001-5319-0977; Farooqi, Sadaf/0000-0001-7609-3504	MRC [G0502115] Funding Source: UKRI; Medical Research Council [G0502115] Funding Source: Medline; Telethon [GJT04008] Funding Source: Medline; Wellcome Trust [077016, 067457, 068086] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome Trust)		BRAY GA, 1990, PROG NEUROENDOCRINOL, V4, P128; Casanueva FF, 1998, BAILLIERE CLIN ENDOC, V12, P297, DOI 10.1016/S0950-351X(98)80024-4; Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Echwald SM, 1997, BIOCHEM BIOPH RES CO, V233, P248, DOI 10.1006/bbrc.1997.6430; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; FOMON SJ, 1982, AM J CLIN NUTR    S1, V35, P169; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HAYTER JE, 1993, EUR J CLIN NUTR, V47, P724; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kiess W, 2001, Obes Rev, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lahlou N, 2000, DIABETES, V49, P1347, DOI 10.2337/diabetes.49.8.1347; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MOLNAR D, 1995, J PEDIATR-US, V127, P571, DOI 10.1016/S0022-3476(95)70114-1; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ozata M, 2000, J CLIN ENDOCR METAB, V85, P416; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	32	425	445	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					237	247		10.1056/NEJMoa063988	http://dx.doi.org/10.1056/NEJMoa063988			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229951	Green Accepted			2022-12-24	WOS:000243488100006
J	Grantham-McGregor, S; Cheung, YB; Cueto, S; Glewwe, P; Richter, L; Strupp, B				Grantham-McGregor, Sally; Cheung, Yin Bun; Cueto, Santiago; Glewwe, Paul; Richter, Linda; Strupp, Barbara		Int Child Dev Steering Grp	Child development in developing countries 1 - Developmental potential in the first 5 years for children in developing countries	LANCET			English	Review							COGNITIVE-DEVELOPMENT; PRIMARY-SCHOOL; ZINC SUPPLEMENTATION; SOCIOECONOMIC-STATUS; MENTAL-DEVELOPMENT; MOTOR DEVELOPMENT; MATERNAL-CARE; FAMILY CHARACTERISTICS; NUTRITIONAL-STATUS; JAMAICAN CHILDREN	Many children younger than 5 years in developing countries are exposed to multiple risks, including poverty, malnutrition, poor health, and unstimulating home environments, which detrimentally affect their cognitive, motor, and social-emotional development. There are few national statistics on the development of young children in developing countries. We therefore identified two factors with available worldwide data-the prevalence of early childhood stunting and the number of people living in absolute poverty-to use as indicators of poor development. We show that both indicators are closely associated with poor cognitive and educational performance in children and use them to estimate that over 200 million children under 5 years are not fulfilling their developmental potential. Most of these children live in south Asia and sub-Saharan Africa. These disadvantaged children are likely to do poorly in school and subsequently have low incomes, high fertility, and provide poor care for their children, thus contributing to the intergenerational transmission of poverty.	UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; London Sch Hyg & Trop Med, London WC1, England; Grp Anal Dev, Lima, Peru; Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA; Human Sci Res Council, Cape Town, South Africa; Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Human Sciences Research Council-South Africa; Cornell University; Cornell University	Grantham-McGregor, S (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England.	s.mcgregor@ich.ucl.ac.uk	Fahimifar, Sepideh/M-5303-2019; Cueto, Santiago/Q-7168-2019	Cueto, Santiago/0000-0002-0639-3429	Medical Research Council [G0700837] Funding Source: Medline; Wellcome Trust [068599] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; AGARWAL DK, 1987, 6 NUTR FDN IND; Aldaz-Carroll E., 2001, CUAD ECON, V38, P155, DOI [10.4067/S0717-68212001011400003, DOI 10.4067/S0717-68212001011400003]; Alderman H, 1997, ECON DEV CULT CHANGE, V46, P97, DOI 10.1086/452323; [Anonymous], 2005, STAT WORLDS CHILDR 2; Baker-Henningham H, 2003, EUR J CLIN NUTR, V57, P786, DOI 10.1038/sj.ejcn.1601611; BAKERHENNINGHAM H, 2006, SPECIAL ED NEEDS STU; Basilio CS, 2005, REV SAUDE PUBL, V39, P725, DOI 10.1590/S0034-89102005000500005; Beasley NMR, 2000, ACTA TROP, V76, P223, DOI 10.1016/S0001-706X(00)00101-7; Behrman JR, 1999, WORLD BANK ECON REV, V13, P211, DOI 10.1093/wber/13.2.211; BEHRMAN JR, 2005, WHAT DETERMINES ADUL; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Bhandari N, 2002, B WORLD HEALTH ORGAN, V80, P189; Bhargava A, 2000, AM J PHYS ANTHROPOL, V111, P89, DOI 10.1002/(SICI)1096-8644(200001)111:1&lt;89::AID-AJPA6&gt;3.0.CO;2-X; BLACK J, 1998, HDB CHILD ADOLESCENT, V1, P31; Black MM, 2004, PEDIATRICS, V113, P1297, DOI 10.1542/peds.113.5.1297; BOGIN B, 1983, CHILD DEV, V54, P115, DOI 10.2307/1129868; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Brito GNO, 2004, ARQ NEURO-PSIQUIAT, V62, P949, DOI 10.1590/S0004-282X2004000600004; Brooker S, 1999, SOC SCI MED, V48, P675, DOI 10.1016/S0277-9536(98)00382-7; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; BYAMUGISHA A, 2005, SACMEQ II PROJECT UG; CHEN S, 2004, 3341 WPS; Cheung YB, 2001, INT J EPIDEMIOL, V30, P66, DOI 10.1093/ije/30.1.66; Cheung YB, 2006, STAT MED, V25, P3011, DOI 10.1002/sim.2467; CHIMOMBO J, 2005, SACMEQ II PROJECT MA; *CHRON POV RES CTR, 2006, CHRON POV REP 2004 0; CLARKE NMA, 1990, ECOL FOOD NUTR, V26, P1; *COMM INT SCI CHIL, 2000, NEUR NEIGHB SCI CHIL; Cueto Santiago, 2005, Food and Nutrition Bulletin, V26, pS251; Currie J., 1999, 6943 NAT BUR EC RES; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; De Onis M, 2006, WHO CHILD GROWTH STA; Deaton A, 2001, WORLD BANK RES OBSER, V16, P125, DOI 10.1093/wbro/16.2.125; Drewett R, 2001, J CHILD PSYCHOL PSYC, V42, P181, DOI 10.1111/1469-7610.00709; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Espy KA, 2001, MERRILL PALMER QUART, V47, P42, DOI 10.1353/mpq.2001.0001; Feinstein L, 2003, ECONOMICA, V70, P73, DOI 10.1111/1468-0335.t01-1-00272; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FLORENCIO C, 1988, NUTR HLTH OTHER DETE; FRANKENBERG E, 1995, J POPULAT, V1, P21; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; GLEWWE P, 1995, REV ECON STAT, V77, P156, DOI 10.2307/2110001; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; GONZALEZ P, 2004, HIGHLIGHTS TRENDS IN; GORDON G, 2003, CHILD POVERTY DEV WO; Gorman KS, 1996, CHILD DEV, V67, P314; Grantham-McGregor SM., 2004, REPORT FAMILY CARE I, DOI [10.7249/rb4545-1, DOI 10.7249/RB4545-1]; Griffiths R., 1970, ABILITIES YOUNG CHIL; GUNNAR M, IN PRESS W ED; Hall A, 2001, EUR J CLIN NUTR, V55, P801, DOI 10.1038/sj.ejcn.1601229; Hamadani JD, 2001, AM J CLIN NUTR, V74, P381; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Hamill PV, 1977, VITAL HLTH STAT 11, V11, P1; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; Hutchinson SE, 1997, EUR J CLIN NUTR, V51, P729, DOI 10.1038/sj.ejcn.1600473; Ivanovic DA, 2004, NUTRITION, V20, P878, DOI 10.1016/j.nut.2004.06.009; JAMISON DT, 1986, J DEV ECON, V20, P299, DOI 10.1016/0304-3878(86)90026-X; JOHNSTON FE, 1987, AM J PHYS ANTHROPOL, V73, P501, DOI 10.1002/ajpa.1330730412; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kariger PK, 2005, J NUTR, V135, P814; KEITHEILE M, 2005, SACMEQ II PROJECT BO; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; Kuklina EV, 2004, J NUTR, V134, P3296; KULPOO D, 2005, SACMEQ II PROJECT MA; Lam D, 1999, J HUM RESOUR, V34, P160, DOI 10.2307/146306; LASKY RE, 1981, CHILD DEV, V52, P219; Liddell C, 2001, BRIT J EDUC PSYCHOL, V71, P413, DOI 10.1348/000709901158596; Lima MC, 2004, ACTA PAEDIATR, V93, P969, DOI 10.1111/j.1651-2227.2004.tb18257.x; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lozoff B, 2004, PEDIATR RES, V55, p23A; Maitra P, 2004, J HEALTH POPUL NUTR, V22, P84; MAKUWA D, 2005, SACMEQ II PROJECT NA; MARTORELL R, 1995, J NUTR, V125, pS1060; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1991, PSYCHONEUROENDOCRINO, V16, P85, DOI 10.1016/0306-4530(91)90072-2; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Mistry RS, 2004, DEV PSYCHOL, V40, P727, DOI 10.1037/0012-1649.40.5.727; MOLO I, 2005, SACMEQ II PROJECT S; MONCKEBERG F, 1972, SCI PUBLICATION, V251, P48; MOOCK PR, 1986, J DEV ECON, V20, P33, DOI 10.1016/0304-3878(86)90004-0; Morgan RE, 2001, NEUROTOXICOL TERATOL, V23, P519, DOI 10.1016/S0892-0362(01)00171-4; MOTHIBELI A, 2005, SACMEQ II PROJECT LE; MRUTU AS, 2005, SACMEQ II PROJECT TA; NASSOR SM, 2005, SACMEQ II PROJECT ZA; *NICHD EARL CHILD, 2001, EARLY ED DEV, V0012; ONSOMU E, 2005, SACMEQ II PROJECT KE; Ozmert EN, 2005, J TROP PEDIATRICS, V51, P25, DOI 10.1093/tropej/fmh070; PASSOS A, 2005, SACMEQ II PROJECT MO; Pianta RC, 1997, J APPL DEV PSYCHOL, V18, P1, DOI 10.1016/S0193-3973(97)90011-3; POLLITT E, 1993, MON SOC CHILD DEV, V58; POPKIN BM, 1982, SOC SCI MED, V16, P53, DOI 10.1016/0277-9536(82)90423-3; POWELL CA, 1985, AM J CLIN NUTR, V41, P1322, DOI 10.1093/ajcn/41.6.1322; PSACHAROPOULOS G, 1989, ECON DEV CULT CHANGE, V37, P683, DOI 10.1086/451755; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Raven J., 1998, COLOURED PROGR MATRI; RICHTER L, 1998, VIEW SCH PREPARATION; RICHTER LM, 1995, PAEDIATR PERINAT EP, V9, P109, DOI 10.1111/j.1365-3016.1995.tb00124.x; Rodier PM, 2004, PEDIATRICS, V113, P1076; ROSENZWEIG MR, 1994, J HUM RESOUR, V29, P670, DOI 10.2307/146115; Rutter M, 2004, DEV PSYCHOL, V40, P81, DOI 10.1037/0012-1649.40.1.81; RUTTER M, 1989, J CHILD PSYCHOL PSYC, V30, P23, DOI 10.1111/j.1469-7610.1989.tb00768.x; Sattler, 1986, STANFORD BINET INTEL; Schady N, 2005, 3605 WORLD BANK; SHABALALA J, 2005, SACMEQ II PROJECT SW; Shariff ZM, 2000, ASIA PAC J CLIN NUTR, V9, P264, DOI 10.1046/j.1440-6047.2000.00191.x; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Siegel EH, 2005, J NUTR, V135, P2840, DOI 10.1093/jn/135.12.2840; SIGMAN M, 1989, J PEDIATR-US, V115, P357, DOI 10.1016/S0022-3476(89)80832-7; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; SIGMAN M, 1989, CHILD DEV, V60, P1463, DOI 10.2307/1130935; STEEGMANN AT, 1992, AM J HUM BIOL, V4, P247, DOI 10.1002/ajhb.1310040209; Stein Aryeh D., 2005, Food and Nutrition Bulletin, V26, pS46; Stith AY, 2003, APPL PSYCHOL-INT REV, V52, P614, DOI 10.1111/1464-0597.00154; Thompson RA, 2001, AM PSYCHOL, V56, P5, DOI 10.1037//0003-066X.56.1.5; *UN, 2002, ROAD MAP IMPL UN MIL; UNESCO, 2005, EFA GLOBAL MONITORIN; *UNICEF, 2006, MULT IND CLUST SURV, V2; Vazir S, 1998, Indian Pediatr, V35, P959; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; VICTORA CG, 2003, CAD SAUDE PUBLICA, P1241; VICTORA MD, 1990, CHILD CARE HLTH DEV, V16, P151, DOI 10.1111/j.1365-2214.1990.tb00647.x; Wachs T., 2000, NECESSARY NOT SUFFIC; WALKER SP, 1990, W INDIAN MED J, V39, P12; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Webb KE, 2005, EUR J CLIN NUTR, V59, P618, DOI 10.1038/sj.ejcn.1602103; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wechsler D., 2008, WAIS 4 WECHSLER ADUL, V4th ed.; Wechsler DW., 1999, INTELLIGENCE SCALE C; WHO, 2006, GLOB DAT CHILD GROWT; Wilson MA, 2000, P NATL ACAD SCI USA, V97, P5540, DOI 10.1073/pnas.97.10.5540; *WORLD BANK, 2005, WORLD DEV IND 2005; World Health Organization, 2006, INT STAT CLASS DIS R; *YOUNG LIV, 2002, JUST CONT 7 5 8 5 YE	138	1785	1839	14	351	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					60	70		10.1016/S0140-6736(07)60032-4	http://dx.doi.org/10.1016/S0140-6736(07)60032-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125AK	17208643	Green Published, Green Accepted			2022-12-24	WOS:000243413700030
J	Zheng, Y; Josefowicz, SZ; Kas, A; Chu, TT; Gavin, MA; Rudensky, AY				Zheng, Ye; Josefowicz, Steven Z.; Kas, Arnold; Chu, Tin-Tin; Gavin, Marc A.; Rudensky, Alexander Y.			Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; PHOSPHORYLATION; OCCUPANCY; LYMPHOMAS; BINDING; MICE; RNA	Transcription factor Foxp3 ( forkhead box P3), restricted in its expression to a specialized regulatory CD4(+) T-cell subset (T-R) with a dedicated suppressor function, controls T-R lineage development. In humans and mice, Foxp3 deficiency results in a paucity of T-R cells and a fatal breach in immunological tolerance, causing highly aggressive multi-organ autoimmune pathology(1-3). Here, through genome-wide analysis combining chromatin immunoprecipitation with mouse genome tiling array profiling, we identify Foxp3 binding regions for 700 genes and for an intergenically encoded microRNA. We find that a large number of Foxp3-bound genes are up-or downregulated in Foxp3(+) T cells, suggesting that Foxp3 acts as both a transcriptional activator and repressor. Foxp3-mediated regulation unique to the thymus affects, among others, genes encoding nuclear factors that control gene expression and chromatin remodelling. In contrast, Foxp3 target genes shared by the thymic and peripheral T-R cells encode primarily plasma membrane proteins, as well as cell signalling proteins. Together, our studies suggest that distinct transcriptional sub-programmes implemented by Foxp3 establish T-R lineage during differentiation and its proliferative and functional competence in the periphery.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	aruden@u.washington.edu	Zheng, Ye/G-4866-2015; Josefowicz, Steven Z/B-8716-2011	Zheng, Ye/0000-0001-5012-4309; josefowicz, steven/0000-0001-7453-779X				Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; GAVIN MA, IN PRESS NATURE; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	18	651	694	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					936	940		10.1038/nature05563	http://dx.doi.org/10.1038/nature05563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17237761				2022-12-24	WOS:000244341200054
J	Kurakawa, T; Ueda, N; Maekawa, M; Kobayashi, K; Kojima, M; Nagato, Y; Sakakibara, H; Kyozuka, J				Kurakawa, Takashi; Ueda, Nanae; Maekawa, Masahiko; Kobayashi, Kaoru; Kojima, Mikiko; Nagato, Yasuo; Sakakibara, Hitoshi; Kyozuka, Junko			Direct control of shoot meristem activity by a cytokinin-activating enzyme	NATURE			English	Article							RESPONSE REGULATORS; ARABIDOPSIS; BIOSYNTHESIS; EXPRESSION; GENES; RICE; METABOLISM; PLANTS; ISOPENTENYLTRANSFERASE; ENCODES	The growth of plants depends on continuous function of the meristems. Shoot meristems are responsible for all the post-embryonic aerial organs, such as leaves, stems and flowers(1). It has been assumed that the phytohormone cytokinin has a positive role in shoot meristem function(2-4). A severe reduction in the size of meristems in a mutant that is defective in all of its cytokinin receptors has provided compelling evidence that cytokinin is required for meristem activity(5,6). Here, we report a novel regulation of meristem activity, which is executed by the meristem-specific activation of cytokinins. The LONELY GUY ( LOG) gene of rice is required to maintain meristem activity and its loss of function causes premature termination of the shoot meristem. LOG encodes a novel cytokinin-activating enzyme that works in the final step of bioactive cytokinin synthesis. Revising the long-held idea of multistep reactions, LOG directly converts inactive cytokinin nucleotides to the free-base forms, which are biologically active, by its cytokinin-specific phosphoribohydrolase activity. LOG messenger RNA is specifically localized in shoot meristem tips, indicating the activation of cytokinins in a specific developmental domain. We propose the fine-tuning of concentrations and the spatial distribution of bioactive cytokinins by a cytokinin-activating enzyme as a mechanism that regulates meristem activity.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Okayama Univ, Res inst Bioresources, Okayama 7100046, Japan	University of Tokyo; RIKEN; Okayama University	Kyozuka, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan.	sakaki@riken.jp; akyozuka@mail.ecc.u-tokyo.ac.jp	Kojima, Mikiko/D-1459-2017; Kyozuka, Junko/E-7844-2012; Ding, Cheng-Qiang/B-6287-2011; Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492; Kyozuka, Junko/0000-0003-2242-7171				Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; CHEN CM, 1981, PLANT PHYSIOL, V68, P1020, DOI 10.1104/pp.68.5.1020; CHEN CM, 1981, PLANT PHYSIOL, V67, P494, DOI 10.1104/pp.67.3.494; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Jain M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-1; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KOUCHI H, 1995, PLANT CELL, V7, P1143, DOI 10.1105/tpc.7.8.1143; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Moriguchi K, 2001, J MOL BIOL, V307, P771, DOI 10.1006/jmbi.2001.4488; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	30	607	675	14	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					652	655		10.1038/nature05504	http://dx.doi.org/10.1038/nature05504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287810				2022-12-24	WOS:000244039400045
J	Grabe, M; Lai, HC; Jain, M; Jan, YN; Jan, LY				Grabe, Michael; Lai, Helen C.; Jain, Monika; Jan, Yuh Nung; Jan, Lily Yeh			Structure prediction for the down state of a potassium channel voltage sensor	NATURE			English	Article							DEPENDENT K+ CHANNEL; GATING-CHARGE; PORE DOMAIN; MOLECULAR-MOVEMENT; CRYSTAL-STRUCTURE; S4; DISPLACEMENT; KAT1	Voltage-gated potassium (Kv) channels, essential for regulating potassium uptake and cell volume in plants and electrical excitability in animals, switch between conducting and non-conducting states as a result of conformational changes in the four voltage-sensing domains (VSDs) that surround the channel pore(1\). This process, known as gating, is initiated by a cluster of positively charged residues on the fourth transmembrane segment (S4) of each VSD, which drives the VSD into a 'down state' at negative voltages and an 'up state' at more positive voltages(2). The crystal structure of Kv1.2 probably corresponds to the up state(3), but the local environment of S4 in the down state and its motion in voltage gating remains unresolved(4-6). Here we employed several conditional lethal/second-site suppressor yeast screens to determine the transmembrane packing of the VSD in the down state. This screen relies on the ability of KAT1, a eukaryotic Kv channel, to conduct potassium when its VSDs are in the down state, thereby rescuing potassium-transport-deficient yeast(7). Starting with KAT1 channels bearing conditional lethal mutations, we identified second-site suppressor mutations throughout the VSD that recover yeast growth. We then constructed a down state model of the channel using six pairs of interacting residues as structural constraints and verified this model by engineering suppressor mutations on the basis of spatial considerations. A comparison of this down state model with the up state Kv1.2 structure suggests that the VSDs undergo large rearrangements during gating, whereas the S4 segment remains positioned between the central pore and the remainder of the VSD in both states.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Grabe, Michael/B-3705-2009	Lai, Helen/0000-0003-4334-0243; Jan, Lily/0000-0003-3938-8498				ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047	28	62	63	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					550	553		10.1038/nature05494	http://dx.doi.org/10.1038/nature05494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17187053				2022-12-24	WOS:000243867300046
J	Vallina, SM; Simo, R				Vallina, Sergio M.; Simo, Rafel			Strong relationship between DMS and the solar radiation dose over the global surface ocean	SCIENCE			English	Article							ATMOSPHERIC SULFUR; DIMETHYLSULFIDE; CLIMATE; SEA	Marine biogenic dimethylsulfide (DMS) is the main natural source of tropospheric sulfur, which may play a key role in cloud formation and albedo over the remote ocean. Through a global data analysis, we found that DMS concentrations are highly positively correlated with the solar radiation dose in the upper mixed layer of the open ocean, irrespective of latitude, plankton biomass, or temperature. This is a necessary condition for the feasibility of a negative feedback in which light-attenuating DMS emissions are in turn driven by the light dose received by the pelagic ecosystem.	CSIC, Inst Ciencias Mar, E-08003 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Vallina, SM (corresponding author), CSIC, Inst Ciencias Mar, Passeig Maritim Barceloneta 37-49, E-08003 Barcelona, Catalonia, Spain.	sergio.vallina@icm.csic.es; rsimo@icm.csic.es		VALLINA, Sergio/0000-0002-1335-9237; Simo, Rafel/0000-0003-3276-7663				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chuck AL, 2002, SCIENCE, V297, P1151, DOI 10.1126/science.1073896; Dacey JWH, 1998, DEEP-SEA RES PT I, V45, P2085, DOI 10.1016/S0967-0637(98)00048-X; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; Meir P, 2006, TRENDS ECOL EVOL, V21, P254, DOI 10.1016/j.tree.2006.03.005; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001829; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Toole DA, 2006, DEEP-SEA RES PT I, V53, P136, DOI 10.1016/j.dsr.2005.09.003; Toole DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019581; Vallina SM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002597	24	209	220	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					506	508		10.1126/science.1133680	http://dx.doi.org/10.1126/science.1133680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255509				2022-12-24	WOS:000243726600044
J	Huang, DT; Hunt, HW; Zhuang, M; Ohi, MD; Holton, JM; Schulman, BA				Huang, Danny T.; Hunt, Harold W.; Zhuang, Min; Ohi, Melanie D.; Holton, James M.; Schulman, Brenda A.			Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity	NATURE			English	Article							ACTIVATING ENZYME; CRYSTAL-STRUCTURE; MECHANISM; BINDING; E1; NEDD8; CONJUGATION; INSIGHTS; COMPLEX; SYSTEM	Ubiquitin-like proteins (UBLs) are conjugated by dynamic E1-E2-E3 enzyme cascades. E1 enzymes activate UBLs by catalysing UBL carboxy-terminal adenylation, forming a covalent E1, UBL thioester intermediate, and generating a thioester-linked E2 similar to UBL product, which must be released for subsequent reactions. Here we report the structural analysis of a trapped UBL activation complex for the human NEDD8 pathway, containing NEDD8's heterodimeric E1 (APPBP1-UBA3), two NEDD8s ( one thioester-linked to E1, one noncovalently associated for adenylation), a catalytically inactive E2 (Ubc12), and MgATP. The results suggest that a thioester switch toggles E1 - E2 affinities. Two E2 binding sites depend on NEDD8 being thioester-linked to E1. One is unmasked by a striking E1 conformational change. The other comes directly from the thioester-bound NEDD8. After NEDD8 transfer to E2, reversion to an alternate E1 conformation would facilitate release of the E2, NEDD8 thioester product. Thus, transferring the UBL's thioester linkage between successive conjugation enzymes can induce conformational changes and alter interaction networks to drive consecutive steps in UBL cascades.	St Jude Childrens Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Struct Biol & Genet, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Interdisciplinary Program, Memphis, TN 38163 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schulman, BA (corresponding author), St Jude Childrens Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.	brenda.schulman@stjude.org	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA021765, P30 CA021765-31] Funding Source: Medline; NIGMS NIH HHS [R01 GM069530, R01 GM077053-02, R01 GM077053, R01 GM069530-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077053, R01GM069530] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	34	164	167	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					394	398		10.1038/nature05490	http://dx.doi.org/10.1038/nature05490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17220875	Green Accepted			2022-12-24	WOS:000243689500031
J	Crosas, B; Hanna, J; Kirkpatrick, DS; Zhang, DP; Tone, Y; Hathaway, NA; Buecker, C; Leggett, DS; Schmidt, M; King, RW; Gygi, SP; Finley, D				Crosas, Bernat; Hanna, John; Kirkpatrick, Donald S.; Zhang, Dan Phoebe; Tone, Yoshiko; Hathaway, Nathaniel A.; Buecker, Christa; Leggett, David S.; Schmidt, Marion; King, Randall W.; Gygi, Steven P.; Finley, Daniel			Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities	CELL			English	Article							26 S-PROTEASOME; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; CONJUGATING ENZYMES; PROTEIN COMPLEXES; DEGRADATION; SUBSTRATE; IDENTIFICATION; RECEPTORS; RAD23	The ubiquitin ligase Hul5 was recently identified as a component of the proteasome, a multisubunit protease that degrades ubiquitin-protein conjugates. We report here a proteasome-dependent conjugating activity of Hul5 that endows proteasomes with the capacity to extend ubiquitin chains. hul5 mutants show reduced degradation of multiple proteasome substrates in vivo, suggesting that the polyubiquitin signal that targets substrates to the proteasome can be productively amplified at the proteasome. However, the products of Hul5 conjugation are subject to disassembly by a proteasome-bound deubiquitinating enzyme, Ubp6. A hul5 null mutation suppresses a ubp6 null mutation, suggesting that a balance of chain-extending and chain-trimming activities is required for proper proteasome function. As the association of Hul5 with proteasomes was found to be strongly stabilized by Ubp6, these enzymes may be situated in proximity to one another. We propose that through dynamic remodeling of ubiquitin chains, proteasomes actively regulate substrate commitment to degradation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CSIC, Inst Biol Mol Barcelona, ES-08034 Barcelona, Spain	Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu		King, Randall/0000-0001-7882-8180; Kirkpatrick, Donald/0000-0003-3091-2804; Buecker, Christa/0000-0003-3055-2642	NIGMS NIH HHS [GM65592, GM67945, GM66492] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM066492, R56GM066492, R01GM065592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	47	235	252	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1401	1413		10.1016/j.cell.2006.09.051	http://dx.doi.org/10.1016/j.cell.2006.09.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190603	Bronze			2022-12-24	WOS:000243690000019
J	de Oliveira, FT; Chanda, A; Banerjee, D; Shan, XP; Mondal, S; Que, L; Bominaar, EL; Munck, E; Collins, TJ				Tiago de Oliveira, Filipe; Chanda, Arani; Banerjee, Deboshri; Shan, Xiaopeng; Mondal, Sujit; Que, Lawrence, Jr.; Bominaar, Emile L.; Muenck, Eckard; Collins, Terrence J.			Chemical and spectroscopic evidence for an Fe-V-Oxo complex	SCIENCE			English	Article							HIGH-VALENT IRON; NONHEME; MONONUCLEAR; LIGANDS	Iron(V)-oxo species have been proposed as key reactive intermediates in the catalysis of oxygen-activating enzymes and synthetic catalysts. Here, we report the synthesis of [Fe(TAML)(O)](-) in nearly quantitative yield, where TAML is a macrocyclic tetraamide ligand. Mass spectrometry, Mossbauer, electron paramagnetic resonance, and x-ray absorption spectroscopies, as well as reactivity studies and density functional theory calculations show that this long-lived (hours at -60 degrees C) intermediate is a spin S=1/2 iron(V)-oxo complex. Iron-TAML systems have proven to be efficient catalysts in the decomposition of numerous pollutants by hydrogen peroxide, and the species we characterized is a likely reactive intermediate in these reactions.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities	Que, L (corresponding author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.	que@chem.umn.edu; eb7g@andrew.cmu.edu; emunck@cmu.edu; tc1u@andrew.cmu.edu	Collins, Terrence J/A-9807-2017; Tiago de Oliveira, Filipe/B-7065-2008	Collins, Terrence J/0000-0003-2611-9184; Tiago de Oliveira, Filipe/0000-0001-5149-5902	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038767] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB001475] Funding Source: Medline; NIGMS NIH HHS [GM-38767] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Banerjee D, 2006, ANGEW CHEM INT EDIT, V45, P3974, DOI 10.1002/anie.200504511; Bartos MJ, 1998, COORDIN CHEM REV, V174, P361, DOI 10.1016/S0010-8545(98)00142-8; BENDIX J, 1993, INORG CHEM, V32, P2838, DOI 10.1021/ic00065a010; Bukowski MR, 2005, SCIENCE, V310, P1000, DOI 10.1126/science.1119092; Chanda A, 2006, J INORG BIOCHEM, V100, P606, DOI 10.1016/j.jinorgbio.2005.12.016; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Decker A, 2006, J INORG BIOCHEM, V100, P697, DOI 10.1016/j.jinorgbio.2006.01.013; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ghosh A, 2005, J AM CHEM SOC, V127, P2505, DOI 10.1021/ja0460458; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Harischandra DN, 2005, J AM CHEM SOC, V127, P13776, DOI 10.1021/ja0542439; Neese F, 2006, J INORG BIOCHEM, V100, P716, DOI 10.1016/j.jinorgbio.2006.01.020; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Parsell TH, 2006, J AM CHEM SOC, V128, P8728, DOI 10.1021/ja062332v; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Sen Gupta S, 2002, SCIENCE, V296, P326, DOI 10.1126/science.1069297; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275	18	348	350	5	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					835	838		10.1126/science.1133417	http://dx.doi.org/10.1126/science.1133417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	134FN	17185561				2022-12-24	WOS:000244069000066
J	Ventura, A; Kirsch, DG; McLaughlin, ME; Tuveson, DA; Grimm, J; Lintault, L; Newman, J; Reczek, EE; Weissleder, R; Jacks, T				Ventura, Andrea; Kirsch, David G.; McLaughlin, Margaret E.; Tuveson, David A.; Grimm, Jan; Lintault, Laura; Newman, Jamie; Reczek, Elizabeth E.; Weissleder, Ralph; Jacks, Tyler			Restoration of p53 function leads to tumour regression in vivo	NATURE			English	Article							LUNG-CANCER; MUTANT P53; SUPPRESSION; MICE; ANGIOGENESIS; RECOMBINASES; EXPRESSION; MUTATIONS; GEFITINIB; EFFICACY	Tumorigenesis is a multi-step process that requires activation of oncogenes and inactivation of tumour suppressor genes(1). Mouse models of human cancers have recently demonstrated that continuous expression of a dominantly acting oncogene ( for example, Hras, Kras and Myc) is often required for tumour maintenance(2-5); this phenotype is referred to as oncogene addiction(6). This concept has received clinical validation by the development of active anticancer drugs that specifically inhibit the function of oncoproteins such as BCR-ABL, c-KIT and EGFR(7-10). Identifying additional gene mutations that are required for tumour maintenance may therefore yield clinically useful targets for new cancer therapies. Although loss of p53 function is a common feature of human cancers(11), it is not known whether sustained inactivation of this or other tumour suppressor pathways is required for tumour maintenance. To explore this issue, we developed a Cre-loxP-based strategy to temporally control tumour suppressor gene expression in vivo. Here we show that restoring endogenous p53 expression leads to regression of autochthonous lymphomas and sarcomas in mice without affecting normal tissues. The mechanism responsible for tumour regression is dependent on the tumour type, with the main consequence of p53 restoration being apoptosis in lymphomas and suppression of cell growth with features of cellular senescence in sarcomas. These results support efforts to treat human cancers by way of pharmacological reactivation of p53.	MIT, Ctr Canc Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Grimm, Jan/B-1937-2008; Ventura, Andrea/F-1789-2011	/0000-0003-0828-4143; Ventura, Andrea/0000-0003-4320-9907				Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haupt S, 2004, SEMIN CANCER BIOL, V14, P244, DOI 10.1016/j.semcancer.2004.04.003; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; XUE W, 2007, NATURE          0124; Zhang LL, 2000, CANCER RES, V60, P3655	31	1342	1397	2	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					661	665		10.1038/nature05541	http://dx.doi.org/10.1038/nature05541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17251932				2022-12-24	WOS:000244039400047
J	Cheng, H; Dufu, K; Lee, CS; Hsu, JL; Dias, A; Reed, R				Cheng, Hong; Dufu, Kobina; Lee, Chung-Sheng; Hsu, Jeanne L.; Dias, Anusha; Reed, Robin			Human mRNA export machinery recruited to the 5 ' end of mRNA	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; CAP-BINDING-PROTEIN; GENOME-WIDE ANALYSIS; NUCLEAR EXPORT; RIBONUCLEOPROTEIN PARTICLE; COUPLING TRANSCRIPTION; BIOCHEMICAL-ANALYSIS; MAMMALIAN-CELLS; POLYMERASE-II	Pre-mRNAs undergo splicing to remove introns, and the spliced mRNA is exported to the cytoplasm for translation. Here we investigated the mechanism for recruitment of the conserved mRNA export machinery (TREX complex) to mRNA. We show that the human TREX complex is recruited to a region near the 5' end of mRNA, with the TREX component Aly bound closest to the 5' cap. Both TREX recruitment and mRNA export require the cap, and these roles for the cap are splicing dependent. CBP80, which is bound to the cap, associates efficiently with TREX, and Aly mediates this interaction. Together, these data indicate that the CBP80-Aly interaction results in recruitment of TREX to the 5' end of mRNA, where it functions in mRNA export. As a consequence, the mRNA would be exported in a 5' to 3' direction through the nuclear pore, as observed in early electron micrographs of giant Balbiani ring mRNPs.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rreed@hms.harvard.edu		Dufu, Kobina/0000-0001-5450-4157				Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Harlow L, 1988, ANTIBODIES LAB MANUA; Herold A, 2003, EMBO J, V22, P2472, DOI 10.1093/emboj/cdg233; Hirose Y, 2000, GENE DEV, V14, P1415; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; MACQUAT LE, 2000, TRANSLATIONAL CONTRO, P827; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Schell T, 2002, GENOME BIOL, V3; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wagner E, 2002, J CELL SCI, V115, P3033; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 2002, P NATL ACAD SCI USA, V99, P12203, DOI 10.1073/pnas.182427099	64	331	350	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1389	1400		10.1016/j.cell.2006.10.044	http://dx.doi.org/10.1016/j.cell.2006.10.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190602	Bronze			2022-12-24	WOS:000243690000018
J	Li, HT; Xu, H; Zhou, Y; Zhang, J; Long, CZ; Li, SQ; Chen, S; Zhou, JM; Shao, F				Li, Hongtao; Xu, Hao; Zhou, Yan; Zhang, Jie; Long, Chengzu; Li, Shuqin; Chen, She; Zhou, Jian-Min; Shao, Feng			The phosphothreonine lyase activity of a bacterial type III effector family	SCIENCE			English	Article							VIRULENCE PLASMID; SECRETION SYSTEM; ACTIVATION; EXPRESSION; INFECTION	Pathogenic bacteria use the type III secretion system to deliver effector proteins into host cells to modulate the host signaling pathways. In this study, the Shigella type III effector OspF was shown to inactivate mitogen-activated protein kinases (MAPKs) [ extracellular signal-regulated kinases 1 and 2 ( Erk1/2), c-Jun N-terminal kinase, and p38]. OspF irreversibly removed phosphate groups from the phosphothreonine but not from the phosphotyrosine residue in the activation loop of MAPKs. Mass spectrometry revealed a mass loss of 98 daltons in p-Erk2, due to the abstraction of the a proton concomitant with cleavage of the C-OP bond in the phosphothreonine residue. This unexpected enzymatic activity, termed phosphothreonine lyase, appeared specific for MAPKs and was shared by other OspF family members.	Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhou, Jian-Min/A-3140-2013	Zhou, Jian-Min/0000-0002-9943-2975; Xu, Hao/0000-0003-3286-0710				Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GULIG PA, 1993, INFECT IMMUN, V61, P504, DOI 10.1128/IAI.61.2.504-511.1993; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	17	316	334	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					1000	1003		10.1126/science.1138960	http://dx.doi.org/10.1126/science.1138960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303758				2022-12-24	WOS:000244229800046
J	Basak, S; Kim, H; Kearns, JD; Tergaonkar, V; O'Dea, E; Werner, SL; Benedict, CA; Ware, CF; Ghosh, G; Verma, IM; Hoffmann, A				Basak, Soumen; Kim, Hana; Kearns, Jeffrey D.; Tergaonkar, Vinay; O'Dea, Ellen; Werner, Shannon L.; Benedict, Chris A.; Ware, Carl F.; Ghosh, Gourisankar; Verma, Inder M.; Hoffmann, Alexander			A fourth I kappa B protein within the NF-kappa B signaling module	CELL			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; GENE-EXPRESSION; ACTIVATION PATHWAYS; LYMPHOID-TISSUES; TEMPORAL CONTROL; TARGET GENES; DNA-BINDING; IKK-ALPHA; NF-KAPPA-B2; KINASE	Inflammatory NF-kappa B/RelA activation is mediated by the three canonical inhibitors, I kappa B alpha, -beta, and -epsilon. We report here the characterization of a fourth inhibitor, nf kappa b2/p100, that forms two distinct inhibitory complexes with RelA, one of which mediates developmental NF-kappa B activation. Our genetic evidence confirms that p100 is required and sufficient as a fourth I kappa B protein for noncanonical NF-kappa B signaling downstream of NIK and IKK1. We develop a mathematical model of the four-I kappa B-containing NF-kappa B signaling module to account for NF-kappa B/BelA:p50 activation in response to inflammatory and developmental stimuli and find signaling crosstalk between them that determines gene-expression programs. Further combined computational and experimental studies reveal that mutant cells with altered balances between canonical and noncanonical I kappa B proteins may exhibit inappropriate inflammatory gene expression in response to developmental signals. Our results have important implications for physiological and pathological scenarios in which inflammatory and developmental signals converge.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; La Jolla Institute for Immunology	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu		Basak, Soumen/0000-0002-3586-1279	NCI NIH HHS [P01 CA069381, CA69381] Funding Source: Medline; NIAID NIH HHS [R37AI33068, AI61549, R21 AI061549] Funding Source: Medline; NIGMS NIH HHS [GM071573, GM071862, P01 GM071862, R01 GM071573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R21AI061549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071573, P01GM071862] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; NAUMANN M, 1993, ONCOGENE, V8, P2275; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	40	292	302	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					369	381		10.1016/j.cell.2006.12.033	http://dx.doi.org/10.1016/j.cell.2006.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254973	Bronze, Green Accepted			2022-12-24	WOS:000244420500020
J	Boyd, NF; Guo, H; Martin, LJ; Sun, LM; Stone, J; Fishell, E; Jong, RA; Hislop, G; Chiarelli, A; Minkin, S; Yaffe, MJ				Boyd, Norman F.; Guo, Helen; Martin, Lisa J.; Sun, Limei; Stone, Jennifer; Fishell, Eve; Jong, Roberta A.; Hislop, Greg; Chiarelli, Anna; Minkin, Salomon; Yaffe, Martin J.			Mammographic density and the risk and detection of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENCHYMAL PATTERNS; SCREENING-PROGRAM; WOMEN; INTERVAL; CLASSIFICATION; FEATURES; FAILURE; SIGNS	BACKGROUND: Extensive mammographic density is associated with an increased risk of breast cancer and makes the detection of cancer by mammography difficult, but the influence of density on risk according to method of cancer detection is unknown. METHODS: We carried out three nested case-control studies in screened populations with 1112 matched case-control pairs. We examined the association of the measured percentage of density in the baseline mammogram with risk of breast cancer, according to method of cancer detection, time since the initiation of screening, and age. RESULTS: As compared with women with density in less than 10% of the mammogram, women with density in 75% or more had an increased risk of breast cancer (odds ratio, 4.7; 95% confidence interval [CI], 3.0 to 7.4), whether detected by screening (odds ratio, 3.5; 95% CI, 2.0 to 6.2) or less than 12 months after a negative screening examination (odds ratio, 17.8; 95% CI, 4.8 to 65.9). Increased risk of breast cancer, whether detected by screening or other means, persisted for at least 8 years after study entry and was greater in younger than in older women. For women younger than the median age of 56 years, 26% of all breast cancers and 50% of cancers detected less than 12 months after a negative screening test were attributable to density in 50% or more of the mammogram. CONCLUSIONS: Extensive mammographic density is strongly associated with the risk of breast cancer detected by screening or between screening tests. A substantial fraction of breast cancers can be attributed to this risk factor.	Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; Womens Hosp Med Ctr, Dept Radiol, Toronto, ON, Canada; Womens Hosp Med Ctr, Dept Imaging Res, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Canc Care Ontario, Ontario Breast Screening Program, Toronto, ON, Canada; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cancer Care Ontario; British Columbia Cancer Agency	Boyd, NF (corresponding author), Ontario Canc Inst, 610 Univ Ave,Room 10-415, Toronto, ON M5G 2M9, Canada.	boyd@uhnres.utoronto.ca	Stone, Jennifer/AAS-3805-2020	Stone, Jennifer/0000-0001-5077-0124				Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; BOYD NF, 1982, BRIT J CANCER, V45, P185, DOI 10.1038/bjc.1982.32; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Crystal P, 2003, AM J ROENTGENOL, V181, P177, DOI 10.2214/ajr.181.1.1810177; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; JOHNS PC, 1987, PHYS MED BIOL, V32, P675, DOI 10.1088/0031-9155/32/6/002; Jong R, 1996, EUR J CANCER PREV, V5, P281, DOI 10.1097/00008469-199608000-00008; Knight JA, 1998, BREAST CANCER RES TR, V48, P65, DOI 10.1023/A:1005990806919; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; MEYER JE, 1984, RADIOLOGY, V150, P335, DOI 10.1148/radiology.150.2.6691085; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1993, CAN MED ASSOC J, V148, P718; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rothman K., 1998, MODERN EPIDEMIOLOGY; Roubidoux MA, 2004, RADIOLOGY, V230, P42, DOI 10.1148/radiol.2301020589; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Sala E, 1998, J MED SCREEN, V5, P207, DOI 10.1136/jms.5.4.207; SICKLES EA, 1986, AM J ROENTGENOL, V146, P661, DOI 10.2214/ajr.146.4.661; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; WHITEHEAD J, 1985, CANCER, V56, P1280, DOI 10.1002/1097-0142(19850915)56:6<1280::AID-CNCR2820560610>3.0.CO;2-8; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130; Wright H, 2005, AM J SURG, V190, P572, DOI 10.1016/j.amjsurg.2005.06.014	34	1542	1574	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2007	356	3					227	236		10.1056/NEJMoa062790	http://dx.doi.org/10.1056/NEJMoa062790			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126BV	17229950				2022-12-24	WOS:000243488100005
J	Portner, HO; Knust, R				Poertner, Hans O.; Knust, Rainer			Climate change affects marine fishes through the oxygen limitation of thermal tolerance	SCIENCE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; PHYSIOLOGICAL-BASIS; GADUS-MORHUA; TRADE-OFFS; COD; RECRUITMENT; PERFORMANCE; EVOLUTION; GROWTH; SEA	A cause-and-effect understanding of climate influences on ecosystems requires evaluation of thermal limits of member species and of their ability to cope with changing temperatures. Laboratory data available for marine fish and invertebrates from various climatic regions led to the hypothesis that, as a unifying principle, a mismatch between the demand for oxygen and the capacity of oxygen supply to tissues is the first mechanism to restrict whole-animal tolerance to thermal extremes. We show in the eelpout, Zoarces viviparus, a bioindicator fish species for environmental monitoring from North and Baltic Seas (Helcom), that thermally limited oxygen delivery closely matches environmental temperatures beyond which growth performance and abundance decrease. Decrements in aerobic performance in warming seas will thus be the first process to cause extinction or relocation to cooler waters.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Portner, HO (corresponding author), Alfred Wegener Inst Polar & Marine Res, Postfach 12 01 61, D-27515 Bremerhaven, Germany.	hpoertner@awi-bremerhaven.de	Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Fonds M, 1989, G31 INT COUNC EXPL S; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; HELAOUET P, IN PRESS MAR ECOL PR; Jensen MN, 2003, SCIENCE, V299, P38, DOI 10.1126/science.299.5603.38; Johnston IA, 1998, J EXP BIOL, V201, P1; KUNDZEWICZ ZW, 2001, IMPACTS ADAPTATION V, P641; Lannig G, 2004, AM J PHYSIOL-REG I, V287, pR902, DOI 10.1152/ajpregu.00700.2003; Linton TK, 1998, CAN J FISH AQUAT SCI, V55, P576, DOI 10.1139/cjfas-55-3-576; Mark FC, 2002, AM J PHYSIOL-REG I, V283, pR1254, DOI 10.1152/ajpregu.00167.2002; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P959, DOI 10.1086/423742; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 2002, J EXP BIOL, V205, P2217; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Sartoris FJ, 2003, J FISH BIOL, V62, P1239, DOI 10.1046/j.1095-8649.2003.00099.x; Sheppard C, 2004, MAR POLLUT BULL, V49, P12, DOI 10.1016/j.marpolbul.2004.05.011; Sogard SM, 1997, B MAR SCI, V60, P1129; *SYST SOFTW INT, SIGMAPLOT; TIEWS K, 1983, ARCH FISCHEREIWISS, V34, P4; TIEWS K, 1990, VEROFF I KUST BINNEN, V103, P1; ULLEWEIT J, 1995, THESIS U BREMEN BREM; Van Dijk PLM, 1999, J EXP BIOL, V202, P3611; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Zakhartsev MV, 2003, J COMP PHYSIOL B, V173, P365, DOI 10.1007/s00360-003-0342-z	32	1323	1346	7	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					95	97		10.1126/science.1135471	http://dx.doi.org/10.1126/science.1135471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17204649				2022-12-24	WOS:000243259100043
J	Charrel, RN; de Lamballerie, X; Raoult, D				Charrel, Remi N.; de Lamballerie, Xavier; Raoult, Didier			Chikungunya outbreaks - The globalization of vectorborne diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France; Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Charrel, RN (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France.		RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251				Mudur Ganapati, 2006, BMJ, V333, P773, DOI 10.1136/bmj.333.7572.773-c; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Shirley SM, 2006, PLOS BIOL, V4, P1311, DOI 10.1371/journal.pbio.0040279; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	5	303	324	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					769	771		10.1056/NEJMp078013	http://dx.doi.org/10.1056/NEJMp078013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314335				2022-12-24	WOS:000244326700002
J	Syntichaki, P; Troulinaki, K; Tavernarakis, N				Syntichaki, Popi; Troulinaki, Kostoula; Tavernarakis, Nektarios			eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans	NATURE			English	Article							INITIATION-FACTOR 4E; CALORIC RESTRICTION; OXIDATIVE STRESS; C-ELEGANS; LIFE-SPAN; PROTEIN-SYNTHESIS; TRANSLATION; PHOSPHORYLATION; TURNOVER; KINASE	Regulation of protein synthesis is critical for cell growth and maintenance. Ageing in many organisms, including humans, is accompanied by marked alterations in both general and specific protein synthesis(1). Whether these alterations are simply a corollary of the ageing process or have a causative role in senescent decline remains unclear. An array of protein factors facilitates the tight control of messenger RNA translation initiation(2). The eukaryotic initiation factor 4E (eIF4E), which binds the 7-monomethyl guanosine cap at the 5' end of all nuclear mRNAs, is a principal regulator of protein synthesis(3). Here we show that loss of a specific eIF4E isoform (IFE-2) that functions in somatic tissues(4) reduces global protein synthesis, protects from oxidative stress and extends lifespan in Caenorhabditis elegans. Lifespan extension is independent of the forkhead transcription factor DAF-16, which mediates the effects of the insulin-like signalling pathway on ageing. Furthermore, IFE-2 deficiency further extends the lifespan of long-lived age and daf nematode mutants. Similarly, lack of IFE-2 enhances the long-lived phenotype of clk and dietary-restricted eat mutant animals. Knockdown of target of rapamycin ( TOR), a phosphatidylinositol kinase-related kinase that controls protein synthesis in response to nutrient cues, further increases the longevity of ife-2 mutants. Thus, signalling via eIF4E in the soma is a newly discovered pathway influencing ageing in C. elegans.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Syntichaki, Popi/ABA-7218-2020	Tavernarakis, Nektarios/0000-0002-5253-1466; Syntichaki, Popi/0000-0001-9536-8905				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Amiri A, 2001, DEVELOPMENT, V128, P3899; Arquier N, 2005, CURR BIOL, V15, P19, DOI 10.1016/j.cub.2004.12.037; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HANSEN M, 2006, AGEING CELL; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; PAN KZ, 2006, AGEING CELL; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5; Reiling JH, 2005, CURR BIOL, V15, P24, DOI 10.1016/j.cub.2004.12.034; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	32	253	277	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					922	926		10.1038/nature05603	http://dx.doi.org/10.1038/nature05603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17277769				2022-12-24	WOS:000244341200051
J	Hibbeln, JR; Davis, JM; Steer, C; Emmett, P; Rogers, I; Williams, C; Golding, J				Hibbeln, Joseph R.; Davis, John M.; Steer, Colin; Emmett, Pauline; Rogers, Imogen; Williams, Cathy; Golding, Jean			Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study	LANCET			English	Article							POLYUNSATURATED FATTY-ACIDS; DIFFICULTIES QUESTIONNAIRE; UNITED-KINGDOM; BIRTH-WEIGHT; FISH INTAKE; SOUTH-WEST; POPULATION; STRENGTHS; CHILDREN; FOOD	Background Seafood is the predominant source of omega-3 fatty acids, which are essential for optimum neural development. However, in the USA, women are advised to limit their seafood intake during pregnancy to 340 g per week. We used the Avon Longitudinal Study of Parents and Children (ALSPAC) to assess the possible benefits and hazards to a child's development of different levels of maternal seafood intake during pregnancy. Methods 11875 pregnant women completed a food frequency questionnaire assessing seafood consumption at 32 weeks' gestation. Multivariable logistic regression models including 28 potential confounders assessing social disadvantage, perinatal, and dietary items were used to compare developmental, behavioural, and cognitive outcomes of the children from age 6 months to 8 years in women consuming none, some (1-340 g per week), and >340 g per week. Findings After adjustment, maternal seafood intake during pregnancy of less than 340 g per week was associated with increased risk of their children being in the lowest quartile for verbal intelligence quotient (IQ) (no seafood consumption, odds ratio [OR] 1.48, 95% Cl 1.16-1.90; some, 1.09, 0.92-1.29; overall trend, p=0.004), compared with mothers who consumed more than 340 g per week. Low maternal seafood intake was also associated with increased risk of suboptimum outcomes for prosocial behaviour, fine motor, communication, and social development scores. For each outcome measure, the lower the intake of seafood during pregnancy, the higher the risk of suboptimum developmental outcome. Interpretation Maternal seafood consumption of less than 340 g per week in pregnancy did not protect children from adverse outcomes; rather, we recorded beneficial effects on child development with maternal seafood intakes of more than 340 g per week, suggesting that advice to limit seafood consumption could actually be detrimental. These results show that risks from the loss of nutrients were greater than the risks of harm from exposure to trace contaminants in 340 g seafood eaten weekly.	US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, Bethesda, MD 20952 USA; Univ Illinois, Chicago, IL USA; Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Bristol	Hibbeln, JR (corresponding author), US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, 31 Ctr Dr Rm 31,1B58,MSC 2088, Bethesda, MD 20952 USA.	jhibbeln@mail.nih.gov	Emmett, Pauline/AAL-6815-2021; Robles-Sardin, Alma E/M-7714-2015; Williams, Cathy/K-4919-2015	Robles-Sardin, Alma E/0000-0003-2044-7793; Golding, Jean/0000-0003-2826-3307; Williams, Cathy/0000-0002-9133-2021; Rogers, Imogen/0000-0001-7275-2437; Emmett, Pauline/0000-0003-1076-4779	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9815508] Funding Source: Medline; NIMH NIH HHS [1 P01MH68580-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH068580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000115] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], [No title captured]; Calderon F, 2004, J NEUROCHEM, V90, P1540, DOI 10.1111/j.1471-4159.2004.02808.x; Caldwell B.M., 1979, HOME OBSERVATION MEA; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; DWARKA S, 1995, HUM EXP TOXICOL, V14, P451, DOI 10.1177/096032719501400511; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Emond Alan, 2005, Dev Med Child Neurol, V47, P646, DOI 10.1017/S0012162205001271; Erkkola M, 2001, AM J EPIDEMIOL, V154, P466, DOI 10.1093/aje/154.5.466; FAO/WHO, 1994, FAO FOOD NUTR PAP, V57, P1; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Griffiths R, 1984, ABILITIES YOUNG CHIL; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Heron J, 2004, PEDIATRICS, V114, P577, DOI 10.1542/peds.2003-1176-L; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kodas E, 2004, J NEUROCHEM, V89, P695, DOI 10.1111/j.1471-4159.2004.02401.x; Mahaffey KR, 2004, ENVIRON HEALTH PERSP, V112, P562, DOI 10.1289/ehp.6587; Martinez M, 2001, J MOL NEUROSCI, V16, P309, DOI 10.1385/JMN:16:2-3:309; Ministry of Agriculture Fisheries and Food London (United Kingdom), 1998, FATT AC 7 SUPPL 5 ED, V7; National Research Council, 2000, TOX EFF METH; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Rogers I, 2003, EUR J CLIN NUTR, V57, P854, DOI 10.1038/sj.ejcn.1601619; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Rojas CV, 2003, INVEST OPHTH VIS SCI, V44, P3170, DOI 10.1167/iovs.02-1138; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; *SCI ADV COMM NUTR, 2004, ADV SEAF CONS BEN RI, P80; Shatenstein B, 1999, ENVIRON RES, V80, pS71, DOI 10.1006/enrs.1998.3925; Simopoulos Artemis P., 1999, Journal of the American College of Nutrition, V18, P487, DOI 10.1046/j.1440-6047.1999.00123.x; *U BRIST SURV DEP, MERC IMP FISH SHELLF; *US DEP HHS, EPA823R04005 US DEP; Wechsler D., 1992, WISC IIIUK WECHSLER; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Willatts P, 1998, LANCET, V352, P688, DOI 10.1016/S0140-6736(97)11374-5; Williams C, 2001, AM J CLIN NUTR, V73, P316	41	673	708	1	153	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					578	585		10.1016/S0140-6736(07)60277-3	http://dx.doi.org/10.1016/S0140-6736(07)60277-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307104				2022-12-24	WOS:000244368000031
J	Goldemberg, J				Goldemberg, Jose			Ethanol for a sustainable energy future	SCIENCE			English	Editorial Material								Renewable energy is one of the most efficient ways to achieve sustainable development. Increasing its share in the world matrix will help prolong the existence of fossil fuel reserves, address the threats posed by climate change, and enable better security of the energy supply on a global scale. Most of the "new renewable energy sources" are still undergoing large-scale commercial development, but some technologies are already well established. These include Brazilian sugarcane ethanol, which, after 30 years of production, is a global energy commodity that is fully competitive with motor gasoline and appropriate for replication in many countries.	Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Goldemberg, J (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	goldemb@iee.usp.br						British Petroleum, BP STAT REV WORLD EN; COELHO ST, 2006, DEVELOPMENT, V10, P26; DASILVA JG, 1978, SCIENCE, V201, P903, DOI 10.1126/science.201.4359.903; ELOBEID A, 2006, 36WP427; Goldemberg J, 2004, ENERG POLICY, V32, P1141, DOI 10.1016/S0301-4215(03)00077-6; Goldemberg J, 2004, BIOMASS BIOENERG, V26, P301, DOI 10.1016/S0961-9534(03)00125-9; GOLDENBERG J, 2004, INT C REN EN BONN; HEALEY JR, 2006, USA TODAY       0330; IEA, 2005, KEY WORLD EN STAT; MACEDO IC, GREENHOUSE GAS EMISS; SHAPOURI H, 721 USDA EC RES SERV; *UN, 1987, UN GEN ASS 96 PLEN M; *UNDP UNDESA WEC, 2005, WORLD EN ASS OV 2004; USDA, 2006, EC FEASIBILITY ETHAN; WOODS J, BU200785REPURN03982; *WORLD BANK, 2006, WORLD BANKS EN FRAM; 2006, REN21 GLOB STAT REP	17	853	907	8	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					808	810		10.1126/science.1137013	http://dx.doi.org/10.1126/science.1137013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289989				2022-12-24	WOS:000244069000057
J	Zheng, Y; Danilenko, DM; Valdez, P; Kasman, I; Eastham-Anderson, J; Wu, JF; Ouyang, WJ				Zheng, Yan; Danilenko, Dimitry M.; Valdez, Patricia; Kasman, Ian; Eastham-Anderson, Jeffrey; Wu, Jianfeng; Ouyang, Wenjun			Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTE; PSORIASIS-VULGARIS; DENDRITIC CELLS; EPIDERMAL DIFFERENTIATION; HUMAN KERATINOCYTES; INTERFERON-GAMMA; TRANSGENIC MICE; GROWTH-FACTOR; FACTOR-ALPHA; EXPRESSION	Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis ( acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels(1). The underlying cause of the epidermal acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells)(2,3), was found to have a potential function in the pathogenesis of psoriasis(4,5). Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced acanthosis and dermal inflammation through the activation of Stat3 ( signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com	Ouyang, Wenjun/ABA-8763-2020; Zheng, Yan/A-6993-2008	Zheng, Yan/0000-0002-7002-277X; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921				Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Kopp T, 2001, J INVEST DERMATOL, V117, P618, DOI 10.1046/j.1523-1747.2001.01441.x; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503	30	1445	1570	1	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					648	651		10.1038/nature05505	http://dx.doi.org/10.1038/nature05505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17187052				2022-12-24	WOS:000244039400044
J	Grosenick, L; Clement, TS; Fernald, RD				Grosenick, Logan; Clement, Tricia S.; Fernald, Russell D.			Fish can infer social rank by observation alone	NATURE			English	Article							TRANSITIVE INFERENCE; HAPLOCHROMIS-BURTONI; INFORMATION; MEMORY; RATS	Transitive inference (TI) involves using known relationships to deduce unknown ones ( for example, using A. B and B. C to infer A. C), and is thus essential to logical reasoning. First described as a developmental milestone in children(1), TI has since been reported in nonhuman primates(2-4), rats(5,6) and birds(7-10). Still, how animals acquire and represent transitive relationships and why such abilities might have evolved remain open problems. Here we show that male fish (Astatotilapia burtoni) can successfully make inferences on a hierarchy implied by pairwise fights between rival males. These fish learned the implied hierarchy vicariously ( as 'bystanders'), by watching fights between rivals arranged around them in separate tank units. Our findings show that fish use TI when trained on socially relevant stimuli, and that they can make such inferences by using indirect information alone. Further, these bystanders seem to have both spatial and featural representations related to rival abilities, which they can use to make correct inferences depending on what kind of information is available to them. Beyond extending TI to fish and experimentally demonstrating indirect TI learning in animals, these results indicate that a universal mechanism underlying TI is unlikely. Rather, animals probably use multiple domain-specific representations adapted to different social and ecological pressures that they encounter during the course of their natural lives.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA	Stanford University; Stanford University	Grosenick, L (corresponding author), Stanford Univ, Ctr Study Language & Informat, Ventura Hall,200 Panama St, Stanford, CA 94305 USA.	logang@stanford.edu						Allen C., 2006, RATIONAL ANIMALS, P175, DOI DOI 10.1093/ACPROF:OSO/9780198528272.003.0007; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; BRYANT PE, 1971, NATURE, V232, P456, DOI 10.1038/232456a0; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Clement TS, 2005, BEHAV ECOL, V16, P83, DOI 10.1093/beheco/arh134; DAVIS H, 1992, J COMP PSYCHOL, V106, P342, DOI 10.1037/0735-7036.106.4.342; DELILLO C, 2001, ANIMAL COGNITION, V4, P61, DOI DOI 10.1007/S100710100092; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; GILLAN DJ, 1981, J EXP PSYCHOL ANIM B, V7, P1, DOI 10.1037/0097-7403.7.1.1; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Lazareva OF, 2004, J EXP ANAL BEHAV, V82, P1, DOI 10.1901/jeab.2004.82-1; MCGONIGLE B, 1992, Q J EXP PSYCHOL-B, V45, P189; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; MCGONIGLE BO, 1986, REASONING DISCOURSE, P141; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Piaget J., 1928, JUDGEMENT REASONING; R Development Core Team, 2006, R LANG ENV STAT COMP; Rapp PR, 1996, BEHAV NEUROSCI, V110, P887, DOI 10.1037/0735-7044.110.5.887; ROBERTS WA, 1994, PSYCHOL SCI, V5, P368, DOI 10.1111/j.1467-9280.1994.tb00287.x; STEIRN JN, 1995, ANIM LEARN BEHAV, V23, P76, DOI 10.3758/BF03198018; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; VONFERSEN L, 1991, J EXP PSYCHOL ANIM B, V17, P334, DOI 10.1037/0097-7403.17.3.334; White SA, 2002, J EXP BIOL, V205, P2567; Wynne CDL, 1998, MODELS OF ACTION: MECHANISMS FOR ADAPTIVE BEHAVIOR, P269; Zentall TR, 2001, BEHAV PROCESS, V54, P65, DOI 10.1016/S0376-6357(01)00150-4	29	330	337	3	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					429	432		10.1038/nature05511	http://dx.doi.org/10.1038/nature05511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	128WD	17251980				2022-12-24	WOS:000243689500040
J	Libert, S; Zwiener, J; Chu, XW; VanVoorhies, W; Roman, G; Pletcher, SD				Libert, Sergiy; Zwiener, Jessica; Chu, Xiaowen; VanVoorhies, Wayne; Roman, Gregg; Pletcher, Scott D.			Regulation of Drosophila life span by olfaction and food-derived odors	SCIENCE			English	Article							DIETARY RESTRICTION; MOLECULAR-BASIS; MELANOGASTER; REPRODUCTION; ELEGANS	Smell is an ancient sensory system present in organisms from bacteria to humans. In the nematode Caeonorhabditis elegans, gustatory and olfactory neurons regulate aging and longevity. Using the fruit fly, Drosophila melanogaster, we showed that exposure to nutrient-derived odorants can modulate life span and partially reverse the longevity-extending effects of dietary restriction. Furthermore, mutation of odorant receptor Or83b resulted in severe olfactory defects, altered adult metabolism, enhanced stress resistance, and extended life span. Our findings indicate that olfaction affects adult physiology and aging in Drosophila, possibly through the perceived availability of nutritional resources, and that olfactory regulation of life span is evolutionarily conserved.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cellular & Mol Biol, Houston, TX 77030 USA; New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77024 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; New Mexico State University; University of Houston System; University of Houston; Baylor College of Medicine	Pletcher, SD (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	pletcher@bcm.tmc.edu	Libert, Sergiy/D-8136-2016; Roman, Gregg/W-1586-2019; Chu, Xiaowen/AAF-2857-2020	Libert, Sergiy/0000-0003-2497-5390; Roman, Gregg/0000-0003-1519-4699; Chu, Xiaowen/0000-0001-9745-4372	NATIONAL CANCER INSTITUTE [U54CA132383, U56CA096286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023166] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA132383, U56 CA096286] Funding Source: Medline; NIA NIH HHS [R01AG023166] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Elmore T, 2003, J NEUROSCI, V23, P9906; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; TAFAR M, 2003, SCIENCE, V299, P1346; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x	22	256	275	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1133	1137		10.1126/science.1136610	http://dx.doi.org/10.1126/science.1136610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17272684	Green Submitted			2022-12-24	WOS:000244387600039
J	Richardson, TL; Jackson, GA				Richardson, Tammi L.; Jackson, George A.			Small phytoplankton and carbon export from the surface ocean	SCIENCE			English	Article							EQUATORIAL PACIFIC; FOOD WEBS; COMMUNITY STRUCTURE; BIOGENIC CARBON; PICOPLANKTON; MODEL; COAGULATION; PARTICLES; FLUXES; TEP	Autotrophic picoplankton dominate primary production over large oceanic regions but are believed to contribute relatively little to carbon export from surface layers. Using analyses of data from the equatorial Pacific Ocean and Arabian Sea, we show that the relative direct and indirect contribution of picoplankton to export is proportional to their total net primary production, despite their small size. We suggest that all primary producers, not just the large cells, can contribute to export from the surface layer of the ocean at rates proportional to their production rates.	Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station	Richardson, TL (corresponding author), Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA.	richardson@biol.sc.edu	Richardson, Tammi/ABB-4163-2021	Richardson, Tammi/0000-0002-0667-3455				Albertano P, 1997, J PLANKTON RES, V19, P1405, DOI 10.1093/plankt/19.10.1405; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; BUESSELER KO, 2006, 116 SCOR WORK GROUP; CADEE GC, 1985, MAR ECOL PROG SER, V24, P193, DOI 10.3354/meps024193; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; GOMES HDR, 1992, J PLANKTON RES, V14, P1307, DOI 10.1093/plankt/14.9.1307; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jackson GA, 2001, DEEP-SEA RES PT I, V48, P95, DOI 10.1016/S0967-0637(00)00040-6; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; KLUT ME, 1991, CAN J FISH AQUAT SCI, V48, P1092, DOI 10.1139/f91-129; LAMPITT RS, 1993, MAR BIOL, V116, P689, DOI 10.1007/BF00355486; Landry MR, 1997, LIMNOL OCEANOGR, V42, P405, DOI 10.4319/lo.1997.42.3.0405; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; LEGENDRE L, 1995, AQUAT MICROB ECOL, V9, P69, DOI 10.3354/ame009069; Mari X, 2004, MAR ECOL PROG SER, V279, P13, DOI 10.3354/meps279013; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; NIVAL P, 1976, LIMNOL OCEANOGR, V21, P24, DOI 10.4319/lo.1976.21.1.0024; Noji TT, 1997, J PLANKTON RES, V19, P863, DOI 10.1093/plankt/19.7.863; Olli K, 1999, J MARINE SYST, V23, P165, DOI 10.1016/S0924-7963(99)00056-1; Passow U, 1999, J PLANKTON RES, V21, P2203, DOI 10.1093/plankt/21.11.2203; REVELANTE N, 1991, J EXP MAR BIOL ECOL, V146, P217, DOI 10.1016/0022-0981(91)90027-T; Richardson TL, 2006, DEEP-SEA RES PT II, V53, P555, DOI 10.1016/j.dsr2.2006.01.015; Richardson TL, 2004, DEEP-SEA RES PT I, V51, P1245, DOI 10.1016/j.dsr.2004.05.005; Rivkin RB, 1996, SCIENCE, V272, P1163, DOI 10.1126/science.272.5265.1163; Roman MR, 2001, DEEP-SEA RES PT II, V49, P175; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; Waite AM, 2000, LIMNOL OCEANOGR, V45, P87, DOI 10.4319/lo.2000.45.1.0087; [No title captured]	30	381	407	13	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					838	840		10.1126/science.1133471	http://dx.doi.org/10.1126/science.1133471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289995				2022-12-24	WOS:000244069000067
J	Wang, F; Podell, ER; Zaug, AJ; Yang, YT; Baciu, P; Cech, TR; Lei, M				Wang, Feng; Podell, Elaine R.; Zaug, Arthur J.; Yang, Yuting; Baciu, Paul; Cech, Thomas R.; Lei, Ming			The POT1-TPP1 telomere complex is a telomerase processivity factor	NATURE			English	Article							END-BINDING-PROTEIN; HUMAN POT1; LENGTH REGULATOR; OXYTRICHA-NOVA; DNA-BINDING; IN-VITRO; CHROMOSOME; SUBUNIT; TRF1; TIN2	Telomeres were originally defined as chromosome caps that prevent the natural ends of linear chromosomes from undergoing deleterious degradation and fusion events. POT1 ( protection of telomeres) protein binds the single-stranded G-rich DNA overhangs at human chromosome ends and suppresses unwanted DNA repair activities. TPP1 is a previously identified binding partner of POT1 that has been proposed to form part of a six-protein shelterin complex at telomeres. Here, the crystal structure of a domain of human TPP1 reveals an oligonucleotide/oligosaccharide-binding fold that is structurally similar to the beta-subunit of the telomere end-binding protein of a ciliated protozoan, suggesting that TPP1 is the missing beta-subunit of human POT1 protein. Telomeric DNA end-binding proteins have generally been found to inhibit rather than stimulate the action of the chromosome end-replicating enzyme, telomerase. In contrast, we find that TPP1 and POT1 form a complex with telomeric DNA that increases the activity and processivity of the human telomerase core enzyme. We propose that POT1 - TPP1 switches from inhibiting telomerase access to the telomere, as a component of shelterin, to serving as a processivity factor for telomerase during telomere extension.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lei, M (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, MSRBIII 5301D,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	leim@umich.edu	Wang, Feng/B-2474-2012					Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; FANG GW, 1991, NUCLEIC ACIDS RES, V19, P5515, DOI 10.1093/nar/19.20.5515; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; HICKE BJ, 1990, P NATL ACAD SCI USA, V87, P1481, DOI 10.1073/pnas.87.4.1481; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	38	499	520	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					506	510		10.1038/nature05454	http://dx.doi.org/10.1038/nature05454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17237768	Green Published			2022-12-24	WOS:000243867300036
J	Naqvi, NH; Rudrauf, D; Damasio, H; Bechara, A				Naqvi, Nasir H.; Rudrauf, David; Damasio, Hanna; Bechara, Antoine			Damage to the insula disrupts addiction to cigarette smoking	SCIENCE			English	Article							DECISION-MAKING; DRUG-ADDICTION; NEURAL SYSTEMS; CORTEX LESIONS; BRAIN ACTIVITY; NICOTINE; ACTIVATION; TOBACCO; STIMULI	A number of brain systems have been implicated in addictive behavior, but none have yet been shown to be necessary for maintaining the addiction to cigarette smoking. We found that smokers with brain damage involving the insula, a region implicated in conscious urges, were more likely than smokers with brain damage not involving the insula to undergo a disruption of smoking addiction, characterized by the ability to quit smoking easily, immediately, without relapse, and without persistence of the urge to smoke. This result suggests that the insula is a critical neural substrate in the addiction to smoking.	Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Neurol, Lab Computat Neuroimaging, Iowa City, IA 52242 USA; Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Iowa; University of Iowa; University of Southern California; University of Southern California	Bechara, A (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, 200 Hawkins Dr, Iowa City, IA 52242 USA.	bechara@usc.edu	Naqvi, Nasir/AAW-7933-2021	Rudrauf, David/0000-0002-9621-1800; Bechara, Antoine/0000-0001-5127-2549	NIDA NIH HHS [R21 DA016708, F30 DA016847, R21 DA16708] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NINDS NIH HHS [P01 NS019632] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA016847, R21DA016708] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		*APA, 2000, DIAGN STAT MAN MENT, P191; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111/j.1360-0443.2005.01030.x; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio Antonio, 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hatsukami D, 1985, NIDA Res Monogr, V53, P56; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Naqvi NH, 2005, PHARMACOL BIOCHEM BE, V81, P821, DOI 10.1016/j.pbb.2005.06.005; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pickworth WB, 1998, PSYCHONEUROENDOCRINO, V23, P131, DOI 10.1016/S0306-4530(97)00075-9; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rose JE, 2006, PSYCHOPHARMACOLOGY, V184, P274, DOI 10.1007/s00213-005-0250-x; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; *US DEP HHS, 1988, 1988 SURG GEN REP HL, P377; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; WESTMAN EC, 1995, CHEST, V107, P1358, DOI 10.1378/chest.107.5.1358	29	801	880	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					531	534		10.1126/science.1135926	http://dx.doi.org/10.1126/science.1135926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255515	Green Accepted			2022-12-24	WOS:000243726600052
J	Paik, JH; Kollipara, R; Chu, G; Ji, HK; Xiao, YH; Ding, ZH; Miao, LL; Tothova, Z; Horner, JW; Carrasco, DR; Jiang, S; Gilliland, DG; Chin, L; Wong, WH; Castrillon, DH; DePinho, RA				Paik, Ji-Hye; Kollipara, Ramya; Chu, Gerald; Ji, Hongkai; Xiao, Yonghong; Ding, Zhihu; Miao, Lili; Tothova, Zuzana; Horner, James W.; Carrasco, Daniel R.; Jiang, Shan; Gilliland, D. Gary; Chin, Lynda; Wong, Wing H.; Castrillon, Diego H.; DePinho, Ronald A.			FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis	CELL			English	Article							TRANSCRIPTION FACTORS; TARGETED DISRUPTION; PTEN LEADS; GENE; AKT; SPROUTY; MICE; P27(KIP1); IDENTIFICATION; INHIBITION	Activated phosphoinositide 3-kinase (PI3K)AKT signaling appears to be an obligate event in the development of cancer. The highly related members of the mammalian FoxO transcription factor family, FoxO1, FoxO3, and FoxO4, represent one of several effector arms of PI3K-AKT signaling, prompting genetic analysis of the role of FoxOs in the neoplastic phenotypes linked to PI3K-AKT activation. While germline or somatic deletion of up to five FoxO alleles produced remarkably modest neoplastic phenotypes, broad somatic deletion of all FoxOs engendered a progressive cancer-prone condition characterized by thymic lymphomas and hemangionnas, demonstrating that the mammalian FoxOs are indeed bona fide tumor suppressors. Transcriptome and promoter analyses of differentially affected endothelium identified direct FoxO targets and revealed that FoxO regulation of these targets in vivo is highly context-specific, even in the same cell type. Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endothelial cell morphogenesis and vascular homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Fdn,Inst Innovat Canc Sci,Ctr Appl Canc Sc, Boston, MA 02115 USA; Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Texas, SW Med Sch, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Sch, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Castrillon, DH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	diego.castrillon@utsouthwestern.edu; ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA117969, R01CA084628, U01CA084313, P01CA095616] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084313, R01 CA084628, P01 CA117969, P01 CA095616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carreira CM, 2001, CANCER RES, V61, P8079; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geisen C, 2003, ONCOGENE, V22, P1724, DOI 10.1038/sj.onc.1206340; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Heryanto B, 2002, REPRODUCTION, V123, P107, DOI 10.1530/rep.0.1230107; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kramer S, 1999, DEVELOPMENT, V126, P2515; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Li G, 2002, DEVELOPMENT, V129, P4159; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RAMIREZ F, 1993, BIOESSAYS, V15, P589, DOI 10.1002/bies.950150904; Reich A, 1999, DEVELOPMENT, V126, P4139; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wanner M, 2001, J AM ACAD DERMATOL, V44, P183, DOI 10.1067/mjd.2001.110390; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099	64	823	851	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					309	323		10.1016/j.cell.2006.12.029	http://dx.doi.org/10.1016/j.cell.2006.12.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254969	Green Accepted, Bronze			2022-12-24	WOS:000244420500016
J	Melichar, HJ; Narayan, K; Der, SD; Hiraoka, Y; Gardiol, N; Jeannet, G; Held, W; Chambers, CA; Kang, JS				Melichar, Heather J.; Narayan, Kavitha; Der, Sandy D.; Hiraoka, Yoshiki; Gardiol, Noemie; Jeannet, Gregoire; Held, Werner; Chambers, Cynthia A.; Kang, Joonsoo			Regulation of gamma delta versus alpha beta T lymphocyte differentiation by the transcription factor SOX13	SCIENCE			English	Article							CELL-RECEPTOR; COLON-CARCINOMA; CATENIN; GENE; EXPRESSION; PATHWAY; TCF-1; PROTEINS	alpha beta and gamma delta T cells originate from a common, multipotential precursor population in the thymus, but the molecular mechanisms regulating this lineage-fate decision are unknown. We have identified Sox13 as a gamma delta-specific gene in the immune system. Using Sox13 transgenic mice, we showed that this transcription factor promotes gd T cell development while opposing ab T cell differentiation. Conversely, mice deficient in Sox13 expression exhibited impaired development of gd T cells but not ab T cells. One mechanism of SOX13 function is the inhibition of signaling by the developmentally important Wnt/T cell factor (TCF) pathway. Our data thus reveal a dominant pathway regulating the developmental fate of these two lineages of T lymphocytes.	Univ Massachusetts, Sch Med, Dept Pathol, Grad Program Immunol & Virol, Worcester, MA 01655 USA; Univ Toronto, Dept Lab Med & Pathobiol, Program Proteom & Bioinformat, Toronto, ON, Canada; Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Univ Lausanne, CH-1066 Epalinges, Switzerland	University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; Keio University; Ludwig Institute for Cancer Research; University of Lausanne	Kang, JS (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Grad Program Immunol & Virol, 55 Lake Ave N, Worcester, MA 01655 USA.	Joonsoo.Kang@umassmed.edu		kang, joonsoo/0000-0001-8419-7995	NATIONAL CANCER INSTITUTE [R01CA100382] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA100382/92614] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Roose J, 1998, NUCLEIC ACIDS RES, V26, P469, DOI 10.1093/nar/26.2.469; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Schilham MW, 1998, J IMMUNOL, V161, P3984; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	23	127	128	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2007	315	5809					230	233		10.1126/science.1135344	http://dx.doi.org/10.1126/science.1135344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17218525				2022-12-24	WOS:000243407400044
J	Beulens, JWJ; Rimm, EB; Ascherio, A; Spiegelman, D; Hendriks, HFJ; Mukamal, KJ				Beulens, Joline W. J.; Rimm, Eric B.; Ascherio, Alberto; Spiegelman, Donna; Hendriks, Henk F. J.; Mukamal, Kenneth J.			Alcohol consumption and risk for coronary heart disease among men with hypertension	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CONFIDENCE-INTERVALS; MEASUREMENT ERROR; MORTALITY; REPRODUCIBILITY; FREQUENCY; VALIDITY; WOMEN; WINE	Background: Heavy alcohol consumption increases risk for hypertension, which is in itself a strong risk factor for cardiovascular disease (CVD). However, data on the association between alcohol consumption and CVD among individuals with hypertension are scarce. Objective: To assess whether alcohol consumption is inversely associated with CVD among men with hypertension. Design: Prospective cohort study. Setting: United States. Participants: 11 711 men with hypertension from the Health Professionals Follow-Up Study. Measurements: Alcohol consumption was assessed every 4 years by using a food-frequency questionnaire. Incident cases of nonfatal myocardial infarction (MI), fatal coronary heart disease, and stroke were documented from 1986 to 2002. Results: During follow-up, 653 patients with MI were documented. Compared with patients abstaining from alcohol, the hazard ratio for participants with MI consuming 0.1 to 4.9 grams of alcohol per day was 1.09 (95% CI, 0.86 to 1.37); consuming 5 to 9.9 grams of alcohol per day was 0.81 (CI, 0.60 to 1.08 g/d); consuming 10 to 14.9 grams of alcohol per day was 0.68 (CI, 0.51 to 0.91 g/d); consuming 15 to 29.9 grams of alcohol per day was 0.72 (CI, 0.54 to 0.97 g/d); consuming 30 to 49.9 grams of alcohol per day was 0.67 (CI, 0.48 to 0.94 g/d); and consuming 50 or more grams of alcohol per day was 0.41 (CI, 0.22 to 0.77 g/d) (P < 0.001 for trend). Associations were similar for fatal and nonfatal MI. Alcohol consumption was not associated with total death or death due to CVD. Risks for total and ischemic stroke for patients consuming 10 to 29.9 g of alcohol per day were 1.40 (CI, 0.93 to 2.12) and 1.55 (CI, 0.90 to 2.68) compared with that of abstainers. When corrected for measurement error in alcohol consumption, dietary variables, and body mass index, the hazard ratio for participants with MI per 12.5 grams per day increment of alcohol intake was 0.68 (CI, 0.46 to 1.00). Limitations: Hypertension, alcohol consumption, and CVD risk factors were assessed by self-report. Available data used to correct for measurement error were primarily restricted to dietary variables. Conclusions: In this population of men with hypertension, moderate alcohol consumption was associated with a decreased risk for MI but not with risks for total death or death due to CVD. As in the general population, men with hypertension who drink moderately and safely may not need to change their drinking habits.	Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Wageningen & Res Ctr, NL-6700 HB Wageningen, Netherlands; TNO Qual Life, Zeist, Netherlands	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Wageningen University & Research; Netherlands Organization Applied Science Research	Beulens, JWJ (corresponding author), Univ Utrecht, Med Ctr, Utrecht Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	J.Beulens@umcutrecht.nl	Mukamal, Kenneth/GVR-7978-2022; Hendriks, Henk/AAU-5987-2021	Beulens, Joline/0000-0002-4181-0937	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Cushman WC, 1998, ARCH INTERN MED, V158, P1197, DOI 10.1001/archinte.158.11.1197; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; FOX MP, 2006, EPIDEMIOLOGIC METHOD; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldberg IJ, 2001, CIRCULATION, V103, P472; HENDRIKS HFJ, 1994, BRIT MED J, V308, P1003, DOI 10.1136/bmj.308.6935.1003; KIYOHARA Y, 1995, STROKE, V26, P368, DOI 10.1161/01.STR.26.3.368; LOGAN R, 1997, SAS BLINPLUS MACRO; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; Malinski MK, 2004, ARCH INTERN MED, V164, P623, DOI 10.1001/archinte.164.6.623; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Ngandu NH, 1997, STAT MED, V16, P611, DOI 10.1002/(SICI)1097-0258(19970330)16:6<611::AID-SIM437>3.0.CO;2-T; PALMER AJ, 1995, J HYPERTENS, V13, P957, DOI 10.1097/00004872-199509000-00004; Rehm JT, 1997, AM J EPIDEMIOL, V146, P495, DOI 10.1093/oxfordjournals.aje.a009303; Reims HM, 2004, J HUM HYPERTENS, V18, P381, DOI 10.1038/sj.jhh.1001731; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1996, AM J EPIDEMIOL, V143, P1094; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rose G, 1982, CARDIOVASCULAR SURVE; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SHAPER AG, 1988, LANCET, V2, P1267; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Tanasescu M, 2001, J AM COLL CARDIOL, V38, P1836, DOI 10.1016/S0735-1097(01)01655-2; Thadhani R, 2002, ARCH INTERN MED, V162, P569, DOI 10.1001/archinte.162.5.569; Therneau T, 1997, P 1 SEATTL S BIOST S, P51; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; WANNAMETHEE G, 1995, BRIT HEART J, V74, P324; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	49	91	99	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					10	W3		10.7326/0003-4819-146-1-200701020-00004	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200217				2022-12-24	WOS:000247893300002
J	Baker, BJ; Tyson, GW; Webb, RI; Flanagan, J; Hugenholtz, P; Allen, EE; Banfield, JF				Baker, Brett J.; Tyson, Gene W.; Webb, Richard I.; Flanagan, Judith; Hugenholtz, Philip; Allen, Eric E.; Banfield, Jillian F.			Lineages of acidophilic archaea revealed by community genomic analysis	SCIENCE			English	Article							MICROORGANISMS; ASSEMBLAGES; DIVERSITY; BACTERIA; PHYLUM	Novel, low-abundance microbial species can be easily overlooked in standard polymerase chain reaction (PCR)-based surveys. We used community genomic data obtained without PCR or cultivation to reconstruct DNA fragments bearing unusual 16S ribosomal RNA ( rRNA) and protein-coding genes from organisms belonging to novel archaeal lineages. The organisms are minor components of all biofilms growing in pH 0.5 to 1.5 solutions within the Richmond Mine, California. Probes specific for 16S rRNA showed that the fraction less than 0.45 micrometers in diameter is dominated by these organisms. Transmission electron microscope images revealed that the cells are pleomorphic with unusual folded membrane protrusions and have apparent volumes of < 0.006 cubic micrometer.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Queensland; University of Queensland	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jill@eps.berkeley.edu	Baker, Brett/P-1783-2014; Hugenholtz, Philip/AAD-9138-2019; Tyson, Gene W/C-6558-2013	Baker, Brett/0000-0002-5971-1021; Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Banfield, Jill/0000-0001-8203-8771; Flanagan, Judith/0000-0002-4053-3288				Baker BJ, 2003, ENVIRON MICROBIOL, V5, P267, DOI 10.1046/j.1462-2920.2003.00408.x; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Huber H, 2003, RES MICROBIOL, V154, P165, DOI 10.1016/S0923-2508(03)00035-4; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Miteva VI, 2005, APPL ENVIRON MICROB, V71, P7806, DOI 10.1128/AEM.71.12.7806-7818.2005; Nomura N, 1998, J BACTERIOL, V180, P3635, DOI 10.1128/JB.180.14.3635-3643.1998; RIEGER G, 1995, J STRUCT BIOL, V115, P78, DOI 10.1006/jsbi.1995.1032; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; *STEER GROUP WORKS, 1999, SIZ LIM VER SMALL MI; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100	24	154	163	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1933	1935		10.1126/science.1132690	http://dx.doi.org/10.1126/science.1132690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185602				2022-12-24	WOS:000242996800051
J	Zaiss, DM; Yang, L; Shah, PR; Kobie, JJ; Urban, JF; Mosmann, TR				Zaiss, Dietmar M.; Yang, Li; Shah, Pranav R.; Kobie, James J.; Urban, Joseph F.; Mosmann, Tim R.			Amphiregulin, a T(H)2 cytokine enhancing resistance to nematodes	SCIENCE			English	Article							PARASITE; MOUSE		Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; ARS, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA	University of Rochester; University of Rochester; United States Department of Agriculture (USDA)	Mosmann, TR (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu		Zaiss, Dietmar M.W./0000-0003-3596-7062; Urban, Joseph/0000-0002-1590-8869	NIAID NIH HHS [AI48604] Funding Source: Medline; PHS HHS [DFG/ZA280] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048604] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Shea-Donohue T, 2004, CURR OPIN GASTROEN, V20, P3, DOI 10.1097/00001574-200401000-00003; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939	7	135	140	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1746	1746		10.1126/science.1133715	http://dx.doi.org/10.1126/science.1133715			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170297				2022-12-24	WOS:000242833600049
J	Fuss, B; Becker, T; Zinke, I; Hoch, M				Fuss, Bernhard; Becker, Thomas; Zinke, Ingo; Hoch, Michael			The cytohesin Steppke is essential for insulin signalling in Drosophila	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHOINOSITIDE 3-KINASE; CELL-GROWTH; RECEPTOR; ARF; NUMBER; MECHANISMS; AKT/PKB; PATHWAY; BINDING	In metazoans, the insulin signalling pathway has a key function in regulating energy metabolism and organismal growth(1). Its activation stimulates a highly conserved downstream kinase cascade that includes phosphatidylinositol-3-OH kinase ( PI( 3) K) and the serine - threonine protein kinase Akt. This study identifies a new component of insulin signalling in Drosophila, the steppke gene ( step). step encodes a member of the cytohesin family of guanine nucleotide exchange factors ( GEFs), which have been characterized as activators for ADP-ribosylation factor (ARF) GTPases(2-4). In step mutant animals both cell size and cell number are reduced, resulting in decreased body size and body weight in larvae, pupae and adults. step acts upstream of PI( 3) K and is required for the proper regulation of Akt and the transcription factor FOXO. Temporally controlled interference with the GEF activity of the Step protein by feeding the chemical inhibitor SecinH3 causes a block of insulin signalling and a phenocopy of the step mutant growth defect. Step represses its own expression and the synthesis of growth inhibitors such as the translational repressor 4E-BP. Our findings indicate a crucial role of an ARF - GEF in insulin signalling that has implications for understanding insulin-related disorders, such as diabetes and obesity.	Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, D-53115 Bonn, Germany	University of Bonn	Hoch, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Gimenez, Luis E Diaz/D-9291-2011					Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hafen E, 2004, SWISS MED WKLY, V134, P711; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Randazzo PA, 2001, TRENDS BIOCHEM SCI, V26, P220, DOI 10.1016/S0968-0004(01)01806-0; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	27	108	109	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					945	948		10.1038/nature05412	http://dx.doi.org/10.1038/nature05412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167488				2022-12-24	WOS:000242805400060
J	Davis, CC; Latvis, M; Nickrent, DL; Wurdack, KJ; Baum, DA				Davis, Charles C.; Latvis, Maribeth; Nickrent, Daniel L.; Wurdack, Kenneth J.; Baum, David A.			Floral gigantism in rafflesiaceae	SCIENCE			English	Article							FLOWERING PLANTS; GENE-TRANSFER		Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; Smithsonian Inst, Dept Bot, Washington, DC 20013 USA; Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	Harvard University; Southern Illinois University System; Southern Illinois University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Wisconsin System; University of Wisconsin Madison	Davis, CC (corresponding author), Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, 22 Divin Ave, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Nickrent, Daniel/AAA-8411-2020; Baum, David/D-6804-2015	Baum, David/0000-0001-8334-6311				[Anonymous], 1969, BIOL PARASITIC FLOWE; Barkman TJ, 2004, P NATL ACAD SCI USA, V101, P787, DOI 10.1073/pnas.0305562101; BROWN R, 1822, T LINN SOC LOND, V13, P201, DOI DOI 10.1111/J.1095-8339.1821.TB00062.X; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Nickrent Daniel L., 1998, P211; Nickrent DL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-40; Nickrent DL, 1997, PLANT MOL BIOL, V34, P717, DOI 10.1023/A:1005860632601; O'Meara BC, 2006, EVOLUTION, V60, P922; OMEARA BC, BROWNIE 2 06B	10	100	104	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1812	1812		10.1126/science.1135260	http://dx.doi.org/10.1126/science.1135260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17218493				2022-12-24	WOS:000245280100033
J	Newton, ILG; Woyke, T; Auchtung, TA; Dilly, GF; Dutton, RJ; Fisher, MC; Fontanez, KM; Lau, E; Stewart, FJ; Richardson, PM; Barry, KW; Saunders, E; Detter, JC; Wu, D; Eisen, JA; Cavanaugh, CM				Newton, I. L. G.; Woyke, T.; Auchtung, T. A.; Dilly, G. F.; Dutton, R. J.; Fisher, M. C.; Fontanez, K. M.; Lau, E.; Stewart, F. J.; Richardson, P. M.; Barry, K. W.; Saunders, E.; Detter, J. C.; Wu, D.; Eisen, J. A.; Cavanaugh, C. M.			The Calyptogena magnifica chemoautotrophic symbiont genome	SCIENCE			English	Article							GALAPAGOS SPREADING CENTER; HYDROTHERMAL VENT CLAM; GENE-CLUSTER; SULFIDE	Chemoautotrophic endosymbionts are the metabolic cornerstone of hydrothermal vent communities, providing invertebrate hosts with nearly all of their nutrition. The Calyptogena magnifica (Bivalvia: Vesicomyidae) symbiont, Candidatus Ruthia magnifica, is the first intracellular sulfur-oxidizing endosymbiont to have its genome sequenced, revealing a suite of metabolic capabilities. The genome encodes major chemoautotrophic pathways as well as pathways for biosynthesis of vitamins, cofactors, and all 20 amino acids required by the clam.	Harvard Univ, Biolabs 4080, Cambridge, MA 02138 USA; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ Calif Davis, Genome Ctr, Genome & Biomed Sci Facil, Davis, CA 95616 USA	Harvard University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Harvard Medical School; J. Craig Venter Institute; University of California System; University of California Davis	Cavanaugh, CM (corresponding author), Harvard Univ, Biolabs 4080, 16 Divin Ave, Cambridge, MA 02138 USA.	cavanaug@fas.harvard.edu	Barry, Kerrie Whitelaw/AAA-5500-2020; Newton, Irene/H-5939-2019; Eisen, Jonathan A./H-2706-2019	Barry, Kerrie Whitelaw/0000-0002-8999-6785; Newton, Irene/0000-0002-7118-0374; Eisen, Jonathan A./0000-0002-0159-2197; Dilly, Geoffrey/0000-0003-2140-4955; Auchtung, Thomas/0000-0002-0135-6266; Lau, Evan/0000-0002-7434-4362				BOSS KJ, 1980, MALACOLOGIA, V20, P161; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Cavanaugh CM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P285; CAVANAUGH CM, 2004, PROKARYOTES; CHILDRESS JJ, 1991, PHYSIOL ZOOL, V64, P1444, DOI 10.1086/physzool.64.6.30158224; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FISHER CR, 1988, DEEP-SEA RES, V35, P1811, DOI 10.1016/0198-0149(88)90051-9; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; ROBINSON JJ, 1997, THESIS HARVARD U CAM; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Verte F, 2002, BIOCHEMISTRY-US, V41, P2932, DOI 10.1021/bi011404m; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; Zal F, 2000, CAH BIOL MAR, V41, P413	16	138	378	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					998	1000		10.1126/science.1138438	http://dx.doi.org/10.1126/science.1138438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303757	Green Submitted			2022-12-24	WOS:000244229800045
J	Watters, AL; Deka, P; Corrent, C; Callender, D; Varani, G; Sosnick, T; Baker, D				Watters, Alexander L.; Deka, Pritilekha; Corrent, Colin; Callender, David; Varani, Gabriele; Sosnick, Tobin; Baker, David			The highly cooperative folding of small naturally occurring proteins is likely the result of natural selection	CELL			English	Article							ENERGY LANDSCAPES; BINDING DOMAIN; EVOLUTION; 2-STATE; DESIGN; AGGREGATION; KINETICS; NMR; STABILITY; INTERMEDIATE	To illuminate the evolutionary pressure acting on the folding free energy landscapes of naturally occurring proteins, we have systematically characterized the folding free energy landscape of Top7, a computationally designed protein lacking an evolutionary history. Stopped-flow kinetics, circular dichroism, and NMR experiments reveal that there are at least three distinct phases in the folding of Top7, that a nonnative conformation is stable at equilibrium, and that multiple fragments of Top7 are stable in isolation. These results indicate that the folding of Top7 is significantly less cooperative than the folding of similarly sized naturally occurring proteins, suggesting that the cooperative folding and smooth free energy landscapes observed for small naturally occurring proteins are not general properties of polypeptide chains that fold to unique stable structures but are instead a product of natural selection.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Freed, Karl F/J-7764-2018; Baker, David/K-8941-2012	Freed, Karl F/0000-0001-6240-2599; Baker, David/0000-0001-7896-6217				ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Bai YW, 2003, BIOCHEM BIOPH RES CO, V305, P785, DOI 10.1016/S0006-291X(03)00800-3; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bolon DN, 2001, BIOCHEMISTRY-US, V40, P10047, DOI 10.1021/bi010427y; Calloni G, 2003, J MOL BIOL, V330, P577, DOI 10.1016/S0022-2836(03)00627-2; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Chan HS, 2000, PROTEINS, V40, P543, DOI 10.1002/1097-0134(20000901)40:4<543::AID-PROT20>3.0.CO;2-O; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dantas G, 2006, J MOL BIOL, V362, P1004, DOI 10.1016/j.jmb.2006.07.092; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson N, 2006, STRUCTURE, V14, P847, DOI 10.1016/j.str.2006.02.011; Ferguson N, 2005, J MOL BIOL, V353, P427, DOI 10.1016/j.jmb.2005.08.031; Ferguson N, 2004, J MOL BIOL, V344, P295, DOI 10.1016/j.jmb.2004.09.069; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; Fukunishi Y, 1998, PROTEINS, V33, P408, DOI 10.1002/(SICI)1097-0134(19981115)33:3<408::AID-PROT9>3.0.CO;2-2; Gillespie B, 2003, J MOL BIOL, V330, P813, DOI 10.1016/S0022-2836(03)00616-8; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GO N, 1984, ADV BIOPHYS, V18, P149, DOI 10.1016/0065-227X(84)90010-8; GOVINDARAJAN S, 1995, PROTEINS, V22, P413, DOI 10.1002/prot.340220411; GRANT JS, 1997, J FAMILY NURSING, V3, P36; GU HD, 1995, PROTEIN SCI, V4, P1108, DOI 10.1002/pro.5560040609; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3; Jack CIA, 2001, AGE AGEING, V30, P428, DOI 10.1093/ageing/30.5.428; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065; JERNTH P, 2004, P NATL ACAD SCI USA, V101, P6450; Jewett AI, 2003, J MOL BIOL, V326, P247, DOI 10.1016/S0022-2836(02)01356-6; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Krantz BA, 2000, BIOCHEMISTRY-US, V39, P11696, DOI 10.1021/bi000792+; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ladurner AG, 1997, J MOL BIOL, V273, P317, DOI 10.1006/jmbi.1997.1303; MATOUSCHEK A, 1991, METHOD ENZYMOL, V202, P82; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scalley ML, 1997, BIOCHEMISTRY-US, V36, P3373, DOI 10.1021/bi9625758; Scalley-Kim M, 2004, J MOL BIOL, V338, P573, DOI 10.1016/j.jmb.2004.02.055; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Srimathi T, 2002, J BIOL CHEM, V277, P47507, DOI 10.1074/jbc.M203407200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yahara I, 1999, GENES CELLS, V4, P375, DOI 10.1046/j.1365-2443.1999.00271.x; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	64	109	111	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					613	624		10.1016/j.cell.2006.12.042	http://dx.doi.org/10.1016/j.cell.2006.12.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289578	Bronze			2022-12-24	WOS:000244842700025
J	Young, DW; Hassan, MQ; Pratap, J; Galindo, M; Zaidi, SK; Lee, SH; Yang, XQ; Xie, RL; Javed, A; Underwood, JM; Furcinitti, P; Imbalzano, AN; Penman, S; Nickerson, JA; Montecino, MA; Lian, JB; Stein, JL; van Wijnen, AJ; Stein, GS				Young, Daniel W.; Hassan, Mohammad Q.; Pratap, Jitesh; Galindo, Mario; Zaidi, Sayyed K.; Lee, Suk-hee; Yang, Xiaoqing; Xie, Ronglin; Javed, Amjad; Underwood, Jean M.; Furcinitti, Paul; Imbalzano, Anthony N.; Penman, Sheldon; Nickerson, Jeffrey A.; Montecino, Martin A.; Lian, Jane B.; Stein, Janet L.; van Wijnen, Andre J.; Stein, Gary S.			Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2	NATURE			English	Article							POLYMERASE-I TRANSCRIPTION; CELL-CYCLE; RDNA TRANSCRIPTION; NUCLEAR-MATRIX; UBF; PROTEINS; DNA; RB; DIFFERENTIATION; CHROMOSOMES	Regulation of ribosomal RNA genes is a fundamental process that supports the growth of cells and is tightly coupled with cell differentiation. Although rRNA transcriptional control by RNA polymerase I (Pol I) and associated factors is well studied, the lineage-specific mechanisms governing rRNA expression remain elusive(1). Runt-related transcription factors Runx1, Runx2 and Runx3 establish and maintain cell identity(2), and convey phenotypic information through successive cell divisions for regulatory events that determine cell cycle progression or exit in progeny cells(3). Here we establish that mammalian Runx2 not only controls lineage commitment and cell proliferation by regulating genes transcribed by RNA Pol II, but also acts as a repressor of RNA Pol I mediated rRNA synthesis. Within the condensed mitotic chromosomes we find that Runx2 is retained in large discrete foci at nucleolar organizing regions where rRNA genes reside. These Runx2 chromosomal foci are associated with open chromatin, colocalize with the RNA Pol I transcription factor UBF1, and undergo transition into nucleoli at sites of rRNA synthesis during interphase. Ribosomal RNA transcription and protein synthesis are enhanced by Runx2 deficiency that results from gene ablation or RNA interference, whereas induction of Runx2 specifically and directly represses rDNA promoter activity. Runx2 forms complexes containing the RNA Pol I transcription factors UBF1 and SL1, co-occupies the rRNA gene promoter with these factors in vivo, and affects local chromatin histone modifications at rDNA regulatory regions. Thus Runx2 is a critical mechanistic link between cell fate, proliferation and growth control. Our results suggest that lineage-specific control of ribosomal biogenesis may be a fundamental function of transcription factors that govern cell fate.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Concepcion, Dept Biol Mol, Fac Ciencias Biol, Concepcion, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Universidad de Concepcion	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Hassan, Mohammad/GZA-7507-2022; Zaidi, Sayyed Kaleem/I-5596-2019	van Wijnen, Andre J./0000-0002-4458-0946; Hassan, Mohammad/0000-0002-1712-0004; Zaidi, Sayyed Kaleem/0000-0001-6664-5168; Javed, Amjad/0000-0002-0847-8266	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049069] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cheutin T, 2002, J CELL SCI, V115, P3297; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; GebraneYounes J, 1997, J CELL SCI, V110, P2429; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Hovhannisyan H, 2003, MOL CELL BIOL, V23, P1460, DOI 10.1128/MCB.23.4.1460-1469.2003; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; Javed A, 2000, J CELL SCI, V113, P2221; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; NICKERSON JA, 1990, P NATL ACAD SCI USA, V87, P2259, DOI 10.1073/pnas.87.6.2259; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; ROUSSEL P, 1993, J CELL SCI, V104, P327; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	30	182	187	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					442	446		10.1038/nature05473	http://dx.doi.org/10.1038/nature05473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251981				2022-12-24	WOS:000243689500043
J	Saeij, JPJ; Coller, S; Boyle, JP; Jerome, ME; White, MW; Boothroyd, JC				Saeij, J. P. J.; Coller, S.; Boyle, J. P.; Jerome, M. E.; White, M. W.; Boothroyd, J. C.			Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue	NATURE			English	Article							GONDII STRAINS; PARASITOPHOROUS VACUOLE; PARASITE GENOTYPE; MACROPHAGES; MICROARRAYS; MEMBRANE; LINEAGES; INVASION; REVEALS; IL-12	Toxoplasma gondii, an obligate intracellular parasite of the phylum Apicomplexa, can cause severe disease in humans with an immature or suppressed immune system. The outcome of Toxoplasma infection is highly dependent on the strain type, as are many of its in vitro growth properties(1). Here we use genetic crosses between type II and III lines to show that strain-specific differences in the modulation of host cell transcription are mediated by a putative protein kinase, ROP16. Upon invasion by the parasite, this polymorphic protein is released from the apical organelles known as rhoptries and injected into the host cell, where it ultimately affects the activation of signal transducer and activator of transcription ( STAT) signalling pathways and consequent downstream effects on a key host cytokine, interleukin (IL)-12. Our findings provide a new mechanism for how an intracellular eukaryotic pathogen can interact with its host and reveal important differences in how different Toxoplasma lineages have evolved to exploit this interaction.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Montana State Univ, Coll Agr, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Stanford University; Montana State University System; Montana State University Bozeman	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild Bldg D305,300 Pasteur Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	White, Michael/A-4978-2012	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI021423, R01 AI021423-20] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BURG JL, 1988, J IMMUNOL, V141, P3584; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Carme B, 2002, J CLIN MICROBIOL, V40, P4037, DOI 10.1128/JCM.40.11.4037-4044.2002; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GILBERT LA, 2006, EUKARYOT CELL   1103, DOI DOI 10.1128/EC/00309-06; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	24	406	439	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					324	327		10.1038/nature05395	http://dx.doi.org/10.1038/nature05395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183270	Green Accepted			2022-12-24	WOS:000243504700047
J	Kolsch, V; Seher, T; Fernandez-Ballester, GJ; Serrano, L; Leptin, M				Koelsch, Verena; Seher, Thomas; Fernandez-Ballester, Gregorio J.; Serrano, Luis; Leptin, Maria			Control of Drosophila gastrulation by apical localization of adherens junctions and RhoGEF2	SCIENCE			English	Article							CELL-SHAPE CHANGES; FOLDED-GASTRULATION; SIGNALING PATHWAY; RHO-GTPASE; PROTEIN; MORPHOLOGY; EXTENSION; TARGET; FURROW	A hallmark of epithelial invagination is the constriction of cells on their apical sides. During Drosophila gastrulation, apical constrictions under the control of the transcription factor Twist lead to the invagination of the mesoderm. Twist-controlled G protein signaling is involved in mediating the invagination but is not sufficient to account for the full activity of Twist. We identified a Twist target, the transmembrane protein T48, which acts in conjunction with G protein signaling to orchestrate shape changes. Together with G protein signaling, T48 recruits adherens junctions and the cytoskeletal regulator RhoGEF2 to the sites of apical constriction, ensuring rapid and intense changes in cell shape.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; European Mol Biol Lab, D-69012 Heidelberg, Germany	University of Cologne; Universidad Miguel Hernandez de Elche; European Molecular Biology Laboratory (EMBL)	Leptin, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	mleptin@uni-koeln.de	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392				Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kwan KM, 2005, DEVELOPMENT, V132, P4599, DOI 10.1242/dev.02041; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; STRUTT DI, 1994, MECH DEVELOP, V46, P27, DOI 10.1016/0925-4773(94)90035-3; SWEETON D, 1991, DEVELOPMENT, V112, P775; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X	20	236	236	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					384	386		10.1126/science.1134833	http://dx.doi.org/10.1126/science.1134833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234948				2022-12-24	WOS:000243535400044
J	Barreto, G; Schafer, A; Marhold, J; Stach, D; Swaminathan, SK; Handa, V; Doderlein, G; Maltry, N; Wu, W; Lyko, F; Niehrs, C				Barreto, Guillermo; Schaefer, Andrea; Marhold, Joachim; Stach, Dirk; Swaminathan, Suresh K.; Handa, Vikas; Doederlein, Gabi; Maltry, Nicole; Wu, Wei; Lyko, Frank; Niehrs, Christof			Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation	NATURE			English	Article							METHYLATION; EXPRESSION; PROTEIN; CELLS; CYCLE	DNA methylation is an epigenetic modification that is essential for gene silencing and genome stability in many organisms. Although methyltransferases that promote DNA methylation are well characterized, the molecular mechanism underlying active DNA demethylation is poorly understood and controversial(1,2). Here we show that Gadd45a ( growth arrest and DNA-damage-inducible protein 45 alpha), a nuclear protein involved in maintenance of genomic stability, DNA repair and suppression of cell growth 3,4, has a key role in active DNA demethylation. Gadd45a overexpression activates methylation-silenced reporter plasmids and promotes global DNA demethylation. Gadd45a knockdown silences gene expression and leads to DNA hypermethylation. During active demethylation of oct4 in Xenopus laevis oocytes(5), Gadd45a is specifically recruited to the site of demethylation. Active demethylation occurs by DNA repair and Gadd45a interacts with and requires the DNA repair endonuclease XPG. We conclude that Gadd45a relieves epigenetic gene silencing by promoting DNA repair, which erases methylation marks.	German Canc Res Ctr, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), German Canc Res Ctr, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz.de	Barreto, Guillermo/U-5718-2017	Barreto, Guillermo/0000-0002-7777-4712				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Escher G, 2005, J LIPID RES, V46, P356, DOI 10.1194/jlr.D400014-JLR200; Fang JY, 2003, WORLD J GASTROENTERO, V9, P1976, DOI 10.3748/wjg.v9.i9.1976; Furukawa T, 2002, GENE CHROMOSOME CANC, V35, P1, DOI 10.1002/gcc.10100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jaenisch R, 2004, COLD SPRING HARB SYM, V69, P19, DOI 10.1101/sqb.2004.69.19; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; PRIVES C, 1991, METHOD CELL BIOL, V36, P185; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Smith ML, 1996, ONCOGENE, V13, P2255; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193	29	570	612	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					671	675		10.1038/nature05515	http://dx.doi.org/10.1038/nature05515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17268471				2022-12-24	WOS:000244039400049
J	Gross, T; Siepmann, A; Sturm, D; Windgassen, M; Scarcelli, JJ; Seedorf, M; Cole, CN; Krebber, H				Gross, Thomas; Siepmann, Anja; Sturm, Dorothee; Windgassen, Merle; Scarcelli, John J.; Seedorf, Matthias; Cole, Charles N.; Krebber, Heike			The DEAD-box RNA helicase Dbp5 functions in translation termination	SCIENCE			English	Article							MESSENGER-RNA; POLY(A)-BINDING PROTEIN; EXPORT; TRANSPORT; NONSENSE	In eukaryotes, termination of messenger RNA (mRNA) translation is mediated by the release factors eRF1 and eRF3. Using Saccharomyces cerevisiae as a model organism, we have identified a member of the DEAD-box protein (DBP) family, the DEAD-box RNA helicase and mRNA export factor Dbp5, as a player in translation termination. Dbp5 interacts genetically with both release factors and the polyadenlyate-binding protein Pab1. A physical interaction was specifically detected with eRF1. Moreover, we show that the helicase activity of Dbp5 is required for efficient stop-codon recognition, and intact Dbp5 is essential for recruitment of eRF3 into termination complexes. Therefore, Dbp5 controls the eRF3-eRF1 interaction and thus eRF3-mediated downstream events.	Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Heidelberg Univ, Zentrum Mol Biol, D-69129 Heidelberg, Germany	Philipps University Marburg; Dartmouth College; Ruprecht Karls University Heidelberg	Krebber, H (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany.	krebber@imt.uni-marburg.de	Cole, Charles/GRR-1551-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033998] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Jacobson A, 2005, NAT STRUCT MOL BIOL, V12, P474, DOI 10.1038/nsmb0605-474; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	13	106	107	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					646	649		10.1126/science.1134641	http://dx.doi.org/10.1126/science.1134641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272721				2022-12-24	WOS:000243909400043
J	Schreier, WJ; Schrader, TE; Koller, FO; Gilch, P; Crespo-Hernandez, CE; Swaminathan, VN; Carell, T; Zinth, W; Kohler, B				Schreier, Wolfgang J.; Schrader, Tobias E.; Koller, Florian O.; Gilch, Peter; Crespo-Hernandez, Carlos E.; Swaminathan, Vijay N.; Carell, Thomas; Zinth, Wolfgang; Kohler, Bern			Thymine dimerization in DNA is an ultrafast photoreaction	SCIENCE			English	Article							EXCITED-STATE DYNAMICS; SINGLE-STRANDED-DNA; DIMER FORMATION; PYRIMIDINE DIMERS; INTERNAL-CONVERSION; CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; BASES; POLYNUCLEOTIDES; PHOTODIMERIZATION	Femtosecond time-resolved infrared spectroscopy was used to study the formation of cyclobutane dimers in the all-thymine oligodeoxynucleotide (dT)(18) by ultraviolet light at 272 nanometers. The appearance of marker bands in the time-resolved spectra indicates that the dimers are fully formed similar to 1 picosecond after ultraviolet excitation. The ultrafast appearance of this mutagenic photolesion points to an excited-state reaction that is approximately barrierless for bases that are properly oriented at the instant of light absorption. The low quantum yield of this photoreaction is proposed to result from infrequent conformational states in the unexcited polymer, revealing a strong link between conformation before light absorption and photodamage.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Univ Munich, Dept Phys, D-80538 Munich, Germany; Univ Munich, Fak Chem & Pharm, D-81377 Munich, Germany	University System of Ohio; Ohio State University; University of Munich; University of Munich	Zinth, W (corresponding author), Ohio State Univ, Dept Chem, 100 W 8th Ave, Columbus, OH 43210 USA.	wolfgang.zinth@physik.uni-muenchen.de; kohler@chemistry.ohio-state.edu	Kohler, Bern/A-1728-2011; Schreier, Wolfgang/B-1336-2012; Carell, Thomas/G-4799-2012; Crespo-Hernández, Carlos E./A-9915-2008	Kohler, Bern/0000-0001-5353-1655; Carell, Thomas/0000-0001-7898-2831; Crespo-Hernández, Carlos E./0000-0002-3594-0890; Zinth, Wolfgang/0000-0003-3695-9486	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064563] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064563-04, GM064563] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4; BECKER MM, 1984, NATURE, V309, P682, DOI 10.1038/309682a0; BECKER MM, 1989, J BIOL CHEM, V264, P4163; BERNARDI F, 1990, J AM CHEM SOC, V112, P1737, DOI 10.1021/ja00161a013; Butenandt J, 1998, CHEM-EUR J, V4, P642, DOI 10.1002/(SICI)1521-3765(19980416)4:4<642::AID-CHEM642>3.0.CO;2-K; Cadet J., 1990, BIOORGANIC PHOTOCHEM, V1, P1; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; DEERING RA, 1963, BIOCHIM BIOPHYS ACTA, V68, P526; Douki T, 2006, J PHOTOCH PHOTOBIO B, V82, P45, DOI 10.1016/j.jphotobiol.2005.08.009; Fuss W, 2002, PHOTOCH PHOTOBIO SCI, V1, P60, DOI 10.1039/b107442c; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Hare PM, 2007, P NATL ACAD SCI USA, V104, P435, DOI 10.1073/pnas.0608055104; HOSSZU JL, 1967, BIOCHEM BIOPH RES CO, V29, P327, DOI 10.1016/0006-291X(67)90457-3; Kuimova MK, 2006, P NATL ACAD SCI USA, V103, P2150, DOI 10.1073/pnas.0506860103; Kundu LM, 2004, CHEM-EUR J, V10, P5697, DOI 10.1002/chem.200305731; LAMOLA AA, 1968, P NATL ACAD SCI USA, V59, P46, DOI 10.1073/pnas.59.1.46; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; LISEWSKI R, 1970, PHOTOCHEM PHOTOBIOL, V11, P327, DOI 10.1111/j.1751-1097.1970.tb06006.x; LYAMICHEV V, 1991, NUCLEIC ACIDS RES, V19, P4491, DOI 10.1093/nar/19.16.4491; Marguet S, 2005, J AM CHEM SOC, V127, P5780, DOI 10.1021/ja050648h; Martinez JM, 2001, J AM CHEM SOC, V123, P12279, DOI 10.1021/ja0108786; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; MITCHELL DL, 1984, PHOTOCHEM PHOTOBIOL, V40, P735; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; RAHN RO, 1968, PHOTOCHEM PHOTOBIOL, V7, P637, DOI 10.1111/j.1751-1097.1968.tb08046.x; RAHN RO, 1966, SCIENCE, V154, P503, DOI 10.1126/science.154.3748.503; Saenger W., 1984, PRINCIPLES NUCL ACID; SCHERER NF, 1990, J CHEM PHYS, V92, P5239, DOI 10.1063/1.458531; Schrader T, 2004, CHEM PHYS LETT, V392, P358, DOI 10.1016/j.cplett.2004.05.090; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P7; TRAMER Z, 1969, ACTA BIOCHIM POL, V16, P83; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; WAGNER PJ, 1983, ACCOUNTS CHEM RES, V16, P461, DOI 10.1021/ar00096a006; Zhang SL, 1998, J PHYS CHEM A, V102, P461, DOI 10.1021/jp972385m	38	410	413	9	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					625	629		10.1126/science.1135428	http://dx.doi.org/10.1126/science.1135428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272716	Green Accepted			2022-12-24	WOS:000243909400037
J	Kim, K; Lerou, P; Yabuuchi, A; Lengerke, C; Ng, K; West, J; Kirby, A; Daly, MJ; Daley, GQ				Kim, Kitai; Lerou, Paul; Yabuuchi, Akiko; Lengerke, Claudia; Ng, Kitwa; West, Jason; Kirby, Andrew; Daly, Mark J.; Daley, George Q.			Histocompatible embryonic stem cells by parthenogenesis	SCIENCE			English	Article							MOUSE; GENOME; INSTABILITY; MICE	Genetically matched pluripotent embryonic stem (ES) cells generated via nuclear transfer or parthenogenesis (pES cells) are a potential source of histocompatible cells and tissues for transplantation. After parthenogenetic activation of murine oocytes and interruption of meiosis I or II, we isolated and genotyped pES cells and characterized those that carried the full complement of major histocompatibility complex (MHC) antigens of the oocyte donor. Differentiated tissues from these pES cells engrafted in immunocompetent MHC-matched mouse recipients, demonstrating that selected pES cells can serve as a source of histocompatible tissues for transplantation.	Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Newborn Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Daly, Mark J/B-2453-2017; West, Jason/I-4445-2014; Lengerke, Claudia/AAV-8745-2021	Daly, Mark J/0000-0002-0949-8752; West, Jason/0000-0002-7252-8651; Lengerke, Claudia/0000-0001-5442-2805	NICHD NIH HHS [T32: HD07466] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN ND, 1994, DEVELOPMENT, V120, P1473; BALAKIER H, 1976, J EMBRYOL EXP MORPH, V35, P25; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Klebs SHG, 2003, J IMMUNOL METHODS, V276, P197, DOI 10.1016/S0022-1759(03)00063-2; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Lin H, 2003, STEM CELLS, V21, P152, DOI 10.1634/stemcells.21-2-152; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Opelz G, 1999, Rev Immunogenet, V1, P334; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; VANDEWATER J, 1989, NEW ENGL J MED, V320, P1377, DOI 10.1056/NEJM198905253202104; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	21	166	186	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					482	486		10.1126/science.1133542	http://dx.doi.org/10.1126/science.1133542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17170255				2022-12-24	WOS:000243726600037
J	Parton, W; Silver, WL; Burke, IC; Grassens, L; Harmon, ME; Currie, WS; King, JY; Adair, EC; Brandt, LA; Hart, SC; Fasth, B				Parton, William; Silver, Whendee L.; Burke, Ingrid C.; Grassens, Leo; Harmon, Mark E.; Currie, William S.; King, Jennifer Y.; Adair, E. Carol; Brandt, Leslie A.; Hart, Stephen C.; Fasth, Becky			Global-scale similarities in nitrogen release patterns during long-term decomposition	SCIENCE			English	Article							FINE-ROOT DECOMPOSITION; ULTRAVIOLET-B RADIATION; LITTER DECOMPOSITION; ORGANIC-MATTER; FOREST SOILS; LEAF-LITTER; MASS-LOSS; DYNAMICS; ECOSYSTEM; CLIMATE	Litter decomposition provides the primary source of mineral nitrogen (N) for biological activity in most terrestrial ecosystems. A 10-year decomposition experiment in 21 sites from seven biomes found that net N release from leaf litter is dominantly driven by the initial tissue N concentration and mass remaining regardless of climate, edaphic conditions, or biota. Arid grasslands exposed to high ultraviolet radiation were an exception, where net N release was insensitive to initial N. Roots released N linearly with decomposition and exhibited little net N immobilization. We suggest that fundamental constraints on decomposer physiologies lead to predictable global-scale patterns in net N release during decomposition.	Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; LSI Log Inc, Loveland, CO 80227 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48103 USA; Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA	Colorado State University; University of California System; University of California Berkeley; Colorado State University; Colorado State University; Oregon State University; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northern Arizona University; Northern Arizona University	Parton, W (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, 200 W Lake,Campus Mail 1499, Ft Collins, CO 80523 USA.		Silver, Whendee L./H-1118-2012; King, Jennifer Y./I-5986-2015; Burke, Ingrid/A-1420-2009	Silver, Whendee L./0000-0003-0372-8745; King, Jennifer Y./0000-0003-3433-5952; Burke, Ingrid/0000-0003-4717-6399; Fasth, Becky/0000-0001-5006-6727; Adair, E. Carol/0000-0002-8567-9045				ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Barrett JE, 2002, J VEG SCI, V13, P383, DOI 10.1111/j.1654-1103.2002.tb02062.x; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; BERG B, 1989, CAN J BOT, V67, P1148, DOI 10.1139/b89-150; Cadisch G., 1997, DRIVEN NATURE PLANT; Chen H, 2002, CAN J FOREST RES, V32, P320, DOI 10.1139/X01-202; Currie WS, 2003, GLOBAL CHANGE BIOL, V9, P919, DOI 10.1046/j.1365-2486.2003.00637.x; Dornbush ME, 2002, ECOLOGY, V83, P2985, DOI 10.1890/0012-9658(2002)083[2985:QFRDAA]2.0.CO;2; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; *LIDET, 1995, PUBLICATION US LONG, V19; LOUSIER JD, 1979, CAN J FOREST RES, V9, P449, DOI 10.1139/x79-073; Moody SA, 2001, PLANT ECOL, V154, P27, DOI 10.1023/A:1012965610170; MOORE B, 1994, AMBIO, V23, P4; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; Moorhead DL, 1999, GLOBAL BIOGEOCHEM CY, V13, P575, DOI 10.1029/1998GB900014; Pancotto VA, 2005, GLOBAL CHANGE BIOL, V11, P1982, DOI 10.1111/j.1365-2486.2005.01027.x; Parton W.J., 1994, SSSA SPECIAL PUBLICA, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; Post WM, 1996, CLIMATIC CHANGE, V34, P253, DOI 10.1007/BF00224636; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Richards EH, 1931, BIOCHEM J, V25, P1769, DOI 10.1042/bj0251769; Rozema J, 1997, PLANT ECOL, V128, P284; SCHIMEL DS, 1991, ECOLOGY, V72, P672, DOI 10.2307/2937207; SEASTEDT TR, 1992, CAN J BOT, V70, P384, DOI 10.1139/b92-052; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Silver WL, 2005, GLOBAL CHANGE BIOL, V11, P290, DOI 10.1111/j.1365-2486.2005.00903.x; SILVER WL, 1993, J ECOL, V81, P729, DOI 10.2307/2261670; Verhoef HA, 2000, BIOL FERT SOILS, V31, P366, DOI 10.1007/s003749900181; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	36	817	941	38	571	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					361	364		10.1126/science.1134853	http://dx.doi.org/10.1126/science.1134853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17234944				2022-12-24	WOS:000243535400037
J	Trotman, LC; Wang, XJ; Alimonti, A; Chen, ZB; Teruya-Feldstein, J; Yang, HJ; Pavletich, NP; Carver, BS; Cordon-Cardo, C; Erdjument-Bromage, H; Tempst, P; Chi, SG; Kim, HJ; Misteli, T; Jiang, XJ; Pandolfi, PP				Trotman, Lloyd C.; Wang, Xinjiang; Alimonti, Andrea; Chen, Zhenbang; Teruya-Feldstein, Julie; Yang, Haijuan; Pavletich, Nikola P.; Carver, Brett S.; Cordon-Cardo, Carlos; Erdjument-Bromage, Hediye; Tempst, Paul; Chi, Sung-Gil; Kim, Hyo-Jong; Misteli, Tom; Jiang, Xuejun; Pandolfi, Pier Paolo			Ubiquitination regulates PTEN nuclear import and tumor suppression	CELL			English	Article							PTEN/MMAC1 GENE; PROSTATE-CANCER; COWDEN-DISEASE; P53; MUTATIONS; PATHWAY; IDENTIFICATION; EXPRESSION; SYSTEM; ROLES	The PTEN tumor suppressor is frequently affected in cancer cells, and inherited PTEN mutation causes cancer-susceptibility conditions such as Cowden syndrome. PTEN acts as a plasma-membrane lipid-phosphatase antagonizing the phosphoinositide 3-kinase/AKT cell survival pathway. However, PTEN is also found in cell nuclei, but mechanism, function, and relevance of nuclear localization remain unclear. We show that nuclear PTEN is essential for tumor suppression and that PTEN nuclear import is mediated by its monoubiquitination. A lysine mutant of PTEN, K289E associated with Cowden syndrome, retains catalytic activity but fails to accumulate in nuclei of patient tissue due to an import defect. We identify this and another lysine residue as major monoubiquitination sites essential for PTEN import. While nuclear PTEN is stable, polyubiquitination leads to its degradation in the cytoplasm. Thus, we identify cancer-associated mutations of PTEN that target its posttranslational modification and demonstrate how a discrete molecular mechanism dictates tumor progression by differentiating between degradation and protection of IPTEN.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Urol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; Kyung Hee Univ, Sch Med, Seoul 130701, South Korea; NCI, NIH, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Korea University; Kyung Hee University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	高, 雨莉/HGU-8187-2022	Alimonti, Andrea/0000-0002-9362-2313; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA137050, R01 CA082328, R01-CA-82328, P30-CA-08748, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082328, P30CA008748, R01CA137050, Z01BC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chi SG, 1998, GASTROENTEROLOGY, V115, P1084, DOI 10.1016/S0016-5085(98)70078-2; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Georgescu MM, 2000, CANCER RES, V60, P7033; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	43	554	600	0	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					141	156		10.1016/j.cell.2006.11.040	http://dx.doi.org/10.1016/j.cell.2006.11.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218261	Green Accepted, Bronze			2022-12-24	WOS:000244420400019
J	Wang, XJ; Trotman, LC; Koppie, T; Alimonti, A; Chen, ZB; Gao, ZH; Wang, JR; Erdjument-Bromage, H; Tempst, P; Cordon-Cardo, C; Pandolfi, PP; Jiang, XJ				Wang, Xinjiang; Trotman, Lloyd C.; Koppie, Theresa; Alimonti, Andrea; Chen, Zhenbang; Gao, Zhonghua; Wang, Junru; Erdjument-Bromage, Hediye; Tempst, Paul; Cordon-Cardo, Carlos; Pandolfi, Pier Paolo; Jiang, Xuejun			NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN	CELL			English	Article							TUMOR-SUPPRESSOR PTEN; PROSTATE-CANCER; PROTEIN-DEGRADATION; CELL-MIGRATION; PATHWAY; GENE; PHOSPHORYLATION; DOMAIN; P53; RECRUITMENT	The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or deleted frequently in various human cancers. Subtle reductions in PTEN expression levels have profound impacts on carcinogenesis. Here we show that PTEN level is regulated by ubiquitin-mediated proteasomal degradation, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. In cells NEDD4-1 negatively regulates PTEN stability by catalyzing PTEN polyubiquitination. Consistent with the tumor-suppressive role of PTEN, overexpression of NEDD4-1 potentiated cellular transformation. Strikingly, in a mouse cancer model and multiple human cancer samples where the genetic background of PTEN was normal but its protein levels were low, NEDD4-1 was highly expressed, suggesting that aberrant upregulation of NEDD4-1 can posttranslationally suppress PTEN in cancers. Elimination of NEDD4-1 expression inhibited xenotransplanted tumor growth in a PTENdependent manner. Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cenc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10021 USA.	jiangx@mskcc.org	高, 雨莉/HGU-8187-2022	Alimonti, Andrea/0000-0002-9362-2313; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NATIONAL CANCER INSTITUTE [R01CA137050, R01CA113890] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113890, R01 CA137050] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adey NB, 2000, CANCER RES, V60, P35; Bakkers J, 2005, CELL CYCLE, V4, P790, DOI 10.4161/cc.4.6.1694; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fostier M, 1998, GENETICS, V150, P1477; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Pao W, 2003, P NATL ACAD SCI USA, V100, P8764, DOI 10.1073/pnas.1133333100; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200	42	513	546	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2007	128	1					129	139		10.1016/j.cell.2006.11.039	http://dx.doi.org/10.1016/j.cell.2006.11.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GN	17218260	Green Accepted, Bronze			2022-12-24	WOS:000244420400018
J	Gomez-Consarnau, L; Gonzalez, JM; Coll-Llado, M; Gourdon, P; Pascher, T; Neutze, R; Pedros-Alio, C; Pinhassi, J				Gomez-Consarnau, Laura; Gonzalez, Jose M.; Coll-Llado, Montserrat; Gourdon, Pontus; Pascher, Torbjoern; Neutze, Richard; Pedros-Alio, Carlos; Pinhassi, Jarone			Light stimulates growth of proteorhodopsin-containing marine Flavobacteria	NATURE			English	Article							OCEAN; PHOTOTROPHY; BACTERIUM; SAR11; SEA	Proteorhodopsins are bacterial light-dependent proton pumps. Their discovery within genomic material from uncultivated marine bacterioplankton caused considerable excitement because it indicated a potential phototrophic function within these organisms, which had previously been considered strictly chemotrophic(1). Subsequent studies established that sequences encoding proteorhodopsin are broadly distributed throughout the world's oceans(2-5). Nevertheless, the role of proteorhodopsins in native marine bacteria is still unknown(6). Here we show, from an analysis of the complete genomes of three marine Flavobacteria, that cultivated bacteria in the phylum Bacteroidetes, one of the principal components of marine bacterioplankton, contain proteorhodopsin. Moreover, growth experiments in both natural and artificial seawater ( low in labile organic matter, which is typical of the world's oceans) establish that exposure to light results in a marked increase in the cell yield of one such bacterium (Dokdonia sp. strain MED134) when compared with cells grown in darkness. Thus, our results show that the phototrophy conferred by proteorhodopsin can provide critical amounts of energy, not only for respiration and maintenance but also for active growth of marine bacterioplankton in their natural environment.	Univ Kalmar, Dept Biol & Environm Sci, SE-39182 KAlmar, Sweden; Univ La Laguna, Dept Microbiol & Cell Biol, ES-38206 Tenerife, Spain; CSIC, CMIMA, Inst Ciencies Mar, ES-08003 Barcelona, Spain; Chalmers, Dept Biol & Chem Engn, SE-41296 Gothenburg, Sweden; Lund Univ, Kemictr, SE-22100 Lund, Sweden; Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden	Linnaeus University; University of Kalmar; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Chalmers University of Technology; Lund University; University of Gothenburg	Pinhassi, J (corresponding author), Univ Kalmar, Dept Biol & Environm Sci, SE-39182 KAlmar, Sweden.	jarone.pinhassi@hik.se	Gourdon, Pontus/HCI-8898-2022; Neutze, Richard/A-7573-2010; Gonzalez, Jose M./C-3333-2013; Pedrós-Alió, Carlos/H-1222-2011; Gourdon, Pontus/E-1076-2014; Gomez-Consarnau, Laura/AAM-1319-2021	Neutze, Richard/0000-0003-0986-6153; Gonzalez, Jose M./0000-0002-9926-3323; Pedrós-Alió, Carlos/0000-0003-1009-4277; Gourdon, Pontus/0000-0002-8631-3539; Coll-Llado, Montserrat/0000-0003-0169-4107				Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bielawski JP, 2004, P NATL ACAD SCI USA, V101, P14824, DOI 10.1073/pnas.0403999101; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Teramoto M, 2003, FEBS LETT, V545, P120, DOI 10.1016/S0014-5793(03)00513-1; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200	26	266	279	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					210	213		10.1038/nature05381	http://dx.doi.org/10.1038/nature05381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17215843				2022-12-24	WOS:000243384300052
J	Platt, MJ; Cans, C; Johnson, A; Surman, G; Topp, M; Torrioli, MG; Krageloh-Mann, I				Platt, Mary Jane; Cans, Christine; Johnson, Ann; Surman, Geraldine; Topp, Monica; Torrioli, Maria Giulia; Krageloh-Mann, Inge			Trends in cerebral palsy among of very low birthweight (< 1500 g) or born prematurely (< 32 weeks) in 16 European centres: a database study	LANCET			English	Article							BRAIN-INJURY; INFANTS; POPULATION; PREVALENCE; ULTRASOUND; SURVIVAL; OUTCOMES; SWEDEN; RATES; GRAMS	Background The risk of cerebral palsy, the commonest physical disability of children in western Europe, is higher in infants of very low birthweight (VLBW)-those born weighing less than 1500 g-and those from multiple pregnancies than in infants of normal birthweight. An increasing proportion of infants from both of these groups survive into childhood. This paper describes changes in the frequency and distribution of cerebral palsy by sex and neurological subtype in infants with a birthweight below 1000 g and 1000-1499 g in the period 1980-96. Methods A group of 16 European centres, Surveillance of Cerebral Palsy in Europe, agreed a standard definition of cerebral palsy and inclusion and exclusion criteria. Data for children with cerebral palsy born in the years 1980-96 were pooled. The data were analysed to describe the distribution and prevalence of cerebral palsy in VLBW infants. Prevalence trends were expressed as both per 1000 livebirths and per 1000 neonatal survivors. Findings There were 1575 VLBW infants born with cerebral palsy; 414 (26%) were of birthweight less than 1000 g and 317 (20%) were from multiple pregnancies. 1426 (94%) had spastic cerebral palsy, which was unilateral (hemiplegic) in 336 (24%). The birth prevalence fell from 60.6 (99% CI 37.8-91.4) per 1000 liveborn VLBW infants in 1980 to 39.5 (28.6-53.0) per 1000 VLBW infants in 1996. This decline was related to a reduction in the frequency of bilateral spastic cerebral palsy among infants of birthweight 1000-1499 g. The frequency of cerebral palsy was higher in male than female babies in the group of birthweight 1000-1499 g (61.0 [53.8-68.2] vs 49.5 [42.8-56.2] per 1000 livebirths; p=0.0025) but not in the group of birthweight below 1000 g. Interpretation These data from a large population base provide evidence that the prevalence of cerebral palsy in children of birthweight less than 1500 g has fallen, which has important implications for parents, health services, and society.	Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; Registre Handicaps Enfant, Grenoble, France; Observ Perinatal Technol Imagerie Modelisat & Cog, Grenoble, France; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; Natl Inst Publ Hlth, Cerebral Palsy Registry, Copenhagen, Denmark; Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Copenhagen, Denmark; Univ Cattolica Sacro Cuore, Fac Med & Chirurg Augostino Gemelli, Rome, Italy; Univ Childrens Hosp, Dept Child Neurol, Tubingen, Germany	University of Liverpool; University of Oxford; University of Copenhagen; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf	Platt, MJ (corresponding author), Univ Liverpool, Div Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.	mjplatt@liv.ac.uk	Cans, Christine/M-6153-2014; Platt, MJ/K-4588-2012	Cans, Christine/0000-0003-3071-9959; Platt, MJ/0000-0002-9372-9575; Johnson, Anne/0000-0003-1330-7100				[Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; Bell R, 2004, ARCH DIS CHILD-FETAL, V89, pF531, DOI 10.1136/adc.2003.038414; Breart G, 2003, EUR J OBSTET GYN R B, V111, pS45, DOI 10.1016/j.ejogrb.2003.09.005; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V80, pF115, DOI 10.1136/fn.80.2.F115; Doyle LW, 2000, J PAEDIATR CHILD H, V36, P7, DOI 10.1046/j.1440-1754.2000.00452.x; ENSDOKKUM ME, 1994, ARCH DIS CHILD-FETAL, V70, P96; Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Krageloh-Mann I, 2004, EXP NEUROL, V190, pS84, DOI 10.1016/j.expneurol.2004.05.037; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; OShea TM, 1997, PEDIATRICS, V100, P982, DOI 10.1542/peds.100.6.982; Piecuch RE, 1997, PEDIATRICS, V100, P633, DOI 10.1542/peds.100.4.633; Pison G, 2006, TWIN RES HUM GENET, V9, P250, DOI 10.1375/twin.9.2.250; Scher AI, 2002, PEDIATR RES, V52, P671, DOI [10.1203/00006450-200211000-00011, 10.1203/01.PDR.0000032159.88318.5B]; Shankaran S, 2004, AM J OBSTET GYNECOL, V191, P1084, DOI 10.1016/j.ajog.2004.05.032; Stanley F, 2000, CLIN DEV MED; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; Tin W, 1997, BRIT J OBSTET GYNAEC, V104, P180, DOI 10.1111/j.1471-0528.1997.tb11041.x; Topp M, 2004, ACTA OBSTET GYN SCAN, V83, P548, DOI 10.1111/j.0001-6349.2004.00545.x; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Vohr BR, 1997, SEMIN PERINATOL, V21, P202, DOI 10.1016/S0146-0005(97)80064-X; Watson L, 1999, REPORT W AUSTR CEREB; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220	28	270	294	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2007	369	9555					43	50		10.1016/S0140-6736(07)60030-0	http://dx.doi.org/10.1016/S0140-6736(07)60030-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125AK	17208641				2022-12-24	WOS:000243413700028
J	Chen, Y; Corriden, R; Inoue, Y; Yip, L; Hashiguchi, N; Zinkernagel, A; Nizet, V; Insel, PA; Junger, WG				Chen, Yu; Corriden, Ross; Inoue, Yoshiaki; Yip, Linda; Hashiguchi, Naoyuki; Zinkernagel, Annelies; Nizet, Victor; Insel, Paul A.; Junger, Wolfgang G.			ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors	SCIENCE			English	Article							ADENOSINE; MIGRATION; CHEMOATTRACTANT; NUCLEOTIDES; STIMULATION; EOSINOPHILS; LEUKOCYTES; SYSTEM; CELLS	Cells must amplify external signals to orient and migrate in chemotactic gradient fields. We find that human neutrophils release adenosine triphosphate (ATP) from the leading edge of the cell surface to amplify chemotactic signals and direct cell orientation by feedback through P2Y2 nucleotide receptors. Neutrophils rapidly hydrolyze released ATP to adenosine that then acts via A3-type adenosine receptors, which are recruited to the leading edge, to promote cell migration. Thus, ATP release and autocrine feedback through P2Y2 and A3 receptors provide signal amplification, controlling gradient sensing and migration of neutrophils.	Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Junger, WG (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	wjunger@ucsd.edu	Nizet, Victor/AAF-3190-2019; Junger, Wolfgang G/I-1932-2013; Zinkernagel, Annelies S/F-1780-2017	Junger, Wolfgang G/0000-0003-3350-8452; Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422	NIDDK NIH HHS [T32 DK007202] Funding Source: Medline; NIGMS NIH HHS [GM-66232, R01 GM-51477, GM-60475] Funding Source: Medline; OCPHP CDC HHS [PR043034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, R01GM051477, R01GM060475] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCPHP CDC HHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Kimmel AR, 2004, CURR OPIN GENET DEV, V14, P540, DOI 10.1016/j.gde.2004.08.001; Knight D, 1997, J LEUKOCYTE BIOL, V62, P465, DOI 10.1002/jlb.62.4.465; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Seo JK, 1997, J IMMUNOL, V158, P1895; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Walker BAM, 1997, AM J RESP CELL MOL, V16, P531, DOI 10.1165/ajrcmb.16.5.9160835; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Zhang Y, 1996, BIOCHEM PHARMACOL, V51, P957, DOI 10.1016/0006-2952(95)02403-4; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	21	637	654	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1792	1795		10.1126/science.1132559	http://dx.doi.org/10.1126/science.1132559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170310				2022-12-24	WOS:000242833600064
J	Giannone, G; Dubin-Thaler, BJ; Rossier, O; Cai, YF; Chaga, O; Jiang, GY; Beaver, W; Dobereiner, HG; Freund, Y; Borisy, G; Sheetz, MP				Giannone, Gregory; Dubin-Thaler, Benjamin J.; Rossier, Olivier; Cai, Yunfei; Chaga, Oleg; Jiang, Guoying; Beaver, William; Dobereiner, Hans-Gunther; Freund, Yoav; Borisy, Gary; Sheetz, Michael P.			Lamellipodial actin mechanically links myosin activity with adhesion-site formation	CELL			English	Article							LEADING-EDGE; CYTOSKELETON; TURNOVER; DYNAMICS; FORCE; PROTRUSION; CONTRACTIONS; FIBRONECTIN; RIGIDITY; COMPLEX	Cell motility proceeds by cycles of edge protrusion, adhesion, and retraction. Whether these functions are coordinated by biochemical or biomechanical processes is unknown. We find that myosin II pulls the rear of the lamellipodial actin network, causing upward bending, edge retraction, and initiation of new adhesion sites. The network then separates from the edge and condenses over the myosin. Protrusion resumes as lamellipodial actin regenerates from the front and extends rearward until it reaches newly assembled myosin, initiating the next cycle. Upward bending, observed by evanescence and electron microscopy, results in ruffle formation when adhesion strength is low. Correlative fluorescence and electron microscopy shows that the regenerating lamellipodium forms a cohesive, separable layer of actin above the lamellum. Thus, actin polymerization periodically builds a mechanical link, the lamellipodium, connecting myosin motors with the initiation of adhesion sites, suggesting that the major functions driving motility are coordinated by a biomechanical process.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Columbia Univ, Dept Biol Sci, Sherman Fairchild Ctr, New York, NY 10027 USA	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Northwestern University; University of California System; University of California San Diego; Columbia University	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Döbereiner, Hans-Günther/F-7302-2012; Rossier, Olivier M/I-6569-2013; Beaver, William/A-1124-2009	Döbereiner, Hans-Günther/0000-0003-1691-634X; Rossier, Olivier M/0000-0002-6932-931X; Giannone, Gregory/0000-0002-0932-1690; Borisy, Gary/0000-0002-0266-8018; freund, yoav/0000-0002-3850-6184	NATIONAL EYE INSTITUTE [PN1EY016586] Funding Source: NIH RePORTER; NEI NIH HHS [PN1 EY016586] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bohnet S, 2006, BIOPHYS J, V90, P1810, DOI 10.1529/biophysj.105.064600; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Dulyaninova NG, 2004, J CELL SCI, V117, P1481, DOI 10.1242/jcs.00993; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wolgemuth CW, 2005, BIOPHYS J, V89, P1643, DOI 10.1529/biophysj.105.066720; Yamazaki D, 2005, GENES CELLS, V10, P381, DOI 10.1111/j.1365-2443.2005.00845.x; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	381	384	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					561	575		10.1016/j.cell.2006.12.039	http://dx.doi.org/10.1016/j.cell.2006.12.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289574	Green Accepted, Bronze			2022-12-24	WOS:000244842700021
J	Xue, W; Zender, L; Miething, C; Dickins, RA; Hernando, E; Krizhanovsky, V; Cordon-Cardo, C; Lowe, SW				Xue, Wen; Zender, Lars; Miething, Cornelius; Dickins, Ross A.; Hernando, Eva; Krizhanovsky, Valery; Cordon-Cardo, Carlos; Lowe, Scott W.			Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas	NATURE			English	Article							CELL SENESCENCE; ONCOGENIC RAS; KILLER-CELLS; SUPPRESSION; CANCER; TUMORIGENESIS; PATHWAY; NEVI	Although cancer arises from a combination of mutations in oncogenes and tumour suppressor genes, the extent to which tumour suppressor gene loss is required for maintaining established tumours is poorly understood. p53 is an important tumour suppressor that acts to restrict proliferation in response to DNA damage or deregulation of mitogenic oncogenes, by leading to the induction of various cell cycle checkpoints, apoptosis or cellular senescence(1,2). Consequently, p53 mutations increase cell proliferation and survival, and in some settings promote genomic instability and resistance to certain chemotherapies(3). To determine the consequences of reactivating the p53 pathway in tumours, we used RNA interference (RNAi) to conditionally regulate endogenous p53 expression in a mosaic mouse model of liver carcinoma(4,5). We show that even brief reactivation of endogenous p53 in p53-deficient tumours can produce complete tumour regressions. The primary response to p53 was not apoptosis, but instead involved the induction of a cellular senescence program that was associated with differentiation and the upregulation of inflammatory cytokines. This program, although producing only cell cycle arrest in vitro, also triggered an innate immune response that targeted the tumour cells in vivo, thereby contributing to tumour clearance. Our study indicates that p53 loss can be required for the maintenance of aggressive carcinomas, and illustrates how the cellular senescence program can act together with the innate immune system to potently limit tumour growth.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Dickins, Ross A/K-2852-2012; Miething, Cornelius/F-9498-2014; Krizhanovsky, Valery/D-1336-2010	Dickins, Ross A/0000-0003-4112-5304; Miething, Cornelius/0000-0003-4699-3805; Krizhanovsky, Valery/0000-0002-3977-5482; Xue, Wen/0000-0002-9797-8042; Hernando, Eva/0000-0003-1023-0312	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA087497] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P01 CA087497] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hong F, 2003, CANCER RES, V63, P9023; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Roninson IB, 2003, CANCER RES, V63, P2705; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; VENTURA A, 2007, NATURE          0124, DOI DOI 10.1038/NATURE05541; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	30	1777	1841	14	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					656	660		10.1038/nature05529	http://dx.doi.org/10.1038/nature05529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17251933	Green Accepted			2022-12-24	WOS:000244039400046
J	MacAlister, CA; Ohashi-Ito, K; Bergmann, DC				MacAlister, Cora A.; Ohashi-Ito, Kyoko; Bergmann, Dominique C.			Transcription factor control of asymmetric cell divisions that establish the stomatal lineage	NATURE			English	Article							ARABIDOPSIS; MOUTHS; TOO; MUTANTS; PATTERN	The establishment of new cell lineages during development often requires a symmetry-breaking event. An asymmetric division in the epidermis of plants initiates a lineage that ultimately produces stomatal guard cells. Stomata are pores in the epidermis that serve as the main conduits for gas exchange between plants and the atmosphere; they are critical for photosynthesis and exert a major influence on global carbon and water cycles(1). Recent studies implicated intercellular signalling in preventing the inappropriate production of stomatal complexes(2-4). Genes required to make stomata, however, remained elusive. Here we report the identification of a gene, SPEECHLESS (SPCH), encoding a basic helix - loop helix ( bHLH) transcription factor that is necessary and sufficient for the asymmetric divisions that establish the stomatal lineage in Arabidopsis thaliana. We demonstrate that SPCH and two paralogues are successively required for the initiation, proliferation and terminal differentiation of cells in the stomatal lineage. The stomatal bHLHs define a molecular pathway sufficient to create one of the key cell types in plants. Similar molecules and regulatory mechanisms are used during muscle and neural development(5,6), highlighting a conserved use of closely related bHLHs for cell fate specification and differentiation.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	dbergmann@stanford.edu		MacAlister, Cora/0000-0003-1470-0596; Bergmann, Dominique/0000-0003-0873-3543				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lucas JR, 2006, J EXP BOT, V57, P71, DOI 10.1093/jxb/erj017; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	20	361	399	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					537	540		10.1038/nature05491	http://dx.doi.org/10.1038/nature05491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183265				2022-12-24	WOS:000243867300043
J	Tom, SM; Fox, CR; Trepel, C; Poldrack, RA				Tom, Sabrina M.; Fox, Craig R.; Trepel, Christopher; Poldrack, Russell A.			The neural basis of loss aversion in decision-making under risk	SCIENCE			English	Article							EVENT-RELATED FMRI; HUMAN BRAIN; PROSPECT-THEORY; EXPERIENCE; UTILITY; THEOREM; CORTEX; CHOICE; BIASES	People typically exhibit greater sensitivity to losses than to equivalent gains when making decisions. We investigated neural correlates of loss aversion while individuals decided whether to accept or reject gambles that offered a 50/50 chance of gaining or losing money. A broad set of areas ( including midbrain dopaminergic regions and their targets) showed increasing activity as potential gains increased. Potential losses were represented by decreasing activity in several of these same gain-sensitive areas. Finally, individual differences in behavioral loss aversion were predicted by a measure of neural loss aversion in several regions, including the ventral striatum and prefrontal cortex.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Poldrack, RA (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	poldrack@ucla.edu	Fox, Craig/A-2293-2014		NCRR NIH HHS [P20 RR020750] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020750] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABDELLAOUI M, IN PRESS MANAGEMENT; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer C, 2005, J MARKETING RES, V42, P129, DOI 10.1509/jmkr.42.2.129.62286; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; CONGDON E, 2005, COGNIT NEUROSCI REV, V4, P262; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; HARDIE BGS, 1993, MARKET SCI, V12, P378, DOI 10.1287/mksc.12.4.378; JOHNSON EJ, 2006, 2015 IZA I STUD LAB; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	28	1052	1084	8	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					515	518		10.1126/science.1134239	http://dx.doi.org/10.1126/science.1134239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	129JU	17255512				2022-12-24	WOS:000243726600047
J	Poelwijk, FJ; Kiviet, DJ; Weinreich, DM; Tans, SJ				Poelwijk, Frank J.; Kiviet, Daniel J.; Weinreich, Daniel M.; Tans, Sander J.			Empirical fitness landscapes reveal accessible evolutionary paths	NATURE			English	Article							PROTEIN-DNA RECOGNITION; FLUCTUATING ENVIRONMENTS; ISOCITRATE DEHYDROGENASE; LAC REPRESSOR; MUTANT; ADAPTATION; ROBUSTNESS; DYNAMICS; EVOLVABILITY; SPECIFICITY		FOM Inst AMOLF, NL-1098 SJ Amsterdam, Netherlands; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	AMOLF; Harvard University	Tans, SJ (corresponding author), FOM Inst AMOLF, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020; Weinreich, Dan/AAZ-6606-2021	Poelwijk, Frank/0000-0002-5696-4357				Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; DARWIN C, 1859, ORIGIN SPECIES, pCH6; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kauffman S.A., 1993, ORIGINS ORDER; KIMURA M, 1962, GENETICS, V47, P713; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LEHMING N, 1990, EMBO J, V9, P615, DOI 10.1002/j.1460-2075.1990.tb08153.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; PAULING L, 1963, ACTA CHEM SCAND, V17, pS9; Poelwijk FJ, 2006, PLOS COMPUT BIOL, V2, P467, DOI 10.1371/journal.pcbi.0020058; Salinas RK, 2005, CHEMBIOCHEM, V6, P1628, DOI 10.1002/cbic.200500049; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	38	345	347	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2007	445	7126					383	386		10.1038/nature05451	http://dx.doi.org/10.1038/nature05451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17251971				2022-12-24	WOS:000243689500029
J	Bocquet, N; de Carvalho, LP; Cartaud, J; Neyton, J; Le Poupon, C; Taly, A; Grutter, T; Changeux, JP; Corringer, PJ				Bocquet, Nicolas; de Carvalho, Lia Prado; Cartaud, Jean; Neyton, Jacques; Le Poupon, Chantal; Taly, Antoine; Grutter, Thomas; Changeux, Jean-Pierre; Corringer, Pierre-Jean			A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family	NATURE			English	Article							BINDING-PROTEIN; GATING MECHANISM; DOMAIN; MODULATION; SUBUNIT; DESENSITIZATION; MUTATIONS; REVEALS; FORM; LOOP	Ligand-gated ion channels (LGICs) mediate excitatory and inhibitory transmission in the nervous system. Among them, the pentameric or 'Cys-loop' receptors (pLGICs) compose a family that until recently was found in only eukaryotes. Yet a recent genome search identified putative homologues of these proteins in several bacterial species(1). Here we report the cloning, expression and functional identification of one of these putative homologues from the cyanobacterium Gloeobacter violaceus. It was expressed as a homo-oligomer in HEK 293 cells and Xenopus oocytes, generating a transmembrane cationic channel that is opened by extracellular protons and shows slow kinetics of activation, no desensitization and a single channel conductance of 8 pS. Electron microscopy and cross-linking experiments of the protein fused to the maltose-binding protein and expressed in Escherichia coli are consistent with a homo-pentameric organization. Sequence comparison shows that it possesses a compact structure, with the absence of the amino-terminal helix, the canonical disulphide bridge and the large cytoplasmic domain found in eukaryotic pLGICs. Therefore it embodies a minimal structure required for signal transduction. These data establish the prokaryotic origin of the family. Because Gloeobacter violaceus carries out photosynthesis and proton transport at the cytoplasmic membrane(2), this new proton-gated ion channel might contribute to adaptation to pH change.	Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France; Univ Paris 06 & 7, Inst Jacques Monod, CNRS, UMR 7590, F-75005 Paris, France; Ecole Normale Super, CNRS, UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Corringer, PJ (corresponding author), Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France.	pjcorrin@pasteur.fr	Taly, Antoine/B-3339-2008	Taly, Antoine/0000-0001-5109-0091; Grutter, Thomas/0000-0002-4351-9203				BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTAUD J, 1978, J CELL SCI, V29, P313; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Fischer M, 2001, P NATL ACAD SCI USA, V98, P3567, DOI 10.1073/pnas.041594798; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paoletti P, 1997, J NEUROSCI, V17, P5711; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030	30	242	281	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					116	119		10.1038/nature05371	http://dx.doi.org/10.1038/nature05371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167423				2022-12-24	WOS:000243225100047
J	Carandang, R; Seshadri, S; Beiser, A; Kelly-Hayes, M; Kase, CS; Kannel, WB; Wolf, PA				Carandang, Raphael; Seshadri, Sudha; Beiser, Alexa; Kelly-Hayes, Margaret; Kase, Carlos S.; Kannel, William B.; Wolf, Philip A.			Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; CASE-FATALITY; INCIDENCE RATES; CARDIOVASCULAR-DISEASE; INTERNATIONAL TRENDS; PRIMARY PREVENTION; UNITED-STATES; NEW-ZEALAND; LUND-ORUP	Context Prior estimates of long-term trends in the incidence and severity of stroke have varied; trends in lifetime risk have not been reported. Objective To determine long-term trends in the incidence, lifetime risk, severity, and 30-day mortality of clinical stroke. Design, Setting, and Participants Prospective evaluation of the community-based Framingham Study original and offspring cohorts. Participants were 9152 men and women free of prevalent stroke and undergoing follow-up for up to 50 years over 3 consecutive periods (1950-1977, 1978-1989, and 1990-2004), with biennial ascertainment of stroke risk factor data and active surveillance for incident clinical stroke and cause-specific mortality. Main Outcome Measures Incidence (age-adjusted, sex-specific), severity, 30-day mortality, and mortality-adjusted 10-year and lifetime risk of stroke in each of the specified periods. Results There were 1030 incident clinical strokes ( 450 [44%] in men, 629 atherothrombotic brain infarctions [61%]) in 9152 persons 55 years or older over 174 917 person-years of follow-up. The age-adjusted incidence of first stroke per 1000 person-years in each of the 3 periods was 7.6, 6.2, and 5.3, respectively, in men (P=. 02 for trend) and 6.2, 5.8, and 5.1 in women ( P=. 01 for trend). The lifetime risk at age 65 years decreased from 19.5% to 14.5% in men ( P=. 11) and from 18.0% to 16.1% in women ( P=. 61). Age-adjusted stroke severity did not vary across periods; however, 30-day mortality decreased significantly in men ( from 23% to 14%; P=. 01) but not significantly in women ( from 21% to 20%; P=. 32). Conclusions In this cohort of men and women free of prevalent clinical stroke at initial examination, incidence of stroke has decreased over the past 50 years but the lifetime risk has not declined to the same degree, perhaps due to improved life expectancy. The results of this study suggest that improved control of risk factors has lowered stroke incidence but emphasize the need for continued primary prevention efforts.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; NHLBI, Framingham Heart Study, Framingham, MA USA	Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wolf, PA (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,B-608, Boston, MA 02118 USA.	pawolf@bu.edu		Kelly-Hayes, Margaret/0000-0001-5938-8052; Kase, Carlos/0000-0002-3047-5010; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Wolf, Philip/0000-0002-3628-301X	NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline; NINDS NIH HHS [5R01-NS17950, R01 NS017950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Heart Association, 2006, HEART DIS STROK STAT; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Broderick J P, 1993, Ann Epidemiol, V3, P476; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Carolei A, 1997, STROKE, V28, P2500, DOI 10.1161/01.STR.28.12.2500; CHENG XM, 1995, STROKE, V26, P1990, DOI 10.1161/01.STR.26.11.1990; COOPER R, 1990, STROKE, V21, P1274, DOI 10.1161/01.STR.21.9.1274; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; DRURY I, 1984, NEUROLOGY, V34, P653, DOI 10.1212/WNL.34.5.653; EISENBLATTER D, 1995, STROKE, V26, P919, DOI 10.1161/01.STR.26.6.919; Fang J, 2001, STROKE, V32, P2221, DOI 10.1161/hs1001.096193; Fogelholm R, 2003, STROKE, V34, P1840, DOI 10.1161/01.STR.0000085565.91317.4C; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Halliday A, 2004, LANCET, V363, P1491; Hallstrom B, 2002, STROKE, V33, P1624, DOI 10.1161/01.STR.0000017222.48968.6E; HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Howard G, 2001, STROKE, V32, P2213, DOI 10.1161/hs1001.096047; Jamrozik K, 1999, STROKE, V30, P2105, DOI 10.1161/01.STR.30.10.2105; Johansson B, 2000, STROKE, V31, P481, DOI 10.1161/01.STR.31.2.481; KAGAN A, 1994, STROKE, V25, P1170, DOI 10.1161/01.STR.25.6.1170; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kubo M, 2006, NEUROLOGY, V66, P1539, DOI 10.1212/01.wnl.0000216132.95207.b4; Kwan J, 2001, CME J GERIATR MED, V3, P94; LAURIA G, 1995, STROKE, V26, P1787, DOI 10.1161/01.STR.26.10.1787; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Muntner P, 2002, STROKE, V33, P1209, DOI 10.1161/01.STR.0000015031.57955.D1; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Pessah-Rasmussen H, 2003, STROKE, V34, P913, DOI 10.1161/01.STR.0000063365.10841.43; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; THORVALDSEN P, 1995, STROKE; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; WOLF PA, 2004, STROKE PATHOPHYSIOLO, P13	56	369	375	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2939	2946		10.1001/jama.296.24.2939	http://dx.doi.org/10.1001/jama.296.24.2939			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190894	Bronze			2022-12-24	WOS:000243069000025
J	Labandeira-Rey, M; Couzon, F; Boisset, S; Brown, EL; Bes, M; Benito, Y; Barbu, EM; Vazquez, V; Hook, M; Etienne, J; Vandenesch, F; Bowden, MG				Labandeira-Rey, Maria; Couzon, Florence; Boisset, Sandrine; Brown, Eric L.; Bes, Michele; Benito, Yvonne; Barbu, Elena M.; Vazquez, Vanessa; Hoeoek, Magnus; Etienne, Jerome; Vandenesch, Francois; Bowden, M. Gabriela			Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia	SCIENCE			English	Article							PROTEIN-A; EXPRESSION; RESISTANCE; REGULATOR; SIGMA(B); STRAINS; GENE	The Staphylococcus aureus Panton-Valentine leukocidin (PVL) is a pore-forming toxin secreted by strains epidemiologically associated with the current outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and with the often-lethal necrotizing pneumonia. To investigate the role of PVL in pulmonary disease, we tested the pathogenicity of clinical isolates, isogenic PVL-negative and PVL-positive S. aureus strains, as well as purified PVL, in a mouse acute pneumonia model. Here we show that PVL is sufficient to cause pneumonia and that the expression of this leukotoxin induces global changes in transcriptional levels of genes encoding secreted and cell wall-anchored staphylococcal proteins, including the lung inflammatory factor staphylococcal protein A ( Spa).	Univ Lyon, F-69008 Lyon, France; Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Univ Lyon 1, Fac Laennec, F-69008 Lyon, France; INSERM, Natl Reference Staphylocoques, E0230, F-69008 Lyon, France; Hop Edouard Herriot, Hosp Civils Lyon, F-69003 Lyon, France	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Vandenesch, F (corresponding author), Univ Lyon, F-69008 Lyon, France.	denesch@univ-lyon1.fr; gbowden@ibt.tamhsc.edu	Boisset, Sandrine/C-3106-2011; Sarathy, Vanessa V./U-7803-2019; ETIENNE, Jerome/C-5471-2014; Vandenesch, Francois/C-7209-2014; Boisset, Sandrine SB/D-8144-2014	Sarathy, Vanessa V./0000-0002-1262-2101; ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; Boisset, Sandrine SB/0000-0001-8717-8749	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER; NIAID NIH HHS [AI020624] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Panton PN, 1932, LANCET, V1, P506; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Thomas P, 2003, PEDIATR INFECT DIS J, V22, P201; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499	19	554	601	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1130	1133		10.1126/science.1137165	http://dx.doi.org/10.1126/science.1137165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17234914				2022-12-24	WOS:000244387600038
J	Leutgeb, JK; Leutgeb, S; Moser, MB; Moser, EI				Leutgeb, Jill K.; Leutgeb, Stefan; Moser, May-Britt; Moser, Edvard I.			Pattern separation in the dentate gyrus and CA3 of the hippocampus	SCIENCE			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; ENTORHINAL CORTEX; GRANULE CELLS; UNIT-ACTIVITY; SPATIAL MAP; REPRESENTATION; ENVIRONMENT; DISTINCT; RECALL	Theoretical models have long pointed to the dentate gyrus as a possible source of neuronal pattern separation. In agreement with predictions from these models, we show that minimal changes in the shape of the environment in which rats are exploring can substantially alter correlated activity patterns among place-modulated granule cells in the dentate gyrus. When the environments are made more different, new cell populations are recruited in CA3 but not in the dentate gyrus. These results imply a dual mechanism for pattern separation in which signals from the entorhinal cortex can be decorrelated both by changes in coincidence patterns in the dentate gyrus and by recruitment of nonoverlapping cell assemblies in CA3.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; FYHN MH, IN PRESS NATURE; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hayman RMA, 2003, EUR J NEUROSCI, V18, P2825, DOI 10.1111/j.1460-9568.2003.03035.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	36	1031	1043	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					961	966		10.1126/science.1135801	http://dx.doi.org/10.1126/science.1135801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303747				2022-12-24	WOS:000244229800034
J	Shang, YH; Claridge-Chang, A; Sjulson, L; Pypaert, M; Miesenbock, G				Shang, Yuhua; Claridge-Chang, Adam; Sjulson, Lucas; Pypaert, Marc; Miesenbock, Gero			Excitatory local circuits and their implications for olfactory processing in the fly antennal lobe	CELL			English	Article							ODOR REPRESENTATIONS; MOLECULAR-BASIS; DROSOPHILA; MAP; TRANSMISSION; INFORMATION; DYNAMICS; BEHAVIOR; SYSTEM; NOISE	Conflicting views exist of how circuits of the antennal lobe, the insect equivalent of the olfactory bulb, translate input from olfactory receptor neurons (ORNs) into projection-neuron (PN) output. Synaptic connections between ORNs and PNs are one-to-one, yet PNs are more broadly tuned to odors than ORNs. The basis for this difference in receptive range remains unknown. Analyzing a Drosophila mutant lacking ORN input to one glomerulus, we show that some of the apparent complexity in the antennal lobe's output arises from lateral, inter-glomerular excitation of PNs. We describe a previously unidentified population of cholinergic local neurons (LNs) with multiglomerular processes. These excitatory LNs respond broadly to odors but exhibit little glomerular specificity in their synaptic output, suggesting that PNs are driven by a combination of glomerulus-specific ORN afferents and diffuse LN excitation. Lateral excitation may boost PN signals and enhance their transmission to third-order neurons in a mechanism akin to stochastic resonance.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@yale.edu		Miesenboeck, Gero/0000-0003-2940-3228; Claridge-Chang, Adam/0000-0002-4583-3650	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005810] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005810, R01 DC005810-05] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BORST A, 1983, J COMP PHYSIOL, V152, P373, DOI 10.1007/BF00606242; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	53	238	242	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					601	612		10.1016/j.cell.2006.12.034	http://dx.doi.org/10.1016/j.cell.2006.12.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289577	Green Accepted, Bronze			2022-12-24	WOS:000244842700024
J	Daley, GQ; Ahrlund-Richter, L; Auerbach, JM; Benvenisty, N; Charo, RA; Chen, G; Deng, HK; Goldstein, LS; Hudson, KL; Hyun, I; Junn, SC; Love, J; Lee, EH; McLaren, A; Mummery, CL; Nakatsuji, N; Racowsky, C; Rooke, H; Rossant, J; Scholer, HR; Solbakk, JH; Taylor, P; Trounson, AO; Weissman, IL; Wilmut, I; Yu, J; Zoloth, L				Daley, George Q.; Ahrlund-Richter, Lars; Auerbach, Jonathan M.; Benvenisty, Nissim; Charo, R. Alta; Chen, Grace; Deng, Hong-kui; Goldstein, Lawrence S.; Hudson, Kathy L.; Hyun, Insoo; Junn, Sung Chull; Love, Jane; Lee, Eng Hin; McLaren, Anne; Mummery, Christine L.; Nakatsuji, Norio; Racowsky, Catherine; Rooke, Heather; Rossant, Janet; Schoeler, Hans R.; Solbakk, Jan Helge; Taylor, Patrick; Trounson, Alan O.; Weissman, Irving L.; Wilmut, Ian; Yu, John; Zoloth, Laurie			The ISSCR guidelines for human embryonic stem cell research	SCIENCE			English	Editorial Material							PARTICIPATION; PAYMENT		Childrens Hosp, Boston, MA 02115 USA; Karolinska Inst, S-10401 Stockholm, Sweden; Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Bird & Bird, Beijing, Peoples R China; Peking Univ, Beijing 100871, Peoples R China; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD 21218 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Inst Global Management, Seoul, South Korea; Wilmer Cutler Pickering Hale & Dorr LLP, Washington, DC USA; Natl Univ Singapore, Singapore 117548, Singapore; Univ Cambridge, Cambridge CB2 1TN, England; Univ Utrecht, Sch Med, NL-3508 TC Utrecht, Netherlands; Kyoto Univ, Kyoto, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Univ Toronto, Toronto, ON, Canada; Max Planck Inst Mol Biomed, Munster, Germany; Univ Oslo, N-0316 Oslo, Norway; Univ Bergen, N-5020 Bergen, Norway; Monash Univ, Clayton, Vic 3168, Australia; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA	Harvard University; Boston Children's Hospital; Karolinska Institutet; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Peking University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Johns Hopkins University; Case Western Reserve University; National University of Singapore; University of Cambridge; Utrecht University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Max Planck Society; University of Oslo; University of Bergen; Monash University; Stanford University; University of Edinburgh; Academia Sinica - Taiwan; Northwestern University; Feinberg School of Medicine	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Lee, Eng Hin/I-3325-2019; , HS/AAB-4434-2019; yu, john/AAA-9255-2021; YU, JOHN/G-8954-2012; Ahrlund-Richter, Lars/C-6226-2012	, HS/0000-0003-2643-5136; Yu, John/0000-0002-3237-4272; Trounson, Alan/0000-0001-5469-0500; Mummery, Christine/0000-0002-4549-6535; Charo, Robin Alta/0000-0003-3710-1043				Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Ethics Comm Am Soc Reprod Med, 2000, FERTIL STERIL, V74, P216; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; *UK COMM HUM FERT, HUM FERT EMBR; Wendler D, 2002, J PEDIATR-US, V141, P166, DOI 10.1067/mpd.2002.124381	6	82	85	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					603	604		10.1126/science.1139337	http://dx.doi.org/10.1126/science.1139337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131YR	17272706				2022-12-24	WOS:000243909400027
J	Miller, KA; Siscovick, DS; Sheppard, L; Shepherd, K; Sullivan, JH; Anderson, GL; Kaufman, JD				Miller, Kristin A.; Siscovick, David S.; Sheppard, Lianne; Shepherd, Kristen; Sullivan, Jeffrey H.; Anderson, Garnet L.; Kaufman, Joel D.			Long-term exposure to air pollution and incidence of cardiovascular events in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; ASSOCIATION; PARTICLES; DISEASE; LINES	BACKGROUND: Fine particulate air pollution has been linked to cardiovascular disease, but previous studies have assessed only mortality and differences in exposure between cities. We examined the association of long-term exposure to particulate matter of less than 2.5 microm in aerodynamic diameter (PM(sub 2.5)) with cardiovascular events. METHODS: We studied 65,893 postmenopausal women without previous cardiovascular disease in 36 U.S. metropolitan areas from 1994 to 1998, with a median follow-up of 6 years. We assessed the women's exposure to air pollutants using the monitor located nearest to each woman's residence. Hazard ratios were estimated for the first cardiovascular event, adjusting for age, race or ethnic group, smoking status, educational level, household income, body-mass index, and presence or absence of diabetes, hypertension, or hypercholesterolemia. RESULTS: A total of 1816 women had one or more fatal or nonfatal cardiovascular events, as confirmed by a review of medical records, including death from coronary heart disease or cerebrovascular disease, coronary revascularization, myocardial infarction, and stroke. In 2000, levels of PM(sub 2.5) exposure varied from 3.4 to 28.3 microg per cubic meter (mean, 13.5). Each increase of 10 microg per cubic meter was associated with a 24% increase in the risk of a cardiovascular event (hazard ratio, 1.24; 95% confidence interval [CI], 1.09 to 1.41) and a 76% increase in the risk of death from cardiovascular disease (hazard ratio, 1.76; 95% CI, 1.25 to 2.47). For cardiovascular events, the between-city effect appeared to be smaller than the within-city effect. The risk of cerebrovascular events was also associated with increased levels of PM(sub 2.5) (hazard ratio, 1.35; 95% CI, 1.08 to 1.68). CONCLUSIONS: Long-term exposure to fine particulate air pollution is associated with the incidence of cardiovascular disease and death among postmenopausal women. Exposure differences within cities are associated with the risk of cardiovascular disease.	Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA 98105 USA; Univ Washington, Dept Biostat, Seattle, WA 98105 USA; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Ctr, Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kaufman, JD (corresponding author), Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, 4225 Roosevelt Way NE,Suite 100, Seattle, WA 98105 USA.	joelk@u.washington.edu	Sheppard, Lianne/AAF-6304-2021; Kaufman, Joel D/B-5761-2008	Sheppard, Lianne/0000-0003-1622-508X; Kaufman, Joel D/0000-0003-4174-9037; Anderson, Garnet/0000-0001-5087-7837	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES013195, P30ES007033, T32ES007262, K23ES011139] Funding Source: NIH RePORTER; NIEHS NIH HHS [K24 ES013195-02, P30ES07033, K24ES013195, K24 ES013195, T32ES07262, K23ES011139, K24 ES013195-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Krewski D., 2000, REANALYSIS HARVARD 6; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; Vedal S, 1997, J AIR WASTE MANAGE, V47, P551, DOI 10.1080/10473289.1997.10463922	18	1291	1360	3	394	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					447	458		10.1056/NEJMoa054409	http://dx.doi.org/10.1056/NEJMoa054409			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267905				2022-12-24	WOS:000243860700005
J	Martin-Belmonte, F; Gassama, A; Datta, A; Yu, W; Rescher, U; Gerke, V; Mostov, K				Martin-Belmonte, Fernando; Gassama, Ama; Datta, Anirban; Yu, Wei; Rescher, Ursula; Gerke, Volker; Mostov, Keith			PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42	CELL			English	Article							BASOLATERAL PLASMA-MEMBRANE; CELL-POLARITY; BINDING-PROTEIN; EXCHANGE FACTOR; MDCK CELLS; IN-VIVO; COMPLEX; ACTIVATION; RAC1; DYNAMICS	Formation of the apical surface and lumen is a fundamental, yet poorly understood, step in epithelial organ development. We show that PTEN localizes to the apical plasma membrane during epithelial morphogenesis to mediate the enrichment of Ptdlns(4,5)P-2 at this domain during cyst development in three-dimensional culture. Ectopic Ptdlns(4,5)P-2 at the basolateral surface causes apical proteins to relocalize to the basolateral surface. Annexin 2 (Anx2) binds Ptdlns(4,5)P-2 and is recruited to the apical surface. Anx2 binds Cdc42, recruiting it to the apical surface. Cdc42 recruits aPKC to the apical surface. Loss of function of PTEN, Anx2, Cdc42, or aPKC prevents normal development of the apical surface and lumen. We conclude that the mechanism of PTEN, Ptdlns(4,5)P-2, Anx2, Cdc42, and aPKC controls apical plasma membrane and lumen formation.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Inst Med Biochem, D-48149 Munster, Germany	University of California System; University of California San Francisco	Martin-Belmonte, F (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	fernando.martin-belmonte@ucsf.edu	Gassama, Ama/M-8832-2017; Martin-Belmonte, Fernando/J-8029-2014	Martin-Belmonte, Fernando/0000-0002-2564-4430; mostov, keith/0000-0002-8123-6247	NIAID NIH HHS [P01 AI053194] Funding Source: Medline; NIDDK NIH HHS [R01 DK067153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Bayless KJ, 2002, J CELL SCI, V115, P1123; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hansen MDH, 2002, J BIOL CHEM, V277, P45371, DOI 10.1074/jbc.M207747200; Hansen MDH, 2001, CURR BIOL, V11, P356, DOI 10.1016/S0960-9822(01)00091-4; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kazmierczak BI, 2004, MOL BIOL CELL, V15, P411, DOI 10.1091/mbc.E03-08-0559; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lacalle RA, 2004, J CELL SCI, V117, P6207, DOI 10.1242/jcs.01545; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; VEGASALAS DE, 1987, J CELL BIOL, V104, P1249, DOI 10.1083/jcb.104.5.1249; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350	47	533	541	1	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					383	397		10.1016/j.cell.2006.11.051	http://dx.doi.org/10.1016/j.cell.2006.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254974	Bronze, Green Accepted			2022-12-24	WOS:000244420500021
J	Kobasa, D; Jones, SM; Shinya, K; Kash, JC; Copps, J; Ebihara, H; Hatta, Y; Kim, JH; Halfmann, P; Hatta, M; Feldmann, F; Alimonti, JB; Fernando, L; Li, Y; Katze, MG; Feldmann, H; Kawaoka, Y				Kobasa, Darwyn; Jones, Steven M.; Shinya, Kyoko; Kash, John C.; Copps, John; Ebihara, Hideki; Hatta, Yasuko; Kim, Jin Hyun; Halfmann, Peter; Hatta, Masato; Feldmann, Friederike; Alimonti, Judie B.; Fernando, Lisa; Li, Yan; Katze, Michael G.; Feldmann, Heinz; Kawaoka, Yoshihiro			Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus	NATURE			English	Article							A VIRUSES; HEMAGGLUTININ; EXPRESSION; DISEASE; ORIGIN; GENES; ROLES	The 1918 influenza pandemic was unusually severe, resulting in about 50 million deaths worldwide(1). The 1918 virus is also highly pathogenic in mice, and studies have identified a multigenic origin of this virulent phenotype in mice(2-4). However, these initial characterizations of the 1918 virus did not address the question of its pathogenic potential in primates. Here we demonstrate that the 1918 virus caused a highly pathogenic respiratory infection in a cynomolgus macaque model that culminated in acute respiratory distress and a fatal outcome. Furthermore, infected animals mounted an immune response, characterized by dysregulation of the antiviral response, that was insufficient for protection, indicating that atypical host innate immune responses may contribute to lethality. The ability of influenza viruses to modulate host immune responses, such as that demonstrated for the avian H5N1 influenza viruses(5), may be a feature shared by the virulent influenza viruses.	Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Publ Hlth Agcy Canada, Special Pathogens Program Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 3R2, Canada; Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808550, Japan; Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB R3E 3M4, Canada; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3220012, Japan; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; Public Health Agency of Canada; University of Manitoba; University of Manitoba; Tottori University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Canadian Food Inspection Agency; Canadian Science Centre for Human & Animal Health; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019; Kash, John/ABE-8280-2021	Ebihara, Hideki/0000-0002-2576-9735				Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Reid AH, 2002, J VIROL, V76, P10717, DOI 10.1128/JVI.76.21.10717-10723.2002; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Winternitz MC, 1920, PATHOLOGY INFLUENZA	30	730	768	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					319	323		10.1038/nature05495	http://dx.doi.org/10.1038/nature05495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17230189				2022-12-24	WOS:000243504700046
J	Kim, PM; Lu, LJ; Xia, Y; Gerstein, MB				Kim, Philip M.; Lu, Long J.; Xia, Yu; Gerstein, Mark B.			Relating three-dimensional structures to protein networks provides evolutionary insights	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; NUMBER; MODULARITY; DEPENDENCE; DATABASE; BIOLOGY; GENOME	Most studies of protein networks operate on a high level of abstraction, neglecting structural and chemical aspects of each interaction. Here, we characterize interactions by using atomic-resolution information from three-dimensional protein structures. We find that some previously recognized relationships between network topology and genomic features ( e. g., hubs tending to be essential proteins) are actually more reflective of a structural quantity, the number of distinct binding interfaces. Subdividing hubs with respect to this quantity provides insight into their evolutionary rate and indicates that additional mechanisms of network growth are active in evolution ( beyond effective preferential attachment through gene duplication).	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; Boston Univ, Dept Chem, Boston, MA 02215 USA	Yale University; Yale University; Yale University; Boston University	Gerstein, MB (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.gerstein@yale.edu	lu, lu/HGA-0894-2022; Xia, Yu/W-6150-2019; lu, lu/HII-7530-2022	Xia, Yu/0000-0002-5596-5518; 	NCRR NIH HHS [RR19895] Funding Source: Medline; NHLBI NIH HHS [N01-HV-28186] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Espadaler J, 2005, P NATL ACAD SCI USA, V102, P7151, DOI 10.1073/pnas.0500831102; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-13; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIM PM, 2003, THESIS MIT CAMBRIDGE, P1; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, PROTEINS, V42, P108; VAZQUEZ A, 2003, PHYS REV E, V67; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204	30	380	383	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1938	1941		10.1126/science.1136174	http://dx.doi.org/10.1126/science.1136174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185604				2022-12-24	WOS:000242996800053
J	Liu, ZP; Neff, RA; Berg, DK				Liu, Zhaoping; Neff, Robert A.; Berg, Darwin K.			Sequential interplay of nicotinic and GABAergic signaling guides neuronal development	SCIENCE			English	Article							CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTOR; GABA; INTERNEURONS; HIPPOCAMPUS; CIRCUITS; CULTURE; MICE; DIFFERENTIATION; EXPRESSION	GABA (gamma-aminobutyric acid), the major inhibitory transmitter in the brain, goes through a transitory phase of excitation during development. The excitatory phase promotes neuronal growth and integration into circuits. We show here that spontaneous nicotinic cholinergic activity is responsible for terminating GABAergic excitation and initiating inhibition. It does so by changing chloride transporter levels, shifting the driving force on GABA-induced currents. The timing of the transition is critical, because the two phases of GABAergic signaling provide contrasting developmental instructions. Synergistic with nicotinic excitation, GABAergic inhibition constrains neuronal morphology and innervation. The results reveal a multitiered activity-dependent strategy controlling neuronal development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dberg@ucsd.edu	liu, zhao/GXV-6141-2022	Neff, Robert/0000-0002-7550-4348	NINDS NIH HHS [NS035469, NS012601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035469, R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; Alkondon M, 1999, J NEUROSCI, V19, P2693; Bansal A, 2000, J NEUROSCI, V20, P7672; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chen M, 2001, J NEUROBIOL, V47, P265, DOI 10.1002/neu.1034; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCEACHERN AE, 1985, J NEUROSCI, V5, P2690; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	28	171	177	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1610	1613		10.1126/science.1134246	http://dx.doi.org/10.1126/science.1134246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158331				2022-12-24	WOS:000242624600046
J	Siripala, AD; Welch, MD				Siripala, Anosha D.; Welch, Matthew D.			SnapShot: Actin regulators II	CELL			English	Editorial Material														Siripala, Anosha/0000-0003-4073-9195	NIGMS NIH HHS [R01 GM059609, R01 GM059609-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					1014	1014		10.1016/j.cell.2007.02.021	http://dx.doi.org/10.1016/j.cell.2007.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350583	Bronze			2022-12-24	WOS:000245073400023
